Last active
August 19, 2021 13:58
-
-
Save minwoopak/ad8a3d1b36e233c50e70d53c96a58c30 to your computer and use it in GitHub Desktop.
210819_ALPACA_v6
This file has been truncated, but you can view the full file.
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
| symbol location kegg exprs | |
| A1BG Extracellular space Summary 2.2901439787779974 | |
| A2M Extracellular space Complement and coagulation cascades 2.698718542339477 | |
| A2ML1 Extracellular space Summary 2.186132512127215 | |
| AAAS Cytoskeleton RNA transport 1.8528998484948849 | |
| AAAS Cytosol RNA transport 1.8528998484948849 | |
| AAAS Nucleus RNA transport 1.8528998484948849 | |
| AACS Cytosol Summary 0.6476449198836426 | |
| AADAT Cytosol Summary 1.4419559318834678 | |
| AADAT Mitochondrion Summary 1.4419559318834678 | |
| AADAT Plasma membrane Summary 1.4419559318834678 | |
| AAGAB Cytosol Summary 0.7066709403787654 | |
| AAGAB Nucleus Summary 0.7066709403787654 | |
| AAK1 Cytosol Summary 1.1086611359307923 | |
| AAK1 Plasma membrane Summary 1.1086611359307923 | |
| AAMDC Cytosol Summary 1.315565681716281 | |
| AAMDC Nucleus Summary 1.315565681716281 | |
| AAMP Cytoskeleton Summary 1.0286518097820183 | |
| AAMP Cytosol Summary 1.0286518097820183 | |
| AAMP Plasma membrane Summary 1.0286518097820183 | |
| AAR2 Cytosol Summary 1.6852628502322553 | |
| AARS Cytosol Summary 1.6186937925924536 | |
| AARS2 Mitochondrion Aminoacyl-tRNA biosynthesis 1.3912528495722944 | |
| AARSD1 Cytosol Summary 0.8859029221753238 | |
| AARSD1 Nucleus Summary 0.8859029221753238 | |
| AASDHPPT Cytosol Summary 1.4593118722448064 | |
| AASDHPPT Mitochondrion Summary 1.4593118722448064 | |
| AASS Cytosol Summary 1.1271588103521466 | |
| AASS Mitochondrion Summary 1.1271588103521466 | |
| AATF Cytoskeleton Summary 2.2909861546906334 | |
| AATF Nucleus Summary 2.2909861546906334 | |
| ABAT Mitochondrion Alanine aspartate and glutamate metabolism 0.07921678421557514 | |
| ABAT Mitochondrion Butanoate metabolism 0.07921678421557514 | |
| ABAT Mitochondrion GABAergic synapse 0.07921678421557514 | |
| ABAT Mitochondrion Metabolic pathways 0.07921678421557514 | |
| ABAT Mitochondrion Propanoate metabolism 0.07921678421557514 | |
| ABAT Mitochondrion Valine leucine and isoleucine degradation 0.07921678421557514 | |
| ABAT Mitochondrion beta-Alanine metabolism 0.07921678421557514 | |
| ABCA1 Cytosol Summary 1.5875424625564838 | |
| ABCA1 Nucleus Summary 1.5875424625564838 | |
| ABCA1 Plasma membrane Summary 1.5875424625564838 | |
| ABCA12 Cytosol Summary 0.8520443768775294 | |
| ABCA12 Nucleus Summary 0.8520443768775294 | |
| ABCA12 Plasma membrane Summary 0.8520443768775294 | |
| ABCA13 Cytoskeleton Summary 0.5914425109123285 | |
| ABCA13 Cytosol Summary 0.5914425109123285 | |
| ABCA2 Endosome ABC transporters 1.5385067756511426 | |
| ABCA2 Endosome Lysosome 1.5385067756511426 | |
| ABCA2 Lysosome ABC transporters 1.5385067756511426 | |
| ABCA2 Lysosome Lysosome 1.5385067756511426 | |
| ABCA3 Cytosol ABC transporters 0.8657083524601812 | |
| ABCA3 Endosome ABC transporters 0.8657083524601812 | |
| ABCA3 Nucleus ABC transporters 0.8657083524601812 | |
| ABCA3 Plasma membrane ABC transporters 0.8657083524601812 | |
| ABCA6 Golgi apparatus Summary 0.9086892427567588 | |
| ABCA6 Nucleus Summary 0.9086892427567588 | |
| ABCA8 Cytosol ABC transporters 1.222879357331326 | |
| ABCA8 Nucleus ABC transporters 1.222879357331326 | |
| ABCA8 Plasma membrane ABC transporters 1.222879357331326 | |
| ABCB1 Nucleus ABC transporters 0.1737050475088678 | |
| ABCB1 Nucleus Bile secretion 0.1737050475088678 | |
| ABCB1 Nucleus Gastric cancer 0.1737050475088678 | |
| ABCB1 Nucleus MicroRNAs in cancer 0.1737050475088678 | |
| ABCB1 Plasma membrane ABC transporters 0.1737050475088678 | |
| ABCB1 Plasma membrane Bile secretion 0.1737050475088678 | |
| ABCB1 Plasma membrane Gastric cancer 0.1737050475088678 | |
| ABCB1 Plasma membrane MicroRNAs in cancer 0.1737050475088678 | |
| ABCB10 Mitochondrion ABC transporters 1.7642182171256264 | |
| ABCB5 Plasma membrane ABC transporters 1.264353274147699 | |
| ABCB6 Cytosol ABC transporters 1.3374763910451355 | |
| ABCB6 Endoplasmic Reticulum ABC transporters 1.3374763910451355 | |
| ABCB6 Golgi apparatus ABC transporters 1.3374763910451355 | |
| ABCB6 Mitochondrion ABC transporters 1.3374763910451355 | |
| ABCB6 Nucleus ABC transporters 1.3374763910451355 | |
| ABCB6 Plasma membrane ABC transporters 1.3374763910451355 | |
| ABCB7 Mitochondrion ABC transporters 0.8981218652177916 | |
| ABCB8 Endoplasmic Reticulum ABC transporters 0.9446556747570308 | |
| ABCB8 Mitochondrion ABC transporters 0.9446556747570308 | |
| ABCB8 Nucleus ABC transporters 0.9446556747570308 | |
| ABCC1 Plasma membrane ABC transporters 1.341445460803939 | |
| ABCC1 Plasma membrane Antifolate resistance 1.341445460803939 | |
| ABCC1 Plasma membrane MicroRNAs in cancer 1.341445460803939 | |
| ABCC1 Plasma membrane Sphingolipid signaling pathway 1.341445460803939 | |
| ABCC1 Plasma membrane Vitamin digestion and absorption 1.341445460803939 | |
| ABCC10 Plasma membrane ABC transporters 0.9908856424859616 | |
| ABCC11 Plasma membrane Summary 0.13948543361692045 | |
| ABCC3 Plasma membrane Summary 0.4513485096009032 | |
| ABCC4 Golgi apparatus Summary 1.809163103198544 | |
| ABCC4 Nucleus Summary 1.809163103198544 | |
| ABCC4 Plasma membrane Summary 1.809163103198544 | |
| ABCC5 Nucleus Summary 0.7255169856808222 | |
| ABCC5 Plasma membrane Summary 0.7255169856808222 | |
| ABCD1 Cytosol ABC transporters 1.7902438142737698 | |
| ABCD1 Cytosol Peroxisome 1.7902438142737698 | |
| ABCD1 Peroxisome ABC transporters 1.7902438142737698 | |
| ABCD1 Peroxisome Peroxisome 1.7902438142737698 | |
| ABCD3 Cytosol ABC transporters 0.2513928719739253 | |
| ABCD3 Cytosol Peroxisome 0.2513928719739253 | |
| ABCD3 Peroxisome ABC transporters 0.2513928719739253 | |
| ABCD3 Peroxisome Peroxisome 0.2513928719739253 | |
| ABCE1 Cytosol Summary 1.8859829959651104 | |
| ABCE1 Mitochondrion Summary 1.8859829959651104 | |
| ABCF1 Cytosol Summary 1.8543854745096475 | |
| ABCF1 Nucleus Summary 1.8543854745096475 | |
| ABCF2 Cytosol Summary 2.046928721158559 | |
| ABCF3 Cytosol Summary 1.2347125362089646 | |
| ABCF3 Nucleus Summary 1.2347125362089646 | |
| ABCG1 Cytosol ABC transporters 0.4065409037619414 | |
| ABCG1 Cytosol Lipid and atherosclerosis 0.4065409037619414 | |
| ABCG1 Endoplasmic Reticulum ABC transporters 0.4065409037619414 | |
| ABCG1 Endoplasmic Reticulum Lipid and atherosclerosis 0.4065409037619414 | |
| ABCG1 Golgi apparatus ABC transporters 0.4065409037619414 | |
| ABCG1 Golgi apparatus Lipid and atherosclerosis 0.4065409037619414 | |
| ABCG1 Mitochondrion ABC transporters 0.4065409037619414 | |
| ABCG1 Mitochondrion Lipid and atherosclerosis 0.4065409037619414 | |
| ABHD10 Mitochondrion Summary 1.249339001461577 | |
| ABHD11 Mitochondrion Summary 1.060115379426019 | |
| ABHD12 Endoplasmic Reticulum Summary 0.3124776783863997 | |
| ABHD13 Cytosol Summary 1.4080172933769683 | |
| ABHD14B Cytosol Summary 0.5437231713783743 | |
| ABHD14B Nucleus Summary 0.5437231713783743 | |
| ABHD17A Cytosol Summary 0.8051868596325229 | |
| ABHD17A Nucleus Summary 0.8051868596325229 | |
| ABHD17A Plasma membrane Summary 0.8051868596325229 | |
| ABHD17B Plasma membrane Summary 1.2152833437626682 | |
| ABHD17C Endosome Summary 0.6080079771446787 | |
| ABHD3 Cytosol Summary 0.3602816716450494 | |
| ABHD3 Nucleus Summary 0.3602816716450494 | |
| ABHD3 Plasma membrane Summary 0.3602816716450494 | |
| ABHD4 Nucleus Summary 1.2430938718493716 | |
| ABHD5 Cytosol Summary 1.7963137031540828 | |
| ABHD5 Nucleus Summary 1.7963137031540828 | |
| ABHD6 Cytosol Summary 0.9008726739064868 | |
| ABHD6 Endosome Summary 0.9008726739064868 | |
| ABHD6 Nucleus Summary 0.9008726739064868 | |
| ABI1 Cytosol Summary 1.9280188388969484 | |
| ABI1 Plasma membrane Summary 1.9280188388969484 | |
| ABI2 Cytosol Summary 1.1663001052026536 | |
| ABI2 Nucleus Summary 1.1663001052026536 | |
| ABI3 Cytosol Summary 1.9439105657056965 | |
| ABI3BP Nucleus Summary 0.8226046690889743 | |
| ABL1 Cytoskeleton Axon guidance 0.9543802670379359 | |
| ABL1 Cytoskeleton Cell cycle 0.9543802670379359 | |
| ABL1 Cytoskeleton Chronic myeloid leukemia 0.9543802670379359 | |
| ABL1 Cytoskeleton ErbB signaling pathway 0.9543802670379359 | |
| ABL1 Cytoskeleton MicroRNAs in cancer 0.9543802670379359 | |
| ABL1 Cytoskeleton Neurotrophin signaling pathway 0.9543802670379359 | |
| ABL1 Cytoskeleton Pathogenic Escherichia coli infection 0.9543802670379359 | |
| ABL1 Cytoskeleton Pathways in cancer 0.9543802670379359 | |
| ABL1 Cytoskeleton Ras signaling pathway 0.9543802670379359 | |
| ABL1 Cytoskeleton Viral myocarditis 0.9543802670379359 | |
| ABL1 Nucleus Axon guidance 0.9543802670379359 | |
| ABL1 Nucleus Cell cycle 0.9543802670379359 | |
| ABL1 Nucleus Chronic myeloid leukemia 0.9543802670379359 | |
| ABL1 Nucleus ErbB signaling pathway 0.9543802670379359 | |
| ABL1 Nucleus MicroRNAs in cancer 0.9543802670379359 | |
| ABL1 Nucleus Neurotrophin signaling pathway 0.9543802670379359 | |
| ABL1 Nucleus Pathogenic Escherichia coli infection 0.9543802670379359 | |
| ABL1 Nucleus Pathways in cancer 0.9543802670379359 | |
| ABL1 Nucleus Ras signaling pathway 0.9543802670379359 | |
| ABL1 Nucleus Viral myocarditis 0.9543802670379359 | |
| ABLIM1 Cytosol Summary 1.3348070138350123 | |
| ABLIM2 Cytoskeleton Axon guidance 1.1141579175093297 | |
| ABLIM2 Cytosol Axon guidance 1.1141579175093297 | |
| ABLIM2 Mitochondrion Axon guidance 1.1141579175093297 | |
| ABLIM2 Nucleus Axon guidance 1.1141579175093297 | |
| ABLIM3 Cytosol Summary 0.32255205916320223 | |
| ABLIM3 Nucleus Summary 0.32255205916320223 | |
| ABLIM3 Plasma membrane Summary 0.32255205916320223 | |
| ABR Cytosol Summary 1.7273395962836222 | |
| ABR Nucleus Summary 1.7273395962836222 | |
| ABRACL Cytosol Summary 1.877051211500149 | |
| ABRACL Nucleus Summary 1.877051211500149 | |
| ABT1 Cytosol Summary 2.3926379835467357 | |
| ABT1 Nucleus Summary 2.3926379835467357 | |
| ABTB1 Cytosol Summary 1.1257979753742753 | |
| ABTB1 Nucleus Summary 1.1257979753742753 | |
| ABTB2 Cytosol Summary 2.1878564202287114 | |
| ABTB2 Nucleus Summary 2.1878564202287114 | |
| ACAA1 Peroxisome Biosynthesis of unsaturated fatty acids 0.9726177165113028 | |
| ACAA1 Peroxisome Fatty acid degradation 0.9726177165113028 | |
| ACAA1 Peroxisome Fatty acid metabolism 0.9726177165113028 | |
| ACAA1 Peroxisome Metabolic pathways 0.9726177165113028 | |
| ACAA1 Peroxisome PPAR signaling pathway 0.9726177165113028 | |
| ACAA1 Peroxisome Peroxisome 0.9726177165113028 | |
| ACAA1 Peroxisome Valine leucine and isoleucine degradation 0.9726177165113028 | |
| ACAA1 Peroxisome alpha-Linolenic acid metabolism 0.9726177165113028 | |
| ACAA2 Mitochondrion Fatty acid degradation 2.457021632556481 | |
| ACAA2 Mitochondrion Fatty acid elongation 2.457021632556481 | |
| ACAA2 Mitochondrion Fatty acid metabolism 2.457021632556481 | |
| ACAA2 Mitochondrion Metabolic pathways 2.457021632556481 | |
| ACAA2 Mitochondrion Valine leucine and isoleucine degradation 2.457021632556481 | |
| ACACA Cytoskeleton Summary 0.4689746546708986 | |
| ACACA Cytosol Summary 0.4689746546708986 | |
| ACACA Nucleus Summary 0.4689746546708986 | |
| ACACB Mitochondrion Summary 0.9884358716958956 | |
| ACAD10 Mitochondrion Summary 1.3641329577619714 | |
| ACAD11 Mitochondrion Summary 1.382153761532054 | |
| ACAD11 Nucleus Summary 1.382153761532054 | |
| ACAD11 Peroxisome Summary 1.382153761532054 | |
| ACAD8 Mitochondrion Metabolic pathways 0.9454855454282676 | |
| ACAD8 Mitochondrion Valine leucine and isoleucine degradation 0.9454855454282676 | |
| ACAD9 Mitochondrion Summary 1.7220090303789328 | |
| ACAD9 Nucleus Summary 1.7220090303789328 | |
| ACADL Mitochondrion Fatty acid degradation 1.4582367212650331 | |
| ACADL Mitochondrion Fatty acid metabolism 1.4582367212650331 | |
| ACADL Mitochondrion Metabolic pathways 1.4582367212650331 | |
| ACADL Mitochondrion PPAR signaling pathway 1.4582367212650331 | |
| ACADM Mitochondrion Fatty acid degradation 1.0053935678398156 | |
| ACADM Mitochondrion Fatty acid metabolism 1.0053935678398156 | |
| ACADM Mitochondrion Metabolic pathways 1.0053935678398156 | |
| ACADM Mitochondrion PPAR signaling pathway 1.0053935678398156 | |
| ACADM Mitochondrion Valine leucine and isoleucine degradation 1.0053935678398156 | |
| ACADS Cytoskeleton Butanoate metabolism 1.3801489356872898 | |
| ACADS Cytoskeleton Carbon metabolism 1.3801489356872898 | |
| ACADS Cytoskeleton Fatty acid degradation 1.3801489356872898 | |
| ACADS Cytoskeleton Fatty acid metabolism 1.3801489356872898 | |
| ACADS Cytoskeleton Metabolic pathways 1.3801489356872898 | |
| ACADS Cytoskeleton Propanoate metabolism 1.3801489356872898 | |
| ACADS Cytoskeleton Valine leucine and isoleucine degradation 1.3801489356872898 | |
| ACADS Cytoskeleton beta-Alanine metabolism 1.3801489356872898 | |
| ACADS Mitochondrion Butanoate metabolism 1.3801489356872898 | |
| ACADS Mitochondrion Carbon metabolism 1.3801489356872898 | |
| ACADS Mitochondrion Fatty acid degradation 1.3801489356872898 | |
| ACADS Mitochondrion Fatty acid metabolism 1.3801489356872898 | |
| ACADS Mitochondrion Metabolic pathways 1.3801489356872898 | |
| ACADS Mitochondrion Propanoate metabolism 1.3801489356872898 | |
| ACADS Mitochondrion Valine leucine and isoleucine degradation 1.3801489356872898 | |
| ACADS Mitochondrion beta-Alanine metabolism 1.3801489356872898 | |
| ACADS Nucleus Butanoate metabolism 1.3801489356872898 | |
| ACADS Nucleus Carbon metabolism 1.3801489356872898 | |
| ACADS Nucleus Fatty acid degradation 1.3801489356872898 | |
| ACADS Nucleus Fatty acid metabolism 1.3801489356872898 | |
| ACADS Nucleus Metabolic pathways 1.3801489356872898 | |
| ACADS Nucleus Propanoate metabolism 1.3801489356872898 | |
| ACADS Nucleus Valine leucine and isoleucine degradation 1.3801489356872898 | |
| ACADS Nucleus beta-Alanine metabolism 1.3801489356872898 | |
| ACADSB Mitochondrion Fatty acid degradation 0.11096928412030417 | |
| ACADSB Mitochondrion Fatty acid metabolism 0.11096928412030417 | |
| ACADSB Mitochondrion Metabolic pathways 0.11096928412030417 | |
| ACADSB Mitochondrion Valine leucine and isoleucine degradation 0.11096928412030417 | |
| ACADVL Mitochondrion Fatty acid degradation 1.8424049266804696 | |
| ACADVL Mitochondrion Fatty acid metabolism 1.8424049266804696 | |
| ACADVL Mitochondrion Metabolic pathways 1.8424049266804696 | |
| ACADVL Nucleus Fatty acid degradation 1.8424049266804696 | |
| ACADVL Nucleus Fatty acid metabolism 1.8424049266804696 | |
| ACADVL Nucleus Metabolic pathways 1.8424049266804696 | |
| ACAN Extracellular space Summary 0.8648023189346854 | |
| ACAP1 Cytosol Summary 1.444611879922744 | |
| ACAP1 Endosome Summary 1.444611879922744 | |
| ACAP1 Golgi apparatus Summary 1.444611879922744 | |
| ACAP2 Endosome Summary 1.2594846979909533 | |
| ACAP3 Golgi apparatus Summary 0.9095215721317644 | |
| ACAP3 Nucleus Summary 0.9095215721317644 | |
| ACAT1 Mitochondrion Butanoate metabolism 1.2992140944903303 | |
| ACAT1 Mitochondrion Carbon metabolism 1.2992140944903303 | |
| ACAT1 Mitochondrion Cholesterol metabolism 1.2992140944903303 | |
| ACAT1 Mitochondrion Fat digestion and absorption 1.2992140944903303 | |
| ACAT1 Mitochondrion Fatty acid degradation 1.2992140944903303 | |
| ACAT1 Mitochondrion Fatty acid metabolism 1.2992140944903303 | |
| ACAT1 Mitochondrion Glyoxylate and dicarboxylate metabolism 1.2992140944903303 | |
| ACAT1 Mitochondrion Lysine degradation 1.2992140944903303 | |
| ACAT1 Mitochondrion Metabolic pathways 1.2992140944903303 | |
| ACAT1 Mitochondrion Propanoate metabolism 1.2992140944903303 | |
| ACAT1 Mitochondrion Pyruvate metabolism 1.2992140944903303 | |
| ACAT1 Mitochondrion Steroid biosynthesis 1.2992140944903303 | |
| ACAT1 Mitochondrion Synthesis and degradation of ketone bodies 1.2992140944903303 | |
| ACAT1 Mitochondrion Terpenoid backbone biosynthesis 1.2992140944903303 | |
| ACAT1 Mitochondrion Tryptophan metabolism 1.2992140944903303 | |
| ACAT1 Mitochondrion Valine leucine and isoleucine degradation 1.2992140944903303 | |
| ACAT2 Cytosol Summary 1.3454881882808707 | |
| ACAT2 Nucleus Summary 1.3454881882808707 | |
| ACBD3 Golgi apparatus Salmonella infection 1.1410010344727746 | |
| ACBD5 Peroxisome Summary 0.8608732044810772 | |
| ACBD6 Cytosol Summary 1.5109306035506842 | |
| ACBD6 Nucleus Summary 1.5109306035506842 | |
| ACBD7 Cytosol Summary 2.066671065912596 | |
| ACCS Golgi apparatus Summary 0.9046695295452656 | |
| ACD Endoplasmic Reticulum Summary 1.750172284420985 | |
| ACD Nucleus Summary 1.750172284420985 | |
| ACE Cytosol Chagas disease 0.505117828726865 | |
| ACE Cytosol Coronavirus disease - COVID-19 0.505117828726865 | |
| ACE Cytosol Diabetic cardiomyopathy 0.505117828726865 | |
| ACE Cytosol Hypertrophic cardiomyopathy 0.505117828726865 | |
| ACE Cytosol Renin secretion 0.505117828726865 | |
| ACE Cytosol Renin-angiotensin system 0.505117828726865 | |
| ACE Extracellular space Chagas disease 0.505117828726865 | |
| ACE Extracellular space Coronavirus disease - COVID-19 0.505117828726865 | |
| ACE Extracellular space Diabetic cardiomyopathy 0.505117828726865 | |
| ACE Extracellular space Hypertrophic cardiomyopathy 0.505117828726865 | |
| ACE Extracellular space Renin secretion 0.505117828726865 | |
| ACE Extracellular space Renin-angiotensin system 0.505117828726865 | |
| ACE Plasma membrane Chagas disease 0.505117828726865 | |
| ACE Plasma membrane Coronavirus disease - COVID-19 0.505117828726865 | |
| ACE Plasma membrane Diabetic cardiomyopathy 0.505117828726865 | |
| ACE Plasma membrane Hypertrophic cardiomyopathy 0.505117828726865 | |
| ACE Plasma membrane Renin secretion 0.505117828726865 | |
| ACE Plasma membrane Renin-angiotensin system 0.505117828726865 | |
| ACE2 Endoplasmic Reticulum Coronavirus disease - COVID-19 0.10676300400492376 | |
| ACE2 Endoplasmic Reticulum Protein digestion and absorption 0.10676300400492376 | |
| ACE2 Endoplasmic Reticulum Renin-angiotensin system 0.10676300400492376 | |
| ACE2 Extracellular space Coronavirus disease - COVID-19 0.10676300400492376 | |
| ACE2 Extracellular space Protein digestion and absorption 0.10676300400492376 | |
| ACE2 Extracellular space Renin-angiotensin system 0.10676300400492376 | |
| ACE2 Plasma membrane Coronavirus disease - COVID-19 0.10676300400492376 | |
| ACE2 Plasma membrane Protein digestion and absorption 0.10676300400492376 | |
| ACE2 Plasma membrane Renin-angiotensin system 0.10676300400492376 | |
| ACIN1 Cytosol RNA transport 1.156304370395962 | |
| ACIN1 Cytosol Spliceosome 1.156304370395962 | |
| ACIN1 Cytosol mRNA surveillance pathway 1.156304370395962 | |
| ACIN1 Nucleus RNA transport 1.156304370395962 | |
| ACIN1 Nucleus Spliceosome 1.156304370395962 | |
| ACIN1 Nucleus mRNA surveillance pathway 1.156304370395962 | |
| ACIN1 Plasma membrane RNA transport 1.156304370395962 | |
| ACIN1 Plasma membrane Spliceosome 1.156304370395962 | |
| ACIN1 Plasma membrane mRNA surveillance pathway 1.156304370395962 | |
| ACLY Cytosol Summary 0.4145889321903986 | |
| ACLY Nucleus Summary 0.4145889321903986 | |
| ACLY Plasma membrane Summary 0.4145889321903986 | |
| ACO1 Cytosol 2-Oxocarboxylic acid metabolism 1.29255777412831 | |
| ACO1 Cytosol Biosynthesis of amino acids 1.29255777412831 | |
| ACO1 Cytosol Carbon metabolism 1.29255777412831 | |
| ACO1 Cytosol Citrate cycle (TCA cycle) 1.29255777412831 | |
| ACO1 Cytosol Glyoxylate and dicarboxylate metabolism 1.29255777412831 | |
| ACO1 Cytosol Metabolic pathways 1.29255777412831 | |
| ACO1 Endoplasmic Reticulum 2-Oxocarboxylic acid metabolism 1.29255777412831 | |
| ACO1 Endoplasmic Reticulum Biosynthesis of amino acids 1.29255777412831 | |
| ACO1 Endoplasmic Reticulum Carbon metabolism 1.29255777412831 | |
| ACO1 Endoplasmic Reticulum Citrate cycle (TCA cycle) 1.29255777412831 | |
| ACO1 Endoplasmic Reticulum Glyoxylate and dicarboxylate metabolism 1.29255777412831 | |
| ACO1 Endoplasmic Reticulum Metabolic pathways 1.29255777412831 | |
| ACO1 Golgi apparatus 2-Oxocarboxylic acid metabolism 1.29255777412831 | |
| ACO1 Golgi apparatus Biosynthesis of amino acids 1.29255777412831 | |
| ACO1 Golgi apparatus Carbon metabolism 1.29255777412831 | |
| ACO1 Golgi apparatus Citrate cycle (TCA cycle) 1.29255777412831 | |
| ACO1 Golgi apparatus Glyoxylate and dicarboxylate metabolism 1.29255777412831 | |
| ACO1 Golgi apparatus Metabolic pathways 1.29255777412831 | |
| ACO1 Mitochondrion 2-Oxocarboxylic acid metabolism 1.29255777412831 | |
| ACO1 Mitochondrion Biosynthesis of amino acids 1.29255777412831 | |
| ACO1 Mitochondrion Carbon metabolism 1.29255777412831 | |
| ACO1 Mitochondrion Citrate cycle (TCA cycle) 1.29255777412831 | |
| ACO1 Mitochondrion Glyoxylate and dicarboxylate metabolism 1.29255777412831 | |
| ACO1 Mitochondrion Metabolic pathways 1.29255777412831 | |
| ACO2 Mitochondrion Summary 1.6921568574752188 | |
| ACOT1 Cytosol Summary 0.8809537975442493 | |
| ACOT1 Mitochondrion Summary 0.8809537975442493 | |
| ACOT11 Cytosol Summary 1.669983645887571 | |
| ACOT11 Mitochondrion Summary 1.669983645887571 | |
| ACOT13 Cytosol Summary 1.841738249444893 | |
| ACOT13 Plasma membrane Summary 1.841738249444893 | |
| ACOT2 Mitochondrion Biosynthesis of unsaturated fatty acids 1.211139817115175 | |
| ACOT2 Mitochondrion Fatty acid elongation 1.211139817115175 | |
| ACOT2 Mitochondrion Metabolic pathways 1.211139817115175 | |
| ACOT2 Mitochondrion Ovarian steroidogenesis 1.211139817115175 | |
| ACOT4 Peroxisome Biosynthesis of unsaturated fatty acids 0.6467610067647732 | |
| ACOT4 Peroxisome Fatty acid elongation 0.6467610067647732 | |
| ACOT4 Peroxisome Metabolic pathways 0.6467610067647732 | |
| ACOT4 Peroxisome Ovarian steroidogenesis 0.6467610067647732 | |
| ACOT7 Cytosol Biosynthesis of unsaturated fatty acids 1.523052946707525 | |
| ACOT7 Cytosol Fatty acid elongation 1.523052946707525 | |
| ACOT7 Mitochondrion Biosynthesis of unsaturated fatty acids 1.523052946707525 | |
| ACOT7 Mitochondrion Fatty acid elongation 1.523052946707525 | |
| ACOT7 Nucleus Biosynthesis of unsaturated fatty acids 1.523052946707525 | |
| ACOT7 Nucleus Fatty acid elongation 1.523052946707525 | |
| ACOT8 Cytosol Metabolic pathways 1.287877239570829 | |
| ACOT8 Cytosol Peroxisome 1.287877239570829 | |
| ACOT8 Cytosol Primary bile acid biosynthesis 1.287877239570829 | |
| ACOT8 Mitochondrion Metabolic pathways 1.287877239570829 | |
| ACOT8 Mitochondrion Peroxisome 1.287877239570829 | |
| ACOT8 Mitochondrion Primary bile acid biosynthesis 1.287877239570829 | |
| ACOT8 Peroxisome Metabolic pathways 1.287877239570829 | |
| ACOT8 Peroxisome Peroxisome 1.287877239570829 | |
| ACOT8 Peroxisome Primary bile acid biosynthesis 1.287877239570829 | |
| ACOT9 Cytosol Summary 2.5541856666659664 | |
| ACOT9 Mitochondrion Summary 2.5541856666659664 | |
| ACOT9 Nucleus Summary 2.5541856666659664 | |
| ACOT9 Plasma membrane Summary 2.5541856666659664 | |
| ACOX1 Mitochondrion Biosynthesis of unsaturated fatty acids 2.0403144513176343 | |
| ACOX1 Mitochondrion Carbon metabolism 2.0403144513176343 | |
| ACOX1 Mitochondrion Fatty acid degradation 2.0403144513176343 | |
| ACOX1 Mitochondrion Fatty acid metabolism 2.0403144513176343 | |
| ACOX1 Mitochondrion Metabolic pathways 2.0403144513176343 | |
| ACOX1 Mitochondrion PPAR signaling pathway 2.0403144513176343 | |
| ACOX1 Mitochondrion Peroxisome 2.0403144513176343 | |
| ACOX1 Mitochondrion Propanoate metabolism 2.0403144513176343 | |
| ACOX1 Mitochondrion alpha-Linolenic acid metabolism 2.0403144513176343 | |
| ACOX1 Mitochondrion beta-Alanine metabolism 2.0403144513176343 | |
| ACOX1 Mitochondrion cAMP signaling pathway 2.0403144513176343 | |
| ACOX1 Nucleus Biosynthesis of unsaturated fatty acids 2.0403144513176343 | |
| ACOX1 Nucleus Carbon metabolism 2.0403144513176343 | |
| ACOX1 Nucleus Fatty acid degradation 2.0403144513176343 | |
| ACOX1 Nucleus Fatty acid metabolism 2.0403144513176343 | |
| ACOX1 Nucleus Metabolic pathways 2.0403144513176343 | |
| ACOX1 Nucleus PPAR signaling pathway 2.0403144513176343 | |
| ACOX1 Nucleus Peroxisome 2.0403144513176343 | |
| ACOX1 Nucleus Propanoate metabolism 2.0403144513176343 | |
| ACOX1 Nucleus alpha-Linolenic acid metabolism 2.0403144513176343 | |
| ACOX1 Nucleus beta-Alanine metabolism 2.0403144513176343 | |
| ACOX1 Nucleus cAMP signaling pathway 2.0403144513176343 | |
| ACOX1 Peroxisome Biosynthesis of unsaturated fatty acids 2.0403144513176343 | |
| ACOX1 Peroxisome Carbon metabolism 2.0403144513176343 | |
| ACOX1 Peroxisome Fatty acid degradation 2.0403144513176343 | |
| ACOX1 Peroxisome Fatty acid metabolism 2.0403144513176343 | |
| ACOX1 Peroxisome Metabolic pathways 2.0403144513176343 | |
| ACOX1 Peroxisome PPAR signaling pathway 2.0403144513176343 | |
| ACOX1 Peroxisome Peroxisome 2.0403144513176343 | |
| ACOX1 Peroxisome Propanoate metabolism 2.0403144513176343 | |
| ACOX1 Peroxisome alpha-Linolenic acid metabolism 2.0403144513176343 | |
| ACOX1 Peroxisome beta-Alanine metabolism 2.0403144513176343 | |
| ACOX1 Peroxisome cAMP signaling pathway 2.0403144513176343 | |
| ACOX3 Peroxisome Summary 0.6790772984778101 | |
| ACP1 Cytosol Adherens junction 1.717844379937291 | |
| ACP1 Cytosol Alzheimer disease 1.717844379937291 | |
| ACP1 Cytosol Amyotrophic lateral sclerosis 1.717844379937291 | |
| ACP1 Cytosol Diabetic cardiomyopathy 1.717844379937291 | |
| ACP1 Cytosol Huntington disease 1.717844379937291 | |
| ACP1 Cytosol Metabolic pathways 1.717844379937291 | |
| ACP1 Cytosol Non-alcoholic fatty liver disease 1.717844379937291 | |
| ACP1 Cytosol Oxidative phosphorylation 1.717844379937291 | |
| ACP1 Cytosol Parkinson disease 1.717844379937291 | |
| ACP1 Cytosol Pathways of neurodegeneration - multiple diseases 1.717844379937291 | |
| ACP1 Cytosol Prion disease 1.717844379937291 | |
| ACP1 Cytosol Retrograde endocannabinoid signaling 1.717844379937291 | |
| ACP1 Cytosol Riboflavin metabolism 1.717844379937291 | |
| ACP1 Cytosol Thermogenesis 1.717844379937291 | |
| ACP1 Cytosol Thiamine metabolism 1.717844379937291 | |
| ACP1 Nucleus Adherens junction 1.717844379937291 | |
| ACP1 Nucleus Alzheimer disease 1.717844379937291 | |
| ACP1 Nucleus Amyotrophic lateral sclerosis 1.717844379937291 | |
| ACP1 Nucleus Diabetic cardiomyopathy 1.717844379937291 | |
| ACP1 Nucleus Huntington disease 1.717844379937291 | |
| ACP1 Nucleus Metabolic pathways 1.717844379937291 | |
| ACP1 Nucleus Non-alcoholic fatty liver disease 1.717844379937291 | |
| ACP1 Nucleus Oxidative phosphorylation 1.717844379937291 | |
| ACP1 Nucleus Parkinson disease 1.717844379937291 | |
| ACP1 Nucleus Pathways of neurodegeneration - multiple diseases 1.717844379937291 | |
| ACP1 Nucleus Prion disease 1.717844379937291 | |
| ACP1 Nucleus Retrograde endocannabinoid signaling 1.717844379937291 | |
| ACP1 Nucleus Riboflavin metabolism 1.717844379937291 | |
| ACP1 Nucleus Thermogenesis 1.717844379937291 | |
| ACP1 Nucleus Thiamine metabolism 1.717844379937291 | |
| ACP1 Plasma membrane Adherens junction 1.717844379937291 | |
| ACP1 Plasma membrane Alzheimer disease 1.717844379937291 | |
| ACP1 Plasma membrane Amyotrophic lateral sclerosis 1.717844379937291 | |
| ACP1 Plasma membrane Diabetic cardiomyopathy 1.717844379937291 | |
| ACP1 Plasma membrane Huntington disease 1.717844379937291 | |
| ACP1 Plasma membrane Metabolic pathways 1.717844379937291 | |
| ACP1 Plasma membrane Non-alcoholic fatty liver disease 1.717844379937291 | |
| ACP1 Plasma membrane Oxidative phosphorylation 1.717844379937291 | |
| ACP1 Plasma membrane Parkinson disease 1.717844379937291 | |
| ACP1 Plasma membrane Pathways of neurodegeneration - multiple diseases 1.717844379937291 | |
| ACP1 Plasma membrane Prion disease 1.717844379937291 | |
| ACP1 Plasma membrane Retrograde endocannabinoid signaling 1.717844379937291 | |
| ACP1 Plasma membrane Riboflavin metabolism 1.717844379937291 | |
| ACP1 Plasma membrane Thermogenesis 1.717844379937291 | |
| ACP1 Plasma membrane Thiamine metabolism 1.717844379937291 | |
| ACP2 Lysosome Lysosome 1.1957583350063203 | |
| ACP2 Lysosome Metabolic pathways 1.1957583350063203 | |
| ACP2 Lysosome Riboflavin metabolism 1.1957583350063203 | |
| ACP5 Cytosol Lysosome 1.4238507040015451 | |
| ACP5 Cytosol Metabolic pathways 1.4238507040015451 | |
| ACP5 Cytosol Osteoclast differentiation 1.4238507040015451 | |
| ACP5 Cytosol Rheumatoid arthritis 1.4238507040015451 | |
| ACP5 Cytosol Riboflavin metabolism 1.4238507040015451 | |
| ACP5 Lysosome Lysosome 1.4238507040015451 | |
| ACP5 Lysosome Metabolic pathways 1.4238507040015451 | |
| ACP5 Lysosome Osteoclast differentiation 1.4238507040015451 | |
| ACP5 Lysosome Rheumatoid arthritis 1.4238507040015451 | |
| ACP5 Lysosome Riboflavin metabolism 1.4238507040015451 | |
| ACP6 Mitochondrion Summary 1.2049780408462811 | |
| ACSF2 Cytoskeleton Summary 0.3796522517546794 | |
| ACSF2 Cytosol Summary 0.3796522517546794 | |
| ACSF2 Mitochondrion Summary 0.3796522517546794 | |
| ACSF2 Nucleus Summary 0.3796522517546794 | |
| ACSF3 Mitochondrion Fatty acid biosynthesis 0.7928597143734561 | |
| ACSF3 Mitochondrion Fatty acid metabolism 0.7928597143734561 | |
| ACSF3 Mitochondrion Metabolic pathways 0.7928597143734561 | |
| ACSF3 Mitochondrion Valine leucine and isoleucine degradation 0.7928597143734561 | |
| ACSL1 Cytosol Adipocytokine signaling pathway 1.6575347971513388 | |
| ACSL1 Cytosol Fatty acid biosynthesis 1.6575347971513388 | |
| ACSL1 Cytosol Fatty acid degradation 1.6575347971513388 | |
| ACSL1 Cytosol Fatty acid metabolism 1.6575347971513388 | |
| ACSL1 Cytosol Ferroptosis 1.6575347971513388 | |
| ACSL1 Cytosol Metabolic pathways 1.6575347971513388 | |
| ACSL1 Cytosol PPAR signaling pathway 1.6575347971513388 | |
| ACSL1 Cytosol Peroxisome 1.6575347971513388 | |
| ACSL1 Cytosol Thermogenesis 1.6575347971513388 | |
| ACSL1 Endoplasmic Reticulum Adipocytokine signaling pathway 1.6575347971513388 | |
| ACSL1 Endoplasmic Reticulum Fatty acid biosynthesis 1.6575347971513388 | |
| ACSL1 Endoplasmic Reticulum Fatty acid degradation 1.6575347971513388 | |
| ACSL1 Endoplasmic Reticulum Fatty acid metabolism 1.6575347971513388 | |
| ACSL1 Endoplasmic Reticulum Ferroptosis 1.6575347971513388 | |
| ACSL1 Endoplasmic Reticulum Metabolic pathways 1.6575347971513388 | |
| ACSL1 Endoplasmic Reticulum PPAR signaling pathway 1.6575347971513388 | |
| ACSL1 Endoplasmic Reticulum Peroxisome 1.6575347971513388 | |
| ACSL1 Endoplasmic Reticulum Thermogenesis 1.6575347971513388 | |
| ACSL1 Mitochondrion Adipocytokine signaling pathway 1.6575347971513388 | |
| ACSL1 Mitochondrion Fatty acid biosynthesis 1.6575347971513388 | |
| ACSL1 Mitochondrion Fatty acid degradation 1.6575347971513388 | |
| ACSL1 Mitochondrion Fatty acid metabolism 1.6575347971513388 | |
| ACSL1 Mitochondrion Ferroptosis 1.6575347971513388 | |
| ACSL1 Mitochondrion Metabolic pathways 1.6575347971513388 | |
| ACSL1 Mitochondrion PPAR signaling pathway 1.6575347971513388 | |
| ACSL1 Mitochondrion Peroxisome 1.6575347971513388 | |
| ACSL1 Mitochondrion Thermogenesis 1.6575347971513388 | |
| ACSL1 Nucleus Adipocytokine signaling pathway 1.6575347971513388 | |
| ACSL1 Nucleus Fatty acid biosynthesis 1.6575347971513388 | |
| ACSL1 Nucleus Fatty acid degradation 1.6575347971513388 | |
| ACSL1 Nucleus Fatty acid metabolism 1.6575347971513388 | |
| ACSL1 Nucleus Ferroptosis 1.6575347971513388 | |
| ACSL1 Nucleus Metabolic pathways 1.6575347971513388 | |
| ACSL1 Nucleus PPAR signaling pathway 1.6575347971513388 | |
| ACSL1 Nucleus Peroxisome 1.6575347971513388 | |
| ACSL1 Nucleus Thermogenesis 1.6575347971513388 | |
| ACSL1 Peroxisome Adipocytokine signaling pathway 1.6575347971513388 | |
| ACSL1 Peroxisome Fatty acid biosynthesis 1.6575347971513388 | |
| ACSL1 Peroxisome Fatty acid degradation 1.6575347971513388 | |
| ACSL1 Peroxisome Fatty acid metabolism 1.6575347971513388 | |
| ACSL1 Peroxisome Ferroptosis 1.6575347971513388 | |
| ACSL1 Peroxisome Metabolic pathways 1.6575347971513388 | |
| ACSL1 Peroxisome PPAR signaling pathway 1.6575347971513388 | |
| ACSL1 Peroxisome Peroxisome 1.6575347971513388 | |
| ACSL1 Peroxisome Thermogenesis 1.6575347971513388 | |
| ACSL3 Endoplasmic Reticulum Adipocytokine signaling pathway 0.6937847065813949 | |
| ACSL3 Endoplasmic Reticulum Fatty acid biosynthesis 0.6937847065813949 | |
| ACSL3 Endoplasmic Reticulum Fatty acid degradation 0.6937847065813949 | |
| ACSL3 Endoplasmic Reticulum Fatty acid metabolism 0.6937847065813949 | |
| ACSL3 Endoplasmic Reticulum Ferroptosis 0.6937847065813949 | |
| ACSL3 Endoplasmic Reticulum Metabolic pathways 0.6937847065813949 | |
| ACSL3 Endoplasmic Reticulum PPAR signaling pathway 0.6937847065813949 | |
| ACSL3 Endoplasmic Reticulum Peroxisome 0.6937847065813949 | |
| ACSL3 Endoplasmic Reticulum Thermogenesis 0.6937847065813949 | |
| ACSL3 Mitochondrion Adipocytokine signaling pathway 0.6937847065813949 | |
| ACSL3 Mitochondrion Fatty acid biosynthesis 0.6937847065813949 | |
| ACSL3 Mitochondrion Fatty acid degradation 0.6937847065813949 | |
| ACSL3 Mitochondrion Fatty acid metabolism 0.6937847065813949 | |
| ACSL3 Mitochondrion Ferroptosis 0.6937847065813949 | |
| ACSL3 Mitochondrion Metabolic pathways 0.6937847065813949 | |
| ACSL3 Mitochondrion PPAR signaling pathway 0.6937847065813949 | |
| ACSL3 Mitochondrion Peroxisome 0.6937847065813949 | |
| ACSL3 Mitochondrion Thermogenesis 0.6937847065813949 | |
| ACSL3 Nucleus Adipocytokine signaling pathway 0.6937847065813949 | |
| ACSL3 Nucleus Fatty acid biosynthesis 0.6937847065813949 | |
| ACSL3 Nucleus Fatty acid degradation 0.6937847065813949 | |
| ACSL3 Nucleus Fatty acid metabolism 0.6937847065813949 | |
| ACSL3 Nucleus Ferroptosis 0.6937847065813949 | |
| ACSL3 Nucleus Metabolic pathways 0.6937847065813949 | |
| ACSL3 Nucleus PPAR signaling pathway 0.6937847065813949 | |
| ACSL3 Nucleus Peroxisome 0.6937847065813949 | |
| ACSL3 Nucleus Thermogenesis 0.6937847065813949 | |
| ACSL3 Peroxisome Adipocytokine signaling pathway 0.6937847065813949 | |
| ACSL3 Peroxisome Fatty acid biosynthesis 0.6937847065813949 | |
| ACSL3 Peroxisome Fatty acid degradation 0.6937847065813949 | |
| ACSL3 Peroxisome Fatty acid metabolism 0.6937847065813949 | |
| ACSL3 Peroxisome Ferroptosis 0.6937847065813949 | |
| ACSL3 Peroxisome Metabolic pathways 0.6937847065813949 | |
| ACSL3 Peroxisome PPAR signaling pathway 0.6937847065813949 | |
| ACSL3 Peroxisome Peroxisome 0.6937847065813949 | |
| ACSL3 Peroxisome Thermogenesis 0.6937847065813949 | |
| ACSL4 Endoplasmic Reticulum Adipocytokine signaling pathway 2.3899896690194016 | |
| ACSL4 Endoplasmic Reticulum Fatty acid biosynthesis 2.3899896690194016 | |
| ACSL4 Endoplasmic Reticulum Fatty acid degradation 2.3899896690194016 | |
| ACSL4 Endoplasmic Reticulum Fatty acid metabolism 2.3899896690194016 | |
| ACSL4 Endoplasmic Reticulum Ferroptosis 2.3899896690194016 | |
| ACSL4 Endoplasmic Reticulum Metabolic pathways 2.3899896690194016 | |
| ACSL4 Endoplasmic Reticulum PPAR signaling pathway 2.3899896690194016 | |
| ACSL4 Endoplasmic Reticulum Peroxisome 2.3899896690194016 | |
| ACSL4 Endoplasmic Reticulum Thermogenesis 2.3899896690194016 | |
| ACSL4 Golgi apparatus Adipocytokine signaling pathway 2.3899896690194016 | |
| ACSL4 Golgi apparatus Fatty acid biosynthesis 2.3899896690194016 | |
| ACSL4 Golgi apparatus Fatty acid degradation 2.3899896690194016 | |
| ACSL4 Golgi apparatus Fatty acid metabolism 2.3899896690194016 | |
| ACSL4 Golgi apparatus Ferroptosis 2.3899896690194016 | |
| ACSL4 Golgi apparatus Metabolic pathways 2.3899896690194016 | |
| ACSL4 Golgi apparatus PPAR signaling pathway 2.3899896690194016 | |
| ACSL4 Golgi apparatus Peroxisome 2.3899896690194016 | |
| ACSL4 Golgi apparatus Thermogenesis 2.3899896690194016 | |
| ACSL4 Mitochondrion Adipocytokine signaling pathway 2.3899896690194016 | |
| ACSL4 Mitochondrion Fatty acid biosynthesis 2.3899896690194016 | |
| ACSL4 Mitochondrion Fatty acid degradation 2.3899896690194016 | |
| ACSL4 Mitochondrion Fatty acid metabolism 2.3899896690194016 | |
| ACSL4 Mitochondrion Ferroptosis 2.3899896690194016 | |
| ACSL4 Mitochondrion Metabolic pathways 2.3899896690194016 | |
| ACSL4 Mitochondrion PPAR signaling pathway 2.3899896690194016 | |
| ACSL4 Mitochondrion Peroxisome 2.3899896690194016 | |
| ACSL4 Mitochondrion Thermogenesis 2.3899896690194016 | |
| ACSL4 Peroxisome Adipocytokine signaling pathway 2.3899896690194016 | |
| ACSL4 Peroxisome Fatty acid biosynthesis 2.3899896690194016 | |
| ACSL4 Peroxisome Fatty acid degradation 2.3899896690194016 | |
| ACSL4 Peroxisome Fatty acid metabolism 2.3899896690194016 | |
| ACSL4 Peroxisome Ferroptosis 2.3899896690194016 | |
| ACSL4 Peroxisome Metabolic pathways 2.3899896690194016 | |
| ACSL4 Peroxisome PPAR signaling pathway 2.3899896690194016 | |
| ACSL4 Peroxisome Peroxisome 2.3899896690194016 | |
| ACSL4 Peroxisome Thermogenesis 2.3899896690194016 | |
| ACSL5 Endoplasmic Reticulum Adipocytokine signaling pathway 2.0285792777380447 | |
| ACSL5 Endoplasmic Reticulum Fatty acid biosynthesis 2.0285792777380447 | |
| ACSL5 Endoplasmic Reticulum Fatty acid degradation 2.0285792777380447 | |
| ACSL5 Endoplasmic Reticulum Fatty acid metabolism 2.0285792777380447 | |
| ACSL5 Endoplasmic Reticulum Ferroptosis 2.0285792777380447 | |
| ACSL5 Endoplasmic Reticulum Metabolic pathways 2.0285792777380447 | |
| ACSL5 Endoplasmic Reticulum PPAR signaling pathway 2.0285792777380447 | |
| ACSL5 Endoplasmic Reticulum Peroxisome 2.0285792777380447 | |
| ACSL5 Endoplasmic Reticulum Thermogenesis 2.0285792777380447 | |
| ACSL5 Mitochondrion Adipocytokine signaling pathway 2.0285792777380447 | |
| ACSL5 Mitochondrion Fatty acid biosynthesis 2.0285792777380447 | |
| ACSL5 Mitochondrion Fatty acid degradation 2.0285792777380447 | |
| ACSL5 Mitochondrion Fatty acid metabolism 2.0285792777380447 | |
| ACSL5 Mitochondrion Ferroptosis 2.0285792777380447 | |
| ACSL5 Mitochondrion Metabolic pathways 2.0285792777380447 | |
| ACSL5 Mitochondrion PPAR signaling pathway 2.0285792777380447 | |
| ACSL5 Mitochondrion Peroxisome 2.0285792777380447 | |
| ACSL5 Mitochondrion Thermogenesis 2.0285792777380447 | |
| ACSL5 Nucleus Adipocytokine signaling pathway 2.0285792777380447 | |
| ACSL5 Nucleus Fatty acid biosynthesis 2.0285792777380447 | |
| ACSL5 Nucleus Fatty acid degradation 2.0285792777380447 | |
| ACSL5 Nucleus Fatty acid metabolism 2.0285792777380447 | |
| ACSL5 Nucleus Ferroptosis 2.0285792777380447 | |
| ACSL5 Nucleus Metabolic pathways 2.0285792777380447 | |
| ACSL5 Nucleus PPAR signaling pathway 2.0285792777380447 | |
| ACSL5 Nucleus Peroxisome 2.0285792777380447 | |
| ACSL5 Nucleus Thermogenesis 2.0285792777380447 | |
| ACSM1 Mitochondrion Butanoate metabolism 0.3937923783476555 | |
| ACSM1 Mitochondrion Lipoic acid metabolism 0.3937923783476555 | |
| ACSM1 Mitochondrion Metabolic pathways 0.3937923783476555 | |
| ACSM3 Mitochondrion Summary 0.9692189726409643 | |
| ACSS1 Mitochondrion Carbon metabolism 0.7625460253806232 | |
| ACSS1 Mitochondrion Glycolysis / Gluconeogenesis 0.7625460253806232 | |
| ACSS1 Mitochondrion Glyoxylate and dicarboxylate metabolism 0.7625460253806232 | |
| ACSS1 Mitochondrion Metabolic pathways 0.7625460253806232 | |
| ACSS1 Mitochondrion Propanoate metabolism 0.7625460253806232 | |
| ACSS1 Mitochondrion Pyruvate metabolism 0.7625460253806232 | |
| ACSS2 Cytosol Summary 0.7824164343629119 | |
| ACSS2 Nucleus Summary 0.7824164343629119 | |
| ACSS3 Mitochondrion Summary 0.18443329806699452 | |
| ACTA1 Cytoskeleton Summary 1.8060671039118503 | |
| ACTA1 Cytosol Summary 1.8060671039118503 | |
| ACTA2 Cytoskeleton Apelin signaling pathway 1.3129997693882394 | |
| ACTA2 Cytoskeleton Relaxin signaling pathway 1.3129997693882394 | |
| ACTA2 Cytoskeleton Vascular smooth muscle contraction 1.3129997693882394 | |
| ACTA2 Cytosol Apelin signaling pathway 1.3129997693882394 | |
| ACTA2 Cytosol Relaxin signaling pathway 1.3129997693882394 | |
| ACTA2 Cytosol Vascular smooth muscle contraction 1.3129997693882394 | |
| ACTB Cytosol Summary 2.4678426935444016 | |
| ACTBL2 Cytosol Summary 1.557674447730186 | |
| ACTG1 Cytosol Summary 1.6638973150904752 | |
| ACTG2 Cytoskeleton Vascular smooth muscle contraction 1.8848595952844585 | |
| ACTG2 Cytosol Vascular smooth muscle contraction 1.8848595952844585 | |
| ACTL6A Cytosol Hepatocellular carcinoma 1.914885402374244 | |
| ACTL6A Cytosol Thermogenesis 1.914885402374244 | |
| ACTL6A Nucleus Hepatocellular carcinoma 1.914885402374244 | |
| ACTL6A Nucleus Thermogenesis 1.914885402374244 | |
| ACTL8 Cytosol Summary 0.3498548352981751 | |
| ACTN1 Cytoskeleton Adherens junction 1.9603910760977152 | |
| ACTN1 Cytoskeleton Amoebiasis 1.9603910760977152 | |
| ACTN1 Cytoskeleton Focal adhesion 1.9603910760977152 | |
| ACTN1 Cytoskeleton Leukocyte transendothelial migration 1.9603910760977152 | |
| ACTN1 Cytoskeleton Regulation of actin cytoskeleton 1.9603910760977152 | |
| ACTN1 Cytoskeleton Shigellosis 1.9603910760977152 | |
| ACTN1 Cytoskeleton Systemic lupus erythematosus 1.9603910760977152 | |
| ACTN1 Cytoskeleton Tight junction 1.9603910760977152 | |
| ACTN1 Cytoskeleton Viral carcinogenesis 1.9603910760977152 | |
| ACTN1 Cytosol Adherens junction 1.9603910760977152 | |
| ACTN1 Cytosol Amoebiasis 1.9603910760977152 | |
| ACTN1 Cytosol Focal adhesion 1.9603910760977152 | |
| ACTN1 Cytosol Leukocyte transendothelial migration 1.9603910760977152 | |
| ACTN1 Cytosol Regulation of actin cytoskeleton 1.9603910760977152 | |
| ACTN1 Cytosol Shigellosis 1.9603910760977152 | |
| ACTN1 Cytosol Systemic lupus erythematosus 1.9603910760977152 | |
| ACTN1 Cytosol Tight junction 1.9603910760977152 | |
| ACTN1 Cytosol Viral carcinogenesis 1.9603910760977152 | |
| ACTN1 Plasma membrane Adherens junction 1.9603910760977152 | |
| ACTN1 Plasma membrane Amoebiasis 1.9603910760977152 | |
| ACTN1 Plasma membrane Focal adhesion 1.9603910760977152 | |
| ACTN1 Plasma membrane Leukocyte transendothelial migration 1.9603910760977152 | |
| ACTN1 Plasma membrane Regulation of actin cytoskeleton 1.9603910760977152 | |
| ACTN1 Plasma membrane Shigellosis 1.9603910760977152 | |
| ACTN1 Plasma membrane Systemic lupus erythematosus 1.9603910760977152 | |
| ACTN1 Plasma membrane Tight junction 1.9603910760977152 | |
| ACTN1 Plasma membrane Viral carcinogenesis 1.9603910760977152 | |
| ACTN2 Cytoskeleton Summary 2.2588649193445525 | |
| ACTN2 Cytosol Summary 2.2588649193445525 | |
| ACTN3 Cytoskeleton Summary 0.9479297631259118 | |
| ACTN4 Cytoskeleton Adherens junction 1.957155594592617 | |
| ACTN4 Cytoskeleton Amoebiasis 1.957155594592617 | |
| ACTN4 Cytoskeleton Focal adhesion 1.957155594592617 | |
| ACTN4 Cytoskeleton Leukocyte transendothelial migration 1.957155594592617 | |
| ACTN4 Cytoskeleton Regulation of actin cytoskeleton 1.957155594592617 | |
| ACTN4 Cytoskeleton Shigellosis 1.957155594592617 | |
| ACTN4 Cytoskeleton Systemic lupus erythematosus 1.957155594592617 | |
| ACTN4 Cytoskeleton Tight junction 1.957155594592617 | |
| ACTN4 Cytoskeleton Viral carcinogenesis 1.957155594592617 | |
| ACTN4 Cytosol Adherens junction 1.957155594592617 | |
| ACTN4 Cytosol Amoebiasis 1.957155594592617 | |
| ACTN4 Cytosol Focal adhesion 1.957155594592617 | |
| ACTN4 Cytosol Leukocyte transendothelial migration 1.957155594592617 | |
| ACTN4 Cytosol Regulation of actin cytoskeleton 1.957155594592617 | |
| ACTN4 Cytosol Shigellosis 1.957155594592617 | |
| ACTN4 Cytosol Systemic lupus erythematosus 1.957155594592617 | |
| ACTN4 Cytosol Tight junction 1.957155594592617 | |
| ACTN4 Cytosol Viral carcinogenesis 1.957155594592617 | |
| ACTN4 Nucleus Adherens junction 1.957155594592617 | |
| ACTN4 Nucleus Amoebiasis 1.957155594592617 | |
| ACTN4 Nucleus Focal adhesion 1.957155594592617 | |
| ACTN4 Nucleus Leukocyte transendothelial migration 1.957155594592617 | |
| ACTN4 Nucleus Regulation of actin cytoskeleton 1.957155594592617 | |
| ACTN4 Nucleus Shigellosis 1.957155594592617 | |
| ACTN4 Nucleus Systemic lupus erythematosus 1.957155594592617 | |
| ACTN4 Nucleus Tight junction 1.957155594592617 | |
| ACTN4 Nucleus Viral carcinogenesis 1.957155594592617 | |
| ACTR1A Cytoskeleton Amyotrophic lateral sclerosis 1.2059435622097103 | |
| ACTR1A Cytoskeleton Huntington disease 1.2059435622097103 | |
| ACTR1A Cytoskeleton Pathways of neurodegeneration - multiple diseases 1.2059435622097103 | |
| ACTR1A Cytoskeleton Salmonella infection 1.2059435622097103 | |
| ACTR1A Cytosol Amyotrophic lateral sclerosis 1.2059435622097103 | |
| ACTR1A Cytosol Huntington disease 1.2059435622097103 | |
| ACTR1A Cytosol Pathways of neurodegeneration - multiple diseases 1.2059435622097103 | |
| ACTR1A Cytosol Salmonella infection 1.2059435622097103 | |
| ACTR1B Cytoskeleton Amyotrophic lateral sclerosis 0.9917355870715656 | |
| ACTR1B Cytoskeleton Huntington disease 0.9917355870715656 | |
| ACTR1B Cytoskeleton Pathways of neurodegeneration - multiple diseases 0.9917355870715656 | |
| ACTR1B Cytoskeleton Salmonella infection 0.9917355870715656 | |
| ACTR1B Cytosol Amyotrophic lateral sclerosis 0.9917355870715656 | |
| ACTR1B Cytosol Huntington disease 0.9917355870715656 | |
| ACTR1B Cytosol Pathways of neurodegeneration - multiple diseases 0.9917355870715656 | |
| ACTR1B Cytosol Salmonella infection 0.9917355870715656 | |
| ACTR2 Cytoskeleton Bacterial invasion of epithelial cells 1.7827919493475215 | |
| ACTR2 Cytoskeleton Endocytosis 1.7827919493475215 | |
| ACTR2 Cytoskeleton Fc gamma R-mediated phagocytosis 1.7827919493475215 | |
| ACTR2 Cytoskeleton Pathogenic Escherichia coli infection 1.7827919493475215 | |
| ACTR2 Cytoskeleton Regulation of actin cytoskeleton 1.7827919493475215 | |
| ACTR2 Cytoskeleton Salmonella infection 1.7827919493475215 | |
| ACTR2 Cytoskeleton Shigellosis 1.7827919493475215 | |
| ACTR2 Cytoskeleton Tight junction 1.7827919493475215 | |
| ACTR2 Cytoskeleton Yersinia infection 1.7827919493475215 | |
| ACTR2 Cytosol Bacterial invasion of epithelial cells 1.7827919493475215 | |
| ACTR2 Cytosol Endocytosis 1.7827919493475215 | |
| ACTR2 Cytosol Fc gamma R-mediated phagocytosis 1.7827919493475215 | |
| ACTR2 Cytosol Pathogenic Escherichia coli infection 1.7827919493475215 | |
| ACTR2 Cytosol Regulation of actin cytoskeleton 1.7827919493475215 | |
| ACTR2 Cytosol Salmonella infection 1.7827919493475215 | |
| ACTR2 Cytosol Shigellosis 1.7827919493475215 | |
| ACTR2 Cytosol Tight junction 1.7827919493475215 | |
| ACTR2 Cytosol Yersinia infection 1.7827919493475215 | |
| ACTR3 Cytoskeleton Bacterial invasion of epithelial cells 1.3717836806446029 | |
| ACTR3 Cytoskeleton Endocytosis 1.3717836806446029 | |
| ACTR3 Cytoskeleton Fc gamma R-mediated phagocytosis 1.3717836806446029 | |
| ACTR3 Cytoskeleton Pathogenic Escherichia coli infection 1.3717836806446029 | |
| ACTR3 Cytoskeleton Regulation of actin cytoskeleton 1.3717836806446029 | |
| ACTR3 Cytoskeleton Salmonella infection 1.3717836806446029 | |
| ACTR3 Cytoskeleton Shigellosis 1.3717836806446029 | |
| ACTR3 Cytoskeleton Tight junction 1.3717836806446029 | |
| ACTR3 Cytoskeleton Yersinia infection 1.3717836806446029 | |
| ACTR3 Cytosol Bacterial invasion of epithelial cells 1.3717836806446029 | |
| ACTR3 Cytosol Endocytosis 1.3717836806446029 | |
| ACTR3 Cytosol Fc gamma R-mediated phagocytosis 1.3717836806446029 | |
| ACTR3 Cytosol Pathogenic Escherichia coli infection 1.3717836806446029 | |
| ACTR3 Cytosol Regulation of actin cytoskeleton 1.3717836806446029 | |
| ACTR3 Cytosol Salmonella infection 1.3717836806446029 | |
| ACTR3 Cytosol Shigellosis 1.3717836806446029 | |
| ACTR3 Cytosol Tight junction 1.3717836806446029 | |
| ACTR3 Cytosol Yersinia infection 1.3717836806446029 | |
| ACTR3B Cytosol Summary 1.4517320732882115 | |
| ACTR5 Nucleus Summary 1.484773842637231 | |
| ACTR6 Cytosol Summary 1.2398419134426522 | |
| ACTR6 Plasma membrane Summary 1.2398419134426522 | |
| ACTR8 Cytoskeleton Summary 1.0553926330062997 | |
| ACTR8 Nucleus Summary 1.0553926330062997 | |
| ACVR1 Cytosol Cytokine-cytokine receptor interaction 1.3126243044749215 | |
| ACVR1 Cytosol Fluid shear stress and atherosclerosis 1.3126243044749215 | |
| ACVR1 Cytosol Signaling pathways regulating pluripotency of stem cells 1.3126243044749215 | |
| ACVR1 Cytosol TGF-beta signaling pathway 1.3126243044749215 | |
| ACVR1 Nucleus Cytokine-cytokine receptor interaction 1.3126243044749215 | |
| ACVR1 Nucleus Fluid shear stress and atherosclerosis 1.3126243044749215 | |
| ACVR1 Nucleus Signaling pathways regulating pluripotency of stem cells 1.3126243044749215 | |
| ACVR1 Nucleus TGF-beta signaling pathway 1.3126243044749215 | |
| ACVR1 Plasma membrane Cytokine-cytokine receptor interaction 1.3126243044749215 | |
| ACVR1 Plasma membrane Fluid shear stress and atherosclerosis 1.3126243044749215 | |
| ACVR1 Plasma membrane Signaling pathways regulating pluripotency of stem cells 1.3126243044749215 | |
| ACVR1 Plasma membrane TGF-beta signaling pathway 1.3126243044749215 | |
| ACY1 Cytosol Summary 0.4630749225046277 | |
| ACYP1 Cytosol Summary 1.123581637226621 | |
| ACYP1 Nucleus Summary 1.123581637226621 | |
| ACYP2 Nucleus Summary 1.7458651295274916 | |
| ADA Cytosol Metabolic pathways 2.35183863284686 | |
| ADA Cytosol Primary immunodeficiency 2.35183863284686 | |
| ADA Cytosol Purine metabolism 2.35183863284686 | |
| ADA Lysosome Metabolic pathways 2.35183863284686 | |
| ADA Lysosome Primary immunodeficiency 2.35183863284686 | |
| ADA Lysosome Purine metabolism 2.35183863284686 | |
| ADA Plasma membrane Metabolic pathways 2.35183863284686 | |
| ADA Plasma membrane Primary immunodeficiency 2.35183863284686 | |
| ADA Plasma membrane Purine metabolism 2.35183863284686 | |
| ADAL Cytoskeleton Summary 0.8992057505831192 | |
| ADAL Cytosol Summary 0.8992057505831192 | |
| ADAL Nucleus Summary 0.8992057505831192 | |
| ADAM10 Cytosol Alzheimer disease 0.4896394720450893 | |
| ADAM10 Cytosol Epithelial cell signaling in Helicobacter pylori infection 0.4896394720450893 | |
| ADAM10 Golgi apparatus Alzheimer disease 0.4896394720450893 | |
| ADAM10 Golgi apparatus Epithelial cell signaling in Helicobacter pylori infection 0.4896394720450893 | |
| ADAM10 Nucleus Alzheimer disease 0.4896394720450893 | |
| ADAM10 Nucleus Epithelial cell signaling in Helicobacter pylori infection 0.4896394720450893 | |
| ADAM10 Plasma membrane Alzheimer disease 0.4896394720450893 | |
| ADAM10 Plasma membrane Epithelial cell signaling in Helicobacter pylori infection 0.4896394720450893 | |
| ADAM12 Extracellular space Summary 1.6392048655789244 | |
| ADAM12 Plasma membrane Summary 1.6392048655789244 | |
| ADAM15 Cytosol Summary 1.0115578633800415 | |
| ADAM17 Cytosol Summary 1.2509608761573623 | |
| ADAM9 Cytosol Summary 2.2795104302233407 | |
| ADAM9 Endoplasmic Reticulum Summary 2.2795104302233407 | |
| ADAM9 Plasma membrane Summary 2.2795104302233407 | |
| ADAMTS1 Cytosol Summary 1.0714632778096531 | |
| ADAMTS1 Extracellular space Summary 1.0714632778096531 | |
| ADAMTS1 Plasma membrane Summary 1.0714632778096531 | |
| ADAMTS12 Extracellular space Summary 0.9872787710351882 | |
| ADAMTS12 Mitochondrion Summary 0.9872787710351882 | |
| ADAMTS12 Nucleus Summary 0.9872787710351882 | |
| ADAMTS15 Cytosol Summary 0.2351752864717448 | |
| ADAMTS15 Extracellular space Summary 0.2351752864717448 | |
| ADAMTS16 Cytoskeleton Summary 1.4920471037636431 | |
| ADAMTS16 Extracellular space Summary 1.4920471037636431 | |
| ADAMTS16 Mitochondrion Summary 1.4920471037636431 | |
| ADAMTS16 Nucleus Summary 1.4920471037636431 | |
| ADAMTS2 Cytosol Summary 1.6454961176228076 | |
| ADAMTS2 Extracellular space Summary 1.6454961176228076 | |
| ADAMTS2 Plasma membrane Summary 1.6454961176228076 | |
| ADAMTS4 Extracellular space Summary 1.757365196126715 | |
| ADAMTS4 Nucleus Summary 1.757365196126715 | |
| ADAMTS7 Cytosol Summary 1.8681194010809932 | |
| ADAMTS7 Extracellular space Summary 1.8681194010809932 | |
| ADAMTSL1 Cytosol Summary 1.5878199092370189 | |
| ADAMTSL1 Extracellular space Summary 1.5878199092370189 | |
| ADAMTSL2 Cytosol Summary 1.1762430761370677 | |
| ADAMTSL2 Nucleus Summary 1.1762430761370677 | |
| ADAMTSL3 Cytosol Summary 1.1881553334681385 | |
| ADAMTSL3 Extracellular space Summary 1.1881553334681385 | |
| ADAMTSL4 Cytosol Summary 1.6706200896034806 | |
| ADAMTSL4 Extracellular space Summary 1.6706200896034806 | |
| ADAMTSL4 Plasma membrane Summary 1.6706200896034806 | |
| ADAP1 Cytosol Summary 1.8266847797751131 | |
| ADAP1 Nucleus Summary 1.8266847797751131 | |
| ADAP1 Plasma membrane Summary 1.8266847797751131 | |
| ADAP2 Cytosol Summary 1.4635461834954897 | |
| ADAP2 Plasma membrane Summary 1.4635461834954897 | |
| ADAR Cytosol Coronavirus disease - COVID-19 2.010569372169935 | |
| ADAR Cytosol Cytosolic DNA-sensing pathway 2.010569372169935 | |
| ADAR Cytosol Influenza A 2.010569372169935 | |
| ADAR Cytosol Measles 2.010569372169935 | |
| ADAR Nucleus Coronavirus disease - COVID-19 2.010569372169935 | |
| ADAR Nucleus Cytosolic DNA-sensing pathway 2.010569372169935 | |
| ADAR Nucleus Influenza A 2.010569372169935 | |
| ADAR Nucleus Measles 2.010569372169935 | |
| ADARB1 Cytosol Summary 1.6112403711107357 | |
| ADARB1 Nucleus Summary 1.6112403711107357 | |
| ADARB2 Nucleus Summary 0.9797945054280229 | |
| ADAT1 Nucleus Summary 0.9811863319653744 | |
| ADAT2 Cytosol Summary 1.886398851201756 | |
| ADAT2 Golgi apparatus Summary 1.886398851201756 | |
| ADAT2 Nucleus Summary 1.886398851201756 | |
| ADAT3 Nucleus Summary 1.7521833786224996 | |
| ADCK1 Nucleus Summary 1.2944828193665558 | |
| ADCK5 Cytosol Summary 1.7251995353481282 | |
| ADCK5 Plasma membrane Summary 1.7251995353481282 | |
| ADCY3 Plasma membrane Summary 1.065810437214929 | |
| ADCY5 Cytoskeleton Summary 1.0180872123362879 | |
| ADCY5 Plasma membrane Summary 1.0180872123362879 | |
| ADCY6 Golgi apparatus Summary 0.6030559032385334 | |
| ADCY6 Plasma membrane Summary 0.6030559032385334 | |
| ADCY7 Cytosol Summary 0.5120497567512916 | |
| ADCY9 Cytosol Summary 0.3993334954045479 | |
| ADCY9 Plasma membrane Summary 0.3993334954045479 | |
| ADD1 Cytoskeleton Summary 1.1373740613372172 | |
| ADD1 Cytosol Summary 1.1373740613372172 | |
| ADD1 Nucleus Summary 1.1373740613372172 | |
| ADD1 Plasma membrane Summary 1.1373740613372172 | |
| ADD2 Cytoskeleton Summary 1.711504758339791 | |
| ADD2 Cytosol Summary 1.711504758339791 | |
| ADD2 Nucleus Summary 1.711504758339791 | |
| ADD2 Plasma membrane Summary 1.711504758339791 | |
| ADD3 Cytoskeleton Summary 1.1916259132268243 | |
| ADD3 Cytosol Summary 1.1916259132268243 | |
| ADD3 Plasma membrane Summary 1.1916259132268243 | |
| ADGB Mitochondrion Summary 0.9085328978265108 | |
| ADGB Nucleus Summary 0.9085328978265108 | |
| ADGRE2 Cytosol Summary 3.1020602631916203 | |
| ADGRE2 Plasma membrane Summary 3.1020602631916203 | |
| ADGRE5 Cytosol Summary 2.80785260868718 | |
| ADGRE5 Extracellular space Summary 2.80785260868718 | |
| ADGRE5 Plasma membrane Summary 2.80785260868718 | |
| ADGRF5 Plasma membrane Summary 2.099357003762138 | |
| ADGRG1 Plasma membrane Summary 2.056287155749005 | |
| ADGRG6 Plasma membrane Summary 1.9593438842870932 | |
| ADGRL1 Plasma membrane Summary 1.327556323975854 | |
| ADGRL2 Plasma membrane Summary 0.8598461069519872 | |
| ADGRL4 Plasma membrane Summary 1.4136233838729932 | |
| ADGRV1 Plasma membrane Summary 1.1527493801101414 | |
| ADH1B Cytosol Summary 1.0563505385159857 | |
| ADH1B Plasma membrane Summary 1.0563505385159857 | |
| ADH1C Cytosol Summary 0.8334778500787349 | |
| ADH1C Nucleus Summary 0.8334778500787349 | |
| ADH1C Plasma membrane Summary 0.8334778500787349 | |
| ADH5 Cytosol Summary 1.2927336594101495 | |
| ADHFE1 Cytosol Summary 0.8872120560643673 | |
| ADHFE1 Mitochondrion Summary 0.8872120560643673 | |
| ADI1 Golgi apparatus Cysteine and methionine metabolism 2.207610982087942 | |
| ADI1 Golgi apparatus Metabolic pathways 2.207610982087942 | |
| ADI1 Nucleus Cysteine and methionine metabolism 2.207610982087942 | |
| ADI1 Nucleus Metabolic pathways 2.207610982087942 | |
| ADI1 Plasma membrane Cysteine and methionine metabolism 2.207610982087942 | |
| ADI1 Plasma membrane Metabolic pathways 2.207610982087942 | |
| ADIPOQ Extracellular space AMPK signaling pathway 0.8621298582607874 | |
| ADIPOQ Extracellular space Adipocytokine signaling pathway 0.8621298582607874 | |
| ADIPOQ Extracellular space Longevity regulating pathway 0.8621298582607874 | |
| ADIPOQ Extracellular space Non-alcoholic fatty liver disease 0.8621298582607874 | |
| ADIPOQ Extracellular space PPAR signaling pathway 0.8621298582607874 | |
| ADIPOQ Extracellular space Type II diabetes mellitus 0.8621298582607874 | |
| ADIPOR1 Plasma membrane Summary 0.1938008411812491 | |
| ADIRF Cytosol Summary 0.04064672188358708 | |
| ADIRF Nucleus Summary 0.04064672188358708 | |
| ADK Cytosol Summary 1.3503448483825438 | |
| ADK Nucleus Summary 1.3503448483825438 | |
| ADK Plasma membrane Summary 1.3503448483825438 | |
| ADNP Nucleus Summary 1.7334633550471181 | |
| ADNP2 Cytosol Summary 1.721058932478012 | |
| ADNP2 Mitochondrion Summary 1.721058932478012 | |
| ADNP2 Nucleus Summary 1.721058932478012 | |
| ADO Cytosol Summary 0.9104075811303908 | |
| ADPGK Cytoskeleton Summary 2.3485759337722274 | |
| ADPRH Nucleus Summary 1.3267675337940554 | |
| ADPRHL2 Nucleus Summary 1.3771972601602835 | |
| ADRM1 Cytosol Alzheimer disease 0.9631178772900206 | |
| ADRM1 Cytosol Amyotrophic lateral sclerosis 0.9631178772900206 | |
| ADRM1 Cytosol Epstein-Barr virus infection 0.9631178772900206 | |
| ADRM1 Cytosol Huntington disease 0.9631178772900206 | |
| ADRM1 Cytosol Parkinson disease 0.9631178772900206 | |
| ADRM1 Cytosol Pathways of neurodegeneration - multiple diseases 0.9631178772900206 | |
| ADRM1 Cytosol Prion disease 0.9631178772900206 | |
| ADRM1 Cytosol Proteasome 0.9631178772900206 | |
| ADRM1 Cytosol Spinocerebellar ataxia 0.9631178772900206 | |
| ADRM1 Nucleus Alzheimer disease 0.9631178772900206 | |
| ADRM1 Nucleus Amyotrophic lateral sclerosis 0.9631178772900206 | |
| ADRM1 Nucleus Epstein-Barr virus infection 0.9631178772900206 | |
| ADRM1 Nucleus Huntington disease 0.9631178772900206 | |
| ADRM1 Nucleus Parkinson disease 0.9631178772900206 | |
| ADRM1 Nucleus Pathways of neurodegeneration - multiple diseases 0.9631178772900206 | |
| ADRM1 Nucleus Prion disease 0.9631178772900206 | |
| ADRM1 Nucleus Proteasome 0.9631178772900206 | |
| ADRM1 Nucleus Spinocerebellar ataxia 0.9631178772900206 | |
| ADRM1 Plasma membrane Alzheimer disease 0.9631178772900206 | |
| ADRM1 Plasma membrane Amyotrophic lateral sclerosis 0.9631178772900206 | |
| ADRM1 Plasma membrane Epstein-Barr virus infection 0.9631178772900206 | |
| ADRM1 Plasma membrane Huntington disease 0.9631178772900206 | |
| ADRM1 Plasma membrane Parkinson disease 0.9631178772900206 | |
| ADRM1 Plasma membrane Pathways of neurodegeneration - multiple diseases 0.9631178772900206 | |
| ADRM1 Plasma membrane Prion disease 0.9631178772900206 | |
| ADRM1 Plasma membrane Proteasome 0.9631178772900206 | |
| ADRM1 Plasma membrane Spinocerebellar ataxia 0.9631178772900206 | |
| ADSL Cytosol Summary 2.1779485454528493 | |
| ADSS Cytosol Summary 2.0883390601607634 | |
| ADSS Plasma membrane Summary 2.0883390601607634 | |
| AEBP1 Cytosol Summary 1.45657947287543 | |
| AEBP1 Nucleus Summary 1.45657947287543 | |
| AES Nucleus Summary 0.5232686775921841 | |
| AFAP1 Cytoskeleton Summary 1.8742542989434752 | |
| AFAP1 Cytosol Summary 1.8742542989434752 | |
| AFAP1L1 Cytoskeleton Summary 2.0716791451648917 | |
| AFAP1L1 Cytosol Summary 2.0716791451648917 | |
| AFAP1L2 Cytosol Summary 1.0372663270853175 | |
| AFAP1L2 Plasma membrane Summary 1.0372663270853175 | |
| AFDN Nucleus Summary 1.4801391900562668 | |
| AFDN Plasma membrane Summary 1.4801391900562668 | |
| AFF1 Mitochondrion Summary 1.49435895127402 | |
| AFF1 Nucleus Summary 1.49435895127402 | |
| AFF2 Nucleus Summary 2.012373180193228 | |
| AFF3 Cytosol Summary 0.12451575790973005 | |
| AFF3 Nucleus Summary 0.12451575790973005 | |
| AFF4 Mitochondrion Summary 1.3105385743303968 | |
| AFF4 Nucleus Summary 1.3105385743303968 | |
| AFG3L2 Mitochondrion Spinocerebellar ataxia 1.3794764109650277 | |
| AFM Extracellular space Summary 2.053299838798241 | |
| AFMID Cytosol Summary 0.18419186328151171 | |
| AFMID Mitochondrion Summary 0.18419186328151171 | |
| AFTPH Cytosol Summary 0.8091563785281317 | |
| AFTPH Golgi apparatus Summary 0.8091563785281317 | |
| AGA Endoplasmic Reticulum Lysosome 0.4976311950451875 | |
| AGA Endoplasmic Reticulum Other glycan degradation 0.4976311950451875 | |
| AGA Lysosome Lysosome 0.4976311950451875 | |
| AGA Lysosome Other glycan degradation 0.4976311950451875 | |
| AGAP1 Cytosol Summary 0.7884271565712386 | |
| AGAP2 Cytoskeleton Endocytosis 1.2573256623305822 | |
| AGAP2 Cytoskeleton FoxO signaling pathway 1.2573256623305822 | |
| AGAP2 Cytosol Endocytosis 1.2573256623305822 | |
| AGAP2 Cytosol FoxO signaling pathway 1.2573256623305822 | |
| AGAP2 Nucleus Endocytosis 1.2573256623305822 | |
| AGAP2 Nucleus FoxO signaling pathway 1.2573256623305822 | |
| AGAP3 Cytosol Summary 0.6592186062916888 | |
| AGAP3 Endoplasmic Reticulum Summary 0.6592186062916888 | |
| AGFG1 Cytosol Summary 1.374075283380085 | |
| AGFG1 Nucleus Summary 1.374075283380085 | |
| AGGF1 Cytosol Summary 1.0167241441456705 | |
| AGGF1 Extracellular space Summary 1.0167241441456705 | |
| AGK Cytosol Summary 1.800270190234943 | |
| AGK Mitochondrion Summary 1.800270190234943 | |
| AGL Cytosol Summary 0.7390682523844979 | |
| AGL Nucleus Summary 0.7390682523844979 | |
| AGMAT Mitochondrion Arginine and proline metabolism 1.6838755360747537 | |
| AGMAT Mitochondrion Metabolic pathways 1.6838755360747537 | |
| AGO1 Cytosol Summary 0.8407905411654227 | |
| AGO2 Cytosol Summary 1.922675423378256 | |
| AGO2 Nucleus Summary 1.922675423378256 | |
| AGO3 Cytosol Summary 1.4047696066546802 | |
| AGO3 Nucleus Summary 1.4047696066546802 | |
| AGO4 Cytosol Summary 1.1293207486923589 | |
| AGO4 Nucleus Summary 1.1293207486923589 | |
| AGPAT1 Endoplasmic Reticulum Summary 0.88023340988774 | |
| AGPAT2 Cytoskeleton Summary 0.8338484206303867 | |
| AGPAT2 Endoplasmic Reticulum Summary 0.8338484206303867 | |
| AGPAT3 Endoplasmic Reticulum Glycerolipid metabolism 0.3706213502259142 | |
| AGPAT3 Endoplasmic Reticulum Glycerophospholipid metabolism 0.3706213502259142 | |
| AGPAT3 Endoplasmic Reticulum Metabolic pathways 0.3706213502259142 | |
| AGPAT3 Endoplasmic Reticulum Phospholipase D signaling pathway 0.3706213502259142 | |
| AGPAT3 Plasma membrane Glycerolipid metabolism 0.3706213502259142 | |
| AGPAT3 Plasma membrane Glycerophospholipid metabolism 0.3706213502259142 | |
| AGPAT3 Plasma membrane Metabolic pathways 0.3706213502259142 | |
| AGPAT3 Plasma membrane Phospholipase D signaling pathway 0.3706213502259142 | |
| AGPAT5 Endoplasmic Reticulum Summary 1.258129395236026 | |
| AGPAT5 Mitochondrion Summary 1.258129395236026 | |
| AGPS Peroxisome Ether lipid metabolism 1.5881477302683216 | |
| AGPS Peroxisome Metabolic pathways 1.5881477302683216 | |
| AGPS Peroxisome Peroxisome 1.5881477302683216 | |
| AGR2 Cytosol Summary 0.1167686477371696 | |
| AGR2 Endoplasmic Reticulum Summary 0.1167686477371696 | |
| AGR2 Extracellular space Summary 0.1167686477371696 | |
| AGR3 Cytosol Summary 0.06782124400728923 | |
| AGR3 Endoplasmic Reticulum Summary 0.06782124400728923 | |
| AGRN Cytosol ECM-receptor interaction 1.3963417408765717 | |
| AGRN Extracellular space ECM-receptor interaction 1.3963417408765717 | |
| AGRN Plasma membrane ECM-receptor interaction 1.3963417408765717 | |
| AGT Extracellular space AGE-RAGE signaling pathway in diabetic complications 2.3793765019991624 | |
| AGT Extracellular space Adrenergic signaling in cardiomyocytes 2.3793765019991624 | |
| AGT Extracellular space Alanine aspartate and glutamate metabolism 2.3793765019991624 | |
| AGT Extracellular space Aldosterone synthesis and secretion 2.3793765019991624 | |
| AGT Extracellular space Carbon metabolism 2.3793765019991624 | |
| AGT Extracellular space Cortisol synthesis and secretion 2.3793765019991624 | |
| AGT Extracellular space Cushing syndrome 2.3793765019991624 | |
| AGT Extracellular space Diabetic cardiomyopathy 2.3793765019991624 | |
| AGT Extracellular space Dilated cardiomyopathy 2.3793765019991624 | |
| AGT Extracellular space Glycine serine and threonine metabolism 2.3793765019991624 | |
| AGT Extracellular space Glyoxylate and dicarboxylate metabolism 2.3793765019991624 | |
| AGT Extracellular space Hypertrophic cardiomyopathy 2.3793765019991624 | |
| AGT Extracellular space Insulin resistance 2.3793765019991624 | |
| AGT Extracellular space Metabolic pathways 2.3793765019991624 | |
| AGT Extracellular space Neuroactive ligand-receptor interaction 2.3793765019991624 | |
| AGT Extracellular space Pathways in cancer 2.3793765019991624 | |
| AGT Extracellular space Peroxisome 2.3793765019991624 | |
| AGT Extracellular space Phospholipase D signaling pathway 2.3793765019991624 | |
| AGT Extracellular space Renin secretion 2.3793765019991624 | |
| AGT Extracellular space Renin-angiotensin system 2.3793765019991624 | |
| AGT Extracellular space Vascular smooth muscle contraction 2.3793765019991624 | |
| AGTPBP1 Cytosol Summary 2.0275951593790658 | |
| AGTPBP1 Nucleus Summary 2.0275951593790658 | |
| AGTRAP Cytosol Summary 1.852467346610906 | |
| AGTRAP Endoplasmic Reticulum Summary 1.852467346610906 | |
| AGTRAP Golgi apparatus Summary 1.852467346610906 | |
| AHCTF1 Cytosol Summary 2.187986449260124 | |
| AHCTF1 Nucleus Summary 2.187986449260124 | |
| AHCY Cytosol Summary 1.1987848188428492 | |
| AHCYL1 Cytosol Summary 0.5224607701782524 | |
| AHCYL1 Endoplasmic Reticulum Summary 0.5224607701782524 | |
| AHCYL2 Cytosol Summary 0.8557867066947059 | |
| AHCYL2 Nucleus Summary 0.8557867066947059 | |
| AHDC1 Nucleus Summary 1.5199162946976472 | |
| AHNAK Cytosol Salmonella infection 0.7267870832004848 | |
| AHNAK Nucleus Salmonella infection 0.7267870832004848 | |
| AHNAK Plasma membrane Salmonella infection 0.7267870832004848 | |
| AHNAK2 Cytosol Summary 1.024020156605261 | |
| AHNAK2 Nucleus Summary 1.024020156605261 | |
| AHNAK2 Plasma membrane Summary 1.024020156605261 | |
| AHR Cytosol Chemical carcinogenesis - receptor activation 1.6558667992010268 | |
| AHR Cytosol Cushing syndrome 1.6558667992010268 | |
| AHR Cytosol Th17 cell differentiation 1.6558667992010268 | |
| AHR Nucleus Chemical carcinogenesis - receptor activation 1.6558667992010268 | |
| AHR Nucleus Cushing syndrome 1.6558667992010268 | |
| AHR Nucleus Th17 cell differentiation 1.6558667992010268 | |
| AHSA1 Cytosol Summary 1.671631194474121 | |
| AHSA1 Endoplasmic Reticulum Summary 1.671631194474121 | |
| AHSG Extracellular space Summary 1.8227685628355743 | |
| AHSG Golgi apparatus Summary 1.8227685628355743 | |
| AHSP Cytosol Summary 1.1091114639685105 | |
| AIDA Cytoskeleton Summary 1.4554285172450832 | |
| AIDA Cytosol Summary 1.4554285172450832 | |
| AIF1 Cytoskeleton Summary 2.050822327453619 | |
| AIF1 Cytosol Summary 2.050822327453619 | |
| AIF1 Nucleus Summary 2.050822327453619 | |
| AIF1 Plasma membrane Summary 2.050822327453619 | |
| AIF1L Cytoskeleton Summary 3.0422258627068994 | |
| AIF1L Cytosol Summary 3.0422258627068994 | |
| AIF1L Plasma membrane Summary 3.0422258627068994 | |
| AIFM1 Mitochondrion Apoptosis 1.5073086230554835 | |
| AIFM1 Mitochondrion Necroptosis 1.5073086230554835 | |
| AIFM1 Nucleus Apoptosis 1.5073086230554835 | |
| AIFM1 Nucleus Necroptosis 1.5073086230554835 | |
| AIFM2 Cytosol p53 signaling pathway 2.1518396693597786 | |
| AIFM2 Mitochondrion p53 signaling pathway 2.1518396693597786 | |
| AIFM2 Plasma membrane p53 signaling pathway 2.1518396693597786 | |
| AIFM3 Endoplasmic Reticulum Summary 0.8382994406520453 | |
| AIFM3 Mitochondrion Summary 0.8382994406520453 | |
| AIM1 Nucleus Summary 1.3108135596716977 | |
| AIMP2 Cytosol Summary 1.4361547986500942 | |
| AIP Cytosol Chemical carcinogenesis - receptor activation 1.6606668375828313 | |
| AIP Cytosol Cushing syndrome 1.6606668375828313 | |
| AJUBA Cytoskeleton Hippo signaling pathway 1.8564009537490065 | |
| AJUBA Cytoskeleton Hippo signaling pathway - multiple species 1.8564009537490065 | |
| AJUBA Golgi apparatus Hippo signaling pathway 1.8564009537490065 | |
| AJUBA Golgi apparatus Hippo signaling pathway - multiple species 1.8564009537490065 | |
| AJUBA Nucleus Hippo signaling pathway 1.8564009537490065 | |
| AJUBA Nucleus Hippo signaling pathway - multiple species 1.8564009537490065 | |
| AJUBA Plasma membrane Hippo signaling pathway 1.8564009537490065 | |
| AJUBA Plasma membrane Hippo signaling pathway - multiple species 1.8564009537490065 | |
| AK1 Cytosol Summary 1.739514301666409 | |
| AK2 Mitochondrion Biosynthesis of cofactors 1.7739741828862263 | |
| AK2 Mitochondrion Metabolic pathways 1.7739741828862263 | |
| AK2 Mitochondrion Purine metabolism 1.7739741828862263 | |
| AK2 Mitochondrion Thiamine metabolism 1.7739741828862263 | |
| AK3 Mitochondrion Summary 1.5034262388799056 | |
| AK4 Mitochondrion Summary 1.118978919900196 | |
| AK5 Cytosol Summary 0.13956579961863688 | |
| AK6 Cytoskeleton Biosynthesis of cofactors 1.5333803569026634 | |
| AK6 Cytoskeleton Metabolic pathways 1.5333803569026634 | |
| AK6 Cytoskeleton Purine metabolism 1.5333803569026634 | |
| AK6 Cytoskeleton Ribosome biogenesis in eukaryotes 1.5333803569026634 | |
| AK6 Cytoskeleton Thiamine metabolism 1.5333803569026634 | |
| AK6 Cytosol Biosynthesis of cofactors 1.5333803569026634 | |
| AK6 Cytosol Metabolic pathways 1.5333803569026634 | |
| AK6 Cytosol Purine metabolism 1.5333803569026634 | |
| AK6 Cytosol Ribosome biogenesis in eukaryotes 1.5333803569026634 | |
| AK6 Cytosol Thiamine metabolism 1.5333803569026634 | |
| AK6 Nucleus Biosynthesis of cofactors 1.5333803569026634 | |
| AK6 Nucleus Metabolic pathways 1.5333803569026634 | |
| AK6 Nucleus Purine metabolism 1.5333803569026634 | |
| AK6 Nucleus Ribosome biogenesis in eukaryotes 1.5333803569026634 | |
| AK6 Nucleus Thiamine metabolism 1.5333803569026634 | |
| AKAP1 Mitochondrion Summary 1.4881799757231395 | |
| AKAP10 Cytosol Summary 0.9560955594573624 | |
| AKAP10 Mitochondrion Summary 0.9560955594573624 | |
| AKAP10 Plasma membrane Summary 0.9560955594573624 | |
| AKAP11 Cytoskeleton Summary 1.2099930160292849 | |
| AKAP11 Cytosol Summary 1.2099930160292849 | |
| AKAP11 Nucleus Summary 1.2099930160292849 | |
| AKAP11 Plasma membrane Summary 1.2099930160292849 | |
| AKAP12 Cytosol Summary 0.6888168382475531 | |
| AKAP12 Plasma membrane Summary 0.6888168382475531 | |
| AKAP13 Cytosol Human cytomegalovirus infection 1.3712834422569258 | |
| AKAP13 Cytosol Parathyroid hormone synthesis secretion and action 1.3712834422569258 | |
| AKAP13 Nucleus Human cytomegalovirus infection 1.3712834422569258 | |
| AKAP13 Nucleus Parathyroid hormone synthesis secretion and action 1.3712834422569258 | |
| AKAP17A Cytosol Summary 1.2628996817684324 | |
| AKAP17A Nucleus Summary 1.2628996817684324 | |
| AKAP5 Endosome Summary 0.2658121015835467 | |
| AKAP5 Nucleus Summary 0.2658121015835467 | |
| AKAP7 Cytosol Summary 1.7984092710495376 | |
| AKAP7 Nucleus Summary 1.7984092710495376 | |
| AKAP8 Nucleus Summary 2.106179208688403 | |
| AKAP8L Nucleus Summary 1.609263164411439 | |
| AKAP9 Cytoskeleton Summary 1.3626600339389516 | |
| AKAP9 Cytosol Summary 1.3626600339389516 | |
| AKAP9 Golgi apparatus Summary 1.3626600339389516 | |
| AKNA Cytoskeleton Summary 1.0429942864250974 | |
| AKNA Cytosol Summary 1.0429942864250974 | |
| AKNA Nucleus Summary 1.0429942864250974 | |
| AKR1A1 Cytosol Summary 0.7735970289566929 | |
| AKR1A1 Nucleus Summary 0.7735970289566929 | |
| AKR1B1 Cytosol Summary 2.157279302409457 | |
| AKR1B1 Nucleus Summary 2.157279302409457 | |
| AKR1B10 Cytosol Folate biosynthesis 0.025162605346943624 | |
| AKR1B10 Cytosol Fructose and mannose metabolism 0.025162605346943624 | |
| AKR1B10 Cytosol Galactose metabolism 0.025162605346943624 | |
| AKR1B10 Cytosol Glycerolipid metabolism 0.025162605346943624 | |
| AKR1B10 Cytosol Metabolic pathways 0.025162605346943624 | |
| AKR1B10 Cytosol Pentose and glucuronate interconversions 0.025162605346943624 | |
| AKR1B10 Extracellular space Folate biosynthesis 0.025162605346943624 | |
| AKR1B10 Extracellular space Fructose and mannose metabolism 0.025162605346943624 | |
| AKR1B10 Extracellular space Galactose metabolism 0.025162605346943624 | |
| AKR1B10 Extracellular space Glycerolipid metabolism 0.025162605346943624 | |
| AKR1B10 Extracellular space Metabolic pathways 0.025162605346943624 | |
| AKR1B10 Extracellular space Pentose and glucuronate interconversions 0.025162605346943624 | |
| AKR1B10 Lysosome Folate biosynthesis 0.025162605346943624 | |
| AKR1B10 Lysosome Fructose and mannose metabolism 0.025162605346943624 | |
| AKR1B10 Lysosome Galactose metabolism 0.025162605346943624 | |
| AKR1B10 Lysosome Glycerolipid metabolism 0.025162605346943624 | |
| AKR1B10 Lysosome Metabolic pathways 0.025162605346943624 | |
| AKR1B10 Lysosome Pentose and glucuronate interconversions 0.025162605346943624 | |
| AKR1B10 Plasma membrane Folate biosynthesis 0.025162605346943624 | |
| AKR1B10 Plasma membrane Fructose and mannose metabolism 0.025162605346943624 | |
| AKR1B10 Plasma membrane Galactose metabolism 0.025162605346943624 | |
| AKR1B10 Plasma membrane Glycerolipid metabolism 0.025162605346943624 | |
| AKR1B10 Plasma membrane Metabolic pathways 0.025162605346943624 | |
| AKR1B10 Plasma membrane Pentose and glucuronate interconversions 0.025162605346943624 | |
| AKR1B15 Cytosol Summary 0.660282665286157 | |
| AKR1B15 Mitochondrion Summary 0.660282665286157 | |
| AKR1B15 Plasma membrane Summary 0.660282665286157 | |
| AKR1C1 Cytosol Metabolism of xenobiotics by cytochrome P450 0.6350578049366634 | |
| AKR1C1 Cytosol Steroid hormone biosynthesis 0.6350578049366634 | |
| AKR1C1 Endoplasmic Reticulum Metabolism of xenobiotics by cytochrome P450 0.6350578049366634 | |
| AKR1C1 Endoplasmic Reticulum Steroid hormone biosynthesis 0.6350578049366634 | |
| AKR1C2 Cytosol Summary 0.5277899070120396 | |
| AKR1C2 Endoplasmic Reticulum Summary 0.5277899070120396 | |
| AKR1C2 Nucleus Summary 0.5277899070120396 | |
| AKR1C3 Cytosol Arachidonic acid metabolism 1.1256136297883137 | |
| AKR1C3 Cytosol Folate biosynthesis 1.1256136297883137 | |
| AKR1C3 Cytosol Metabolic pathways 1.1256136297883137 | |
| AKR1C3 Cytosol Ovarian steroidogenesis 1.1256136297883137 | |
| AKR1C3 Cytosol Steroid hormone biosynthesis 1.1256136297883137 | |
| AKR1C3 Endoplasmic Reticulum Arachidonic acid metabolism 1.1256136297883137 | |
| AKR1C3 Endoplasmic Reticulum Folate biosynthesis 1.1256136297883137 | |
| AKR1C3 Endoplasmic Reticulum Metabolic pathways 1.1256136297883137 | |
| AKR1C3 Endoplasmic Reticulum Ovarian steroidogenesis 1.1256136297883137 | |
| AKR1C3 Endoplasmic Reticulum Steroid hormone biosynthesis 1.1256136297883137 | |
| AKR1C3 Nucleus Arachidonic acid metabolism 1.1256136297883137 | |
| AKR1C3 Nucleus Folate biosynthesis 1.1256136297883137 | |
| AKR1C3 Nucleus Metabolic pathways 1.1256136297883137 | |
| AKR1C3 Nucleus Ovarian steroidogenesis 1.1256136297883137 | |
| AKR1C3 Nucleus Steroid hormone biosynthesis 1.1256136297883137 | |
| AKR1E2 Cytosol Summary 0.8675508662954575 | |
| AKR1E2 Golgi apparatus Summary 0.8675508662954575 | |
| AKR1E2 Nucleus Summary 0.8675508662954575 | |
| AKR7A2 Cytosol Summary 0.4742944141744213 | |
| AKR7A2 Golgi apparatus Summary 0.4742944141744213 | |
| AKR7A3 Cytosol Summary 0.048879020702364065 | |
| AKT1 Cytoskeleton AGE-RAGE signaling pathway in diabetic complications 0.5052878834160216 | |
| AKT1 Cytoskeleton AMPK signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Acute myeloid leukemia 0.5052878834160216 | |
| AKT1 Cytoskeleton Adipocytokine signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Adrenergic signaling in cardiomyocytes 0.5052878834160216 | |
| AKT1 Cytoskeleton Alzheimer disease 0.5052878834160216 | |
| AKT1 Cytoskeleton Apelin signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Apoptosis 0.5052878834160216 | |
| AKT1 Cytoskeleton Autophagy - animal 0.5052878834160216 | |
| AKT1 Cytoskeleton B cell receptor signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Breast cancer 0.5052878834160216 | |
| AKT1 Cytoskeleton C-type lectin receptor signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Carbohydrate digestion and absorption 0.5052878834160216 | |
| AKT1 Cytoskeleton Cellular senescence 0.5052878834160216 | |
| AKT1 Cytoskeleton Central carbon metabolism in cancer 0.5052878834160216 | |
| AKT1 Cytoskeleton Chagas disease 0.5052878834160216 | |
| AKT1 Cytoskeleton Chemical carcinogenesis - receptor activation 0.5052878834160216 | |
| AKT1 Cytoskeleton Chemokine signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Choline metabolism in cancer 0.5052878834160216 | |
| AKT1 Cytoskeleton Cholinergic synapse 0.5052878834160216 | |
| AKT1 Cytoskeleton Chronic myeloid leukemia 0.5052878834160216 | |
| AKT1 Cytoskeleton Colorectal cancer 0.5052878834160216 | |
| AKT1 Cytoskeleton Diabetic cardiomyopathy 0.5052878834160216 | |
| AKT1 Cytoskeleton Dopaminergic synapse 0.5052878834160216 | |
| AKT1 Cytoskeleton EGFR tyrosine kinase inhibitor resistance 0.5052878834160216 | |
| AKT1 Cytoskeleton Endocrine resistance 0.5052878834160216 | |
| AKT1 Cytoskeleton Endometrial cancer 0.5052878834160216 | |
| AKT1 Cytoskeleton Epstein-Barr virus infection 0.5052878834160216 | |
| AKT1 Cytoskeleton ErbB signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Estrogen signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Fc epsilon RI signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Fc gamma R-mediated phagocytosis 0.5052878834160216 | |
| AKT1 Cytoskeleton Fluid shear stress and atherosclerosis 0.5052878834160216 | |
| AKT1 Cytoskeleton Focal adhesion 0.5052878834160216 | |
| AKT1 Cytoskeleton FoxO signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Gastric cancer 0.5052878834160216 | |
| AKT1 Cytoskeleton Glioma 0.5052878834160216 | |
| AKT1 Cytoskeleton Glucagon signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton GnRH secretion 0.5052878834160216 | |
| AKT1 Cytoskeleton Growth hormone synthesis secretion and action 0.5052878834160216 | |
| AKT1 Cytoskeleton HIF-1 signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Hepatitis B 0.5052878834160216 | |
| AKT1 Cytoskeleton Hepatitis C 0.5052878834160216 | |
| AKT1 Cytoskeleton Hepatocellular carcinoma 0.5052878834160216 | |
| AKT1 Cytoskeleton Herpes simplex virus 1 infection 0.5052878834160216 | |
| AKT1 Cytoskeleton Human T-cell leukemia virus 1 infection 0.5052878834160216 | |
| AKT1 Cytoskeleton Human cytomegalovirus infection 0.5052878834160216 | |
| AKT1 Cytoskeleton Human immunodeficiency virus 1 infection 0.5052878834160216 | |
| AKT1 Cytoskeleton Human papillomavirus infection 0.5052878834160216 | |
| AKT1 Cytoskeleton Influenza A 0.5052878834160216 | |
| AKT1 Cytoskeleton Insulin resistance 0.5052878834160216 | |
| AKT1 Cytoskeleton Insulin signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton JAK-STAT signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Kaposi sarcoma-associated herpesvirus infection 0.5052878834160216 | |
| AKT1 Cytoskeleton Lipid and atherosclerosis 0.5052878834160216 | |
| AKT1 Cytoskeleton Longevity regulating pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Longevity regulating pathway - multiple species 0.5052878834160216 | |
| AKT1 Cytoskeleton MAPK signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Measles 0.5052878834160216 | |
| AKT1 Cytoskeleton Melanoma 0.5052878834160216 | |
| AKT1 Cytoskeleton Neurotrophin signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Neutrophil extracellular trap formation 0.5052878834160216 | |
| AKT1 Cytoskeleton Non-alcoholic fatty liver disease 0.5052878834160216 | |
| AKT1 Cytoskeleton Non-small cell lung cancer 0.5052878834160216 | |
| AKT1 Cytoskeleton Osteoclast differentiation 0.5052878834160216 | |
| AKT1 Cytoskeleton PD-L1 expression and PD-1 checkpoint pathway in cancer 0.5052878834160216 | |
| AKT1 Cytoskeleton PI3K-Akt signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Pancreatic cancer 0.5052878834160216 | |
| AKT1 Cytoskeleton Pathways in cancer 0.5052878834160216 | |
| AKT1 Cytoskeleton Phospholipase D signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Platelet activation 0.5052878834160216 | |
| AKT1 Cytoskeleton Platinum drug resistance 0.5052878834160216 | |
| AKT1 Cytoskeleton Progesterone-mediated oocyte maturation 0.5052878834160216 | |
| AKT1 Cytoskeleton Prolactin signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Prostate cancer 0.5052878834160216 | |
| AKT1 Cytoskeleton Proteoglycans in cancer 0.5052878834160216 | |
| AKT1 Cytoskeleton Rap1 signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Ras signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Regulation of lipolysis in adipocytes 0.5052878834160216 | |
| AKT1 Cytoskeleton Relaxin signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Renal cell carcinoma 0.5052878834160216 | |
| AKT1 Cytoskeleton Salmonella infection 0.5052878834160216 | |
| AKT1 Cytoskeleton Shigellosis 0.5052878834160216 | |
| AKT1 Cytoskeleton Signaling pathways regulating pluripotency of stem cells 0.5052878834160216 | |
| AKT1 Cytoskeleton Small cell lung cancer 0.5052878834160216 | |
| AKT1 Cytoskeleton Sphingolipid signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Spinocerebellar ataxia 0.5052878834160216 | |
| AKT1 Cytoskeleton T cell receptor signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton TNF signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Thyroid hormone signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Toll-like receptor signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Toxoplasmosis 0.5052878834160216 | |
| AKT1 Cytoskeleton Tuberculosis 0.5052878834160216 | |
| AKT1 Cytoskeleton VEGF signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton Yersinia infection 0.5052878834160216 | |
| AKT1 Cytoskeleton cAMP signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton cGMP-PKG signaling pathway 0.5052878834160216 | |
| AKT1 Cytoskeleton mTOR signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol AGE-RAGE signaling pathway in diabetic complications 0.5052878834160216 | |
| AKT1 Cytosol AMPK signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Acute myeloid leukemia 0.5052878834160216 | |
| AKT1 Cytosol Adipocytokine signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Adrenergic signaling in cardiomyocytes 0.5052878834160216 | |
| AKT1 Cytosol Alzheimer disease 0.5052878834160216 | |
| AKT1 Cytosol Apelin signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Apoptosis 0.5052878834160216 | |
| AKT1 Cytosol Autophagy - animal 0.5052878834160216 | |
| AKT1 Cytosol B cell receptor signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Breast cancer 0.5052878834160216 | |
| AKT1 Cytosol C-type lectin receptor signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Carbohydrate digestion and absorption 0.5052878834160216 | |
| AKT1 Cytosol Cellular senescence 0.5052878834160216 | |
| AKT1 Cytosol Central carbon metabolism in cancer 0.5052878834160216 | |
| AKT1 Cytosol Chagas disease 0.5052878834160216 | |
| AKT1 Cytosol Chemical carcinogenesis - receptor activation 0.5052878834160216 | |
| AKT1 Cytosol Chemokine signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Choline metabolism in cancer 0.5052878834160216 | |
| AKT1 Cytosol Cholinergic synapse 0.5052878834160216 | |
| AKT1 Cytosol Chronic myeloid leukemia 0.5052878834160216 | |
| AKT1 Cytosol Colorectal cancer 0.5052878834160216 | |
| AKT1 Cytosol Diabetic cardiomyopathy 0.5052878834160216 | |
| AKT1 Cytosol Dopaminergic synapse 0.5052878834160216 | |
| AKT1 Cytosol EGFR tyrosine kinase inhibitor resistance 0.5052878834160216 | |
| AKT1 Cytosol Endocrine resistance 0.5052878834160216 | |
| AKT1 Cytosol Endometrial cancer 0.5052878834160216 | |
| AKT1 Cytosol Epstein-Barr virus infection 0.5052878834160216 | |
| AKT1 Cytosol ErbB signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Estrogen signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Fc epsilon RI signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Fc gamma R-mediated phagocytosis 0.5052878834160216 | |
| AKT1 Cytosol Fluid shear stress and atherosclerosis 0.5052878834160216 | |
| AKT1 Cytosol Focal adhesion 0.5052878834160216 | |
| AKT1 Cytosol FoxO signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Gastric cancer 0.5052878834160216 | |
| AKT1 Cytosol Glioma 0.5052878834160216 | |
| AKT1 Cytosol Glucagon signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol GnRH secretion 0.5052878834160216 | |
| AKT1 Cytosol Growth hormone synthesis secretion and action 0.5052878834160216 | |
| AKT1 Cytosol HIF-1 signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Hepatitis B 0.5052878834160216 | |
| AKT1 Cytosol Hepatitis C 0.5052878834160216 | |
| AKT1 Cytosol Hepatocellular carcinoma 0.5052878834160216 | |
| AKT1 Cytosol Herpes simplex virus 1 infection 0.5052878834160216 | |
| AKT1 Cytosol Human T-cell leukemia virus 1 infection 0.5052878834160216 | |
| AKT1 Cytosol Human cytomegalovirus infection 0.5052878834160216 | |
| AKT1 Cytosol Human immunodeficiency virus 1 infection 0.5052878834160216 | |
| AKT1 Cytosol Human papillomavirus infection 0.5052878834160216 | |
| AKT1 Cytosol Influenza A 0.5052878834160216 | |
| AKT1 Cytosol Insulin resistance 0.5052878834160216 | |
| AKT1 Cytosol Insulin signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol JAK-STAT signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Kaposi sarcoma-associated herpesvirus infection 0.5052878834160216 | |
| AKT1 Cytosol Lipid and atherosclerosis 0.5052878834160216 | |
| AKT1 Cytosol Longevity regulating pathway 0.5052878834160216 | |
| AKT1 Cytosol Longevity regulating pathway - multiple species 0.5052878834160216 | |
| AKT1 Cytosol MAPK signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Measles 0.5052878834160216 | |
| AKT1 Cytosol Melanoma 0.5052878834160216 | |
| AKT1 Cytosol Neurotrophin signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Neutrophil extracellular trap formation 0.5052878834160216 | |
| AKT1 Cytosol Non-alcoholic fatty liver disease 0.5052878834160216 | |
| AKT1 Cytosol Non-small cell lung cancer 0.5052878834160216 | |
| AKT1 Cytosol Osteoclast differentiation 0.5052878834160216 | |
| AKT1 Cytosol PD-L1 expression and PD-1 checkpoint pathway in cancer 0.5052878834160216 | |
| AKT1 Cytosol PI3K-Akt signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Pancreatic cancer 0.5052878834160216 | |
| AKT1 Cytosol Pathways in cancer 0.5052878834160216 | |
| AKT1 Cytosol Phospholipase D signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Platelet activation 0.5052878834160216 | |
| AKT1 Cytosol Platinum drug resistance 0.5052878834160216 | |
| AKT1 Cytosol Progesterone-mediated oocyte maturation 0.5052878834160216 | |
| AKT1 Cytosol Prolactin signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Prostate cancer 0.5052878834160216 | |
| AKT1 Cytosol Proteoglycans in cancer 0.5052878834160216 | |
| AKT1 Cytosol Rap1 signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Ras signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Regulation of lipolysis in adipocytes 0.5052878834160216 | |
| AKT1 Cytosol Relaxin signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Renal cell carcinoma 0.5052878834160216 | |
| AKT1 Cytosol Salmonella infection 0.5052878834160216 | |
| AKT1 Cytosol Shigellosis 0.5052878834160216 | |
| AKT1 Cytosol Signaling pathways regulating pluripotency of stem cells 0.5052878834160216 | |
| AKT1 Cytosol Small cell lung cancer 0.5052878834160216 | |
| AKT1 Cytosol Sphingolipid signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Spinocerebellar ataxia 0.5052878834160216 | |
| AKT1 Cytosol T cell receptor signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol TNF signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Thyroid hormone signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Toll-like receptor signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Toxoplasmosis 0.5052878834160216 | |
| AKT1 Cytosol Tuberculosis 0.5052878834160216 | |
| AKT1 Cytosol VEGF signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol Yersinia infection 0.5052878834160216 | |
| AKT1 Cytosol cAMP signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol cGMP-PKG signaling pathway 0.5052878834160216 | |
| AKT1 Cytosol mTOR signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus AGE-RAGE signaling pathway in diabetic complications 0.5052878834160216 | |
| AKT1 Nucleus AMPK signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Acute myeloid leukemia 0.5052878834160216 | |
| AKT1 Nucleus Adipocytokine signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Adrenergic signaling in cardiomyocytes 0.5052878834160216 | |
| AKT1 Nucleus Alzheimer disease 0.5052878834160216 | |
| AKT1 Nucleus Apelin signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Apoptosis 0.5052878834160216 | |
| AKT1 Nucleus Autophagy - animal 0.5052878834160216 | |
| AKT1 Nucleus B cell receptor signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Breast cancer 0.5052878834160216 | |
| AKT1 Nucleus C-type lectin receptor signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Carbohydrate digestion and absorption 0.5052878834160216 | |
| AKT1 Nucleus Cellular senescence 0.5052878834160216 | |
| AKT1 Nucleus Central carbon metabolism in cancer 0.5052878834160216 | |
| AKT1 Nucleus Chagas disease 0.5052878834160216 | |
| AKT1 Nucleus Chemical carcinogenesis - receptor activation 0.5052878834160216 | |
| AKT1 Nucleus Chemokine signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Choline metabolism in cancer 0.5052878834160216 | |
| AKT1 Nucleus Cholinergic synapse 0.5052878834160216 | |
| AKT1 Nucleus Chronic myeloid leukemia 0.5052878834160216 | |
| AKT1 Nucleus Colorectal cancer 0.5052878834160216 | |
| AKT1 Nucleus Diabetic cardiomyopathy 0.5052878834160216 | |
| AKT1 Nucleus Dopaminergic synapse 0.5052878834160216 | |
| AKT1 Nucleus EGFR tyrosine kinase inhibitor resistance 0.5052878834160216 | |
| AKT1 Nucleus Endocrine resistance 0.5052878834160216 | |
| AKT1 Nucleus Endometrial cancer 0.5052878834160216 | |
| AKT1 Nucleus Epstein-Barr virus infection 0.5052878834160216 | |
| AKT1 Nucleus ErbB signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Estrogen signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Fc epsilon RI signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Fc gamma R-mediated phagocytosis 0.5052878834160216 | |
| AKT1 Nucleus Fluid shear stress and atherosclerosis 0.5052878834160216 | |
| AKT1 Nucleus Focal adhesion 0.5052878834160216 | |
| AKT1 Nucleus FoxO signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Gastric cancer 0.5052878834160216 | |
| AKT1 Nucleus Glioma 0.5052878834160216 | |
| AKT1 Nucleus Glucagon signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus GnRH secretion 0.5052878834160216 | |
| AKT1 Nucleus Growth hormone synthesis secretion and action 0.5052878834160216 | |
| AKT1 Nucleus HIF-1 signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Hepatitis B 0.5052878834160216 | |
| AKT1 Nucleus Hepatitis C 0.5052878834160216 | |
| AKT1 Nucleus Hepatocellular carcinoma 0.5052878834160216 | |
| AKT1 Nucleus Herpes simplex virus 1 infection 0.5052878834160216 | |
| AKT1 Nucleus Human T-cell leukemia virus 1 infection 0.5052878834160216 | |
| AKT1 Nucleus Human cytomegalovirus infection 0.5052878834160216 | |
| AKT1 Nucleus Human immunodeficiency virus 1 infection 0.5052878834160216 | |
| AKT1 Nucleus Human papillomavirus infection 0.5052878834160216 | |
| AKT1 Nucleus Influenza A 0.5052878834160216 | |
| AKT1 Nucleus Insulin resistance 0.5052878834160216 | |
| AKT1 Nucleus Insulin signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus JAK-STAT signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Kaposi sarcoma-associated herpesvirus infection 0.5052878834160216 | |
| AKT1 Nucleus Lipid and atherosclerosis 0.5052878834160216 | |
| AKT1 Nucleus Longevity regulating pathway 0.5052878834160216 | |
| AKT1 Nucleus Longevity regulating pathway - multiple species 0.5052878834160216 | |
| AKT1 Nucleus MAPK signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Measles 0.5052878834160216 | |
| AKT1 Nucleus Melanoma 0.5052878834160216 | |
| AKT1 Nucleus Neurotrophin signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Neutrophil extracellular trap formation 0.5052878834160216 | |
| AKT1 Nucleus Non-alcoholic fatty liver disease 0.5052878834160216 | |
| AKT1 Nucleus Non-small cell lung cancer 0.5052878834160216 | |
| AKT1 Nucleus Osteoclast differentiation 0.5052878834160216 | |
| AKT1 Nucleus PD-L1 expression and PD-1 checkpoint pathway in cancer 0.5052878834160216 | |
| AKT1 Nucleus PI3K-Akt signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Pancreatic cancer 0.5052878834160216 | |
| AKT1 Nucleus Pathways in cancer 0.5052878834160216 | |
| AKT1 Nucleus Phospholipase D signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Platelet activation 0.5052878834160216 | |
| AKT1 Nucleus Platinum drug resistance 0.5052878834160216 | |
| AKT1 Nucleus Progesterone-mediated oocyte maturation 0.5052878834160216 | |
| AKT1 Nucleus Prolactin signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Prostate cancer 0.5052878834160216 | |
| AKT1 Nucleus Proteoglycans in cancer 0.5052878834160216 | |
| AKT1 Nucleus Rap1 signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Ras signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Regulation of lipolysis in adipocytes 0.5052878834160216 | |
| AKT1 Nucleus Relaxin signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Renal cell carcinoma 0.5052878834160216 | |
| AKT1 Nucleus Salmonella infection 0.5052878834160216 | |
| AKT1 Nucleus Shigellosis 0.5052878834160216 | |
| AKT1 Nucleus Signaling pathways regulating pluripotency of stem cells 0.5052878834160216 | |
| AKT1 Nucleus Small cell lung cancer 0.5052878834160216 | |
| AKT1 Nucleus Sphingolipid signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Spinocerebellar ataxia 0.5052878834160216 | |
| AKT1 Nucleus T cell receptor signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus TNF signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Thyroid hormone signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Toll-like receptor signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Toxoplasmosis 0.5052878834160216 | |
| AKT1 Nucleus Tuberculosis 0.5052878834160216 | |
| AKT1 Nucleus VEGF signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus Yersinia infection 0.5052878834160216 | |
| AKT1 Nucleus cAMP signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus cGMP-PKG signaling pathway 0.5052878834160216 | |
| AKT1 Nucleus mTOR signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane AGE-RAGE signaling pathway in diabetic complications 0.5052878834160216 | |
| AKT1 Plasma membrane AMPK signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Acute myeloid leukemia 0.5052878834160216 | |
| AKT1 Plasma membrane Adipocytokine signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Adrenergic signaling in cardiomyocytes 0.5052878834160216 | |
| AKT1 Plasma membrane Alzheimer disease 0.5052878834160216 | |
| AKT1 Plasma membrane Apelin signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Apoptosis 0.5052878834160216 | |
| AKT1 Plasma membrane Autophagy - animal 0.5052878834160216 | |
| AKT1 Plasma membrane B cell receptor signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Breast cancer 0.5052878834160216 | |
| AKT1 Plasma membrane C-type lectin receptor signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Carbohydrate digestion and absorption 0.5052878834160216 | |
| AKT1 Plasma membrane Cellular senescence 0.5052878834160216 | |
| AKT1 Plasma membrane Central carbon metabolism in cancer 0.5052878834160216 | |
| AKT1 Plasma membrane Chagas disease 0.5052878834160216 | |
| AKT1 Plasma membrane Chemical carcinogenesis - receptor activation 0.5052878834160216 | |
| AKT1 Plasma membrane Chemokine signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Choline metabolism in cancer 0.5052878834160216 | |
| AKT1 Plasma membrane Cholinergic synapse 0.5052878834160216 | |
| AKT1 Plasma membrane Chronic myeloid leukemia 0.5052878834160216 | |
| AKT1 Plasma membrane Colorectal cancer 0.5052878834160216 | |
| AKT1 Plasma membrane Diabetic cardiomyopathy 0.5052878834160216 | |
| AKT1 Plasma membrane Dopaminergic synapse 0.5052878834160216 | |
| AKT1 Plasma membrane EGFR tyrosine kinase inhibitor resistance 0.5052878834160216 | |
| AKT1 Plasma membrane Endocrine resistance 0.5052878834160216 | |
| AKT1 Plasma membrane Endometrial cancer 0.5052878834160216 | |
| AKT1 Plasma membrane Epstein-Barr virus infection 0.5052878834160216 | |
| AKT1 Plasma membrane ErbB signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Estrogen signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Fc epsilon RI signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Fc gamma R-mediated phagocytosis 0.5052878834160216 | |
| AKT1 Plasma membrane Fluid shear stress and atherosclerosis 0.5052878834160216 | |
| AKT1 Plasma membrane Focal adhesion 0.5052878834160216 | |
| AKT1 Plasma membrane FoxO signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Gastric cancer 0.5052878834160216 | |
| AKT1 Plasma membrane Glioma 0.5052878834160216 | |
| AKT1 Plasma membrane Glucagon signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane GnRH secretion 0.5052878834160216 | |
| AKT1 Plasma membrane Growth hormone synthesis secretion and action 0.5052878834160216 | |
| AKT1 Plasma membrane HIF-1 signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Hepatitis B 0.5052878834160216 | |
| AKT1 Plasma membrane Hepatitis C 0.5052878834160216 | |
| AKT1 Plasma membrane Hepatocellular carcinoma 0.5052878834160216 | |
| AKT1 Plasma membrane Herpes simplex virus 1 infection 0.5052878834160216 | |
| AKT1 Plasma membrane Human T-cell leukemia virus 1 infection 0.5052878834160216 | |
| AKT1 Plasma membrane Human cytomegalovirus infection 0.5052878834160216 | |
| AKT1 Plasma membrane Human immunodeficiency virus 1 infection 0.5052878834160216 | |
| AKT1 Plasma membrane Human papillomavirus infection 0.5052878834160216 | |
| AKT1 Plasma membrane Influenza A 0.5052878834160216 | |
| AKT1 Plasma membrane Insulin resistance 0.5052878834160216 | |
| AKT1 Plasma membrane Insulin signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane JAK-STAT signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Kaposi sarcoma-associated herpesvirus infection 0.5052878834160216 | |
| AKT1 Plasma membrane Lipid and atherosclerosis 0.5052878834160216 | |
| AKT1 Plasma membrane Longevity regulating pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Longevity regulating pathway - multiple species 0.5052878834160216 | |
| AKT1 Plasma membrane MAPK signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Measles 0.5052878834160216 | |
| AKT1 Plasma membrane Melanoma 0.5052878834160216 | |
| AKT1 Plasma membrane Neurotrophin signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Neutrophil extracellular trap formation 0.5052878834160216 | |
| AKT1 Plasma membrane Non-alcoholic fatty liver disease 0.5052878834160216 | |
| AKT1 Plasma membrane Non-small cell lung cancer 0.5052878834160216 | |
| AKT1 Plasma membrane Osteoclast differentiation 0.5052878834160216 | |
| AKT1 Plasma membrane PD-L1 expression and PD-1 checkpoint pathway in cancer 0.5052878834160216 | |
| AKT1 Plasma membrane PI3K-Akt signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Pancreatic cancer 0.5052878834160216 | |
| AKT1 Plasma membrane Pathways in cancer 0.5052878834160216 | |
| AKT1 Plasma membrane Phospholipase D signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Platelet activation 0.5052878834160216 | |
| AKT1 Plasma membrane Platinum drug resistance 0.5052878834160216 | |
| AKT1 Plasma membrane Progesterone-mediated oocyte maturation 0.5052878834160216 | |
| AKT1 Plasma membrane Prolactin signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Prostate cancer 0.5052878834160216 | |
| AKT1 Plasma membrane Proteoglycans in cancer 0.5052878834160216 | |
| AKT1 Plasma membrane Rap1 signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Ras signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Regulation of lipolysis in adipocytes 0.5052878834160216 | |
| AKT1 Plasma membrane Relaxin signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Renal cell carcinoma 0.5052878834160216 | |
| AKT1 Plasma membrane Salmonella infection 0.5052878834160216 | |
| AKT1 Plasma membrane Shigellosis 0.5052878834160216 | |
| AKT1 Plasma membrane Signaling pathways regulating pluripotency of stem cells 0.5052878834160216 | |
| AKT1 Plasma membrane Small cell lung cancer 0.5052878834160216 | |
| AKT1 Plasma membrane Sphingolipid signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Spinocerebellar ataxia 0.5052878834160216 | |
| AKT1 Plasma membrane T cell receptor signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane TNF signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Thyroid hormone signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Toll-like receptor signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Toxoplasmosis 0.5052878834160216 | |
| AKT1 Plasma membrane Tuberculosis 0.5052878834160216 | |
| AKT1 Plasma membrane VEGF signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane Yersinia infection 0.5052878834160216 | |
| AKT1 Plasma membrane cAMP signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane cGMP-PKG signaling pathway 0.5052878834160216 | |
| AKT1 Plasma membrane mTOR signaling pathway 0.5052878834160216 | |
| AKT1S1 Cytosol Summary 1.0079717462911704 | |
| AKT2 Cytosol AGE-RAGE signaling pathway in diabetic complications 1.0081920816519705 | |
| AKT2 Cytosol AMPK signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Acute myeloid leukemia 1.0081920816519705 | |
| AKT2 Cytosol Adipocytokine signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Adrenergic signaling in cardiomyocytes 1.0081920816519705 | |
| AKT2 Cytosol Alzheimer disease 1.0081920816519705 | |
| AKT2 Cytosol Apelin signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Apoptosis 1.0081920816519705 | |
| AKT2 Cytosol Autophagy - animal 1.0081920816519705 | |
| AKT2 Cytosol B cell receptor signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Breast cancer 1.0081920816519705 | |
| AKT2 Cytosol C-type lectin receptor signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Carbohydrate digestion and absorption 1.0081920816519705 | |
| AKT2 Cytosol Cellular senescence 1.0081920816519705 | |
| AKT2 Cytosol Central carbon metabolism in cancer 1.0081920816519705 | |
| AKT2 Cytosol Chagas disease 1.0081920816519705 | |
| AKT2 Cytosol Chemical carcinogenesis - receptor activation 1.0081920816519705 | |
| AKT2 Cytosol Chemokine signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Choline metabolism in cancer 1.0081920816519705 | |
| AKT2 Cytosol Cholinergic synapse 1.0081920816519705 | |
| AKT2 Cytosol Chronic myeloid leukemia 1.0081920816519705 | |
| AKT2 Cytosol Colorectal cancer 1.0081920816519705 | |
| AKT2 Cytosol Diabetic cardiomyopathy 1.0081920816519705 | |
| AKT2 Cytosol Dopaminergic synapse 1.0081920816519705 | |
| AKT2 Cytosol EGFR tyrosine kinase inhibitor resistance 1.0081920816519705 | |
| AKT2 Cytosol Endocrine resistance 1.0081920816519705 | |
| AKT2 Cytosol Endometrial cancer 1.0081920816519705 | |
| AKT2 Cytosol Epstein-Barr virus infection 1.0081920816519705 | |
| AKT2 Cytosol ErbB signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Estrogen signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Fc epsilon RI signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Fc gamma R-mediated phagocytosis 1.0081920816519705 | |
| AKT2 Cytosol Fluid shear stress and atherosclerosis 1.0081920816519705 | |
| AKT2 Cytosol Focal adhesion 1.0081920816519705 | |
| AKT2 Cytosol FoxO signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Gastric cancer 1.0081920816519705 | |
| AKT2 Cytosol Glioma 1.0081920816519705 | |
| AKT2 Cytosol Glucagon signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol GnRH secretion 1.0081920816519705 | |
| AKT2 Cytosol Growth hormone synthesis secretion and action 1.0081920816519705 | |
| AKT2 Cytosol HIF-1 signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Hepatitis B 1.0081920816519705 | |
| AKT2 Cytosol Hepatitis C 1.0081920816519705 | |
| AKT2 Cytosol Hepatocellular carcinoma 1.0081920816519705 | |
| AKT2 Cytosol Herpes simplex virus 1 infection 1.0081920816519705 | |
| AKT2 Cytosol Human T-cell leukemia virus 1 infection 1.0081920816519705 | |
| AKT2 Cytosol Human cytomegalovirus infection 1.0081920816519705 | |
| AKT2 Cytosol Human immunodeficiency virus 1 infection 1.0081920816519705 | |
| AKT2 Cytosol Human papillomavirus infection 1.0081920816519705 | |
| AKT2 Cytosol Influenza A 1.0081920816519705 | |
| AKT2 Cytosol Insulin resistance 1.0081920816519705 | |
| AKT2 Cytosol Insulin signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol JAK-STAT signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Kaposi sarcoma-associated herpesvirus infection 1.0081920816519705 | |
| AKT2 Cytosol Lipid and atherosclerosis 1.0081920816519705 | |
| AKT2 Cytosol Longevity regulating pathway 1.0081920816519705 | |
| AKT2 Cytosol Longevity regulating pathway - multiple species 1.0081920816519705 | |
| AKT2 Cytosol MAPK signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Measles 1.0081920816519705 | |
| AKT2 Cytosol Melanoma 1.0081920816519705 | |
| AKT2 Cytosol Neurotrophin signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Neutrophil extracellular trap formation 1.0081920816519705 | |
| AKT2 Cytosol Non-alcoholic fatty liver disease 1.0081920816519705 | |
| AKT2 Cytosol Non-small cell lung cancer 1.0081920816519705 | |
| AKT2 Cytosol Osteoclast differentiation 1.0081920816519705 | |
| AKT2 Cytosol PD-L1 expression and PD-1 checkpoint pathway in cancer 1.0081920816519705 | |
| AKT2 Cytosol PI3K-Akt signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Pancreatic cancer 1.0081920816519705 | |
| AKT2 Cytosol Pathways in cancer 1.0081920816519705 | |
| AKT2 Cytosol Phospholipase D signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Platelet activation 1.0081920816519705 | |
| AKT2 Cytosol Platinum drug resistance 1.0081920816519705 | |
| AKT2 Cytosol Progesterone-mediated oocyte maturation 1.0081920816519705 | |
| AKT2 Cytosol Prolactin signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Prostate cancer 1.0081920816519705 | |
| AKT2 Cytosol Proteoglycans in cancer 1.0081920816519705 | |
| AKT2 Cytosol Rap1 signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Ras signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Regulation of lipolysis in adipocytes 1.0081920816519705 | |
| AKT2 Cytosol Relaxin signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Renal cell carcinoma 1.0081920816519705 | |
| AKT2 Cytosol Salmonella infection 1.0081920816519705 | |
| AKT2 Cytosol Shigellosis 1.0081920816519705 | |
| AKT2 Cytosol Signaling pathways regulating pluripotency of stem cells 1.0081920816519705 | |
| AKT2 Cytosol Small cell lung cancer 1.0081920816519705 | |
| AKT2 Cytosol Sphingolipid signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Spinocerebellar ataxia 1.0081920816519705 | |
| AKT2 Cytosol T cell receptor signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol TNF signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Thyroid hormone signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Toll-like receptor signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Toxoplasmosis 1.0081920816519705 | |
| AKT2 Cytosol Tuberculosis 1.0081920816519705 | |
| AKT2 Cytosol VEGF signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol Yersinia infection 1.0081920816519705 | |
| AKT2 Cytosol cAMP signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol cGMP-PKG signaling pathway 1.0081920816519705 | |
| AKT2 Cytosol mTOR signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus AGE-RAGE signaling pathway in diabetic complications 1.0081920816519705 | |
| AKT2 Nucleus AMPK signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Acute myeloid leukemia 1.0081920816519705 | |
| AKT2 Nucleus Adipocytokine signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Adrenergic signaling in cardiomyocytes 1.0081920816519705 | |
| AKT2 Nucleus Alzheimer disease 1.0081920816519705 | |
| AKT2 Nucleus Apelin signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Apoptosis 1.0081920816519705 | |
| AKT2 Nucleus Autophagy - animal 1.0081920816519705 | |
| AKT2 Nucleus B cell receptor signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Breast cancer 1.0081920816519705 | |
| AKT2 Nucleus C-type lectin receptor signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Carbohydrate digestion and absorption 1.0081920816519705 | |
| AKT2 Nucleus Cellular senescence 1.0081920816519705 | |
| AKT2 Nucleus Central carbon metabolism in cancer 1.0081920816519705 | |
| AKT2 Nucleus Chagas disease 1.0081920816519705 | |
| AKT2 Nucleus Chemical carcinogenesis - receptor activation 1.0081920816519705 | |
| AKT2 Nucleus Chemokine signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Choline metabolism in cancer 1.0081920816519705 | |
| AKT2 Nucleus Cholinergic synapse 1.0081920816519705 | |
| AKT2 Nucleus Chronic myeloid leukemia 1.0081920816519705 | |
| AKT2 Nucleus Colorectal cancer 1.0081920816519705 | |
| AKT2 Nucleus Diabetic cardiomyopathy 1.0081920816519705 | |
| AKT2 Nucleus Dopaminergic synapse 1.0081920816519705 | |
| AKT2 Nucleus EGFR tyrosine kinase inhibitor resistance 1.0081920816519705 | |
| AKT2 Nucleus Endocrine resistance 1.0081920816519705 | |
| AKT2 Nucleus Endometrial cancer 1.0081920816519705 | |
| AKT2 Nucleus Epstein-Barr virus infection 1.0081920816519705 | |
| AKT2 Nucleus ErbB signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Estrogen signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Fc epsilon RI signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Fc gamma R-mediated phagocytosis 1.0081920816519705 | |
| AKT2 Nucleus Fluid shear stress and atherosclerosis 1.0081920816519705 | |
| AKT2 Nucleus Focal adhesion 1.0081920816519705 | |
| AKT2 Nucleus FoxO signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Gastric cancer 1.0081920816519705 | |
| AKT2 Nucleus Glioma 1.0081920816519705 | |
| AKT2 Nucleus Glucagon signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus GnRH secretion 1.0081920816519705 | |
| AKT2 Nucleus Growth hormone synthesis secretion and action 1.0081920816519705 | |
| AKT2 Nucleus HIF-1 signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Hepatitis B 1.0081920816519705 | |
| AKT2 Nucleus Hepatitis C 1.0081920816519705 | |
| AKT2 Nucleus Hepatocellular carcinoma 1.0081920816519705 | |
| AKT2 Nucleus Herpes simplex virus 1 infection 1.0081920816519705 | |
| AKT2 Nucleus Human T-cell leukemia virus 1 infection 1.0081920816519705 | |
| AKT2 Nucleus Human cytomegalovirus infection 1.0081920816519705 | |
| AKT2 Nucleus Human immunodeficiency virus 1 infection 1.0081920816519705 | |
| AKT2 Nucleus Human papillomavirus infection 1.0081920816519705 | |
| AKT2 Nucleus Influenza A 1.0081920816519705 | |
| AKT2 Nucleus Insulin resistance 1.0081920816519705 | |
| AKT2 Nucleus Insulin signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus JAK-STAT signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Kaposi sarcoma-associated herpesvirus infection 1.0081920816519705 | |
| AKT2 Nucleus Lipid and atherosclerosis 1.0081920816519705 | |
| AKT2 Nucleus Longevity regulating pathway 1.0081920816519705 | |
| AKT2 Nucleus Longevity regulating pathway - multiple species 1.0081920816519705 | |
| AKT2 Nucleus MAPK signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Measles 1.0081920816519705 | |
| AKT2 Nucleus Melanoma 1.0081920816519705 | |
| AKT2 Nucleus Neurotrophin signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Neutrophil extracellular trap formation 1.0081920816519705 | |
| AKT2 Nucleus Non-alcoholic fatty liver disease 1.0081920816519705 | |
| AKT2 Nucleus Non-small cell lung cancer 1.0081920816519705 | |
| AKT2 Nucleus Osteoclast differentiation 1.0081920816519705 | |
| AKT2 Nucleus PD-L1 expression and PD-1 checkpoint pathway in cancer 1.0081920816519705 | |
| AKT2 Nucleus PI3K-Akt signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Pancreatic cancer 1.0081920816519705 | |
| AKT2 Nucleus Pathways in cancer 1.0081920816519705 | |
| AKT2 Nucleus Phospholipase D signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Platelet activation 1.0081920816519705 | |
| AKT2 Nucleus Platinum drug resistance 1.0081920816519705 | |
| AKT2 Nucleus Progesterone-mediated oocyte maturation 1.0081920816519705 | |
| AKT2 Nucleus Prolactin signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Prostate cancer 1.0081920816519705 | |
| AKT2 Nucleus Proteoglycans in cancer 1.0081920816519705 | |
| AKT2 Nucleus Rap1 signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Ras signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Regulation of lipolysis in adipocytes 1.0081920816519705 | |
| AKT2 Nucleus Relaxin signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Renal cell carcinoma 1.0081920816519705 | |
| AKT2 Nucleus Salmonella infection 1.0081920816519705 | |
| AKT2 Nucleus Shigellosis 1.0081920816519705 | |
| AKT2 Nucleus Signaling pathways regulating pluripotency of stem cells 1.0081920816519705 | |
| AKT2 Nucleus Small cell lung cancer 1.0081920816519705 | |
| AKT2 Nucleus Sphingolipid signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Spinocerebellar ataxia 1.0081920816519705 | |
| AKT2 Nucleus T cell receptor signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus TNF signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Thyroid hormone signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Toll-like receptor signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Toxoplasmosis 1.0081920816519705 | |
| AKT2 Nucleus Tuberculosis 1.0081920816519705 | |
| AKT2 Nucleus VEGF signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus Yersinia infection 1.0081920816519705 | |
| AKT2 Nucleus cAMP signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus cGMP-PKG signaling pathway 1.0081920816519705 | |
| AKT2 Nucleus mTOR signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane AGE-RAGE signaling pathway in diabetic complications 1.0081920816519705 | |
| AKT2 Plasma membrane AMPK signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Acute myeloid leukemia 1.0081920816519705 | |
| AKT2 Plasma membrane Adipocytokine signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Adrenergic signaling in cardiomyocytes 1.0081920816519705 | |
| AKT2 Plasma membrane Alzheimer disease 1.0081920816519705 | |
| AKT2 Plasma membrane Apelin signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Apoptosis 1.0081920816519705 | |
| AKT2 Plasma membrane Autophagy - animal 1.0081920816519705 | |
| AKT2 Plasma membrane B cell receptor signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Breast cancer 1.0081920816519705 | |
| AKT2 Plasma membrane C-type lectin receptor signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Carbohydrate digestion and absorption 1.0081920816519705 | |
| AKT2 Plasma membrane Cellular senescence 1.0081920816519705 | |
| AKT2 Plasma membrane Central carbon metabolism in cancer 1.0081920816519705 | |
| AKT2 Plasma membrane Chagas disease 1.0081920816519705 | |
| AKT2 Plasma membrane Chemical carcinogenesis - receptor activation 1.0081920816519705 | |
| AKT2 Plasma membrane Chemokine signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Choline metabolism in cancer 1.0081920816519705 | |
| AKT2 Plasma membrane Cholinergic synapse 1.0081920816519705 | |
| AKT2 Plasma membrane Chronic myeloid leukemia 1.0081920816519705 | |
| AKT2 Plasma membrane Colorectal cancer 1.0081920816519705 | |
| AKT2 Plasma membrane Diabetic cardiomyopathy 1.0081920816519705 | |
| AKT2 Plasma membrane Dopaminergic synapse 1.0081920816519705 | |
| AKT2 Plasma membrane EGFR tyrosine kinase inhibitor resistance 1.0081920816519705 | |
| AKT2 Plasma membrane Endocrine resistance 1.0081920816519705 | |
| AKT2 Plasma membrane Endometrial cancer 1.0081920816519705 | |
| AKT2 Plasma membrane Epstein-Barr virus infection 1.0081920816519705 | |
| AKT2 Plasma membrane ErbB signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Estrogen signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Fc epsilon RI signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Fc gamma R-mediated phagocytosis 1.0081920816519705 | |
| AKT2 Plasma membrane Fluid shear stress and atherosclerosis 1.0081920816519705 | |
| AKT2 Plasma membrane Focal adhesion 1.0081920816519705 | |
| AKT2 Plasma membrane FoxO signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Gastric cancer 1.0081920816519705 | |
| AKT2 Plasma membrane Glioma 1.0081920816519705 | |
| AKT2 Plasma membrane Glucagon signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane GnRH secretion 1.0081920816519705 | |
| AKT2 Plasma membrane Growth hormone synthesis secretion and action 1.0081920816519705 | |
| AKT2 Plasma membrane HIF-1 signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Hepatitis B 1.0081920816519705 | |
| AKT2 Plasma membrane Hepatitis C 1.0081920816519705 | |
| AKT2 Plasma membrane Hepatocellular carcinoma 1.0081920816519705 | |
| AKT2 Plasma membrane Herpes simplex virus 1 infection 1.0081920816519705 | |
| AKT2 Plasma membrane Human T-cell leukemia virus 1 infection 1.0081920816519705 | |
| AKT2 Plasma membrane Human cytomegalovirus infection 1.0081920816519705 | |
| AKT2 Plasma membrane Human immunodeficiency virus 1 infection 1.0081920816519705 | |
| AKT2 Plasma membrane Human papillomavirus infection 1.0081920816519705 | |
| AKT2 Plasma membrane Influenza A 1.0081920816519705 | |
| AKT2 Plasma membrane Insulin resistance 1.0081920816519705 | |
| AKT2 Plasma membrane Insulin signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane JAK-STAT signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Kaposi sarcoma-associated herpesvirus infection 1.0081920816519705 | |
| AKT2 Plasma membrane Lipid and atherosclerosis 1.0081920816519705 | |
| AKT2 Plasma membrane Longevity regulating pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Longevity regulating pathway - multiple species 1.0081920816519705 | |
| AKT2 Plasma membrane MAPK signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Measles 1.0081920816519705 | |
| AKT2 Plasma membrane Melanoma 1.0081920816519705 | |
| AKT2 Plasma membrane Neurotrophin signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Neutrophil extracellular trap formation 1.0081920816519705 | |
| AKT2 Plasma membrane Non-alcoholic fatty liver disease 1.0081920816519705 | |
| AKT2 Plasma membrane Non-small cell lung cancer 1.0081920816519705 | |
| AKT2 Plasma membrane Osteoclast differentiation 1.0081920816519705 | |
| AKT2 Plasma membrane PD-L1 expression and PD-1 checkpoint pathway in cancer 1.0081920816519705 | |
| AKT2 Plasma membrane PI3K-Akt signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Pancreatic cancer 1.0081920816519705 | |
| AKT2 Plasma membrane Pathways in cancer 1.0081920816519705 | |
| AKT2 Plasma membrane Phospholipase D signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Platelet activation 1.0081920816519705 | |
| AKT2 Plasma membrane Platinum drug resistance 1.0081920816519705 | |
| AKT2 Plasma membrane Progesterone-mediated oocyte maturation 1.0081920816519705 | |
| AKT2 Plasma membrane Prolactin signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Prostate cancer 1.0081920816519705 | |
| AKT2 Plasma membrane Proteoglycans in cancer 1.0081920816519705 | |
| AKT2 Plasma membrane Rap1 signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Ras signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Regulation of lipolysis in adipocytes 1.0081920816519705 | |
| AKT2 Plasma membrane Relaxin signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Renal cell carcinoma 1.0081920816519705 | |
| AKT2 Plasma membrane Salmonella infection 1.0081920816519705 | |
| AKT2 Plasma membrane Shigellosis 1.0081920816519705 | |
| AKT2 Plasma membrane Signaling pathways regulating pluripotency of stem cells 1.0081920816519705 | |
| AKT2 Plasma membrane Small cell lung cancer 1.0081920816519705 | |
| AKT2 Plasma membrane Sphingolipid signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Spinocerebellar ataxia 1.0081920816519705 | |
| AKT2 Plasma membrane T cell receptor signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane TNF signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Thyroid hormone signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Toll-like receptor signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Toxoplasmosis 1.0081920816519705 | |
| AKT2 Plasma membrane Tuberculosis 1.0081920816519705 | |
| AKT2 Plasma membrane VEGF signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane Yersinia infection 1.0081920816519705 | |
| AKT2 Plasma membrane cAMP signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane cGMP-PKG signaling pathway 1.0081920816519705 | |
| AKT2 Plasma membrane mTOR signaling pathway 1.0081920816519705 | |
| AKT3 Cytosol AGE-RAGE signaling pathway in diabetic complications 2.28218108548139 | |
| AKT3 Cytosol AMPK signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Acute myeloid leukemia 2.28218108548139 | |
| AKT3 Cytosol Adipocytokine signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Adrenergic signaling in cardiomyocytes 2.28218108548139 | |
| AKT3 Cytosol Alzheimer disease 2.28218108548139 | |
| AKT3 Cytosol Apelin signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Apoptosis 2.28218108548139 | |
| AKT3 Cytosol Autophagy - animal 2.28218108548139 | |
| AKT3 Cytosol B cell receptor signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Breast cancer 2.28218108548139 | |
| AKT3 Cytosol C-type lectin receptor signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Carbohydrate digestion and absorption 2.28218108548139 | |
| AKT3 Cytosol Cellular senescence 2.28218108548139 | |
| AKT3 Cytosol Central carbon metabolism in cancer 2.28218108548139 | |
| AKT3 Cytosol Chagas disease 2.28218108548139 | |
| AKT3 Cytosol Chemical carcinogenesis - receptor activation 2.28218108548139 | |
| AKT3 Cytosol Chemokine signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Choline metabolism in cancer 2.28218108548139 | |
| AKT3 Cytosol Cholinergic synapse 2.28218108548139 | |
| AKT3 Cytosol Chronic myeloid leukemia 2.28218108548139 | |
| AKT3 Cytosol Colorectal cancer 2.28218108548139 | |
| AKT3 Cytosol Diabetic cardiomyopathy 2.28218108548139 | |
| AKT3 Cytosol Dopaminergic synapse 2.28218108548139 | |
| AKT3 Cytosol EGFR tyrosine kinase inhibitor resistance 2.28218108548139 | |
| AKT3 Cytosol Endocrine resistance 2.28218108548139 | |
| AKT3 Cytosol Endometrial cancer 2.28218108548139 | |
| AKT3 Cytosol Epstein-Barr virus infection 2.28218108548139 | |
| AKT3 Cytosol ErbB signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Estrogen signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Fc epsilon RI signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Fc gamma R-mediated phagocytosis 2.28218108548139 | |
| AKT3 Cytosol Fluid shear stress and atherosclerosis 2.28218108548139 | |
| AKT3 Cytosol Focal adhesion 2.28218108548139 | |
| AKT3 Cytosol FoxO signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Gastric cancer 2.28218108548139 | |
| AKT3 Cytosol Glioma 2.28218108548139 | |
| AKT3 Cytosol Glucagon signaling pathway 2.28218108548139 | |
| AKT3 Cytosol GnRH secretion 2.28218108548139 | |
| AKT3 Cytosol Growth hormone synthesis secretion and action 2.28218108548139 | |
| AKT3 Cytosol HIF-1 signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Hepatitis B 2.28218108548139 | |
| AKT3 Cytosol Hepatitis C 2.28218108548139 | |
| AKT3 Cytosol Hepatocellular carcinoma 2.28218108548139 | |
| AKT3 Cytosol Herpes simplex virus 1 infection 2.28218108548139 | |
| AKT3 Cytosol Human T-cell leukemia virus 1 infection 2.28218108548139 | |
| AKT3 Cytosol Human cytomegalovirus infection 2.28218108548139 | |
| AKT3 Cytosol Human immunodeficiency virus 1 infection 2.28218108548139 | |
| AKT3 Cytosol Human papillomavirus infection 2.28218108548139 | |
| AKT3 Cytosol Influenza A 2.28218108548139 | |
| AKT3 Cytosol Insulin resistance 2.28218108548139 | |
| AKT3 Cytosol Insulin signaling pathway 2.28218108548139 | |
| AKT3 Cytosol JAK-STAT signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Kaposi sarcoma-associated herpesvirus infection 2.28218108548139 | |
| AKT3 Cytosol Lipid and atherosclerosis 2.28218108548139 | |
| AKT3 Cytosol Longevity regulating pathway 2.28218108548139 | |
| AKT3 Cytosol Longevity regulating pathway - multiple species 2.28218108548139 | |
| AKT3 Cytosol MAPK signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Measles 2.28218108548139 | |
| AKT3 Cytosol Melanoma 2.28218108548139 | |
| AKT3 Cytosol Neurotrophin signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Neutrophil extracellular trap formation 2.28218108548139 | |
| AKT3 Cytosol Non-alcoholic fatty liver disease 2.28218108548139 | |
| AKT3 Cytosol Non-small cell lung cancer 2.28218108548139 | |
| AKT3 Cytosol Osteoclast differentiation 2.28218108548139 | |
| AKT3 Cytosol PD-L1 expression and PD-1 checkpoint pathway in cancer 2.28218108548139 | |
| AKT3 Cytosol PI3K-Akt signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Pancreatic cancer 2.28218108548139 | |
| AKT3 Cytosol Pathways in cancer 2.28218108548139 | |
| AKT3 Cytosol Phospholipase D signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Platelet activation 2.28218108548139 | |
| AKT3 Cytosol Platinum drug resistance 2.28218108548139 | |
| AKT3 Cytosol Progesterone-mediated oocyte maturation 2.28218108548139 | |
| AKT3 Cytosol Prolactin signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Prostate cancer 2.28218108548139 | |
| AKT3 Cytosol Proteoglycans in cancer 2.28218108548139 | |
| AKT3 Cytosol Rap1 signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Ras signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Regulation of lipolysis in adipocytes 2.28218108548139 | |
| AKT3 Cytosol Relaxin signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Renal cell carcinoma 2.28218108548139 | |
| AKT3 Cytosol Salmonella infection 2.28218108548139 | |
| AKT3 Cytosol Shigellosis 2.28218108548139 | |
| AKT3 Cytosol Signaling pathways regulating pluripotency of stem cells 2.28218108548139 | |
| AKT3 Cytosol Small cell lung cancer 2.28218108548139 | |
| AKT3 Cytosol Sphingolipid signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Spinocerebellar ataxia 2.28218108548139 | |
| AKT3 Cytosol T cell receptor signaling pathway 2.28218108548139 | |
| AKT3 Cytosol TNF signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Thyroid hormone signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Toll-like receptor signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Toxoplasmosis 2.28218108548139 | |
| AKT3 Cytosol Tuberculosis 2.28218108548139 | |
| AKT3 Cytosol VEGF signaling pathway 2.28218108548139 | |
| AKT3 Cytosol Yersinia infection 2.28218108548139 | |
| AKT3 Cytosol cAMP signaling pathway 2.28218108548139 | |
| AKT3 Cytosol cGMP-PKG signaling pathway 2.28218108548139 | |
| AKT3 Cytosol mTOR signaling pathway 2.28218108548139 | |
| AKT3 Nucleus AGE-RAGE signaling pathway in diabetic complications 2.28218108548139 | |
| AKT3 Nucleus AMPK signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Acute myeloid leukemia 2.28218108548139 | |
| AKT3 Nucleus Adipocytokine signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Adrenergic signaling in cardiomyocytes 2.28218108548139 | |
| AKT3 Nucleus Alzheimer disease 2.28218108548139 | |
| AKT3 Nucleus Apelin signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Apoptosis 2.28218108548139 | |
| AKT3 Nucleus Autophagy - animal 2.28218108548139 | |
| AKT3 Nucleus B cell receptor signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Breast cancer 2.28218108548139 | |
| AKT3 Nucleus C-type lectin receptor signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Carbohydrate digestion and absorption 2.28218108548139 | |
| AKT3 Nucleus Cellular senescence 2.28218108548139 | |
| AKT3 Nucleus Central carbon metabolism in cancer 2.28218108548139 | |
| AKT3 Nucleus Chagas disease 2.28218108548139 | |
| AKT3 Nucleus Chemical carcinogenesis - receptor activation 2.28218108548139 | |
| AKT3 Nucleus Chemokine signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Choline metabolism in cancer 2.28218108548139 | |
| AKT3 Nucleus Cholinergic synapse 2.28218108548139 | |
| AKT3 Nucleus Chronic myeloid leukemia 2.28218108548139 | |
| AKT3 Nucleus Colorectal cancer 2.28218108548139 | |
| AKT3 Nucleus Diabetic cardiomyopathy 2.28218108548139 | |
| AKT3 Nucleus Dopaminergic synapse 2.28218108548139 | |
| AKT3 Nucleus EGFR tyrosine kinase inhibitor resistance 2.28218108548139 | |
| AKT3 Nucleus Endocrine resistance 2.28218108548139 | |
| AKT3 Nucleus Endometrial cancer 2.28218108548139 | |
| AKT3 Nucleus Epstein-Barr virus infection 2.28218108548139 | |
| AKT3 Nucleus ErbB signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Estrogen signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Fc epsilon RI signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Fc gamma R-mediated phagocytosis 2.28218108548139 | |
| AKT3 Nucleus Fluid shear stress and atherosclerosis 2.28218108548139 | |
| AKT3 Nucleus Focal adhesion 2.28218108548139 | |
| AKT3 Nucleus FoxO signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Gastric cancer 2.28218108548139 | |
| AKT3 Nucleus Glioma 2.28218108548139 | |
| AKT3 Nucleus Glucagon signaling pathway 2.28218108548139 | |
| AKT3 Nucleus GnRH secretion 2.28218108548139 | |
| AKT3 Nucleus Growth hormone synthesis secretion and action 2.28218108548139 | |
| AKT3 Nucleus HIF-1 signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Hepatitis B 2.28218108548139 | |
| AKT3 Nucleus Hepatitis C 2.28218108548139 | |
| AKT3 Nucleus Hepatocellular carcinoma 2.28218108548139 | |
| AKT3 Nucleus Herpes simplex virus 1 infection 2.28218108548139 | |
| AKT3 Nucleus Human T-cell leukemia virus 1 infection 2.28218108548139 | |
| AKT3 Nucleus Human cytomegalovirus infection 2.28218108548139 | |
| AKT3 Nucleus Human immunodeficiency virus 1 infection 2.28218108548139 | |
| AKT3 Nucleus Human papillomavirus infection 2.28218108548139 | |
| AKT3 Nucleus Influenza A 2.28218108548139 | |
| AKT3 Nucleus Insulin resistance 2.28218108548139 | |
| AKT3 Nucleus Insulin signaling pathway 2.28218108548139 | |
| AKT3 Nucleus JAK-STAT signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Kaposi sarcoma-associated herpesvirus infection 2.28218108548139 | |
| AKT3 Nucleus Lipid and atherosclerosis 2.28218108548139 | |
| AKT3 Nucleus Longevity regulating pathway 2.28218108548139 | |
| AKT3 Nucleus Longevity regulating pathway - multiple species 2.28218108548139 | |
| AKT3 Nucleus MAPK signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Measles 2.28218108548139 | |
| AKT3 Nucleus Melanoma 2.28218108548139 | |
| AKT3 Nucleus Neurotrophin signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Neutrophil extracellular trap formation 2.28218108548139 | |
| AKT3 Nucleus Non-alcoholic fatty liver disease 2.28218108548139 | |
| AKT3 Nucleus Non-small cell lung cancer 2.28218108548139 | |
| AKT3 Nucleus Osteoclast differentiation 2.28218108548139 | |
| AKT3 Nucleus PD-L1 expression and PD-1 checkpoint pathway in cancer 2.28218108548139 | |
| AKT3 Nucleus PI3K-Akt signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Pancreatic cancer 2.28218108548139 | |
| AKT3 Nucleus Pathways in cancer 2.28218108548139 | |
| AKT3 Nucleus Phospholipase D signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Platelet activation 2.28218108548139 | |
| AKT3 Nucleus Platinum drug resistance 2.28218108548139 | |
| AKT3 Nucleus Progesterone-mediated oocyte maturation 2.28218108548139 | |
| AKT3 Nucleus Prolactin signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Prostate cancer 2.28218108548139 | |
| AKT3 Nucleus Proteoglycans in cancer 2.28218108548139 | |
| AKT3 Nucleus Rap1 signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Ras signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Regulation of lipolysis in adipocytes 2.28218108548139 | |
| AKT3 Nucleus Relaxin signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Renal cell carcinoma 2.28218108548139 | |
| AKT3 Nucleus Salmonella infection 2.28218108548139 | |
| AKT3 Nucleus Shigellosis 2.28218108548139 | |
| AKT3 Nucleus Signaling pathways regulating pluripotency of stem cells 2.28218108548139 | |
| AKT3 Nucleus Small cell lung cancer 2.28218108548139 | |
| AKT3 Nucleus Sphingolipid signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Spinocerebellar ataxia 2.28218108548139 | |
| AKT3 Nucleus T cell receptor signaling pathway 2.28218108548139 | |
| AKT3 Nucleus TNF signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Thyroid hormone signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Toll-like receptor signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Toxoplasmosis 2.28218108548139 | |
| AKT3 Nucleus Tuberculosis 2.28218108548139 | |
| AKT3 Nucleus VEGF signaling pathway 2.28218108548139 | |
| AKT3 Nucleus Yersinia infection 2.28218108548139 | |
| AKT3 Nucleus cAMP signaling pathway 2.28218108548139 | |
| AKT3 Nucleus cGMP-PKG signaling pathway 2.28218108548139 | |
| AKT3 Nucleus mTOR signaling pathway 2.28218108548139 | |
| AKTIP Cytosol Summary 1.141628858003485 | |
| AKTIP Plasma membrane Summary 1.141628858003485 | |
| ALAS1 Mitochondrion Biosynthesis of cofactors 2.3549980623030424 | |
| ALAS1 Mitochondrion Glycine serine and threonine metabolism 2.3549980623030424 | |
| ALAS1 Mitochondrion Metabolic pathways 2.3549980623030424 | |
| ALAS1 Mitochondrion Porphyrin and chlorophyll metabolism 2.3549980623030424 | |
| ALAS1 Nucleus Biosynthesis of cofactors 2.3549980623030424 | |
| ALAS1 Nucleus Glycine serine and threonine metabolism 2.3549980623030424 | |
| ALAS1 Nucleus Metabolic pathways 2.3549980623030424 | |
| ALAS1 Nucleus Porphyrin and chlorophyll metabolism 2.3549980623030424 | |
| ALB Endoplasmic Reticulum Thyroid hormone synthesis 2.2496340747311665 | |
| ALB Extracellular space Thyroid hormone synthesis 2.2496340747311665 | |
| ALB Golgi apparatus Thyroid hormone synthesis 2.2496340747311665 | |
| ALCAM Plasma membrane Summary 0.20491213316473936 | |
| ALDH16A1 Mitochondrion Summary 0.6403956224326683 | |
| ALDH18A1 Mitochondrion Arginine and proline metabolism 1.1401990772646016 | |
| ALDH18A1 Mitochondrion Biosynthesis of amino acids 1.1401990772646016 | |
| ALDH18A1 Mitochondrion Metabolic pathways 1.1401990772646016 | |
| ALDH1A1 Cytosol Summary 1.381308968558861 | |
| ALDH1A2 Cytosol Summary 1.1587514294905816 | |
| ALDH1A3 Cytosol Summary 1.3436923947560249 | |
| ALDH1A3 Nucleus Summary 1.3436923947560249 | |
| ALDH1B1 Cytosol Arginine and proline metabolism 2.2630794115154944 | |
| ALDH1B1 Cytosol Ascorbate and aldarate metabolism 2.2630794115154944 | |
| ALDH1B1 Cytosol Biosynthesis of cofactors 2.2630794115154944 | |
| ALDH1B1 Cytosol Fatty acid degradation 2.2630794115154944 | |
| ALDH1B1 Cytosol Glycerolipid metabolism 2.2630794115154944 | |
| ALDH1B1 Cytosol Glycolysis / Gluconeogenesis 2.2630794115154944 | |
| ALDH1B1 Cytosol Histidine metabolism 2.2630794115154944 | |
| ALDH1B1 Cytosol Lysine degradation 2.2630794115154944 | |
| ALDH1B1 Cytosol Metabolic pathways 2.2630794115154944 | |
| ALDH1B1 Cytosol Pantothenate and CoA biosynthesis 2.2630794115154944 | |
| ALDH1B1 Cytosol Pyruvate metabolism 2.2630794115154944 | |
| ALDH1B1 Cytosol Tryptophan metabolism 2.2630794115154944 | |
| ALDH1B1 Cytosol Valine leucine and isoleucine degradation 2.2630794115154944 | |
| ALDH1B1 Cytosol beta-Alanine metabolism 2.2630794115154944 | |
| ALDH1B1 Mitochondrion Arginine and proline metabolism 2.2630794115154944 | |
| ALDH1B1 Mitochondrion Ascorbate and aldarate metabolism 2.2630794115154944 | |
| ALDH1B1 Mitochondrion Biosynthesis of cofactors 2.2630794115154944 | |
| ALDH1B1 Mitochondrion Fatty acid degradation 2.2630794115154944 | |
| ALDH1B1 Mitochondrion Glycerolipid metabolism 2.2630794115154944 | |
| ALDH1B1 Mitochondrion Glycolysis / Gluconeogenesis 2.2630794115154944 | |
| ALDH1B1 Mitochondrion Histidine metabolism 2.2630794115154944 | |
| ALDH1B1 Mitochondrion Lysine degradation 2.2630794115154944 | |
| ALDH1B1 Mitochondrion Metabolic pathways 2.2630794115154944 | |
| ALDH1B1 Mitochondrion Pantothenate and CoA biosynthesis 2.2630794115154944 | |
| ALDH1B1 Mitochondrion Pyruvate metabolism 2.2630794115154944 | |
| ALDH1B1 Mitochondrion Tryptophan metabolism 2.2630794115154944 | |
| ALDH1B1 Mitochondrion Valine leucine and isoleucine degradation 2.2630794115154944 | |
| ALDH1B1 Mitochondrion beta-Alanine metabolism 2.2630794115154944 | |
| ALDH1B1 Nucleus Arginine and proline metabolism 2.2630794115154944 | |
| ALDH1B1 Nucleus Ascorbate and aldarate metabolism 2.2630794115154944 | |
| ALDH1B1 Nucleus Biosynthesis of cofactors 2.2630794115154944 | |
| ALDH1B1 Nucleus Fatty acid degradation 2.2630794115154944 | |
| ALDH1B1 Nucleus Glycerolipid metabolism 2.2630794115154944 | |
| ALDH1B1 Nucleus Glycolysis / Gluconeogenesis 2.2630794115154944 | |
| ALDH1B1 Nucleus Histidine metabolism 2.2630794115154944 | |
| ALDH1B1 Nucleus Lysine degradation 2.2630794115154944 | |
| ALDH1B1 Nucleus Metabolic pathways 2.2630794115154944 | |
| ALDH1B1 Nucleus Pantothenate and CoA biosynthesis 2.2630794115154944 | |
| ALDH1B1 Nucleus Pyruvate metabolism 2.2630794115154944 | |
| ALDH1B1 Nucleus Tryptophan metabolism 2.2630794115154944 | |
| ALDH1B1 Nucleus Valine leucine and isoleucine degradation 2.2630794115154944 | |
| ALDH1B1 Nucleus beta-Alanine metabolism 2.2630794115154944 | |
| ALDH1L1 Cytosol Summary 2.05772590485566 | |
| ALDH1L2 Mitochondrion One carbon pool by folate 2.82535269410806 | |
| ALDH2 Mitochondrion Arginine and proline metabolism 2.069141155607237 | |
| ALDH2 Mitochondrion Ascorbate and aldarate metabolism 2.069141155607237 | |
| ALDH2 Mitochondrion Biosynthesis of cofactors 2.069141155607237 | |
| ALDH2 Mitochondrion Fatty acid degradation 2.069141155607237 | |
| ALDH2 Mitochondrion Glycerolipid metabolism 2.069141155607237 | |
| ALDH2 Mitochondrion Glycolysis / Gluconeogenesis 2.069141155607237 | |
| ALDH2 Mitochondrion Histidine metabolism 2.069141155607237 | |
| ALDH2 Mitochondrion Lysine degradation 2.069141155607237 | |
| ALDH2 Mitochondrion Metabolic pathways 2.069141155607237 | |
| ALDH2 Mitochondrion Pantothenate and CoA biosynthesis 2.069141155607237 | |
| ALDH2 Mitochondrion Pyruvate metabolism 2.069141155607237 | |
| ALDH2 Mitochondrion Tryptophan metabolism 2.069141155607237 | |
| ALDH2 Mitochondrion Valine leucine and isoleucine degradation 2.069141155607237 | |
| ALDH2 Mitochondrion beta-Alanine metabolism 2.069141155607237 | |
| ALDH3A2 Endoplasmic Reticulum Arginine and proline metabolism 0.5960674517430561 | |
| ALDH3A2 Endoplasmic Reticulum Ascorbate and aldarate metabolism 0.5960674517430561 | |
| ALDH3A2 Endoplasmic Reticulum Biosynthesis of cofactors 0.5960674517430561 | |
| ALDH3A2 Endoplasmic Reticulum Fatty acid degradation 0.5960674517430561 | |
| ALDH3A2 Endoplasmic Reticulum Glycerolipid metabolism 0.5960674517430561 | |
| ALDH3A2 Endoplasmic Reticulum Glycolysis / Gluconeogenesis 0.5960674517430561 | |
| ALDH3A2 Endoplasmic Reticulum Histidine metabolism 0.5960674517430561 | |
| ALDH3A2 Endoplasmic Reticulum Lysine degradation 0.5960674517430561 | |
| ALDH3A2 Endoplasmic Reticulum Metabolic pathways 0.5960674517430561 | |
| ALDH3A2 Endoplasmic Reticulum Pantothenate and CoA biosynthesis 0.5960674517430561 | |
| ALDH3A2 Endoplasmic Reticulum Pyruvate metabolism 0.5960674517430561 | |
| ALDH3A2 Endoplasmic Reticulum Tryptophan metabolism 0.5960674517430561 | |
| ALDH3A2 Endoplasmic Reticulum Valine leucine and isoleucine degradation 0.5960674517430561 | |
| ALDH3A2 Endoplasmic Reticulum beta-Alanine metabolism 0.5960674517430561 | |
| ALDH3B1 Plasma membrane Summary 1.3389039383683807 | |
| ALDH4A1 Mitochondrion Alanine aspartate and glutamate metabolism 0.3706932185696317 | |
| ALDH4A1 Mitochondrion Arginine and proline metabolism 0.3706932185696317 | |
| ALDH4A1 Mitochondrion Metabolic pathways 0.3706932185696317 | |
| ALDH5A1 Mitochondrion Alanine aspartate and glutamate metabolism 0.9297311888449646 | |
| ALDH5A1 Mitochondrion Butanoate metabolism 0.9297311888449646 | |
| ALDH5A1 Mitochondrion Metabolic pathways 0.9297311888449646 | |
| ALDH6A1 Mitochondrion Carbon metabolism 0.3600041692375352 | |
| ALDH6A1 Mitochondrion Inositol phosphate metabolism 0.3600041692375352 | |
| ALDH6A1 Mitochondrion Metabolic pathways 0.3600041692375352 | |
| ALDH6A1 Mitochondrion Propanoate metabolism 0.3600041692375352 | |
| ALDH6A1 Mitochondrion Valine leucine and isoleucine degradation 0.3600041692375352 | |
| ALDH6A1 Mitochondrion beta-Alanine metabolism 0.3600041692375352 | |
| ALDH7A1 Cytosol Arginine and proline metabolism 1.2537341895104757 | |
| ALDH7A1 Cytosol Ascorbate and aldarate metabolism 1.2537341895104757 | |
| ALDH7A1 Cytosol Fatty acid degradation 1.2537341895104757 | |
| ALDH7A1 Cytosol Glycerolipid metabolism 1.2537341895104757 | |
| ALDH7A1 Cytosol Glycine serine and threonine metabolism 1.2537341895104757 | |
| ALDH7A1 Cytosol Glycolysis / Gluconeogenesis 1.2537341895104757 | |
| ALDH7A1 Cytosol Histidine metabolism 1.2537341895104757 | |
| ALDH7A1 Cytosol Lysine degradation 1.2537341895104757 | |
| ALDH7A1 Cytosol Metabolic pathways 1.2537341895104757 | |
| ALDH7A1 Cytosol Pyruvate metabolism 1.2537341895104757 | |
| ALDH7A1 Cytosol Tryptophan metabolism 1.2537341895104757 | |
| ALDH7A1 Cytosol Valine leucine and isoleucine degradation 1.2537341895104757 | |
| ALDH7A1 Cytosol beta-Alanine metabolism 1.2537341895104757 | |
| ALDH7A1 Mitochondrion Arginine and proline metabolism 1.2537341895104757 | |
| ALDH7A1 Mitochondrion Ascorbate and aldarate metabolism 1.2537341895104757 | |
| ALDH7A1 Mitochondrion Fatty acid degradation 1.2537341895104757 | |
| ALDH7A1 Mitochondrion Glycerolipid metabolism 1.2537341895104757 | |
| ALDH7A1 Mitochondrion Glycine serine and threonine metabolism 1.2537341895104757 | |
| ALDH7A1 Mitochondrion Glycolysis / Gluconeogenesis 1.2537341895104757 | |
| ALDH7A1 Mitochondrion Histidine metabolism 1.2537341895104757 | |
| ALDH7A1 Mitochondrion Lysine degradation 1.2537341895104757 | |
| ALDH7A1 Mitochondrion Metabolic pathways 1.2537341895104757 | |
| ALDH7A1 Mitochondrion Pyruvate metabolism 1.2537341895104757 | |
| ALDH7A1 Mitochondrion Tryptophan metabolism 1.2537341895104757 | |
| ALDH7A1 Mitochondrion Valine leucine and isoleucine degradation 1.2537341895104757 | |
| ALDH7A1 Mitochondrion beta-Alanine metabolism 1.2537341895104757 | |
| ALDH7A1 Nucleus Arginine and proline metabolism 1.2537341895104757 | |
| ALDH7A1 Nucleus Ascorbate and aldarate metabolism 1.2537341895104757 | |
| ALDH7A1 Nucleus Fatty acid degradation 1.2537341895104757 | |
| ALDH7A1 Nucleus Glycerolipid metabolism 1.2537341895104757 | |
| ALDH7A1 Nucleus Glycine serine and threonine metabolism 1.2537341895104757 | |
| ALDH7A1 Nucleus Glycolysis / Gluconeogenesis 1.2537341895104757 | |
| ALDH7A1 Nucleus Histidine metabolism 1.2537341895104757 | |
| ALDH7A1 Nucleus Lysine degradation 1.2537341895104757 | |
| ALDH7A1 Nucleus Metabolic pathways 1.2537341895104757 | |
| ALDH7A1 Nucleus Pyruvate metabolism 1.2537341895104757 | |
| ALDH7A1 Nucleus Tryptophan metabolism 1.2537341895104757 | |
| ALDH7A1 Nucleus Valine leucine and isoleucine degradation 1.2537341895104757 | |
| ALDH7A1 Nucleus beta-Alanine metabolism 1.2537341895104757 | |
| ALDH9A1 Cytosol Summary 0.8632043828069719 | |
| ALDOA Cytosol Summary 1.0842827535277404 | |
| ALDOB Cytosol Summary 1.3042960469098457 | |
| ALDOC Cytosol Summary 2.104610516489243 | |
| ALDOC Nucleus Summary 2.104610516489243 | |
| ALG1 Endoplasmic Reticulum Metabolic pathways 0.4505513841402423 | |
| ALG1 Endoplasmic Reticulum N-Glycan biosynthesis 0.4505513841402423 | |
| ALG1 Endoplasmic Reticulum Various types of N-glycan biosynthesis 0.4505513841402423 | |
| ALG1 Nucleus Metabolic pathways 0.4505513841402423 | |
| ALG1 Nucleus N-Glycan biosynthesis 0.4505513841402423 | |
| ALG1 Nucleus Various types of N-glycan biosynthesis 0.4505513841402423 | |
| ALG11 Endoplasmic Reticulum Summary 0.5437684591874172 | |
| ALG12 Endoplasmic Reticulum Metabolic pathways 1.046067136553178 | |
| ALG12 Endoplasmic Reticulum N-Glycan biosynthesis 1.046067136553178 | |
| ALG12 Endoplasmic Reticulum Various types of N-glycan biosynthesis 1.046067136553178 | |
| ALG13 Cytosol Summary 0.9073220555219854 | |
| ALG13 Endoplasmic Reticulum Summary 0.9073220555219854 | |
| ALG2 Cytoskeleton Metabolic pathways 0.8133949621250525 | |
| ALG2 Cytoskeleton N-Glycan biosynthesis 0.8133949621250525 | |
| ALG2 Cytoskeleton Various types of N-glycan biosynthesis 0.8133949621250525 | |
| ALG2 Cytosol Metabolic pathways 0.8133949621250525 | |
| ALG2 Cytosol N-Glycan biosynthesis 0.8133949621250525 | |
| ALG2 Cytosol Various types of N-glycan biosynthesis 0.8133949621250525 | |
| ALG2 Nucleus Metabolic pathways 0.8133949621250525 | |
| ALG2 Nucleus N-Glycan biosynthesis 0.8133949621250525 | |
| ALG2 Nucleus Various types of N-glycan biosynthesis 0.8133949621250525 | |
| ALG5 Cytosol Metabolic pathways 0.7785122643778071 | |
| ALG5 Cytosol N-Glycan biosynthesis 0.7785122643778071 | |
| ALG5 Endoplasmic Reticulum Metabolic pathways 0.7785122643778071 | |
| ALG5 Endoplasmic Reticulum N-Glycan biosynthesis 0.7785122643778071 | |
| ALG6 Endoplasmic Reticulum Summary 1.2175913218523935 | |
| ALG8 Endoplasmic Reticulum Metabolic pathways 1.6236072681736178 | |
| ALG8 Endoplasmic Reticulum N-Glycan biosynthesis 1.6236072681736178 | |
| ALG8 Nucleus Metabolic pathways 1.6236072681736178 | |
| ALG8 Nucleus N-Glycan biosynthesis 1.6236072681736178 | |
| ALG9 Endoplasmic Reticulum Summary 0.8254445762765071 | |
| ALKBH1 Endoplasmic Reticulum Summary 1.3867178565396263 | |
| ALKBH1 Mitochondrion Summary 1.3867178565396263 | |
| ALKBH1 Nucleus Summary 1.3867178565396263 | |
| ALKBH2 Nucleus Summary 2.3780029728314727 | |
| ALKBH3 Mitochondrion Summary 1.4391031781706811 | |
| ALKBH3 Nucleus Summary 1.4391031781706811 | |
| ALKBH4 Cytosol Summary 1.7575015606899118 | |
| ALKBH4 Nucleus Summary 1.7575015606899118 | |
| ALKBH5 Cytosol Summary 1.730827440753387 | |
| ALKBH5 Golgi apparatus Summary 1.730827440753387 | |
| ALKBH5 Nucleus Summary 1.730827440753387 | |
| ALKBH6 Cytosol Summary 2.0449611261578693 | |
| ALKBH6 Nucleus Summary 2.0449611261578693 | |
| ALKBH7 Mitochondrion Summary 1.1136761634637269 | |
| ALKBH7 Nucleus Summary 1.1136761634637269 | |
| ALKBH8 Cytosol Summary 0.8431104990157464 | |
| ALKBH8 Nucleus Summary 0.8431104990157464 | |
| ALMS1 Cytoskeleton Summary 1.0478483590080754 | |
| ALMS1 Cytosol Summary 1.0478483590080754 | |
| ALMS1 Nucleus Summary 1.0478483590080754 | |
| ALOX12B Cytosol Summary 0.15553351285694642 | |
| ALOX15B Cytosol Summary 0.0550135456355215 | |
| ALOX15B Nucleus Summary 0.0550135456355215 | |
| ALOX15B Plasma membrane Summary 0.0550135456355215 | |
| ALOX5 Cytosol Arachidonic acid metabolism 1.8214938196323287 | |
| ALOX5 Cytosol Fc epsilon RI signaling pathway 1.8214938196323287 | |
| ALOX5 Cytosol Metabolic pathways 1.8214938196323287 | |
| ALOX5 Cytosol Ovarian steroidogenesis 1.8214938196323287 | |
| ALOX5 Cytosol Serotonergic synapse 1.8214938196323287 | |
| ALOX5 Cytosol Toxoplasmosis 1.8214938196323287 | |
| ALOX5 Nucleus Arachidonic acid metabolism 1.8214938196323287 | |
| ALOX5 Nucleus Fc epsilon RI signaling pathway 1.8214938196323287 | |
| ALOX5 Nucleus Metabolic pathways 1.8214938196323287 | |
| ALOX5 Nucleus Ovarian steroidogenesis 1.8214938196323287 | |
| ALOX5 Nucleus Serotonergic synapse 1.8214938196323287 | |
| ALOX5 Nucleus Toxoplasmosis 1.8214938196323287 | |
| ALOXE3 Cytosol Summary 0.21404314197783336 | |
| ALOXE3 Plasma membrane Summary 0.21404314197783336 | |
| ALPK1 Cytoskeleton Summary 1.7161705958348483 | |
| ALPK1 Cytosol Summary 1.7161705958348483 | |
| ALPL Cytosol Biosynthesis of cofactors 1.4818902780807692 | |
| ALPL Cytosol Folate biosynthesis 1.4818902780807692 | |
| ALPL Cytosol Metabolic pathways 1.4818902780807692 | |
| ALPL Cytosol Thiamine metabolism 1.4818902780807692 | |
| ALPL Plasma membrane Biosynthesis of cofactors 1.4818902780807692 | |
| ALPL Plasma membrane Folate biosynthesis 1.4818902780807692 | |
| ALPL Plasma membrane Metabolic pathways 1.4818902780807692 | |
| ALPL Plasma membrane Thiamine metabolism 1.4818902780807692 | |
| ALS2 Cytoskeleton Amyotrophic lateral sclerosis 1.3184484763745776 | |
| ALS2 Cytoskeleton Pathways of neurodegeneration - multiple diseases 1.3184484763745776 | |
| ALS2 Cytosol Amyotrophic lateral sclerosis 1.3184484763745776 | |
| ALS2 Cytosol Pathways of neurodegeneration - multiple diseases 1.3184484763745776 | |
| ALS2 Endosome Amyotrophic lateral sclerosis 1.3184484763745776 | |
| ALS2 Endosome Pathways of neurodegeneration - multiple diseases 1.3184484763745776 | |
| ALYREF Nucleus Summary 2.614239775567914 | |
| AMACR Cytosol Metabolic pathways 0.7152326021402711 | |
| AMACR Cytosol Peroxisome 0.7152326021402711 | |
| AMACR Cytosol Primary bile acid biosynthesis 0.7152326021402711 | |
| AMACR Mitochondrion Metabolic pathways 0.7152326021402711 | |
| AMACR Mitochondrion Peroxisome 0.7152326021402711 | |
| AMACR Mitochondrion Primary bile acid biosynthesis 0.7152326021402711 | |
| AMACR Peroxisome Metabolic pathways 0.7152326021402711 | |
| AMACR Peroxisome Peroxisome 0.7152326021402711 | |
| AMACR Peroxisome Primary bile acid biosynthesis 0.7152326021402711 | |
| AMACR Plasma membrane Metabolic pathways 0.7152326021402711 | |
| AMACR Plasma membrane Peroxisome 0.7152326021402711 | |
| AMACR Plasma membrane Primary bile acid biosynthesis 0.7152326021402711 | |
| AMBP Cytosol Summary 2.7992620758703834 | |
| AMBP Extracellular space Summary 2.7992620758703834 | |
| AMBP Golgi apparatus Summary 2.7992620758703834 | |
| AMBP Plasma membrane Summary 2.7992620758703834 | |
| AMBRA1 Cytosol Summary 1.403405589344624 | |
| AMBRA1 Mitochondrion Summary 1.403405589344624 | |
| AMDHD1 Cytoskeleton Summary 0.3491289276504017 | |
| AMDHD1 Cytosol Summary 0.3491289276504017 | |
| AMDHD1 Nucleus Summary 0.3491289276504017 | |
| AMDHD1 Plasma membrane Summary 0.3491289276504017 | |
| AMDHD2 Cytosol Summary 0.7614976417631423 | |
| AMDHD2 Nucleus Summary 0.7614976417631423 | |
| AMFR Endoplasmic Reticulum Protein processing in endoplasmic reticulum 0.7063374667900921 | |
| AMFR Golgi apparatus Protein processing in endoplasmic reticulum 0.7063374667900921 | |
| AMMECR1 Mitochondrion Summary 1.7668366550288614 | |
| AMMECR1 Nucleus Summary 1.7668366550288614 | |
| AMMECR1 Plasma membrane Summary 1.7668366550288614 | |
| AMN1 Cytoskeleton Summary 1.3032246287522369 | |
| AMOT Cytoskeleton Hippo signaling pathway 1.164397159475771 | |
| AMOT Cytoskeleton Tight junction 1.164397159475771 | |
| AMOT Nucleus Hippo signaling pathway 1.164397159475771 | |
| AMOT Nucleus Tight junction 1.164397159475771 | |
| AMOT Plasma membrane Hippo signaling pathway 1.164397159475771 | |
| AMOT Plasma membrane Tight junction 1.164397159475771 | |
| AMOTL1 Cytosol Tight junction 2.009858902385497 | |
| AMOTL1 Plasma membrane Tight junction 2.009858902385497 | |
| AMOTL2 Cytoskeleton Summary 1.2910781750250648 | |
| AMOTL2 Endosome Summary 1.2910781750250648 | |
| AMOTL2 Plasma membrane Summary 1.2910781750250648 | |
| AMPD2 Cytosol Summary 1.4115227236908623 | |
| AMPD3 Nucleus Summary 2.090275378145302 | |
| AMPH Cytoskeleton Endocytosis 0.22149801089762192 | |
| AMPH Cytoskeleton Fc gamma R-mediated phagocytosis 0.22149801089762192 | |
| AMPH Cytosol Endocytosis 0.22149801089762192 | |
| AMPH Cytosol Fc gamma R-mediated phagocytosis 0.22149801089762192 | |
| AMPH Plasma membrane Endocytosis 0.22149801089762192 | |
| AMPH Plasma membrane Fc gamma R-mediated phagocytosis 0.22149801089762192 | |
| AMZ2 Cytosol Summary 0.9225478861314976 | |
| AMZ2 Nucleus Summary 0.9225478861314976 | |
| ANAPC1 Cytosol Cell cycle 1.2243464079151585 | |
| ANAPC1 Cytosol Human T-cell leukemia virus 1 infection 1.2243464079151585 | |
| ANAPC1 Cytosol Oocyte meiosis 1.2243464079151585 | |
| ANAPC1 Cytosol Progesterone-mediated oocyte maturation 1.2243464079151585 | |
| ANAPC1 Cytosol Ubiquitin mediated proteolysis 1.2243464079151585 | |
| ANAPC1 Nucleus Cell cycle 1.2243464079151585 | |
| ANAPC1 Nucleus Human T-cell leukemia virus 1 infection 1.2243464079151585 | |
| ANAPC1 Nucleus Oocyte meiosis 1.2243464079151585 | |
| ANAPC1 Nucleus Progesterone-mediated oocyte maturation 1.2243464079151585 | |
| ANAPC1 Nucleus Ubiquitin mediated proteolysis 1.2243464079151585 | |
| ANAPC10 Golgi apparatus Cell cycle 1.5533864038792198 | |
| ANAPC10 Golgi apparatus Human T-cell leukemia virus 1 infection 1.5533864038792198 | |
| ANAPC10 Golgi apparatus Oocyte meiosis 1.5533864038792198 | |
| ANAPC10 Golgi apparatus Progesterone-mediated oocyte maturation 1.5533864038792198 | |
| ANAPC10 Golgi apparatus Ubiquitin mediated proteolysis 1.5533864038792198 | |
| ANAPC10 Nucleus Cell cycle 1.5533864038792198 | |
| ANAPC10 Nucleus Human T-cell leukemia virus 1 infection 1.5533864038792198 | |
| ANAPC10 Nucleus Oocyte meiosis 1.5533864038792198 | |
| ANAPC10 Nucleus Progesterone-mediated oocyte maturation 1.5533864038792198 | |
| ANAPC10 Nucleus Ubiquitin mediated proteolysis 1.5533864038792198 | |
| ANAPC11 Cytosol Cell cycle 1.653356214283374 | |
| ANAPC11 Cytosol Human T-cell leukemia virus 1 infection 1.653356214283374 | |
| ANAPC11 Cytosol Oocyte meiosis 1.653356214283374 | |
| ANAPC11 Cytosol Progesterone-mediated oocyte maturation 1.653356214283374 | |
| ANAPC11 Cytosol Ubiquitin mediated proteolysis 1.653356214283374 | |
| ANAPC11 Nucleus Cell cycle 1.653356214283374 | |
| ANAPC11 Nucleus Human T-cell leukemia virus 1 infection 1.653356214283374 | |
| ANAPC11 Nucleus Oocyte meiosis 1.653356214283374 | |
| ANAPC11 Nucleus Progesterone-mediated oocyte maturation 1.653356214283374 | |
| ANAPC11 Nucleus Ubiquitin mediated proteolysis 1.653356214283374 | |
| ANAPC13 Cytosol Cell cycle 2.1952448788426286 | |
| ANAPC13 Cytosol Oocyte meiosis 2.1952448788426286 | |
| ANAPC13 Cytosol Progesterone-mediated oocyte maturation 2.1952448788426286 | |
| ANAPC13 Cytosol Ubiquitin mediated proteolysis 2.1952448788426286 | |
| ANAPC13 Mitochondrion Cell cycle 2.1952448788426286 | |
| ANAPC13 Mitochondrion Oocyte meiosis 2.1952448788426286 | |
| ANAPC13 Mitochondrion Progesterone-mediated oocyte maturation 2.1952448788426286 | |
| ANAPC13 Mitochondrion Ubiquitin mediated proteolysis 2.1952448788426286 | |
| ANAPC13 Nucleus Cell cycle 2.1952448788426286 | |
| ANAPC13 Nucleus Oocyte meiosis 2.1952448788426286 | |
| ANAPC13 Nucleus Progesterone-mediated oocyte maturation 2.1952448788426286 | |
| ANAPC13 Nucleus Ubiquitin mediated proteolysis 2.1952448788426286 | |
| ANAPC15 Cytosol Summary 1.4229844024428695 | |
| ANAPC15 Nucleus Summary 1.4229844024428695 | |
| ANAPC16 Cytosol Summary 1.7872506221427922 | |
| ANAPC16 Nucleus Summary 1.7872506221427922 | |
| ANAPC2 Nucleus Cell cycle 1.0775799156160362 | |
| ANAPC2 Nucleus Human T-cell leukemia virus 1 infection 1.0775799156160362 | |
| ANAPC2 Nucleus Oocyte meiosis 1.0775799156160362 | |
| ANAPC2 Nucleus Progesterone-mediated oocyte maturation 1.0775799156160362 | |
| ANAPC2 Nucleus Ubiquitin mediated proteolysis 1.0775799156160362 | |
| ANAPC4 Cytoskeleton Cell cycle 1.4838348005620765 | |
| ANAPC4 Cytoskeleton Human T-cell leukemia virus 1 infection 1.4838348005620765 | |
| ANAPC4 Cytoskeleton Oocyte meiosis 1.4838348005620765 | |
| ANAPC4 Cytoskeleton Progesterone-mediated oocyte maturation 1.4838348005620765 | |
| ANAPC4 Cytoskeleton Ubiquitin mediated proteolysis 1.4838348005620765 | |
| ANAPC4 Nucleus Cell cycle 1.4838348005620765 | |
| ANAPC4 Nucleus Human T-cell leukemia virus 1 infection 1.4838348005620765 | |
| ANAPC4 Nucleus Oocyte meiosis 1.4838348005620765 | |
| ANAPC4 Nucleus Progesterone-mediated oocyte maturation 1.4838348005620765 | |
| ANAPC4 Nucleus Ubiquitin mediated proteolysis 1.4838348005620765 | |
| ANAPC5 Nucleus Cell cycle 1.1954523232501486 | |
| ANAPC5 Nucleus Human T-cell leukemia virus 1 infection 1.1954523232501486 | |
| ANAPC5 Nucleus IL-17 signaling pathway 1.1954523232501486 | |
| ANAPC5 Nucleus Oocyte meiosis 1.1954523232501486 | |
| ANAPC5 Nucleus Progesterone-mediated oocyte maturation 1.1954523232501486 | |
| ANAPC5 Nucleus Ubiquitin mediated proteolysis 1.1954523232501486 | |
| ANAPC7 Cytosol Cell cycle 1.2822619753999565 | |
| ANAPC7 Cytosol Human T-cell leukemia virus 1 infection 1.2822619753999565 | |
| ANAPC7 Cytosol Oocyte meiosis 1.2822619753999565 | |
| ANAPC7 Cytosol Progesterone-mediated oocyte maturation 1.2822619753999565 | |
| ANAPC7 Cytosol Ubiquitin mediated proteolysis 1.2822619753999565 | |
| ANAPC7 Nucleus Cell cycle 1.2822619753999565 | |
| ANAPC7 Nucleus Human T-cell leukemia virus 1 infection 1.2822619753999565 | |
| ANAPC7 Nucleus Oocyte meiosis 1.2822619753999565 | |
| ANAPC7 Nucleus Progesterone-mediated oocyte maturation 1.2822619753999565 | |
| ANAPC7 Nucleus Ubiquitin mediated proteolysis 1.2822619753999565 | |
| ANG Cytoskeleton Amyotrophic lateral sclerosis 0.8656857745851292 | |
| ANG Cytosol Amyotrophic lateral sclerosis 0.8656857745851292 | |
| ANG Extracellular space Amyotrophic lateral sclerosis 0.8656857745851292 | |
| ANG Mitochondrion Amyotrophic lateral sclerosis 0.8656857745851292 | |
| ANG Nucleus Amyotrophic lateral sclerosis 0.8656857745851292 | |
| ANGEL2 Mitochondrion Summary 0.9106379607728796 | |
| ANGEL2 Nucleus Summary 0.9106379607728796 | |
| ANGPT2 Extracellular space HIF-1 signaling pathway 1.5290515288603934 | |
| ANGPT2 Extracellular space Kaposi sarcoma-associated herpesvirus infection 1.5290515288603934 | |
| ANGPT2 Extracellular space MAPK signaling pathway 1.5290515288603934 | |
| ANGPT2 Extracellular space PI3K-Akt signaling pathway 1.5290515288603934 | |
| ANGPT2 Extracellular space Rap1 signaling pathway 1.5290515288603934 | |
| ANGPT2 Extracellular space Ras signaling pathway 1.5290515288603934 | |
| ANGPTL2 Extracellular space Summary 1.6261371715533783 | |
| ANGPTL2 Golgi apparatus Summary 1.6261371715533783 | |
| ANGPTL4 Cytosol Cholesterol metabolism 1.9491516004200764 | |
| ANGPTL4 Cytosol PPAR signaling pathway 1.9491516004200764 | |
| ANGPTL4 Extracellular space Cholesterol metabolism 1.9491516004200764 | |
| ANGPTL4 Extracellular space PPAR signaling pathway 1.9491516004200764 | |
| ANGPTL4 Nucleus Cholesterol metabolism 1.9491516004200764 | |
| ANGPTL4 Nucleus PPAR signaling pathway 1.9491516004200764 | |
| ANK1 Cytoskeleton Proteoglycans in cancer 1.293901678253658 | |
| ANK1 Endoplasmic Reticulum Proteoglycans in cancer 1.293901678253658 | |
| ANK1 Plasma membrane Proteoglycans in cancer 1.293901678253658 | |
| ANK2 Cytoskeleton Proteoglycans in cancer 1.991127884957152 | |
| ANK2 Cytosol Proteoglycans in cancer 1.991127884957152 | |
| ANK2 Plasma membrane Proteoglycans in cancer 1.991127884957152 | |
| ANK3 Cytoskeleton Proteoglycans in cancer 0.5512017218984567 | |
| ANK3 Cytosol Proteoglycans in cancer 0.5512017218984567 | |
| ANK3 Plasma membrane Proteoglycans in cancer 0.5512017218984567 | |
| ANKFY1 Cytosol Summary 1.0080106406696536 | |
| ANKFY1 Endosome Summary 1.0080106406696536 | |
| ANKIB1 Cytosol Summary 1.0011131749369933 | |
| ANKIB1 Plasma membrane Summary 1.0011131749369933 | |
| ANKLE2 Endoplasmic Reticulum Summary 1.3879337303591828 | |
| ANKLE2 Plasma membrane Summary 1.3879337303591828 | |
| ANKMY2 Cytosol Summary 0.652657073417438 | |
| ANKMY2 Nucleus Summary 0.652657073417438 | |
| ANKRD10 Cytoskeleton Summary 1.9341495942271512 | |
| ANKRD10 Cytosol Summary 1.9341495942271512 | |
| ANKRD11 Cytosol Summary 1.8930993205906377 | |
| ANKRD11 Nucleus Summary 1.8930993205906377 | |
| ANKRD12 Cytosol Summary 1.1578119989797944 | |
| ANKRD12 Nucleus Summary 1.1578119989797944 | |
| ANKRD13A Plasma membrane Summary 1.1509155203568715 | |
| ANKRD13C Endoplasmic Reticulum Summary 2.1040176058987945 | |
| ANKRD13D Mitochondrion Summary 0.6140862096337366 | |
| ANKRD13D Nucleus Summary 0.6140862096337366 | |
| ANKRD13D Plasma membrane Summary 0.6140862096337366 | |
| ANKRD16 Cytosol Summary 1.6545954836234509 | |
| ANKRD16 Endoplasmic Reticulum Summary 1.6545954836234509 | |
| ANKRD17 Cytosol Summary 1.5588848347130824 | |
| ANKRD17 Nucleus Summary 1.5588848347130824 | |
| ANKRD18A Cytosol Summary 0.56303487938964 | |
| ANKRD18A Nucleus Summary 0.56303487938964 | |
| ANKRD22 Nucleus Summary 1.324435810852421 | |
| ANKRD26 Cytoskeleton Summary 0.8285098312399776 | |
| ANKRD26 Cytosol Summary 0.8285098312399776 | |
| ANKRD26 Golgi apparatus Summary 0.8285098312399776 | |
| ANKRD27 Cytosol Summary 1.6934580373924462 | |
| ANKRD27 Endosome Summary 1.6934580373924462 | |
| ANKRD28 Nucleus Summary 1.3413326634054714 | |
| ANKRD30A Nucleus Summary 1.1059569317957119 | |
| ANKRD30B Nucleus Summary 1.5656007399207104 | |
| ANKRD31 Nucleus Summary 0.7862065751936939 | |
| ANKRD36C Cytosol Summary 1.7601828248903493 | |
| ANKRD36C Nucleus Summary 1.7601828248903493 | |
| ANKRD39 Cytosol Summary 1.3828454272525534 | |
| ANKRD39 Nucleus Summary 1.3828454272525534 | |
| ANKRD40 Cytosol Summary 0.53917037425058 | |
| ANKRD40 Golgi apparatus Summary 0.53917037425058 | |
| ANKRD40 Nucleus Summary 0.53917037425058 | |
| ANKRD44 Mitochondrion Summary 1.5156362057896111 | |
| ANKRD44 Nucleus Summary 1.5156362057896111 | |
| ANKRD46 Cytosol Summary 1.7984548599341088 | |
| ANKRD49 Golgi apparatus Summary 1.5335026110082532 | |
| ANKRD49 Nucleus Summary 1.5335026110082532 | |
| ANKRD50 Cytosol Summary 0.8301070985968985 | |
| ANKRD50 Endosome Summary 0.8301070985968985 | |
| ANKRD50 Nucleus Summary 0.8301070985968985 | |
| ANKRD52 Mitochondrion Summary 0.8997619176377579 | |
| ANKRD52 Nucleus Summary 0.8997619176377579 | |
| ANKRD54 Cytoskeleton Summary 1.0862232532361662 | |
| ANKRD54 Nucleus Summary 1.0862232532361662 | |
| ANKS1A Cytosol Summary 1.2371234372067492 | |
| ANKS1A Nucleus Summary 1.2371234372067492 | |
| ANKS3 Cytosol Summary 1.6411772122571848 | |
| ANKS3 Nucleus Summary 1.6411772122571848 | |
| ANKZF1 Cytosol Summary 2.1538996106468145 | |
| ANKZF1 Nucleus Summary 2.1538996106468145 | |
| ANLN Cytoskeleton Summary 2.830459087145333 | |
| ANLN Nucleus Summary 2.830459087145333 | |
| ANO1 Nucleus Summary 0.2793087296253949 | |
| ANO1 Plasma membrane Summary 0.2793087296253949 | |
| ANO10 Cytosol Summary 0.618407987845829 | |
| ANO10 Plasma membrane Summary 0.618407987845829 | |
| ANO5 Endoplasmic Reticulum Summary 0.8327053075675159 | |
| ANO6 Cytosol Summary 0.8590649634060386 | |
| ANO6 Plasma membrane Summary 0.8590649634060386 | |
| ANO8 Nucleus Summary 1.3410303001090904 | |
| ANO8 Plasma membrane Summary 1.3410303001090904 | |
| ANOS1 Extracellular space Summary 0.6883427124645641 | |
| ANOS1 Plasma membrane Summary 0.6883427124645641 | |
| ANP32A Cytoskeleton Summary 0.8388986469309772 | |
| ANP32A Cytosol Summary 0.8388986469309772 | |
| ANP32A Endoplasmic Reticulum Summary 0.8388986469309772 | |
| ANP32A Nucleus Summary 0.8388986469309772 | |
| ANP32B Cytoskeleton Summary 1.6082406673977236 | |
| ANP32B Cytosol Summary 1.6082406673977236 | |
| ANP32B Nucleus Summary 1.6082406673977236 | |
| ANP32E Cytoskeleton Summary 3.1031493090812536 | |
| ANP32E Cytosol Summary 3.1031493090812536 | |
| ANP32E Nucleus Summary 3.1031493090812536 | |
| ANPEP Nucleus Glutathione metabolism 0.22751689952147236 | |
| ANPEP Nucleus Hematopoietic cell lineage 0.22751689952147236 | |
| ANPEP Nucleus Metabolic pathways 0.22751689952147236 | |
| ANPEP Nucleus Renin-angiotensin system 0.22751689952147236 | |
| ANPEP Plasma membrane Glutathione metabolism 0.22751689952147236 | |
| ANPEP Plasma membrane Hematopoietic cell lineage 0.22751689952147236 | |
| ANPEP Plasma membrane Metabolic pathways 0.22751689952147236 | |
| ANPEP Plasma membrane Renin-angiotensin system 0.22751689952147236 | |
| ANTXR1 Cytosol NOD-like receptor signaling pathway 1.2936453207822085 | |
| ANTXR1 Plasma membrane NOD-like receptor signaling pathway 1.2936453207822085 | |
| ANTXR2 Endoplasmic Reticulum NOD-like receptor signaling pathway 1.453386472552305 | |
| ANTXR2 Extracellular space NOD-like receptor signaling pathway 1.453386472552305 | |
| ANTXR2 Plasma membrane NOD-like receptor signaling pathway 1.453386472552305 | |
| ANXA1 Cytoskeleton Summary 3.142273455231927 | |
| ANXA1 Cytosol Summary 3.142273455231927 | |
| ANXA1 Nucleus Summary 3.142273455231927 | |
| ANXA1 Plasma membrane Summary 3.142273455231927 | |
| ANXA11 Cytoskeleton Amyotrophic lateral sclerosis 1.0299977498241513 | |
| ANXA11 Cytosol Amyotrophic lateral sclerosis 1.0299977498241513 | |
| ANXA11 Lysosome Amyotrophic lateral sclerosis 1.0299977498241513 | |
| ANXA11 Nucleus Amyotrophic lateral sclerosis 1.0299977498241513 | |
| ANXA2 Cytosol Salmonella infection 1.3791634563291404 | |
| ANXA2 Extracellular space Salmonella infection 1.3791634563291404 | |
| ANXA2 Plasma membrane Salmonella infection 1.3791634563291404 | |
| ANXA3 Cytosol Summary 1.3408736977895797 | |
| ANXA3 Plasma membrane Summary 1.3408736977895797 | |
| ANXA4 Cytosol Summary 1.0492143938004992 | |
| ANXA5 Nucleus Summary 1.6680345734744564 | |
| ANXA6 Cytosol Summary 1.033244591101132 | |
| ANXA6 Nucleus Summary 1.033244591101132 | |
| ANXA7 Cytosol Summary 0.8927216929623027 | |
| ANXA7 Nucleus Summary 0.8927216929623027 | |
| ANXA8 Nucleus Summary 0.6003320947263465 | |
| ANXA8L1 Nucleus Summary 0.5249761358860395 | |
| ANXA9 Cytosol Summary 0.16789755735872794 | |
| ANXA9 Nucleus Summary 0.16789755735872794 | |
| AOAH Cytosol Summary 2.1526980828422837 | |
| AOC3 Cytosol Glycine serine and threonine metabolism 1.5262708488974677 | |
| AOC3 Cytosol Metabolic pathways 1.5262708488974677 | |
| AOC3 Cytosol Phenylalanine metabolism 1.5262708488974677 | |
| AOC3 Cytosol Tyrosine metabolism 1.5262708488974677 | |
| AOC3 Cytosol beta-Alanine metabolism 1.5262708488974677 | |
| AOC3 Golgi apparatus Glycine serine and threonine metabolism 1.5262708488974677 | |
| AOC3 Golgi apparatus Metabolic pathways 1.5262708488974677 | |
| AOC3 Golgi apparatus Phenylalanine metabolism 1.5262708488974677 | |
| AOC3 Golgi apparatus Tyrosine metabolism 1.5262708488974677 | |
| AOC3 Golgi apparatus beta-Alanine metabolism 1.5262708488974677 | |
| AOC3 Plasma membrane Glycine serine and threonine metabolism 1.5262708488974677 | |
| AOC3 Plasma membrane Metabolic pathways 1.5262708488974677 | |
| AOC3 Plasma membrane Phenylalanine metabolism 1.5262708488974677 | |
| AOC3 Plasma membrane Tyrosine metabolism 1.5262708488974677 | |
| AOC3 Plasma membrane beta-Alanine metabolism 1.5262708488974677 | |
| AOX1 Cytosol Summary 1.4115989439055596 | |
| AOX1 Nucleus Summary 1.4115989439055596 | |
| AP1AR Endosome Summary 0.6863546283820593 | |
| AP1AR Golgi apparatus Summary 0.6863546283820593 | |
| AP1AR Nucleus Summary 0.6863546283820593 | |
| AP1B1 Cytosol Human immunodeficiency virus 1 infection 1.3561153377926232 | |
| AP1B1 Cytosol Lysosome 1.3561153377926232 | |
| AP1B1 Golgi apparatus Human immunodeficiency virus 1 infection 1.3561153377926232 | |
| AP1B1 Golgi apparatus Lysosome 1.3561153377926232 | |
| AP1G1 Cytosol Human immunodeficiency virus 1 infection 0.7101908221198842 | |
| AP1G1 Cytosol Lysosome 0.7101908221198842 | |
| AP1G1 Endosome Human immunodeficiency virus 1 infection 0.7101908221198842 | |
| AP1G1 Endosome Lysosome 0.7101908221198842 | |
| AP1G1 Golgi apparatus Human immunodeficiency virus 1 infection 0.7101908221198842 | |
| AP1G1 Golgi apparatus Lysosome 0.7101908221198842 | |
| AP1G2 Endosome Human immunodeficiency virus 1 infection 0.6293451751177892 | |
| AP1G2 Endosome Lysosome 0.6293451751177892 | |
| AP1G2 Golgi apparatus Human immunodeficiency virus 1 infection 0.6293451751177892 | |
| AP1G2 Golgi apparatus Lysosome 0.6293451751177892 | |
| AP1M1 Golgi apparatus Human immunodeficiency virus 1 infection 1.1181885211413178 | |
| AP1M1 Golgi apparatus Lysosome 1.1181885211413178 | |
| AP1M2 Cytosol Human immunodeficiency virus 1 infection 0.4100353461780977 | |
| AP1M2 Cytosol Lysosome 0.4100353461780977 | |
| AP1M2 Golgi apparatus Human immunodeficiency virus 1 infection 0.4100353461780977 | |
| AP1M2 Golgi apparatus Lysosome 0.4100353461780977 | |
| AP1S1 Cytosol Human immunodeficiency virus 1 infection 0.6100228777850848 | |
| AP1S1 Cytosol Lysosome 0.6100228777850848 | |
| AP1S1 Golgi apparatus Human immunodeficiency virus 1 infection 0.6100228777850848 | |
| AP1S1 Golgi apparatus Lysosome 0.6100228777850848 | |
| AP1S2 Cytosol Human immunodeficiency virus 1 infection 1.1053592733853774 | |
| AP1S2 Cytosol Lysosome 1.1053592733853774 | |
| AP1S2 Golgi apparatus Human immunodeficiency virus 1 infection 1.1053592733853774 | |
| AP1S2 Golgi apparatus Lysosome 1.1053592733853774 | |
| AP1S3 Cytosol Human immunodeficiency virus 1 infection 0.8616732476923933 | |
| AP1S3 Cytosol Lysosome 0.8616732476923933 | |
| AP1S3 Golgi apparatus Human immunodeficiency virus 1 infection 0.8616732476923933 | |
| AP1S3 Golgi apparatus Lysosome 0.8616732476923933 | |
| AP2A1 Cytosol Endocrine and other factor-regulated calcium reabsorption 1.0650035687928685 | |
| AP2A1 Cytosol Endocytosis 1.0650035687928685 | |
| AP2A1 Cytosol Huntington disease 1.0650035687928685 | |
| AP2A1 Cytosol Synaptic vesicle cycle 1.0650035687928685 | |
| AP2A1 Golgi apparatus Endocrine and other factor-regulated calcium reabsorption 1.0650035687928685 | |
| AP2A1 Golgi apparatus Endocytosis 1.0650035687928685 | |
| AP2A1 Golgi apparatus Huntington disease 1.0650035687928685 | |
| AP2A1 Golgi apparatus Synaptic vesicle cycle 1.0650035687928685 | |
| AP2A1 Plasma membrane Endocrine and other factor-regulated calcium reabsorption 1.0650035687928685 | |
| AP2A1 Plasma membrane Endocytosis 1.0650035687928685 | |
| AP2A1 Plasma membrane Huntington disease 1.0650035687928685 | |
| AP2A1 Plasma membrane Synaptic vesicle cycle 1.0650035687928685 | |
| AP2A2 Cytosol Endocrine and other factor-regulated calcium reabsorption 1.2811016556750985 | |
| AP2A2 Cytosol Endocytosis 1.2811016556750985 | |
| AP2A2 Cytosol Huntington disease 1.2811016556750985 | |
| AP2A2 Cytosol Synaptic vesicle cycle 1.2811016556750985 | |
| AP2A2 Nucleus Endocrine and other factor-regulated calcium reabsorption 1.2811016556750985 | |
| AP2A2 Nucleus Endocytosis 1.2811016556750985 | |
| AP2A2 Nucleus Huntington disease 1.2811016556750985 | |
| AP2A2 Nucleus Synaptic vesicle cycle 1.2811016556750985 | |
| AP2A2 Plasma membrane Endocrine and other factor-regulated calcium reabsorption 1.2811016556750985 | |
| AP2A2 Plasma membrane Endocytosis 1.2811016556750985 | |
| AP2A2 Plasma membrane Huntington disease 1.2811016556750985 | |
| AP2A2 Plasma membrane Synaptic vesicle cycle 1.2811016556750985 | |
| AP2B1 Cytosol Summary 0.8889758790708611 | |
| AP2B1 Plasma membrane Summary 0.8889758790708611 | |
| AP2M1 Plasma membrane Endocrine and other factor-regulated calcium reabsorption 0.9423445337052132 | |
| AP2M1 Plasma membrane Endocytosis 0.9423445337052132 | |
| AP2M1 Plasma membrane Huntington disease 0.9423445337052132 | |
| AP2M1 Plasma membrane Synaptic vesicle cycle 0.9423445337052132 | |
| AP2S1 Cytosol Endocrine and other factor-regulated calcium reabsorption 0.9990740107766442 | |
| AP2S1 Cytosol Endocytosis 0.9990740107766442 | |
| AP2S1 Cytosol Huntington disease 0.9990740107766442 | |
| AP2S1 Cytosol Synaptic vesicle cycle 0.9990740107766442 | |
| AP2S1 Plasma membrane Endocrine and other factor-regulated calcium reabsorption 0.9990740107766442 | |
| AP2S1 Plasma membrane Endocytosis 0.9990740107766442 | |
| AP2S1 Plasma membrane Huntington disease 0.9990740107766442 | |
| AP2S1 Plasma membrane Synaptic vesicle cycle 0.9990740107766442 | |
| AP3B1 Cytosol Lysosome 0.6830307823189193 | |
| AP3B1 Golgi apparatus Lysosome 0.6830307823189193 | |
| AP3B1 Nucleus Lysosome 0.6830307823189193 | |
| AP3B2 Cytosol Lysosome 0.3790278460830919 | |
| AP3B2 Golgi apparatus Lysosome 0.3790278460830919 | |
| AP3B2 Nucleus Lysosome 0.3790278460830919 | |
| AP3D1 Cytosol Lysosome 0.6265948112416118 | |
| AP3D1 Endosome Lysosome 0.6265948112416118 | |
| AP3D1 Golgi apparatus Lysosome 0.6265948112416118 | |
| AP3M1 Golgi apparatus Lysosome 0.8173943281153859 | |
| AP3M2 Golgi apparatus Lysosome 1.000148232677276 | |
| AP3S1 Cytosol Lysosome 0.7053356428607958 | |
| AP3S1 Golgi apparatus Lysosome 0.7053356428607958 | |
| AP4B1 Cytosol Summary 0.9245526593696703 | |
| AP4B1 Golgi apparatus Summary 0.9245526593696703 | |
| AP4E1 Golgi apparatus Summary 1.134071727360522 | |
| AP4M1 Golgi apparatus Summary 0.9601633209318704 | |
| AP4S1 Cytosol Summary 0.9869555812670512 | |
| AP4S1 Golgi apparatus Summary 0.9869555812670512 | |
| AP5B1 Cytosol Summary 1.1382548727815072 | |
| AP5B1 Golgi apparatus Summary 1.1382548727815072 | |
| AP5B1 Nucleus Summary 1.1382548727815072 | |
| AP5M1 Cytosol Summary 1.5907574659669286 | |
| AP5M1 Endosome Summary 1.5907574659669286 | |
| AP5M1 Lysosome Summary 1.5907574659669286 | |
| AP5S1 Cytosol Summary 0.8643528703162853 | |
| AP5S1 Endosome Summary 0.8643528703162853 | |
| AP5S1 Lysosome Summary 0.8643528703162853 | |
| AP5S1 Nucleus Summary 0.8643528703162853 | |
| AP5Z1 Nucleus Summary 1.2052253993389437 | |
| APAF1 Cytosol Alzheimer disease 0.9991443581162528 | |
| APAF1 Cytosol Amyotrophic lateral sclerosis 0.9991443581162528 | |
| APAF1 Cytosol Apoptosis 0.9991443581162528 | |
| APAF1 Cytosol Apoptosis - multiple species 0.9991443581162528 | |
| APAF1 Cytosol Epstein-Barr virus infection 0.9991443581162528 | |
| APAF1 Cytosol Hepatitis B 0.9991443581162528 | |
| APAF1 Cytosol Hepatitis C 0.9991443581162528 | |
| APAF1 Cytosol Herpes simplex virus 1 infection 0.9991443581162528 | |
| APAF1 Cytosol Huntington disease 0.9991443581162528 | |
| APAF1 Cytosol Influenza A 0.9991443581162528 | |
| APAF1 Cytosol Legionellosis 0.9991443581162528 | |
| APAF1 Cytosol Lipid and atherosclerosis 0.9991443581162528 | |
| APAF1 Cytosol Measles 0.9991443581162528 | |
| APAF1 Cytosol Parkinson disease 0.9991443581162528 | |
| APAF1 Cytosol Pathways in cancer 0.9991443581162528 | |
| APAF1 Cytosol Pathways of neurodegeneration - multiple diseases 0.9991443581162528 | |
| APAF1 Cytosol Platinum drug resistance 0.9991443581162528 | |
| APAF1 Cytosol Prion disease 0.9991443581162528 | |
| APAF1 Cytosol Small cell lung cancer 0.9991443581162528 | |
| APAF1 Cytosol Tuberculosis 0.9991443581162528 | |
| APAF1 Cytosol p53 signaling pathway 0.9991443581162528 | |
| APAF1 Golgi apparatus Alzheimer disease 0.9991443581162528 | |
| APAF1 Golgi apparatus Amyotrophic lateral sclerosis 0.9991443581162528 | |
| APAF1 Golgi apparatus Apoptosis 0.9991443581162528 | |
| APAF1 Golgi apparatus Apoptosis - multiple species 0.9991443581162528 | |
| APAF1 Golgi apparatus Epstein-Barr virus infection 0.9991443581162528 | |
| APAF1 Golgi apparatus Hepatitis B 0.9991443581162528 | |
| APAF1 Golgi apparatus Hepatitis C 0.9991443581162528 | |
| APAF1 Golgi apparatus Herpes simplex virus 1 infection 0.9991443581162528 | |
| APAF1 Golgi apparatus Huntington disease 0.9991443581162528 | |
| APAF1 Golgi apparatus Influenza A 0.9991443581162528 | |
| APAF1 Golgi apparatus Legionellosis 0.9991443581162528 | |
| APAF1 Golgi apparatus Lipid and atherosclerosis 0.9991443581162528 | |
| APAF1 Golgi apparatus Measles 0.9991443581162528 | |
| APAF1 Golgi apparatus Parkinson disease 0.9991443581162528 | |
| APAF1 Golgi apparatus Pathways in cancer 0.9991443581162528 | |
| APAF1 Golgi apparatus Pathways of neurodegeneration - multiple diseases 0.9991443581162528 | |
| APAF1 Golgi apparatus Platinum drug resistance 0.9991443581162528 | |
| APAF1 Golgi apparatus Prion disease 0.9991443581162528 | |
| APAF1 Golgi apparatus Small cell lung cancer 0.9991443581162528 | |
| APAF1 Golgi apparatus Tuberculosis 0.9991443581162528 | |
| APAF1 Golgi apparatus p53 signaling pathway 0.9991443581162528 | |
| APAF1 Nucleus Alzheimer disease 0.9991443581162528 | |
| APAF1 Nucleus Amyotrophic lateral sclerosis 0.9991443581162528 | |
| APAF1 Nucleus Apoptosis 0.9991443581162528 | |
| APAF1 Nucleus Apoptosis - multiple species 0.9991443581162528 | |
| APAF1 Nucleus Epstein-Barr virus infection 0.9991443581162528 | |
| APAF1 Nucleus Hepatitis B 0.9991443581162528 | |
| APAF1 Nucleus Hepatitis C 0.9991443581162528 | |
| APAF1 Nucleus Herpes simplex virus 1 infection 0.9991443581162528 | |
| APAF1 Nucleus Huntington disease 0.9991443581162528 | |
| APAF1 Nucleus Influenza A 0.9991443581162528 | |
| APAF1 Nucleus Legionellosis 0.9991443581162528 | |
| APAF1 Nucleus Lipid and atherosclerosis 0.9991443581162528 | |
| APAF1 Nucleus Measles 0.9991443581162528 | |
| APAF1 Nucleus Parkinson disease 0.9991443581162528 | |
| APAF1 Nucleus Pathways in cancer 0.9991443581162528 | |
| APAF1 Nucleus Pathways of neurodegeneration - multiple diseases 0.9991443581162528 | |
| APAF1 Nucleus Platinum drug resistance 0.9991443581162528 | |
| APAF1 Nucleus Prion disease 0.9991443581162528 | |
| APAF1 Nucleus Small cell lung cancer 0.9991443581162528 | |
| APAF1 Nucleus Tuberculosis 0.9991443581162528 | |
| APAF1 Nucleus p53 signaling pathway 0.9991443581162528 | |
| APBA1 Cytosol Summary 1.930105748770245 | |
| APBA1 Golgi apparatus Summary 1.930105748770245 | |
| APBA1 Nucleus Summary 1.930105748770245 | |
| APBA2 Golgi apparatus Summary 2.963495342950785 | |
| APBA2 Nucleus Summary 2.963495342950785 | |
| APBA3 Cytosol Summary 1.3670998678008224 | |
| APBA3 Nucleus Summary 1.3670998678008224 | |
| APBB1 Nucleus Alzheimer disease 1.0873773793960653 | |
| APBB1 Plasma membrane Alzheimer disease 1.0873773793960653 | |
| APBB1IP Cytosol Platelet activation 1.5660038826440557 | |
| APBB1IP Cytosol Rap1 signaling pathway 1.5660038826440557 | |
| APBB1IP Plasma membrane Platelet activation 1.5660038826440557 | |
| APBB1IP Plasma membrane Rap1 signaling pathway 1.5660038826440557 | |
| APBB2 Mitochondrion Summary 0.4903528649781608 | |
| APC Cytoskeleton Alzheimer disease 0.9547553768937364 | |
| APC Cytoskeleton Basal cell carcinoma 0.9547553768937364 | |
| APC Cytoskeleton Breast cancer 0.9547553768937364 | |
| APC Cytoskeleton Colorectal cancer 0.9547553768937364 | |
| APC Cytoskeleton Complement and coagulation cascades 0.9547553768937364 | |
| APC Cytoskeleton Cushing syndrome 0.9547553768937364 | |
| APC Cytoskeleton Endometrial cancer 0.9547553768937364 | |
| APC Cytoskeleton Gastric cancer 0.9547553768937364 | |
| APC Cytoskeleton Hepatocellular carcinoma 0.9547553768937364 | |
| APC Cytoskeleton Hippo signaling pathway 0.9547553768937364 | |
| APC Cytoskeleton Human papillomavirus infection 0.9547553768937364 | |
| APC Cytoskeleton MicroRNAs in cancer 0.9547553768937364 | |
| APC Cytoskeleton Pathways in cancer 0.9547553768937364 | |
| APC Cytoskeleton Pathways of neurodegeneration - multiple diseases 0.9547553768937364 | |
| APC Cytoskeleton Regulation of actin cytoskeleton 0.9547553768937364 | |
| APC Cytoskeleton Signaling pathways regulating pluripotency of stem cells 0.9547553768937364 | |
| APC Cytoskeleton Wnt signaling pathway 0.9547553768937364 | |
| APC Golgi apparatus Alzheimer disease 0.9547553768937364 | |
| APC Golgi apparatus Basal cell carcinoma 0.9547553768937364 | |
| APC Golgi apparatus Breast cancer 0.9547553768937364 | |
| APC Golgi apparatus Colorectal cancer 0.9547553768937364 | |
| APC Golgi apparatus Complement and coagulation cascades 0.9547553768937364 | |
| APC Golgi apparatus Cushing syndrome 0.9547553768937364 | |
| APC Golgi apparatus Endometrial cancer 0.9547553768937364 | |
| APC Golgi apparatus Gastric cancer 0.9547553768937364 | |
| APC Golgi apparatus Hepatocellular carcinoma 0.9547553768937364 | |
| APC Golgi apparatus Hippo signaling pathway 0.9547553768937364 | |
| APC Golgi apparatus Human papillomavirus infection 0.9547553768937364 | |
| APC Golgi apparatus MicroRNAs in cancer 0.9547553768937364 | |
| APC Golgi apparatus Pathways in cancer 0.9547553768937364 | |
| APC Golgi apparatus Pathways of neurodegeneration - multiple diseases 0.9547553768937364 | |
| APC Golgi apparatus Regulation of actin cytoskeleton 0.9547553768937364 | |
| APC Golgi apparatus Signaling pathways regulating pluripotency of stem cells 0.9547553768937364 | |
| APC Golgi apparatus Wnt signaling pathway 0.9547553768937364 | |
| APC Nucleus Alzheimer disease 0.9547553768937364 | |
| APC Nucleus Basal cell carcinoma 0.9547553768937364 | |
| APC Nucleus Breast cancer 0.9547553768937364 | |
| APC Nucleus Colorectal cancer 0.9547553768937364 | |
| APC Nucleus Complement and coagulation cascades 0.9547553768937364 | |
| APC Nucleus Cushing syndrome 0.9547553768937364 | |
| APC Nucleus Endometrial cancer 0.9547553768937364 | |
| APC Nucleus Gastric cancer 0.9547553768937364 | |
| APC Nucleus Hepatocellular carcinoma 0.9547553768937364 | |
| APC Nucleus Hippo signaling pathway 0.9547553768937364 | |
| APC Nucleus Human papillomavirus infection 0.9547553768937364 | |
| APC Nucleus MicroRNAs in cancer 0.9547553768937364 | |
| APC Nucleus Pathways in cancer 0.9547553768937364 | |
| APC Nucleus Pathways of neurodegeneration - multiple diseases 0.9547553768937364 | |
| APC Nucleus Regulation of actin cytoskeleton 0.9547553768937364 | |
| APC Nucleus Signaling pathways regulating pluripotency of stem cells 0.9547553768937364 | |
| APC Nucleus Wnt signaling pathway 0.9547553768937364 | |
| APC Plasma membrane Alzheimer disease 0.9547553768937364 | |
| APC Plasma membrane Basal cell carcinoma 0.9547553768937364 | |
| APC Plasma membrane Breast cancer 0.9547553768937364 | |
| APC Plasma membrane Colorectal cancer 0.9547553768937364 | |
| APC Plasma membrane Complement and coagulation cascades 0.9547553768937364 | |
| APC Plasma membrane Cushing syndrome 0.9547553768937364 | |
| APC Plasma membrane Endometrial cancer 0.9547553768937364 | |
| APC Plasma membrane Gastric cancer 0.9547553768937364 | |
| APC Plasma membrane Hepatocellular carcinoma 0.9547553768937364 | |
| APC Plasma membrane Hippo signaling pathway 0.9547553768937364 | |
| APC Plasma membrane Human papillomavirus infection 0.9547553768937364 | |
| APC Plasma membrane MicroRNAs in cancer 0.9547553768937364 | |
| APC Plasma membrane Pathways in cancer 0.9547553768937364 | |
| APC Plasma membrane Pathways of neurodegeneration - multiple diseases 0.9547553768937364 | |
| APC Plasma membrane Regulation of actin cytoskeleton 0.9547553768937364 | |
| APC Plasma membrane Signaling pathways regulating pluripotency of stem cells 0.9547553768937364 | |
| APC Plasma membrane Wnt signaling pathway 0.9547553768937364 | |
| APC2 Cytoskeleton Alzheimer disease 0.7520728831273202 | |
| APC2 Cytoskeleton Basal cell carcinoma 0.7520728831273202 | |
| APC2 Cytoskeleton Breast cancer 0.7520728831273202 | |
| APC2 Cytoskeleton Cell cycle 0.7520728831273202 | |
| APC2 Cytoskeleton Colorectal cancer 0.7520728831273202 | |
| APC2 Cytoskeleton Cushing syndrome 0.7520728831273202 | |
| APC2 Cytoskeleton Endometrial cancer 0.7520728831273202 | |
| APC2 Cytoskeleton Gastric cancer 0.7520728831273202 | |
| APC2 Cytoskeleton Hepatocellular carcinoma 0.7520728831273202 | |
| APC2 Cytoskeleton Hippo signaling pathway 0.7520728831273202 | |
| APC2 Cytoskeleton Human T-cell leukemia virus 1 infection 0.7520728831273202 | |
| APC2 Cytoskeleton Human papillomavirus infection 0.7520728831273202 | |
| APC2 Cytoskeleton MicroRNAs in cancer 0.7520728831273202 | |
| APC2 Cytoskeleton Oocyte meiosis 0.7520728831273202 | |
| APC2 Cytoskeleton Pathways in cancer 0.7520728831273202 | |
| APC2 Cytoskeleton Pathways of neurodegeneration - multiple diseases 0.7520728831273202 | |
| APC2 Cytoskeleton Progesterone-mediated oocyte maturation 0.7520728831273202 | |
| APC2 Cytoskeleton Regulation of actin cytoskeleton 0.7520728831273202 | |
| APC2 Cytoskeleton Signaling pathways regulating pluripotency of stem cells 0.7520728831273202 | |
| APC2 Cytoskeleton Ubiquitin mediated proteolysis 0.7520728831273202 | |
| APC2 Cytoskeleton Wnt signaling pathway 0.7520728831273202 | |
| APC2 Cytosol Alzheimer disease 0.7520728831273202 | |
| APC2 Cytosol Basal cell carcinoma 0.7520728831273202 | |
| APC2 Cytosol Breast cancer 0.7520728831273202 | |
| APC2 Cytosol Cell cycle 0.7520728831273202 | |
| APC2 Cytosol Colorectal cancer 0.7520728831273202 | |
| APC2 Cytosol Cushing syndrome 0.7520728831273202 | |
| APC2 Cytosol Endometrial cancer 0.7520728831273202 | |
| APC2 Cytosol Gastric cancer 0.7520728831273202 | |
| APC2 Cytosol Hepatocellular carcinoma 0.7520728831273202 | |
| APC2 Cytosol Hippo signaling pathway 0.7520728831273202 | |
| APC2 Cytosol Human T-cell leukemia virus 1 infection 0.7520728831273202 | |
| APC2 Cytosol Human papillomavirus infection 0.7520728831273202 | |
| APC2 Cytosol MicroRNAs in cancer 0.7520728831273202 | |
| APC2 Cytosol Oocyte meiosis 0.7520728831273202 | |
| APC2 Cytosol Pathways in cancer 0.7520728831273202 | |
| APC2 Cytosol Pathways of neurodegeneration - multiple diseases 0.7520728831273202 | |
| APC2 Cytosol Progesterone-mediated oocyte maturation 0.7520728831273202 | |
| APC2 Cytosol Regulation of actin cytoskeleton 0.7520728831273202 | |
| APC2 Cytosol Signaling pathways regulating pluripotency of stem cells 0.7520728831273202 | |
| APC2 Cytosol Ubiquitin mediated proteolysis 0.7520728831273202 | |
| APC2 Cytosol Wnt signaling pathway 0.7520728831273202 | |
| APC2 Golgi apparatus Alzheimer disease 0.7520728831273202 | |
| APC2 Golgi apparatus Basal cell carcinoma 0.7520728831273202 | |
| APC2 Golgi apparatus Breast cancer 0.7520728831273202 | |
| APC2 Golgi apparatus Cell cycle 0.7520728831273202 | |
| APC2 Golgi apparatus Colorectal cancer 0.7520728831273202 | |
| APC2 Golgi apparatus Cushing syndrome 0.7520728831273202 | |
| APC2 Golgi apparatus Endometrial cancer 0.7520728831273202 | |
| APC2 Golgi apparatus Gastric cancer 0.7520728831273202 | |
| APC2 Golgi apparatus Hepatocellular carcinoma 0.7520728831273202 | |
| APC2 Golgi apparatus Hippo signaling pathway 0.7520728831273202 | |
| APC2 Golgi apparatus Human T-cell leukemia virus 1 infection 0.7520728831273202 | |
| APC2 Golgi apparatus Human papillomavirus infection 0.7520728831273202 | |
| APC2 Golgi apparatus MicroRNAs in cancer 0.7520728831273202 | |
| APC2 Golgi apparatus Oocyte meiosis 0.7520728831273202 | |
| APC2 Golgi apparatus Pathways in cancer 0.7520728831273202 | |
| APC2 Golgi apparatus Pathways of neurodegeneration - multiple diseases 0.7520728831273202 | |
| APC2 Golgi apparatus Progesterone-mediated oocyte maturation 0.7520728831273202 | |
| APC2 Golgi apparatus Regulation of actin cytoskeleton 0.7520728831273202 | |
| APC2 Golgi apparatus Signaling pathways regulating pluripotency of stem cells 0.7520728831273202 | |
| APC2 Golgi apparatus Ubiquitin mediated proteolysis 0.7520728831273202 | |
| APC2 Golgi apparatus Wnt signaling pathway 0.7520728831273202 | |
| APC2 Plasma membrane Alzheimer disease 0.7520728831273202 | |
| APC2 Plasma membrane Basal cell carcinoma 0.7520728831273202 | |
| APC2 Plasma membrane Breast cancer 0.7520728831273202 | |
| APC2 Plasma membrane Cell cycle 0.7520728831273202 | |
| APC2 Plasma membrane Colorectal cancer 0.7520728831273202 | |
| APC2 Plasma membrane Cushing syndrome 0.7520728831273202 | |
| APC2 Plasma membrane Endometrial cancer 0.7520728831273202 | |
| APC2 Plasma membrane Gastric cancer 0.7520728831273202 | |
| APC2 Plasma membrane Hepatocellular carcinoma 0.7520728831273202 | |
| APC2 Plasma membrane Hippo signaling pathway 0.7520728831273202 | |
| APC2 Plasma membrane Human T-cell leukemia virus 1 infection 0.7520728831273202 | |
| APC2 Plasma membrane Human papillomavirus infection 0.7520728831273202 | |
| APC2 Plasma membrane MicroRNAs in cancer 0.7520728831273202 | |
| APC2 Plasma membrane Oocyte meiosis 0.7520728831273202 | |
| APC2 Plasma membrane Pathways in cancer 0.7520728831273202 | |
| APC2 Plasma membrane Pathways of neurodegeneration - multiple diseases 0.7520728831273202 | |
| APC2 Plasma membrane Progesterone-mediated oocyte maturation 0.7520728831273202 | |
| APC2 Plasma membrane Regulation of actin cytoskeleton 0.7520728831273202 | |
| APC2 Plasma membrane Signaling pathways regulating pluripotency of stem cells 0.7520728831273202 | |
| APC2 Plasma membrane Ubiquitin mediated proteolysis 0.7520728831273202 | |
| APC2 Plasma membrane Wnt signaling pathway 0.7520728831273202 | |
| APCS Extracellular space Summary 0.7983491553846158 | |
| APEH Cytosol Summary 0.7637170915909508 | |
| APEX1 Endoplasmic Reticulum Base excision repair 1.2584633190665706 | |
| APEX1 Mitochondrion Base excision repair 1.2584633190665706 | |
| APEX1 Nucleus Base excision repair 1.2584633190665706 | |
| APEX2 Cytosol Base excision repair 1.979642003666035 | |
| APEX2 Nucleus Base excision repair 1.979642003666035 | |
| API5 Nucleus Summary 1.5877324397537318 | |
| APIP Cytosol Summary 0.8625337919185717 | |
| APIP Nucleus Summary 0.8625337919185717 | |
| APLF Cytosol Summary 1.7267407386312863 | |
| APLF Nucleus Summary 1.7267407386312863 | |
| APLP2 Cytosol Summary 1.1441644163158515 | |
| APLP2 Nucleus Summary 1.1441644163158515 | |
| APLP2 Plasma membrane Summary 1.1441644163158515 | |
| APMAP Plasma membrane Summary 1.0333036185850326 | |
| APOA1 Cytosol African trypanosomiasis 1.4495053702670768 | |
| APOA1 Cytosol Cholesterol metabolism 1.4495053702670768 | |
| APOA1 Cytosol Fat digestion and absorption 1.4495053702670768 | |
| APOA1 Cytosol Lipid and atherosclerosis 1.4495053702670768 | |
| APOA1 Cytosol PPAR signaling pathway 1.4495053702670768 | |
| APOA1 Cytosol Vitamin digestion and absorption 1.4495053702670768 | |
| APOA1 Extracellular space African trypanosomiasis 1.4495053702670768 | |
| APOA1 Extracellular space Cholesterol metabolism 1.4495053702670768 | |
| APOA1 Extracellular space Fat digestion and absorption 1.4495053702670768 | |
| APOA1 Extracellular space Lipid and atherosclerosis 1.4495053702670768 | |
| APOA1 Extracellular space PPAR signaling pathway 1.4495053702670768 | |
| APOA1 Extracellular space Vitamin digestion and absorption 1.4495053702670768 | |
| APOA2 Extracellular space Cholesterol metabolism 1.4005914176416032 | |
| APOA2 Extracellular space PPAR signaling pathway 1.4005914176416032 | |
| APOA4 Cytosol Cholesterol metabolism 1.939821454248092 | |
| APOA4 Cytosol Fat digestion and absorption 1.939821454248092 | |
| APOA4 Cytosol Lipid and atherosclerosis 1.939821454248092 | |
| APOA4 Cytosol Vitamin digestion and absorption 1.939821454248092 | |
| APOA4 Extracellular space Cholesterol metabolism 1.939821454248092 | |
| APOA4 Extracellular space Fat digestion and absorption 1.939821454248092 | |
| APOA4 Extracellular space Lipid and atherosclerosis 1.939821454248092 | |
| APOA4 Extracellular space Vitamin digestion and absorption 1.939821454248092 | |
| APOB Cytosol Cholesterol metabolism 1.4731106742418865 | |
| APOB Cytosol Fat digestion and absorption 1.4731106742418865 | |
| APOB Cytosol Lipid and atherosclerosis 1.4731106742418865 | |
| APOB Cytosol Vitamin digestion and absorption 1.4731106742418865 | |
| APOB Extracellular space Cholesterol metabolism 1.4731106742418865 | |
| APOB Extracellular space Fat digestion and absorption 1.4731106742418865 | |
| APOB Extracellular space Lipid and atherosclerosis 1.4731106742418865 | |
| APOB Extracellular space Vitamin digestion and absorption 1.4731106742418865 | |
| APOBEC3B Nucleus Summary 2.446733563904595 | |
| APOBEC3C Cytoskeleton Summary 2.386788424741915 | |
| APOBEC3C Nucleus Summary 2.386788424741915 | |
| APOBEC3D Cytosol Summary 1.2462940534371725 | |
| APOBEC3F Cytosol Summary 1.1845333942161045 | |
| APOBEC3F Nucleus Summary 1.1845333942161045 | |
| APOBEC3G Cytosol Human immunodeficiency virus 1 infection 1.7304062977703774 | |
| APOBEC3G Nucleus Human immunodeficiency virus 1 infection 1.7304062977703774 | |
| APOBR Plasma membrane Summary 1.6975375063730846 | |
| APOC2 Extracellular space Cholesterol metabolism 1.4012765800932043 | |
| APOC3 Extracellular space Cholesterol metabolism 1.5147901610489811 | |
| APOC3 Extracellular space PPAR signaling pathway 1.5147901610489811 | |
| APOC3 Nucleus Cholesterol metabolism 1.5147901610489811 | |
| APOC3 Nucleus PPAR signaling pathway 1.5147901610489811 | |
| APOC3 Plasma membrane Cholesterol metabolism 1.5147901610489811 | |
| APOC3 Plasma membrane PPAR signaling pathway 1.5147901610489811 | |
| APOD Cytosol Summary 0.21442032397311148 | |
| APOD Extracellular space Summary 0.21442032397311148 | |
| APOD Plasma membrane Summary 0.21442032397311148 | |
| APOE Cytosol Alzheimer disease 1.1358065104006976 | |
| APOE Cytosol Cholesterol metabolism 1.1358065104006976 | |
| APOE Extracellular space Alzheimer disease 1.1358065104006976 | |
| APOE Extracellular space Cholesterol metabolism 1.1358065104006976 | |
| APOF Extracellular space Summary 1.4415745817341072 | |
| APOH Extracellular space Cholesterol metabolism 1.7778634746327162 | |
| APOH Golgi apparatus Cholesterol metabolism 1.7778634746327162 | |
| APOL1 Extracellular space African trypanosomiasis 1.9330633065955305 | |
| APOL2 Cytosol Summary 1.2910270257600616 | |
| APOL2 Endoplasmic Reticulum Summary 1.2910270257600616 | |
| APOL2 Nucleus Summary 1.2910270257600616 | |
| APOL3 Cytosol Summary 1.205876906540316 | |
| APOL3 Nucleus Summary 1.205876906540316 | |
| APOM Extracellular space Summary 1.8814735121537007 | |
| APOM Golgi apparatus Summary 1.8814735121537007 | |
| APOO Cytosol Summary 1.2609022133440768 | |
| APOO Extracellular space Summary 1.2609022133440768 | |
| APOO Mitochondrion Summary 1.2609022133440768 | |
| APOOL Mitochondrion Summary 1.605192834799693 | |
| APP Cytosol Summary 1.9051002113774345 | |
| APP Golgi apparatus Summary 1.9051002113774345 | |
| APP Plasma membrane Summary 1.9051002113774345 | |
| APPBP2 Cytoskeleton Summary 1.0360811236844545 | |
| APPBP2 Cytosol Summary 1.0360811236844545 | |
| APPBP2 Nucleus Summary 1.0360811236844545 | |
| APPL1 Cytoskeleton Colorectal cancer 0.8298177087766635 | |
| APPL1 Cytoskeleton Longevity regulating pathway 0.8298177087766635 | |
| APPL1 Cytoskeleton Pathways in cancer 0.8298177087766635 | |
| APPL1 Endosome Colorectal cancer 0.8298177087766635 | |
| APPL1 Endosome Longevity regulating pathway 0.8298177087766635 | |
| APPL1 Endosome Pathways in cancer 0.8298177087766635 | |
| APPL1 Mitochondrion Colorectal cancer 0.8298177087766635 | |
| APPL1 Mitochondrion Longevity regulating pathway 0.8298177087766635 | |
| APPL1 Mitochondrion Pathways in cancer 0.8298177087766635 | |
| APPL1 Nucleus Colorectal cancer 0.8298177087766635 | |
| APPL1 Nucleus Longevity regulating pathway 0.8298177087766635 | |
| APPL1 Nucleus Pathways in cancer 0.8298177087766635 | |
| APPL2 Endosome Summary 0.4319426740242627 | |
| APPL2 Nucleus Summary 0.4319426740242627 | |
| APRT Cytosol Summary 0.9948354812461384 | |
| APRT Nucleus Summary 0.9948354812461384 | |
| APTX Nucleus Summary 0.7659135601891705 | |
| AQP1 Nucleus Bile secretion 1.5047066619630824 | |
| AQP1 Nucleus Proximal tubule bicarbonate reclamation 1.5047066619630824 | |
| AQP1 Nucleus Renin secretion 1.5047066619630824 | |
| AQP1 Plasma membrane Bile secretion 1.5047066619630824 | |
| AQP1 Plasma membrane Proximal tubule bicarbonate reclamation 1.5047066619630824 | |
| AQP1 Plasma membrane Renin secretion 1.5047066619630824 | |
| AQR Nucleus Spliceosome 1.3775712886068705 | |
| AR Cytosol Chemical carcinogenesis - receptor activation 0.2101198068265024 | |
| AR Cytosol Colorectal cancer 0.2101198068265024 | |
| AR Cytosol ErbB signaling pathway 0.2101198068265024 | |
| AR Cytosol Folate biosynthesis 0.2101198068265024 | |
| AR Cytosol Fructose and mannose metabolism 0.2101198068265024 | |
| AR Cytosol Galactose metabolism 0.2101198068265024 | |
| AR Cytosol Glycerolipid metabolism 0.2101198068265024 | |
| AR Cytosol Hippo signaling pathway 0.2101198068265024 | |
| AR Cytosol MAPK signaling pathway 0.2101198068265024 | |
| AR Cytosol Metabolic pathways 0.2101198068265024 | |
| AR Cytosol Oocyte meiosis 0.2101198068265024 | |
| AR Cytosol PI3K-Akt signaling pathway 0.2101198068265024 | |
| AR Cytosol Pathways in cancer 0.2101198068265024 | |
| AR Cytosol Pentose and glucuronate interconversions 0.2101198068265024 | |
| AR Cytosol Prostate cancer 0.2101198068265024 | |
| AR Mitochondrion Chemical carcinogenesis - receptor activation 0.2101198068265024 | |
| AR Mitochondrion Colorectal cancer 0.2101198068265024 | |
| AR Mitochondrion ErbB signaling pathway 0.2101198068265024 | |
| AR Mitochondrion Folate biosynthesis 0.2101198068265024 | |
| AR Mitochondrion Fructose and mannose metabolism 0.2101198068265024 | |
| AR Mitochondrion Galactose metabolism 0.2101198068265024 | |
| AR Mitochondrion Glycerolipid metabolism 0.2101198068265024 | |
| AR Mitochondrion Hippo signaling pathway 0.2101198068265024 | |
| AR Mitochondrion MAPK signaling pathway 0.2101198068265024 | |
| AR Mitochondrion Metabolic pathways 0.2101198068265024 | |
| AR Mitochondrion Oocyte meiosis 0.2101198068265024 | |
| AR Mitochondrion PI3K-Akt signaling pathway 0.2101198068265024 | |
| AR Mitochondrion Pathways in cancer 0.2101198068265024 | |
| AR Mitochondrion Pentose and glucuronate interconversions 0.2101198068265024 | |
| AR Mitochondrion Prostate cancer 0.2101198068265024 | |
| AR Nucleus Chemical carcinogenesis - receptor activation 0.2101198068265024 | |
| AR Nucleus Colorectal cancer 0.2101198068265024 | |
| AR Nucleus ErbB signaling pathway 0.2101198068265024 | |
| AR Nucleus Folate biosynthesis 0.2101198068265024 | |
| AR Nucleus Fructose and mannose metabolism 0.2101198068265024 | |
| AR Nucleus Galactose metabolism 0.2101198068265024 | |
| AR Nucleus Glycerolipid metabolism 0.2101198068265024 | |
| AR Nucleus Hippo signaling pathway 0.2101198068265024 | |
| AR Nucleus MAPK signaling pathway 0.2101198068265024 | |
| AR Nucleus Metabolic pathways 0.2101198068265024 | |
| AR Nucleus Oocyte meiosis 0.2101198068265024 | |
| AR Nucleus PI3K-Akt signaling pathway 0.2101198068265024 | |
| AR Nucleus Pathways in cancer 0.2101198068265024 | |
| AR Nucleus Pentose and glucuronate interconversions 0.2101198068265024 | |
| AR Nucleus Prostate cancer 0.2101198068265024 | |
| AR Plasma membrane Chemical carcinogenesis - receptor activation 0.2101198068265024 | |
| AR Plasma membrane Colorectal cancer 0.2101198068265024 | |
| AR Plasma membrane ErbB signaling pathway 0.2101198068265024 | |
| AR Plasma membrane Folate biosynthesis 0.2101198068265024 | |
| AR Plasma membrane Fructose and mannose metabolism 0.2101198068265024 | |
| AR Plasma membrane Galactose metabolism 0.2101198068265024 | |
| AR Plasma membrane Glycerolipid metabolism 0.2101198068265024 | |
| AR Plasma membrane Hippo signaling pathway 0.2101198068265024 | |
| AR Plasma membrane MAPK signaling pathway 0.2101198068265024 | |
| AR Plasma membrane Metabolic pathways 0.2101198068265024 | |
| AR Plasma membrane Oocyte meiosis 0.2101198068265024 | |
| AR Plasma membrane PI3K-Akt signaling pathway 0.2101198068265024 | |
| AR Plasma membrane Pathways in cancer 0.2101198068265024 | |
| AR Plasma membrane Pentose and glucuronate interconversions 0.2101198068265024 | |
| AR Plasma membrane Prostate cancer 0.2101198068265024 | |
| ARAF Nucleus Summary 0.7570399315826852 | |
| ARAP1 Cytosol Endocytosis 1.1991916332027732 | |
| ARAP1 Golgi apparatus Endocytosis 1.1991916332027732 | |
| ARAP1 Nucleus Endocytosis 1.1991916332027732 | |
| ARAP1 Plasma membrane Endocytosis 1.1991916332027732 | |
| ARAP2 Cytoskeleton Summary 1.6126026079157256 | |
| ARAP2 Cytosol Summary 1.6126026079157256 | |
| ARAP2 Nucleus Summary 1.6126026079157256 | |
| ARAP3 Cytosol Endocytosis 1.8733491186289952 | |
| ARAP3 Cytosol Rap1 signaling pathway 1.8733491186289952 | |
| ARAP3 Cytosol cAMP signaling pathway 1.8733491186289952 | |
| ARAP3 Plasma membrane Endocytosis 1.8733491186289952 | |
| ARAP3 Plasma membrane Rap1 signaling pathway 1.8733491186289952 | |
| ARAP3 Plasma membrane cAMP signaling pathway 1.8733491186289952 | |
| ARCN1 Cytosol Summary 0.9596644731748564 | |
| ARCN1 Golgi apparatus Summary 0.9596644731748564 | |
| ARF1 Cytosol Endocytosis 0.7260894468186346 | |
| ARF1 Cytosol Legionellosis 0.7260894468186346 | |
| ARF1 Cytosol Pathogenic Escherichia coli infection 0.7260894468186346 | |
| ARF1 Cytosol Phospholipase D signaling pathway 0.7260894468186346 | |
| ARF1 Cytosol Salmonella infection 0.7260894468186346 | |
| ARF1 Cytosol Shigellosis 0.7260894468186346 | |
| ARF1 Cytosol Vibrio cholerae infection 0.7260894468186346 | |
| ARF1 Golgi apparatus Endocytosis 0.7260894468186346 | |
| ARF1 Golgi apparatus Legionellosis 0.7260894468186346 | |
| ARF1 Golgi apparatus Pathogenic Escherichia coli infection 0.7260894468186346 | |
| ARF1 Golgi apparatus Phospholipase D signaling pathway 0.7260894468186346 | |
| ARF1 Golgi apparatus Salmonella infection 0.7260894468186346 | |
| ARF1 Golgi apparatus Shigellosis 0.7260894468186346 | |
| ARF1 Golgi apparatus Vibrio cholerae infection 0.7260894468186346 | |
| ARF1 Plasma membrane Endocytosis 0.7260894468186346 | |
| ARF1 Plasma membrane Legionellosis 0.7260894468186346 | |
| ARF1 Plasma membrane Pathogenic Escherichia coli infection 0.7260894468186346 | |
| ARF1 Plasma membrane Phospholipase D signaling pathway 0.7260894468186346 | |
| ARF1 Plasma membrane Salmonella infection 0.7260894468186346 | |
| ARF1 Plasma membrane Shigellosis 0.7260894468186346 | |
| ARF1 Plasma membrane Vibrio cholerae infection 0.7260894468186346 | |
| ARF4 Golgi apparatus Endocytosis 0.7298467015801958 | |
| ARF5 Golgi apparatus Endocytosis 1.1880864960909423 | |
| ARF6 Cytosol Endocytosis 1.250856968194265 | |
| ARF6 Cytosol Fc gamma R-mediated phagocytosis 1.250856968194265 | |
| ARF6 Cytosol Pathogenic Escherichia coli infection 1.250856968194265 | |
| ARF6 Cytosol Phospholipase D signaling pathway 1.250856968194265 | |
| ARF6 Cytosol Ras signaling pathway 1.250856968194265 | |
| ARF6 Cytosol Salmonella infection 1.250856968194265 | |
| ARF6 Cytosol Shigellosis 1.250856968194265 | |
| ARF6 Cytosol Yersinia infection 1.250856968194265 | |
| ARF6 Endosome Endocytosis 1.250856968194265 | |
| ARF6 Endosome Fc gamma R-mediated phagocytosis 1.250856968194265 | |
| ARF6 Endosome Pathogenic Escherichia coli infection 1.250856968194265 | |
| ARF6 Endosome Phospholipase D signaling pathway 1.250856968194265 | |
| ARF6 Endosome Ras signaling pathway 1.250856968194265 | |
| ARF6 Endosome Salmonella infection 1.250856968194265 | |
| ARF6 Endosome Shigellosis 1.250856968194265 | |
| ARF6 Endosome Yersinia infection 1.250856968194265 | |
| ARF6 Golgi apparatus Endocytosis 1.250856968194265 | |
| ARF6 Golgi apparatus Fc gamma R-mediated phagocytosis 1.250856968194265 | |
| ARF6 Golgi apparatus Pathogenic Escherichia coli infection 1.250856968194265 | |
| ARF6 Golgi apparatus Phospholipase D signaling pathway 1.250856968194265 | |
| ARF6 Golgi apparatus Ras signaling pathway 1.250856968194265 | |
| ARF6 Golgi apparatus Salmonella infection 1.250856968194265 | |
| ARF6 Golgi apparatus Shigellosis 1.250856968194265 | |
| ARF6 Golgi apparatus Yersinia infection 1.250856968194265 | |
| ARF6 Plasma membrane Endocytosis 1.250856968194265 | |
| ARF6 Plasma membrane Fc gamma R-mediated phagocytosis 1.250856968194265 | |
| ARF6 Plasma membrane Pathogenic Escherichia coli infection 1.250856968194265 | |
| ARF6 Plasma membrane Phospholipase D signaling pathway 1.250856968194265 | |
| ARF6 Plasma membrane Ras signaling pathway 1.250856968194265 | |
| ARF6 Plasma membrane Salmonella infection 1.250856968194265 | |
| ARF6 Plasma membrane Shigellosis 1.250856968194265 | |
| ARF6 Plasma membrane Yersinia infection 1.250856968194265 | |
| ARFGAP1 Cytosol Summary 1.3201239096047108 | |
| ARFGAP1 Golgi apparatus Summary 1.3201239096047108 | |
| ARFGAP1 Nucleus Summary 1.3201239096047108 | |
| ARFGAP2 Cytosol Summary 0.7080667041611048 | |
| ARFGAP2 Golgi apparatus Summary 0.7080667041611048 | |
| ARFGAP3 Cytosol Endocytosis 1.3032573885466785 | |
| ARFGAP3 Golgi apparatus Endocytosis 1.3032573885466785 | |
| ARFGEF1 Cytosol Summary 0.7161797763975186 | |
| ARFGEF1 Golgi apparatus Summary 0.7161797763975186 | |
| ARFGEF1 Nucleus Summary 0.7161797763975186 | |
| ARFGEF2 Cytosol Endocytosis 0.5987325986874038 | |
| ARFGEF2 Golgi apparatus Endocytosis 0.5987325986874038 | |
| ARFGEF2 Nucleus Endocytosis 0.5987325986874038 | |
| ARFGEF3 Cytosol Summary 0.14934084346737111 | |
| ARFIP1 Cytosol Summary 0.9099379705372972 | |
| ARFIP1 Golgi apparatus Summary 0.9099379705372972 | |
| ARFIP1 Nucleus Summary 0.9099379705372972 | |
| ARFIP2 Golgi apparatus Summary 0.4406163063987443 | |
| ARFIP2 Nucleus Summary 0.4406163063987443 | |
| ARFIP2 Plasma membrane Summary 0.4406163063987443 | |
| ARFRP1 Golgi apparatus Summary 1.2687736480572251 | |
| ARG1 Cytosol Summary 1.108866508972417 | |
| ARGLU1 Cytosol Summary 2.1066986430018475 | |
| ARGLU1 Mitochondrion Summary 2.1066986430018475 | |
| ARGLU1 Nucleus Summary 2.1066986430018475 | |
| ARHGAP1 Cytosol Summary 1.072360259689116 | |
| ARHGAP10 Cytosol Summary 1.8773025292622616 | |
| ARHGAP10 Nucleus Summary 1.8773025292622616 | |
| ARHGAP15 Cytosol Summary 1.1472380009844203 | |
| ARHGAP15 Golgi apparatus Summary 1.1472380009844203 | |
| ARHGAP15 Nucleus Summary 1.1472380009844203 | |
| ARHGAP17 Cytosol Tight junction 1.5030713748228193 | |
| ARHGAP17 Nucleus Tight junction 1.5030713748228193 | |
| ARHGAP17 Plasma membrane Tight junction 1.5030713748228193 | |
| ARHGAP18 Cytosol Summary 1.4838366229760391 | |
| ARHGAP18 Nucleus Summary 1.4838366229760391 | |
| ARHGAP18 Plasma membrane Summary 1.4838366229760391 | |
| ARHGAP21 Cytoskeleton Summary 1.9642107066522605 | |
| ARHGAP21 Golgi apparatus Summary 1.9642107066522605 | |
| ARHGAP21 Plasma membrane Summary 1.9642107066522605 | |
| ARHGAP22 Cytosol Summary 1.5662438693532168 | |
| ARHGAP22 Nucleus Summary 1.5662438693532168 | |
| ARHGAP22 Plasma membrane Summary 1.5662438693532168 | |
| ARHGAP23 Cytosol Summary 2.0437230512384685 | |
| ARHGAP23 Nucleus Summary 2.0437230512384685 | |
| ARHGAP23 Plasma membrane Summary 2.0437230512384685 | |
| ARHGAP24 Cytosol Summary 1.5968534725416634 | |
| ARHGAP24 Plasma membrane Summary 1.5968534725416634 | |
| ARHGAP25 Cytosol Summary 1.304095211522608 | |
| ARHGAP25 Nucleus Summary 1.304095211522608 | |
| ARHGAP26 Cytosol Summary 2.151178280219236 | |
| ARHGAP26 Plasma membrane Summary 2.151178280219236 | |
| ARHGAP27 Cytosol Summary 1.3068089623436894 | |
| ARHGAP27 Nucleus Summary 1.3068089623436894 | |
| ARHGAP28 Plasma membrane Summary 2.2479573406387456 | |
| ARHGAP29 Cytoskeleton Summary 1.2699530944622457 | |
| ARHGAP29 Cytosol Summary 1.2699530944622457 | |
| ARHGAP29 Nucleus Summary 1.2699530944622457 | |
| ARHGAP29 Plasma membrane Summary 1.2699530944622457 | |
| ARHGAP30 Cytosol Summary 1.3266707711316732 | |
| ARHGAP31 Plasma membrane Summary 1.7686782785602144 | |
| ARHGAP32 Cytoskeleton Summary 0.5745009659906708 | |
| ARHGAP32 Golgi apparatus Summary 0.5745009659906708 | |
| ARHGAP32 Nucleus Summary 0.5745009659906708 | |
| ARHGAP32 Plasma membrane Summary 0.5745009659906708 | |
| ARHGAP35 Cytosol Summary 0.4135231086692739 | |
| ARHGAP35 Nucleus Summary 0.4135231086692739 | |
| ARHGAP39 Cytoskeleton Summary 1.3674806517578921 | |
| ARHGAP39 Cytosol Summary 1.3674806517578921 | |
| ARHGAP39 Nucleus Summary 1.3674806517578921 | |
| ARHGAP4 Cytosol Summary 1.4488469175022394 | |
| ARHGAP4 Nucleus Summary 1.4488469175022394 | |
| ARHGAP42 Cytosol Summary 1.7058571499892676 | |
| ARHGAP42 Nucleus Summary 1.7058571499892676 | |
| ARHGAP45 Cytosol Summary 1.5471991806337342 | |
| ARHGAP5 Cytosol Summary 1.0057978877534182 | |
| ARHGAP5 Endoplasmic Reticulum Summary 1.0057978877534182 | |
| ARHGAP6 Cytoskeleton Summary 1.0889820949589768 | |
| ARHGAP6 Cytosol Summary 1.0889820949589768 | |
| ARHGAP9 Plasma membrane Summary 1.4497723718027231 | |
| ARHGDIA Cytoskeleton Neurotrophin signaling pathway 0.86181562747219 | |
| ARHGDIA Cytoskeleton Vasopressin-regulated water reabsorption 0.86181562747219 | |
| ARHGDIA Cytosol Neurotrophin signaling pathway 0.86181562747219 | |
| ARHGDIA Cytosol Vasopressin-regulated water reabsorption 0.86181562747219 | |
| ARHGDIB Cytoskeleton Neurotrophin signaling pathway 1.0677265469790262 | |
| ARHGDIB Cytoskeleton Vasopressin-regulated water reabsorption 1.0677265469790262 | |
| ARHGDIB Cytosol Neurotrophin signaling pathway 1.0677265469790262 | |
| ARHGDIB Cytosol Vasopressin-regulated water reabsorption 1.0677265469790262 | |
| ARHGEF1 Cytosol Summary 1.6471822946371235 | |
| ARHGEF1 Plasma membrane Summary 1.6471822946371235 | |
| ARHGEF10 Nucleus Summary 2.408467075171625 | |
| ARHGEF10L Cytosol Summary 1.3319299717836508 | |
| ARHGEF10L Golgi apparatus Summary 1.3319299717836508 | |
| ARHGEF11 Cytosol Summary 1.808457331762704 | |
| ARHGEF11 Golgi apparatus Summary 1.808457331762704 | |
| ARHGEF11 Nucleus Summary 1.808457331762704 | |
| ARHGEF11 Plasma membrane Summary 1.808457331762704 | |
| ARHGEF12 Cytosol Summary 0.6192165945419713 | |
| ARHGEF12 Nucleus Summary 0.6192165945419713 | |
| ARHGEF12 Plasma membrane Summary 0.6192165945419713 | |
| ARHGEF16 Cytosol Summary 0.5386715592227184 | |
| ARHGEF17 Cytosol Summary 1.3041762903031318 | |
| ARHGEF18 Cytosol Summary 1.0987057088941632 | |
| ARHGEF2 Cytoskeleton Fluid shear stress and atherosclerosis 2.953002737908065 | |
| ARHGEF2 Cytoskeleton Pathogenic Escherichia coli infection 2.953002737908065 | |
| ARHGEF2 Cytoskeleton Shigellosis 2.953002737908065 | |
| ARHGEF2 Cytoskeleton Tight junction 2.953002737908065 | |
| ARHGEF2 Cytosol Fluid shear stress and atherosclerosis 2.953002737908065 | |
| ARHGEF2 Cytosol Pathogenic Escherichia coli infection 2.953002737908065 | |
| ARHGEF2 Cytosol Shigellosis 2.953002737908065 | |
| ARHGEF2 Cytosol Tight junction 2.953002737908065 | |
| ARHGEF2 Golgi apparatus Fluid shear stress and atherosclerosis 2.953002737908065 | |
| ARHGEF2 Golgi apparatus Pathogenic Escherichia coli infection 2.953002737908065 | |
| ARHGEF2 Golgi apparatus Shigellosis 2.953002737908065 | |
| ARHGEF2 Golgi apparatus Tight junction 2.953002737908065 | |
| ARHGEF2 Plasma membrane Fluid shear stress and atherosclerosis 2.953002737908065 | |
| ARHGEF2 Plasma membrane Pathogenic Escherichia coli infection 2.953002737908065 | |
| ARHGEF2 Plasma membrane Shigellosis 2.953002737908065 | |
| ARHGEF2 Plasma membrane Tight junction 2.953002737908065 | |
| ARHGEF26 Cytosol Summary 0.7938396124326496 | |
| ARHGEF26 Nucleus Summary 0.7938396124326496 | |
| ARHGEF26 Plasma membrane Summary 0.7938396124326496 | |
| ARHGEF28 Cytoskeleton Summary 1.160684535970428 | |
| ARHGEF28 Cytosol Summary 1.160684535970428 | |
| ARHGEF28 Plasma membrane Summary 1.160684535970428 | |
| ARHGEF3 Cytosol Summary 0.9376980302392328 | |
| ARHGEF37 Cytosol Summary 0.7304327874058364 | |
| ARHGEF38 Cytoskeleton Summary 0.5839178208786304 | |
| ARHGEF38 Nucleus Summary 0.5839178208786304 | |
| ARHGEF40 Cytosol Summary 1.4821183554332649 | |
| ARHGEF40 Plasma membrane Summary 1.4821183554332649 | |
| ARHGEF5 Cytosol Summary 1.4019452214703971 | |
| ARHGEF5 Nucleus Summary 1.4019452214703971 | |
| ARHGEF5 Plasma membrane Summary 1.4019452214703971 | |
| ARHGEF6 Cytosol Summary 1.638139670890788 | |
| ARHGEF7 Plasma membrane Summary 1.4420032173179471 | |
| ARID1A Nucleus Hepatocellular carcinoma 1.1761175042406866 | |
| ARID1A Nucleus Thermogenesis 1.1761175042406866 | |
| ARID1B Nucleus Summary 1.4321680083593615 | |
| ARID2 Nucleus Hepatocellular carcinoma 1.3613147719766374 | |
| ARID2 Plasma membrane Hepatocellular carcinoma 1.3613147719766374 | |
| ARID3A Cytosol Summary 1.7279601322009617 | |
| ARID3A Nucleus Summary 1.7279601322009617 | |
| ARID4A Cytosol Summary 1.3455104551960022 | |
| ARID4A Nucleus Summary 1.3455104551960022 | |
| ARID4A Plasma membrane Summary 1.3455104551960022 | |
| ARID4B Cytosol Summary 1.4441932672793152 | |
| ARID4B Mitochondrion Summary 1.4441932672793152 | |
| ARID4B Nucleus Summary 1.4441932672793152 | |
| ARID5B Cytosol Summary 1.3949492354490411 | |
| ARID5B Endoplasmic Reticulum Summary 1.3949492354490411 | |
| ARID5B Nucleus Summary 1.3949492354490411 | |
| ARID5B Plasma membrane Summary 1.3949492354490411 | |
| ARIH1 Cytosol Summary 1.0598146645952855 | |
| ARIH1 Golgi apparatus Summary 1.0598146645952855 | |
| ARIH1 Nucleus Summary 1.0598146645952855 | |
| ARIH2 Nucleus Summary 1.5995499493086296 | |
| ARL1 Golgi apparatus Folate biosynthesis 0.7450950788867206 | |
| ARL1 Golgi apparatus Fructose and mannose metabolism 0.7450950788867206 | |
| ARL1 Golgi apparatus Galactose metabolism 0.7450950788867206 | |
| ARL1 Golgi apparatus Glycerolipid metabolism 0.7450950788867206 | |
| ARL1 Golgi apparatus Metabolic pathways 0.7450950788867206 | |
| ARL1 Golgi apparatus Pentose and glucuronate interconversions 0.7450950788867206 | |
| ARL14EP Cytosol Summary 1.9339686364219213 | |
| ARL14EP Nucleus Summary 1.9339686364219213 | |
| ARL15 Golgi apparatus Summary 1.2778522234060872 | |
| ARL15 Plasma membrane Summary 1.2778522234060872 | |
| ARL2 Cytoskeleton Summary 1.9593565350058595 | |
| ARL2 Cytosol Summary 1.9593565350058595 | |
| ARL2 Golgi apparatus Summary 1.9593565350058595 | |
| ARL2 Mitochondrion Summary 1.9593565350058595 | |
| ARL2 Nucleus Summary 1.9593565350058595 | |
| ARL2BP Cytoskeleton Summary 0.9801820526852231 | |
| ARL2BP Mitochondrion Summary 0.9801820526852231 | |
| ARL2BP Nucleus Summary 0.9801820526852231 | |
| ARL3 Cytoskeleton Summary 0.6771334695415315 | |
| ARL3 Golgi apparatus Summary 0.6771334695415315 | |
| ARL3 Nucleus Summary 0.6771334695415315 | |
| ARL4C Cytosol Summary 1.432177847752325 | |
| ARL4C Plasma membrane Summary 1.432177847752325 | |
| ARL6 Cytoskeleton Summary 1.606548735445159 | |
| ARL6 Cytosol Summary 1.606548735445159 | |
| ARL6 Nucleus Summary 1.606548735445159 | |
| ARL6 Plasma membrane Summary 1.606548735445159 | |
| ARL6IP1 Endoplasmic Reticulum Summary 0.5718788908590512 | |
| ARL6IP4 Mitochondrion Summary 1.2598110902647115 | |
| ARL6IP4 Nucleus Summary 1.2598110902647115 | |
| ARL6IP5 Endoplasmic Reticulum Summary 0.4949678096020237 | |
| ARL6IP6 Cytosol Summary 1.5891970418086832 | |
| ARL6IP6 Nucleus Summary 1.5891970418086832 | |
| ARL8A Cytoskeleton Salmonella infection 1.3700868231802181 | |
| ARL8A Endosome Salmonella infection 1.3700868231802181 | |
| ARL8A Lysosome Salmonella infection 1.3700868231802181 | |
| ARL8B Cytoskeleton Salmonella infection 1.2912013274228324 | |
| ARL8B Endosome Salmonella infection 1.2912013274228324 | |
| ARL8B Lysosome Salmonella infection 1.2912013274228324 | |
| ARMC1 Cytosol Summary 1.7562222747386829 | |
| ARMC1 Mitochondrion Summary 1.7562222747386829 | |
| ARMC10 Endoplasmic Reticulum Summary 1.9395667143179731 | |
| ARMC10 Mitochondrion Summary 1.9395667143179731 | |
| ARMC5 Cytosol Summary 1.0211767298204246 | |
| ARMC5 Nucleus Summary 1.0211767298204246 | |
| ARMC6 Cytosol Summary 2.1301884957678503 | |
| ARMC8 Cytosol Summary 1.1819569307803588 | |
| ARMC8 Nucleus Summary 1.1819569307803588 | |
| ARMC9 Cytosol Summary 0.7419580398240061 | |
| ARMC9 Nucleus Summary 0.7419580398240061 | |
| ARMCX1 Cytosol Summary 1.2816936664962928 | |
| ARMCX1 Mitochondrion Summary 1.2816936664962928 | |
| ARMCX1 Nucleus Summary 1.2816936664962928 | |
| ARMCX2 Mitochondrion Summary 1.6065819062988589 | |
| ARMCX2 Nucleus Summary 1.6065819062988589 | |
| ARMCX3 Cytosol Summary 1.052967549452669 | |
| ARMCX3 Golgi apparatus Summary 1.052967549452669 | |
| ARMCX3 Mitochondrion Summary 1.052967549452669 | |
| ARMCX3 Nucleus Summary 1.052967549452669 | |
| ARMCX4 Cytosol Summary 1.548897172079 | |
| ARMCX4 Nucleus Summary 1.548897172079 | |
| ARMCX5 Cytosol Summary 1.106896524577669 | |
| ARMCX5 Nucleus Summary 1.106896524577669 | |
| ARMCX5 Plasma membrane Summary 1.106896524577669 | |
| ARMT1 Cytosol Summary 0.049603743851967634 | |
| ARMT1 Nucleus Summary 0.049603743851967634 | |
| ARNT Cytosol Chemical carcinogenesis - receptor activation 1.4759524136023825 | |
| ARNT Cytosol Cushing syndrome 1.4759524136023825 | |
| ARNT Cytosol HIF-1 signaling pathway 1.4759524136023825 | |
| ARNT Cytosol Pathways in cancer 1.4759524136023825 | |
| ARNT Cytosol Renal cell carcinoma 1.4759524136023825 | |
| ARNT Nucleus Chemical carcinogenesis - receptor activation 1.4759524136023825 | |
| ARNT Nucleus Cushing syndrome 1.4759524136023825 | |
| ARNT Nucleus HIF-1 signaling pathway 1.4759524136023825 | |
| ARNT Nucleus Pathways in cancer 1.4759524136023825 | |
| ARNT Nucleus Renal cell carcinoma 1.4759524136023825 | |
| ARNT2 Nucleus Pathways in cancer 0.8674648132693683 | |
| ARNT2 Nucleus Renal cell carcinoma 0.8674648132693683 | |
| ARNT2 Nucleus Transcriptional misregulation in cancer 0.8674648132693683 | |
| ARNTL Cytosol Summary 0.610336003615954 | |
| ARNTL Nucleus Summary 0.610336003615954 | |
| ARPC1A Cytosol Summary 0.8920015004770349 | |
| ARPC1A Plasma membrane Summary 0.8920015004770349 | |
| ARPC1B Cytosol Summary 1.8378099226245084 | |
| ARPC2 Cytoskeleton Bacterial invasion of epithelial cells 1.4257045985698642 | |
| ARPC2 Cytoskeleton Endocytosis 1.4257045985698642 | |
| ARPC2 Cytoskeleton Fc gamma R-mediated phagocytosis 1.4257045985698642 | |
| ARPC2 Cytoskeleton Pathogenic Escherichia coli infection 1.4257045985698642 | |
| ARPC2 Cytoskeleton Regulation of actin cytoskeleton 1.4257045985698642 | |
| ARPC2 Cytoskeleton Salmonella infection 1.4257045985698642 | |
| ARPC2 Cytoskeleton Shigellosis 1.4257045985698642 | |
| ARPC2 Cytoskeleton Tight junction 1.4257045985698642 | |
| ARPC2 Cytoskeleton Yersinia infection 1.4257045985698642 | |
| ARPC2 Cytosol Bacterial invasion of epithelial cells 1.4257045985698642 | |
| ARPC2 Cytosol Endocytosis 1.4257045985698642 | |
| ARPC2 Cytosol Fc gamma R-mediated phagocytosis 1.4257045985698642 | |
| ARPC2 Cytosol Pathogenic Escherichia coli infection 1.4257045985698642 | |
| ARPC2 Cytosol Regulation of actin cytoskeleton 1.4257045985698642 | |
| ARPC2 Cytosol Salmonella infection 1.4257045985698642 | |
| ARPC2 Cytosol Shigellosis 1.4257045985698642 | |
| ARPC2 Cytosol Tight junction 1.4257045985698642 | |
| ARPC2 Cytosol Yersinia infection 1.4257045985698642 | |
| ARPC2 Golgi apparatus Bacterial invasion of epithelial cells 1.4257045985698642 | |
| ARPC2 Golgi apparatus Endocytosis 1.4257045985698642 | |
| ARPC2 Golgi apparatus Fc gamma R-mediated phagocytosis 1.4257045985698642 | |
| ARPC2 Golgi apparatus Pathogenic Escherichia coli infection 1.4257045985698642 | |
| ARPC2 Golgi apparatus Regulation of actin cytoskeleton 1.4257045985698642 | |
| ARPC2 Golgi apparatus Salmonella infection 1.4257045985698642 | |
| ARPC2 Golgi apparatus Shigellosis 1.4257045985698642 | |
| ARPC2 Golgi apparatus Tight junction 1.4257045985698642 | |
| ARPC2 Golgi apparatus Yersinia infection 1.4257045985698642 | |
| ARPC2 Nucleus Bacterial invasion of epithelial cells 1.4257045985698642 | |
| ARPC2 Nucleus Endocytosis 1.4257045985698642 | |
| ARPC2 Nucleus Fc gamma R-mediated phagocytosis 1.4257045985698642 | |
| ARPC2 Nucleus Pathogenic Escherichia coli infection 1.4257045985698642 | |
| ARPC2 Nucleus Regulation of actin cytoskeleton 1.4257045985698642 | |
| ARPC2 Nucleus Salmonella infection 1.4257045985698642 | |
| ARPC2 Nucleus Shigellosis 1.4257045985698642 | |
| ARPC2 Nucleus Tight junction 1.4257045985698642 | |
| ARPC2 Nucleus Yersinia infection 1.4257045985698642 | |
| ARPC3 Cytoskeleton Bacterial invasion of epithelial cells 1.7258515514440913 | |
| ARPC3 Cytoskeleton Endocytosis 1.7258515514440913 | |
| ARPC3 Cytoskeleton Fc gamma R-mediated phagocytosis 1.7258515514440913 | |
| ARPC3 Cytoskeleton Pathogenic Escherichia coli infection 1.7258515514440913 | |
| ARPC3 Cytoskeleton Regulation of actin cytoskeleton 1.7258515514440913 | |
| ARPC3 Cytoskeleton Salmonella infection 1.7258515514440913 | |
| ARPC3 Cytoskeleton Shigellosis 1.7258515514440913 | |
| ARPC3 Cytoskeleton Tight junction 1.7258515514440913 | |
| ARPC3 Cytoskeleton Yersinia infection 1.7258515514440913 | |
| ARPC3 Cytosol Bacterial invasion of epithelial cells 1.7258515514440913 | |
| ARPC3 Cytosol Endocytosis 1.7258515514440913 | |
| ARPC3 Cytosol Fc gamma R-mediated phagocytosis 1.7258515514440913 | |
| ARPC3 Cytosol Pathogenic Escherichia coli infection 1.7258515514440913 | |
| ARPC3 Cytosol Regulation of actin cytoskeleton 1.7258515514440913 | |
| ARPC3 Cytosol Salmonella infection 1.7258515514440913 | |
| ARPC3 Cytosol Shigellosis 1.7258515514440913 | |
| ARPC3 Cytosol Tight junction 1.7258515514440913 | |
| ARPC3 Cytosol Yersinia infection 1.7258515514440913 | |
| ARPC3 Nucleus Bacterial invasion of epithelial cells 1.7258515514440913 | |
| ARPC3 Nucleus Endocytosis 1.7258515514440913 | |
| ARPC3 Nucleus Fc gamma R-mediated phagocytosis 1.7258515514440913 | |
| ARPC3 Nucleus Pathogenic Escherichia coli infection 1.7258515514440913 | |
| ARPC3 Nucleus Regulation of actin cytoskeleton 1.7258515514440913 | |
| ARPC3 Nucleus Salmonella infection 1.7258515514440913 | |
| ARPC3 Nucleus Shigellosis 1.7258515514440913 | |
| ARPC3 Nucleus Tight junction 1.7258515514440913 | |
| ARPC3 Nucleus Yersinia infection 1.7258515514440913 | |
| ARPC4 Cytoskeleton Bacterial invasion of epithelial cells 2.5535946138545307 | |
| ARPC4 Cytoskeleton Endocytosis 2.5535946138545307 | |
| ARPC4 Cytoskeleton Fc gamma R-mediated phagocytosis 2.5535946138545307 | |
| ARPC4 Cytoskeleton Pathogenic Escherichia coli infection 2.5535946138545307 | |
| ARPC4 Cytoskeleton Regulation of actin cytoskeleton 2.5535946138545307 | |
| ARPC4 Cytoskeleton Salmonella infection 2.5535946138545307 | |
| ARPC4 Cytoskeleton Shigellosis 2.5535946138545307 | |
| ARPC4 Cytoskeleton Tight junction 2.5535946138545307 | |
| ARPC4 Cytoskeleton Yersinia infection 2.5535946138545307 | |
| ARPC4 Cytosol Bacterial invasion of epithelial cells 2.5535946138545307 | |
| ARPC4 Cytosol Endocytosis 2.5535946138545307 | |
| ARPC4 Cytosol Fc gamma R-mediated phagocytosis 2.5535946138545307 | |
| ARPC4 Cytosol Pathogenic Escherichia coli infection 2.5535946138545307 | |
| ARPC4 Cytosol Regulation of actin cytoskeleton 2.5535946138545307 | |
| ARPC4 Cytosol Salmonella infection 2.5535946138545307 | |
| ARPC4 Cytosol Shigellosis 2.5535946138545307 | |
| ARPC4 Cytosol Tight junction 2.5535946138545307 | |
| ARPC4 Cytosol Yersinia infection 2.5535946138545307 | |
| ARPC5 Cytoskeleton Bacterial invasion of epithelial cells 1.9196989735652787 | |
| ARPC5 Cytoskeleton Endocytosis 1.9196989735652787 | |
| ARPC5 Cytoskeleton Fc gamma R-mediated phagocytosis 1.9196989735652787 | |
| ARPC5 Cytoskeleton Pathogenic Escherichia coli infection 1.9196989735652787 | |
| ARPC5 Cytoskeleton Regulation of actin cytoskeleton 1.9196989735652787 | |
| ARPC5 Cytoskeleton Salmonella infection 1.9196989735652787 | |
| ARPC5 Cytoskeleton Shigellosis 1.9196989735652787 | |
| ARPC5 Cytoskeleton Tight junction 1.9196989735652787 | |
| ARPC5 Cytoskeleton Yersinia infection 1.9196989735652787 | |
| ARPC5 Cytosol Bacterial invasion of epithelial cells 1.9196989735652787 | |
| ARPC5 Cytosol Endocytosis 1.9196989735652787 | |
| ARPC5 Cytosol Fc gamma R-mediated phagocytosis 1.9196989735652787 | |
| ARPC5 Cytosol Pathogenic Escherichia coli infection 1.9196989735652787 | |
| ARPC5 Cytosol Regulation of actin cytoskeleton 1.9196989735652787 | |
| ARPC5 Cytosol Salmonella infection 1.9196989735652787 | |
| ARPC5 Cytosol Shigellosis 1.9196989735652787 | |
| ARPC5 Cytosol Tight junction 1.9196989735652787 | |
| ARPC5 Cytosol Yersinia infection 1.9196989735652787 | |
| ARPC5 Plasma membrane Bacterial invasion of epithelial cells 1.9196989735652787 | |
| ARPC5 Plasma membrane Endocytosis 1.9196989735652787 | |
| ARPC5 Plasma membrane Fc gamma R-mediated phagocytosis 1.9196989735652787 | |
| ARPC5 Plasma membrane Pathogenic Escherichia coli infection 1.9196989735652787 | |
| ARPC5 Plasma membrane Regulation of actin cytoskeleton 1.9196989735652787 | |
| ARPC5 Plasma membrane Salmonella infection 1.9196989735652787 | |
| ARPC5 Plasma membrane Shigellosis 1.9196989735652787 | |
| ARPC5 Plasma membrane Tight junction 1.9196989735652787 | |
| ARPC5 Plasma membrane Yersinia infection 1.9196989735652787 | |
| ARPC5L Cytosol Summary 1.9271132057329183 | |
| ARPP19 Cytosol Summary 0.8505312198075049 | |
| ARRB1 Nucleus Summary 1.1064327262758755 | |
| ARRB2 Cytosol Chemical carcinogenesis - receptor activation 1.7069704729089423 | |
| ARRB2 Cytosol Chemokine signaling pathway 1.7069704729089423 | |
| ARRB2 Cytosol Dopaminergic synapse 1.7069704729089423 | |
| ARRB2 Cytosol Endocytosis 1.7069704729089423 | |
| ARRB2 Cytosol GnRH secretion 1.7069704729089423 | |
| ARRB2 Cytosol Hedgehog signaling pathway 1.7069704729089423 | |
| ARRB2 Cytosol MAPK signaling pathway 1.7069704729089423 | |
| ARRB2 Cytosol Morphine addiction 1.7069704729089423 | |
| ARRB2 Cytosol Olfactory transduction 1.7069704729089423 | |
| ARRB2 Cytosol Parathyroid hormone synthesis secretion and action 1.7069704729089423 | |
| ARRB2 Cytosol Relaxin signaling pathway 1.7069704729089423 | |
| ARRB2 Nucleus Chemical carcinogenesis - receptor activation 1.7069704729089423 | |
| ARRB2 Nucleus Chemokine signaling pathway 1.7069704729089423 | |
| ARRB2 Nucleus Dopaminergic synapse 1.7069704729089423 | |
| ARRB2 Nucleus Endocytosis 1.7069704729089423 | |
| ARRB2 Nucleus GnRH secretion 1.7069704729089423 | |
| ARRB2 Nucleus Hedgehog signaling pathway 1.7069704729089423 | |
| ARRB2 Nucleus MAPK signaling pathway 1.7069704729089423 | |
| ARRB2 Nucleus Morphine addiction 1.7069704729089423 | |
| ARRB2 Nucleus Olfactory transduction 1.7069704729089423 | |
| ARRB2 Nucleus Parathyroid hormone synthesis secretion and action 1.7069704729089423 | |
| ARRB2 Nucleus Relaxin signaling pathway 1.7069704729089423 | |
| ARRB2 Plasma membrane Chemical carcinogenesis - receptor activation 1.7069704729089423 | |
| ARRB2 Plasma membrane Chemokine signaling pathway 1.7069704729089423 | |
| ARRB2 Plasma membrane Dopaminergic synapse 1.7069704729089423 | |
| ARRB2 Plasma membrane Endocytosis 1.7069704729089423 | |
| ARRB2 Plasma membrane GnRH secretion 1.7069704729089423 | |
| ARRB2 Plasma membrane Hedgehog signaling pathway 1.7069704729089423 | |
| ARRB2 Plasma membrane MAPK signaling pathway 1.7069704729089423 | |
| ARRB2 Plasma membrane Morphine addiction 1.7069704729089423 | |
| ARRB2 Plasma membrane Olfactory transduction 1.7069704729089423 | |
| ARRB2 Plasma membrane Parathyroid hormone synthesis secretion and action 1.7069704729089423 | |
| ARRB2 Plasma membrane Relaxin signaling pathway 1.7069704729089423 | |
| ARRDC1 Nucleus Summary 0.7871378460416855 | |
| ARRDC1 Plasma membrane Summary 0.7871378460416855 | |
| ARSA Cytosol Lysosome 0.6129559784721634 | |
| ARSA Cytosol Sphingolipid metabolism 0.6129559784721634 | |
| ARSA Golgi apparatus Lysosome 0.6129559784721634 | |
| ARSA Golgi apparatus Sphingolipid metabolism 0.6129559784721634 | |
| ARSA Lysosome Lysosome 0.6129559784721634 | |
| ARSA Lysosome Sphingolipid metabolism 0.6129559784721634 | |
| ARSB Golgi apparatus Glycosaminoglycan degradation 1.63039055466588 | |
| ARSB Golgi apparatus Lysosome 1.63039055466588 | |
| ARSB Golgi apparatus Metabolic pathways 1.63039055466588 | |
| ARSB Lysosome Glycosaminoglycan degradation 1.63039055466588 | |
| ARSB Lysosome Lysosome 1.63039055466588 | |
| ARSB Lysosome Metabolic pathways 1.63039055466588 | |
| ARSD Cytosol Summary 0.4597009646226166 | |
| ARSD Lysosome Summary 0.4597009646226166 | |
| ARSI Endoplasmic Reticulum Summary 1.8121987603341965 | |
| ARSI Extracellular space Summary 1.8121987603341965 | |
| ARSI Golgi apparatus Summary 1.8121987603341965 | |
| ARV1 Cytosol Summary 0.7119480932126221 | |
| ARV1 Endoplasmic Reticulum Summary 0.7119480932126221 | |
| ARVCF Nucleus Summary 0.8853267829482551 | |
| ARVCF Plasma membrane Summary 0.8853267829482551 | |
| AS3MT Cytosol Summary 0.7820747146582059 | |
| AS3MT Mitochondrion Summary 0.7820747146582059 | |
| ASAH1 Lysosome Lysosome 0.4760729575301727 | |
| ASAH1 Lysosome Metabolic pathways 0.4760729575301727 | |
| ASAH1 Lysosome Sphingolipid metabolism 0.4760729575301727 | |
| ASAH1 Lysosome Sphingolipid signaling pathway 0.4760729575301727 | |
| ASAP1 Cytoskeleton Summary 1.7894331620347006 | |
| ASAP1 Cytosol Summary 1.7894331620347006 | |
| ASAP1 Plasma membrane Summary 1.7894331620347006 | |
| ASAP2 Cytosol Endocytosis 2.0439264019488097 | |
| ASAP2 Cytosol Fc gamma R-mediated phagocytosis 2.0439264019488097 | |
| ASAP2 Golgi apparatus Endocytosis 2.0439264019488097 | |
| ASAP2 Golgi apparatus Fc gamma R-mediated phagocytosis 2.0439264019488097 | |
| ASAP2 Plasma membrane Endocytosis 2.0439264019488097 | |
| ASAP2 Plasma membrane Fc gamma R-mediated phagocytosis 2.0439264019488097 | |
| ASAP3 Cytosol Summary 1.2016836632660484 | |
| ASAP3 Nucleus Summary 1.2016836632660484 | |
| ASB13 Golgi apparatus Summary 0.3103223953825025 | |
| ASB13 Nucleus Summary 0.3103223953825025 | |
| ASB6 Cytosol Summary 1.5658543080063585 | |
| ASB9 Cytosol Summary 1.2134408586989658 | |
| ASB9 Mitochondrion Summary 1.2134408586989658 | |
| ASB9 Nucleus Summary 1.2134408586989658 | |
| ASCC1 Cytosol Summary 1.25426299525512 | |
| ASCC1 Nucleus Summary 1.25426299525512 | |
| ASCC2 Cytosol Summary 1.3558226328072758 | |
| ASCC2 Nucleus Summary 1.3558226328072758 | |
| ASCC3 Cytosol Summary 1.3171557642017004 | |
| ASCC3 Golgi apparatus Summary 1.3171557642017004 | |
| ASCC3 Nucleus Summary 1.3171557642017004 | |
| ASF1A Nucleus Summary 1.9663171504178367 | |
| ASF1B Nucleus Summary 1.9435117305000025 | |
| ASH1L Golgi apparatus Lysine degradation 2.172132231838701 | |
| ASH1L Golgi apparatus Metabolic pathways 2.172132231838701 | |
| ASH1L Nucleus Lysine degradation 2.172132231838701 | |
| ASH1L Nucleus Metabolic pathways 2.172132231838701 | |
| ASH1L Plasma membrane Lysine degradation 2.172132231838701 | |
| ASH1L Plasma membrane Metabolic pathways 2.172132231838701 | |
| ASH2L Nucleus Cushing syndrome 1.5736734457913182 | |
| ASH2L Plasma membrane Cushing syndrome 1.5736734457913182 | |
| ASL Cytosol Summary 0.5713975182122966 | |
| ASMTL Cytosol Summary 0.5695562429384571 | |
| ASNA1 Nucleus Summary 1.3339257917680132 | |
| ASNS Cytosol Summary 2.092316635002704 | |
| ASNSD1 Cytosol Summary 1.3945316158366494 | |
| ASPA Cytosol Summary 1.4715444814655163 | |
| ASPA Nucleus Summary 1.4715444814655163 | |
| ASPH Endoplasmic Reticulum Calcium signaling pathway 0.630415197894438 | |
| ASPH Endoplasmic Reticulum Cardiac muscle contraction 0.630415197894438 | |
| ASPH Plasma membrane Calcium signaling pathway 0.630415197894438 | |
| ASPH Plasma membrane Cardiac muscle contraction 0.630415197894438 | |
| ASPM Cytosol Summary 1.8786790293249451 | |
| ASPM Plasma membrane Summary 1.8786790293249451 | |
| ASPN Cytosol Summary 0.7713751525955415 | |
| ASPN Extracellular space Summary 0.7713751525955415 | |
| ASPN Nucleus Summary 0.7713751525955415 | |
| ASPSCR1 Cytosol Summary 1.1181791385334956 | |
| ASPSCR1 Nucleus Summary 1.1181791385334956 | |
| ASPSCR1 Plasma membrane Summary 1.1181791385334956 | |
| ASRGL1 Cytoskeleton Summary 0.9375529214895936 | |
| ASRGL1 Cytosol Summary 0.9375529214895936 | |
| ASRGL1 Nucleus Summary 0.9375529214895936 | |
| ASS1 Cytosol Summary 2.285674202281076 | |
| ASS1 Nucleus Summary 2.285674202281076 | |
| ASTN2 Cytosol Summary 1.0884861062292994 | |
| ASTN2 Nucleus Summary 1.0884861062292994 | |
| ASXL2 Nucleus Summary 1.1695738876147497 | |
| ASXL3 Nucleus Summary 0.8912350082984778 | |
| ATAD1 Mitochondrion Summary 0.9721200739284726 | |
| ATAD1 Nucleus Summary 0.9721200739284726 | |
| ATAD2 Nucleus Summary 2.5930078147368123 | |
| ATAD2B Nucleus Summary 1.6857314202250082 | |
| ATAD3A Mitochondrion Summary 2.5058216101378017 | |
| ATAD3B Mitochondrion Summary 3.2552496620620293 | |
| ATAD5 Cytosol Summary 4.807146051684357 | |
| ATAD5 Nucleus Summary 4.807146051684357 | |
| ATAT1 Cytosol Summary 1.8354154390814523 | |
| ATAT1 Golgi apparatus Summary 1.8354154390814523 | |
| ATE1 Nucleus Summary 0.539018973844373 | |
| ATF1 Nucleus Aldosterone synthesis and secretion 1.2721537121266642 | |
| ATF1 Nucleus Calcium signaling pathway 1.2721537121266642 | |
| ATF1 Nucleus Transcriptional misregulation in cancer 1.2721537121266642 | |
| ATF2 Nucleus Adrenergic signaling in cardiomyocytes 1.225180110244722 | |
| ATF2 Nucleus Alcoholism 1.225180110244722 | |
| ATF2 Nucleus Aldosterone synthesis and secretion 1.225180110244722 | |
| ATF2 Nucleus Amphetamine addiction 1.225180110244722 | |
| ATF2 Nucleus Calcium signaling pathway 1.225180110244722 | |
| ATF2 Nucleus Chemical carcinogenesis - receptor activation 1.225180110244722 | |
| ATF2 Nucleus Cocaine addiction 1.225180110244722 | |
| ATF2 Nucleus Cortisol synthesis and secretion 1.225180110244722 | |
| ATF2 Nucleus Cushing syndrome 1.225180110244722 | |
| ATF2 Nucleus Dopaminergic synapse 1.225180110244722 | |
| ATF2 Nucleus Estrogen signaling pathway 1.225180110244722 | |
| ATF2 Nucleus Glucagon signaling pathway 1.225180110244722 | |
| ATF2 Nucleus Growth hormone synthesis secretion and action 1.225180110244722 | |
| ATF2 Nucleus Hepatitis B 1.225180110244722 | |
| ATF2 Nucleus Human T-cell leukemia virus 1 infection 1.225180110244722 | |
| ATF2 Nucleus Human cytomegalovirus infection 1.225180110244722 | |
| ATF2 Nucleus Insulin secretion 1.225180110244722 | |
| ATF2 Nucleus Longevity regulating pathway 1.225180110244722 | |
| ATF2 Nucleus MAPK signaling pathway 1.225180110244722 | |
| ATF2 Nucleus PI3K-Akt signaling pathway 1.225180110244722 | |
| ATF2 Nucleus Parathyroid hormone synthesis secretion and action 1.225180110244722 | |
| ATF2 Nucleus Prion disease 1.225180110244722 | |
| ATF2 Nucleus Relaxin signaling pathway 1.225180110244722 | |
| ATF2 Nucleus TNF signaling pathway 1.225180110244722 | |
| ATF2 Nucleus Thermogenesis 1.225180110244722 | |
| ATF2 Nucleus Thyroid hormone synthesis 1.225180110244722 | |
| ATF2 Nucleus Viral carcinogenesis 1.225180110244722 | |
| ATF2 Nucleus cGMP-PKG signaling pathway 1.225180110244722 | |
| ATF6 Cytosol Alzheimer disease 1.3859083872956814 | |
| ATF6 Cytosol Amyotrophic lateral sclerosis 1.3859083872956814 | |
| ATF6 Cytosol Lipid and atherosclerosis 1.3859083872956814 | |
| ATF6 Cytosol Parkinson disease 1.3859083872956814 | |
| ATF6 Cytosol Pathways of neurodegeneration - multiple diseases 1.3859083872956814 | |
| ATF6 Cytosol Protein processing in endoplasmic reticulum 1.3859083872956814 | |
| ATF6 Endoplasmic Reticulum Alzheimer disease 1.3859083872956814 | |
| ATF6 Endoplasmic Reticulum Amyotrophic lateral sclerosis 1.3859083872956814 | |
| ATF6 Endoplasmic Reticulum Lipid and atherosclerosis 1.3859083872956814 | |
| ATF6 Endoplasmic Reticulum Parkinson disease 1.3859083872956814 | |
| ATF6 Endoplasmic Reticulum Pathways of neurodegeneration - multiple diseases 1.3859083872956814 | |
| ATF6 Endoplasmic Reticulum Protein processing in endoplasmic reticulum 1.3859083872956814 | |
| ATF6 Nucleus Alzheimer disease 1.3859083872956814 | |
| ATF6 Nucleus Amyotrophic lateral sclerosis 1.3859083872956814 | |
| ATF6 Nucleus Lipid and atherosclerosis 1.3859083872956814 | |
| ATF6 Nucleus Parkinson disease 1.3859083872956814 | |
| ATF6 Nucleus Pathways of neurodegeneration - multiple diseases 1.3859083872956814 | |
| ATF6 Nucleus Protein processing in endoplasmic reticulum 1.3859083872956814 | |
| ATF7 Cytosol Summary 1.0613035813743883 | |
| ATF7 Nucleus Summary 1.0613035813743883 | |
| ATF7IP Nucleus Summary 1.76771004987294 | |
| ATG101 Cytosol Summary 1.3832239876891577 | |
| ATG12 Cytosol Summary 1.0157455216302893 | |
| ATG13 Cytosol Summary 1.1725478189594851 | |
| ATG13 Nucleus Summary 1.1725478189594851 | |
| ATG13 Plasma membrane Summary 1.1725478189594851 | |
| ATG14 Cytosol Alzheimer disease 0.8711469320467714 | |
| ATG14 Cytosol Amyotrophic lateral sclerosis 0.8711469320467714 | |
| ATG14 Cytosol Autophagy - animal 0.8711469320467714 | |
| ATG14 Cytosol Huntington disease 0.8711469320467714 | |
| ATG14 Cytosol Kaposi sarcoma-associated herpesvirus infection 0.8711469320467714 | |
| ATG14 Cytosol Pathways of neurodegeneration - multiple diseases 0.8711469320467714 | |
| ATG14 Cytosol Shigellosis 0.8711469320467714 | |
| ATG14 Cytosol Spinocerebellar ataxia 0.8711469320467714 | |
| ATG14 Endoplasmic Reticulum Alzheimer disease 0.8711469320467714 | |
| ATG14 Endoplasmic Reticulum Amyotrophic lateral sclerosis 0.8711469320467714 | |
| ATG14 Endoplasmic Reticulum Autophagy - animal 0.8711469320467714 | |
| ATG14 Endoplasmic Reticulum Huntington disease 0.8711469320467714 | |
| ATG14 Endoplasmic Reticulum Kaposi sarcoma-associated herpesvirus infection 0.8711469320467714 | |
| ATG14 Endoplasmic Reticulum Pathways of neurodegeneration - multiple diseases 0.8711469320467714 | |
| ATG14 Endoplasmic Reticulum Shigellosis 0.8711469320467714 | |
| ATG14 Endoplasmic Reticulum Spinocerebellar ataxia 0.8711469320467714 | |
| ATG16L1 Cytosol Summary 0.7248200161868349 | |
| ATG2A Cytosol Summary 1.1279555457156203 | |
| ATG2A Nucleus Summary 1.1279555457156203 | |
| ATG2B Nucleus Summary 0.6601102950003818 | |
| ATG3 Cytosol Autophagy - animal 1.6653831876774865 | |
| ATG3 Cytosol Autophagy - other 1.6653831876774865 | |
| ATG3 Cytosol Kaposi sarcoma-associated herpesvirus infection 1.6653831876774865 | |
| ATG3 Plasma membrane Autophagy - animal 1.6653831876774865 | |
| ATG3 Plasma membrane Autophagy - other 1.6653831876774865 | |
| ATG3 Plasma membrane Kaposi sarcoma-associated herpesvirus infection 1.6653831876774865 | |
| ATG4A Cytoskeleton Summary 1.2321968624515365 | |
| ATG4A Cytosol Summary 1.2321968624515365 | |
| ATG4B Cytosol Summary 1.9033303593556443 | |
| ATG4B Nucleus Summary 1.9033303593556443 | |
| ATG4C Cytosol Autophagy - animal 1.1201227081833631 | |
| ATG4C Cytosol Autophagy - other 1.1201227081833631 | |
| ATG4C Extracellular space Autophagy - animal 1.1201227081833631 | |
| ATG4C Extracellular space Autophagy - other 1.1201227081833631 | |
| ATG4C Nucleus Autophagy - animal 1.1201227081833631 | |
| ATG4C Nucleus Autophagy - other 1.1201227081833631 | |
| ATG5 Cytoskeleton Summary 0.9185218103413508 | |
| ATG5 Cytosol Summary 0.9185218103413508 | |
| ATG7 Cytosol Summary 1.0133762194891351 | |
| ATG7 Nucleus Summary 1.0133762194891351 | |
| ATG7 Plasma membrane Summary 1.0133762194891351 | |
| ATG9A Cytosol Autophagy - animal 1.9097662006609704 | |
| ATG9A Cytosol Autophagy - other 1.9097662006609704 | |
| ATG9A Cytosol Mitophagy - animal 1.9097662006609704 | |
| ATG9A Endosome Autophagy - animal 1.9097662006609704 | |
| ATG9A Endosome Autophagy - other 1.9097662006609704 | |
| ATG9A Endosome Mitophagy - animal 1.9097662006609704 | |
| ATG9A Nucleus Autophagy - animal 1.9097662006609704 | |
| ATG9A Nucleus Autophagy - other 1.9097662006609704 | |
| ATG9A Nucleus Mitophagy - animal 1.9097662006609704 | |
| ATIC Cytosol Summary 1.0608111719762758 | |
| ATIC Plasma membrane Summary 1.0608111719762758 | |
| ATL1 Endoplasmic Reticulum Transcriptional misregulation in cancer 0.9139111669331316 | |
| ATL1 Extracellular space Transcriptional misregulation in cancer 0.9139111669331316 | |
| ATL1 Golgi apparatus Transcriptional misregulation in cancer 0.9139111669331316 | |
| ATL2 Endoplasmic Reticulum Summary 2.582590066348753 | |
| ATL3 Endoplasmic Reticulum Summary 0.4533327481172688 | |
| ATL3 Extracellular space Summary 0.4533327481172688 | |
| ATM Cytosol Apoptosis 0.9530156806021688 | |
| ATM Cytosol Cell cycle 0.9530156806021688 | |
| ATM Cytosol Cellular senescence 0.9530156806021688 | |
| ATM Cytosol FoxO signaling pathway 0.9530156806021688 | |
| ATM Cytosol Homologous recombination 0.9530156806021688 | |
| ATM Cytosol Human T-cell leukemia virus 1 infection 0.9530156806021688 | |
| ATM Cytosol Human immunodeficiency virus 1 infection 0.9530156806021688 | |
| ATM Cytosol Human papillomavirus infection 0.9530156806021688 | |
| ATM Cytosol MicroRNAs in cancer 0.9530156806021688 | |
| ATM Cytosol NF-kappa B signaling pathway 0.9530156806021688 | |
| ATM Cytosol Platinum drug resistance 0.9530156806021688 | |
| ATM Cytosol Shigellosis 0.9530156806021688 | |
| ATM Cytosol Transcriptional misregulation in cancer 0.9530156806021688 | |
| ATM Cytosol p53 signaling pathway 0.9530156806021688 | |
| ATM Nucleus Apoptosis 0.9530156806021688 | |
| ATM Nucleus Cell cycle 0.9530156806021688 | |
| ATM Nucleus Cellular senescence 0.9530156806021688 | |
| ATM Nucleus FoxO signaling pathway 0.9530156806021688 | |
| ATM Nucleus Homologous recombination 0.9530156806021688 | |
| ATM Nucleus Human T-cell leukemia virus 1 infection 0.9530156806021688 | |
| ATM Nucleus Human immunodeficiency virus 1 infection 0.9530156806021688 | |
| ATM Nucleus Human papillomavirus infection 0.9530156806021688 | |
| ATM Nucleus MicroRNAs in cancer 0.9530156806021688 | |
| ATM Nucleus NF-kappa B signaling pathway 0.9530156806021688 | |
| ATM Nucleus Platinum drug resistance 0.9530156806021688 | |
| ATM Nucleus Shigellosis 0.9530156806021688 | |
| ATM Nucleus Transcriptional misregulation in cancer 0.9530156806021688 | |
| ATM Nucleus p53 signaling pathway 0.9530156806021688 | |
| ATN1 Nucleus Summary 1.1558467708024804 | |
| ATOX1 Cytosol Mineral absorption 1.1193908208242098 | |
| ATOX1 Nucleus Mineral absorption 1.1193908208242098 | |
| ATOX1 Plasma membrane Mineral absorption 1.1193908208242098 | |
| ATP10A Endoplasmic Reticulum Summary 0.5909874887060621 | |
| ATP10A Plasma membrane Summary 0.5909874887060621 | |
| ATP11A Cytosol Summary 1.3263954356270633 | |
| ATP11A Plasma membrane Summary 1.3263954356270633 | |
| ATP11B Cytosol Summary 1.28369155557166 | |
| ATP11B Endoplasmic Reticulum Summary 1.28369155557166 | |
| ATP11B Endosome Summary 1.28369155557166 | |
| ATP11B Nucleus Summary 1.28369155557166 | |
| ATP11C Endoplasmic Reticulum Summary 2.052476863511973 | |
| ATP11C Plasma membrane Summary 2.052476863511973 | |
| ATP12A Cytoskeleton Summary 2.2048359998477696 | |
| ATP12A Cytosol Summary 2.2048359998477696 | |
| ATP12A Plasma membrane Summary 2.2048359998477696 | |
| ATP13A1 Cytosol Summary 1.0041254555314207 | |
| ATP13A1 Endoplasmic Reticulum Summary 1.0041254555314207 | |
| ATP13A2 Lysosome Summary 0.875962265035751 | |
| ATP13A3 Cytosol Summary 0.9044636652774944 | |
| ATP13A3 Nucleus Summary 0.9044636652774944 | |
| ATP13A3 Plasma membrane Summary 0.9044636652774944 | |
| ATP1A1 Plasma membrane Adrenergic signaling in cardiomyocytes 0.8877692011314797 | |
| ATP1A1 Plasma membrane Aldosterone synthesis and secretion 0.8877692011314797 | |
| ATP1A1 Plasma membrane Aldosterone-regulated sodium reabsorption 0.8877692011314797 | |
| ATP1A1 Plasma membrane Bile secretion 0.8877692011314797 | |
| ATP1A1 Plasma membrane Carbohydrate digestion and absorption 0.8877692011314797 | |
| ATP1A1 Plasma membrane Cardiac muscle contraction 0.8877692011314797 | |
| ATP1A1 Plasma membrane Endocrine and other factor-regulated calcium reabsorption 0.8877692011314797 | |
| ATP1A1 Plasma membrane Gastric acid secretion 0.8877692011314797 | |
| ATP1A1 Plasma membrane Insulin secretion 0.8877692011314797 | |
| ATP1A1 Plasma membrane Mineral absorption 0.8877692011314797 | |
| ATP1A1 Plasma membrane Pancreatic secretion 0.8877692011314797 | |
| ATP1A1 Plasma membrane Protein digestion and absorption 0.8877692011314797 | |
| ATP1A1 Plasma membrane Proximal tubule bicarbonate reclamation 0.8877692011314797 | |
| ATP1A1 Plasma membrane Salivary secretion 0.8877692011314797 | |
| ATP1A1 Plasma membrane Thyroid hormone signaling pathway 0.8877692011314797 | |
| ATP1A1 Plasma membrane Thyroid hormone synthesis 0.8877692011314797 | |
| ATP1A1 Plasma membrane cAMP signaling pathway 0.8877692011314797 | |
| ATP1A1 Plasma membrane cGMP-PKG signaling pathway 0.8877692011314797 | |
| ATP1B1 Plasma membrane Summary 1.0199294716662166 | |
| ATP1B3 Plasma membrane Summary 1.6489941382304103 | |
| ATP2A2 Endoplasmic Reticulum Summary 1.1196483185153805 | |
| ATP2A2 Nucleus Summary 1.1196483185153805 | |
| ATP2B1 Plasma membrane Adrenergic signaling in cardiomyocytes 0.6580965263339803 | |
| ATP2B1 Plasma membrane Aldosterone synthesis and secretion 0.6580965263339803 | |
| ATP2B1 Plasma membrane Calcium signaling pathway 0.6580965263339803 | |
| ATP2B1 Plasma membrane Endocrine and other factor-regulated calcium reabsorption 0.6580965263339803 | |
| ATP2B1 Plasma membrane Mineral absorption 0.6580965263339803 | |
| ATP2B1 Plasma membrane Pancreatic secretion 0.6580965263339803 | |
| ATP2B1 Plasma membrane Salivary secretion 0.6580965263339803 | |
| ATP2B1 Plasma membrane cAMP signaling pathway 0.6580965263339803 | |
| ATP2B1 Plasma membrane cGMP-PKG signaling pathway 0.6580965263339803 | |
| ATP2B4 Plasma membrane Adrenergic signaling in cardiomyocytes 1.1983439229113892 | |
| ATP2B4 Plasma membrane Aldosterone synthesis and secretion 1.1983439229113892 | |
| ATP2B4 Plasma membrane Calcium signaling pathway 1.1983439229113892 | |
| ATP2B4 Plasma membrane Endocrine and other factor-regulated calcium reabsorption 1.1983439229113892 | |
| ATP2B4 Plasma membrane Mineral absorption 1.1983439229113892 | |
| ATP2B4 Plasma membrane Pancreatic secretion 1.1983439229113892 | |
| ATP2B4 Plasma membrane Salivary secretion 1.1983439229113892 | |
| ATP2B4 Plasma membrane cAMP signaling pathway 1.1983439229113892 | |
| ATP2B4 Plasma membrane cGMP-PKG signaling pathway 1.1983439229113892 | |
| ATP2C1 Golgi apparatus Summary 1.103052310828867 | |
| ATP5A1 Mitochondrion Summary 1.4969194199281377 | |
| ATP5B Mitochondrion Summary 1.5460676668261146 | |
| ATP5F1 Nucleus Summary 1.0656170506952505 | |
| ATP5H Nucleus Summary 1.9377779105945172 | |
| ATP5I Mitochondrion Summary 1.6669973846751536 | |
| ATP5J Mitochondrion Summary 1.7091057908449352 | |
| ATP5J2-PTCD1 Mitochondrion Summary 1.9586223742356481 | |
| ATP5L Mitochondrion Summary 2.441233231301994 | |
| ATP5O Mitochondrion Summary 1.4015003230651828 | |
| ATP5S Mitochondrion Summary 0.8512662747792372 | |
| ATP5S Nucleus Summary 0.8512662747792372 | |
| ATP5SL Mitochondrion Summary 1.239572024772719 | |
| ATP6AP1 Cytosol Summary 0.7942441162612696 | |
| ATP6AP1 Endoplasmic Reticulum Summary 0.7942441162612696 | |
| ATP6V0A1 Cytosol Collecting duct acid secretion 0.3770117861462308 | |
| ATP6V0A1 Cytosol Epithelial cell signaling in Helicobacter pylori infection 0.3770117861462308 | |
| ATP6V0A1 Cytosol Human papillomavirus infection 0.3770117861462308 | |
| ATP6V0A1 Cytosol Lysosome 0.3770117861462308 | |
| ATP6V0A1 Cytosol Metabolic pathways 0.3770117861462308 | |
| ATP6V0A1 Cytosol Oxidative phosphorylation 0.3770117861462308 | |
| ATP6V0A1 Cytosol Phagosome 0.3770117861462308 | |
| ATP6V0A1 Cytosol Rheumatoid arthritis 0.3770117861462308 | |
| ATP6V0A1 Cytosol Synaptic vesicle cycle 0.3770117861462308 | |
| ATP6V0A1 Cytosol Tuberculosis 0.3770117861462308 | |
| ATP6V0A1 Cytosol Vibrio cholerae infection 0.3770117861462308 | |
| ATP6V0A1 Golgi apparatus Collecting duct acid secretion 0.3770117861462308 | |
| ATP6V0A1 Golgi apparatus Epithelial cell signaling in Helicobacter pylori infection 0.3770117861462308 | |
| ATP6V0A1 Golgi apparatus Human papillomavirus infection 0.3770117861462308 | |
| ATP6V0A1 Golgi apparatus Lysosome 0.3770117861462308 | |
| ATP6V0A1 Golgi apparatus Metabolic pathways 0.3770117861462308 | |
| ATP6V0A1 Golgi apparatus Oxidative phosphorylation 0.3770117861462308 | |
| ATP6V0A1 Golgi apparatus Phagosome 0.3770117861462308 | |
| ATP6V0A1 Golgi apparatus Rheumatoid arthritis 0.3770117861462308 | |
| ATP6V0A1 Golgi apparatus Synaptic vesicle cycle 0.3770117861462308 | |
| ATP6V0A1 Golgi apparatus Tuberculosis 0.3770117861462308 | |
| ATP6V0A1 Golgi apparatus Vibrio cholerae infection 0.3770117861462308 | |
| ATP6V0A1 Nucleus Collecting duct acid secretion 0.3770117861462308 | |
| ATP6V0A1 Nucleus Epithelial cell signaling in Helicobacter pylori infection 0.3770117861462308 | |
| ATP6V0A1 Nucleus Human papillomavirus infection 0.3770117861462308 | |
| ATP6V0A1 Nucleus Lysosome 0.3770117861462308 | |
| ATP6V0A1 Nucleus Metabolic pathways 0.3770117861462308 | |
| ATP6V0A1 Nucleus Oxidative phosphorylation 0.3770117861462308 | |
| ATP6V0A1 Nucleus Phagosome 0.3770117861462308 | |
| ATP6V0A1 Nucleus Rheumatoid arthritis 0.3770117861462308 | |
| ATP6V0A1 Nucleus Synaptic vesicle cycle 0.3770117861462308 | |
| ATP6V0A1 Nucleus Tuberculosis 0.3770117861462308 | |
| ATP6V0A1 Nucleus Vibrio cholerae infection 0.3770117861462308 | |
| ATP6V0A1 Plasma membrane Collecting duct acid secretion 0.3770117861462308 | |
| ATP6V0A1 Plasma membrane Epithelial cell signaling in Helicobacter pylori infection 0.3770117861462308 | |
| ATP6V0A1 Plasma membrane Human papillomavirus infection 0.3770117861462308 | |
| ATP6V0A1 Plasma membrane Lysosome 0.3770117861462308 | |
| ATP6V0A1 Plasma membrane Metabolic pathways 0.3770117861462308 | |
| ATP6V0A1 Plasma membrane Oxidative phosphorylation 0.3770117861462308 | |
| ATP6V0A1 Plasma membrane Phagosome 0.3770117861462308 | |
| ATP6V0A1 Plasma membrane Rheumatoid arthritis 0.3770117861462308 | |
| ATP6V0A1 Plasma membrane Synaptic vesicle cycle 0.3770117861462308 | |
| ATP6V0A1 Plasma membrane Tuberculosis 0.3770117861462308 | |
| ATP6V0A1 Plasma membrane Vibrio cholerae infection 0.3770117861462308 | |
| ATP6V0A2 Cytosol Collecting duct acid secretion 1.0505787983136068 | |
| ATP6V0A2 Cytosol Epithelial cell signaling in Helicobacter pylori infection 1.0505787983136068 | |
| ATP6V0A2 Cytosol Human papillomavirus infection 1.0505787983136068 | |
| ATP6V0A2 Cytosol Lysosome 1.0505787983136068 | |
| ATP6V0A2 Cytosol Metabolic pathways 1.0505787983136068 | |
| ATP6V0A2 Cytosol Oxidative phosphorylation 1.0505787983136068 | |
| ATP6V0A2 Cytosol Phagosome 1.0505787983136068 | |
| ATP6V0A2 Cytosol Rheumatoid arthritis 1.0505787983136068 | |
| ATP6V0A2 Cytosol Synaptic vesicle cycle 1.0505787983136068 | |
| ATP6V0A2 Cytosol Tuberculosis 1.0505787983136068 | |
| ATP6V0A2 Cytosol Vibrio cholerae infection 1.0505787983136068 | |
| ATP6V0A2 Endosome Collecting duct acid secretion 1.0505787983136068 | |
| ATP6V0A2 Endosome Epithelial cell signaling in Helicobacter pylori infection 1.0505787983136068 | |
| ATP6V0A2 Endosome Human papillomavirus infection 1.0505787983136068 | |
| ATP6V0A2 Endosome Lysosome 1.0505787983136068 | |
| ATP6V0A2 Endosome Metabolic pathways 1.0505787983136068 | |
| ATP6V0A2 Endosome Oxidative phosphorylation 1.0505787983136068 | |
| ATP6V0A2 Endosome Phagosome 1.0505787983136068 | |
| ATP6V0A2 Endosome Rheumatoid arthritis 1.0505787983136068 | |
| ATP6V0A2 Endosome Synaptic vesicle cycle 1.0505787983136068 | |
| ATP6V0A2 Endosome Tuberculosis 1.0505787983136068 | |
| ATP6V0A2 Endosome Vibrio cholerae infection 1.0505787983136068 | |
| ATP6V0A2 Plasma membrane Collecting duct acid secretion 1.0505787983136068 | |
| ATP6V0A2 Plasma membrane Epithelial cell signaling in Helicobacter pylori infection 1.0505787983136068 | |
| ATP6V0A2 Plasma membrane Human papillomavirus infection 1.0505787983136068 | |
| ATP6V0A2 Plasma membrane Lysosome 1.0505787983136068 | |
| ATP6V0A2 Plasma membrane Metabolic pathways 1.0505787983136068 | |
| ATP6V0A2 Plasma membrane Oxidative phosphorylation 1.0505787983136068 | |
| ATP6V0A2 Plasma membrane Phagosome 1.0505787983136068 | |
| ATP6V0A2 Plasma membrane Rheumatoid arthritis 1.0505787983136068 | |
| ATP6V0A2 Plasma membrane Synaptic vesicle cycle 1.0505787983136068 | |
| ATP6V0A2 Plasma membrane Tuberculosis 1.0505787983136068 | |
| ATP6V0A2 Plasma membrane Vibrio cholerae infection 1.0505787983136068 | |
| ATP6V0A4 Cytosol Collecting duct acid secretion 1.3929117285175894 | |
| ATP6V0A4 Cytosol Epithelial cell signaling in Helicobacter pylori infection 1.3929117285175894 | |
| ATP6V0A4 Cytosol Human papillomavirus infection 1.3929117285175894 | |
| ATP6V0A4 Cytosol Lysosome 1.3929117285175894 | |
| ATP6V0A4 Cytosol Metabolic pathways 1.3929117285175894 | |
| ATP6V0A4 Cytosol Oxidative phosphorylation 1.3929117285175894 | |
| ATP6V0A4 Cytosol Phagosome 1.3929117285175894 | |
| ATP6V0A4 Cytosol Rheumatoid arthritis 1.3929117285175894 | |
| ATP6V0A4 Cytosol Synaptic vesicle cycle 1.3929117285175894 | |
| ATP6V0A4 Cytosol Tuberculosis 1.3929117285175894 | |
| ATP6V0A4 Cytosol Vibrio cholerae infection 1.3929117285175894 | |
| ATP6V0A4 Plasma membrane Collecting duct acid secretion 1.3929117285175894 | |
| ATP6V0A4 Plasma membrane Epithelial cell signaling in Helicobacter pylori infection 1.3929117285175894 | |
| ATP6V0A4 Plasma membrane Human papillomavirus infection 1.3929117285175894 | |
| ATP6V0A4 Plasma membrane Lysosome 1.3929117285175894 | |
| ATP6V0A4 Plasma membrane Metabolic pathways 1.3929117285175894 | |
| ATP6V0A4 Plasma membrane Oxidative phosphorylation 1.3929117285175894 | |
| ATP6V0A4 Plasma membrane Phagosome 1.3929117285175894 | |
| ATP6V0A4 Plasma membrane Rheumatoid arthritis 1.3929117285175894 | |
| ATP6V0A4 Plasma membrane Synaptic vesicle cycle 1.3929117285175894 | |
| ATP6V0A4 Plasma membrane Tuberculosis 1.3929117285175894 | |
| ATP6V0A4 Plasma membrane Vibrio cholerae infection 1.3929117285175894 | |
| ATP6V1A Cytosol Summary 1.5607523216864547 | |
| ATP6V1A Nucleus Summary 1.5607523216864547 | |
| ATP6V1B1 Endoplasmic Reticulum Collecting duct acid secretion 0.6600942299288062 | |
| ATP6V1B1 Endoplasmic Reticulum Epithelial cell signaling in Helicobacter pylori infection 0.6600942299288062 | |
| ATP6V1B1 Endoplasmic Reticulum Human papillomavirus infection 0.6600942299288062 | |
| ATP6V1B1 Endoplasmic Reticulum Metabolic pathways 0.6600942299288062 | |
| ATP6V1B1 Endoplasmic Reticulum Oxidative phosphorylation 0.6600942299288062 | |
| ATP6V1B1 Endoplasmic Reticulum Phagosome 0.6600942299288062 | |
| ATP6V1B1 Endoplasmic Reticulum Rheumatoid arthritis 0.6600942299288062 | |
| ATP6V1B1 Endoplasmic Reticulum Synaptic vesicle cycle 0.6600942299288062 | |
| ATP6V1B1 Endoplasmic Reticulum Vibrio cholerae infection 0.6600942299288062 | |
| ATP6V1B1 Endoplasmic Reticulum mTOR signaling pathway 0.6600942299288062 | |
| ATP6V1B1 Nucleus Collecting duct acid secretion 0.6600942299288062 | |
| ATP6V1B1 Nucleus Epithelial cell signaling in Helicobacter pylori infection 0.6600942299288062 | |
| ATP6V1B1 Nucleus Human papillomavirus infection 0.6600942299288062 | |
| ATP6V1B1 Nucleus Metabolic pathways 0.6600942299288062 | |
| ATP6V1B1 Nucleus Oxidative phosphorylation 0.6600942299288062 | |
| ATP6V1B1 Nucleus Phagosome 0.6600942299288062 | |
| ATP6V1B1 Nucleus Rheumatoid arthritis 0.6600942299288062 | |
| ATP6V1B1 Nucleus Synaptic vesicle cycle 0.6600942299288062 | |
| ATP6V1B1 Nucleus Vibrio cholerae infection 0.6600942299288062 | |
| ATP6V1B1 Nucleus mTOR signaling pathway 0.6600942299288062 | |
| ATP6V1B1 Plasma membrane Collecting duct acid secretion 0.6600942299288062 | |
| ATP6V1B1 Plasma membrane Epithelial cell signaling in Helicobacter pylori infection 0.6600942299288062 | |
| ATP6V1B1 Plasma membrane Human papillomavirus infection 0.6600942299288062 | |
| ATP6V1B1 Plasma membrane Metabolic pathways 0.6600942299288062 | |
| ATP6V1B1 Plasma membrane Oxidative phosphorylation 0.6600942299288062 | |
| ATP6V1B1 Plasma membrane Phagosome 0.6600942299288062 | |
| ATP6V1B1 Plasma membrane Rheumatoid arthritis 0.6600942299288062 | |
| ATP6V1B1 Plasma membrane Synaptic vesicle cycle 0.6600942299288062 | |
| ATP6V1B1 Plasma membrane Vibrio cholerae infection 0.6600942299288062 | |
| ATP6V1B1 Plasma membrane mTOR signaling pathway 0.6600942299288062 | |
| ATP6V1B2 Cytosol Summary 1.7875169575240546 | |
| ATP6V1B2 Endoplasmic Reticulum Summary 1.7875169575240546 | |
| ATP6V1C1 Cytosol Summary 1.0620629418620997 | |
| ATP6V1C1 Nucleus Summary 1.0620629418620997 | |
| ATP6V1C2 Mitochondrion Summary 0.8374441222700203 | |
| ATP6V1D Nucleus Summary 1.6320528992829584 | |
| ATP6V1E1 Nucleus Summary 1.770918388568402 | |
| ATP6V1G1 Nucleus Collecting duct acid secretion 1.8907069141232733 | |
| ATP6V1G1 Nucleus Epithelial cell signaling in Helicobacter pylori infection 1.8907069141232733 | |
| ATP6V1G1 Nucleus Human papillomavirus infection 1.8907069141232733 | |
| ATP6V1G1 Nucleus Metabolic pathways 1.8907069141232733 | |
| ATP6V1G1 Nucleus Oxidative phosphorylation 1.8907069141232733 | |
| ATP6V1G1 Nucleus Phagosome 1.8907069141232733 | |
| ATP6V1G1 Nucleus Rheumatoid arthritis 1.8907069141232733 | |
| ATP6V1G1 Nucleus Synaptic vesicle cycle 1.8907069141232733 | |
| ATP6V1G1 Nucleus Vibrio cholerae infection 1.8907069141232733 | |
| ATP6V1G1 Nucleus mTOR signaling pathway 1.8907069141232733 | |
| ATP6V1G1 Plasma membrane Collecting duct acid secretion 1.8907069141232733 | |
| ATP6V1G1 Plasma membrane Epithelial cell signaling in Helicobacter pylori infection 1.8907069141232733 | |
| ATP6V1G1 Plasma membrane Human papillomavirus infection 1.8907069141232733 | |
| ATP6V1G1 Plasma membrane Metabolic pathways 1.8907069141232733 | |
| ATP6V1G1 Plasma membrane Oxidative phosphorylation 1.8907069141232733 | |
| ATP6V1G1 Plasma membrane Phagosome 1.8907069141232733 | |
| ATP6V1G1 Plasma membrane Rheumatoid arthritis 1.8907069141232733 | |
| ATP6V1G1 Plasma membrane Synaptic vesicle cycle 1.8907069141232733 | |
| ATP6V1G1 Plasma membrane Vibrio cholerae infection 1.8907069141232733 | |
| ATP6V1G1 Plasma membrane mTOR signaling pathway 1.8907069141232733 | |
| ATP6V1H Cytoskeleton Summary 1.2689477981064905 | |
| ATP6V1H Cytosol Summary 1.2689477981064905 | |
| ATP6V1H Plasma membrane Summary 1.2689477981064905 | |
| ATP7A Endoplasmic Reticulum Mineral absorption 0.5933159667261251 | |
| ATP7A Endoplasmic Reticulum Platinum drug resistance 0.5933159667261251 | |
| ATP7A Endosome Mineral absorption 0.5933159667261251 | |
| ATP7A Endosome Platinum drug resistance 0.5933159667261251 | |
| ATP7A Golgi apparatus Mineral absorption 0.5933159667261251 | |
| ATP7A Golgi apparatus Platinum drug resistance 0.5933159667261251 | |
| ATP7A Plasma membrane Mineral absorption 0.5933159667261251 | |
| ATP7A Plasma membrane Platinum drug resistance 0.5933159667261251 | |
| ATP8A1 Cytosol Summary 0.8852785656258574 | |
| ATP8A1 Endoplasmic Reticulum Summary 0.8852785656258574 | |
| ATP8A1 Plasma membrane Summary 0.8852785656258574 | |
| ATP8A2 Nucleus Summary 1.8291443418201236 | |
| ATP8A2 Plasma membrane Summary 1.8291443418201236 | |
| ATP8B1 Cytosol Summary 0.16545782996212507 | |
| ATP8B1 Nucleus Summary 0.16545782996212507 | |
| ATP8B1 Plasma membrane Summary 0.16545782996212507 | |
| ATP8B2 Golgi apparatus Summary 0.3812919854946216 | |
| ATP8B3 Cytosol Summary 0.8415669209217145 | |
| ATP9A Endosome Summary 0.5120298732827285 | |
| ATP9B Golgi apparatus Summary 0.9759761565812286 | |
| ATPAF1 Mitochondrion Summary 1.1525736696596125 | |
| ATPAF2 Cytosol Summary 0.8590457665614537 | |
| ATPAF2 Mitochondrion Summary 0.8590457665614537 | |
| ATPIF1 Mitochondrion Summary 1.1699377669618394 | |
| ATR Golgi apparatus Biosynthesis of cofactors 1.068638864704701 | |
| ATR Golgi apparatus Cell cycle 1.068638864704701 | |
| ATR Golgi apparatus Cellular senescence 1.068638864704701 | |
| ATR Golgi apparatus Fanconi anemia pathway 1.068638864704701 | |
| ATR Golgi apparatus Human T-cell leukemia virus 1 infection 1.068638864704701 | |
| ATR Golgi apparatus Human immunodeficiency virus 1 infection 1.068638864704701 | |
| ATR Golgi apparatus Human papillomavirus infection 1.068638864704701 | |
| ATR Golgi apparatus Metabolic pathways 1.068638864704701 | |
| ATR Golgi apparatus NOD-like receptor signaling pathway 1.068638864704701 | |
| ATR Golgi apparatus Porphyrin and chlorophyll metabolism 1.068638864704701 | |
| ATR Golgi apparatus p53 signaling pathway 1.068638864704701 | |
| ATR Nucleus Biosynthesis of cofactors 1.068638864704701 | |
| ATR Nucleus Cell cycle 1.068638864704701 | |
| ATR Nucleus Cellular senescence 1.068638864704701 | |
| ATR Nucleus Fanconi anemia pathway 1.068638864704701 | |
| ATR Nucleus Human T-cell leukemia virus 1 infection 1.068638864704701 | |
| ATR Nucleus Human immunodeficiency virus 1 infection 1.068638864704701 | |
| ATR Nucleus Human papillomavirus infection 1.068638864704701 | |
| ATR Nucleus Metabolic pathways 1.068638864704701 | |
| ATR Nucleus NOD-like receptor signaling pathway 1.068638864704701 | |
| ATR Nucleus Porphyrin and chlorophyll metabolism 1.068638864704701 | |
| ATR Nucleus p53 signaling pathway 1.068638864704701 | |
| ATRAID Nucleus Summary 1.3543952733372564 | |
| ATRAID Plasma membrane Summary 1.3543952733372564 | |
| ATRIP Nucleus Fanconi anemia pathway 1.4703959745971718 | |
| ATRN Cytosol Summary 1.2990579666272837 | |
| ATRN Extracellular space Summary 1.2990579666272837 | |
| ATRN Plasma membrane Summary 1.2990579666272837 | |
| ATRX Nucleus Summary 1.1745658209005416 | |
| ATXN1 Cytosol Notch signaling pathway 1.380618338969576 | |
| ATXN1 Cytosol Pathways of neurodegeneration - multiple diseases 1.380618338969576 | |
| ATXN1 Cytosol Spinocerebellar ataxia 1.380618338969576 | |
| ATXN1 Nucleus Notch signaling pathway 1.380618338969576 | |
| ATXN1 Nucleus Pathways of neurodegeneration - multiple diseases 1.380618338969576 | |
| ATXN1 Nucleus Spinocerebellar ataxia 1.380618338969576 | |
| ATXN10 Cytosol Summary 1.159698832188009 | |
| ATXN10 Nucleus Summary 1.159698832188009 | |
| ATXN10 Plasma membrane Summary 1.159698832188009 | |
| ATXN1L Nucleus Notch signaling pathway 1.2488301192152809 | |
| ATXN1L Nucleus Pathways of neurodegeneration - multiple diseases 1.2488301192152809 | |
| ATXN1L Nucleus Spinocerebellar ataxia 1.2488301192152809 | |
| ATXN2 Cytosol Summary 0.9061680122907966 | |
| ATXN2L Cytosol Summary 1.8329583025262868 | |
| ATXN3 Nucleus Pathways of neurodegeneration - multiple diseases 1.3029474848909286 | |
| ATXN3 Nucleus Protein processing in endoplasmic reticulum 1.3029474848909286 | |
| ATXN3 Nucleus Spinocerebellar ataxia 1.3029474848909286 | |
| ATXN3 Plasma membrane Pathways of neurodegeneration - multiple diseases 1.3029474848909286 | |
| ATXN3 Plasma membrane Protein processing in endoplasmic reticulum 1.3029474848909286 | |
| ATXN3 Plasma membrane Spinocerebellar ataxia 1.3029474848909286 | |
| ATXN7 Cytosol Summary 1.076814807686543 | |
| ATXN7 Nucleus Summary 1.076814807686543 | |
| ATXN7L2 Cytosol Summary 1.7527366683953756 | |
| ATXN7L2 Nucleus Summary 1.7527366683953756 | |
| ATXN7L3 Nucleus Summary 1.885010789119392 | |
| ATXN7L3 Plasma membrane Summary 1.885010789119392 | |
| ATXN7L3B Cytosol Summary 1.6495405405920462 | |
| ATXN7L3B Nucleus Summary 1.6495405405920462 | |
| AUH Mitochondrion Summary 0.7913490072940506 | |
| AUP1 Cytosol Summary 0.8246628443542091 | |
| AUP1 Endoplasmic Reticulum Summary 0.8246628443542091 | |
| AUP1 Nucleus Summary 0.8246628443542091 | |
| AURKA Cytoskeleton Oocyte meiosis 2.5462296387475387 | |
| AURKA Cytoskeleton Progesterone-mediated oocyte maturation 2.5462296387475387 | |
| AURKA Cytosol Oocyte meiosis 2.5462296387475387 | |
| AURKA Cytosol Progesterone-mediated oocyte maturation 2.5462296387475387 | |
| AURKA Nucleus Oocyte meiosis 2.5462296387475387 | |
| AURKA Nucleus Progesterone-mediated oocyte maturation 2.5462296387475387 | |
| AURKB Cytoskeleton Summary 2.89744752372444 | |
| AURKB Nucleus Summary 2.89744752372444 | |
| AUTS2 Cytosol Summary 1.1753160225430548 | |
| AUTS2 Nucleus Summary 1.1753160225430548 | |
| AVEN Cytoskeleton Summary 1.5107761993901783 | |
| AVEN Endoplasmic Reticulum Summary 1.5107761993901783 | |
| AVEN Plasma membrane Summary 1.5107761993901783 | |
| AVL9 Endoplasmic Reticulum Summary 0.882636749082078 | |
| AVL9 Endosome Summary 0.882636749082078 | |
| AXIN1 Cytosol Alzheimer disease 1.044757065841007 | |
| AXIN1 Cytosol Basal cell carcinoma 1.044757065841007 | |
| AXIN1 Cytosol Breast cancer 1.044757065841007 | |
| AXIN1 Cytosol Colorectal cancer 1.044757065841007 | |
| AXIN1 Cytosol Cushing syndrome 1.044757065841007 | |
| AXIN1 Cytosol Endometrial cancer 1.044757065841007 | |
| AXIN1 Cytosol Gastric cancer 1.044757065841007 | |
| AXIN1 Cytosol Hepatocellular carcinoma 1.044757065841007 | |
| AXIN1 Cytosol Hippo signaling pathway 1.044757065841007 | |
| AXIN1 Cytosol Human papillomavirus infection 1.044757065841007 | |
| AXIN1 Cytosol Pathways in cancer 1.044757065841007 | |
| AXIN1 Cytosol Pathways of neurodegeneration - multiple diseases 1.044757065841007 | |
| AXIN1 Cytosol Signaling pathways regulating pluripotency of stem cells 1.044757065841007 | |
| AXIN1 Cytosol Wnt signaling pathway 1.044757065841007 | |
| AXIN1 Nucleus Alzheimer disease 1.044757065841007 | |
| AXIN1 Nucleus Basal cell carcinoma 1.044757065841007 | |
| AXIN1 Nucleus Breast cancer 1.044757065841007 | |
| AXIN1 Nucleus Colorectal cancer 1.044757065841007 | |
| AXIN1 Nucleus Cushing syndrome 1.044757065841007 | |
| AXIN1 Nucleus Endometrial cancer 1.044757065841007 | |
| AXIN1 Nucleus Gastric cancer 1.044757065841007 | |
| AXIN1 Nucleus Hepatocellular carcinoma 1.044757065841007 | |
| AXIN1 Nucleus Hippo signaling pathway 1.044757065841007 | |
| AXIN1 Nucleus Human papillomavirus infection 1.044757065841007 | |
| AXIN1 Nucleus Pathways in cancer 1.044757065841007 | |
| AXIN1 Nucleus Pathways of neurodegeneration - multiple diseases 1.044757065841007 | |
| AXIN1 Nucleus Signaling pathways regulating pluripotency of stem cells 1.044757065841007 | |
| AXIN1 Nucleus Wnt signaling pathway 1.044757065841007 | |
| AXIN1 Plasma membrane Alzheimer disease 1.044757065841007 | |
| AXIN1 Plasma membrane Basal cell carcinoma 1.044757065841007 | |
| AXIN1 Plasma membrane Breast cancer 1.044757065841007 | |
| AXIN1 Plasma membrane Colorectal cancer 1.044757065841007 | |
| AXIN1 Plasma membrane Cushing syndrome 1.044757065841007 | |
| AXIN1 Plasma membrane Endometrial cancer 1.044757065841007 | |
| AXIN1 Plasma membrane Gastric cancer 1.044757065841007 | |
| AXIN1 Plasma membrane Hepatocellular carcinoma 1.044757065841007 | |
| AXIN1 Plasma membrane Hippo signaling pathway 1.044757065841007 | |
| AXIN1 Plasma membrane Human papillomavirus infection 1.044757065841007 | |
| AXIN1 Plasma membrane Pathways in cancer 1.044757065841007 | |
| AXIN1 Plasma membrane Pathways of neurodegeneration - multiple diseases 1.044757065841007 | |
| AXIN1 Plasma membrane Signaling pathways regulating pluripotency of stem cells 1.044757065841007 | |
| AXIN1 Plasma membrane Wnt signaling pathway 1.044757065841007 | |
| AXL Cytoskeleton EGFR tyrosine kinase inhibitor resistance 2.362436352372587 | |
| AXL Cytosol EGFR tyrosine kinase inhibitor resistance 2.362436352372587 | |
| AXL Extracellular space EGFR tyrosine kinase inhibitor resistance 2.362436352372587 | |
| AXL Plasma membrane EGFR tyrosine kinase inhibitor resistance 2.362436352372587 | |
| AZGP1 Cytosol Summary 0.0933367593453326 | |
| AZGP1 Extracellular space Summary 0.0933367593453326 | |
| AZGP1 Nucleus Summary 0.0933367593453326 | |
| AZI2 Cytosol Summary 0.8097043632322296 | |
| AZI2 Mitochondrion Summary 0.8097043632322296 | |
| AZIN2 Cytosol Summary 1.2075595658629033 | |
| AZIN2 Nucleus Summary 1.2075595658629033 | |
| AZU1 Cytosol Neutrophil extracellular trap formation 2.8422714391867143 | |
| AZU1 Extracellular space Neutrophil extracellular trap formation 2.8422714391867143 | |
| AZU1 Lysosome Neutrophil extracellular trap formation 2.8422714391867143 | |
| B2M Cytosol Antigen processing and presentation 2.1234869857424115 | |
| B2M Cytosol Epstein-Barr virus infection 2.1234869857424115 | |
| B2M Cytosol Herpes simplex virus 1 infection 2.1234869857424115 | |
| B2M Cytosol Human T-cell leukemia virus 1 infection 2.1234869857424115 | |
| B2M Cytosol Human cytomegalovirus infection 2.1234869857424115 | |
| B2M Cytosol Human immunodeficiency virus 1 infection 2.1234869857424115 | |
| B2M Extracellular space Antigen processing and presentation 2.1234869857424115 | |
| B2M Extracellular space Epstein-Barr virus infection 2.1234869857424115 | |
| B2M Extracellular space Herpes simplex virus 1 infection 2.1234869857424115 | |
| B2M Extracellular space Human T-cell leukemia virus 1 infection 2.1234869857424115 | |
| B2M Extracellular space Human cytomegalovirus infection 2.1234869857424115 | |
| B2M Extracellular space Human immunodeficiency virus 1 infection 2.1234869857424115 | |
| B2M Golgi apparatus Antigen processing and presentation 2.1234869857424115 | |
| B2M Golgi apparatus Epstein-Barr virus infection 2.1234869857424115 | |
| B2M Golgi apparatus Herpes simplex virus 1 infection 2.1234869857424115 | |
| B2M Golgi apparatus Human T-cell leukemia virus 1 infection 2.1234869857424115 | |
| B2M Golgi apparatus Human cytomegalovirus infection 2.1234869857424115 | |
| B2M Golgi apparatus Human immunodeficiency virus 1 infection 2.1234869857424115 | |
| B2M Plasma membrane Antigen processing and presentation 2.1234869857424115 | |
| B2M Plasma membrane Epstein-Barr virus infection 2.1234869857424115 | |
| B2M Plasma membrane Herpes simplex virus 1 infection 2.1234869857424115 | |
| B2M Plasma membrane Human T-cell leukemia virus 1 infection 2.1234869857424115 | |
| B2M Plasma membrane Human cytomegalovirus infection 2.1234869857424115 | |
| B2M Plasma membrane Human immunodeficiency virus 1 infection 2.1234869857424115 | |
| B3GAT3 Golgi apparatus Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 1.6271290509674283 | |
| B3GAT3 Golgi apparatus Glycosaminoglycan biosynthesis - heparan sulfate / heparin 1.6271290509674283 | |
| B3GAT3 Golgi apparatus Metabolic pathways 1.6271290509674283 | |
| B3GLCT Endoplasmic Reticulum Other types of O-glycan biosynthesis 1.8343558163496148 | |
| B3GNT2 Cytosol Glycosaminoglycan biosynthesis - keratan sulfate 1.6563633564620064 | |
| B3GNT2 Cytosol Glycosphingolipid biosynthesis - lacto and neolacto series 1.6563633564620064 | |
| B3GNT2 Cytosol Metabolic pathways 1.6563633564620064 | |
| B3GNT2 Golgi apparatus Glycosaminoglycan biosynthesis - keratan sulfate 1.6563633564620064 | |
| B3GNT2 Golgi apparatus Glycosphingolipid biosynthesis - lacto and neolacto series 1.6563633564620064 | |
| B3GNT2 Golgi apparatus Metabolic pathways 1.6563633564620064 | |
| B3GNTL1 Cytosol Summary 1.0686228227489825 | |
| B3GNTL1 Nucleus Summary 1.0686228227489825 | |
| B4GALT1 Extracellular space Galactose metabolism 0.6011504512709122 | |
| B4GALT1 Extracellular space Glycosaminoglycan biosynthesis - keratan sulfate 0.6011504512709122 | |
| B4GALT1 Extracellular space Glycosphingolipid biosynthesis - lacto and neolacto series 0.6011504512709122 | |
| B4GALT1 Extracellular space Mannose type O-glycan biosynthesis 0.6011504512709122 | |
| B4GALT1 Extracellular space Metabolic pathways 0.6011504512709122 | |
| B4GALT1 Extracellular space N-Glycan biosynthesis 0.6011504512709122 | |
| B4GALT1 Extracellular space Other types of O-glycan biosynthesis 0.6011504512709122 | |
| B4GALT1 Extracellular space Various types of N-glycan biosynthesis 0.6011504512709122 | |
| B4GALT1 Golgi apparatus Galactose metabolism 0.6011504512709122 | |
| B4GALT1 Golgi apparatus Glycosaminoglycan biosynthesis - keratan sulfate 0.6011504512709122 | |
| B4GALT1 Golgi apparatus Glycosphingolipid biosynthesis - lacto and neolacto series 0.6011504512709122 | |
| B4GALT1 Golgi apparatus Mannose type O-glycan biosynthesis 0.6011504512709122 | |
| B4GALT1 Golgi apparatus Metabolic pathways 0.6011504512709122 | |
| B4GALT1 Golgi apparatus N-Glycan biosynthesis 0.6011504512709122 | |
| B4GALT1 Golgi apparatus Other types of O-glycan biosynthesis 0.6011504512709122 | |
| B4GALT1 Golgi apparatus Various types of N-glycan biosynthesis 0.6011504512709122 | |
| B4GALT1 Plasma membrane Galactose metabolism 0.6011504512709122 | |
| B4GALT1 Plasma membrane Glycosaminoglycan biosynthesis - keratan sulfate 0.6011504512709122 | |
| B4GALT1 Plasma membrane Glycosphingolipid biosynthesis - lacto and neolacto series 0.6011504512709122 | |
| B4GALT1 Plasma membrane Mannose type O-glycan biosynthesis 0.6011504512709122 | |
| B4GALT1 Plasma membrane Metabolic pathways 0.6011504512709122 | |
| B4GALT1 Plasma membrane N-Glycan biosynthesis 0.6011504512709122 | |
| B4GALT1 Plasma membrane Other types of O-glycan biosynthesis 0.6011504512709122 | |
| B4GALT1 Plasma membrane Various types of N-glycan biosynthesis 0.6011504512709122 | |
| B4GALT2 Cytosol Galactose metabolism 1.4700000447808963 | |
| B4GALT2 Cytosol Glycosaminoglycan biosynthesis - keratan sulfate 1.4700000447808963 | |
| B4GALT2 Cytosol Glycosphingolipid biosynthesis - lacto and neolacto series 1.4700000447808963 | |
| B4GALT2 Cytosol Mannose type O-glycan biosynthesis 1.4700000447808963 | |
| B4GALT2 Cytosol Metabolic pathways 1.4700000447808963 | |
| B4GALT2 Cytosol N-Glycan biosynthesis 1.4700000447808963 | |
| B4GALT2 Cytosol Other types of O-glycan biosynthesis 1.4700000447808963 | |
| B4GALT2 Cytosol Various types of N-glycan biosynthesis 1.4700000447808963 | |
| B4GALT2 Golgi apparatus Galactose metabolism 1.4700000447808963 | |
| B4GALT2 Golgi apparatus Glycosaminoglycan biosynthesis - keratan sulfate 1.4700000447808963 | |
| B4GALT2 Golgi apparatus Glycosphingolipid biosynthesis - lacto and neolacto series 1.4700000447808963 | |
| B4GALT2 Golgi apparatus Mannose type O-glycan biosynthesis 1.4700000447808963 | |
| B4GALT2 Golgi apparatus Metabolic pathways 1.4700000447808963 | |
| B4GALT2 Golgi apparatus N-Glycan biosynthesis 1.4700000447808963 | |
| B4GALT2 Golgi apparatus Other types of O-glycan biosynthesis 1.4700000447808963 | |
| B4GALT2 Golgi apparatus Various types of N-glycan biosynthesis 1.4700000447808963 | |
| B4GALT3 Cytosol Glycosaminoglycan biosynthesis - keratan sulfate 1.6335458170294916 | |
| B4GALT3 Cytosol Glycosphingolipid biosynthesis - lacto and neolacto series 1.6335458170294916 | |
| B4GALT3 Cytosol Mannose type O-glycan biosynthesis 1.6335458170294916 | |
| B4GALT3 Cytosol Metabolic pathways 1.6335458170294916 | |
| B4GALT3 Cytosol N-Glycan biosynthesis 1.6335458170294916 | |
| B4GALT3 Cytosol Other types of O-glycan biosynthesis 1.6335458170294916 | |
| B4GALT3 Cytosol Various types of N-glycan biosynthesis 1.6335458170294916 | |
| B4GALT3 Golgi apparatus Glycosaminoglycan biosynthesis - keratan sulfate 1.6335458170294916 | |
| B4GALT3 Golgi apparatus Glycosphingolipid biosynthesis - lacto and neolacto series 1.6335458170294916 | |
| B4GALT3 Golgi apparatus Mannose type O-glycan biosynthesis 1.6335458170294916 | |
| B4GALT3 Golgi apparatus Metabolic pathways 1.6335458170294916 | |
| B4GALT3 Golgi apparatus N-Glycan biosynthesis 1.6335458170294916 | |
| B4GALT3 Golgi apparatus Other types of O-glycan biosynthesis 1.6335458170294916 | |
| B4GALT3 Golgi apparatus Various types of N-glycan biosynthesis 1.6335458170294916 | |
| B4GALT4 Golgi apparatus Glycosaminoglycan biosynthesis - keratan sulfate 1.442723784374029 | |
| B4GALT4 Golgi apparatus Glycosphingolipid biosynthesis - lacto and neolacto series 1.442723784374029 | |
| B4GALT4 Golgi apparatus Metabolic pathways 1.442723784374029 | |
| B4GALT7 Golgi apparatus Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 1.0190322718726392 | |
| B4GALT7 Golgi apparatus Glycosaminoglycan biosynthesis - heparan sulfate / heparin 1.0190322718726392 | |
| B4GALT7 Golgi apparatus Metabolic pathways 1.0190322718726392 | |
| B4GAT1 Golgi apparatus Mannose type O-glycan biosynthesis 0.7059871236181939 | |
| B4GAT1 Golgi apparatus Metabolic pathways 0.7059871236181939 | |
| B9D1 Cytoskeleton Summary 1.0787662636328892 | |
| B9D1 Cytosol Summary 1.0787662636328892 | |
| BABAM1 Cytosol Homologous recombination 0.9468989674474322 | |
| BABAM1 Nucleus Homologous recombination 0.9468989674474322 | |
| BACH1 Cytosol Fanconi anemia pathway 1.4244228461137969 | |
| BACH1 Cytosol Homologous recombination 1.4244228461137969 | |
| BACH1 Nucleus Fanconi anemia pathway 1.4244228461137969 | |
| BACH1 Nucleus Homologous recombination 1.4244228461137969 | |
| BAD Cytosol Acute myeloid leukemia 0.7719484578166456 | |
| BAD Cytosol Alzheimer disease 0.7719484578166456 | |
| BAD Cytosol Amyotrophic lateral sclerosis 0.7719484578166456 | |
| BAD Cytosol Apoptosis 0.7719484578166456 | |
| BAD Cytosol Autophagy - animal 0.7719484578166456 | |
| BAD Cytosol Chemical carcinogenesis - receptor activation 0.7719484578166456 | |
| BAD Cytosol Chemokine signaling pathway 0.7719484578166456 | |
| BAD Cytosol Chronic myeloid leukemia 0.7719484578166456 | |
| BAD Cytosol Colorectal cancer 0.7719484578166456 | |
| BAD Cytosol EGFR tyrosine kinase inhibitor resistance 0.7719484578166456 | |
| BAD Cytosol Endocrine resistance 0.7719484578166456 | |
| BAD Cytosol Endometrial cancer 0.7719484578166456 | |
| BAD Cytosol ErbB signaling pathway 0.7719484578166456 | |
| BAD Cytosol Focal adhesion 0.7719484578166456 | |
| BAD Cytosol Hepatitis B 0.7719484578166456 | |
| BAD Cytosol Hepatitis C 0.7719484578166456 | |
| BAD Cytosol Hepatocellular carcinoma 0.7719484578166456 | |
| BAD Cytosol Herpes simplex virus 1 infection 0.7719484578166456 | |
| BAD Cytosol Human immunodeficiency virus 1 infection 0.7719484578166456 | |
| BAD Cytosol Human papillomavirus infection 0.7719484578166456 | |
| BAD Cytosol Insulin signaling pathway 0.7719484578166456 | |
| BAD Cytosol Lipid and atherosclerosis 0.7719484578166456 | |
| BAD Cytosol Measles 0.7719484578166456 | |
| BAD Cytosol Melanoma 0.7719484578166456 | |
| BAD Cytosol Neurotrophin signaling pathway 0.7719484578166456 | |
| BAD Cytosol Non-small cell lung cancer 0.7719484578166456 | |
| BAD Cytosol PI3K-Akt signaling pathway 0.7719484578166456 | |
| BAD Cytosol Pancreatic cancer 0.7719484578166456 | |
| BAD Cytosol Pathways in cancer 0.7719484578166456 | |
| BAD Cytosol Pathways of neurodegeneration - multiple diseases 0.7719484578166456 | |
| BAD Cytosol Platinum drug resistance 0.7719484578166456 | |
| BAD Cytosol Prion disease 0.7719484578166456 | |
| BAD Cytosol Prostate cancer 0.7719484578166456 | |
| BAD Cytosol Ras signaling pathway 0.7719484578166456 | |
| BAD Cytosol Renal cell carcinoma 0.7719484578166456 | |
| BAD Cytosol Thyroid hormone signaling pathway 0.7719484578166456 | |
| BAD Cytosol Toxoplasmosis 0.7719484578166456 | |
| BAD Cytosol Tuberculosis 0.7719484578166456 | |
| BAD Cytosol VEGF signaling pathway 0.7719484578166456 | |
| BAD Cytosol Viral carcinogenesis 0.7719484578166456 | |
| BAD Cytosol cAMP signaling pathway 0.7719484578166456 | |
| BAD Cytosol cGMP-PKG signaling pathway 0.7719484578166456 | |
| BAD Mitochondrion Acute myeloid leukemia 0.7719484578166456 | |
| BAD Mitochondrion Alzheimer disease 0.7719484578166456 | |
| BAD Mitochondrion Amyotrophic lateral sclerosis 0.7719484578166456 | |
| BAD Mitochondrion Apoptosis 0.7719484578166456 | |
| BAD Mitochondrion Autophagy - animal 0.7719484578166456 | |
| BAD Mitochondrion Chemical carcinogenesis - receptor activation 0.7719484578166456 | |
| BAD Mitochondrion Chemokine signaling pathway 0.7719484578166456 | |
| BAD Mitochondrion Chronic myeloid leukemia 0.7719484578166456 | |
| BAD Mitochondrion Colorectal cancer 0.7719484578166456 | |
| BAD Mitochondrion EGFR tyrosine kinase inhibitor resistance 0.7719484578166456 | |
| BAD Mitochondrion Endocrine resistance 0.7719484578166456 | |
| BAD Mitochondrion Endometrial cancer 0.7719484578166456 | |
| BAD Mitochondrion ErbB signaling pathway 0.7719484578166456 | |
| BAD Mitochondrion Focal adhesion 0.7719484578166456 | |
| BAD Mitochondrion Hepatitis B 0.7719484578166456 | |
| BAD Mitochondrion Hepatitis C 0.7719484578166456 | |
| BAD Mitochondrion Hepatocellular carcinoma 0.7719484578166456 | |
| BAD Mitochondrion Herpes simplex virus 1 infection 0.7719484578166456 | |
| BAD Mitochondrion Human immunodeficiency virus 1 infection 0.7719484578166456 | |
| BAD Mitochondrion Human papillomavirus infection 0.7719484578166456 | |
| BAD Mitochondrion Insulin signaling pathway 0.7719484578166456 | |
| BAD Mitochondrion Lipid and atherosclerosis 0.7719484578166456 | |
| BAD Mitochondrion Measles 0.7719484578166456 | |
| BAD Mitochondrion Melanoma 0.7719484578166456 | |
| BAD Mitochondrion Neurotrophin signaling pathway 0.7719484578166456 | |
| BAD Mitochondrion Non-small cell lung cancer 0.7719484578166456 | |
| BAD Mitochondrion PI3K-Akt signaling pathway 0.7719484578166456 | |
| BAD Mitochondrion Pancreatic cancer 0.7719484578166456 | |
| BAD Mitochondrion Pathways in cancer 0.7719484578166456 | |
| BAD Mitochondrion Pathways of neurodegeneration - multiple diseases 0.7719484578166456 | |
| BAD Mitochondrion Platinum drug resistance 0.7719484578166456 | |
| BAD Mitochondrion Prion disease 0.7719484578166456 | |
| BAD Mitochondrion Prostate cancer 0.7719484578166456 | |
| BAD Mitochondrion Ras signaling pathway 0.7719484578166456 | |
| BAD Mitochondrion Renal cell carcinoma 0.7719484578166456 | |
| BAD Mitochondrion Thyroid hormone signaling pathway 0.7719484578166456 | |
| BAD Mitochondrion Toxoplasmosis 0.7719484578166456 | |
| BAD Mitochondrion Tuberculosis 0.7719484578166456 | |
| BAD Mitochondrion VEGF signaling pathway 0.7719484578166456 | |
| BAD Mitochondrion Viral carcinogenesis 0.7719484578166456 | |
| BAD Mitochondrion cAMP signaling pathway 0.7719484578166456 | |
| BAD Mitochondrion cGMP-PKG signaling pathway 0.7719484578166456 | |
| BAG1 Nucleus Summary 0.3003636218278233 | |
| BAG2 Cytoskeleton Summary 3.23641867619326 | |
| BAG2 Cytosol Summary 3.23641867619326 | |
| BAG2 Nucleus Summary 3.23641867619326 | |
| BAG3 Cytosol Summary 0.5461541764928456 | |
| BAG3 Nucleus Summary 0.5461541764928456 | |
| BAG3 Plasma membrane Summary 0.5461541764928456 | |
| BAG4 Cytosol TNF signaling pathway 0.8813157740038241 | |
| BAG4 Nucleus TNF signaling pathway 0.8813157740038241 | |
| BAG4 Plasma membrane TNF signaling pathway 0.8813157740038241 | |
| BAG5 Cytosol Summary 1.3452671341940552 | |
| BAHCC1 Nucleus Summary 0.9264695034348148 | |
| BAHD1 Nucleus Summary 1.091544567160127 | |
| BAIAP2 Cytoskeleton Adherens junction 1.0341483682918813 | |
| BAIAP2 Cytoskeleton Pathogenic Escherichia coli infection 1.0341483682918813 | |
| BAIAP2 Cytoskeleton Regulation of actin cytoskeleton 1.0341483682918813 | |
| BAIAP2 Cytoskeleton Yersinia infection 1.0341483682918813 | |
| BAIAP2 Cytosol Adherens junction 1.0341483682918813 | |
| BAIAP2 Cytosol Pathogenic Escherichia coli infection 1.0341483682918813 | |
| BAIAP2 Cytosol Regulation of actin cytoskeleton 1.0341483682918813 | |
| BAIAP2 Cytosol Yersinia infection 1.0341483682918813 | |
| BAIAP2 Plasma membrane Adherens junction 1.0341483682918813 | |
| BAIAP2 Plasma membrane Pathogenic Escherichia coli infection 1.0341483682918813 | |
| BAIAP2 Plasma membrane Regulation of actin cytoskeleton 1.0341483682918813 | |
| BAIAP2 Plasma membrane Yersinia infection 1.0341483682918813 | |
| BAIAP2L1 Cytoskeleton Pathogenic Escherichia coli infection 1.6903841487757012 | |
| BAIAP2L1 Cytosol Pathogenic Escherichia coli infection 1.6903841487757012 | |
| BAIAP2L1 Plasma membrane Pathogenic Escherichia coli infection 1.6903841487757012 | |
| BAK1 Mitochondrion Apoptosis 1.5844367428265518 | |
| BAK1 Mitochondrion Apoptosis - multiple species 1.5844367428265518 | |
| BAK1 Mitochondrion Basal cell carcinoma 1.5844367428265518 | |
| BAK1 Mitochondrion Breast cancer 1.5844367428265518 | |
| BAK1 Mitochondrion Chronic myeloid leukemia 1.5844367428265518 | |
| BAK1 Mitochondrion Colorectal cancer 1.5844367428265518 | |
| BAK1 Mitochondrion Endometrial cancer 1.5844367428265518 | |
| BAK1 Mitochondrion Epstein-Barr virus infection 1.5844367428265518 | |
| BAK1 Mitochondrion Gastric cancer 1.5844367428265518 | |
| BAK1 Mitochondrion Glioma 1.5844367428265518 | |
| BAK1 Mitochondrion Hepatitis C 1.5844367428265518 | |
| BAK1 Mitochondrion Hepatocellular carcinoma 1.5844367428265518 | |
| BAK1 Mitochondrion Herpes simplex virus 1 infection 1.5844367428265518 | |
| BAK1 Mitochondrion Human cytomegalovirus infection 1.5844367428265518 | |
| BAK1 Mitochondrion Human immunodeficiency virus 1 infection 1.5844367428265518 | |
| BAK1 Mitochondrion Human papillomavirus infection 1.5844367428265518 | |
| BAK1 Mitochondrion Influenza A 1.5844367428265518 | |
| BAK1 Mitochondrion Kaposi sarcoma-associated herpesvirus infection 1.5844367428265518 | |
| BAK1 Mitochondrion Measles 1.5844367428265518 | |
| BAK1 Mitochondrion Melanoma 1.5844367428265518 | |
| BAK1 Mitochondrion MicroRNAs in cancer 1.5844367428265518 | |
| BAK1 Mitochondrion Non-small cell lung cancer 1.5844367428265518 | |
| BAK1 Mitochondrion Pancreatic cancer 1.5844367428265518 | |
| BAK1 Mitochondrion Pathogenic Escherichia coli infection 1.5844367428265518 | |
| BAK1 Mitochondrion Pathways in cancer 1.5844367428265518 | |
| BAK1 Mitochondrion Pathways of neurodegeneration - multiple diseases 1.5844367428265518 | |
| BAK1 Mitochondrion Platinum drug resistance 1.5844367428265518 | |
| BAK1 Mitochondrion Protein processing in endoplasmic reticulum 1.5844367428265518 | |
| BAK1 Mitochondrion Salmonella infection 1.5844367428265518 | |
| BAK1 Mitochondrion Small cell lung cancer 1.5844367428265518 | |
| BAK1 Mitochondrion Thyroid cancer 1.5844367428265518 | |
| BAK1 Mitochondrion Transcriptional misregulation in cancer 1.5844367428265518 | |
| BAK1 Mitochondrion Viral carcinogenesis 1.5844367428265518 | |
| BANF1 Cytosol Summary 1.7918658218411854 | |
| BANF1 Nucleus Summary 1.7918658218411854 | |
| BANP Nucleus Summary 1.3859973441595832 | |
| BAP1 Cytosol Human papillomavirus infection 1.6605160725809542 | |
| BAP1 Cytosol PI3K-Akt signaling pathway 1.6605160725809542 | |
| BAP1 Cytosol Rap1 signaling pathway 1.6605160725809542 | |
| BAP1 Cytosol Tight junction 1.6605160725809542 | |
| BAP1 Nucleus Human papillomavirus infection 1.6605160725809542 | |
| BAP1 Nucleus PI3K-Akt signaling pathway 1.6605160725809542 | |
| BAP1 Nucleus Rap1 signaling pathway 1.6605160725809542 | |
| BAP1 Nucleus Tight junction 1.6605160725809542 | |
| BARD1 Cytosol Homologous recombination 1.3845826376960095 | |
| BARD1 Nucleus Homologous recombination 1.3845826376960095 | |
| BASP1 Plasma membrane Summary 1.0754558022791303 | |
| BAX Cytosol AGE-RAGE signaling pathway in diabetic complications 0.8979332569294182 | |
| BAX Cytosol Amyotrophic lateral sclerosis 0.8979332569294182 | |
| BAX Cytosol Apoptosis 0.8979332569294182 | |
| BAX Cytosol Apoptosis - multiple species 0.8979332569294182 | |
| BAX Cytosol Basal cell carcinoma 0.8979332569294182 | |
| BAX Cytosol Breast cancer 0.8979332569294182 | |
| BAX Cytosol Chronic myeloid leukemia 0.8979332569294182 | |
| BAX Cytosol Colorectal cancer 0.8979332569294182 | |
| BAX Cytosol EGFR tyrosine kinase inhibitor resistance 0.8979332569294182 | |
| BAX Cytosol Endocrine resistance 0.8979332569294182 | |
| BAX Cytosol Endometrial cancer 0.8979332569294182 | |
| BAX Cytosol Epstein-Barr virus infection 0.8979332569294182 | |
| BAX Cytosol Gastric cancer 0.8979332569294182 | |
| BAX Cytosol Glioma 0.8979332569294182 | |
| BAX Cytosol Hepatitis B 0.8979332569294182 | |
| BAX Cytosol Hepatitis C 0.8979332569294182 | |
| BAX Cytosol Hepatocellular carcinoma 0.8979332569294182 | |
| BAX Cytosol Herpes simplex virus 1 infection 0.8979332569294182 | |
| BAX Cytosol Human T-cell leukemia virus 1 infection 0.8979332569294182 | |
| BAX Cytosol Human cytomegalovirus infection 0.8979332569294182 | |
| BAX Cytosol Human immunodeficiency virus 1 infection 0.8979332569294182 | |
| BAX Cytosol Human papillomavirus infection 0.8979332569294182 | |
| BAX Cytosol Huntington disease 0.8979332569294182 | |
| BAX Cytosol Influenza A 0.8979332569294182 | |
| BAX Cytosol Kaposi sarcoma-associated herpesvirus infection 0.8979332569294182 | |
| BAX Cytosol Lipid and atherosclerosis 0.8979332569294182 | |
| BAX Cytosol Longevity regulating pathway 0.8979332569294182 | |
| BAX Cytosol Measles 0.8979332569294182 | |
| BAX Cytosol Melanoma 0.8979332569294182 | |
| BAX Cytosol Necroptosis 0.8979332569294182 | |
| BAX Cytosol Neurotrophin signaling pathway 0.8979332569294182 | |
| BAX Cytosol Non-alcoholic fatty liver disease 0.8979332569294182 | |
| BAX Cytosol Non-small cell lung cancer 0.8979332569294182 | |
| BAX Cytosol Pancreatic cancer 0.8979332569294182 | |
| BAX Cytosol Parkinson disease 0.8979332569294182 | |
| BAX Cytosol Pathogenic Escherichia coli infection 0.8979332569294182 | |
| BAX Cytosol Pathways in cancer 0.8979332569294182 | |
| BAX Cytosol Pathways of neurodegeneration - multiple diseases 0.8979332569294182 | |
| BAX Cytosol Platinum drug resistance 0.8979332569294182 | |
| BAX Cytosol Prion disease 0.8979332569294182 | |
| BAX Cytosol Protein processing in endoplasmic reticulum 0.8979332569294182 | |
| BAX Cytosol Salmonella infection 0.8979332569294182 | |
| BAX Cytosol Shigellosis 0.8979332569294182 | |
| BAX Cytosol Small cell lung cancer 0.8979332569294182 | |
| BAX Cytosol Sphingolipid signaling pathway 0.8979332569294182 | |
| BAX Cytosol Thyroid cancer 0.8979332569294182 | |
| BAX Cytosol Transcriptional misregulation in cancer 0.8979332569294182 | |
| BAX Cytosol Tuberculosis 0.8979332569294182 | |
| BAX Cytosol Viral carcinogenesis 0.8979332569294182 | |
| BAX Cytosol p53 signaling pathway 0.8979332569294182 | |
| BAX Mitochondrion AGE-RAGE signaling pathway in diabetic complications 0.8979332569294182 | |
| BAX Mitochondrion Amyotrophic lateral sclerosis 0.8979332569294182 | |
| BAX Mitochondrion Apoptosis 0.8979332569294182 | |
| BAX Mitochondrion Apoptosis - multiple species 0.8979332569294182 | |
| BAX Mitochondrion Basal cell carcinoma 0.8979332569294182 | |
| BAX Mitochondrion Breast cancer 0.8979332569294182 | |
| BAX Mitochondrion Chronic myeloid leukemia 0.8979332569294182 | |
| BAX Mitochondrion Colorectal cancer 0.8979332569294182 | |
| BAX Mitochondrion EGFR tyrosine kinase inhibitor resistance 0.8979332569294182 | |
| BAX Mitochondrion Endocrine resistance 0.8979332569294182 | |
| BAX Mitochondrion Endometrial cancer 0.8979332569294182 | |
| BAX Mitochondrion Epstein-Barr virus infection 0.8979332569294182 | |
| BAX Mitochondrion Gastric cancer 0.8979332569294182 | |
| BAX Mitochondrion Glioma 0.8979332569294182 | |
| BAX Mitochondrion Hepatitis B 0.8979332569294182 | |
| BAX Mitochondrion Hepatitis C 0.8979332569294182 | |
| BAX Mitochondrion Hepatocellular carcinoma 0.8979332569294182 | |
| BAX Mitochondrion Herpes simplex virus 1 infection 0.8979332569294182 | |
| BAX Mitochondrion Human T-cell leukemia virus 1 infection 0.8979332569294182 | |
| BAX Mitochondrion Human cytomegalovirus infection 0.8979332569294182 | |
| BAX Mitochondrion Human immunodeficiency virus 1 infection 0.8979332569294182 | |
| BAX Mitochondrion Human papillomavirus infection 0.8979332569294182 | |
| BAX Mitochondrion Huntington disease 0.8979332569294182 | |
| BAX Mitochondrion Influenza A 0.8979332569294182 | |
| BAX Mitochondrion Kaposi sarcoma-associated herpesvirus infection 0.8979332569294182 | |
| BAX Mitochondrion Lipid and atherosclerosis 0.8979332569294182 | |
| BAX Mitochondrion Longevity regulating pathway 0.8979332569294182 | |
| BAX Mitochondrion Measles 0.8979332569294182 | |
| BAX Mitochondrion Melanoma 0.8979332569294182 | |
| BAX Mitochondrion Necroptosis 0.8979332569294182 | |
| BAX Mitochondrion Neurotrophin signaling pathway 0.8979332569294182 | |
| BAX Mitochondrion Non-alcoholic fatty liver disease 0.8979332569294182 | |
| BAX Mitochondrion Non-small cell lung cancer 0.8979332569294182 | |
| BAX Mitochondrion Pancreatic cancer 0.8979332569294182 | |
| BAX Mitochondrion Parkinson disease 0.8979332569294182 | |
| BAX Mitochondrion Pathogenic Escherichia coli infection 0.8979332569294182 | |
| BAX Mitochondrion Pathways in cancer 0.8979332569294182 | |
| BAX Mitochondrion Pathways of neurodegeneration - multiple diseases 0.8979332569294182 | |
| BAX Mitochondrion Platinum drug resistance 0.8979332569294182 | |
| BAX Mitochondrion Prion disease 0.8979332569294182 | |
| BAX Mitochondrion Protein processing in endoplasmic reticulum 0.8979332569294182 | |
| BAX Mitochondrion Salmonella infection 0.8979332569294182 | |
| BAX Mitochondrion Shigellosis 0.8979332569294182 | |
| BAX Mitochondrion Small cell lung cancer 0.8979332569294182 | |
| BAX Mitochondrion Sphingolipid signaling pathway 0.8979332569294182 | |
| BAX Mitochondrion Thyroid cancer 0.8979332569294182 | |
| BAX Mitochondrion Transcriptional misregulation in cancer 0.8979332569294182 | |
| BAX Mitochondrion Tuberculosis 0.8979332569294182 | |
| BAX Mitochondrion Viral carcinogenesis 0.8979332569294182 | |
| BAX Mitochondrion p53 signaling pathway 0.8979332569294182 | |
| BAZ1A Endoplasmic Reticulum Summary 2.1963982547243117 | |
| BAZ1A Nucleus Summary 2.1963982547243117 | |
| BAZ1B Endoplasmic Reticulum Summary 2.5980487671110217 | |
| BAZ1B Nucleus Summary 2.5980487671110217 | |
| BAZ2A Nucleus Summary 1.0962314871328975 | |
| BAZ2B Cytosol Summary 1.42685128807755 | |
| BAZ2B Nucleus Summary 1.42685128807755 | |
| BBC3 Cytosol Apoptosis 0.6533392498209166 | |
| BBC3 Cytosol Apoptosis - multiple species 0.6533392498209166 | |
| BBC3 Cytosol Colorectal cancer 0.6533392498209166 | |
| BBC3 Cytosol Hippo signaling pathway 0.6533392498209166 | |
| BBC3 Cytosol Huntington disease 0.6533392498209166 | |
| BBC3 Cytosol Measles 0.6533392498209166 | |
| BBC3 Cytosol Pathways in cancer 0.6533392498209166 | |
| BBC3 Cytosol Platinum drug resistance 0.6533392498209166 | |
| BBC3 Cytosol p53 signaling pathway 0.6533392498209166 | |
| BBC3 Mitochondrion Apoptosis 0.6533392498209166 | |
| BBC3 Mitochondrion Apoptosis - multiple species 0.6533392498209166 | |
| BBC3 Mitochondrion Colorectal cancer 0.6533392498209166 | |
| BBC3 Mitochondrion Hippo signaling pathway 0.6533392498209166 | |
| BBC3 Mitochondrion Huntington disease 0.6533392498209166 | |
| BBC3 Mitochondrion Measles 0.6533392498209166 | |
| BBC3 Mitochondrion Pathways in cancer 0.6533392498209166 | |
| BBC3 Mitochondrion Platinum drug resistance 0.6533392498209166 | |
| BBC3 Mitochondrion p53 signaling pathway 0.6533392498209166 | |
| BBOX1 Cytoskeleton Summary 1.5631144281875609 | |
| BBOX1 Cytosol Summary 1.5631144281875609 | |
| BBS1 Cytoskeleton Summary 0.6398804373012277 | |
| BBS1 Cytosol Summary 0.6398804373012277 | |
| BBS2 Cytosol Summary 0.6811367098154054 | |
| BBS2 Plasma membrane Summary 0.6811367098154054 | |
| BBS4 Cytoskeleton Summary 0.5658340064766624 | |
| BBS4 Cytosol Summary 0.5658340064766624 | |
| BBS4 Plasma membrane Summary 0.5658340064766624 | |
| BBS7 Cytoskeleton Summary 0.6782755749915053 | |
| BBS7 Plasma membrane Summary 0.6782755749915053 | |
| BBS9 Cytoskeleton Summary 0.7736151911919457 | |
| BBS9 Cytosol Summary 0.7736151911919457 | |
| BBS9 Plasma membrane Summary 0.7736151911919457 | |
| BBX Cytosol Summary 1.472402491941385 | |
| BBX Nucleus Summary 1.472402491941385 | |
| BCAM Nucleus Summary 0.2735023034895226 | |
| BCAP29 Cytosol Summary 0.4030507537299976 | |
| BCAP29 Endoplasmic Reticulum Summary 0.4030507537299976 | |
| BCAP31 Endoplasmic Reticulum Human papillomavirus infection 0.6594052586341352 | |
| BCAP31 Endoplasmic Reticulum Protein processing in endoplasmic reticulum 0.6594052586341352 | |
| BCAP31 Plasma membrane Human papillomavirus infection 0.6594052586341352 | |
| BCAP31 Plasma membrane Protein processing in endoplasmic reticulum 0.6594052586341352 | |
| BCAR1 Cytosol Bacterial invasion of epithelial cells 0.8151474524678444 | |
| BCAR1 Cytosol Chemokine signaling pathway 0.8151474524678444 | |
| BCAR1 Cytosol Focal adhesion 0.8151474524678444 | |
| BCAR1 Cytosol Growth hormone synthesis secretion and action 0.8151474524678444 | |
| BCAR1 Cytosol Human cytomegalovirus infection 0.8151474524678444 | |
| BCAR1 Cytosol Leukocyte transendothelial migration 0.8151474524678444 | |
| BCAR1 Cytosol Rap1 signaling pathway 0.8151474524678444 | |
| BCAR1 Cytosol Regulation of actin cytoskeleton 0.8151474524678444 | |
| BCAR1 Cytosol Shigellosis 0.8151474524678444 | |
| BCAR1 Cytosol Yersinia infection 0.8151474524678444 | |
| BCAR1 Plasma membrane Bacterial invasion of epithelial cells 0.8151474524678444 | |
| BCAR1 Plasma membrane Chemokine signaling pathway 0.8151474524678444 | |
| BCAR1 Plasma membrane Focal adhesion 0.8151474524678444 | |
| BCAR1 Plasma membrane Growth hormone synthesis secretion and action 0.8151474524678444 | |
| BCAR1 Plasma membrane Human cytomegalovirus infection 0.8151474524678444 | |
| BCAR1 Plasma membrane Leukocyte transendothelial migration 0.8151474524678444 | |
| BCAR1 Plasma membrane Rap1 signaling pathway 0.8151474524678444 | |
| BCAR1 Plasma membrane Regulation of actin cytoskeleton 0.8151474524678444 | |
| BCAR1 Plasma membrane Shigellosis 0.8151474524678444 | |
| BCAR1 Plasma membrane Yersinia infection 0.8151474524678444 | |
| BCAR3 Cytoskeleton Summary 0.7306932952117717 | |
| BCAR3 Cytosol Summary 0.7306932952117717 | |
| BCAR3 Plasma membrane Summary 0.7306932952117717 | |
| BCAS1 Cytosol Summary 0.013804996478726102 | |
| BCAS3 Nucleus Summary 0.8986339636597402 | |
| BCAS4 Cytoskeleton Summary 1.365098464402326 | |
| BCAS4 Cytosol Summary 1.365098464402326 | |
| BCAT1 Cytosol Summary 1.7621313210191119 | |
| BCAT2 Mitochondrion 2-Oxocarboxylic acid metabolism 0.34808851711752303 | |
| BCAT2 Mitochondrion Biosynthesis of amino acids 0.34808851711752303 | |
| BCAT2 Mitochondrion Biosynthesis of cofactors 0.34808851711752303 | |
| BCAT2 Mitochondrion Cysteine and methionine metabolism 0.34808851711752303 | |
| BCAT2 Mitochondrion Metabolic pathways 0.34808851711752303 | |
| BCAT2 Mitochondrion Pantothenate and CoA biosynthesis 0.34808851711752303 | |
| BCAT2 Mitochondrion Valine leucine and isoleucine biosynthesis 0.34808851711752303 | |
| BCAT2 Mitochondrion Valine leucine and isoleucine degradation 0.34808851711752303 | |
| BCCIP Cytosol Summary 1.351179787895877 | |
| BCCIP Nucleus Summary 1.351179787895877 | |
| BCHE Extracellular space Summary 1.7906379851558278 | |
| BCKDHA Mitochondrion Metabolic pathways 1.234209434000498 | |
| BCKDHA Mitochondrion Propanoate metabolism 1.234209434000498 | |
| BCKDHA Mitochondrion Valine leucine and isoleucine degradation 1.234209434000498 | |
| BCKDHB Mitochondrion Metabolic pathways 1.2638372449377495 | |
| BCKDHB Mitochondrion Propanoate metabolism 1.2638372449377495 | |
| BCKDHB Mitochondrion Valine leucine and isoleucine degradation 1.2638372449377495 | |
| BCKDHB Nucleus Metabolic pathways 1.2638372449377495 | |
| BCKDHB Nucleus Propanoate metabolism 1.2638372449377495 | |
| BCKDHB Nucleus Valine leucine and isoleucine degradation 1.2638372449377495 | |
| BCKDK Mitochondrion Summary 1.4011259117454211 | |
| BCL10 Nucleus Summary 2.0062955307182917 | |
| BCL11A Cytosol Summary 3.772076679507855 | |
| BCL11A Nucleus Summary 3.772076679507855 | |
| BCL11B Nucleus Summary 2.4657163803199857 | |
| BCL2 Endoplasmic Reticulum AGE-RAGE signaling pathway in diabetic complications 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Adrenergic signaling in cardiomyocytes 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Amyotrophic lateral sclerosis 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Apoptosis 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Apoptosis - multiple species 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Autophagy - animal 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Chemical carcinogenesis - receptor activation 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Cholinergic synapse 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Colorectal cancer 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum EGFR tyrosine kinase inhibitor resistance 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Endocrine resistance 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Epstein-Barr virus infection 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Estrogen signaling pathway 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Fluid shear stress and atherosclerosis 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Focal adhesion 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Gastric cancer 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum HIF-1 signaling pathway 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Hedgehog signaling pathway 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Hepatitis B 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Herpes simplex virus 1 infection 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Human immunodeficiency virus 1 infection 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum JAK-STAT signaling pathway 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Lipid and atherosclerosis 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Measles 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum MicroRNAs in cancer 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum NF-kappa B signaling pathway 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum NOD-like receptor signaling pathway 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Necroptosis 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Neurotrophin signaling pathway 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum PI3K-Akt signaling pathway 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Parathyroid hormone synthesis secretion and action 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Pathways in cancer 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Pathways of neurodegeneration - multiple diseases 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Platinum drug resistance 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Prostate cancer 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Protein processing in endoplasmic reticulum 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Salmonella infection 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Shigellosis 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Small cell lung cancer 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Sphingolipid signaling pathway 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Toxoplasmosis 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum Tuberculosis 0.6937552220459429 | |
| BCL2 Endoplasmic Reticulum p53 signaling pathway 0.6937552220459429 | |
| BCL2 Mitochondrion AGE-RAGE signaling pathway in diabetic complications 0.6937552220459429 | |
| BCL2 Mitochondrion Adrenergic signaling in cardiomyocytes 0.6937552220459429 | |
| BCL2 Mitochondrion Amyotrophic lateral sclerosis 0.6937552220459429 | |
| BCL2 Mitochondrion Apoptosis 0.6937552220459429 | |
| BCL2 Mitochondrion Apoptosis - multiple species 0.6937552220459429 | |
| BCL2 Mitochondrion Autophagy - animal 0.6937552220459429 | |
| BCL2 Mitochondrion Chemical carcinogenesis - receptor activation 0.6937552220459429 | |
| BCL2 Mitochondrion Cholinergic synapse 0.6937552220459429 | |
| BCL2 Mitochondrion Colorectal cancer 0.6937552220459429 | |
| BCL2 Mitochondrion EGFR tyrosine kinase inhibitor resistance 0.6937552220459429 | |
| BCL2 Mitochondrion Endocrine resistance 0.6937552220459429 | |
| BCL2 Mitochondrion Epstein-Barr virus infection 0.6937552220459429 | |
| BCL2 Mitochondrion Estrogen signaling pathway 0.6937552220459429 | |
| BCL2 Mitochondrion Fluid shear stress and atherosclerosis 0.6937552220459429 | |
| BCL2 Mitochondrion Focal adhesion 0.6937552220459429 | |
| BCL2 Mitochondrion Gastric cancer 0.6937552220459429 | |
| BCL2 Mitochondrion HIF-1 signaling pathway 0.6937552220459429 | |
| BCL2 Mitochondrion Hedgehog signaling pathway 0.6937552220459429 | |
| BCL2 Mitochondrion Hepatitis B 0.6937552220459429 | |
| BCL2 Mitochondrion Herpes simplex virus 1 infection 0.6937552220459429 | |
| BCL2 Mitochondrion Human immunodeficiency virus 1 infection 0.6937552220459429 | |
| BCL2 Mitochondrion JAK-STAT signaling pathway 0.6937552220459429 | |
| BCL2 Mitochondrion Lipid and atherosclerosis 0.6937552220459429 | |
| BCL2 Mitochondrion Measles 0.6937552220459429 | |
| BCL2 Mitochondrion MicroRNAs in cancer 0.6937552220459429 | |
| BCL2 Mitochondrion NF-kappa B signaling pathway 0.6937552220459429 | |
| BCL2 Mitochondrion NOD-like receptor signaling pathway 0.6937552220459429 | |
| BCL2 Mitochondrion Necroptosis 0.6937552220459429 | |
| BCL2 Mitochondrion Neurotrophin signaling pathway 0.6937552220459429 | |
| BCL2 Mitochondrion PI3K-Akt signaling pathway 0.6937552220459429 | |
| BCL2 Mitochondrion Parathyroid hormone synthesis secretion and action 0.6937552220459429 | |
| BCL2 Mitochondrion Pathways in cancer 0.6937552220459429 | |
| BCL2 Mitochondrion Pathways of neurodegeneration - multiple diseases 0.6937552220459429 | |
| BCL2 Mitochondrion Platinum drug resistance 0.6937552220459429 | |
| BCL2 Mitochondrion Prostate cancer 0.6937552220459429 | |
| BCL2 Mitochondrion Protein processing in endoplasmic reticulum 0.6937552220459429 | |
| BCL2 Mitochondrion Salmonella infection 0.6937552220459429 | |
| BCL2 Mitochondrion Shigellosis 0.6937552220459429 | |
| BCL2 Mitochondrion Small cell lung cancer 0.6937552220459429 | |
| BCL2 Mitochondrion Sphingolipid signaling pathway 0.6937552220459429 | |
| BCL2 Mitochondrion Toxoplasmosis 0.6937552220459429 | |
| BCL2 Mitochondrion Tuberculosis 0.6937552220459429 | |
| BCL2 Mitochondrion p53 signaling pathway 0.6937552220459429 | |
| BCL2 Nucleus AGE-RAGE signaling pathway in diabetic complications 0.6937552220459429 | |
| BCL2 Nucleus Adrenergic signaling in cardiomyocytes 0.6937552220459429 | |
| BCL2 Nucleus Amyotrophic lateral sclerosis 0.6937552220459429 | |
| BCL2 Nucleus Apoptosis 0.6937552220459429 | |
| BCL2 Nucleus Apoptosis - multiple species 0.6937552220459429 | |
| BCL2 Nucleus Autophagy - animal 0.6937552220459429 | |
| BCL2 Nucleus Chemical carcinogenesis - receptor activation 0.6937552220459429 | |
| BCL2 Nucleus Cholinergic synapse 0.6937552220459429 | |
| BCL2 Nucleus Colorectal cancer 0.6937552220459429 | |
| BCL2 Nucleus EGFR tyrosine kinase inhibitor resistance 0.6937552220459429 | |
| BCL2 Nucleus Endocrine resistance 0.6937552220459429 | |
| BCL2 Nucleus Epstein-Barr virus infection 0.6937552220459429 | |
| BCL2 Nucleus Estrogen signaling pathway 0.6937552220459429 | |
| BCL2 Nucleus Fluid shear stress and atherosclerosis 0.6937552220459429 | |
| BCL2 Nucleus Focal adhesion 0.6937552220459429 | |
| BCL2 Nucleus Gastric cancer 0.6937552220459429 | |
| BCL2 Nucleus HIF-1 signaling pathway 0.6937552220459429 | |
| BCL2 Nucleus Hedgehog signaling pathway 0.6937552220459429 | |
| BCL2 Nucleus Hepatitis B 0.6937552220459429 | |
| BCL2 Nucleus Herpes simplex virus 1 infection 0.6937552220459429 | |
| BCL2 Nucleus Human immunodeficiency virus 1 infection 0.6937552220459429 | |
| BCL2 Nucleus JAK-STAT signaling pathway 0.6937552220459429 | |
| BCL2 Nucleus Lipid and atherosclerosis 0.6937552220459429 | |
| BCL2 Nucleus Measles 0.6937552220459429 | |
| BCL2 Nucleus MicroRNAs in cancer 0.6937552220459429 | |
| BCL2 Nucleus NF-kappa B signaling pathway 0.6937552220459429 | |
| BCL2 Nucleus NOD-like receptor signaling pathway 0.6937552220459429 | |
| BCL2 Nucleus Necroptosis 0.6937552220459429 | |
| BCL2 Nucleus Neurotrophin signaling pathway 0.6937552220459429 | |
| BCL2 Nucleus PI3K-Akt signaling pathway 0.6937552220459429 | |
| BCL2 Nucleus Parathyroid hormone synthesis secretion and action 0.6937552220459429 | |
| BCL2 Nucleus Pathways in cancer 0.6937552220459429 | |
| BCL2 Nucleus Pathways of neurodegeneration - multiple diseases 0.6937552220459429 | |
| BCL2 Nucleus Platinum drug resistance 0.6937552220459429 | |
| BCL2 Nucleus Prostate cancer 0.6937552220459429 | |
| BCL2 Nucleus Protein processing in endoplasmic reticulum 0.6937552220459429 | |
| BCL2 Nucleus Salmonella infection 0.6937552220459429 | |
| BCL2 Nucleus Shigellosis 0.6937552220459429 | |
| BCL2 Nucleus Small cell lung cancer 0.6937552220459429 | |
| BCL2 Nucleus Sphingolipid signaling pathway 0.6937552220459429 | |
| BCL2 Nucleus Toxoplasmosis 0.6937552220459429 | |
| BCL2 Nucleus Tuberculosis 0.6937552220459429 | |
| BCL2 Nucleus p53 signaling pathway 0.6937552220459429 | |
| BCL2L1 Cytoskeleton Amyotrophic lateral sclerosis 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Apoptosis 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Apoptosis - multiple species 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Autophagy - animal 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Chronic myeloid leukemia 0.6422825950358179 | |
| BCL2L1 Cytoskeleton EGFR tyrosine kinase inhibitor resistance 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Hepatocellular carcinoma 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Herpes simplex virus 1 infection 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Human T-cell leukemia virus 1 infection 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Human immunodeficiency virus 1 infection 0.6422825950358179 | |
| BCL2L1 Cytoskeleton JAK-STAT signaling pathway 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Lipid and atherosclerosis 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Measles 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Mitophagy - animal 0.6422825950358179 | |
| BCL2L1 Cytoskeleton NF-kappa B signaling pathway 0.6422825950358179 | |
| BCL2L1 Cytoskeleton NOD-like receptor signaling pathway 0.6422825950358179 | |
| BCL2L1 Cytoskeleton PI3K-Akt signaling pathway 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Pancreatic cancer 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Parkinson disease 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Pathways in cancer 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Pathways of neurodegeneration - multiple diseases 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Platinum drug resistance 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Ras signaling pathway 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Shigellosis 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Small cell lung cancer 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Toxoplasmosis 0.6422825950358179 | |
| BCL2L1 Cytoskeleton Transcriptional misregulation in cancer 0.6422825950358179 | |
| BCL2L1 Cytoskeleton p53 signaling pathway 0.6422825950358179 | |
| BCL2L1 Mitochondrion Amyotrophic lateral sclerosis 0.6422825950358179 | |
| BCL2L1 Mitochondrion Apoptosis 0.6422825950358179 | |
| BCL2L1 Mitochondrion Apoptosis - multiple species 0.6422825950358179 | |
| BCL2L1 Mitochondrion Autophagy - animal 0.6422825950358179 | |
| BCL2L1 Mitochondrion Chronic myeloid leukemia 0.6422825950358179 | |
| BCL2L1 Mitochondrion EGFR tyrosine kinase inhibitor resistance 0.6422825950358179 | |
| BCL2L1 Mitochondrion Hepatocellular carcinoma 0.6422825950358179 | |
| BCL2L1 Mitochondrion Herpes simplex virus 1 infection 0.6422825950358179 | |
| BCL2L1 Mitochondrion Human T-cell leukemia virus 1 infection 0.6422825950358179 | |
| BCL2L1 Mitochondrion Human immunodeficiency virus 1 infection 0.6422825950358179 | |
| BCL2L1 Mitochondrion JAK-STAT signaling pathway 0.6422825950358179 | |
| BCL2L1 Mitochondrion Lipid and atherosclerosis 0.6422825950358179 | |
| BCL2L1 Mitochondrion Measles 0.6422825950358179 | |
| BCL2L1 Mitochondrion Mitophagy - animal 0.6422825950358179 | |
| BCL2L1 Mitochondrion NF-kappa B signaling pathway 0.6422825950358179 | |
| BCL2L1 Mitochondrion NOD-like receptor signaling pathway 0.6422825950358179 | |
| BCL2L1 Mitochondrion PI3K-Akt signaling pathway 0.6422825950358179 | |
| BCL2L1 Mitochondrion Pancreatic cancer 0.6422825950358179 | |
| BCL2L1 Mitochondrion Parkinson disease 0.6422825950358179 | |
| BCL2L1 Mitochondrion Pathways in cancer 0.6422825950358179 | |
| BCL2L1 Mitochondrion Pathways of neurodegeneration - multiple diseases 0.6422825950358179 | |
| BCL2L1 Mitochondrion Platinum drug resistance 0.6422825950358179 | |
| BCL2L1 Mitochondrion Ras signaling pathway 0.6422825950358179 | |
| BCL2L1 Mitochondrion Shigellosis 0.6422825950358179 | |
| BCL2L1 Mitochondrion Small cell lung cancer 0.6422825950358179 | |
| BCL2L1 Mitochondrion Toxoplasmosis 0.6422825950358179 | |
| BCL2L1 Mitochondrion Transcriptional misregulation in cancer 0.6422825950358179 | |
| BCL2L1 Mitochondrion p53 signaling pathway 0.6422825950358179 | |
| BCL2L1 Nucleus Amyotrophic lateral sclerosis 0.6422825950358179 | |
| BCL2L1 Nucleus Apoptosis 0.6422825950358179 | |
| BCL2L1 Nucleus Apoptosis - multiple species 0.6422825950358179 | |
| BCL2L1 Nucleus Autophagy - animal 0.6422825950358179 | |
| BCL2L1 Nucleus Chronic myeloid leukemia 0.6422825950358179 | |
| BCL2L1 Nucleus EGFR tyrosine kinase inhibitor resistance 0.6422825950358179 | |
| BCL2L1 Nucleus Hepatocellular carcinoma 0.6422825950358179 | |
| BCL2L1 Nucleus Herpes simplex virus 1 infection 0.6422825950358179 | |
| BCL2L1 Nucleus Human T-cell leukemia virus 1 infection 0.6422825950358179 | |
| BCL2L1 Nucleus Human immunodeficiency virus 1 infection 0.6422825950358179 | |
| BCL2L1 Nucleus JAK-STAT signaling pathway 0.6422825950358179 | |
| BCL2L1 Nucleus Lipid and atherosclerosis 0.6422825950358179 | |
| BCL2L1 Nucleus Measles 0.6422825950358179 | |
| BCL2L1 Nucleus Mitophagy - animal 0.6422825950358179 | |
| BCL2L1 Nucleus NF-kappa B signaling pathway 0.6422825950358179 | |
| BCL2L1 Nucleus NOD-like receptor signaling pathway 0.6422825950358179 | |
| BCL2L1 Nucleus PI3K-Akt signaling pathway 0.6422825950358179 | |
| BCL2L1 Nucleus Pancreatic cancer 0.6422825950358179 | |
| BCL2L1 Nucleus Parkinson disease 0.6422825950358179 | |
| BCL2L1 Nucleus Pathways in cancer 0.6422825950358179 | |
| BCL2L1 Nucleus Pathways of neurodegeneration - multiple diseases 0.6422825950358179 | |
| BCL2L1 Nucleus Platinum drug resistance 0.6422825950358179 | |
| BCL2L1 Nucleus Ras signaling pathway 0.6422825950358179 | |
| BCL2L1 Nucleus Shigellosis 0.6422825950358179 | |
| BCL2L1 Nucleus Small cell lung cancer 0.6422825950358179 | |
| BCL2L1 Nucleus Toxoplasmosis 0.6422825950358179 | |
| BCL2L1 Nucleus Transcriptional misregulation in cancer 0.6422825950358179 | |
| BCL2L1 Nucleus p53 signaling pathway 0.6422825950358179 | |
| BCL2L11 Mitochondrion Summary 0.8165367447626246 | |
| BCL2L13 Mitochondrion Legionellosis 1.405588162227145 | |
| BCL2L13 Mitochondrion Mitophagy - animal 1.405588162227145 | |
| BCL2L2-PABPN1 Mitochondrion Summary 1.2814676463600558 | |
| BCL2L2-PABPN1 Nucleus Summary 1.2814676463600558 | |
| BCL3 Cytoskeleton C-type lectin receptor signaling pathway 1.1728587138801794 | |
| BCL3 Cytoskeleton TNF signaling pathway 1.1728587138801794 | |
| BCL3 Cytosol C-type lectin receptor signaling pathway 1.1728587138801794 | |
| BCL3 Cytosol TNF signaling pathway 1.1728587138801794 | |
| BCL3 Nucleus C-type lectin receptor signaling pathway 1.1728587138801794 | |
| BCL3 Nucleus TNF signaling pathway 1.1728587138801794 | |
| BCL6 Nucleus Chemical carcinogenesis - receptor activation 1.717671509375258 | |
| BCL6 Nucleus FoxO signaling pathway 1.717671509375258 | |
| BCL6 Nucleus Transcriptional misregulation in cancer 1.717671509375258 | |
| BCL7A Cytosol Summary 1.6037581968400219 | |
| BCL7A Nucleus Summary 1.6037581968400219 | |
| BCL7B Nucleus Summary 1.4200742515418232 | |
| BCL7C Nucleus Summary 1.3152973102949599 | |
| BCL9 Nucleus Summary 1.7874223155429776 | |
| BCL9L Nucleus Summary 1.1615470622248167 | |
| BCLAF1 Nucleus Summary 2.2487025999320682 | |
| BCOR Nucleus Summary 1.2056567369970117 | |
| BCORL1 Nucleus Summary 2.1800255009139344 | |
| BCORL1 Plasma membrane Summary 2.1800255009139344 | |
| BCR Cytosol Summary 1.0518856404738888 | |
| BCR Nucleus Summary 1.0518856404738888 | |
| BCR Plasma membrane Summary 1.0518856404738888 | |
| BCS1L Cytosol Summary 1.676742978636165 | |
| BCS1L Mitochondrion Summary 1.676742978636165 | |
| BDH1 Mitochondrion Butanoate metabolism 0.86960727822844 | |
| BDH1 Mitochondrion Metabolic pathways 0.86960727822844 | |
| BDH1 Mitochondrion Synthesis and degradation of ketone bodies 0.86960727822844 | |
| BDH2 Cytosol Summary 0.9409773144837414 | |
| BDP1 Nucleus Summary 1.495302691918314 | |
| BECN1 Cytoskeleton Summary 0.9828057593388596 | |
| BECN1 Cytosol Summary 0.9828057593388596 | |
| BEND3 Nucleus Summary 3.2119581048639985 | |
| BEND5 Cytosol Summary 1.8258902058457367 | |
| BEND5 Nucleus Summary 1.8258902058457367 | |
| BET1 Endoplasmic Reticulum SNARE interactions in vesicular transport 0.914747892130828 | |
| BET1 Golgi apparatus SNARE interactions in vesicular transport 0.914747892130828 | |
| BET1L Golgi apparatus SNARE interactions in vesicular transport 0.43502293384663415 | |
| BET1L Nucleus SNARE interactions in vesicular transport 0.43502293384663415 | |
| BGN Endoplasmic Reticulum Summary 1.0904219796029064 | |
| BGN Extracellular space Summary 1.0904219796029064 | |
| BGN Golgi apparatus Summary 1.0904219796029064 | |
| BHLHE40 Cytosol Circadian rhythm 0.9040637577225854 | |
| BHLHE40 Nucleus Circadian rhythm 0.9040637577225854 | |
| BICC1 Cytoskeleton Summary 1.3482293000138026 | |
| BICC1 Cytosol Summary 1.3482293000138026 | |
| BICC1 Nucleus Summary 1.3482293000138026 | |
| BICD1 Cytosol Summary 1.7695357526668891 | |
| BICD1 Golgi apparatus Summary 1.7695357526668891 | |
| BICD2 Cytoskeleton Summary 1.940141242324711 | |
| BICD2 Cytosol Summary 1.940141242324711 | |
| BICD2 Golgi apparatus Summary 1.940141242324711 | |
| BICD2 Plasma membrane Summary 1.940141242324711 | |
| BICDL2 Cytoskeleton Summary 1.8607567557474447 | |
| BICDL2 Cytosol Summary 1.8607567557474447 | |
| BID Cytosol Alzheimer disease 1.9381947119152985 | |
| BID Cytosol Amyotrophic lateral sclerosis 1.9381947119152985 | |
| BID Cytosol Apoptosis 1.9381947119152985 | |
| BID Cytosol Apoptosis - multiple species 1.9381947119152985 | |
| BID Cytosol Epstein-Barr virus infection 1.9381947119152985 | |
| BID Cytosol Hepatitis B 1.9381947119152985 | |
| BID Cytosol Hepatitis C 1.9381947119152985 | |
| BID Cytosol Herpes simplex virus 1 infection 1.9381947119152985 | |
| BID Cytosol Human cytomegalovirus infection 1.9381947119152985 | |
| BID Cytosol Human immunodeficiency virus 1 infection 1.9381947119152985 | |
| BID Cytosol Influenza A 1.9381947119152985 | |
| BID Cytosol Kaposi sarcoma-associated herpesvirus infection 1.9381947119152985 | |
| BID Cytosol Lipid and atherosclerosis 1.9381947119152985 | |
| BID Cytosol Measles 1.9381947119152985 | |
| BID Cytosol Natural killer cell mediated cytotoxicity 1.9381947119152985 | |
| BID Cytosol Necroptosis 1.9381947119152985 | |
| BID Cytosol Non-alcoholic fatty liver disease 1.9381947119152985 | |
| BID Cytosol Pathways in cancer 1.9381947119152985 | |
| BID Cytosol Pathways of neurodegeneration - multiple diseases 1.9381947119152985 | |
| BID Cytosol Platinum drug resistance 1.9381947119152985 | |
| BID Cytosol Sphingolipid signaling pathway 1.9381947119152985 | |
| BID Cytosol Tuberculosis 1.9381947119152985 | |
| BID Cytosol Viral myocarditis 1.9381947119152985 | |
| BID Cytosol p53 signaling pathway 1.9381947119152985 | |
| BID Mitochondrion Alzheimer disease 1.9381947119152985 | |
| BID Mitochondrion Amyotrophic lateral sclerosis 1.9381947119152985 | |
| BID Mitochondrion Apoptosis 1.9381947119152985 | |
| BID Mitochondrion Apoptosis - multiple species 1.9381947119152985 | |
| BID Mitochondrion Epstein-Barr virus infection 1.9381947119152985 | |
| BID Mitochondrion Hepatitis B 1.9381947119152985 | |
| BID Mitochondrion Hepatitis C 1.9381947119152985 | |
| BID Mitochondrion Herpes simplex virus 1 infection 1.9381947119152985 | |
| BID Mitochondrion Human cytomegalovirus infection 1.9381947119152985 | |
| BID Mitochondrion Human immunodeficiency virus 1 infection 1.9381947119152985 | |
| BID Mitochondrion Influenza A 1.9381947119152985 | |
| BID Mitochondrion Kaposi sarcoma-associated herpesvirus infection 1.9381947119152985 | |
| BID Mitochondrion Lipid and atherosclerosis 1.9381947119152985 | |
| BID Mitochondrion Measles 1.9381947119152985 | |
| BID Mitochondrion Natural killer cell mediated cytotoxicity 1.9381947119152985 | |
| BID Mitochondrion Necroptosis 1.9381947119152985 | |
| BID Mitochondrion Non-alcoholic fatty liver disease 1.9381947119152985 | |
| BID Mitochondrion Pathways in cancer 1.9381947119152985 | |
| BID Mitochondrion Pathways of neurodegeneration - multiple diseases 1.9381947119152985 | |
| BID Mitochondrion Platinum drug resistance 1.9381947119152985 | |
| BID Mitochondrion Sphingolipid signaling pathway 1.9381947119152985 | |
| BID Mitochondrion Tuberculosis 1.9381947119152985 | |
| BID Mitochondrion Viral myocarditis 1.9381947119152985 | |
| BID Mitochondrion p53 signaling pathway 1.9381947119152985 | |
| BIN2 Plasma membrane Summary 1.7747527750265182 | |
| BIN3 Cytoskeleton Summary 0.5411953833118661 | |
| BIN3 Cytosol Summary 0.5411953833118661 | |
| BIRC2 Cytosol Apoptosis 1.313303531518416 | |
| BIRC2 Cytosol Apoptosis - multiple species 1.313303531518416 | |
| BIRC2 Cytosol Focal adhesion 1.313303531518416 | |
| BIRC2 Cytosol Herpes simplex virus 1 infection 1.313303531518416 | |
| BIRC2 Cytosol Hippo signaling pathway 1.313303531518416 | |
| BIRC2 Cytosol NF-kappa B signaling pathway 1.313303531518416 | |
| BIRC2 Cytosol NOD-like receptor signaling pathway 1.313303531518416 | |
| BIRC2 Cytosol Necroptosis 1.313303531518416 | |
| BIRC2 Cytosol Pathways in cancer 1.313303531518416 | |
| BIRC2 Cytosol Platinum drug resistance 1.313303531518416 | |
| BIRC2 Cytosol Salmonella infection 1.313303531518416 | |
| BIRC2 Cytosol Small cell lung cancer 1.313303531518416 | |
| BIRC2 Cytosol TNF signaling pathway 1.313303531518416 | |
| BIRC2 Cytosol Toxoplasmosis 1.313303531518416 | |
| BIRC2 Cytosol Transcriptional misregulation in cancer 1.313303531518416 | |
| BIRC2 Cytosol Ubiquitin mediated proteolysis 1.313303531518416 | |
| BIRC2 Extracellular space Apoptosis 1.313303531518416 | |
| BIRC2 Extracellular space Apoptosis - multiple species 1.313303531518416 | |
| BIRC2 Extracellular space Focal adhesion 1.313303531518416 | |
| BIRC2 Extracellular space Herpes simplex virus 1 infection 1.313303531518416 | |
| BIRC2 Extracellular space Hippo signaling pathway 1.313303531518416 | |
| BIRC2 Extracellular space NF-kappa B signaling pathway 1.313303531518416 | |
| BIRC2 Extracellular space NOD-like receptor signaling pathway 1.313303531518416 | |
| BIRC2 Extracellular space Necroptosis 1.313303531518416 | |
| BIRC2 Extracellular space Pathways in cancer 1.313303531518416 | |
| BIRC2 Extracellular space Platinum drug resistance 1.313303531518416 | |
| BIRC2 Extracellular space Salmonella infection 1.313303531518416 | |
| BIRC2 Extracellular space Small cell lung cancer 1.313303531518416 | |
| BIRC2 Extracellular space TNF signaling pathway 1.313303531518416 | |
| BIRC2 Extracellular space Toxoplasmosis 1.313303531518416 | |
| BIRC2 Extracellular space Transcriptional misregulation in cancer 1.313303531518416 | |
| BIRC2 Extracellular space Ubiquitin mediated proteolysis 1.313303531518416 | |
| BIRC2 Nucleus Apoptosis 1.313303531518416 | |
| BIRC2 Nucleus Apoptosis - multiple species 1.313303531518416 | |
| BIRC2 Nucleus Focal adhesion 1.313303531518416 | |
| BIRC2 Nucleus Herpes simplex virus 1 infection 1.313303531518416 | |
| BIRC2 Nucleus Hippo signaling pathway 1.313303531518416 | |
| BIRC2 Nucleus NF-kappa B signaling pathway 1.313303531518416 | |
| BIRC2 Nucleus NOD-like receptor signaling pathway 1.313303531518416 | |
| BIRC2 Nucleus Necroptosis 1.313303531518416 | |
| BIRC2 Nucleus Pathways in cancer 1.313303531518416 | |
| BIRC2 Nucleus Platinum drug resistance 1.313303531518416 | |
| BIRC2 Nucleus Salmonella infection 1.313303531518416 | |
| BIRC2 Nucleus Small cell lung cancer 1.313303531518416 | |
| BIRC2 Nucleus TNF signaling pathway 1.313303531518416 | |
| BIRC2 Nucleus Toxoplasmosis 1.313303531518416 | |
| BIRC2 Nucleus Transcriptional misregulation in cancer 1.313303531518416 | |
| BIRC2 Nucleus Ubiquitin mediated proteolysis 1.313303531518416 | |
| BIRC5 Cytoskeleton Apoptosis 3.2776685785315665 | |
| BIRC5 Cytoskeleton Apoptosis - multiple species 3.2776685785315665 | |
| BIRC5 Cytoskeleton Chemical carcinogenesis - receptor activation 3.2776685785315665 | |
| BIRC5 Cytoskeleton Colorectal cancer 3.2776685785315665 | |
| BIRC5 Cytoskeleton Hepatitis B 3.2776685785315665 | |
| BIRC5 Cytoskeleton Hippo signaling pathway 3.2776685785315665 | |
| BIRC5 Cytoskeleton Pathways in cancer 3.2776685785315665 | |
| BIRC5 Cytoskeleton Platinum drug resistance 3.2776685785315665 | |
| BIRC5 Cytosol Apoptosis 3.2776685785315665 | |
| BIRC5 Cytosol Apoptosis - multiple species 3.2776685785315665 | |
| BIRC5 Cytosol Chemical carcinogenesis - receptor activation 3.2776685785315665 | |
| BIRC5 Cytosol Colorectal cancer 3.2776685785315665 | |
| BIRC5 Cytosol Hepatitis B 3.2776685785315665 | |
| BIRC5 Cytosol Hippo signaling pathway 3.2776685785315665 | |
| BIRC5 Cytosol Pathways in cancer 3.2776685785315665 | |
| BIRC5 Cytosol Platinum drug resistance 3.2776685785315665 | |
| BIRC5 Nucleus Apoptosis 3.2776685785315665 | |
| BIRC5 Nucleus Apoptosis - multiple species 3.2776685785315665 | |
| BIRC5 Nucleus Chemical carcinogenesis - receptor activation 3.2776685785315665 | |
| BIRC5 Nucleus Colorectal cancer 3.2776685785315665 | |
| BIRC5 Nucleus Hepatitis B 3.2776685785315665 | |
| BIRC5 Nucleus Hippo signaling pathway 3.2776685785315665 | |
| BIRC5 Nucleus Pathways in cancer 3.2776685785315665 | |
| BIRC5 Nucleus Platinum drug resistance 3.2776685785315665 | |
| BIRC6 Cytoskeleton Apoptosis - multiple species 1.1223404066277451 | |
| BIRC6 Cytoskeleton Ubiquitin mediated proteolysis 1.1223404066277451 | |
| BIRC6 Cytosol Apoptosis - multiple species 1.1223404066277451 | |
| BIRC6 Cytosol Ubiquitin mediated proteolysis 1.1223404066277451 | |
| BIRC6 Endosome Apoptosis - multiple species 1.1223404066277451 | |
| BIRC6 Endosome Ubiquitin mediated proteolysis 1.1223404066277451 | |
| BIRC6 Golgi apparatus Apoptosis - multiple species 1.1223404066277451 | |
| BIRC6 Golgi apparatus Ubiquitin mediated proteolysis 1.1223404066277451 | |
| BIRC6 Mitochondrion Apoptosis - multiple species 1.1223404066277451 | |
| BIRC6 Mitochondrion Ubiquitin mediated proteolysis 1.1223404066277451 | |
| BLK Nucleus Summary 2.708686607110622 | |
| BLK Plasma membrane Summary 2.708686607110622 | |
| BLM Cytosol Fanconi anemia pathway 2.255065050156726 | |
| BLM Cytosol Homologous recombination 2.255065050156726 | |
| BLM Nucleus Fanconi anemia pathway 2.255065050156726 | |
| BLM Nucleus Homologous recombination 2.255065050156726 | |
| BLMH Cytosol Summary 1.7436631619297485 | |
| BLMH Nucleus Summary 1.7436631619297485 | |
| BLNK Cytosol B cell receptor signaling pathway 1.151172132939437 | |
| BLNK Cytosol Epstein-Barr virus infection 1.151172132939437 | |
| BLNK Cytosol NF-kappa B signaling pathway 1.151172132939437 | |
| BLNK Cytosol Osteoclast differentiation 1.151172132939437 | |
| BLNK Cytosol Primary immunodeficiency 1.151172132939437 | |
| BLNK Nucleus B cell receptor signaling pathway 1.151172132939437 | |
| BLNK Nucleus Epstein-Barr virus infection 1.151172132939437 | |
| BLNK Nucleus NF-kappa B signaling pathway 1.151172132939437 | |
| BLNK Nucleus Osteoclast differentiation 1.151172132939437 | |
| BLNK Nucleus Primary immunodeficiency 1.151172132939437 | |
| BLNK Plasma membrane B cell receptor signaling pathway 1.151172132939437 | |
| BLNK Plasma membrane Epstein-Barr virus infection 1.151172132939437 | |
| BLNK Plasma membrane NF-kappa B signaling pathway 1.151172132939437 | |
| BLNK Plasma membrane Osteoclast differentiation 1.151172132939437 | |
| BLNK Plasma membrane Primary immunodeficiency 1.151172132939437 | |
| BLOC1S1 Mitochondrion Summary 1.5646781194813817 | |
| BLOC1S2 Cytosol Summary 1.2466544552943009 | |
| BLOC1S3 Cytosol Summary 0.9533751980443576 | |
| BLOC1S3 Golgi apparatus Summary 0.9533751980443576 | |
| BLOC1S4 Cytosol Summary 1.2226716706366472 | |
| BLOC1S5 Cytosol Summary 1.0116363514972218 | |
| BLOC1S6 Cytosol Summary 1.457075567809368 | |
| BLVRA Cytosol Summary 0.5304472514348952 | |
| BLVRB Cytosol Metabolic pathways 1.363855002497282 | |
| BLVRB Cytosol Porphyrin and chlorophyll metabolism 1.363855002497282 | |
| BLVRB Cytosol Riboflavin metabolism 1.363855002497282 | |
| BLVRB Nucleus Metabolic pathways 1.363855002497282 | |
| BLVRB Nucleus Porphyrin and chlorophyll metabolism 1.363855002497282 | |
| BLVRB Nucleus Riboflavin metabolism 1.363855002497282 | |
| BLVRB Plasma membrane Metabolic pathways 1.363855002497282 | |
| BLVRB Plasma membrane Porphyrin and chlorophyll metabolism 1.363855002497282 | |
| BLVRB Plasma membrane Riboflavin metabolism 1.363855002497282 | |
| BLZF1 Golgi apparatus Summary 1.0306235022161387 | |
| BLZF1 Nucleus Summary 1.0306235022161387 | |
| BMF Nucleus Summary 1.1368419095091256 | |
| BMP1 Golgi apparatus Summary 2.8037614277163185 | |
| BMP1 Plasma membrane Summary 2.8037614277163185 | |
| BMP2K Nucleus Summary 0.9767542652274565 | |
| BMPER Extracellular space Summary 0.17115548713590906 | |
| BMPR2 Nucleus Summary 1.0302705550584006 | |
| BMPR2 Plasma membrane Summary 1.0302705550584006 | |
| BMS1 Mitochondrion Summary 2.108348679487774 | |
| BMS1 Nucleus Summary 2.108348679487774 | |
| BNIP1 Endoplasmic Reticulum SNARE interactions in vesicular transport 0.6591837186494364 | |
| BNIP1 Mitochondrion SNARE interactions in vesicular transport 0.6591837186494364 | |
| BNIP1 Nucleus SNARE interactions in vesicular transport 0.6591837186494364 | |
| BNIP2 Cytosol Summary 1.7897877514906066 | |
| BNIP2 Nucleus Summary 1.7897877514906066 | |
| BNIP3 Cytosol Autophagy - animal 1.3206244220100525 | |
| BNIP3 Cytosol FoxO signaling pathway 1.3206244220100525 | |
| BNIP3 Cytosol Legionellosis 1.3206244220100525 | |
| BNIP3 Cytosol Mitophagy - animal 1.3206244220100525 | |
| BNIP3 Cytosol Shigellosis 1.3206244220100525 | |
| BNIP3 Mitochondrion Autophagy - animal 1.3206244220100525 | |
| BNIP3 Mitochondrion FoxO signaling pathway 1.3206244220100525 | |
| BNIP3 Mitochondrion Legionellosis 1.3206244220100525 | |
| BNIP3 Mitochondrion Mitophagy - animal 1.3206244220100525 | |
| BNIP3 Mitochondrion Shigellosis 1.3206244220100525 | |
| BNIP3 Nucleus Autophagy - animal 1.3206244220100525 | |
| BNIP3 Nucleus FoxO signaling pathway 1.3206244220100525 | |
| BNIP3 Nucleus Legionellosis 1.3206244220100525 | |
| BNIP3 Nucleus Mitophagy - animal 1.3206244220100525 | |
| BNIP3 Nucleus Shigellosis 1.3206244220100525 | |
| BNIP3L Endoplasmic Reticulum Mitophagy - animal 0.5974947264935966 | |
| BNIP3L Mitochondrion Mitophagy - animal 0.5974947264935966 | |
| BNIP3L Nucleus Mitophagy - animal 0.5974947264935966 | |
| BOD1 Cytoskeleton Summary 1.1188455560658015 | |
| BOD1 Cytosol Summary 1.1188455560658015 | |
| BOD1L1 Nucleus Summary 0.9618883384063336 | |
| BOD1L2 Cytosol Summary 1.3607747408594297 | |
| BOK Mitochondrion Apoptosis - multiple species 0.602780521271182 | |
| BOK Nucleus Apoptosis - multiple species 0.602780521271182 | |
| BOLA1 Extracellular space Summary 2.1979857041649757 | |
| BOLA1 Mitochondrion Summary 2.1979857041649757 | |
| BOLA2 Cytosol Summary 1.7544271172006016 | |
| BOLA2 Nucleus Summary 1.7544271172006016 | |
| BOLA3 Cytosol Summary 1.2202059018762683 | |
| BOLA3 Extracellular space Summary 1.2202059018762683 | |
| BOLA3 Mitochondrion Summary 1.2202059018762683 | |
| BOLA3 Nucleus Summary 1.2202059018762683 | |
| BOP1 Mitochondrion Summary 2.4523261876251103 | |
| BOP1 Nucleus Summary 2.4523261876251103 | |
| BORCS5 Cytosol Summary 1.1851165687305736 | |
| BORCS5 Lysosome Summary 1.1851165687305736 | |
| BORCS5 Plasma membrane Summary 1.1851165687305736 | |
| BORCS6 Cytosol Summary 0.994267962463047 | |
| BORCS6 Golgi apparatus Summary 0.994267962463047 | |
| BORCS6 Lysosome Summary 0.994267962463047 | |
| BORCS7 Cytosol Summary 1.3279887036027662 | |
| BORCS7 Lysosome Summary 1.3279887036027662 | |
| BORCS7 Nucleus Summary 1.3279887036027662 | |
| BORCS8 Cytosol Summary 1.5878998795027215 | |
| BORCS8 Lysosome Summary 1.5878998795027215 | |
| BORCS8 Nucleus Summary 1.5878998795027215 | |
| BPGM Nucleus Summary 1.4745225902255323 | |
| BPHL Mitochondrion Summary 1.640334564578123 | |
| BPHL Nucleus Summary 1.640334564578123 | |
| BPI Extracellular space Summary 1.00425834261346 | |
| BPIFB2 Cytosol Summary 0.9640487997980616 | |
| BPNT1 Nucleus Summary 1.2659882333080301 | |
| BPTF Nucleus Summary 1.1513259852577462 | |
| BRAF Cytosol Summary 0.8201726331883844 | |
| BRAP Cytosol Summary 1.1619574464842186 | |
| BRAP Nucleus Summary 1.1619574464842186 | |
| BRAT1 Nucleus Summary 1.3440561919989893 | |
| BRCA1 Cytoskeleton Breast cancer 1.5148990468718837 | |
| BRCA1 Cytoskeleton Fanconi anemia pathway 1.5148990468718837 | |
| BRCA1 Cytoskeleton Homologous recombination 1.5148990468718837 | |
| BRCA1 Cytoskeleton MicroRNAs in cancer 1.5148990468718837 | |
| BRCA1 Cytoskeleton PI3K-Akt signaling pathway 1.5148990468718837 | |
| BRCA1 Cytoskeleton Platinum drug resistance 1.5148990468718837 | |
| BRCA1 Cytoskeleton Ubiquitin mediated proteolysis 1.5148990468718837 | |
| BRCA1 Nucleus Breast cancer 1.5148990468718837 | |
| BRCA1 Nucleus Fanconi anemia pathway 1.5148990468718837 | |
| BRCA1 Nucleus Homologous recombination 1.5148990468718837 | |
| BRCA1 Nucleus MicroRNAs in cancer 1.5148990468718837 | |
| BRCA1 Nucleus PI3K-Akt signaling pathway 1.5148990468718837 | |
| BRCA1 Nucleus Platinum drug resistance 1.5148990468718837 | |
| BRCA1 Nucleus Ubiquitin mediated proteolysis 1.5148990468718837 | |
| BRCA2 Cytoskeleton Breast cancer 1.6104692380582497 | |
| BRCA2 Cytoskeleton Fanconi anemia pathway 1.6104692380582497 | |
| BRCA2 Cytoskeleton Homologous recombination 1.6104692380582497 | |
| BRCA2 Cytoskeleton Pancreatic cancer 1.6104692380582497 | |
| BRCA2 Cytoskeleton Pathways in cancer 1.6104692380582497 | |
| BRCA2 Cytosol Breast cancer 1.6104692380582497 | |
| BRCA2 Cytosol Fanconi anemia pathway 1.6104692380582497 | |
| BRCA2 Cytosol Homologous recombination 1.6104692380582497 | |
| BRCA2 Cytosol Pancreatic cancer 1.6104692380582497 | |
| BRCA2 Cytosol Pathways in cancer 1.6104692380582497 | |
| BRCA2 Nucleus Breast cancer 1.6104692380582497 | |
| BRCA2 Nucleus Fanconi anemia pathway 1.6104692380582497 | |
| BRCA2 Nucleus Homologous recombination 1.6104692380582497 | |
| BRCA2 Nucleus Pancreatic cancer 1.6104692380582497 | |
| BRCA2 Nucleus Pathways in cancer 1.6104692380582497 | |
| BRCC3 Nucleus Homologous recombination 0.8555396164898612 | |
| BRCC3 Nucleus NOD-like receptor signaling pathway 0.8555396164898612 | |
| BRD1 Nucleus Summary 1.5074322137460177 | |
| BRD2 Nucleus Summary 1.295368689042344 | |
| BRD3 Nucleus Summary 1.1795111726905951 | |
| BRD4 Nucleus Summary 1.8489719158477345 | |
| BRD7 Cytosol Hepatocellular carcinoma 1.3199044289464823 | |
| BRD7 Nucleus Hepatocellular carcinoma 1.3199044289464823 | |
| BRD8 Mitochondrion Summary 1.4022120362681552 | |
| BRD8 Nucleus Summary 1.4022120362681552 | |
| BRD9 Nucleus Summary 1.4331181396105082 | |
| BRDT Nucleus Summary 1.2932072884261951 | |
| BRE Cytosol Summary 0.9397926314639731 | |
| BRF1 Nucleus Cellular senescence 1.0617291297870326 | |
| BRI3BP Mitochondrion Summary 0.8927573573701798 | |
| BRI3BP Nucleus Summary 0.8927573573701798 | |
| BRIP1 Nucleus Fanconi anemia pathway 3.70756984045707 | |
| BRIP1 Nucleus Homologous recombination 3.70756984045707 | |
| BRIP1 Nucleus Ribosome 3.70756984045707 | |
| BRIX1 Mitochondrion Summary 2.4796293393549753 | |
| BRIX1 Nucleus Summary 2.4796293393549753 | |
| BRK1 Cytosol Summary 1.6271525922339043 | |
| BRK1 Nucleus Summary 1.6271525922339043 | |
| BRK1 Plasma membrane Summary 1.6271525922339043 | |
| BRMS1 Cytoskeleton Summary 1.5104589698249735 | |
| BRMS1 Nucleus Summary 1.5104589698249735 | |
| BRMS1L Nucleus Summary 1.9857725227929672 | |
| BROX Cytosol Summary 1.1019624725385968 | |
| BROX Golgi apparatus Summary 1.1019624725385968 | |
| BROX Nucleus Summary 1.1019624725385968 | |
| BRPF1 Cytosol Summary 1.2084487183386343 | |
| BRPF1 Nucleus Summary 1.2084487183386343 | |
| BRPF1 Plasma membrane Summary 1.2084487183386343 | |
| BRPF3 Mitochondrion Summary 1.0743609844411866 | |
| BRPF3 Nucleus Summary 1.0743609844411866 | |
| BRWD1 Cytosol Summary 0.8962365129699488 | |
| BRWD1 Nucleus Summary 0.8962365129699488 | |
| BRWD3 Cytosol Summary 0.8799886957765133 | |
| BRWD3 Nucleus Summary 0.8799886957765133 | |
| BSCL2 Endoplasmic Reticulum Summary 0.1978044293151065 | |
| BSDC1 Golgi apparatus Summary 1.0422445737765385 | |
| BSDC1 Plasma membrane Summary 1.0422445737765385 | |
| BSG Cytosol Summary 2.721904341481784 | |
| BSG Plasma membrane Summary 2.721904341481784 | |
| BSN Cytoskeleton Summary 1.069589457302903 | |
| BSN Cytosol Summary 1.069589457302903 | |
| BSPRY Cytosol Summary 0.4671854179908104 | |
| BSPRY Nucleus Summary 0.4671854179908104 | |
| BST1 Plasma membrane Metabolic pathways 1.3636864557992894 | |
| BST1 Plasma membrane Nicotinate and nicotinamide metabolism 1.3636864557992894 | |
| BST1 Plasma membrane Pancreatic secretion 1.3636864557992894 | |
| BST1 Plasma membrane Salivary secretion 1.3636864557992894 | |
| BST2 Cytosol Herpes simplex virus 1 infection 0.5455568638967331 | |
| BST2 Cytosol Human immunodeficiency virus 1 infection 0.5455568638967331 | |
| BST2 Endosome Herpes simplex virus 1 infection 0.5455568638967331 | |
| BST2 Endosome Human immunodeficiency virus 1 infection 0.5455568638967331 | |
| BST2 Golgi apparatus Herpes simplex virus 1 infection 0.5455568638967331 | |
| BST2 Golgi apparatus Human immunodeficiency virus 1 infection 0.5455568638967331 | |
| BST2 Plasma membrane Herpes simplex virus 1 infection 0.5455568638967331 | |
| BST2 Plasma membrane Human immunodeficiency virus 1 infection 0.5455568638967331 | |
| BTAF1 Cytosol Summary 1.2022105894665964 | |
| BTAF1 Nucleus Summary 1.2022105894665964 | |
| BTBD1 Cytosol Summary 1.6801148742761234 | |
| BTBD1 Nucleus Summary 1.6801148742761234 | |
| BTBD10 Nucleus Summary 1.3852705329600838 | |
| BTBD16 Cytosol Summary 0.9220092094785696 | |
| BTBD16 Nucleus Summary 0.9220092094785696 | |
| BTBD2 Cytosol Summary 0.816512547823962 | |
| BTBD9 Nucleus Summary 1.652905705218665 | |
| BTD Extracellular space Biotin metabolism 0.9243162339202384 | |
| BTD Extracellular space Metabolic pathways 0.9243162339202384 | |
| BTD Extracellular space Vitamin digestion and absorption 0.9243162339202384 | |
| BTF3 Cytosol Summary 1.4590685221815836 | |
| BTF3 Nucleus Summary 1.4590685221815836 | |
| BTF3L4 Cytosol Summary 1.7274296395596278 | |
| BTF3L4 Nucleus Summary 1.7274296395596278 | |
| BTK Cytosol B cell receptor signaling pathway 1.5702295958044767 | |
| BTK Cytosol Epstein-Barr virus infection 1.5702295958044767 | |
| BTK Cytosol Fc epsilon RI signaling pathway 1.5702295958044767 | |
| BTK Cytosol NF-kappa B signaling pathway 1.5702295958044767 | |
| BTK Cytosol Osteoclast differentiation 1.5702295958044767 | |
| BTK Cytosol Platelet activation 1.5702295958044767 | |
| BTK Cytosol Primary immunodeficiency 1.5702295958044767 | |
| BTK Nucleus B cell receptor signaling pathway 1.5702295958044767 | |
| BTK Nucleus Epstein-Barr virus infection 1.5702295958044767 | |
| BTK Nucleus Fc epsilon RI signaling pathway 1.5702295958044767 | |
| BTK Nucleus NF-kappa B signaling pathway 1.5702295958044767 | |
| BTK Nucleus Osteoclast differentiation 1.5702295958044767 | |
| BTK Nucleus Platelet activation 1.5702295958044767 | |
| BTK Nucleus Primary immunodeficiency 1.5702295958044767 | |
| BTK Plasma membrane B cell receptor signaling pathway 1.5702295958044767 | |
| BTK Plasma membrane Epstein-Barr virus infection 1.5702295958044767 | |
| BTK Plasma membrane Fc epsilon RI signaling pathway 1.5702295958044767 | |
| BTK Plasma membrane NF-kappa B signaling pathway 1.5702295958044767 | |
| BTK Plasma membrane Osteoclast differentiation 1.5702295958044767 | |
| BTK Plasma membrane Platelet activation 1.5702295958044767 | |
| BTK Plasma membrane Primary immunodeficiency 1.5702295958044767 | |
| BTN2A1 Plasma membrane Summary 2.3484047581464225 | |
| BTN3A1 Cytosol Summary 1.7834922760521534 | |
| BTN3A1 Plasma membrane Summary 1.7834922760521534 | |
| BTN3A3 Plasma membrane Summary 1.5531205069057163 | |
| BUB1 Cytosol Cell cycle 1.130063990899572 | |
| BUB1 Cytosol Oocyte meiosis 1.130063990899572 | |
| BUB1 Cytosol Progesterone-mediated oocyte maturation 1.130063990899572 | |
| BUB1 Nucleus Cell cycle 1.130063990899572 | |
| BUB1 Nucleus Oocyte meiosis 1.130063990899572 | |
| BUB1 Nucleus Progesterone-mediated oocyte maturation 1.130063990899572 | |
| BUB1B Cytoskeleton Cell cycle 2.0996130365479617 | |
| BUB1B Cytoskeleton Human T-cell leukemia virus 1 infection 2.0996130365479617 | |
| BUB1B Cytosol Cell cycle 2.0996130365479617 | |
| BUB1B Cytosol Human T-cell leukemia virus 1 infection 2.0996130365479617 | |
| BUB1B Nucleus Cell cycle 2.0996130365479617 | |
| BUB1B Nucleus Human T-cell leukemia virus 1 infection 2.0996130365479617 | |
| BUB1B-PAK6 Nucleus Summary 0.7470590260087586 | |
| BUB1B-PAK6 Plasma membrane Summary 0.7470590260087586 | |
| BUD13 Nucleus Summary 2.147431355898429 | |
| BUD31 Cytoskeleton Summary 1.7300700126512252 | |
| BUD31 Nucleus Summary 1.7300700126512252 | |
| BYSL Cytosol Summary 1.9157721808860932 | |
| BYSL Mitochondrion Summary 1.9157721808860932 | |
| BYSL Nucleus Summary 1.9157721808860932 | |
| BZW1 Cytosol Summary 0.5789893004783582 | |
| BZW2 Cytoskeleton Summary 1.017147843141125 | |
| BZW2 Cytosol Summary 1.017147843141125 | |
| BZW2 Plasma membrane Summary 1.017147843141125 | |
| C10orf11 Nucleus Summary 1.2362092189715124 | |
| C10orf12 Nucleus Summary 2.7066205197034217 | |
| C10orf35 Nucleus Summary 1.802886610603667 | |
| C10orf54 Nucleus Summary 1.5399224918350285 | |
| C10orf76 Cytosol Summary 0.6513964943448872 | |
| C10orf88 Cytosol Summary 1.1722065371221175 | |
| C11orf31 Nucleus Summary 1.4901266275396885 | |
| C11orf52 Plasma membrane Summary 0.42003533784260016 | |
| C11orf54 Nucleus Summary 1.2004924415989089 | |
| C11orf57 Cytosol Summary 2.3432522800207125 | |
| C11orf58 Endoplasmic Reticulum Summary 1.0466887501192383 | |
| C11orf58 Nucleus Summary 1.0466887501192383 | |
| C11orf68 Nucleus Summary 1.2553078792829908 | |
| C11orf84 Nucleus Summary 2.08271001845577 | |
| C11orf96 Cytosol Summary 1.9869109140090235 | |
| C11orf96 Nucleus Summary 1.9869109140090235 | |
| C12orf10 Nucleus Summary 0.811316286065215 | |
| C12orf29 Cytosol Summary 1.0777169546802041 | |
| C12orf4 Cytosol Summary 0.7619585509928272 | |
| C12orf4 Nucleus Summary 0.7619585509928272 | |
| C12orf43 Golgi apparatus Summary 1.397018174648944 | |
| C12orf43 Nucleus Summary 1.397018174648944 | |
| C12orf45 Nucleus Summary 1.6417598641179567 | |
| C12orf57 Cytosol Summary 1.015228450599879 | |
| C12orf57 Nucleus Summary 1.015228450599879 | |
| C12orf66 Lysosome Summary 0.5034536069312173 | |
| C12orf66 Mitochondrion Summary 0.5034536069312173 | |
| C12orf75 Cytosol Summary 0.3632650904102916 | |
| C14orf119 Cytosol Summary 1.5787110274597025 | |
| C14orf119 Mitochondrion Summary 1.5787110274597025 | |
| C14orf159 Cytosol Summary 0.9119317587604006 | |
| C14orf169 Nucleus Summary 1.1563239366706686 | |
| C14orf2 Nucleus Summary 2.1546098733004158 | |
| C15orf38-AP3S2 Cytosol Summary 1.1379707936820658 | |
| C15orf39 Cytosol Summary 1.879062412610039 | |
| C15orf40 Cytosol Summary 1.0381013539967792 | |
| C15orf40 Nucleus Summary 1.0381013539967792 | |
| C15orf48 Mitochondrion Summary 1.4746610753566076 | |
| C15orf48 Nucleus Summary 1.4746610753566076 | |
| C15orf52 Nucleus Summary 1.5783871736101405 | |
| C15orf57 Nucleus Summary 0.916994234914117 | |
| C16orf46 Cytosol Summary 1.233147372917642 | |
| C16orf46 Nucleus Summary 1.233147372917642 | |
| C16orf58 Cytosol Summary 0.4823768964883627 | |
| C16orf58 Golgi apparatus Summary 0.4823768964883627 | |
| C16orf58 Nucleus Summary 0.4823768964883627 | |
| C16orf62 Mitochondrion Summary 0.8529040748536781 | |
| C16orf70 Cytosol Summary 0.998179047714114 | |
| C16orf70 Nucleus Summary 0.998179047714114 | |
| C17orf49 Cytosol Summary 1.6187148866258014 | |
| C17orf49 Nucleus Summary 1.6187148866258014 | |
| C17orf62 Plasma membrane Summary 0.7083130263630778 | |
| C17orf75 Cytosol Summary 0.914626739679252 | |
| C17orf75 Golgi apparatus Summary 0.914626739679252 | |
| C17orf80 Cytosol Summary 1.0380463531698203 | |
| C17orf80 Nucleus Summary 1.0380463531698203 | |
| C17orf97 Cytosol Summary 1.3259787278302648 | |
| C17orf97 Nucleus Summary 1.3259787278302648 | |
| C18orf21 Nucleus Summary 1.514285139219684 | |
| C18orf21 Plasma membrane Summary 1.514285139219684 | |
| C18orf25 Cytosol Summary 1.3800558829078724 | |
| C18orf25 Nucleus Summary 1.3800558829078724 | |
| C18orf32 Cytosol Summary 0.4870618368077549 | |
| C18orf32 Nucleus Summary 0.4870618368077549 | |
| C18orf63 Mitochondrion Summary 0.8409145613230868 | |
| C18orf8 Nucleus Summary 1.264207414679812 | |
| C19orf12 Cytosol Summary 0.8072669488317579 | |
| C19orf12 Mitochondrion Summary 0.8072669488317579 | |
| C19orf25 Cytoskeleton Summary 0.866321197709806 | |
| C19orf33 Cytosol Summary 0.3744081376567797 | |
| C19orf33 Nucleus Summary 0.3744081376567797 | |
| C19orf33 Plasma membrane Summary 0.3744081376567797 | |
| C19orf43 Nucleus Summary 1.565027102475886 | |
| C19orf47 Nucleus Summary 1.6634891633595483 | |
| C19orf52 Nucleus Summary 0.8412990658593055 | |
| C19orf53 Nucleus Summary 1.005143336267265 | |
| C19orf54 Cytoskeleton Summary 1.725604863445832 | |
| C19orf66 Cytosol Summary 1.4421217509446185 | |
| C19orf66 Nucleus Summary 1.4421217509446185 | |
| C19orf70 Mitochondrion Summary 1.6782536429569632 | |
| C19orf70 Nucleus Summary 1.6782536429569632 | |
| C1D Nucleus RNA degradation 1.3821188716301445 | |
| C1QA Extracellular space Chagas disease 1.7304358667512356 | |
| C1QA Extracellular space Complement and coagulation cascades 1.7304358667512356 | |
| C1QA Extracellular space Coronavirus disease - COVID-19 1.7304358667512356 | |
| C1QA Extracellular space Pertussis 1.7304358667512356 | |
| C1QA Extracellular space Prion disease 1.7304358667512356 | |
| C1QA Extracellular space Staphylococcus aureus infection 1.7304358667512356 | |
| C1QA Extracellular space Systemic lupus erythematosus 1.7304358667512356 | |
| C1QA Golgi apparatus Chagas disease 1.7304358667512356 | |
| C1QA Golgi apparatus Complement and coagulation cascades 1.7304358667512356 | |
| C1QA Golgi apparatus Coronavirus disease - COVID-19 1.7304358667512356 | |
| C1QA Golgi apparatus Pertussis 1.7304358667512356 | |
| C1QA Golgi apparatus Prion disease 1.7304358667512356 | |
| C1QA Golgi apparatus Staphylococcus aureus infection 1.7304358667512356 | |
| C1QA Golgi apparatus Systemic lupus erythematosus 1.7304358667512356 | |
| C1QBP Mitochondrion Summary 1.7459686283613525 | |
| C1QBP Nucleus Summary 1.7459686283613525 | |
| C1QBP Plasma membrane Summary 1.7459686283613525 | |
| C1QC Cytosol Chagas disease 1.9651459887752627 | |
| C1QC Cytosol Complement and coagulation cascades 1.9651459887752627 | |
| C1QC Cytosol Coronavirus disease - COVID-19 1.9651459887752627 | |
| C1QC Cytosol Pertussis 1.9651459887752627 | |
| C1QC Cytosol Prion disease 1.9651459887752627 | |
| C1QC Cytosol Staphylococcus aureus infection 1.9651459887752627 | |
| C1QC Cytosol Systemic lupus erythematosus 1.9651459887752627 | |
| C1QC Extracellular space Chagas disease 1.9651459887752627 | |
| C1QC Extracellular space Complement and coagulation cascades 1.9651459887752627 | |
| C1QC Extracellular space Coronavirus disease - COVID-19 1.9651459887752627 | |
| C1QC Extracellular space Pertussis 1.9651459887752627 | |
| C1QC Extracellular space Prion disease 1.9651459887752627 | |
| C1QC Extracellular space Staphylococcus aureus infection 1.9651459887752627 | |
| C1QC Extracellular space Systemic lupus erythematosus 1.9651459887752627 | |
| C1QTNF3 Golgi apparatus Summary 0.419915440710918 | |
| C1QTNF6 Nucleus Summary 0.9205986104655438 | |
| C1R Cytosol Summary 2.315464285961516 | |
| C1R Nucleus Summary 2.315464285961516 | |
| C1RL Cytosol Summary 1.8724053753716292 | |
| C1RL Extracellular space Summary 1.8724053753716292 | |
| C1S Cytosol Summary 2.6326056097501023 | |
| C1S Nucleus Summary 2.6326056097501023 | |
| C1orf109 Cytosol Summary 1.7442729703774054 | |
| C1orf109 Nucleus Summary 1.7442729703774054 | |
| C1orf116 Cytosol Summary 1.7754899729874207 | |
| C1orf116 Plasma membrane Summary 1.7754899729874207 | |
| C1orf123 Cytosol Summary 1.0272583912380298 | |
| C1orf123 Mitochondrion Summary 1.0272583912380298 | |
| C1orf131 Nucleus Summary 1.9611480027370225 | |
| C1orf174 Nucleus Summary 1.6422421162062413 | |
| C1orf198 Cytosol Summary 1.5475602016618513 | |
| C1orf21 Cytosol Summary 0.13442824233732933 | |
| C1orf21 Nucleus Summary 0.13442824233732933 | |
| C1orf226 Nucleus Summary 0.8340680592771125 | |
| C1orf27 Nucleus Summary 0.4831698923440677 | |
| C1orf35 Cytosol Summary 1.8270611680441804 | |
| C1orf35 Nucleus Summary 1.8270611680441804 | |
| C1orf35 Plasma membrane Summary 1.8270611680441804 | |
| C1orf52 Nucleus Summary 1.7985702782427981 | |
| C2 Extracellular space Complement and coagulation cascades 2.2421406199432967 | |
| C2 Extracellular space Coronavirus disease - COVID-19 2.2421406199432967 | |
| C2 Extracellular space Pertussis 2.2421406199432967 | |
| C2 Extracellular space Spliceosome 2.2421406199432967 | |
| C2 Extracellular space Staphylococcus aureus infection 2.2421406199432967 | |
| C2 Extracellular space Systemic lupus erythematosus 2.2421406199432967 | |
| C20orf24 Cytosol Summary 1.6869276260357398 | |
| C20orf27 Cytosol Summary 1.3302004188500065 | |
| C20orf27 Nucleus Summary 1.3302004188500065 | |
| C21orf2 Cytosol Summary 1.1456214329872438 | |
| C21orf2 Mitochondrion Summary 1.1456214329872438 | |
| C21orf2 Nucleus Summary 1.1456214329872438 | |
| C21orf33 Cytoskeleton Summary 1.391774836580311 | |
| C21orf33 Mitochondrion Summary 1.391774836580311 | |
| C2CD2 Cytosol Summary 1.0936740330963792 | |
| C2CD2 Nucleus Summary 1.0936740330963792 | |
| C2CD2L Cytosol Summary 0.5586529805633216 | |
| C2CD2L Endoplasmic Reticulum Summary 0.5586529805633216 | |
| C2CD2L Nucleus Summary 0.5586529805633216 | |
| C2CD3 Cytoskeleton Summary 1.2826678500141937 | |
| C2CD3 Cytosol Summary 1.2826678500141937 | |
| C2CD3 Nucleus Summary 1.2826678500141937 | |
| C2CD5 Cytosol Summary 1.0117734382958752 | |
| C2orf16 Nucleus Summary 0.7409566476144097 | |
| C2orf47 Mitochondrion Summary 1.7285042786534763 | |
| C2orf49 Mitochondrion Summary 1.2692654934549448 | |
| C2orf49 Nucleus Summary 1.2692654934549448 | |
| C2orf54 Golgi apparatus Summary 1.1382882285178728 | |
| C2orf54 Nucleus Summary 1.1382882285178728 | |
| C2orf68 Mitochondrion Summary 1.5925793707095088 | |
| C2orf68 Nucleus Summary 1.5925793707095088 | |
| C2orf72 Nucleus Summary 1.6045764491755157 | |
| C2orf72 Plasma membrane Summary 1.6045764491755157 | |
| C2orf76 Endoplasmic Reticulum Summary 1.2020113152842855 | |
| C3 Extracellular space Chagas disease 2.166066944692321 | |
| C3 Extracellular space Complement and coagulation cascades 2.166066944692321 | |
| C3 Extracellular space Coronavirus disease - COVID-19 2.166066944692321 | |
| C3 Extracellular space Herpes simplex virus 1 infection 2.166066944692321 | |
| C3 Extracellular space Kaposi sarcoma-associated herpesvirus infection 2.166066944692321 | |
| C3 Extracellular space Legionellosis 2.166066944692321 | |
| C3 Extracellular space Leishmaniasis 2.166066944692321 | |
| C3 Extracellular space Neuroactive ligand-receptor interaction 2.166066944692321 | |
| C3 Extracellular space Neutrophil extracellular trap formation 2.166066944692321 | |
| C3 Extracellular space Pertussis 2.166066944692321 | |
| C3 Extracellular space Phagosome 2.166066944692321 | |
| C3 Extracellular space Shigellosis 2.166066944692321 | |
| C3 Extracellular space Staphylococcus aureus infection 2.166066944692321 | |
| C3 Extracellular space Systemic lupus erythematosus 2.166066944692321 | |
| C3 Extracellular space Tuberculosis 2.166066944692321 | |
| C3 Extracellular space Viral carcinogenesis 2.166066944692321 | |
| C3orf38 Cytosol Summary 0.8853067166420906 | |
| C3orf38 Nucleus Summary 0.8853067166420906 | |
| C3orf38 Plasma membrane Summary 0.8853067166420906 | |
| C4A Extracellular space Complement and coagulation cascades 1.050101264851864 | |
| C4A Extracellular space Coronavirus disease - COVID-19 1.050101264851864 | |
| C4A Extracellular space Pertussis 1.050101264851864 | |
| C4A Extracellular space Staphylococcus aureus infection 1.050101264851864 | |
| C4A Extracellular space Systemic lupus erythematosus 1.050101264851864 | |
| C4A Plasma membrane Complement and coagulation cascades 1.050101264851864 | |
| C4A Plasma membrane Coronavirus disease - COVID-19 1.050101264851864 | |
| C4A Plasma membrane Pertussis 1.050101264851864 | |
| C4A Plasma membrane Staphylococcus aureus infection 1.050101264851864 | |
| C4A Plasma membrane Systemic lupus erythematosus 1.050101264851864 | |
| C4B Extracellular space Complement and coagulation cascades 1.1199907169513943 | |
| C4B Extracellular space Coronavirus disease - COVID-19 1.1199907169513943 | |
| C4B Extracellular space Pertussis 1.1199907169513943 | |
| C4B Extracellular space Staphylococcus aureus infection 1.1199907169513943 | |
| C4B Extracellular space Systemic lupus erythematosus 1.1199907169513943 | |
| C4B Plasma membrane Complement and coagulation cascades 1.1199907169513943 | |
| C4B Plasma membrane Coronavirus disease - COVID-19 1.1199907169513943 | |
| C4B Plasma membrane Pertussis 1.1199907169513943 | |
| C4B Plasma membrane Staphylococcus aureus infection 1.1199907169513943 | |
| C4B Plasma membrane Systemic lupus erythematosus 1.1199907169513943 | |
| C4BPA Extracellular space Complement and coagulation cascades 1.4421682774248266 | |
| C4BPA Extracellular space Pertussis 1.4421682774248266 | |
| C4BPB Extracellular space Complement and coagulation cascades 2.5376329772890878 | |
| C4BPB Extracellular space Pertussis 2.5376329772890878 | |
| C4orf3 Cytosol Summary 0.9568928923781912 | |
| C4orf3 Endoplasmic Reticulum Summary 0.9568928923781912 | |
| C4orf32 Golgi apparatus Summary 0.3706229847070791 | |
| C4orf33 Golgi apparatus Summary 1.180103681896472 | |
| C4orf33 Nucleus Summary 1.180103681896472 | |
| C5 Extracellular space Complement and coagulation cascades 2.5415242322114597 | |
| C5 Extracellular space Coronavirus disease - COVID-19 2.5415242322114597 | |
| C5 Extracellular space Herpes simplex virus 1 infection 2.5415242322114597 | |
| C5 Extracellular space Neuroactive ligand-receptor interaction 2.5415242322114597 | |
| C5 Extracellular space Neutrophil extracellular trap formation 2.5415242322114597 | |
| C5 Extracellular space Pertussis 2.5415242322114597 | |
| C5 Extracellular space Prion disease 2.5415242322114597 | |
| C5 Extracellular space Staphylococcus aureus infection 2.5415242322114597 | |
| C5 Extracellular space Systemic lupus erythematosus 2.5415242322114597 | |
| C5orf15 Golgi apparatus Summary 1.8818616489303093 | |
| C5orf22 Nucleus Summary 2.193442357848146 | |
| C5orf24 Nucleus Summary 0.7989596213680437 | |
| C5orf30 Nucleus Summary 0.7356794517838771 | |
| C5orf42 Cytosol Summary 0.8398934057556718 | |
| C5orf45 Cytosol Summary 0.7118589920464229 | |
| C5orf51 Cytosol Summary 1.0633650382030664 | |
| C5orf51 Nucleus Summary 1.0633650382030664 | |
| C6 Extracellular space Alzheimer disease 2.2430250253389423 | |
| C6 Extracellular space Amyotrophic lateral sclerosis 2.2430250253389423 | |
| C6 Extracellular space Complement and coagulation cascades 2.2430250253389423 | |
| C6 Extracellular space Coronavirus disease - COVID-19 2.2430250253389423 | |
| C6 Extracellular space Huntington disease 2.2430250253389423 | |
| C6 Extracellular space Parkinson disease 2.2430250253389423 | |
| C6 Extracellular space Pathways of neurodegeneration - multiple diseases 2.2430250253389423 | |
| C6 Extracellular space Prion disease 2.2430250253389423 | |
| C6 Extracellular space Proteasome 2.2430250253389423 | |
| C6 Extracellular space Spinocerebellar ataxia 2.2430250253389423 | |
| C6 Extracellular space Systemic lupus erythematosus 2.2430250253389423 | |
| C6orf106 Cytoskeleton Summary 1.6288411259829718 | |
| C6orf106 Cytosol Summary 1.6288411259829718 | |
| C6orf106 Nucleus Summary 1.6288411259829718 | |
| C6orf120 Extracellular space Summary 0.7253655430587772 | |
| C6orf132 Cytosol Summary 1.2203012048686273 | |
| C6orf132 Golgi apparatus Summary 1.2203012048686273 | |
| C6orf47 Cytosol Summary 1.2031727333476292 | |
| C6orf89 Golgi apparatus Summary 1.5359548964658931 | |
| C6orf89 Plasma membrane Summary 1.5359548964658931 | |
| C7 Extracellular space Chemokine signaling pathway 1.7388939215760593 | |
| C7 Extracellular space Complement and coagulation cascades 1.7388939215760593 | |
| C7 Extracellular space Coronavirus disease - COVID-19 1.7388939215760593 | |
| C7 Extracellular space Cytokine-cytokine receptor interaction 1.7388939215760593 | |
| C7 Extracellular space Cytosolic DNA-sensing pathway 1.7388939215760593 | |
| C7 Extracellular space Epstein-Barr virus infection 1.7388939215760593 | |
| C7 Extracellular space Hepatitis C 1.7388939215760593 | |
| C7 Extracellular space IL-17 signaling pathway 1.7388939215760593 | |
| C7 Extracellular space Influenza A 1.7388939215760593 | |
| C7 Extracellular space Prion disease 1.7388939215760593 | |
| C7 Extracellular space RIG-I-like receptor signaling pathway 1.7388939215760593 | |
| C7 Extracellular space Systemic lupus erythematosus 1.7388939215760593 | |
| C7 Extracellular space TNF signaling pathway 1.7388939215760593 | |
| C7 Extracellular space Toll-like receptor signaling pathway 1.7388939215760593 | |
| C7 Extracellular space Viral protein interaction with cytokine and cytokine receptor 1.7388939215760593 | |
| C7orf25 Cytosol Summary 1.5233399736125908 | |
| C7orf25 Nucleus Summary 1.5233399736125908 | |
| C7orf26 Cytoskeleton Summary 1.5971717258372713 | |
| C7orf26 Cytosol Summary 1.5971717258372713 | |
| C7orf26 Nucleus Summary 1.5971717258372713 | |
| C7orf43 Cytoskeleton Summary 0.688415976998146 | |
| C7orf43 Cytosol Summary 0.688415976998146 | |
| C7orf43 Plasma membrane Summary 0.688415976998146 | |
| C7orf50 Nucleus Summary 1.5000790175384222 | |
| C7orf55-LUC7L2 Nucleus Summary 1.592546685772208 | |
| C8A Extracellular space Amoebiasis 1.8761025692666748 | |
| C8A Extracellular space Complement and coagulation cascades 1.8761025692666748 | |
| C8A Extracellular space Coronavirus disease - COVID-19 1.8761025692666748 | |
| C8A Extracellular space Prion disease 1.8761025692666748 | |
| C8A Extracellular space Systemic lupus erythematosus 1.8761025692666748 | |
| C8A Plasma membrane Amoebiasis 1.8761025692666748 | |
| C8A Plasma membrane Complement and coagulation cascades 1.8761025692666748 | |
| C8A Plasma membrane Coronavirus disease - COVID-19 1.8761025692666748 | |
| C8A Plasma membrane Prion disease 1.8761025692666748 | |
| C8A Plasma membrane Systemic lupus erythematosus 1.8761025692666748 | |
| C8B Extracellular space Amoebiasis 1.8655945078220797 | |
| C8B Extracellular space Complement and coagulation cascades 1.8655945078220797 | |
| C8B Extracellular space Coronavirus disease - COVID-19 1.8655945078220797 | |
| C8B Extracellular space Prion disease 1.8655945078220797 | |
| C8B Extracellular space Systemic lupus erythematosus 1.8655945078220797 | |
| C8G Endoplasmic Reticulum Summary 2.5092345293903104 | |
| C8orf33 Nucleus Summary 1.5483980185549555 | |
| C8orf33 Plasma membrane Summary 1.5483980185549555 | |
| C8orf37 Cytosol Summary 1.1892822427690346 | |
| C8orf37 Plasma membrane Summary 1.1892822427690346 | |
| C8orf59 Cytosol Summary 0.9096411871684109 | |
| C8orf59 Nucleus Summary 0.9096411871684109 | |
| C8orf82 Nucleus Summary 2.0005209996749174 | |
| C9 Cytosol Amoebiasis 2.229977322365098 | |
| C9 Cytosol Complement and coagulation cascades 2.229977322365098 | |
| C9 Cytosol Coronavirus disease - COVID-19 2.229977322365098 | |
| C9 Cytosol Metabolism of xenobiotics by cytochrome P450 2.229977322365098 | |
| C9 Cytosol Prion disease 2.229977322365098 | |
| C9 Cytosol Steroid hormone biosynthesis 2.229977322365098 | |
| C9 Cytosol Systemic lupus erythematosus 2.229977322365098 | |
| C9 Extracellular space Amoebiasis 2.229977322365098 | |
| C9 Extracellular space Complement and coagulation cascades 2.229977322365098 | |
| C9 Extracellular space Coronavirus disease - COVID-19 2.229977322365098 | |
| C9 Extracellular space Metabolism of xenobiotics by cytochrome P450 2.229977322365098 | |
| C9 Extracellular space Prion disease 2.229977322365098 | |
| C9 Extracellular space Steroid hormone biosynthesis 2.229977322365098 | |
| C9 Extracellular space Systemic lupus erythematosus 2.229977322365098 | |
| C9 Plasma membrane Amoebiasis 2.229977322365098 | |
| C9 Plasma membrane Complement and coagulation cascades 2.229977322365098 | |
| C9 Plasma membrane Coronavirus disease - COVID-19 2.229977322365098 | |
| C9 Plasma membrane Metabolism of xenobiotics by cytochrome P450 2.229977322365098 | |
| C9 Plasma membrane Prion disease 2.229977322365098 | |
| C9 Plasma membrane Steroid hormone biosynthesis 2.229977322365098 | |
| C9 Plasma membrane Systemic lupus erythematosus 2.229977322365098 | |
| C9orf142 Nucleus Summary 0.5281615261979377 | |
| C9orf152 Nucleus Summary 0.08115089533648717 | |
| C9orf16 Cytoskeleton Summary 0.7388193871191816 | |
| C9orf40 Cytoskeleton Summary 1.8769425423330781 | |
| C9orf40 Cytosol Summary 1.8769425423330781 | |
| C9orf40 Nucleus Summary 1.8769425423330781 | |
| C9orf64 Golgi apparatus Summary 0.5297064647250923 | |
| C9orf72 Cytoskeleton Amyotrophic lateral sclerosis 2.1544955876778 | |
| C9orf72 Cytoskeleton Autophagy - animal 2.1544955876778 | |
| C9orf72 Cytoskeleton Pathways of neurodegeneration - multiple diseases 2.1544955876778 | |
| C9orf72 Cytosol Amyotrophic lateral sclerosis 2.1544955876778 | |
| C9orf72 Cytosol Autophagy - animal 2.1544955876778 | |
| C9orf72 Cytosol Pathways of neurodegeneration - multiple diseases 2.1544955876778 | |
| C9orf72 Nucleus Amyotrophic lateral sclerosis 2.1544955876778 | |
| C9orf72 Nucleus Autophagy - animal 2.1544955876778 | |
| C9orf72 Nucleus Pathways of neurodegeneration - multiple diseases 2.1544955876778 | |
| C9orf78 Nucleus Summary 1.518088680166609 | |
| CA1 Cytosol Summary 1.2200925967593523 | |
| CA12 Nucleus Summary 0.030683159016250964 | |
| CA12 Plasma membrane Summary 0.030683159016250964 | |
| CA13 Cytosol Summary 2.095446456149625 | |
| CA13 Nucleus Summary 2.095446456149625 | |
| CA2 Cytosol Summary 0.7789787872307313 | |
| CA3 Cytosol Summary 1.0132730596241266 | |
| CA5B Mitochondrion Metabolic pathways 1.5808782663565093 | |
| CA5B Mitochondrion Nitrogen metabolism 1.5808782663565093 | |
| CA9 Cytosol Metabolic pathways 1.3439955775127108 | |
| CA9 Cytosol Nitrogen metabolism 1.3439955775127108 | |
| CA9 Nucleus Metabolic pathways 1.3439955775127108 | |
| CA9 Nucleus Nitrogen metabolism 1.3439955775127108 | |
| CA9 Plasma membrane Metabolic pathways 1.3439955775127108 | |
| CA9 Plasma membrane Nitrogen metabolism 1.3439955775127108 | |
| CAAP1 Cytosol Summary 1.517669298533498 | |
| CAB39 Cytosol Summary 0.6863625756550253 | |
| CAB39 Nucleus Summary 0.6863625756550253 | |
| CAB39L Cytosol Summary 0.2610850841482412 | |
| CABIN1 Cytosol Summary 0.933460237367578 | |
| CABIN1 Nucleus Summary 0.933460237367578 | |
| CABLES1 Cytosol Summary 0.6002947873623682 | |
| CABLES1 Nucleus Summary 0.6002947873623682 | |
| CACHD1 Nucleus Summary 1.2907107019121111 | |
| CACNA1F Plasma membrane Adrenergic signaling in cardiomyocytes 1.4665942482882377 | |
| CACNA1F Plasma membrane Aldosterone synthesis and secretion 1.4665942482882377 | |
| CACNA1F Plasma membrane Alzheimer disease 1.4665942482882377 | |
| CACNA1F Plasma membrane Arrhythmogenic right ventricular cardiomyopathy 1.4665942482882377 | |
| CACNA1F Plasma membrane Calcium signaling pathway 1.4665942482882377 | |
| CACNA1F Plasma membrane Cardiac muscle contraction 1.4665942482882377 | |
| CACNA1F Plasma membrane Chemical carcinogenesis - receptor activation 1.4665942482882377 | |
| CACNA1F Plasma membrane Cholinergic synapse 1.4665942482882377 | |
| CACNA1F Plasma membrane Cortisol synthesis and secretion 1.4665942482882377 | |
| CACNA1F Plasma membrane Cushing syndrome 1.4665942482882377 | |
| CACNA1F Plasma membrane Dilated cardiomyopathy 1.4665942482882377 | |
| CACNA1F Plasma membrane GABAergic synapse 1.4665942482882377 | |
| CACNA1F Plasma membrane GnRH secretion 1.4665942482882377 | |
| CACNA1F Plasma membrane GnRH signaling pathway 1.4665942482882377 | |
| CACNA1F Plasma membrane Growth hormone synthesis secretion and action 1.4665942482882377 | |
| CACNA1F Plasma membrane Hypertrophic cardiomyopathy 1.4665942482882377 | |
| CACNA1F Plasma membrane Insulin secretion 1.4665942482882377 | |
| CACNA1F Plasma membrane MAPK signaling pathway 1.4665942482882377 | |
| CACNA1F Plasma membrane Oxytocin signaling pathway 1.4665942482882377 | |
| CACNA1F Plasma membrane Pathways of neurodegeneration - multiple diseases 1.4665942482882377 | |
| CACNA1F Plasma membrane Prion disease 1.4665942482882377 | |
| CACNA1F Plasma membrane Renin secretion 1.4665942482882377 | |
| CACNA1F Plasma membrane Retrograde endocannabinoid signaling 1.4665942482882377 | |
| CACNA1F Plasma membrane Serotonergic synapse 1.4665942482882377 | |
| CACNA1F Plasma membrane Vascular smooth muscle contraction 1.4665942482882377 | |
| CACNA1F Plasma membrane cAMP signaling pathway 1.4665942482882377 | |
| CACNA1F Plasma membrane cGMP-PKG signaling pathway 1.4665942482882377 | |
| CACNA2D1 Plasma membrane Adrenergic signaling in cardiomyocytes 1.2585323801696209 | |
| CACNA2D1 Plasma membrane Arrhythmogenic right ventricular cardiomyopathy 1.2585323801696209 | |
| CACNA2D1 Plasma membrane Cardiac muscle contraction 1.2585323801696209 | |
| CACNA2D1 Plasma membrane Dilated cardiomyopathy 1.2585323801696209 | |
| CACNA2D1 Plasma membrane Hypertrophic cardiomyopathy 1.2585323801696209 | |
| CACNA2D1 Plasma membrane MAPK signaling pathway 1.2585323801696209 | |
| CACNA2D1 Plasma membrane Oxytocin signaling pathway 1.2585323801696209 | |
| CACNA2D2 Cytosol Summary 0.21730007053668546 | |
| CACNA2D3 Nucleus Summary 1.2599574744732138 | |
| CACNB3 Cytosol Adrenergic signaling in cardiomyocytes 1.2387902819363323 | |
| CACNB3 Cytosol Arrhythmogenic right ventricular cardiomyopathy 1.2387902819363323 | |
| CACNB3 Cytosol Cardiac muscle contraction 1.2387902819363323 | |
| CACNB3 Cytosol Dilated cardiomyopathy 1.2387902819363323 | |
| CACNB3 Cytosol Hypertrophic cardiomyopathy 1.2387902819363323 | |
| CACNB3 Cytosol MAPK signaling pathway 1.2387902819363323 | |
| CACNB3 Cytosol Oxytocin signaling pathway 1.2387902819363323 | |
| CACNB3 Golgi apparatus Adrenergic signaling in cardiomyocytes 1.2387902819363323 | |
| CACNB3 Golgi apparatus Arrhythmogenic right ventricular cardiomyopathy 1.2387902819363323 | |
| CACNB3 Golgi apparatus Cardiac muscle contraction 1.2387902819363323 | |
| CACNB3 Golgi apparatus Dilated cardiomyopathy 1.2387902819363323 | |
| CACNB3 Golgi apparatus Hypertrophic cardiomyopathy 1.2387902819363323 | |
| CACNB3 Golgi apparatus MAPK signaling pathway 1.2387902819363323 | |
| CACNB3 Golgi apparatus Oxytocin signaling pathway 1.2387902819363323 | |
| CACNB3 Plasma membrane Adrenergic signaling in cardiomyocytes 1.2387902819363323 | |
| CACNB3 Plasma membrane Arrhythmogenic right ventricular cardiomyopathy 1.2387902819363323 | |
| CACNB3 Plasma membrane Cardiac muscle contraction 1.2387902819363323 | |
| CACNB3 Plasma membrane Dilated cardiomyopathy 1.2387902819363323 | |
| CACNB3 Plasma membrane Hypertrophic cardiomyopathy 1.2387902819363323 | |
| CACNB3 Plasma membrane MAPK signaling pathway 1.2387902819363323 | |
| CACNB3 Plasma membrane Oxytocin signaling pathway 1.2387902819363323 | |
| CACNG6 Cytosol Adrenergic signaling in cardiomyocytes 1.9597510947843888 | |
| CACNG6 Cytosol Arrhythmogenic right ventricular cardiomyopathy 1.9597510947843888 | |
| CACNG6 Cytosol Cardiac muscle contraction 1.9597510947843888 | |
| CACNG6 Cytosol Dilated cardiomyopathy 1.9597510947843888 | |
| CACNG6 Cytosol Hypertrophic cardiomyopathy 1.9597510947843888 | |
| CACNG6 Cytosol MAPK signaling pathway 1.9597510947843888 | |
| CACNG6 Cytosol Oxytocin signaling pathway 1.9597510947843888 | |
| CACNG6 Nucleus Adrenergic signaling in cardiomyocytes 1.9597510947843888 | |
| CACNG6 Nucleus Arrhythmogenic right ventricular cardiomyopathy 1.9597510947843888 | |
| CACNG6 Nucleus Cardiac muscle contraction 1.9597510947843888 | |
| CACNG6 Nucleus Dilated cardiomyopathy 1.9597510947843888 | |
| CACNG6 Nucleus Hypertrophic cardiomyopathy 1.9597510947843888 | |
| CACNG6 Nucleus MAPK signaling pathway 1.9597510947843888 | |
| CACNG6 Nucleus Oxytocin signaling pathway 1.9597510947843888 | |
| CACNG6 Plasma membrane Adrenergic signaling in cardiomyocytes 1.9597510947843888 | |
| CACNG6 Plasma membrane Arrhythmogenic right ventricular cardiomyopathy 1.9597510947843888 | |
| CACNG6 Plasma membrane Cardiac muscle contraction 1.9597510947843888 | |
| CACNG6 Plasma membrane Dilated cardiomyopathy 1.9597510947843888 | |
| CACNG6 Plasma membrane Hypertrophic cardiomyopathy 1.9597510947843888 | |
| CACNG6 Plasma membrane MAPK signaling pathway 1.9597510947843888 | |
| CACNG6 Plasma membrane Oxytocin signaling pathway 1.9597510947843888 | |
| CACTIN Cytosol Summary 1.6835848857625189 | |
| CACTIN Nucleus Summary 1.6835848857625189 | |
| CACUL1 Nucleus Summary 1.1821552102190886 | |
| CACYBP Cytosol Wnt signaling pathway 2.2511065161490893 | |
| CACYBP Nucleus Wnt signaling pathway 2.2511065161490893 | |
| CAD Cytosol Summary 1.9161028190016531 | |
| CAD Nucleus Summary 1.9161028190016531 | |
| CADM1 Plasma membrane Cell adhesion molecules 1.5564455678311169 | |
| CADM4 Nucleus Summary 1.1030585373314203 | |
| CADPS2 Cytosol Summary 0.3496223689017394 | |
| CADPS2 Nucleus Summary 0.3496223689017394 | |
| CALB2 Cytosol Summary 0.8625903326095612 | |
| CALCOCO1 Cytosol Summary 1.0324642583560868 | |
| CALCOCO1 Nucleus Summary 1.0324642583560868 | |
| CALCOCO2 Cytoskeleton Influenza A 0.990526413723148 | |
| CALCOCO2 Cytoskeleton Mitophagy - animal 0.990526413723148 | |
| CALCOCO2 Cytoskeleton Shigellosis 0.990526413723148 | |
| CALCOCO2 Cytosol Influenza A 0.990526413723148 | |
| CALCOCO2 Cytosol Mitophagy - animal 0.990526413723148 | |
| CALCOCO2 Cytosol Shigellosis 0.990526413723148 | |
| CALCOCO2 Golgi apparatus Influenza A 0.990526413723148 | |
| CALCOCO2 Golgi apparatus Mitophagy - animal 0.990526413723148 | |
| CALCOCO2 Golgi apparatus Shigellosis 0.990526413723148 | |
| CALCOCO2 Nucleus Influenza A 0.990526413723148 | |
| CALCOCO2 Nucleus Mitophagy - animal 0.990526413723148 | |
| CALCOCO2 Nucleus Shigellosis 0.990526413723148 | |
| CALD1 Cytoskeleton Summary 1.3514464533161925 | |
| CALD1 Cytosol Summary 1.3514464533161925 | |
| CALD1 Plasma membrane Summary 1.3514464533161925 | |
| CALM2 Cytoskeleton Adrenergic signaling in cardiomyocytes 1.0127557929168851 | |
| CALM2 Cytoskeleton Alcoholism 1.0127557929168851 | |
| CALM2 Cytoskeleton Aldosterone synthesis and secretion 1.0127557929168851 | |
| CALM2 Cytoskeleton Alzheimer disease 1.0127557929168851 | |
| CALM2 Cytoskeleton Amphetamine addiction 1.0127557929168851 | |
| CALM2 Cytoskeleton Apelin signaling pathway 1.0127557929168851 | |
| CALM2 Cytoskeleton C-type lectin receptor signaling pathway 1.0127557929168851 | |
| CALM2 Cytoskeleton Calcium signaling pathway 1.0127557929168851 | |
| CALM2 Cytoskeleton Cellular senescence 1.0127557929168851 | |
| CALM2 Cytoskeleton Circadian entrainment 1.0127557929168851 | |
| CALM2 Cytoskeleton Dopaminergic synapse 1.0127557929168851 | |
| CALM2 Cytoskeleton Estrogen signaling pathway 1.0127557929168851 | |
| CALM2 Cytoskeleton Fluid shear stress and atherosclerosis 1.0127557929168851 | |
| CALM2 Cytoskeleton Gastric acid secretion 1.0127557929168851 | |
| CALM2 Cytoskeleton Glioma 1.0127557929168851 | |
| CALM2 Cytoskeleton Glucagon signaling pathway 1.0127557929168851 | |
| CALM2 Cytoskeleton GnRH signaling pathway 1.0127557929168851 | |
| CALM2 Cytoskeleton Human cytomegalovirus infection 1.0127557929168851 | |
| CALM2 Cytoskeleton Human immunodeficiency virus 1 infection 1.0127557929168851 | |
| CALM2 Cytoskeleton Inflammatory mediator regulation of TRP channels 1.0127557929168851 | |
| CALM2 Cytoskeleton Insulin signaling pathway 1.0127557929168851 | |
| CALM2 Cytoskeleton Kaposi sarcoma-associated herpesvirus infection 1.0127557929168851 | |
| CALM2 Cytoskeleton Lipid and atherosclerosis 1.0127557929168851 | |
| CALM2 Cytoskeleton Long-term potentiation 1.0127557929168851 | |
| CALM2 Cytoskeleton Melanogenesis 1.0127557929168851 | |
| CALM2 Cytoskeleton Neurotrophin signaling pathway 1.0127557929168851 | |
| CALM2 Cytoskeleton Olfactory transduction 1.0127557929168851 | |
| CALM2 Cytoskeleton Oocyte meiosis 1.0127557929168851 | |
| CALM2 Cytoskeleton Oxytocin signaling pathway 1.0127557929168851 | |
| CALM2 Cytoskeleton Parkinson disease 1.0127557929168851 | |
| CALM2 Cytoskeleton Pathways in cancer 1.0127557929168851 | |
| CALM2 Cytoskeleton Pathways of neurodegeneration - multiple diseases 1.0127557929168851 | |
| CALM2 Cytoskeleton Pertussis 1.0127557929168851 | |
| CALM2 Cytoskeleton Phosphatidylinositol signaling system 1.0127557929168851 | |
| CALM2 Cytoskeleton Phototransduction 1.0127557929168851 | |
| CALM2 Cytoskeleton Rap1 signaling pathway 1.0127557929168851 | |
| CALM2 Cytoskeleton Ras signaling pathway 1.0127557929168851 | |
| CALM2 Cytoskeleton Renin secretion 1.0127557929168851 | |
| CALM2 Cytoskeleton Salivary secretion 1.0127557929168851 | |
| CALM2 Cytoskeleton Tuberculosis 1.0127557929168851 | |
| CALM2 Cytoskeleton Vascular smooth muscle contraction 1.0127557929168851 | |
| CALM2 Cytoskeleton cAMP signaling pathway 1.0127557929168851 | |
| CALM2 Cytoskeleton cGMP-PKG signaling pathway 1.0127557929168851 | |
| CALM2 Cytosol Adrenergic signaling in cardiomyocytes 1.0127557929168851 | |
| CALM2 Cytosol Alcoholism 1.0127557929168851 | |
| CALM2 Cytosol Aldosterone synthesis and secretion 1.0127557929168851 | |
| CALM2 Cytosol Alzheimer disease 1.0127557929168851 | |
| CALM2 Cytosol Amphetamine addiction 1.0127557929168851 | |
| CALM2 Cytosol Apelin signaling pathway 1.0127557929168851 | |
| CALM2 Cytosol C-type lectin receptor signaling pathway 1.0127557929168851 | |
| CALM2 Cytosol Calcium signaling pathway 1.0127557929168851 | |
| CALM2 Cytosol Cellular senescence 1.0127557929168851 | |
| CALM2 Cytosol Circadian entrainment 1.0127557929168851 | |
| CALM2 Cytosol Dopaminergic synapse 1.0127557929168851 | |
| CALM2 Cytosol Estrogen signaling pathway 1.0127557929168851 | |
| CALM2 Cytosol Fluid shear stress and atherosclerosis 1.0127557929168851 | |
| CALM2 Cytosol Gastric acid secretion 1.0127557929168851 | |
| CALM2 Cytosol Glioma 1.0127557929168851 | |
| CALM2 Cytosol Glucagon signaling pathway 1.0127557929168851 | |
| CALM2 Cytosol GnRH signaling pathway 1.0127557929168851 | |
| CALM2 Cytosol Human cytomegalovirus infection 1.0127557929168851 | |
| CALM2 Cytosol Human immunodeficiency virus 1 infection 1.0127557929168851 | |
| CALM2 Cytosol Inflammatory mediator regulation of TRP channels 1.0127557929168851 | |
| CALM2 Cytosol Insulin signaling pathway 1.0127557929168851 | |
| CALM2 Cytosol Kaposi sarcoma-associated herpesvirus infection 1.0127557929168851 | |
| CALM2 Cytosol Lipid and atherosclerosis 1.0127557929168851 | |
| CALM2 Cytosol Long-term potentiation 1.0127557929168851 | |
| CALM2 Cytosol Melanogenesis 1.0127557929168851 | |
| CALM2 Cytosol Neurotrophin signaling pathway 1.0127557929168851 | |
| CALM2 Cytosol Olfactory transduction 1.0127557929168851 | |
| CALM2 Cytosol Oocyte meiosis 1.0127557929168851 | |
| CALM2 Cytosol Oxytocin signaling pathway 1.0127557929168851 | |
| CALM2 Cytosol Parkinson disease 1.0127557929168851 | |
| CALM2 Cytosol Pathways in cancer 1.0127557929168851 | |
| CALM2 Cytosol Pathways of neurodegeneration - multiple diseases 1.0127557929168851 | |
| CALM2 Cytosol Pertussis 1.0127557929168851 | |
| CALM2 Cytosol Phosphatidylinositol signaling system 1.0127557929168851 | |
| CALM2 Cytosol Phototransduction 1.0127557929168851 | |
| CALM2 Cytosol Rap1 signaling pathway 1.0127557929168851 | |
| CALM2 Cytosol Ras signaling pathway 1.0127557929168851 | |
| CALM2 Cytosol Renin secretion 1.0127557929168851 | |
| CALM2 Cytosol Salivary secretion 1.0127557929168851 | |
| CALM2 Cytosol Tuberculosis 1.0127557929168851 | |
| CALM2 Cytosol Vascular smooth muscle contraction 1.0127557929168851 | |
| CALM2 Cytosol cAMP signaling pathway 1.0127557929168851 | |
| CALM2 Cytosol cGMP-PKG signaling pathway 1.0127557929168851 | |
| CALM2 Plasma membrane Adrenergic signaling in cardiomyocytes 1.0127557929168851 | |
| CALM2 Plasma membrane Alcoholism 1.0127557929168851 | |
| CALM2 Plasma membrane Aldosterone synthesis and secretion 1.0127557929168851 | |
| CALM2 Plasma membrane Alzheimer disease 1.0127557929168851 | |
| CALM2 Plasma membrane Amphetamine addiction 1.0127557929168851 | |
| CALM2 Plasma membrane Apelin signaling pathway 1.0127557929168851 | |
| CALM2 Plasma membrane C-type lectin receptor signaling pathway 1.0127557929168851 | |
| CALM2 Plasma membrane Calcium signaling pathway 1.0127557929168851 | |
| CALM2 Plasma membrane Cellular senescence 1.0127557929168851 | |
| CALM2 Plasma membrane Circadian entrainment 1.0127557929168851 | |
| CALM2 Plasma membrane Dopaminergic synapse 1.0127557929168851 | |
| CALM2 Plasma membrane Estrogen signaling pathway 1.0127557929168851 | |
| CALM2 Plasma membrane Fluid shear stress and atherosclerosis 1.0127557929168851 | |
| CALM2 Plasma membrane Gastric acid secretion 1.0127557929168851 | |
| CALM2 Plasma membrane Glioma 1.0127557929168851 | |
| CALM2 Plasma membrane Glucagon signaling pathway 1.0127557929168851 | |
| CALM2 Plasma membrane GnRH signaling pathway 1.0127557929168851 | |
| CALM2 Plasma membrane Human cytomegalovirus infection 1.0127557929168851 | |
| CALM2 Plasma membrane Human immunodeficiency virus 1 infection 1.0127557929168851 | |
| CALM2 Plasma membrane Inflammatory mediator regulation of TRP channels 1.0127557929168851 | |
| CALM2 Plasma membrane Insulin signaling pathway 1.0127557929168851 | |
| CALM2 Plasma membrane Kaposi sarcoma-associated herpesvirus infection 1.0127557929168851 | |
| CALM2 Plasma membrane Lipid and atherosclerosis 1.0127557929168851 | |
| CALM2 Plasma membrane Long-term potentiation 1.0127557929168851 | |
| CALM2 Plasma membrane Melanogenesis 1.0127557929168851 | |
| CALM2 Plasma membrane Neurotrophin signaling pathway 1.0127557929168851 | |
| CALM2 Plasma membrane Olfactory transduction 1.0127557929168851 | |
| CALM2 Plasma membrane Oocyte meiosis 1.0127557929168851 | |
| CALM2 Plasma membrane Oxytocin signaling pathway 1.0127557929168851 | |
| CALM2 Plasma membrane Parkinson disease 1.0127557929168851 | |
| CALM2 Plasma membrane Pathways in cancer 1.0127557929168851 | |
| CALM2 Plasma membrane Pathways of neurodegeneration - multiple diseases 1.0127557929168851 | |
| CALM2 Plasma membrane Pertussis 1.0127557929168851 | |
| CALM2 Plasma membrane Phosphatidylinositol signaling system 1.0127557929168851 | |
| CALM2 Plasma membrane Phototransduction 1.0127557929168851 | |
| CALM2 Plasma membrane Rap1 signaling pathway 1.0127557929168851 | |
| CALM2 Plasma membrane Ras signaling pathway 1.0127557929168851 | |
| CALM2 Plasma membrane Renin secretion 1.0127557929168851 | |
| CALM2 Plasma membrane Salivary secretion 1.0127557929168851 | |
| CALM2 Plasma membrane Tuberculosis 1.0127557929168851 | |
| CALM2 Plasma membrane Vascular smooth muscle contraction 1.0127557929168851 | |
| CALM2 Plasma membrane cAMP signaling pathway 1.0127557929168851 | |
| CALM2 Plasma membrane cGMP-PKG signaling pathway 1.0127557929168851 | |
| CALML5 Cytosol Summary 0.8588920120166689 | |
| CALML5 Plasma membrane Summary 0.8588920120166689 | |
| CALR Cytosol Antigen processing and presentation 2.4183798641414667 | |
| CALR Cytosol Chagas disease 2.4183798641414667 | |
| CALR Cytosol Epstein-Barr virus infection 2.4183798641414667 | |
| CALR Cytosol Herpes simplex virus 1 infection 2.4183798641414667 | |
| CALR Cytosol Human T-cell leukemia virus 1 infection 2.4183798641414667 | |
| CALR Cytosol Human cytomegalovirus infection 2.4183798641414667 | |
| CALR Cytosol Human immunodeficiency virus 1 infection 2.4183798641414667 | |
| CALR Cytosol Phagosome 2.4183798641414667 | |
| CALR Cytosol Protein processing in endoplasmic reticulum 2.4183798641414667 | |
| CALR Endoplasmic Reticulum Antigen processing and presentation 2.4183798641414667 | |
| CALR Endoplasmic Reticulum Chagas disease 2.4183798641414667 | |
| CALR Endoplasmic Reticulum Epstein-Barr virus infection 2.4183798641414667 | |
| CALR Endoplasmic Reticulum Herpes simplex virus 1 infection 2.4183798641414667 | |
| CALR Endoplasmic Reticulum Human T-cell leukemia virus 1 infection 2.4183798641414667 | |
| CALR Endoplasmic Reticulum Human cytomegalovirus infection 2.4183798641414667 | |
| CALR Endoplasmic Reticulum Human immunodeficiency virus 1 infection 2.4183798641414667 | |
| CALR Endoplasmic Reticulum Phagosome 2.4183798641414667 | |
| CALR Endoplasmic Reticulum Protein processing in endoplasmic reticulum 2.4183798641414667 | |
| CALR Extracellular space Antigen processing and presentation 2.4183798641414667 | |
| CALR Extracellular space Chagas disease 2.4183798641414667 | |
| CALR Extracellular space Epstein-Barr virus infection 2.4183798641414667 | |
| CALR Extracellular space Herpes simplex virus 1 infection 2.4183798641414667 | |
| CALR Extracellular space Human T-cell leukemia virus 1 infection 2.4183798641414667 | |
| CALR Extracellular space Human cytomegalovirus infection 2.4183798641414667 | |
| CALR Extracellular space Human immunodeficiency virus 1 infection 2.4183798641414667 | |
| CALR Extracellular space Phagosome 2.4183798641414667 | |
| CALR Extracellular space Protein processing in endoplasmic reticulum 2.4183798641414667 | |
| CALU Endoplasmic Reticulum Summary 2.106113482556812 | |
| CALU Extracellular space Summary 2.106113482556812 | |
| CAMK1 Cytosol Summary 0.9737658931581518 | |
| CAMK1D Cytosol Summary 1.5598822005261774 | |
| CAMK1D Nucleus Summary 1.5598822005261774 | |
| CAMK2B Cytoskeleton Adrenergic signaling in cardiomyocytes 0.4623655798545673 | |
| CAMK2B Cytoskeleton Aldosterone synthesis and secretion 0.4623655798545673 | |
| CAMK2B Cytoskeleton Amphetamine addiction 0.4623655798545673 | |
| CAMK2B Cytoskeleton Axon guidance 0.4623655798545673 | |
| CAMK2B Cytoskeleton Calcium signaling pathway 0.4623655798545673 | |
| CAMK2B Cytoskeleton Cholinergic synapse 0.4623655798545673 | |
| CAMK2B Cytoskeleton Circadian entrainment 0.4623655798545673 | |
| CAMK2B Cytoskeleton Cushing syndrome 0.4623655798545673 | |
| CAMK2B Cytoskeleton Diabetic cardiomyopathy 0.4623655798545673 | |
| CAMK2B Cytoskeleton Dopaminergic synapse 0.4623655798545673 | |
| CAMK2B Cytoskeleton ErbB signaling pathway 0.4623655798545673 | |
| CAMK2B Cytoskeleton Gastric acid secretion 0.4623655798545673 | |
| CAMK2B Cytoskeleton Glioma 0.4623655798545673 | |
| CAMK2B Cytoskeleton Glucagon signaling pathway 0.4623655798545673 | |
| CAMK2B Cytoskeleton GnRH signaling pathway 0.4623655798545673 | |
| CAMK2B Cytoskeleton HIF-1 signaling pathway 0.4623655798545673 | |
| CAMK2B Cytoskeleton Inflammatory mediator regulation of TRP channels 0.4623655798545673 | |
| CAMK2B Cytoskeleton Insulin secretion 0.4623655798545673 | |
| CAMK2B Cytoskeleton Lipid and atherosclerosis 0.4623655798545673 | |
| CAMK2B Cytoskeleton Long-term potentiation 0.4623655798545673 | |
| CAMK2B Cytoskeleton Melanogenesis 0.4623655798545673 | |
| CAMK2B Cytoskeleton Necroptosis 0.4623655798545673 | |
| CAMK2B Cytoskeleton Neurotrophin signaling pathway 0.4623655798545673 | |
| CAMK2B Cytoskeleton Olfactory transduction 0.4623655798545673 | |
| CAMK2B Cytoskeleton Oocyte meiosis 0.4623655798545673 | |
| CAMK2B Cytoskeleton Oxytocin signaling pathway 0.4623655798545673 | |
| CAMK2B Cytoskeleton Parkinson disease 0.4623655798545673 | |
| CAMK2B Cytoskeleton Pathways in cancer 0.4623655798545673 | |
| CAMK2B Cytoskeleton Pathways of neurodegeneration - multiple diseases 0.4623655798545673 | |
| CAMK2B Cytoskeleton Proteoglycans in cancer 0.4623655798545673 | |
| CAMK2B Cytoskeleton Tuberculosis 0.4623655798545673 | |
| CAMK2B Cytoskeleton Wnt signaling pathway 0.4623655798545673 | |
| CAMK2B Cytoskeleton cAMP signaling pathway 0.4623655798545673 | |
| CAMK2B Cytosol Adrenergic signaling in cardiomyocytes 0.4623655798545673 | |
| CAMK2B Cytosol Aldosterone synthesis and secretion 0.4623655798545673 | |
| CAMK2B Cytosol Amphetamine addiction 0.4623655798545673 | |
| CAMK2B Cytosol Axon guidance 0.4623655798545673 | |
| CAMK2B Cytosol Calcium signaling pathway 0.4623655798545673 | |
| CAMK2B Cytosol Cholinergic synapse 0.4623655798545673 | |
| CAMK2B Cytosol Circadian entrainment 0.4623655798545673 | |
| CAMK2B Cytosol Cushing syndrome 0.4623655798545673 | |
| CAMK2B Cytosol Diabetic cardiomyopathy 0.4623655798545673 | |
| CAMK2B Cytosol Dopaminergic synapse 0.4623655798545673 | |
| CAMK2B Cytosol ErbB signaling pathway 0.4623655798545673 | |
| CAMK2B Cytosol Gastric acid secretion 0.4623655798545673 | |
| CAMK2B Cytosol Glioma 0.4623655798545673 | |
| CAMK2B Cytosol Glucagon signaling pathway 0.4623655798545673 | |
| CAMK2B Cytosol GnRH signaling pathway 0.4623655798545673 | |
| CAMK2B Cytosol HIF-1 signaling pathway 0.4623655798545673 | |
| CAMK2B Cytosol Inflammatory mediator regulation of TRP channels 0.4623655798545673 | |
| CAMK2B Cytosol Insulin secretion 0.4623655798545673 | |
| CAMK2B Cytosol Lipid and atherosclerosis 0.4623655798545673 | |
| CAMK2B Cytosol Long-term potentiation 0.4623655798545673 | |
| CAMK2B Cytosol Melanogenesis 0.4623655798545673 | |
| CAMK2B Cytosol Necroptosis 0.4623655798545673 | |
| CAMK2B Cytosol Neurotrophin signaling pathway 0.4623655798545673 | |
| CAMK2B Cytosol Olfactory transduction 0.4623655798545673 | |
| CAMK2B Cytosol Oocyte meiosis 0.4623655798545673 | |
| CAMK2B Cytosol Oxytocin signaling pathway 0.4623655798545673 | |
| CAMK2B Cytosol Parkinson disease 0.4623655798545673 | |
| CAMK2B Cytosol Pathways in cancer 0.4623655798545673 | |
| CAMK2B Cytosol Pathways of neurodegeneration - multiple diseases 0.4623655798545673 | |
| CAMK2B Cytosol Proteoglycans in cancer 0.4623655798545673 | |
| CAMK2B Cytosol Tuberculosis 0.4623655798545673 | |
| CAMK2B Cytosol Wnt signaling pathway 0.4623655798545673 | |
| CAMK2B Cytosol cAMP signaling pathway 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Adrenergic signaling in cardiomyocytes 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Aldosterone synthesis and secretion 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Amphetamine addiction 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Axon guidance 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Calcium signaling pathway 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Cholinergic synapse 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Circadian entrainment 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Cushing syndrome 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Diabetic cardiomyopathy 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Dopaminergic synapse 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum ErbB signaling pathway 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Gastric acid secretion 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Glioma 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Glucagon signaling pathway 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum GnRH signaling pathway 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum HIF-1 signaling pathway 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Inflammatory mediator regulation of TRP channels 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Insulin secretion 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Lipid and atherosclerosis 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Long-term potentiation 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Melanogenesis 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Necroptosis 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Neurotrophin signaling pathway 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Olfactory transduction 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Oocyte meiosis 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Oxytocin signaling pathway 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Parkinson disease 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Pathways in cancer 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Pathways of neurodegeneration - multiple diseases 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Proteoglycans in cancer 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Tuberculosis 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum Wnt signaling pathway 0.4623655798545673 | |
| CAMK2B Endoplasmic Reticulum cAMP signaling pathway 0.4623655798545673 | |
| CAMK2B Plasma membrane Adrenergic signaling in cardiomyocytes 0.4623655798545673 | |
| CAMK2B Plasma membrane Aldosterone synthesis and secretion 0.4623655798545673 | |
| CAMK2B Plasma membrane Amphetamine addiction 0.4623655798545673 | |
| CAMK2B Plasma membrane Axon guidance 0.4623655798545673 | |
| CAMK2B Plasma membrane Calcium signaling pathway 0.4623655798545673 | |
| CAMK2B Plasma membrane Cholinergic synapse 0.4623655798545673 | |
| CAMK2B Plasma membrane Circadian entrainment 0.4623655798545673 | |
| CAMK2B Plasma membrane Cushing syndrome 0.4623655798545673 | |
| CAMK2B Plasma membrane Diabetic cardiomyopathy 0.4623655798545673 | |
| CAMK2B Plasma membrane Dopaminergic synapse 0.4623655798545673 | |
| CAMK2B Plasma membrane ErbB signaling pathway 0.4623655798545673 | |
| CAMK2B Plasma membrane Gastric acid secretion 0.4623655798545673 | |
| CAMK2B Plasma membrane Glioma 0.4623655798545673 | |
| CAMK2B Plasma membrane Glucagon signaling pathway 0.4623655798545673 | |
| CAMK2B Plasma membrane GnRH signaling pathway 0.4623655798545673 | |
| CAMK2B Plasma membrane HIF-1 signaling pathway 0.4623655798545673 | |
| CAMK2B Plasma membrane Inflammatory mediator regulation of TRP channels 0.4623655798545673 | |
| CAMK2B Plasma membrane Insulin secretion 0.4623655798545673 | |
| CAMK2B Plasma membrane Lipid and atherosclerosis 0.4623655798545673 | |
| CAMK2B Plasma membrane Long-term potentiation 0.4623655798545673 | |
| CAMK2B Plasma membrane Melanogenesis 0.4623655798545673 | |
| CAMK2B Plasma membrane Necroptosis 0.4623655798545673 | |
| CAMK2B Plasma membrane Neurotrophin signaling pathway 0.4623655798545673 | |
| CAMK2B Plasma membrane Olfactory transduction 0.4623655798545673 | |
| CAMK2B Plasma membrane Oocyte meiosis 0.4623655798545673 | |
| CAMK2B Plasma membrane Oxytocin signaling pathway 0.4623655798545673 | |
| CAMK2B Plasma membrane Parkinson disease 0.4623655798545673 | |
| CAMK2B Plasma membrane Pathways in cancer 0.4623655798545673 | |
| CAMK2B Plasma membrane Pathways of neurodegeneration - multiple diseases 0.4623655798545673 | |
| CAMK2B Plasma membrane Proteoglycans in cancer 0.4623655798545673 | |
| CAMK2B Plasma membrane Tuberculosis 0.4623655798545673 | |
| CAMK2B Plasma membrane Wnt signaling pathway 0.4623655798545673 | |
| CAMK2B Plasma membrane cAMP signaling pathway 0.4623655798545673 | |
| CAMK2D Cytosol Adrenergic signaling in cardiomyocytes 1.6268333089618439 | |
| CAMK2D Cytosol Aldosterone synthesis and secretion 1.6268333089618439 | |
| CAMK2D Cytosol Amphetamine addiction 1.6268333089618439 | |
| CAMK2D Cytosol Axon guidance 1.6268333089618439 | |
| CAMK2D Cytosol Calcium signaling pathway 1.6268333089618439 | |
| CAMK2D Cytosol Cholinergic synapse 1.6268333089618439 | |
| CAMK2D Cytosol Circadian entrainment 1.6268333089618439 | |
| CAMK2D Cytosol Cushing syndrome 1.6268333089618439 | |
| CAMK2D Cytosol Diabetic cardiomyopathy 1.6268333089618439 | |
| CAMK2D Cytosol Dopaminergic synapse 1.6268333089618439 | |
| CAMK2D Cytosol ErbB signaling pathway 1.6268333089618439 | |
| CAMK2D Cytosol Gastric acid secretion 1.6268333089618439 | |
| CAMK2D Cytosol Glioma 1.6268333089618439 | |
| CAMK2D Cytosol Glucagon signaling pathway 1.6268333089618439 | |
| CAMK2D Cytosol GnRH signaling pathway 1.6268333089618439 | |
| CAMK2D Cytosol HIF-1 signaling pathway 1.6268333089618439 | |
| CAMK2D Cytosol Inflammatory mediator regulation of TRP channels 1.6268333089618439 | |
| CAMK2D Cytosol Insulin secretion 1.6268333089618439 | |
| CAMK2D Cytosol Lipid and atherosclerosis 1.6268333089618439 | |
| CAMK2D Cytosol Long-term potentiation 1.6268333089618439 | |
| CAMK2D Cytosol Melanogenesis 1.6268333089618439 | |
| CAMK2D Cytosol Necroptosis 1.6268333089618439 | |
| CAMK2D Cytosol Neurotrophin signaling pathway 1.6268333089618439 | |
| CAMK2D Cytosol Olfactory transduction 1.6268333089618439 | |
| CAMK2D Cytosol Oocyte meiosis 1.6268333089618439 | |
| CAMK2D Cytosol Oxytocin signaling pathway 1.6268333089618439 | |
| CAMK2D Cytosol Parkinson disease 1.6268333089618439 | |
| CAMK2D Cytosol Pathways in cancer 1.6268333089618439 | |
| CAMK2D Cytosol Pathways of neurodegeneration - multiple diseases 1.6268333089618439 | |
| CAMK2D Cytosol Proteoglycans in cancer 1.6268333089618439 | |
| CAMK2D Cytosol Tuberculosis 1.6268333089618439 | |
| CAMK2D Cytosol Wnt signaling pathway 1.6268333089618439 | |
| CAMK2D Cytosol cAMP signaling pathway 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Adrenergic signaling in cardiomyocytes 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Aldosterone synthesis and secretion 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Amphetamine addiction 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Axon guidance 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Calcium signaling pathway 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Cholinergic synapse 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Circadian entrainment 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Cushing syndrome 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Diabetic cardiomyopathy 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Dopaminergic synapse 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum ErbB signaling pathway 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Gastric acid secretion 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Glioma 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Glucagon signaling pathway 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum GnRH signaling pathway 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum HIF-1 signaling pathway 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Inflammatory mediator regulation of TRP channels 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Insulin secretion 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Lipid and atherosclerosis 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Long-term potentiation 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Melanogenesis 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Necroptosis 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Neurotrophin signaling pathway 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Olfactory transduction 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Oocyte meiosis 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Oxytocin signaling pathway 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Parkinson disease 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Pathways in cancer 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Pathways of neurodegeneration - multiple diseases 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Proteoglycans in cancer 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Tuberculosis 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum Wnt signaling pathway 1.6268333089618439 | |
| CAMK2D Endoplasmic Reticulum cAMP signaling pathway 1.6268333089618439 | |
| CAMK2D Plasma membrane Adrenergic signaling in cardiomyocytes 1.6268333089618439 | |
| CAMK2D Plasma membrane Aldosterone synthesis and secretion 1.6268333089618439 | |
| CAMK2D Plasma membrane Amphetamine addiction 1.6268333089618439 | |
| CAMK2D Plasma membrane Axon guidance 1.6268333089618439 | |
| CAMK2D Plasma membrane Calcium signaling pathway 1.6268333089618439 | |
| CAMK2D Plasma membrane Cholinergic synapse 1.6268333089618439 | |
| CAMK2D Plasma membrane Circadian entrainment 1.6268333089618439 | |
| CAMK2D Plasma membrane Cushing syndrome 1.6268333089618439 | |
| CAMK2D Plasma membrane Diabetic cardiomyopathy 1.6268333089618439 | |
| CAMK2D Plasma membrane Dopaminergic synapse 1.6268333089618439 | |
| CAMK2D Plasma membrane ErbB signaling pathway 1.6268333089618439 | |
| CAMK2D Plasma membrane Gastric acid secretion 1.6268333089618439 | |
| CAMK2D Plasma membrane Glioma 1.6268333089618439 | |
| CAMK2D Plasma membrane Glucagon signaling pathway 1.6268333089618439 | |
| CAMK2D Plasma membrane GnRH signaling pathway 1.6268333089618439 | |
| CAMK2D Plasma membrane HIF-1 signaling pathway 1.6268333089618439 | |
| CAMK2D Plasma membrane Inflammatory mediator regulation of TRP channels 1.6268333089618439 | |
| CAMK2D Plasma membrane Insulin secretion 1.6268333089618439 | |
| CAMK2D Plasma membrane Lipid and atherosclerosis 1.6268333089618439 | |
| CAMK2D Plasma membrane Long-term potentiation 1.6268333089618439 | |
| CAMK2D Plasma membrane Melanogenesis 1.6268333089618439 | |
| CAMK2D Plasma membrane Necroptosis 1.6268333089618439 | |
| CAMK2D Plasma membrane Neurotrophin signaling pathway 1.6268333089618439 | |
| CAMK2D Plasma membrane Olfactory transduction 1.6268333089618439 | |
| CAMK2D Plasma membrane Oocyte meiosis 1.6268333089618439 | |
| CAMK2D Plasma membrane Oxytocin signaling pathway 1.6268333089618439 | |
| CAMK2D Plasma membrane Parkinson disease 1.6268333089618439 | |
| CAMK2D Plasma membrane Pathways in cancer 1.6268333089618439 | |
| CAMK2D Plasma membrane Pathways of neurodegeneration - multiple diseases 1.6268333089618439 | |
| CAMK2D Plasma membrane Proteoglycans in cancer 1.6268333089618439 | |
| CAMK2D Plasma membrane Tuberculosis 1.6268333089618439 | |
| CAMK2D Plasma membrane Wnt signaling pathway 1.6268333089618439 | |
| CAMK2D Plasma membrane cAMP signaling pathway 1.6268333089618439 | |
| CAMK2G Cytosol Adrenergic signaling in cardiomyocytes 1.1323040318013935 | |
| CAMK2G Cytosol Aldosterone synthesis and secretion 1.1323040318013935 | |
| CAMK2G Cytosol Amphetamine addiction 1.1323040318013935 | |
| CAMK2G Cytosol Axon guidance 1.1323040318013935 | |
| CAMK2G Cytosol Calcium signaling pathway 1.1323040318013935 | |
| CAMK2G Cytosol Cholinergic synapse 1.1323040318013935 | |
| CAMK2G Cytosol Circadian entrainment 1.1323040318013935 | |
| CAMK2G Cytosol Cushing syndrome 1.1323040318013935 | |
| CAMK2G Cytosol Diabetic cardiomyopathy 1.1323040318013935 | |
| CAMK2G Cytosol Dopaminergic synapse 1.1323040318013935 | |
| CAMK2G Cytosol ErbB signaling pathway 1.1323040318013935 | |
| CAMK2G Cytosol Gastric acid secretion 1.1323040318013935 | |
| CAMK2G Cytosol Glioma 1.1323040318013935 | |
| CAMK2G Cytosol Glucagon signaling pathway 1.1323040318013935 | |
| CAMK2G Cytosol GnRH signaling pathway 1.1323040318013935 | |
| CAMK2G Cytosol HIF-1 signaling pathway 1.1323040318013935 | |
| CAMK2G Cytosol Inflammatory mediator regulation of TRP channels 1.1323040318013935 | |
| CAMK2G Cytosol Insulin secretion 1.1323040318013935 | |
| CAMK2G Cytosol Lipid and atherosclerosis 1.1323040318013935 | |
| CAMK2G Cytosol Long-term potentiation 1.1323040318013935 | |
| CAMK2G Cytosol Melanogenesis 1.1323040318013935 | |
| CAMK2G Cytosol Necroptosis 1.1323040318013935 | |
| CAMK2G Cytosol Neurotrophin signaling pathway 1.1323040318013935 | |
| CAMK2G Cytosol Olfactory transduction 1.1323040318013935 | |
| CAMK2G Cytosol Oocyte meiosis 1.1323040318013935 | |
| CAMK2G Cytosol Oxytocin signaling pathway 1.1323040318013935 | |
| CAMK2G Cytosol Parkinson disease 1.1323040318013935 | |
| CAMK2G Cytosol Pathways in cancer 1.1323040318013935 | |
| CAMK2G Cytosol Pathways of neurodegeneration - multiple diseases 1.1323040318013935 | |
| CAMK2G Cytosol Proteoglycans in cancer 1.1323040318013935 | |
| CAMK2G Cytosol Tuberculosis 1.1323040318013935 | |
| CAMK2G Cytosol Wnt signaling pathway 1.1323040318013935 | |
| CAMK2G Cytosol cAMP signaling pathway 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Adrenergic signaling in cardiomyocytes 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Aldosterone synthesis and secretion 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Amphetamine addiction 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Axon guidance 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Calcium signaling pathway 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Cholinergic synapse 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Circadian entrainment 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Cushing syndrome 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Diabetic cardiomyopathy 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Dopaminergic synapse 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum ErbB signaling pathway 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Gastric acid secretion 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Glioma 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Glucagon signaling pathway 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum GnRH signaling pathway 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum HIF-1 signaling pathway 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Inflammatory mediator regulation of TRP channels 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Insulin secretion 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Lipid and atherosclerosis 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Long-term potentiation 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Melanogenesis 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Necroptosis 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Neurotrophin signaling pathway 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Olfactory transduction 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Oocyte meiosis 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Oxytocin signaling pathway 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Parkinson disease 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Pathways in cancer 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Pathways of neurodegeneration - multiple diseases 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Proteoglycans in cancer 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Tuberculosis 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum Wnt signaling pathway 1.1323040318013935 | |
| CAMK2G Endoplasmic Reticulum cAMP signaling pathway 1.1323040318013935 | |
| CAMK2G Plasma membrane Adrenergic signaling in cardiomyocytes 1.1323040318013935 | |
| CAMK2G Plasma membrane Aldosterone synthesis and secretion 1.1323040318013935 | |
| CAMK2G Plasma membrane Amphetamine addiction 1.1323040318013935 | |
| CAMK2G Plasma membrane Axon guidance 1.1323040318013935 | |
| CAMK2G Plasma membrane Calcium signaling pathway 1.1323040318013935 | |
| CAMK2G Plasma membrane Cholinergic synapse 1.1323040318013935 | |
| CAMK2G Plasma membrane Circadian entrainment 1.1323040318013935 | |
| CAMK2G Plasma membrane Cushing syndrome 1.1323040318013935 | |
| CAMK2G Plasma membrane Diabetic cardiomyopathy 1.1323040318013935 | |
| CAMK2G Plasma membrane Dopaminergic synapse 1.1323040318013935 | |
| CAMK2G Plasma membrane ErbB signaling pathway 1.1323040318013935 | |
| CAMK2G Plasma membrane Gastric acid secretion 1.1323040318013935 | |
| CAMK2G Plasma membrane Glioma 1.1323040318013935 | |
| CAMK2G Plasma membrane Glucagon signaling pathway 1.1323040318013935 | |
| CAMK2G Plasma membrane GnRH signaling pathway 1.1323040318013935 | |
| CAMK2G Plasma membrane HIF-1 signaling pathway 1.1323040318013935 | |
| CAMK2G Plasma membrane Inflammatory mediator regulation of TRP channels 1.1323040318013935 | |
| CAMK2G Plasma membrane Insulin secretion 1.1323040318013935 | |
| CAMK2G Plasma membrane Lipid and atherosclerosis 1.1323040318013935 | |
| CAMK2G Plasma membrane Long-term potentiation 1.1323040318013935 | |
| CAMK2G Plasma membrane Melanogenesis 1.1323040318013935 | |
| CAMK2G Plasma membrane Necroptosis 1.1323040318013935 | |
| CAMK2G Plasma membrane Neurotrophin signaling pathway 1.1323040318013935 | |
| CAMK2G Plasma membrane Olfactory transduction 1.1323040318013935 | |
| CAMK2G Plasma membrane Oocyte meiosis 1.1323040318013935 | |
| CAMK2G Plasma membrane Oxytocin signaling pathway 1.1323040318013935 | |
| CAMK2G Plasma membrane Parkinson disease 1.1323040318013935 | |
| CAMK2G Plasma membrane Pathways in cancer 1.1323040318013935 | |
| CAMK2G Plasma membrane Pathways of neurodegeneration - multiple diseases 1.1323040318013935 | |
| CAMK2G Plasma membrane Proteoglycans in cancer 1.1323040318013935 | |
| CAMK2G Plasma membrane Tuberculosis 1.1323040318013935 | |
| CAMK2G Plasma membrane Wnt signaling pathway 1.1323040318013935 | |
| CAMK2G Plasma membrane cAMP signaling pathway 1.1323040318013935 | |
| CAMK4 Nucleus Alcoholism 1.133707665856589 | |
| CAMK4 Nucleus Aldosterone synthesis and secretion 1.133707665856589 | |
| CAMK4 Nucleus Amphetamine addiction 1.133707665856589 | |
| CAMK4 Nucleus Apelin signaling pathway 1.133707665856589 | |
| CAMK4 Nucleus Calcium signaling pathway 1.133707665856589 | |
| CAMK4 Nucleus Cholinergic synapse 1.133707665856589 | |
| CAMK4 Nucleus Glioma 1.133707665856589 | |
| CAMK4 Nucleus Long-term potentiation 1.133707665856589 | |
| CAMK4 Nucleus Longevity regulating pathway 1.133707665856589 | |
| CAMK4 Nucleus Neurotrophin signaling pathway 1.133707665856589 | |
| CAMK4 Nucleus Osteoclast differentiation 1.133707665856589 | |
| CAMK4 Nucleus Oxytocin signaling pathway 1.133707665856589 | |
| CAMK4 Nucleus cAMP signaling pathway 1.133707665856589 | |
| CAMKK1 Cytosol Summary 1.0488717760913542 | |
| CAMKK2 Cytosol Summary 1.0907905837967653 | |
| CAMKK2 Nucleus Summary 1.0907905837967653 | |
| CAMKMT Cytosol Summary 1.2888980453688246 | |
| CAMKMT Nucleus Summary 1.2888980453688246 | |
| CAMLG Cytosol Summary 0.5840811418988754 | |
| CAMLG Endoplasmic Reticulum Summary 0.5840811418988754 | |
| CAMLG Nucleus Summary 0.5840811418988754 | |
| CAMP Extracellular space NOD-like receptor signaling pathway 0.7068055370625109 | |
| CAMP Extracellular space Neutrophil extracellular trap formation 0.7068055370625109 | |
| CAMP Extracellular space Salivary secretion 0.7068055370625109 | |
| CAMP Extracellular space Staphylococcus aureus infection 0.7068055370625109 | |
| CAMP Extracellular space Tuberculosis 0.7068055370625109 | |
| CAMSAP1 Cytosol Summary 1.3264550113808624 | |
| CAMSAP1 Mitochondrion Summary 1.3264550113808624 | |
| CAMSAP2 Cytoskeleton Summary 1.823619839811707 | |
| CAMSAP2 Cytosol Summary 1.823619839811707 | |
| CAMSAP3 Cytoskeleton Summary 0.9483016668309444 | |
| CAMSAP3 Cytosol Summary 0.9483016668309444 | |
| CAMSAP3 Nucleus Summary 0.9483016668309444 | |
| CAMSAP3 Plasma membrane Summary 0.9483016668309444 | |
| CAND1 Cytosol Summary 0.9053016616950637 | |
| CAND1 Golgi apparatus Summary 0.9053016616950637 | |
| CAND1 Nucleus Summary 0.9053016616950637 | |
| CAND2 Cytosol Summary 1.7364567670936832 | |
| CAND2 Nucleus Summary 1.7364567670936832 | |
| CANT1 Endoplasmic Reticulum Metabolic pathways 0.4982532749730328 | |
| CANT1 Endoplasmic Reticulum Purine metabolism 0.4982532749730328 | |
| CANT1 Endoplasmic Reticulum Pyrimidine metabolism 0.4982532749730328 | |
| CANT1 Golgi apparatus Metabolic pathways 0.4982532749730328 | |
| CANT1 Golgi apparatus Purine metabolism 0.4982532749730328 | |
| CANT1 Golgi apparatus Pyrimidine metabolism 0.4982532749730328 | |
| CANX Endoplasmic Reticulum Antigen processing and presentation 0.8487118401433574 | |
| CANX Endoplasmic Reticulum Human T-cell leukemia virus 1 infection 0.8487118401433574 | |
| CANX Endoplasmic Reticulum Phagosome 0.8487118401433574 | |
| CANX Endoplasmic Reticulum Protein processing in endoplasmic reticulum 0.8487118401433574 | |
| CANX Endoplasmic Reticulum Thyroid hormone synthesis 0.8487118401433574 | |
| CAP1 Cytosol Coronavirus disease - COVID-19 1.5593959997845892 | |
| CAP1 Cytosol Epstein-Barr virus infection 1.5593959997845892 | |
| CAP1 Cytosol Hepatitis B 1.5593959997845892 | |
| CAP1 Cytosol Hepatitis C 1.5593959997845892 | |
| CAP1 Cytosol Herpes simplex virus 1 infection 1.5593959997845892 | |
| CAP1 Cytosol Human papillomavirus infection 1.5593959997845892 | |
| CAP1 Cytosol IL-17 signaling pathway 1.5593959997845892 | |
| CAP1 Cytosol Influenza A 1.5593959997845892 | |
| CAP1 Cytosol Kaposi sarcoma-associated herpesvirus infection 1.5593959997845892 | |
| CAP1 Cytosol Lipid and atherosclerosis 1.5593959997845892 | |
| CAP1 Cytosol Measles 1.5593959997845892 | |
| CAP1 Cytosol NF-kappa B signaling pathway 1.5593959997845892 | |
| CAP1 Cytosol NOD-like receptor signaling pathway 1.5593959997845892 | |
| CAP1 Cytosol Pathways in cancer 1.5593959997845892 | |
| CAP1 Cytosol RIG-I-like receptor signaling pathway 1.5593959997845892 | |
| CAP1 Cytosol Small cell lung cancer 1.5593959997845892 | |
| CAP1 Cytosol TNF signaling pathway 1.5593959997845892 | |
| CAP1 Cytosol Toll-like receptor signaling pathway 1.5593959997845892 | |
| CAP1 Cytosol Viral carcinogenesis 1.5593959997845892 | |
| CAP1 Plasma membrane Coronavirus disease - COVID-19 1.5593959997845892 | |
| CAP1 Plasma membrane Epstein-Barr virus infection 1.5593959997845892 | |
| CAP1 Plasma membrane Hepatitis B 1.5593959997845892 | |
| CAP1 Plasma membrane Hepatitis C 1.5593959997845892 | |
| CAP1 Plasma membrane Herpes simplex virus 1 infection 1.5593959997845892 | |
| CAP1 Plasma membrane Human papillomavirus infection 1.5593959997845892 | |
| CAP1 Plasma membrane IL-17 signaling pathway 1.5593959997845892 | |
| CAP1 Plasma membrane Influenza A 1.5593959997845892 | |
| CAP1 Plasma membrane Kaposi sarcoma-associated herpesvirus infection 1.5593959997845892 | |
| CAP1 Plasma membrane Lipid and atherosclerosis 1.5593959997845892 | |
| CAP1 Plasma membrane Measles 1.5593959997845892 | |
| CAP1 Plasma membrane NF-kappa B signaling pathway 1.5593959997845892 | |
| CAP1 Plasma membrane NOD-like receptor signaling pathway 1.5593959997845892 | |
| CAP1 Plasma membrane Pathways in cancer 1.5593959997845892 | |
| CAP1 Plasma membrane RIG-I-like receptor signaling pathway 1.5593959997845892 | |
| CAP1 Plasma membrane Small cell lung cancer 1.5593959997845892 | |
| CAP1 Plasma membrane TNF signaling pathway 1.5593959997845892 | |
| CAP1 Plasma membrane Toll-like receptor signaling pathway 1.5593959997845892 | |
| CAP1 Plasma membrane Viral carcinogenesis 1.5593959997845892 | |
| CAP2 Cytosol Influenza A 1.0337919464570526 | |
| CAP2 Nucleus Influenza A 1.0337919464570526 | |
| CAP2 Plasma membrane Influenza A 1.0337919464570526 | |
| CAPG Nucleus Summary 1.7188982843165053 | |
| CAPN1 Cytosol Alzheimer disease 0.9528874523049854 | |
| CAPN1 Cytosol Apoptosis 0.9528874523049854 | |
| CAPN1 Cytosol Cellular senescence 0.9528874523049854 | |
| CAPN1 Cytosol Necroptosis 0.9528874523049854 | |
| CAPN1 Cytosol Pathways of neurodegeneration - multiple diseases 0.9528874523049854 | |
| CAPN1 Cytosol Protein processing in endoplasmic reticulum 0.9528874523049854 | |
| CAPN1 Cytosol Shigellosis 0.9528874523049854 | |
| CAPN1 Plasma membrane Alzheimer disease 0.9528874523049854 | |
| CAPN1 Plasma membrane Apoptosis 0.9528874523049854 | |
| CAPN1 Plasma membrane Cellular senescence 0.9528874523049854 | |
| CAPN1 Plasma membrane Necroptosis 0.9528874523049854 | |
| CAPN1 Plasma membrane Pathways of neurodegeneration - multiple diseases 0.9528874523049854 | |
| CAPN1 Plasma membrane Protein processing in endoplasmic reticulum 0.9528874523049854 | |
| CAPN1 Plasma membrane Shigellosis 0.9528874523049854 | |
| CAPN13 Nucleus Summary 0.08950716146532063 | |
| CAPN15 Nucleus Summary 1.1609259020880272 | |
| CAPN2 Cytosol Alzheimer disease 0.5951704053588576 | |
| CAPN2 Cytosol Apoptosis 0.5951704053588576 | |
| CAPN2 Cytosol Cellular senescence 0.5951704053588576 | |
| CAPN2 Cytosol Focal adhesion 0.5951704053588576 | |
| CAPN2 Cytosol Necroptosis 0.5951704053588576 | |
| CAPN2 Cytosol Pathways of neurodegeneration - multiple diseases 0.5951704053588576 | |
| CAPN2 Cytosol Protein processing in endoplasmic reticulum 0.5951704053588576 | |
| CAPN2 Cytosol Shigellosis 0.5951704053588576 | |
| CAPN2 Plasma membrane Alzheimer disease 0.5951704053588576 | |
| CAPN2 Plasma membrane Apoptosis 0.5951704053588576 | |
| CAPN2 Plasma membrane Cellular senescence 0.5951704053588576 | |
| CAPN2 Plasma membrane Focal adhesion 0.5951704053588576 | |
| CAPN2 Plasma membrane Necroptosis 0.5951704053588576 | |
| CAPN2 Plasma membrane Pathways of neurodegeneration - multiple diseases 0.5951704053588576 | |
| CAPN2 Plasma membrane Protein processing in endoplasmic reticulum 0.5951704053588576 | |
| CAPN2 Plasma membrane Shigellosis 0.5951704053588576 | |
| CAPN5 Cytosol Summary 1.1776935777937536 | |
| CAPN5 Nucleus Summary 1.1776935777937536 | |
| CAPN6 Cytoskeleton Summary 1.1692585004429104 | |
| CAPN6 Cytosol Summary 1.1692585004429104 | |
| CAPN6 Nucleus Summary 1.1692585004429104 | |
| CAPN7 Cytoskeleton Summary 0.7923993197741859 | |
| CAPN7 Cytosol Summary 0.7923993197741859 | |
| CAPN7 Nucleus Summary 0.7923993197741859 | |
| CAPN9 Cytosol Summary 1.3446943045951436 | |
| CAPN9 Golgi apparatus Summary 1.3446943045951436 | |
| CAPNS1 Cytosol Summary 1.1992008848395104 | |
| CAPNS1 Nucleus Summary 1.1992008848395104 | |
| CAPNS2 Cytosol Summary 1.1494626806396455 | |
| CAPRIN1 Cytosol Summary 1.508857133971485 | |
| CAPS Cytosol Summary 0.9897488313723511 | |
| CAPS Nucleus Summary 0.9897488313723511 | |
| CAPS Plasma membrane Summary 0.9897488313723511 | |
| CAPZA1 Cytosol Summary 1.5714037511291887 | |
| CAPZA2 Cytosol Summary 1.4270792052743464 | |
| CAPZA2 Endoplasmic Reticulum Summary 1.4270792052743464 | |
| CARD10 Cytoskeleton Summary 0.8789485881557221 | |
| CARD10 Cytosol Summary 0.8789485881557221 | |
| CARD11 Cytosol B cell receptor signaling pathway 1.6578033834867392 | |
| CARD11 Cytosol NF-kappa B signaling pathway 1.6578033834867392 | |
| CARD11 Cytosol T cell receptor signaling pathway 1.6578033834867392 | |
| CARD11 Plasma membrane B cell receptor signaling pathway 1.6578033834867392 | |
| CARD11 Plasma membrane NF-kappa B signaling pathway 1.6578033834867392 | |
| CARD11 Plasma membrane T cell receptor signaling pathway 1.6578033834867392 | |
| CARD14 Cytosol NF-kappa B signaling pathway 0.9692780259820948 | |
| CARD14 Plasma membrane NF-kappa B signaling pathway 0.9692780259820948 | |
| CARD19 Cytosol Summary 0.6812344930994506 | |
| CARD19 Mitochondrion Summary 0.6812344930994506 | |
| CARD19 Nucleus Summary 0.6812344930994506 | |
| CARD6 Cytosol Summary 2.7902633071095297 | |
| CARD8 Cytosol Summary 1.6326989776264829 | |
| CARD8 Nucleus Summary 1.6326989776264829 | |
| CARD9 Cytosol Summary 2.234662942369177 | |
| CARHSP1 Cytosol Summary 0.9307477695694912 | |
| CARM1 Nucleus Endocrine resistance 1.8476761193257776 | |
| CARMIL1 Cytosol Summary 1.0688216391704066 | |
| CARMIL2 Cytosol Summary 2.2424335459093783 | |
| CARNMT1 Cytosol Summary 0.7450422310213046 | |
| CARS Cytosol Summary 1.3900869349855358 | |
| CARS2 Mitochondrion Summary 1.754550707104182 | |
| CARS2 Nucleus Summary 1.754550707104182 | |
| CASC3 Cytosol RNA transport 0.8031746043184826 | |
| CASC3 Cytosol mRNA surveillance pathway 0.8031746043184826 | |
| CASC3 Nucleus RNA transport 0.8031746043184826 | |
| CASC3 Nucleus mRNA surveillance pathway 0.8031746043184826 | |
| CASC4 Golgi apparatus Summary 0.5106074256671376 | |
| CASD1 Golgi apparatus Summary 0.26738070121086266 | |
| CASD1 Nucleus Summary 0.26738070121086266 | |
| CASK Cytosol Summary 1.421233736512494 | |
| CASK Extracellular space Summary 1.421233736512494 | |
| CASK Nucleus Summary 1.421233736512494 | |
| CASK Plasma membrane Summary 1.421233736512494 | |
| CASKIN2 Cytosol Summary 1.070438140958934 | |
| CASKIN2 Nucleus Summary 1.070438140958934 | |
| CASKIN2 Plasma membrane Summary 1.070438140958934 | |
| CASP1 Cytosol Summary 2.025602054863224 | |
| CASP1 Nucleus Summary 2.025602054863224 | |
| CASP10 Cytosol Summary 1.4361555954101766 | |
| CASP10 Golgi apparatus Summary 1.4361555954101766 | |
| CASP14 Cytosol Summary 0.38053308141623066 | |
| CASP14 Mitochondrion Summary 0.38053308141623066 | |
| CASP14 Nucleus Summary 0.38053308141623066 | |
| CASP2 Nucleus Summary 1.6479110107969717 | |
| CASP3 Cytosol Summary 1.4885584760021158 | |
| CASP3 Mitochondrion Summary 1.4885584760021158 | |
| CASP3 Nucleus Summary 1.4885584760021158 | |
| CASP4 Cytosol Summary 1.597350222032755 | |
| CASP4 Plasma membrane Summary 1.597350222032755 | |
| CASP6 Cytosol Summary 0.7554680288250958 | |
| CASP6 Nucleus Summary 0.7554680288250958 | |
| CASP7 Cytosol Summary 1.250529645676186 | |
| CASP8 Cytosol Alzheimer disease 1.0664895028740138 | |
| CASP8 Cytosol Apoptosis 1.0664895028740138 | |
| CASP8 Cytosol Apoptosis - multiple species 1.0664895028740138 | |
| CASP8 Cytosol C-type lectin receptor signaling pathway 1.0664895028740138 | |
| CASP8 Cytosol Chagas disease 1.0664895028740138 | |
| CASP8 Cytosol Epstein-Barr virus infection 1.0664895028740138 | |
| CASP8 Cytosol Hepatitis B 1.0664895028740138 | |
| CASP8 Cytosol Hepatitis C 1.0664895028740138 | |
| CASP8 Cytosol Herpes simplex virus 1 infection 1.0664895028740138 | |
| CASP8 Cytosol Human cytomegalovirus infection 1.0664895028740138 | |
| CASP8 Cytosol Human immunodeficiency virus 1 infection 1.0664895028740138 | |
| CASP8 Cytosol Human papillomavirus infection 1.0664895028740138 | |
| CASP8 Cytosol Huntington disease 1.0664895028740138 | |
| CASP8 Cytosol IL-17 signaling pathway 1.0664895028740138 | |
| CASP8 Cytosol Influenza A 1.0664895028740138 | |
| CASP8 Cytosol Kaposi sarcoma-associated herpesvirus infection 1.0664895028740138 | |
| CASP8 Cytosol Legionellosis 1.0664895028740138 | |
| CASP8 Cytosol Lipid and atherosclerosis 1.0664895028740138 | |
| CASP8 Cytosol Measles 1.0664895028740138 | |
| CASP8 Cytosol NOD-like receptor signaling pathway 1.0664895028740138 | |
| CASP8 Cytosol Necroptosis 1.0664895028740138 | |
| CASP8 Cytosol Non-alcoholic fatty liver disease 1.0664895028740138 | |
| CASP8 Cytosol Pathogenic Escherichia coli infection 1.0664895028740138 | |
| CASP8 Cytosol Pathways in cancer 1.0664895028740138 | |
| CASP8 Cytosol Pathways of neurodegeneration - multiple diseases 1.0664895028740138 | |
| CASP8 Cytosol Platinum drug resistance 1.0664895028740138 | |
| CASP8 Cytosol RIG-I-like receptor signaling pathway 1.0664895028740138 | |
| CASP8 Cytosol Salmonella infection 1.0664895028740138 | |
| CASP8 Cytosol TNF signaling pathway 1.0664895028740138 | |
| CASP8 Cytosol Toll-like receptor signaling pathway 1.0664895028740138 | |
| CASP8 Cytosol Toxoplasmosis 1.0664895028740138 | |
| CASP8 Cytosol Tuberculosis 1.0664895028740138 | |
| CASP8 Cytosol Viral carcinogenesis 1.0664895028740138 | |
| CASP8 Cytosol Viral myocarditis 1.0664895028740138 | |
| CASP8 Cytosol p53 signaling pathway 1.0664895028740138 | |
| CASP8 Nucleus Alzheimer disease 1.0664895028740138 | |
| CASP8 Nucleus Apoptosis 1.0664895028740138 | |
| CASP8 Nucleus Apoptosis - multiple species 1.0664895028740138 | |
| CASP8 Nucleus C-type lectin receptor signaling pathway 1.0664895028740138 | |
| CASP8 Nucleus Chagas disease 1.0664895028740138 | |
| CASP8 Nucleus Epstein-Barr virus infection 1.0664895028740138 | |
| CASP8 Nucleus Hepatitis B 1.0664895028740138 | |
| CASP8 Nucleus Hepatitis C 1.0664895028740138 | |
| CASP8 Nucleus Herpes simplex virus 1 infection 1.0664895028740138 | |
| CASP8 Nucleus Human cytomegalovirus infection 1.0664895028740138 | |
| CASP8 Nucleus Human immunodeficiency virus 1 infection 1.0664895028740138 | |
| CASP8 Nucleus Human papillomavirus infection 1.0664895028740138 | |
| CASP8 Nucleus Huntington disease 1.0664895028740138 | |
| CASP8 Nucleus IL-17 signaling pathway 1.0664895028740138 | |
| CASP8 Nucleus Influenza A 1.0664895028740138 | |
| CASP8 Nucleus Kaposi sarcoma-associated herpesvirus infection 1.0664895028740138 | |
| CASP8 Nucleus Legionellosis 1.0664895028740138 | |
| CASP8 Nucleus Lipid and atherosclerosis 1.0664895028740138 | |
| CASP8 Nucleus Measles 1.0664895028740138 | |
| CASP8 Nucleus NOD-like receptor signaling pathway 1.0664895028740138 | |
| CASP8 Nucleus Necroptosis 1.0664895028740138 | |
| CASP8 Nucleus Non-alcoholic fatty liver disease 1.0664895028740138 | |
| CASP8 Nucleus Pathogenic Escherichia coli infection 1.0664895028740138 | |
| CASP8 Nucleus Pathways in cancer 1.0664895028740138 | |
| CASP8 Nucleus Pathways of neurodegeneration - multiple diseases 1.0664895028740138 | |
| CASP8 Nucleus Platinum drug resistance 1.0664895028740138 | |
| CASP8 Nucleus RIG-I-like receptor signaling pathway 1.0664895028740138 | |
| CASP8 Nucleus Salmonella infection 1.0664895028740138 | |
| CASP8 Nucleus TNF signaling pathway 1.0664895028740138 | |
| CASP8 Nucleus Toll-like receptor signaling pathway 1.0664895028740138 | |
| CASP8 Nucleus Toxoplasmosis 1.0664895028740138 | |
| CASP8 Nucleus Tuberculosis 1.0664895028740138 | |
| CASP8 Nucleus Viral carcinogenesis 1.0664895028740138 | |
| CASP8 Nucleus Viral myocarditis 1.0664895028740138 | |
| CASP8 Nucleus p53 signaling pathway 1.0664895028740138 | |
| CASP8 Plasma membrane Alzheimer disease 1.0664895028740138 | |
| CASP8 Plasma membrane Apoptosis 1.0664895028740138 | |
| CASP8 Plasma membrane Apoptosis - multiple species 1.0664895028740138 | |
| CASP8 Plasma membrane C-type lectin receptor signaling pathway 1.0664895028740138 | |
| CASP8 Plasma membrane Chagas disease 1.0664895028740138 | |
| CASP8 Plasma membrane Epstein-Barr virus infection 1.0664895028740138 | |
| CASP8 Plasma membrane Hepatitis B 1.0664895028740138 | |
| CASP8 Plasma membrane Hepatitis C 1.0664895028740138 | |
| CASP8 Plasma membrane Herpes simplex virus 1 infection 1.0664895028740138 | |
| CASP8 Plasma membrane Human cytomegalovirus infection 1.0664895028740138 | |
| CASP8 Plasma membrane Human immunodeficiency virus 1 infection 1.0664895028740138 | |
| CASP8 Plasma membrane Human papillomavirus infection 1.0664895028740138 | |
| CASP8 Plasma membrane Huntington disease 1.0664895028740138 | |
| CASP8 Plasma membrane IL-17 signaling pathway 1.0664895028740138 | |
| CASP8 Plasma membrane Influenza A 1.0664895028740138 | |
| CASP8 Plasma membrane Kaposi sarcoma-associated herpesvirus infection 1.0664895028740138 | |
| CASP8 Plasma membrane Legionellosis 1.0664895028740138 | |
| CASP8 Plasma membrane Lipid and atherosclerosis 1.0664895028740138 | |
| CASP8 Plasma membrane Measles 1.0664895028740138 | |
| CASP8 Plasma membrane NOD-like receptor signaling pathway 1.0664895028740138 | |
| CASP8 Plasma membrane Necroptosis 1.0664895028740138 | |
| CASP8 Plasma membrane Non-alcoholic fatty liver disease 1.0664895028740138 | |
| CASP8 Plasma membrane Pathogenic Escherichia coli infection 1.0664895028740138 | |
| CASP8 Plasma membrane Pathways in cancer 1.0664895028740138 | |
| CASP8 Plasma membrane Pathways of neurodegeneration - multiple diseases 1.0664895028740138 | |
| CASP8 Plasma membrane Platinum drug resistance 1.0664895028740138 | |
| CASP8 Plasma membrane RIG-I-like receptor signaling pathway 1.0664895028740138 | |
| CASP8 Plasma membrane Salmonella infection 1.0664895028740138 | |
| CASP8 Plasma membrane TNF signaling pathway 1.0664895028740138 | |
| CASP8 Plasma membrane Toll-like receptor signaling pathway 1.0664895028740138 | |
| CASP8 Plasma membrane Toxoplasmosis 1.0664895028740138 | |
| CASP8 Plasma membrane Tuberculosis 1.0664895028740138 | |
| CASP8 Plasma membrane Viral carcinogenesis 1.0664895028740138 | |
| CASP8 Plasma membrane Viral myocarditis 1.0664895028740138 | |
| CASP8 Plasma membrane p53 signaling pathway 1.0664895028740138 | |
| CASP9 Cytosol Alzheimer disease 0.9635407030919662 | |
| CASP9 Cytosol Amyotrophic lateral sclerosis 0.9635407030919662 | |
| CASP9 Cytosol Apoptosis 0.9635407030919662 | |
| CASP9 Cytosol Apoptosis - multiple species 0.9635407030919662 | |
| CASP9 Cytosol Colorectal cancer 0.9635407030919662 | |
| CASP9 Cytosol Endometrial cancer 0.9635407030919662 | |
| CASP9 Cytosol Epstein-Barr virus infection 0.9635407030919662 | |
| CASP9 Cytosol Hepatitis B 0.9635407030919662 | |
| CASP9 Cytosol Hepatitis C 0.9635407030919662 | |
| CASP9 Cytosol Herpes simplex virus 1 infection 0.9635407030919662 | |
| CASP9 Cytosol Human cytomegalovirus infection 0.9635407030919662 | |
| CASP9 Cytosol Human immunodeficiency virus 1 infection 0.9635407030919662 | |
| CASP9 Cytosol Huntington disease 0.9635407030919662 | |
| CASP9 Cytosol Influenza A 0.9635407030919662 | |
| CASP9 Cytosol Kaposi sarcoma-associated herpesvirus infection 0.9635407030919662 | |
| CASP9 Cytosol Legionellosis 0.9635407030919662 | |
| CASP9 Cytosol Lipid and atherosclerosis 0.9635407030919662 | |
| CASP9 Cytosol Measles 0.9635407030919662 | |
| CASP9 Cytosol Non-small cell lung cancer 0.9635407030919662 | |
| CASP9 Cytosol PI3K-Akt signaling pathway 0.9635407030919662 | |
| CASP9 Cytosol Pancreatic cancer 0.9635407030919662 | |
| CASP9 Cytosol Parkinson disease 0.9635407030919662 | |
| CASP9 Cytosol Pathogenic Escherichia coli infection 0.9635407030919662 | |
| CASP9 Cytosol Pathways in cancer 0.9635407030919662 | |
| CASP9 Cytosol Pathways of neurodegeneration - multiple diseases 0.9635407030919662 | |
| CASP9 Cytosol Platinum drug resistance 0.9635407030919662 | |
| CASP9 Cytosol Prion disease 0.9635407030919662 | |
| CASP9 Cytosol Prostate cancer 0.9635407030919662 | |
| CASP9 Cytosol Small cell lung cancer 0.9635407030919662 | |
| CASP9 Cytosol Thyroid hormone signaling pathway 0.9635407030919662 | |
| CASP9 Cytosol Toxoplasmosis 0.9635407030919662 | |
| CASP9 Cytosol Tuberculosis 0.9635407030919662 | |
| CASP9 Cytosol VEGF signaling pathway 0.9635407030919662 | |
| CASP9 Cytosol Viral myocarditis 0.9635407030919662 | |
| CASP9 Cytosol p53 signaling pathway 0.9635407030919662 | |
| CASP9 Mitochondrion Alzheimer disease 0.9635407030919662 | |
| CASP9 Mitochondrion Amyotrophic lateral sclerosis 0.9635407030919662 | |
| CASP9 Mitochondrion Apoptosis 0.9635407030919662 | |
| CASP9 Mitochondrion Apoptosis - multiple species 0.9635407030919662 | |
| CASP9 Mitochondrion Colorectal cancer 0.9635407030919662 | |
| CASP9 Mitochondrion Endometrial cancer 0.9635407030919662 | |
| CASP9 Mitochondrion Epstein-Barr virus infection 0.9635407030919662 | |
| CASP9 Mitochondrion Hepatitis B 0.9635407030919662 | |
| CASP9 Mitochondrion Hepatitis C 0.9635407030919662 | |
| CASP9 Mitochondrion Herpes simplex virus 1 infection 0.9635407030919662 | |
| CASP9 Mitochondrion Human cytomegalovirus infection 0.9635407030919662 | |
| CASP9 Mitochondrion Human immunodeficiency virus 1 infection 0.9635407030919662 | |
| CASP9 Mitochondrion Huntington disease 0.9635407030919662 | |
| CASP9 Mitochondrion Influenza A 0.9635407030919662 | |
| CASP9 Mitochondrion Kaposi sarcoma-associated herpesvirus infection 0.9635407030919662 | |
| CASP9 Mitochondrion Legionellosis 0.9635407030919662 | |
| CASP9 Mitochondrion Lipid and atherosclerosis 0.9635407030919662 | |
| CASP9 Mitochondrion Measles 0.9635407030919662 | |
| CASP9 Mitochondrion Non-small cell lung cancer 0.9635407030919662 | |
| CASP9 Mitochondrion PI3K-Akt signaling pathway 0.9635407030919662 | |
| CASP9 Mitochondrion Pancreatic cancer 0.9635407030919662 | |
| CASP9 Mitochondrion Parkinson disease 0.9635407030919662 | |
| CASP9 Mitochondrion Pathogenic Escherichia coli infection 0.9635407030919662 | |
| CASP9 Mitochondrion Pathways in cancer 0.9635407030919662 | |
| CASP9 Mitochondrion Pathways of neurodegeneration - multiple diseases 0.9635407030919662 | |
| CASP9 Mitochondrion Platinum drug resistance 0.9635407030919662 | |
| CASP9 Mitochondrion Prion disease 0.9635407030919662 | |
| CASP9 Mitochondrion Prostate cancer 0.9635407030919662 | |
| CASP9 Mitochondrion Small cell lung cancer 0.9635407030919662 | |
| CASP9 Mitochondrion Thyroid hormone signaling pathway 0.9635407030919662 | |
| CASP9 Mitochondrion Toxoplasmosis 0.9635407030919662 | |
| CASP9 Mitochondrion Tuberculosis 0.9635407030919662 | |
| CASP9 Mitochondrion VEGF signaling pathway 0.9635407030919662 | |
| CASP9 Mitochondrion Viral myocarditis 0.9635407030919662 | |
| CASP9 Mitochondrion p53 signaling pathway 0.9635407030919662 | |
| CASQ2 Endoplasmic Reticulum Calcium signaling pathway 2.830082371925081 | |
| CASQ2 Endoplasmic Reticulum Cardiac muscle contraction 2.830082371925081 | |
| CAST Cytosol Summary 0.9872331872435088 | |
| CAST Endoplasmic Reticulum Summary 0.9872331872435088 | |
| CAST Plasma membrane Summary 0.9872331872435088 | |
| CASZ1 Cytosol Summary 0.7117315548443421 | |
| CASZ1 Nucleus Summary 0.7117315548443421 | |
| CAT Cytosol Amyotrophic lateral sclerosis 1.7770929270025613 | |
| CAT Cytosol Carbon metabolism 1.7770929270025613 | |
| CAT Cytosol FoxO signaling pathway 1.7770929270025613 | |
| CAT Cytosol Glyoxylate and dicarboxylate metabolism 1.7770929270025613 | |
| CAT Cytosol Longevity regulating pathway 1.7770929270025613 | |
| CAT Cytosol Longevity regulating pathway - multiple species 1.7770929270025613 | |
| CAT Cytosol Metabolic pathways 1.7770929270025613 | |
| CAT Cytosol Pathways of neurodegeneration - multiple diseases 1.7770929270025613 | |
| CAT Cytosol Peroxisome 1.7770929270025613 | |
| CAT Cytosol Phenylalanine metabolism 1.7770929270025613 | |
| CAT Cytosol Tryptophan metabolism 1.7770929270025613 | |
| CAT Peroxisome Amyotrophic lateral sclerosis 1.7770929270025613 | |
| CAT Peroxisome Carbon metabolism 1.7770929270025613 | |
| CAT Peroxisome FoxO signaling pathway 1.7770929270025613 | |
| CAT Peroxisome Glyoxylate and dicarboxylate metabolism 1.7770929270025613 | |
| CAT Peroxisome Longevity regulating pathway 1.7770929270025613 | |
| CAT Peroxisome Longevity regulating pathway - multiple species 1.7770929270025613 | |
| CAT Peroxisome Metabolic pathways 1.7770929270025613 | |
| CAT Peroxisome Pathways of neurodegeneration - multiple diseases 1.7770929270025613 | |
| CAT Peroxisome Peroxisome 1.7770929270025613 | |
| CAT Peroxisome Phenylalanine metabolism 1.7770929270025613 | |
| CAT Peroxisome Tryptophan metabolism 1.7770929270025613 | |
| CAV1 Endosome Bacterial invasion of epithelial cells 0.7063018288464669 | |
| CAV1 Endosome Endocytosis 0.7063018288464669 | |
| CAV1 Endosome Fluid shear stress and atherosclerosis 0.7063018288464669 | |
| CAV1 Endosome Focal adhesion 0.7063018288464669 | |
| CAV1 Endosome Prion disease 0.7063018288464669 | |
| CAV1 Endosome Proteoglycans in cancer 0.7063018288464669 | |
| CAV1 Endosome Viral myocarditis 0.7063018288464669 | |
| CAV1 Golgi apparatus Bacterial invasion of epithelial cells 0.7063018288464669 | |
| CAV1 Golgi apparatus Endocytosis 0.7063018288464669 | |
| CAV1 Golgi apparatus Fluid shear stress and atherosclerosis 0.7063018288464669 | |
| CAV1 Golgi apparatus Focal adhesion 0.7063018288464669 | |
| CAV1 Golgi apparatus Prion disease 0.7063018288464669 | |
| CAV1 Golgi apparatus Proteoglycans in cancer 0.7063018288464669 | |
| CAV1 Golgi apparatus Viral myocarditis 0.7063018288464669 | |
| CAV1 Plasma membrane Bacterial invasion of epithelial cells 0.7063018288464669 | |
| CAV1 Plasma membrane Endocytosis 0.7063018288464669 | |
| CAV1 Plasma membrane Fluid shear stress and atherosclerosis 0.7063018288464669 | |
| CAV1 Plasma membrane Focal adhesion 0.7063018288464669 | |
| CAV1 Plasma membrane Prion disease 0.7063018288464669 | |
| CAV1 Plasma membrane Proteoglycans in cancer 0.7063018288464669 | |
| CAV1 Plasma membrane Viral myocarditis 0.7063018288464669 | |
| CBFA2T2 Nucleus Summary 1.5870075477054342 | |
| CBFA2T3 Golgi apparatus Summary 1.7279776584794218 | |
| CBFA2T3 Nucleus Summary 1.7279776584794218 | |
| CBFB Cytosol Summary 2.0235851923214767 | |
| CBFB Nucleus Summary 2.0235851923214767 | |
| CBL Cytosol Bacterial invasion of epithelial cells 2.058430961299096 | |
| CBL Cytosol Chronic myeloid leukemia 2.058430961299096 | |
| CBL Cytosol Endocytosis 2.058430961299096 | |
| CBL Cytosol ErbB signaling pathway 2.058430961299096 | |
| CBL Cytosol Insulin signaling pathway 2.058430961299096 | |
| CBL Cytosol Pathways in cancer 2.058430961299096 | |
| CBL Cytosol Proteoglycans in cancer 2.058430961299096 | |
| CBL Cytosol Ubiquitin mediated proteolysis 2.058430961299096 | |
| CBL Plasma membrane Bacterial invasion of epithelial cells 2.058430961299096 | |
| CBL Plasma membrane Chronic myeloid leukemia 2.058430961299096 | |
| CBL Plasma membrane Endocytosis 2.058430961299096 | |
| CBL Plasma membrane ErbB signaling pathway 2.058430961299096 | |
| CBL Plasma membrane Insulin signaling pathway 2.058430961299096 | |
| CBL Plasma membrane Pathways in cancer 2.058430961299096 | |
| CBL Plasma membrane Proteoglycans in cancer 2.058430961299096 | |
| CBL Plasma membrane Ubiquitin mediated proteolysis 2.058430961299096 | |
| CBLB Cytosol Summary 1.720918893482219 | |
| CBLB Nucleus Summary 1.720918893482219 | |
| CBLL1 Nucleus Summary 1.4143164424378991 | |
| CBR1 Cytosol Summary 2.554886075089249 | |
| CBR1 Nucleus Summary 2.554886075089249 | |
| CBR3 Cytosol Arachidonic acid metabolism 1.9017411362014898 | |
| CBR3 Cytosol Metabolic pathways 1.9017411362014898 | |
| CBR3 Cytosol Metabolism of xenobiotics by cytochrome P450 1.9017411362014898 | |
| CBR3 Nucleus Arachidonic acid metabolism 1.9017411362014898 | |
| CBR3 Nucleus Metabolic pathways 1.9017411362014898 | |
| CBR3 Nucleus Metabolism of xenobiotics by cytochrome P450 1.9017411362014898 | |
| CBR4 Mitochondrion Fatty acid biosynthesis 0.4864977906619215 | |
| CBR4 Mitochondrion Fatty acid metabolism 0.4864977906619215 | |
| CBR4 Mitochondrion Metabolic pathways 0.4864977906619215 | |
| CBS Cytosol Biosynthesis of amino acids 1.6349354010484571 | |
| CBS Cytosol Cysteine and methionine metabolism 1.6349354010484571 | |
| CBS Cytosol Glycine serine and threonine metabolism 1.6349354010484571 | |
| CBS Cytosol Metabolic pathways 1.6349354010484571 | |
| CBS Nucleus Biosynthesis of amino acids 1.6349354010484571 | |
| CBS Nucleus Cysteine and methionine metabolism 1.6349354010484571 | |
| CBS Nucleus Glycine serine and threonine metabolism 1.6349354010484571 | |
| CBS Nucleus Metabolic pathways 1.6349354010484571 | |
| CBWD2 Plasma membrane Summary 1.4102520888061651 | |
| CBX1 Cytoskeleton Summary 1.7388839892954953 | |
| CBX1 Endoplasmic Reticulum Summary 1.7388839892954953 | |
| CBX1 Nucleus Summary 1.7388839892954953 | |
| CBX2 Endoplasmic Reticulum Summary 2.709261893264563 | |
| CBX2 Nucleus Summary 2.709261893264563 | |
| CBX3 Cytoskeleton Shigellosis 2.2265488892568253 | |
| CBX3 Nucleus Shigellosis 2.2265488892568253 | |
| CBX4 Golgi apparatus Summary 0.42915609001282734 | |
| CBX4 Nucleus Summary 0.42915609001282734 | |
| CBX5 Nucleus Summary 1.3267041853863175 | |
| CBX6 Mitochondrion Summary 1.0961573145143622 | |
| CBX6 Nucleus Summary 1.0961573145143622 | |
| CBX7 Cytosol Summary 1.170539790810562 | |
| CBX7 Endoplasmic Reticulum Summary 1.170539790810562 | |
| CBX7 Nucleus Summary 1.170539790810562 | |
| CBX8 Endoplasmic Reticulum Summary 0.8338196211667558 | |
| CBX8 Nucleus Summary 0.8338196211667558 | |
| CC2D1A Cytoskeleton Summary 1.0545353488786355 | |
| CC2D1A Cytosol Summary 1.0545353488786355 | |
| CC2D1A Nucleus Summary 1.0545353488786355 | |
| CC2D1A Plasma membrane Summary 1.0545353488786355 | |
| CC2D1B Cytosol Summary 1.1683539491624344 | |
| CC2D1B Nucleus Summary 1.1683539491624344 | |
| CC2D2A Cytosol Summary 1.3177530747075463 | |
| CCAR1 Cytosol Summary 1.114571025060248 | |
| CCAR1 Golgi apparatus Summary 1.114571025060248 | |
| CCAR1 Nucleus Summary 1.114571025060248 | |
| CCAR2 Mitochondrion Summary 1.3963511633755967 | |
| CCAR2 Nucleus Summary 1.3963511633755967 | |
| CCDC102A Nucleus Summary 1.430321495336322 | |
| CCDC115 Cytosol Summary 1.0775485645203318 | |
| CCDC115 Endosome Summary 1.0775485645203318 | |
| CCDC115 Plasma membrane Summary 1.0775485645203318 | |
| CCDC117 Cytoskeleton Summary 0.3413566456044087 | |
| CCDC117 Cytosol Summary 0.3413566456044087 | |
| CCDC117 Nucleus Summary 0.3413566456044087 | |
| CCDC12 Nucleus Summary 1.3702281752645722 | |
| CCDC120 Cytosol Summary 1.6791408253358584 | |
| CCDC120 Mitochondrion Summary 1.6791408253358584 | |
| CCDC121 Cytoskeleton Summary 0.5244339032733413 | |
| CCDC121 Cytosol Summary 0.5244339032733413 | |
| CCDC124 Cytosol Summary 1.383310958228985 | |
| CCDC124 Plasma membrane Summary 1.383310958228985 | |
| CCDC125 Cytoskeleton Summary 0.33075583651368184 | |
| CCDC125 Cytosol Summary 0.33075583651368184 | |
| CCDC125 Nucleus Summary 0.33075583651368184 | |
| CCDC127 Nucleus Summary 0.634932119081662 | |
| CCDC13 Cytoskeleton Summary 0.6844866387505587 | |
| CCDC13 Cytosol Summary 0.6844866387505587 | |
| CCDC130 Cytosol Summary 2.061053989392949 | |
| CCDC134 Nucleus Summary 2.7592557406250524 | |
| CCDC137 Mitochondrion Summary 2.545240772980359 | |
| CCDC137 Nucleus Summary 2.545240772980359 | |
| CCDC14 Cytoskeleton Summary 0.5201272483448014 | |
| CCDC14 Cytosol Summary 0.5201272483448014 | |
| CCDC141 Nucleus Summary 1.230222916293887 | |
| CCDC144A Cytosol Summary 0.9643559368954654 | |
| CCDC144A Nucleus Summary 0.9643559368954654 | |
| CCDC146 Cytosol Summary 1.1297065144679104 | |
| CCDC146 Golgi apparatus Summary 1.1297065144679104 | |
| CCDC149 Nucleus Summary 0.5531978032164965 | |
| CCDC150 Nucleus Summary 0.23311239173643694 | |
| CCDC151 Nucleus Summary 1.7214692438933967 | |
| CCDC168 Cytoskeleton Summary 1.3209810315914163 | |
| CCDC168 Cytosol Summary 1.3209810315914163 | |
| CCDC168 Nucleus Summary 1.3209810315914163 | |
| CCDC174 Nucleus Summary 2.00208317923561 | |
| CCDC175 Cytosol Summary 0.9245044477162468 | |
| CCDC175 Nucleus Summary 0.9245044477162468 | |
| CCDC18 Cytosol Summary 1.7528809748864498 | |
| CCDC18 Nucleus Summary 1.7528809748864498 | |
| CCDC181 Cytosol Summary 2.1325319023820475 | |
| CCDC181 Nucleus Summary 2.1325319023820475 | |
| CCDC186 Golgi apparatus Summary 1.0326349139754227 | |
| CCDC22 Cytosol Summary 1.0587690966265826 | |
| CCDC22 Endosome Summary 1.0587690966265826 | |
| CCDC22 Nucleus Summary 1.0587690966265826 | |
| CCDC25 Cytosol Summary 1.2522277884352526 | |
| CCDC25 Golgi apparatus Summary 1.2522277884352526 | |
| CCDC25 Nucleus Summary 1.2522277884352526 | |
| CCDC25 Plasma membrane Summary 1.2522277884352526 | |
| CCDC28A Cytosol Summary 0.9985817864663616 | |
| CCDC28A Nucleus Summary 0.9985817864663616 | |
| CCDC28A Plasma membrane Summary 0.9985817864663616 | |
| CCDC43 Cytosol Summary 1.343812672035008 | |
| CCDC47 Endoplasmic Reticulum Summary 0.9224508062643232 | |
| CCDC50 Cytosol Summary 1.451404330969018 | |
| CCDC50 Mitochondrion Summary 1.451404330969018 | |
| CCDC51 Cytoskeleton Summary 1.7990404483941846 | |
| CCDC51 Mitochondrion Summary 1.7990404483941846 | |
| CCDC51 Nucleus Summary 1.7990404483941846 | |
| CCDC53 Cytosol Summary 1.301047211247257 | |
| CCDC57 Cytoskeleton Summary 1.3010823175059891 | |
| CCDC57 Cytosol Summary 1.3010823175059891 | |
| CCDC58 Mitochondrion Summary 2.3230917032382514 | |
| CCDC58 Nucleus Summary 2.3230917032382514 | |
| CCDC6 Cytosol Pathways in cancer 1.0689729107030512 | |
| CCDC6 Cytosol Thyroid cancer 1.0689729107030512 | |
| CCDC6 Endosome Pathways in cancer 1.0689729107030512 | |
| CCDC6 Endosome Thyroid cancer 1.0689729107030512 | |
| CCDC6 Plasma membrane Pathways in cancer 1.0689729107030512 | |
| CCDC6 Plasma membrane Thyroid cancer 1.0689729107030512 | |
| CCDC61 Cytosol Summary 1.1724954641457663 | |
| CCDC61 Nucleus Summary 1.1724954641457663 | |
| CCDC7 Cytosol Summary 1.1386268773722488 | |
| CCDC7 Mitochondrion Summary 1.1386268773722488 | |
| CCDC7 Nucleus Summary 1.1386268773722488 | |
| CCDC71L Cytoskeleton Summary 2.1401580963426743 | |
| CCDC71L Cytosol Summary 2.1401580963426743 | |
| CCDC71L Golgi apparatus Summary 2.1401580963426743 | |
| CCDC8 Cytosol Summary 1.146097488572809 | |
| CCDC8 Nucleus Summary 1.146097488572809 | |
| CCDC8 Plasma membrane Summary 1.146097488572809 | |
| CCDC80 Extracellular space Summary 0.9682405238074796 | |
| CCDC85B Cytoskeleton Summary 1.832749932642256 | |
| CCDC85B Nucleus Summary 1.832749932642256 | |
| CCDC85C Mitochondrion Summary 1.0372101122120734 | |
| CCDC85C Nucleus Summary 1.0372101122120734 | |
| CCDC85C Plasma membrane Summary 1.0372101122120734 | |
| CCDC86 Mitochondrion Summary 1.3600011571997184 | |
| CCDC86 Nucleus Summary 1.3600011571997184 | |
| CCDC88A Cytosol Summary 2.660323262904755 | |
| CCDC88A Endoplasmic Reticulum Summary 2.660323262904755 | |
| CCDC88A Golgi apparatus Summary 2.660323262904755 | |
| CCDC88A Plasma membrane Summary 2.660323262904755 | |
| CCDC88B Cytoskeleton Summary 1.8594705504849476 | |
| CCDC88B Cytosol Summary 1.8594705504849476 | |
| CCDC88B Nucleus Summary 1.8594705504849476 | |
| CCDC88C Cytosol Summary 0.4509561573514429 | |
| CCDC88C Nucleus Summary 0.4509561573514429 | |
| CCDC9 Cytosol Summary 0.8198667632080029 | |
| CCDC90B Mitochondrion Summary 1.7423238723522998 | |
| CCDC91 Golgi apparatus Summary 0.9587479115396442 | |
| CCDC91 Nucleus Summary 0.9587479115396442 | |
| CCDC92 Cytoskeleton Summary 2.1527759707205734 | |
| CCDC92 Cytosol Summary 2.1527759707205734 | |
| CCDC92 Nucleus Summary 2.1527759707205734 | |
| CCDC93 Cytosol Summary 0.9173295442827274 | |
| CCDC93 Endosome Summary 0.9173295442827274 | |
| CCDC93 Plasma membrane Summary 0.9173295442827274 | |
| CCDC94 Nucleus Summary 1.4830707817298507 | |
| CCDC97 Cytosol Summary 1.6618740856499483 | |
| CCDC97 Nucleus Summary 1.6618740856499483 | |
| CCDC97 Plasma membrane Summary 1.6618740856499483 | |
| CCHCR1 Cytosol Summary 1.2736627433106371 | |
| CCHCR1 Nucleus Summary 1.2736627433106371 | |
| CCL14 Extracellular space Summary 1.5833508057872598 | |
| CCL16 Extracellular space Summary 2.6726776420593654 | |
| CCL18 Extracellular space Summary 1.4635110841622219 | |
| CCL21 Extracellular space Chemokine signaling pathway 1.2750976320295135 | |
| CCL21 Extracellular space Cytokine-cytokine receptor interaction 1.2750976320295135 | |
| CCL21 Extracellular space NF-kappa B signaling pathway 1.2750976320295135 | |
| CCL21 Extracellular space Viral protein interaction with cytokine and cytokine receptor 1.2750976320295135 | |
| CCL5 Cytosol Summary 1.3360360288239002 | |
| CCM2 Cytosol Summary 1.136819359829594 | |
| CCM2 Mitochondrion Summary 1.136819359829594 | |
| CCNA2 Cytosol AMPK signaling pathway 2.002546544037424 | |
| CCNA2 Cytosol Acute myeloid leukemia 2.002546544037424 | |
| CCNA2 Cytosol Cell cycle 2.002546544037424 | |
| CCNA2 Cytosol Cellular senescence 2.002546544037424 | |
| CCNA2 Cytosol Epstein-Barr virus infection 2.002546544037424 | |
| CCNA2 Cytosol Hepatitis B 2.002546544037424 | |
| CCNA2 Cytosol Human T-cell leukemia virus 1 infection 2.002546544037424 | |
| CCNA2 Cytosol Human papillomavirus infection 2.002546544037424 | |
| CCNA2 Cytosol Pathways in cancer 2.002546544037424 | |
| CCNA2 Cytosol Progesterone-mediated oocyte maturation 2.002546544037424 | |
| CCNA2 Cytosol Transcriptional misregulation in cancer 2.002546544037424 | |
| CCNA2 Cytosol Viral carcinogenesis 2.002546544037424 | |
| CCNA2 Nucleus AMPK signaling pathway 2.002546544037424 | |
| CCNA2 Nucleus Acute myeloid leukemia 2.002546544037424 | |
| CCNA2 Nucleus Cell cycle 2.002546544037424 | |
| CCNA2 Nucleus Cellular senescence 2.002546544037424 | |
| CCNA2 Nucleus Epstein-Barr virus infection 2.002546544037424 | |
| CCNA2 Nucleus Hepatitis B 2.002546544037424 | |
| CCNA2 Nucleus Human T-cell leukemia virus 1 infection 2.002546544037424 | |
| CCNA2 Nucleus Human papillomavirus infection 2.002546544037424 | |
| CCNA2 Nucleus Pathways in cancer 2.002546544037424 | |
| CCNA2 Nucleus Progesterone-mediated oocyte maturation 2.002546544037424 | |
| CCNA2 Nucleus Transcriptional misregulation in cancer 2.002546544037424 | |
| CCNA2 Nucleus Viral carcinogenesis 2.002546544037424 | |
| CCNB1 Cytoskeleton Cell cycle 3.0060676858813618 | |
| CCNB1 Cytoskeleton Cellular senescence 3.0060676858813618 | |
| CCNB1 Cytoskeleton FoxO signaling pathway 3.0060676858813618 | |
| CCNB1 Cytoskeleton Human immunodeficiency virus 1 infection 3.0060676858813618 | |
| CCNB1 Cytoskeleton Oocyte meiosis 3.0060676858813618 | |
| CCNB1 Cytoskeleton Progesterone-mediated oocyte maturation 3.0060676858813618 | |
| CCNB1 Cytoskeleton p53 signaling pathway 3.0060676858813618 | |
| CCNB1 Cytosol Cell cycle 3.0060676858813618 | |
| CCNB1 Cytosol Cellular senescence 3.0060676858813618 | |
| CCNB1 Cytosol FoxO signaling pathway 3.0060676858813618 | |
| CCNB1 Cytosol Human immunodeficiency virus 1 infection 3.0060676858813618 | |
| CCNB1 Cytosol Oocyte meiosis 3.0060676858813618 | |
| CCNB1 Cytosol Progesterone-mediated oocyte maturation 3.0060676858813618 | |
| CCNB1 Cytosol p53 signaling pathway 3.0060676858813618 | |
| CCNB1 Nucleus Cell cycle 3.0060676858813618 | |
| CCNB1 Nucleus Cellular senescence 3.0060676858813618 | |
| CCNB1 Nucleus FoxO signaling pathway 3.0060676858813618 | |
| CCNB1 Nucleus Human immunodeficiency virus 1 infection 3.0060676858813618 | |
| CCNB1 Nucleus Oocyte meiosis 3.0060676858813618 | |
| CCNB1 Nucleus Progesterone-mediated oocyte maturation 3.0060676858813618 | |
| CCNB1 Nucleus p53 signaling pathway 3.0060676858813618 | |
| CCNB2 Cytoskeleton Cell cycle 2.877806150748332 | |
| CCNB2 Cytoskeleton Cellular senescence 2.877806150748332 | |
| CCNB2 Cytoskeleton FoxO signaling pathway 2.877806150748332 | |
| CCNB2 Cytoskeleton Human T-cell leukemia virus 1 infection 2.877806150748332 | |
| CCNB2 Cytoskeleton Human immunodeficiency virus 1 infection 2.877806150748332 | |
| CCNB2 Cytoskeleton Oocyte meiosis 2.877806150748332 | |
| CCNB2 Cytoskeleton Progesterone-mediated oocyte maturation 2.877806150748332 | |
| CCNB2 Cytoskeleton p53 signaling pathway 2.877806150748332 | |
| CCNB2 Cytosol Cell cycle 2.877806150748332 | |
| CCNB2 Cytosol Cellular senescence 2.877806150748332 | |
| CCNB2 Cytosol FoxO signaling pathway 2.877806150748332 | |
| CCNB2 Cytosol Human T-cell leukemia virus 1 infection 2.877806150748332 | |
| CCNB2 Cytosol Human immunodeficiency virus 1 infection 2.877806150748332 | |
| CCNB2 Cytosol Oocyte meiosis 2.877806150748332 | |
| CCNB2 Cytosol Progesterone-mediated oocyte maturation 2.877806150748332 | |
| CCNB2 Cytosol p53 signaling pathway 2.877806150748332 | |
| CCNB2 Golgi apparatus Cell cycle 2.877806150748332 | |
| CCNB2 Golgi apparatus Cellular senescence 2.877806150748332 | |
| CCNB2 Golgi apparatus FoxO signaling pathway 2.877806150748332 | |
| CCNB2 Golgi apparatus Human T-cell leukemia virus 1 infection 2.877806150748332 | |
| CCNB2 Golgi apparatus Human immunodeficiency virus 1 infection 2.877806150748332 | |
| CCNB2 Golgi apparatus Oocyte meiosis 2.877806150748332 | |
| CCNB2 Golgi apparatus Progesterone-mediated oocyte maturation 2.877806150748332 | |
| CCNB2 Golgi apparatus p53 signaling pathway 2.877806150748332 | |
| CCNC Cytosol Summary 1.2261794055611723 | |
| CCNC Nucleus Summary 1.2261794055611723 | |
| CCND1 Nucleus AGE-RAGE signaling pathway in diabetic complications 0.7546689207605601 | |
| CCND1 Nucleus AMPK signaling pathway 0.7546689207605601 | |
| CCND1 Nucleus Acute myeloid leukemia 0.7546689207605601 | |
| CCND1 Nucleus Apelin signaling pathway 0.7546689207605601 | |
| CCND1 Nucleus Bladder cancer 0.7546689207605601 | |
| CCND1 Nucleus Breast cancer 0.7546689207605601 | |
| CCND1 Nucleus Cell cycle 0.7546689207605601 | |
| CCND1 Nucleus Cellular senescence 0.7546689207605601 | |
| CCND1 Nucleus Chemical carcinogenesis - receptor activation 0.7546689207605601 | |
| CCND1 Nucleus Chronic myeloid leukemia 0.7546689207605601 | |
| CCND1 Nucleus Colorectal cancer 0.7546689207605601 | |
| CCND1 Nucleus Cushing syndrome 0.7546689207605601 | |
| CCND1 Nucleus Endocrine resistance 0.7546689207605601 | |
| CCND1 Nucleus Endometrial cancer 0.7546689207605601 | |
| CCND1 Nucleus Epstein-Barr virus infection 0.7546689207605601 | |
| CCND1 Nucleus Focal adhesion 0.7546689207605601 | |
| CCND1 Nucleus FoxO signaling pathway 0.7546689207605601 | |
| CCND1 Nucleus Gastric cancer 0.7546689207605601 | |
| CCND1 Nucleus Glioma 0.7546689207605601 | |
| CCND1 Nucleus Hedgehog signaling pathway 0.7546689207605601 | |
| CCND1 Nucleus Hepatitis C 0.7546689207605601 | |
| CCND1 Nucleus Hepatocellular carcinoma 0.7546689207605601 | |
| CCND1 Nucleus Hippo signaling pathway 0.7546689207605601 | |
| CCND1 Nucleus Human T-cell leukemia virus 1 infection 0.7546689207605601 | |
| CCND1 Nucleus Human cytomegalovirus infection 0.7546689207605601 | |
| CCND1 Nucleus Human papillomavirus infection 0.7546689207605601 | |
| CCND1 Nucleus JAK-STAT signaling pathway 0.7546689207605601 | |
| CCND1 Nucleus Kaposi sarcoma-associated herpesvirus infection 0.7546689207605601 | |
| CCND1 Nucleus Measles 0.7546689207605601 | |
| CCND1 Nucleus Melanoma 0.7546689207605601 | |
| CCND1 Nucleus MicroRNAs in cancer 0.7546689207605601 | |
| CCND1 Nucleus Non-small cell lung cancer 0.7546689207605601 | |
| CCND1 Nucleus Oxytocin signaling pathway 0.7546689207605601 | |
| CCND1 Nucleus PI3K-Akt signaling pathway 0.7546689207605601 | |
| CCND1 Nucleus Pancreatic cancer 0.7546689207605601 | |
| CCND1 Nucleus Pathways in cancer 0.7546689207605601 | |
| CCND1 Nucleus Prolactin signaling pathway 0.7546689207605601 | |
| CCND1 Nucleus Prostate cancer 0.7546689207605601 | |
| CCND1 Nucleus Proteoglycans in cancer 0.7546689207605601 | |
| CCND1 Nucleus Small cell lung cancer 0.7546689207605601 | |
| CCND1 Nucleus Thyroid cancer 0.7546689207605601 | |
| CCND1 Nucleus Thyroid hormone signaling pathway 0.7546689207605601 | |
| CCND1 Nucleus Tight junction 0.7546689207605601 | |
| CCND1 Nucleus Viral carcinogenesis 0.7546689207605601 | |
| CCND1 Nucleus Viral myocarditis 0.7546689207605601 | |
| CCND1 Nucleus Wnt signaling pathway 0.7546689207605601 | |
| CCND1 Nucleus p53 signaling pathway 0.7546689207605601 | |
| CCNDBP1 Nucleus Summary 1.0686541692617901 | |
| CCNH Nucleus Basal transcription factors 1.6700892723685483 | |
| CCNH Nucleus Cell cycle 1.6700892723685483 | |
| CCNH Nucleus Nucleotide excision repair 1.6700892723685483 | |
| CCNK Nucleus Summary 0.8545794672963869 | |
| CCNL1 Nucleus Summary 2.0430553255860526 | |
| CCNL2 Nucleus Summary 2.3055237916387443 | |
| CCNT1 Nucleus Transcriptional misregulation in cancer 0.8114940511015101 | |
| CCNT2 Cytosol Transcriptional misregulation in cancer 1.1455755232570035 | |
| CCNT2 Nucleus Transcriptional misregulation in cancer 1.1455755232570035 | |
| CCNT2 Plasma membrane Transcriptional misregulation in cancer 1.1455755232570035 | |
| CCNY Nucleus Summary 1.6686708274959094 | |
| CCNY Plasma membrane Summary 1.6686708274959094 | |
| CCNYL1 Plasma membrane Summary 1.2401280988686645 | |
| CCP110 Cytoskeleton Summary 1.196375225820317 | |
| CCP110 Cytosol Summary 1.196375225820317 | |
| CCPG1 Cytosol Summary 0.6936054467858884 | |
| CCPG1 Endoplasmic Reticulum Summary 0.6936054467858884 | |
| CCPG1 Golgi apparatus Summary 0.6936054467858884 | |
| CCS Cytosol Amyotrophic lateral sclerosis 1.4936811646167774 | |
| CCS Cytosol Pathways of neurodegeneration - multiple diseases 1.4936811646167774 | |
| CCS Nucleus Amyotrophic lateral sclerosis 1.4936811646167774 | |
| CCS Nucleus Pathways of neurodegeneration - multiple diseases 1.4936811646167774 | |
| CCSAP Cytoskeleton Summary 1.6159161963441424 | |
| CCSAP Cytosol Summary 1.6159161963441424 | |
| CCSAP Nucleus Summary 1.6159161963441424 | |
| CCSER2 Cytosol Summary 1.7556109905207 | |
| CCSER2 Nucleus Summary 1.7556109905207 | |
| CCT2 Cytosol Summary 1.7328520277345558 | |
| CCT3 Cytosol Summary 1.5406476614968947 | |
| CCT3 Plasma membrane Summary 1.5406476614968947 | |
| CCT4 Cytoskeleton Summary 1.7729191950112384 | |
| CCT4 Cytosol Summary 1.7729191950112384 | |
| CCT4 Nucleus Summary 1.7729191950112384 | |
| CCT5 Cytoskeleton Summary 1.6189680553995844 | |
| CCT5 Cytosol Summary 1.6189680553995844 | |
| CCT5 Nucleus Summary 1.6189680553995844 | |
| CCT6A Cytosol Summary 1.6212733885247383 | |
| CCT7 Cytosol Summary 1.5872884095679085 | |
| CCT8 Cytoskeleton Summary 1.318591641930546 | |
| CCT8 Cytosol Summary 1.318591641930546 | |
| CCT8 Nucleus Summary 1.318591641930546 | |
| CCZ1 Cytosol Summary 1.325984585484166 | |
| CCZ1 Lysosome Summary 1.325984585484166 | |
| CD109 Cytosol Summary 1.500803788030971 | |
| CD109 Plasma membrane Summary 1.500803788030971 | |
| CD14 Cytosol Acute myeloid leukemia 1.9256390974579871 | |
| CD14 Cytosol Alzheimer disease 1.9256390974579871 | |
| CD14 Cytosol Amoebiasis 1.9256390974579871 | |
| CD14 Cytosol Amyotrophic lateral sclerosis 1.9256390974579871 | |
| CD14 Cytosol Diabetic cardiomyopathy 1.9256390974579871 | |
| CD14 Cytosol Hematopoietic cell lineage 1.9256390974579871 | |
| CD14 Cytosol Huntington disease 1.9256390974579871 | |
| CD14 Cytosol Legionellosis 1.9256390974579871 | |
| CD14 Cytosol Lipid and atherosclerosis 1.9256390974579871 | |
| CD14 Cytosol MAPK signaling pathway 1.9256390974579871 | |
| CD14 Cytosol Metabolic pathways 1.9256390974579871 | |
| CD14 Cytosol NF-kappa B signaling pathway 1.9256390974579871 | |
| CD14 Cytosol Non-alcoholic fatty liver disease 1.9256390974579871 | |
| CD14 Cytosol Oxidative phosphorylation 1.9256390974579871 | |
| CD14 Cytosol Parkinson disease 1.9256390974579871 | |
| CD14 Cytosol Pathways of neurodegeneration - multiple diseases 1.9256390974579871 | |
| CD14 Cytosol Pertussis 1.9256390974579871 | |
| CD14 Cytosol Phagosome 1.9256390974579871 | |
| CD14 Cytosol Prion disease 1.9256390974579871 | |
| CD14 Cytosol Retrograde endocannabinoid signaling 1.9256390974579871 | |
| CD14 Cytosol Salmonella infection 1.9256390974579871 | |
| CD14 Cytosol Shigellosis 1.9256390974579871 | |
| CD14 Cytosol Thermogenesis 1.9256390974579871 | |
| CD14 Cytosol Toll-like receptor signaling pathway 1.9256390974579871 | |
| CD14 Cytosol Transcriptional misregulation in cancer 1.9256390974579871 | |
| CD14 Cytosol Tuberculosis 1.9256390974579871 | |
| CD14 Plasma membrane Acute myeloid leukemia 1.9256390974579871 | |
| CD14 Plasma membrane Alzheimer disease 1.9256390974579871 | |
| CD14 Plasma membrane Amoebiasis 1.9256390974579871 | |
| CD14 Plasma membrane Amyotrophic lateral sclerosis 1.9256390974579871 | |
| CD14 Plasma membrane Diabetic cardiomyopathy 1.9256390974579871 | |
| CD14 Plasma membrane Hematopoietic cell lineage 1.9256390974579871 | |
| CD14 Plasma membrane Huntington disease 1.9256390974579871 | |
| CD14 Plasma membrane Legionellosis 1.9256390974579871 | |
| CD14 Plasma membrane Lipid and atherosclerosis 1.9256390974579871 | |
| CD14 Plasma membrane MAPK signaling pathway 1.9256390974579871 | |
| CD14 Plasma membrane Metabolic pathways 1.9256390974579871 | |
| CD14 Plasma membrane NF-kappa B signaling pathway 1.9256390974579871 | |
| CD14 Plasma membrane Non-alcoholic fatty liver disease 1.9256390974579871 | |
| CD14 Plasma membrane Oxidative phosphorylation 1.9256390974579871 | |
| CD14 Plasma membrane Parkinson disease 1.9256390974579871 | |
| CD14 Plasma membrane Pathways of neurodegeneration - multiple diseases 1.9256390974579871 | |
| CD14 Plasma membrane Pertussis 1.9256390974579871 | |
| CD14 Plasma membrane Phagosome 1.9256390974579871 | |
| CD14 Plasma membrane Prion disease 1.9256390974579871 | |
| CD14 Plasma membrane Retrograde endocannabinoid signaling 1.9256390974579871 | |
| CD14 Plasma membrane Salmonella infection 1.9256390974579871 | |
| CD14 Plasma membrane Shigellosis 1.9256390974579871 | |
| CD14 Plasma membrane Thermogenesis 1.9256390974579871 | |
| CD14 Plasma membrane Toll-like receptor signaling pathway 1.9256390974579871 | |
| CD14 Plasma membrane Transcriptional misregulation in cancer 1.9256390974579871 | |
| CD14 Plasma membrane Tuberculosis 1.9256390974579871 | |
| CD163 Extracellular space Summary 2.7380516809283013 | |
| CD163 Plasma membrane Summary 2.7380516809283013 | |
| CD180 Plasma membrane Summary 1.2324096649473668 | |
| CD2 Plasma membrane Cell adhesion molecules 0.4268086236507105 | |
| CD2 Plasma membrane Hematopoietic cell lineage 0.4268086236507105 | |
| CD207 Cytosol Summary 0.7919375405098249 | |
| CD209 Plasma membrane C-type lectin receptor signaling pathway 2.0290185626393944 | |
| CD209 Plasma membrane Measles 2.0290185626393944 | |
| CD209 Plasma membrane Phagosome 2.0290185626393944 | |
| CD209 Plasma membrane Tuberculosis 2.0290185626393944 | |
| CD248 Extracellular space Summary 1.584476162571178 | |
| CD248 Nucleus Summary 1.584476162571178 | |
| CD248 Plasma membrane Summary 1.584476162571178 | |
| CD276 Cytosol Summary 1.0332471207677698 | |
| CD2AP Cytoskeleton Bacterial invasion of epithelial cells 0.8514248652475552 | |
| CD2AP Cytosol Bacterial invasion of epithelial cells 0.8514248652475552 | |
| CD2AP Plasma membrane Bacterial invasion of epithelial cells 0.8514248652475552 | |
| CD2BP2 Cytosol Summary 1.3750211900278453 | |
| CD2BP2 Nucleus Summary 1.3750211900278453 | |
| CD300A Cytosol Summary 2.312675527647773 | |
| CD300A Plasma membrane Summary 2.312675527647773 | |
| CD320 Cytosol Summary 2.408974773638982 | |
| CD320 Plasma membrane Summary 2.408974773638982 | |
| CD34 Extracellular space Cell adhesion molecules 0.8511546156031611 | |
| CD34 Extracellular space Hematopoietic cell lineage 0.8511546156031611 | |
| CD34 Nucleus Cell adhesion molecules 0.8511546156031611 | |
| CD34 Nucleus Hematopoietic cell lineage 0.8511546156031611 | |
| CD34 Plasma membrane Cell adhesion molecules 0.8511546156031611 | |
| CD34 Plasma membrane Hematopoietic cell lineage 0.8511546156031611 | |
| CD36 Golgi apparatus Summary 0.9669823530964796 | |
| CD36 Plasma membrane Summary 0.9669823530964796 | |
| CD38 Plasma membrane Summary 0.5277652540262006 | |
| CD3E Endoplasmic Reticulum Chagas disease 1.1336290217482252 | |
| CD3E Endoplasmic Reticulum Epstein-Barr virus infection 1.1336290217482252 | |
| CD3E Endoplasmic Reticulum Hematopoietic cell lineage 1.1336290217482252 | |
| CD3E Endoplasmic Reticulum Human T-cell leukemia virus 1 infection 1.1336290217482252 | |
| CD3E Endoplasmic Reticulum Human immunodeficiency virus 1 infection 1.1336290217482252 | |
| CD3E Endoplasmic Reticulum Measles 1.1336290217482252 | |
| CD3E Endoplasmic Reticulum PD-L1 expression and PD-1 checkpoint pathway in cancer 1.1336290217482252 | |
| CD3E Endoplasmic Reticulum Primary immunodeficiency 1.1336290217482252 | |
| CD3E Endoplasmic Reticulum T cell receptor signaling pathway 1.1336290217482252 | |
| CD3E Endoplasmic Reticulum Th1 and Th2 cell differentiation 1.1336290217482252 | |
| CD3E Endoplasmic Reticulum Th17 cell differentiation 1.1336290217482252 | |
| CD3E Plasma membrane Chagas disease 1.1336290217482252 | |
| CD3E Plasma membrane Epstein-Barr virus infection 1.1336290217482252 | |
| CD3E Plasma membrane Hematopoietic cell lineage 1.1336290217482252 | |
| CD3E Plasma membrane Human T-cell leukemia virus 1 infection 1.1336290217482252 | |
| CD3E Plasma membrane Human immunodeficiency virus 1 infection 1.1336290217482252 | |
| CD3E Plasma membrane Measles 1.1336290217482252 | |
| CD3E Plasma membrane PD-L1 expression and PD-1 checkpoint pathway in cancer 1.1336290217482252 | |
| CD3E Plasma membrane Primary immunodeficiency 1.1336290217482252 | |
| CD3E Plasma membrane T cell receptor signaling pathway 1.1336290217482252 | |
| CD3E Plasma membrane Th1 and Th2 cell differentiation 1.1336290217482252 | |
| CD3E Plasma membrane Th17 cell differentiation 1.1336290217482252 | |
| CD3EAP Mitochondrion Summary 2.172287263379153 | |
| CD3EAP Nucleus Summary 2.172287263379153 | |
| CD3G Cytosol Chagas disease 1.518322462522259 | |
| CD3G Cytosol Epstein-Barr virus infection 1.518322462522259 | |
| CD3G Cytosol Hematopoietic cell lineage 1.518322462522259 | |
| CD3G Cytosol Human T-cell leukemia virus 1 infection 1.518322462522259 | |
| CD3G Cytosol Human immunodeficiency virus 1 infection 1.518322462522259 | |
| CD3G Cytosol Measles 1.518322462522259 | |
| CD3G Cytosol PD-L1 expression and PD-1 checkpoint pathway in cancer 1.518322462522259 | |
| CD3G Cytosol T cell receptor signaling pathway 1.518322462522259 | |
| CD3G Cytosol Th1 and Th2 cell differentiation 1.518322462522259 | |
| CD3G Cytosol Th17 cell differentiation 1.518322462522259 | |
| CD3G Plasma membrane Chagas disease 1.518322462522259 | |
| CD3G Plasma membrane Epstein-Barr virus infection 1.518322462522259 | |
| CD3G Plasma membrane Hematopoietic cell lineage 1.518322462522259 | |
| CD3G Plasma membrane Human T-cell leukemia virus 1 infection 1.518322462522259 | |
| CD3G Plasma membrane Human immunodeficiency virus 1 infection 1.518322462522259 | |
| CD3G Plasma membrane Measles 1.518322462522259 | |
| CD3G Plasma membrane PD-L1 expression and PD-1 checkpoint pathway in cancer 1.518322462522259 | |
| CD3G Plasma membrane T cell receptor signaling pathway 1.518322462522259 | |
| CD3G Plasma membrane Th1 and Th2 cell differentiation 1.518322462522259 | |
| CD3G Plasma membrane Th17 cell differentiation 1.518322462522259 | |
| CD4 Endosome Antigen processing and presentation 1.6271661584766308 | |
| CD4 Endosome Cell adhesion molecules 1.6271661584766308 | |
| CD4 Endosome Cytokine-cytokine receptor interaction 1.6271661584766308 | |
| CD4 Endosome Hematopoietic cell lineage 1.6271661584766308 | |
| CD4 Endosome Human T-cell leukemia virus 1 infection 1.6271661584766308 | |
| CD4 Endosome Human immunodeficiency virus 1 infection 1.6271661584766308 | |
| CD4 Endosome PD-L1 expression and PD-1 checkpoint pathway in cancer 1.6271661584766308 | |
| CD4 Endosome Primary immunodeficiency 1.6271661584766308 | |
| CD4 Endosome T cell receptor signaling pathway 1.6271661584766308 | |
| CD4 Endosome Th1 and Th2 cell differentiation 1.6271661584766308 | |
| CD4 Endosome Th17 cell differentiation 1.6271661584766308 | |
| CD4 Endosome Yersinia infection 1.6271661584766308 | |
| CD4 Plasma membrane Antigen processing and presentation 1.6271661584766308 | |
| CD4 Plasma membrane Cell adhesion molecules 1.6271661584766308 | |
| CD4 Plasma membrane Cytokine-cytokine receptor interaction 1.6271661584766308 | |
| CD4 Plasma membrane Hematopoietic cell lineage 1.6271661584766308 | |
| CD4 Plasma membrane Human T-cell leukemia virus 1 infection 1.6271661584766308 | |
| CD4 Plasma membrane Human immunodeficiency virus 1 infection 1.6271661584766308 | |
| CD4 Plasma membrane PD-L1 expression and PD-1 checkpoint pathway in cancer 1.6271661584766308 | |
| CD4 Plasma membrane Primary immunodeficiency 1.6271661584766308 | |
| CD4 Plasma membrane T cell receptor signaling pathway 1.6271661584766308 | |
| CD4 Plasma membrane Th1 and Th2 cell differentiation 1.6271661584766308 | |
| CD4 Plasma membrane Th17 cell differentiation 1.6271661584766308 | |
| CD4 Plasma membrane Yersinia infection 1.6271661584766308 | |
| CD40 Extracellular space Allograft rejection 1.2786682764934385 | |
| CD40 Extracellular space Asthma 1.2786682764934385 | |
| CD40 Extracellular space Autoimmune thyroid disease 1.2786682764934385 | |
| CD40 Extracellular space Cell adhesion molecules 1.2786682764934385 | |
| CD40 Extracellular space Cytokine-cytokine receptor interaction 1.2786682764934385 | |
| CD40 Extracellular space Epstein-Barr virus infection 1.2786682764934385 | |
| CD40 Extracellular space Human T-cell leukemia virus 1 infection 1.2786682764934385 | |
| CD40 Extracellular space Intestinal immune network for IgA production 1.2786682764934385 | |
| CD40 Extracellular space Lipid and atherosclerosis 1.2786682764934385 | |
| CD40 Extracellular space Malaria 1.2786682764934385 | |
| CD40 Extracellular space NF-kappa B signaling pathway 1.2786682764934385 | |
| CD40 Extracellular space Primary immunodeficiency 1.2786682764934385 | |
| CD40 Extracellular space Systemic lupus erythematosus 1.2786682764934385 | |
| CD40 Extracellular space Toll-like receptor signaling pathway 1.2786682764934385 | |
| CD40 Extracellular space Toxoplasmosis 1.2786682764934385 | |
| CD40 Extracellular space Transcriptional misregulation in cancer 1.2786682764934385 | |
| CD40 Extracellular space Viral myocarditis 1.2786682764934385 | |
| CD40 Plasma membrane Allograft rejection 1.2786682764934385 | |
| CD40 Plasma membrane Asthma 1.2786682764934385 | |
| CD40 Plasma membrane Autoimmune thyroid disease 1.2786682764934385 | |
| CD40 Plasma membrane Cell adhesion molecules 1.2786682764934385 | |
| CD40 Plasma membrane Cytokine-cytokine receptor interaction 1.2786682764934385 | |
| CD40 Plasma membrane Epstein-Barr virus infection 1.2786682764934385 | |
| CD40 Plasma membrane Human T-cell leukemia virus 1 infection 1.2786682764934385 | |
| CD40 Plasma membrane Intestinal immune network for IgA production 1.2786682764934385 | |
| CD40 Plasma membrane Lipid and atherosclerosis 1.2786682764934385 | |
| CD40 Plasma membrane Malaria 1.2786682764934385 | |
| CD40 Plasma membrane NF-kappa B signaling pathway 1.2786682764934385 | |
| CD40 Plasma membrane Primary immunodeficiency 1.2786682764934385 | |
| CD40 Plasma membrane Systemic lupus erythematosus 1.2786682764934385 | |
| CD40 Plasma membrane Toll-like receptor signaling pathway 1.2786682764934385 | |
| CD40 Plasma membrane Toxoplasmosis 1.2786682764934385 | |
| CD40 Plasma membrane Transcriptional misregulation in cancer 1.2786682764934385 | |
| CD40 Plasma membrane Viral myocarditis 1.2786682764934385 | |
| CD44 Golgi apparatus ECM-receptor interaction 1.2944895443267412 | |
| CD44 Golgi apparatus Epstein-Barr virus infection 1.2944895443267412 | |
| CD44 Golgi apparatus Hematopoietic cell lineage 1.2944895443267412 | |
| CD44 Golgi apparatus MicroRNAs in cancer 1.2944895443267412 | |
| CD44 Golgi apparatus Proteoglycans in cancer 1.2944895443267412 | |
| CD44 Golgi apparatus Shigellosis 1.2944895443267412 | |
| CD44 Plasma membrane ECM-receptor interaction 1.2944895443267412 | |
| CD44 Plasma membrane Epstein-Barr virus infection 1.2944895443267412 | |
| CD44 Plasma membrane Hematopoietic cell lineage 1.2944895443267412 | |
| CD44 Plasma membrane MicroRNAs in cancer 1.2944895443267412 | |
| CD44 Plasma membrane Proteoglycans in cancer 1.2944895443267412 | |
| CD44 Plasma membrane Shigellosis 1.2944895443267412 | |
| CD46 Cytosol Summary 0.32239088885744543 | |
| CD46 Plasma membrane Summary 0.32239088885744543 | |
| CD47 Cytosol ECM-receptor interaction 1.7649045526841092 | |
| CD47 Extracellular space ECM-receptor interaction 1.7649045526841092 | |
| CD47 Golgi apparatus ECM-receptor interaction 1.7649045526841092 | |
| CD47 Plasma membrane ECM-receptor interaction 1.7649045526841092 | |
| CD48 Cytosol Natural killer cell mediated cytotoxicity 1.184974536762713 | |
| CD48 Nucleus Natural killer cell mediated cytotoxicity 1.184974536762713 | |
| CD48 Plasma membrane Natural killer cell mediated cytotoxicity 1.184974536762713 | |
| CD5 Plasma membrane Hematopoietic cell lineage 1.6219286822937788 | |
| CD55 Cytoskeleton Complement and coagulation cascades 1.0992507232598685 | |
| CD55 Cytoskeleton Hematopoietic cell lineage 1.0992507232598685 | |
| CD55 Cytoskeleton Viral myocarditis 1.0992507232598685 | |
| CD55 Plasma membrane Complement and coagulation cascades 1.0992507232598685 | |
| CD55 Plasma membrane Hematopoietic cell lineage 1.0992507232598685 | |
| CD55 Plasma membrane Viral myocarditis 1.0992507232598685 | |
| CD58 Plasma membrane Cell adhesion molecules 2.3074926372971487 | |
| CD58 Plasma membrane Epstein-Barr virus infection 2.3074926372971487 | |
| CD59 Cytosol Complement and coagulation cascades 0.894783947804774 | |
| CD59 Cytosol Hematopoietic cell lineage 0.894783947804774 | |
| CD59 Extracellular space Complement and coagulation cascades 0.894783947804774 | |
| CD59 Extracellular space Hematopoietic cell lineage 0.894783947804774 | |
| CD59 Golgi apparatus Complement and coagulation cascades 0.894783947804774 | |
| CD59 Golgi apparatus Hematopoietic cell lineage 0.894783947804774 | |
| CD59 Plasma membrane Complement and coagulation cascades 0.894783947804774 | |
| CD59 Plasma membrane Hematopoietic cell lineage 0.894783947804774 | |
| CD5L Extracellular space Summary 2.0198089990399715 | |
| CD6 Plasma membrane Summary 0.7977701723307303 | |
| CD63 Cytosol Lysosome 0.18605797336412644 | |
| CD63 Cytosol Proteoglycans in cancer 0.18605797336412644 | |
| CD63 Endosome Lysosome 0.18605797336412644 | |
| CD63 Endosome Proteoglycans in cancer 0.18605797336412644 | |
| CD63 Lysosome Lysosome 0.18605797336412644 | |
| CD63 Lysosome Proteoglycans in cancer 0.18605797336412644 | |
| CD63 Plasma membrane Lysosome 0.18605797336412644 | |
| CD63 Plasma membrane Proteoglycans in cancer 0.18605797336412644 | |
| CD74 Endoplasmic Reticulum Antigen processing and presentation 2.043897276585815 | |
| CD74 Endoplasmic Reticulum Herpes simplex virus 1 infection 2.043897276585815 | |
| CD74 Endoplasmic Reticulum Tuberculosis 2.043897276585815 | |
| CD74 Endosome Antigen processing and presentation 2.043897276585815 | |
| CD74 Endosome Herpes simplex virus 1 infection 2.043897276585815 | |
| CD74 Endosome Tuberculosis 2.043897276585815 | |
| CD74 Golgi apparatus Antigen processing and presentation 2.043897276585815 | |
| CD74 Golgi apparatus Herpes simplex virus 1 infection 2.043897276585815 | |
| CD74 Golgi apparatus Tuberculosis 2.043897276585815 | |
| CD74 Lysosome Antigen processing and presentation 2.043897276585815 | |
| CD74 Lysosome Herpes simplex virus 1 infection 2.043897276585815 | |
| CD74 Lysosome Tuberculosis 2.043897276585815 | |
| CD74 Plasma membrane Antigen processing and presentation 2.043897276585815 | |
| CD74 Plasma membrane Herpes simplex virus 1 infection 2.043897276585815 | |
| CD74 Plasma membrane Tuberculosis 2.043897276585815 | |
| CD79A Plasma membrane B cell receptor signaling pathway 1.5428020588703817 | |
| CD79A Plasma membrane Primary immunodeficiency 1.5428020588703817 | |
| CD81 Plasma membrane B cell receptor signaling pathway 1.046192582666865 | |
| CD81 Plasma membrane Hepatitis C 1.046192582666865 | |
| CD81 Plasma membrane Malaria 1.046192582666865 | |
| CD82 Cytosol Summary 1.0545166864796962 | |
| CD82 Plasma membrane Summary 1.0545166864796962 | |
| CD84 Cytosol Summary 1.6291221419589148 | |
| CD84 Plasma membrane Summary 1.6291221419589148 | |
| CD8A Extracellular space Antigen processing and presentation 1.3005213695854538 | |
| CD8A Extracellular space Cell adhesion molecules 1.3005213695854538 | |
| CD8A Extracellular space Hematopoietic cell lineage 1.3005213695854538 | |
| CD8A Extracellular space Primary immunodeficiency 1.3005213695854538 | |
| CD8A Extracellular space T cell receptor signaling pathway 1.3005213695854538 | |
| CD8A Extracellular space Yersinia infection 1.3005213695854538 | |
| CD8A Plasma membrane Antigen processing and presentation 1.3005213695854538 | |
| CD8A Plasma membrane Cell adhesion molecules 1.3005213695854538 | |
| CD8A Plasma membrane Hematopoietic cell lineage 1.3005213695854538 | |
| CD8A Plasma membrane Primary immunodeficiency 1.3005213695854538 | |
| CD8A Plasma membrane T cell receptor signaling pathway 1.3005213695854538 | |
| CD8A Plasma membrane Yersinia infection 1.3005213695854538 | |
| CD9 Plasma membrane Hematopoietic cell lineage 0.8624166945730461 | |
| CD93 Cytosol Summary 2.50541784313473 | |
| CD93 Plasma membrane Summary 2.50541784313473 | |
| CD99 Golgi apparatus Summary 1.6557233446464446 | |
| CD99L2 Golgi apparatus Cell adhesion molecules 0.8493022010286159 | |
| CD99L2 Golgi apparatus Leukocyte transendothelial migration 0.8493022010286159 | |
| CD99L2 Plasma membrane Cell adhesion molecules 0.8493022010286159 | |
| CD99L2 Plasma membrane Leukocyte transendothelial migration 0.8493022010286159 | |
| CDA Cytosol Drug metabolism - other enzymes 2.0305540962157864 | |
| CDA Cytosol Metabolic pathways 2.0305540962157864 | |
| CDA Cytosol Pyrimidine metabolism 2.0305540962157864 | |
| CDA Extracellular space Drug metabolism - other enzymes 2.0305540962157864 | |
| CDA Extracellular space Metabolic pathways 2.0305540962157864 | |
| CDA Extracellular space Pyrimidine metabolism 2.0305540962157864 | |
| CDA Nucleus Drug metabolism - other enzymes 2.0305540962157864 | |
| CDA Nucleus Metabolic pathways 2.0305540962157864 | |
| CDA Nucleus Pyrimidine metabolism 2.0305540962157864 | |
| CDAN1 Cytosol Summary 0.5856095688545515 | |
| CDAN1 Nucleus Summary 0.5856095688545515 | |
| CDAN1 Plasma membrane Summary 0.5856095688545515 | |
| CDC123 Cytosol Summary 2.1763538716930744 | |
| CDC123 Golgi apparatus Summary 2.1763538716930744 | |
| CDC123 Nucleus Summary 2.1763538716930744 | |
| CDC16 Cytoskeleton Cell cycle 1.2318245482159922 | |
| CDC16 Cytoskeleton Human T-cell leukemia virus 1 infection 1.2318245482159922 | |
| CDC16 Cytoskeleton Oocyte meiosis 1.2318245482159922 | |
| CDC16 Cytoskeleton Progesterone-mediated oocyte maturation 1.2318245482159922 | |
| CDC16 Cytoskeleton Ubiquitin mediated proteolysis 1.2318245482159922 | |
| CDC16 Cytosol Cell cycle 1.2318245482159922 | |
| CDC16 Cytosol Human T-cell leukemia virus 1 infection 1.2318245482159922 | |
| CDC16 Cytosol Oocyte meiosis 1.2318245482159922 | |
| CDC16 Cytosol Progesterone-mediated oocyte maturation 1.2318245482159922 | |
| CDC16 Cytosol Ubiquitin mediated proteolysis 1.2318245482159922 | |
| CDC16 Nucleus Cell cycle 1.2318245482159922 | |
| CDC16 Nucleus Human T-cell leukemia virus 1 infection 1.2318245482159922 | |
| CDC16 Nucleus Oocyte meiosis 1.2318245482159922 | |
| CDC16 Nucleus Progesterone-mediated oocyte maturation 1.2318245482159922 | |
| CDC16 Nucleus Ubiquitin mediated proteolysis 1.2318245482159922 | |
| CDC20 Cytoskeleton Cell cycle 3.0861930064796472 | |
| CDC20 Cytoskeleton Human T-cell leukemia virus 1 infection 3.0861930064796472 | |
| CDC20 Cytoskeleton Oocyte meiosis 3.0861930064796472 | |
| CDC20 Cytoskeleton Ubiquitin mediated proteolysis 3.0861930064796472 | |
| CDC20 Cytoskeleton Viral carcinogenesis 3.0861930064796472 | |
| CDC20 Cytosol Cell cycle 3.0861930064796472 | |
| CDC20 Cytosol Human T-cell leukemia virus 1 infection 3.0861930064796472 | |
| CDC20 Cytosol Oocyte meiosis 3.0861930064796472 | |
| CDC20 Cytosol Ubiquitin mediated proteolysis 3.0861930064796472 | |
| CDC20 Cytosol Viral carcinogenesis 3.0861930064796472 | |
| CDC20 Nucleus Cell cycle 3.0861930064796472 | |
| CDC20 Nucleus Human T-cell leukemia virus 1 infection 3.0861930064796472 | |
| CDC20 Nucleus Oocyte meiosis 3.0861930064796472 | |
| CDC20 Nucleus Ubiquitin mediated proteolysis 3.0861930064796472 | |
| CDC20 Nucleus Viral carcinogenesis 3.0861930064796472 | |
| CDC23 Nucleus Cell cycle 1.0069100112531553 | |
| CDC23 Nucleus Human T-cell leukemia virus 1 infection 1.0069100112531553 | |
| CDC23 Nucleus Oocyte meiosis 1.0069100112531553 | |
| CDC23 Nucleus Progesterone-mediated oocyte maturation 1.0069100112531553 | |
| CDC23 Nucleus Ubiquitin mediated proteolysis 1.0069100112531553 | |
| CDC25C Nucleus Cell cycle 2.178955715761826 | |
| CDC25C Nucleus Human immunodeficiency virus 1 infection 2.178955715761826 | |
| CDC25C Nucleus MicroRNAs in cancer 2.178955715761826 | |
| CDC25C Nucleus Oocyte meiosis 2.178955715761826 | |
| CDC25C Nucleus Progesterone-mediated oocyte maturation 2.178955715761826 | |
| CDC26 Nucleus Cell cycle 1.2936454514875173 | |
| CDC26 Nucleus Human T-cell leukemia virus 1 infection 1.2936454514875173 | |
| CDC26 Nucleus Oocyte meiosis 1.2936454514875173 | |
| CDC26 Nucleus Progesterone-mediated oocyte maturation 1.2936454514875173 | |
| CDC26 Nucleus Ubiquitin mediated proteolysis 1.2936454514875173 | |
| CDC27 Nucleus Summary 1.6996621273548662 | |
| CDC34 Cytosol Ubiquitin mediated proteolysis 1.4229406119223325 | |
| CDC34 Nucleus Ubiquitin mediated proteolysis 1.4229406119223325 | |
| CDC37 Cytosol Summary 1.6589774993166766 | |
| CDC37L1 Cytosol Summary 0.9775473573296124 | |
| CDC40 Nucleus Spliceosome 1.4061494571886977 | |
| CDC42 Cytoskeleton AGE-RAGE signaling pathway in diabetic complications 1.7082130855588802 | |
| CDC42 Cytoskeleton Adherens junction 1.7082130855588802 | |
| CDC42 Cytoskeleton Axon guidance 1.7082130855588802 | |
| CDC42 Cytoskeleton Bacterial invasion of epithelial cells 1.7082130855588802 | |
| CDC42 Cytoskeleton Chemokine signaling pathway 1.7082130855588802 | |
| CDC42 Cytoskeleton Endocytosis 1.7082130855588802 | |
| CDC42 Cytoskeleton Epithelial cell signaling in Helicobacter pylori infection 1.7082130855588802 | |
| CDC42 Cytoskeleton Fc gamma R-mediated phagocytosis 1.7082130855588802 | |
| CDC42 Cytoskeleton Focal adhesion 1.7082130855588802 | |
| CDC42 Cytoskeleton GnRH signaling pathway 1.7082130855588802 | |
| CDC42 Cytoskeleton Human papillomavirus infection 1.7082130855588802 | |
| CDC42 Cytoskeleton Leukocyte transendothelial migration 1.7082130855588802 | |
| CDC42 Cytoskeleton Lipid and atherosclerosis 1.7082130855588802 | |
| CDC42 Cytoskeleton MAPK signaling pathway 1.7082130855588802 | |
| CDC42 Cytoskeleton Neurotrophin signaling pathway 1.7082130855588802 | |
| CDC42 Cytoskeleton Non-alcoholic fatty liver disease 1.7082130855588802 | |
| CDC42 Cytoskeleton Pancreatic cancer 1.7082130855588802 | |
| CDC42 Cytoskeleton Pathogenic Escherichia coli infection 1.7082130855588802 | |
| CDC42 Cytoskeleton Pathways in cancer 1.7082130855588802 | |
| CDC42 Cytoskeleton Proteoglycans in cancer 1.7082130855588802 | |
| CDC42 Cytoskeleton Rap1 signaling pathway 1.7082130855588802 | |
| CDC42 Cytoskeleton Ras signaling pathway 1.7082130855588802 | |
| CDC42 Cytoskeleton Regulation of actin cytoskeleton 1.7082130855588802 | |
| CDC42 Cytoskeleton Renal cell carcinoma 1.7082130855588802 | |
| CDC42 Cytoskeleton Salmonella infection 1.7082130855588802 | |
| CDC42 Cytoskeleton Shigellosis 1.7082130855588802 | |
| CDC42 Cytoskeleton T cell receptor signaling pathway 1.7082130855588802 | |
| CDC42 Cytoskeleton Tight junction 1.7082130855588802 | |
| CDC42 Cytoskeleton VEGF signaling pathway 1.7082130855588802 | |
| CDC42 Cytoskeleton Viral carcinogenesis 1.7082130855588802 | |
| CDC42 Cytoskeleton Yersinia infection 1.7082130855588802 | |
| CDC42 Plasma membrane AGE-RAGE signaling pathway in diabetic complications 1.7082130855588802 | |
| CDC42 Plasma membrane Adherens junction 1.7082130855588802 | |
| CDC42 Plasma membrane Axon guidance 1.7082130855588802 | |
| CDC42 Plasma membrane Bacterial invasion of epithelial cells 1.7082130855588802 | |
| CDC42 Plasma membrane Chemokine signaling pathway 1.7082130855588802 | |
| CDC42 Plasma membrane Endocytosis 1.7082130855588802 | |
| CDC42 Plasma membrane Epithelial cell signaling in Helicobacter pylori infection 1.7082130855588802 | |
| CDC42 Plasma membrane Fc gamma R-mediated phagocytosis 1.7082130855588802 | |
| CDC42 Plasma membrane Focal adhesion 1.7082130855588802 | |
| CDC42 Plasma membrane GnRH signaling pathway 1.7082130855588802 | |
| CDC42 Plasma membrane Human papillomavirus infection 1.7082130855588802 | |
| CDC42 Plasma membrane Leukocyte transendothelial migration 1.7082130855588802 | |
| CDC42 Plasma membrane Lipid and atherosclerosis 1.7082130855588802 | |
| CDC42 Plasma membrane MAPK signaling pathway 1.7082130855588802 | |
| CDC42 Plasma membrane Neurotrophin signaling pathway 1.7082130855588802 | |
| CDC42 Plasma membrane Non-alcoholic fatty liver disease 1.7082130855588802 | |
| CDC42 Plasma membrane Pancreatic cancer 1.7082130855588802 | |
| CDC42 Plasma membrane Pathogenic Escherichia coli infection 1.7082130855588802 | |
| CDC42 Plasma membrane Pathways in cancer 1.7082130855588802 | |
| CDC42 Plasma membrane Proteoglycans in cancer 1.7082130855588802 | |
| CDC42 Plasma membrane Rap1 signaling pathway 1.7082130855588802 | |
| CDC42 Plasma membrane Ras signaling pathway 1.7082130855588802 | |
| CDC42 Plasma membrane Regulation of actin cytoskeleton 1.7082130855588802 | |
| CDC42 Plasma membrane Renal cell carcinoma 1.7082130855588802 | |
| CDC42 Plasma membrane Salmonella infection 1.7082130855588802 | |
| CDC42 Plasma membrane Shigellosis 1.7082130855588802 | |
| CDC42 Plasma membrane T cell receptor signaling pathway 1.7082130855588802 | |
| CDC42 Plasma membrane Tight junction 1.7082130855588802 | |
| CDC42 Plasma membrane VEGF signaling pathway 1.7082130855588802 | |
| CDC42 Plasma membrane Viral carcinogenesis 1.7082130855588802 | |
| CDC42 Plasma membrane Yersinia infection 1.7082130855588802 | |
| CDC42BPA Cytoskeleton Summary 1.5319189330337288 | |
| CDC42BPA Cytosol Summary 1.5319189330337288 | |
| CDC42BPB Cytoskeleton Summary 0.6190173771907557 | |
| CDC42BPB Cytosol Summary 0.6190173771907557 | |
| CDC42BPB Nucleus Summary 0.6190173771907557 | |
| CDC42BPB Plasma membrane Summary 0.6190173771907557 | |
| CDC42BPG Cytosol Summary 1.4250526481791748 | |
| CDC42EP1 Cytoskeleton Summary 1.9062236505136927 | |
| CDC42EP1 Nucleus Summary 1.9062236505136927 | |
| CDC42EP1 Plasma membrane Summary 1.9062236505136927 | |
| CDC42EP2 Cytoskeleton Summary 1.5259183353801324 | |
| CDC42EP2 Cytosol Summary 1.5259183353801324 | |
| CDC42EP2 Plasma membrane Summary 1.5259183353801324 | |
| CDC42EP3 Cytoskeleton Summary 1.4601061000611306 | |
| CDC42EP3 Nucleus Summary 1.4601061000611306 | |
| CDC42EP3 Plasma membrane Summary 1.4601061000611306 | |
| CDC42EP4 Cytoskeleton Summary 2.48635919544202 | |
| CDC42EP4 Cytosol Summary 2.48635919544202 | |
| CDC42EP4 Plasma membrane Summary 2.48635919544202 | |
| CDC42SE1 Cytosol Summary 1.3355646414813611 | |
| CDC42SE1 Plasma membrane Summary 1.3355646414813611 | |
| CDC42SE2 Cytoskeleton Summary 1.210586833965345 | |
| CDC42SE2 Cytosol Summary 1.210586833965345 | |
| CDC42SE2 Plasma membrane Summary 1.210586833965345 | |
| CDC73 Cytosol Summary 1.5222999442613012 | |
| CDC73 Nucleus Summary 1.5222999442613012 | |
| CDCA2 Cytosol Summary 2.4852081233456254 | |
| CDCA2 Nucleus Summary 2.4852081233456254 | |
| CDCA5 Nucleus MicroRNAs in cancer 2.07129273650124 | |
| CDCA7L Cytosol Summary 1.5621722157450866 | |
| CDCA7L Nucleus Summary 1.5621722157450866 | |
| CDCA8 Cytoskeleton Summary 2.8350149824547968 | |
| CDCA8 Nucleus Summary 2.8350149824547968 | |
| CDCP1 Extracellular space Summary 1.283019091798708 | |
| CDCP1 Plasma membrane Summary 1.283019091798708 | |
| CDH1 Endosome Adherens junction 0.6118239736736286 | |
| CDH1 Endosome Apelin signaling pathway 0.6118239736736286 | |
| CDH1 Endosome Bacterial invasion of epithelial cells 0.6118239736736286 | |
| CDH1 Endosome Bladder cancer 0.6118239736736286 | |
| CDH1 Endosome Cell adhesion molecules 0.6118239736736286 | |
| CDH1 Endosome Cell cycle 0.6118239736736286 | |
| CDH1 Endosome Endometrial cancer 0.6118239736736286 | |
| CDH1 Endosome Gastric cancer 0.6118239736736286 | |
| CDH1 Endosome Hippo signaling pathway 0.6118239736736286 | |
| CDH1 Endosome Melanoma 0.6118239736736286 | |
| CDH1 Endosome Pathways in cancer 0.6118239736736286 | |
| CDH1 Endosome Progesterone-mediated oocyte maturation 0.6118239736736286 | |
| CDH1 Endosome Rap1 signaling pathway 0.6118239736736286 | |
| CDH1 Endosome Thyroid cancer 0.6118239736736286 | |
| CDH1 Endosome Ubiquitin mediated proteolysis 0.6118239736736286 | |
| CDH1 Golgi apparatus Adherens junction 0.6118239736736286 | |
| CDH1 Golgi apparatus Apelin signaling pathway 0.6118239736736286 | |
| CDH1 Golgi apparatus Bacterial invasion of epithelial cells 0.6118239736736286 | |
| CDH1 Golgi apparatus Bladder cancer 0.6118239736736286 | |
| CDH1 Golgi apparatus Cell adhesion molecules 0.6118239736736286 | |
| CDH1 Golgi apparatus Cell cycle 0.6118239736736286 | |
| CDH1 Golgi apparatus Endometrial cancer 0.6118239736736286 | |
| CDH1 Golgi apparatus Gastric cancer 0.6118239736736286 | |
| CDH1 Golgi apparatus Hippo signaling pathway 0.6118239736736286 | |
| CDH1 Golgi apparatus Melanoma 0.6118239736736286 | |
| CDH1 Golgi apparatus Pathways in cancer 0.6118239736736286 | |
| CDH1 Golgi apparatus Progesterone-mediated oocyte maturation 0.6118239736736286 | |
| CDH1 Golgi apparatus Rap1 signaling pathway 0.6118239736736286 | |
| CDH1 Golgi apparatus Thyroid cancer 0.6118239736736286 | |
| CDH1 Golgi apparatus Ubiquitin mediated proteolysis 0.6118239736736286 | |
| CDH1 Plasma membrane Adherens junction 0.6118239736736286 | |
| CDH1 Plasma membrane Apelin signaling pathway 0.6118239736736286 | |
| CDH1 Plasma membrane Bacterial invasion of epithelial cells 0.6118239736736286 | |
| CDH1 Plasma membrane Bladder cancer 0.6118239736736286 | |
| CDH1 Plasma membrane Cell adhesion molecules 0.6118239736736286 | |
| CDH1 Plasma membrane Cell cycle 0.6118239736736286 | |
| CDH1 Plasma membrane Endometrial cancer 0.6118239736736286 | |
| CDH1 Plasma membrane Gastric cancer 0.6118239736736286 | |
| CDH1 Plasma membrane Hippo signaling pathway 0.6118239736736286 | |
| CDH1 Plasma membrane Melanoma 0.6118239736736286 | |
| CDH1 Plasma membrane Pathways in cancer 0.6118239736736286 | |
| CDH1 Plasma membrane Progesterone-mediated oocyte maturation 0.6118239736736286 | |
| CDH1 Plasma membrane Rap1 signaling pathway 0.6118239736736286 | |
| CDH1 Plasma membrane Thyroid cancer 0.6118239736736286 | |
| CDH1 Plasma membrane Ubiquitin mediated proteolysis 0.6118239736736286 | |
| CDH11 Plasma membrane Summary 1.6689606969918993 | |
| CDH13 Plasma membrane Summary 1.6628898076140053 | |
| CDH2 Plasma membrane Arrhythmogenic right ventricular cardiomyopathy 1.3512573164002808 | |
| CDH2 Plasma membrane Cell adhesion molecules 1.3512573164002808 | |
| CDH5 Nucleus Cell adhesion molecules 1.2223052693375331 | |
| CDH5 Nucleus Fluid shear stress and atherosclerosis 1.2223052693375331 | |
| CDH5 Nucleus Leukocyte transendothelial migration 1.2223052693375331 | |
| CDH5 Plasma membrane Cell adhesion molecules 1.2223052693375331 | |
| CDH5 Plasma membrane Fluid shear stress and atherosclerosis 1.2223052693375331 | |
| CDH5 Plasma membrane Leukocyte transendothelial migration 1.2223052693375331 | |
| CDIPT Endoplasmic Reticulum Glycerophospholipid metabolism 0.6220694888754056 | |
| CDIPT Endoplasmic Reticulum Inositol phosphate metabolism 0.6220694888754056 | |
| CDIPT Endoplasmic Reticulum Metabolic pathways 0.6220694888754056 | |
| CDIPT Endoplasmic Reticulum Phosphatidylinositol signaling system 0.6220694888754056 | |
| CDIPT Golgi apparatus Glycerophospholipid metabolism 0.6220694888754056 | |
| CDIPT Golgi apparatus Inositol phosphate metabolism 0.6220694888754056 | |
| CDIPT Golgi apparatus Metabolic pathways 0.6220694888754056 | |
| CDIPT Golgi apparatus Phosphatidylinositol signaling system 0.6220694888754056 | |
| CDIPT Nucleus Glycerophospholipid metabolism 0.6220694888754056 | |
| CDIPT Nucleus Inositol phosphate metabolism 0.6220694888754056 | |
| CDIPT Nucleus Metabolic pathways 0.6220694888754056 | |
| CDIPT Nucleus Phosphatidylinositol signaling system 0.6220694888754056 | |
| CDIPT Plasma membrane Glycerophospholipid metabolism 0.6220694888754056 | |
| CDIPT Plasma membrane Inositol phosphate metabolism 0.6220694888754056 | |
| CDIPT Plasma membrane Metabolic pathways 0.6220694888754056 | |
| CDIPT Plasma membrane Phosphatidylinositol signaling system 0.6220694888754056 | |
| CDK1 Cytosol Summary 2.788706483112938 | |
| CDK1 Nucleus Summary 2.788706483112938 | |
| CDK11A Cytosol Summary 1.6040413153049429 | |
| CDK11A Nucleus Summary 1.6040413153049429 | |
| CDK11B Nucleus Summary 1.9852888523647576 | |
| CDK12 Nucleus Summary 0.71987524287479 | |
| CDK13 Cytosol Summary 1.1241216204985152 | |
| CDK13 Golgi apparatus Summary 1.1241216204985152 | |
| CDK13 Nucleus Summary 1.1241216204985152 | |
| CDK14 Cytosol Transcriptional misregulation in cancer 2.1707728729787084 | |
| CDK14 Nucleus Transcriptional misregulation in cancer 2.1707728729787084 | |
| CDK14 Plasma membrane Transcriptional misregulation in cancer 2.1707728729787084 | |
| CDK16 Cytoskeleton Summary 1.587050158203286 | |
| CDK16 Cytosol Summary 1.587050158203286 | |
| CDK16 Plasma membrane Summary 1.587050158203286 | |
| CDK17 Cytosol Summary 0.8545962925849498 | |
| CDK17 Nucleus Summary 0.8545962925849498 | |
| CDK18 Cytoskeleton Summary 1.7761531697827395 | |
| CDK19 Cytosol Summary 2.1770020003024517 | |
| CDK19 Nucleus Summary 2.1770020003024517 | |
| CDK2 Cytoskeleton Cell cycle 2.1568474693670816 | |
| CDK2 Cytoskeleton Cellular senescence 2.1568474693670816 | |
| CDK2 Cytoskeleton Cushing syndrome 2.1568474693670816 | |
| CDK2 Cytoskeleton Epstein-Barr virus infection 2.1568474693670816 | |
| CDK2 Cytoskeleton FoxO signaling pathway 2.1568474693670816 | |
| CDK2 Cytoskeleton Gastric cancer 2.1568474693670816 | |
| CDK2 Cytoskeleton Hepatitis B 2.1568474693670816 | |
| CDK2 Cytoskeleton Hepatitis C 2.1568474693670816 | |
| CDK2 Cytoskeleton Human T-cell leukemia virus 1 infection 2.1568474693670816 | |
| CDK2 Cytoskeleton Human papillomavirus infection 2.1568474693670816 | |
| CDK2 Cytoskeleton Measles 2.1568474693670816 | |
| CDK2 Cytoskeleton Oocyte meiosis 2.1568474693670816 | |
| CDK2 Cytoskeleton PI3K-Akt signaling pathway 2.1568474693670816 | |
| CDK2 Cytoskeleton Pathways in cancer 2.1568474693670816 | |
| CDK2 Cytoskeleton Progesterone-mediated oocyte maturation 2.1568474693670816 | |
| CDK2 Cytoskeleton Prostate cancer 2.1568474693670816 | |
| CDK2 Cytoskeleton Small cell lung cancer 2.1568474693670816 | |
| CDK2 Cytoskeleton Viral carcinogenesis 2.1568474693670816 | |
| CDK2 Cytoskeleton p53 signaling pathway 2.1568474693670816 | |
| CDK2 Cytosol Cell cycle 2.1568474693670816 | |
| CDK2 Cytosol Cellular senescence 2.1568474693670816 | |
| CDK2 Cytosol Cushing syndrome 2.1568474693670816 | |
| CDK2 Cytosol Epstein-Barr virus infection 2.1568474693670816 | |
| CDK2 Cytosol FoxO signaling pathway 2.1568474693670816 | |
| CDK2 Cytosol Gastric cancer 2.1568474693670816 | |
| CDK2 Cytosol Hepatitis B 2.1568474693670816 | |
| CDK2 Cytosol Hepatitis C 2.1568474693670816 | |
| CDK2 Cytosol Human T-cell leukemia virus 1 infection 2.1568474693670816 | |
| CDK2 Cytosol Human papillomavirus infection 2.1568474693670816 | |
| CDK2 Cytosol Measles 2.1568474693670816 | |
| CDK2 Cytosol Oocyte meiosis 2.1568474693670816 | |
| CDK2 Cytosol PI3K-Akt signaling pathway 2.1568474693670816 | |
| CDK2 Cytosol Pathways in cancer 2.1568474693670816 | |
| CDK2 Cytosol Progesterone-mediated oocyte maturation 2.1568474693670816 | |
| CDK2 Cytosol Prostate cancer 2.1568474693670816 | |
| CDK2 Cytosol Small cell lung cancer 2.1568474693670816 | |
| CDK2 Cytosol Viral carcinogenesis 2.1568474693670816 | |
| CDK2 Cytosol p53 signaling pathway 2.1568474693670816 | |
| CDK2 Endosome Cell cycle 2.1568474693670816 | |
| CDK2 Endosome Cellular senescence 2.1568474693670816 | |
| CDK2 Endosome Cushing syndrome 2.1568474693670816 | |
| CDK2 Endosome Epstein-Barr virus infection 2.1568474693670816 | |
| CDK2 Endosome FoxO signaling pathway 2.1568474693670816 | |
| CDK2 Endosome Gastric cancer 2.1568474693670816 | |
| CDK2 Endosome Hepatitis B 2.1568474693670816 | |
| CDK2 Endosome Hepatitis C 2.1568474693670816 | |
| CDK2 Endosome Human T-cell leukemia virus 1 infection 2.1568474693670816 | |
| CDK2 Endosome Human papillomavirus infection 2.1568474693670816 | |
| CDK2 Endosome Measles 2.1568474693670816 | |
| CDK2 Endosome Oocyte meiosis 2.1568474693670816 | |
| CDK2 Endosome PI3K-Akt signaling pathway 2.1568474693670816 | |
| CDK2 Endosome Pathways in cancer 2.1568474693670816 | |
| CDK2 Endosome Progesterone-mediated oocyte maturation 2.1568474693670816 | |
| CDK2 Endosome Prostate cancer 2.1568474693670816 | |
| CDK2 Endosome Small cell lung cancer 2.1568474693670816 | |
| CDK2 Endosome Viral carcinogenesis 2.1568474693670816 | |
| CDK2 Endosome p53 signaling pathway 2.1568474693670816 | |
| CDK2 Nucleus Cell cycle 2.1568474693670816 | |
| CDK2 Nucleus Cellular senescence 2.1568474693670816 | |
| CDK2 Nucleus Cushing syndrome 2.1568474693670816 | |
| CDK2 Nucleus Epstein-Barr virus infection 2.1568474693670816 | |
| CDK2 Nucleus FoxO signaling pathway 2.1568474693670816 | |
| CDK2 Nucleus Gastric cancer 2.1568474693670816 | |
| CDK2 Nucleus Hepatitis B 2.1568474693670816 | |
| CDK2 Nucleus Hepatitis C 2.1568474693670816 | |
| CDK2 Nucleus Human T-cell leukemia virus 1 infection 2.1568474693670816 | |
| CDK2 Nucleus Human papillomavirus infection 2.1568474693670816 | |
| CDK2 Nucleus Measles 2.1568474693670816 | |
| CDK2 Nucleus Oocyte meiosis 2.1568474693670816 | |
| CDK2 Nucleus PI3K-Akt signaling pathway 2.1568474693670816 | |
| CDK2 Nucleus Pathways in cancer 2.1568474693670816 | |
| CDK2 Nucleus Progesterone-mediated oocyte maturation 2.1568474693670816 | |
| CDK2 Nucleus Prostate cancer 2.1568474693670816 | |
| CDK2 Nucleus Small cell lung cancer 2.1568474693670816 | |
| CDK2 Nucleus Viral carcinogenesis 2.1568474693670816 | |
| CDK2 Nucleus p53 signaling pathway 2.1568474693670816 | |
| CDK20 Nucleus Summary 2.5148371504950835 | |
| CDK2AP1 Nucleus Summary 1.8622726346214007 | |
| CDK4 Cytosol AGE-RAGE signaling pathway in diabetic complications 2.268356450757953 | |
| CDK4 Cytosol Bladder cancer 2.268356450757953 | |
| CDK4 Cytosol Breast cancer 2.268356450757953 | |
| CDK4 Cytosol Cell cycle 2.268356450757953 | |
| CDK4 Cytosol Cellular senescence 2.268356450757953 | |
| CDK4 Cytosol Chronic myeloid leukemia 2.268356450757953 | |
| CDK4 Cytosol Cushing syndrome 2.268356450757953 | |
| CDK4 Cytosol Endocrine resistance 2.268356450757953 | |
| CDK4 Cytosol Epstein-Barr virus infection 2.268356450757953 | |
| CDK4 Cytosol Glioma 2.268356450757953 | |
| CDK4 Cytosol Hepatitis C 2.268356450757953 | |
| CDK4 Cytosol Hepatocellular carcinoma 2.268356450757953 | |
| CDK4 Cytosol Human T-cell leukemia virus 1 infection 2.268356450757953 | |
| CDK4 Cytosol Human cytomegalovirus infection 2.268356450757953 | |
| CDK4 Cytosol Human papillomavirus infection 2.268356450757953 | |
| CDK4 Cytosol Influenza A 2.268356450757953 | |
| CDK4 Cytosol Kaposi sarcoma-associated herpesvirus infection 2.268356450757953 | |
| CDK4 Cytosol Measles 2.268356450757953 | |
| CDK4 Cytosol Melanoma 2.268356450757953 | |
| CDK4 Cytosol Non-small cell lung cancer 2.268356450757953 | |
| CDK4 Cytosol PI3K-Akt signaling pathway 2.268356450757953 | |
| CDK4 Cytosol Pancreatic cancer 2.268356450757953 | |
| CDK4 Cytosol Pathways in cancer 2.268356450757953 | |
| CDK4 Cytosol Small cell lung cancer 2.268356450757953 | |
| CDK4 Cytosol T cell receptor signaling pathway 2.268356450757953 | |
| CDK4 Cytosol Tight junction 2.268356450757953 | |
| CDK4 Cytosol Viral carcinogenesis 2.268356450757953 | |
| CDK4 Cytosol p53 signaling pathway 2.268356450757953 | |
| CDK4 Nucleus AGE-RAGE signaling pathway in diabetic complications 2.268356450757953 | |
| CDK4 Nucleus Bladder cancer 2.268356450757953 | |
| CDK4 Nucleus Breast cancer 2.268356450757953 | |
| CDK4 Nucleus Cell cycle 2.268356450757953 | |
| CDK4 Nucleus Cellular senescence 2.268356450757953 | |
| CDK4 Nucleus Chronic myeloid leukemia 2.268356450757953 | |
| CDK4 Nucleus Cushing syndrome 2.268356450757953 | |
| CDK4 Nucleus Endocrine resistance 2.268356450757953 | |
| CDK4 Nucleus Epstein-Barr virus infection 2.268356450757953 | |
| CDK4 Nucleus Glioma 2.268356450757953 | |
| CDK4 Nucleus Hepatitis C 2.268356450757953 | |
| CDK4 Nucleus Hepatocellular carcinoma 2.268356450757953 | |
| CDK4 Nucleus Human T-cell leukemia virus 1 infection 2.268356450757953 | |
| CDK4 Nucleus Human cytomegalovirus infection 2.268356450757953 | |
| CDK4 Nucleus Human papillomavirus infection 2.268356450757953 | |
| CDK4 Nucleus Influenza A 2.268356450757953 | |
| CDK4 Nucleus Kaposi sarcoma-associated herpesvirus infection 2.268356450757953 | |
| CDK4 Nucleus Measles 2.268356450757953 | |
| CDK4 Nucleus Melanoma 2.268356450757953 | |
| CDK4 Nucleus Non-small cell lung cancer 2.268356450757953 | |
| CDK4 Nucleus PI3K-Akt signaling pathway 2.268356450757953 | |
| CDK4 Nucleus Pancreatic cancer 2.268356450757953 | |
| CDK4 Nucleus Pathways in cancer 2.268356450757953 | |
| CDK4 Nucleus Small cell lung cancer 2.268356450757953 | |
| CDK4 Nucleus T cell receptor signaling pathway 2.268356450757953 | |
| CDK4 Nucleus Tight junction 2.268356450757953 | |
| CDK4 Nucleus Viral carcinogenesis 2.268356450757953 | |
| CDK4 Nucleus p53 signaling pathway 2.268356450757953 | |
| CDK5 Cytosol Alzheimer disease 1.3625423947545718 | |
| CDK5 Cytosol Axon guidance 1.3625423947545718 | |
| CDK5 Cytosol Cocaine addiction 1.3625423947545718 | |
| CDK5 Cytosol Pathways of neurodegeneration - multiple diseases 1.3625423947545718 | |
| CDK5 Nucleus Alzheimer disease 1.3625423947545718 | |
| CDK5 Nucleus Axon guidance 1.3625423947545718 | |
| CDK5 Nucleus Cocaine addiction 1.3625423947545718 | |
| CDK5 Nucleus Pathways of neurodegeneration - multiple diseases 1.3625423947545718 | |
| CDK5 Plasma membrane Alzheimer disease 1.3625423947545718 | |
| CDK5 Plasma membrane Axon guidance 1.3625423947545718 | |
| CDK5 Plasma membrane Cocaine addiction 1.3625423947545718 | |
| CDK5 Plasma membrane Pathways of neurodegeneration - multiple diseases 1.3625423947545718 | |
| CDK5RAP1 Mitochondrion Summary 1.8400814940767296 | |
| CDK5RAP1 Nucleus Summary 1.8400814940767296 | |
| CDK5RAP2 Cytoskeleton Summary 1.2184646814147475 | |
| CDK5RAP2 Cytosol Summary 1.2184646814147475 | |
| CDK5RAP2 Golgi apparatus Summary 1.2184646814147475 | |
| CDK5RAP2 Plasma membrane Summary 1.2184646814147475 | |
| CDK5RAP3 Cytosol Summary 0.9383659417085768 | |
| CDK5RAP3 Nucleus Summary 0.9383659417085768 | |
| CDK6 Cytosol Breast cancer 3.0493662706733486 | |
| CDK6 Cytosol Cell cycle 3.0493662706733486 | |
| CDK6 Cytosol Cellular senescence 3.0493662706733486 | |
| CDK6 Cytosol Chronic myeloid leukemia 3.0493662706733486 | |
| CDK6 Cytosol Cushing syndrome 3.0493662706733486 | |
| CDK6 Cytosol Epstein-Barr virus infection 3.0493662706733486 | |
| CDK6 Cytosol Glioma 3.0493662706733486 | |
| CDK6 Cytosol Hepatitis C 3.0493662706733486 | |
| CDK6 Cytosol Hepatocellular carcinoma 3.0493662706733486 | |
| CDK6 Cytosol Human cytomegalovirus infection 3.0493662706733486 | |
| CDK6 Cytosol Human papillomavirus infection 3.0493662706733486 | |
| CDK6 Cytosol Influenza A 3.0493662706733486 | |
| CDK6 Cytosol Kaposi sarcoma-associated herpesvirus infection 3.0493662706733486 | |
| CDK6 Cytosol Measles 3.0493662706733486 | |
| CDK6 Cytosol Melanoma 3.0493662706733486 | |
| CDK6 Cytosol MicroRNAs in cancer 3.0493662706733486 | |
| CDK6 Cytosol Non-small cell lung cancer 3.0493662706733486 | |
| CDK6 Cytosol PI3K-Akt signaling pathway 3.0493662706733486 | |
| CDK6 Cytosol Pancreatic cancer 3.0493662706733486 | |
| CDK6 Cytosol Pathways in cancer 3.0493662706733486 | |
| CDK6 Cytosol Small cell lung cancer 3.0493662706733486 | |
| CDK6 Cytosol Viral carcinogenesis 3.0493662706733486 | |
| CDK6 Cytosol p53 signaling pathway 3.0493662706733486 | |
| CDK6 Nucleus Breast cancer 3.0493662706733486 | |
| CDK6 Nucleus Cell cycle 3.0493662706733486 | |
| CDK6 Nucleus Cellular senescence 3.0493662706733486 | |
| CDK6 Nucleus Chronic myeloid leukemia 3.0493662706733486 | |
| CDK6 Nucleus Cushing syndrome 3.0493662706733486 | |
| CDK6 Nucleus Epstein-Barr virus infection 3.0493662706733486 | |
| CDK6 Nucleus Glioma 3.0493662706733486 | |
| CDK6 Nucleus Hepatitis C 3.0493662706733486 | |
| CDK6 Nucleus Hepatocellular carcinoma 3.0493662706733486 | |
| CDK6 Nucleus Human cytomegalovirus infection 3.0493662706733486 | |
| CDK6 Nucleus Human papillomavirus infection 3.0493662706733486 | |
| CDK6 Nucleus Influenza A 3.0493662706733486 | |
| CDK6 Nucleus Kaposi sarcoma-associated herpesvirus infection 3.0493662706733486 | |
| CDK6 Nucleus Measles 3.0493662706733486 | |
| CDK6 Nucleus Melanoma 3.0493662706733486 | |
| CDK6 Nucleus MicroRNAs in cancer 3.0493662706733486 | |
| CDK6 Nucleus Non-small cell lung cancer 3.0493662706733486 | |
| CDK6 Nucleus PI3K-Akt signaling pathway 3.0493662706733486 | |
| CDK6 Nucleus Pancreatic cancer 3.0493662706733486 | |
| CDK6 Nucleus Pathways in cancer 3.0493662706733486 | |
| CDK6 Nucleus Small cell lung cancer 3.0493662706733486 | |
| CDK6 Nucleus Viral carcinogenesis 3.0493662706733486 | |
| CDK6 Nucleus p53 signaling pathway 3.0493662706733486 | |
| CDK7 Cytosol Basal transcription factors 1.0944495493155992 | |
| CDK7 Cytosol Cell cycle 1.0944495493155992 | |
| CDK7 Cytosol Nucleotide excision repair 1.0944495493155992 | |
| CDK7 Nucleus Basal transcription factors 1.0944495493155992 | |
| CDK7 Nucleus Cell cycle 1.0944495493155992 | |
| CDK7 Nucleus Nucleotide excision repair 1.0944495493155992 | |
| CDK7 Plasma membrane Basal transcription factors 1.0944495493155992 | |
| CDK7 Plasma membrane Cell cycle 1.0944495493155992 | |
| CDK7 Plasma membrane Nucleotide excision repair 1.0944495493155992 | |
| CDK8 Nucleus Summary 1.8684303932111332 | |
| CDK9 Cytosol Transcriptional misregulation in cancer 0.7585657974023206 | |
| CDK9 Nucleus Transcriptional misregulation in cancer 0.7585657974023206 | |
| CDKAL1 Cytosol Summary 1.477877443616021 | |
| CDKAL1 Endoplasmic Reticulum Summary 1.477877443616021 | |
| CDKL2 Cytoskeleton Summary 2.056759584134117 | |
| CDKL2 Cytosol Summary 2.056759584134117 | |
| CDKL2 Nucleus Summary 2.056759584134117 | |
| CDKL3 Cytosol Summary 1.6757911978705349 | |
| CDKL3 Nucleus Summary 1.6757911978705349 | |
| CDKL5 Cytosol Summary 1.943427177543624 | |
| CDKL5 Nucleus Summary 1.943427177543624 | |
| CDKN1A Cytosol Basal cell carcinoma 0.6790975811195187 | |
| CDKN1A Cytosol Bladder cancer 0.6790975811195187 | |
| CDKN1A Cytosol Breast cancer 0.6790975811195187 | |
| CDKN1A Cytosol Cell cycle 0.6790975811195187 | |
| CDKN1A Cytosol Cellular senescence 0.6790975811195187 | |
| CDKN1A Cytosol Chronic myeloid leukemia 0.6790975811195187 | |
| CDKN1A Cytosol Colorectal cancer 0.6790975811195187 | |
| CDKN1A Cytosol Cushing syndrome 0.6790975811195187 | |
| CDKN1A Cytosol Endocrine resistance 0.6790975811195187 | |
| CDKN1A Cytosol Endometrial cancer 0.6790975811195187 | |
| CDKN1A Cytosol Epstein-Barr virus infection 0.6790975811195187 | |
| CDKN1A Cytosol ErbB signaling pathway 0.6790975811195187 | |
| CDKN1A Cytosol FoxO signaling pathway 0.6790975811195187 | |
| CDKN1A Cytosol Gastric cancer 0.6790975811195187 | |
| CDKN1A Cytosol Glioma 0.6790975811195187 | |
| CDKN1A Cytosol HIF-1 signaling pathway 0.6790975811195187 | |
| CDKN1A Cytosol Hepatitis B 0.6790975811195187 | |
| CDKN1A Cytosol Hepatitis C 0.6790975811195187 | |
| CDKN1A Cytosol Hepatocellular carcinoma 0.6790975811195187 | |
| CDKN1A Cytosol Human T-cell leukemia virus 1 infection 0.6790975811195187 | |
| CDKN1A Cytosol Human cytomegalovirus infection 0.6790975811195187 | |
| CDKN1A Cytosol Human papillomavirus infection 0.6790975811195187 | |
| CDKN1A Cytosol JAK-STAT signaling pathway 0.6790975811195187 | |
| CDKN1A Cytosol Kaposi sarcoma-associated herpesvirus infection 0.6790975811195187 | |
| CDKN1A Cytosol Melanoma 0.6790975811195187 | |
| CDKN1A Cytosol MicroRNAs in cancer 0.6790975811195187 | |
| CDKN1A Cytosol Non-small cell lung cancer 0.6790975811195187 | |
| CDKN1A Cytosol Oxytocin signaling pathway 0.6790975811195187 | |
| CDKN1A Cytosol PI3K-Akt signaling pathway 0.6790975811195187 | |
| CDKN1A Cytosol Pancreatic cancer 0.6790975811195187 | |
| CDKN1A Cytosol Parathyroid hormone synthesis secretion and action 0.6790975811195187 | |
| CDKN1A Cytosol Pathways in cancer 0.6790975811195187 | |
| CDKN1A Cytosol Platinum drug resistance 0.6790975811195187 | |
| CDKN1A Cytosol Prostate cancer 0.6790975811195187 | |
| CDKN1A Cytosol Proteoglycans in cancer 0.6790975811195187 | |
| CDKN1A Cytosol Renal cell carcinoma 0.6790975811195187 | |
| CDKN1A Cytosol Small cell lung cancer 0.6790975811195187 | |
| CDKN1A Cytosol Thyroid cancer 0.6790975811195187 | |
| CDKN1A Cytosol Transcriptional misregulation in cancer 0.6790975811195187 | |
| CDKN1A Cytosol Viral carcinogenesis 0.6790975811195187 | |
| CDKN1A Cytosol p53 signaling pathway 0.6790975811195187 | |
| CDKN1A Nucleus Basal cell carcinoma 0.6790975811195187 | |
| CDKN1A Nucleus Bladder cancer 0.6790975811195187 | |
| CDKN1A Nucleus Breast cancer 0.6790975811195187 | |
| CDKN1A Nucleus Cell cycle 0.6790975811195187 | |
| CDKN1A Nucleus Cellular senescence 0.6790975811195187 | |
| CDKN1A Nucleus Chronic myeloid leukemia 0.6790975811195187 | |
| CDKN1A Nucleus Colorectal cancer 0.6790975811195187 | |
| CDKN1A Nucleus Cushing syndrome 0.6790975811195187 | |
| CDKN1A Nucleus Endocrine resistance 0.6790975811195187 | |
| CDKN1A Nucleus Endometrial cancer 0.6790975811195187 | |
| CDKN1A Nucleus Epstein-Barr virus infection 0.6790975811195187 | |
| CDKN1A Nucleus ErbB signaling pathway 0.6790975811195187 | |
| CDKN1A Nucleus FoxO signaling pathway 0.6790975811195187 | |
| CDKN1A Nucleus Gastric cancer 0.6790975811195187 | |
| CDKN1A Nucleus Glioma 0.6790975811195187 | |
| CDKN1A Nucleus HIF-1 signaling pathway 0.6790975811195187 | |
| CDKN1A Nucleus Hepatitis B 0.6790975811195187 | |
| CDKN1A Nucleus Hepatitis C 0.6790975811195187 | |
| CDKN1A Nucleus Hepatocellular carcinoma 0.6790975811195187 | |
| CDKN1A Nucleus Human T-cell leukemia virus 1 infection 0.6790975811195187 | |
| CDKN1A Nucleus Human cytomegalovirus infection 0.6790975811195187 | |
| CDKN1A Nucleus Human papillomavirus infection 0.6790975811195187 | |
| CDKN1A Nucleus JAK-STAT signaling pathway 0.6790975811195187 | |
| CDKN1A Nucleus Kaposi sarcoma-associated herpesvirus infection 0.6790975811195187 | |
| CDKN1A Nucleus Melanoma 0.6790975811195187 | |
| CDKN1A Nucleus MicroRNAs in cancer 0.6790975811195187 | |
| CDKN1A Nucleus Non-small cell lung cancer 0.6790975811195187 | |
| CDKN1A Nucleus Oxytocin signaling pathway 0.6790975811195187 | |
| CDKN1A Nucleus PI3K-Akt signaling pathway 0.6790975811195187 | |
| CDKN1A Nucleus Pancreatic cancer 0.6790975811195187 | |
| CDKN1A Nucleus Parathyroid hormone synthesis secretion and action 0.6790975811195187 | |
| CDKN1A Nucleus Pathways in cancer 0.6790975811195187 | |
| CDKN1A Nucleus Platinum drug resistance 0.6790975811195187 | |
| CDKN1A Nucleus Prostate cancer 0.6790975811195187 | |
| CDKN1A Nucleus Proteoglycans in cancer 0.6790975811195187 | |
| CDKN1A Nucleus Renal cell carcinoma 0.6790975811195187 | |
| CDKN1A Nucleus Small cell lung cancer 0.6790975811195187 | |
| CDKN1A Nucleus Thyroid cancer 0.6790975811195187 | |
| CDKN1A Nucleus Transcriptional misregulation in cancer 0.6790975811195187 | |
| CDKN1A Nucleus Viral carcinogenesis 0.6790975811195187 | |
| CDKN1A Nucleus p53 signaling pathway 0.6790975811195187 | |
| CDKN1B Cytosol AGE-RAGE signaling pathway in diabetic complications 1.2158194364232993 | |
| CDKN1B Cytosol Cell cycle 1.2158194364232993 | |
| CDKN1B Cytosol Chronic myeloid leukemia 1.2158194364232993 | |
| CDKN1B Cytosol Cushing syndrome 1.2158194364232993 | |
| CDKN1B Cytosol Endocrine resistance 1.2158194364232993 | |
| CDKN1B Cytosol Epstein-Barr virus infection 1.2158194364232993 | |
| CDKN1B Cytosol ErbB signaling pathway 1.2158194364232993 | |
| CDKN1B Cytosol FoxO signaling pathway 1.2158194364232993 | |
| CDKN1B Cytosol Gastric cancer 1.2158194364232993 | |
| CDKN1B Cytosol HIF-1 signaling pathway 1.2158194364232993 | |
| CDKN1B Cytosol Human papillomavirus infection 1.2158194364232993 | |
| CDKN1B Cytosol Measles 1.2158194364232993 | |
| CDKN1B Cytosol MicroRNAs in cancer 1.2158194364232993 | |
| CDKN1B Cytosol PI3K-Akt signaling pathway 1.2158194364232993 | |
| CDKN1B Cytosol Pathways in cancer 1.2158194364232993 | |
| CDKN1B Cytosol Prostate cancer 1.2158194364232993 | |
| CDKN1B Cytosol Small cell lung cancer 1.2158194364232993 | |
| CDKN1B Cytosol Transcriptional misregulation in cancer 1.2158194364232993 | |
| CDKN1B Cytosol Viral carcinogenesis 1.2158194364232993 | |
| CDKN1B Nucleus AGE-RAGE signaling pathway in diabetic complications 1.2158194364232993 | |
| CDKN1B Nucleus Cell cycle 1.2158194364232993 | |
| CDKN1B Nucleus Chronic myeloid leukemia 1.2158194364232993 | |
| CDKN1B Nucleus Cushing syndrome 1.2158194364232993 | |
| CDKN1B Nucleus Endocrine resistance 1.2158194364232993 | |
| CDKN1B Nucleus Epstein-Barr virus infection 1.2158194364232993 | |
| CDKN1B Nucleus ErbB signaling pathway 1.2158194364232993 | |
| CDKN1B Nucleus FoxO signaling pathway 1.2158194364232993 | |
| CDKN1B Nucleus Gastric cancer 1.2158194364232993 | |
| CDKN1B Nucleus HIF-1 signaling pathway 1.2158194364232993 | |
| CDKN1B Nucleus Human papillomavirus infection 1.2158194364232993 | |
| CDKN1B Nucleus Measles 1.2158194364232993 | |
| CDKN1B Nucleus MicroRNAs in cancer 1.2158194364232993 | |
| CDKN1B Nucleus PI3K-Akt signaling pathway 1.2158194364232993 | |
| CDKN1B Nucleus Pathways in cancer 1.2158194364232993 | |
| CDKN1B Nucleus Prostate cancer 1.2158194364232993 | |
| CDKN1B Nucleus Small cell lung cancer 1.2158194364232993 | |
| CDKN1B Nucleus Transcriptional misregulation in cancer 1.2158194364232993 | |
| CDKN1B Nucleus Viral carcinogenesis 1.2158194364232993 | |
| CDKN1C Cytosol Summary 1.2549184152746664 | |
| CDKN1C Nucleus Summary 1.2549184152746664 | |
| CDKN2A Cytosol Summary 1.46914131268419 | |
| CDKN2A Nucleus Summary 1.46914131268419 | |
| CDKN2AIP Nucleus Summary 0.9136359639046484 | |
| CDKN2C Cytosol Summary 1.4450424851290176 | |
| CDKN2C Nucleus Summary 1.4450424851290176 | |
| CDPF1 Cytosol Summary 2.0154618764997885 | |
| CDPF1 Nucleus Summary 2.0154618764997885 | |
| CDR2 Nucleus Summary 1.0991143793068745 | |
| CDR2L Cytosol Summary 1.6551497083208908 | |
| CDS2 Endoplasmic Reticulum Glycerophospholipid metabolism 0.7990450431239261 | |
| CDS2 Endoplasmic Reticulum Metabolic pathways 0.7990450431239261 | |
| CDS2 Endoplasmic Reticulum Phosphatidylinositol signaling system 0.7990450431239261 | |
| CDS2 Mitochondrion Glycerophospholipid metabolism 0.7990450431239261 | |
| CDS2 Mitochondrion Metabolic pathways 0.7990450431239261 | |
| CDS2 Mitochondrion Phosphatidylinositol signaling system 0.7990450431239261 | |
| CDV3 Cytosol Summary 1.287359214017428 | |
| CDV3 Nucleus Summary 1.287359214017428 | |
| CDV3 Plasma membrane Summary 1.287359214017428 | |
| CDYL Nucleus Summary 1.9731373020903715 | |
| CDYL2 Nucleus Summary 0.1753992147368394 | |
| CEACAM1 Extracellular space Summary 1.5555304265384498 | |
| CEACAM1 Plasma membrane Summary 1.5555304265384498 | |
| CEACAM5 Plasma membrane Summary 0.2616810227036746 | |
| CEACAM6 Plasma membrane Summary 1.1639970853021315 | |
| CEBPA Cytosol Summary 2.845450626965965 | |
| CEBPA Nucleus Summary 2.845450626965965 | |
| CEBPB Cytosol IL-17 signaling pathway 3.1478337040658935 | |
| CEBPB Cytosol TNF signaling pathway 3.1478337040658935 | |
| CEBPB Cytosol Transcriptional misregulation in cancer 3.1478337040658935 | |
| CEBPB Cytosol Tuberculosis 3.1478337040658935 | |
| CEBPB Nucleus IL-17 signaling pathway 3.1478337040658935 | |
| CEBPB Nucleus TNF signaling pathway 3.1478337040658935 | |
| CEBPB Nucleus Transcriptional misregulation in cancer 3.1478337040658935 | |
| CEBPB Nucleus Tuberculosis 3.1478337040658935 | |
| CEBPD Nucleus Summary 1.2582472529162498 | |
| CEBPG Nucleus Tuberculosis 2.3110908320775705 | |
| CEBPZ Cytosol Alzheimer disease 2.054905546448172 | |
| CEBPZ Cytosol Amyotrophic lateral sclerosis 2.054905546448172 | |
| CEBPZ Cytosol Apoptosis 2.054905546448172 | |
| CEBPZ Cytosol Lipid and atherosclerosis 2.054905546448172 | |
| CEBPZ Cytosol MAPK signaling pathway 2.054905546448172 | |
| CEBPZ Cytosol Non-alcoholic fatty liver disease 2.054905546448172 | |
| CEBPZ Cytosol Parkinson disease 2.054905546448172 | |
| CEBPZ Cytosol Pathways of neurodegeneration - multiple diseases 2.054905546448172 | |
| CEBPZ Cytosol Prion disease 2.054905546448172 | |
| CEBPZ Cytosol Protein processing in endoplasmic reticulum 2.054905546448172 | |
| CEBPZ Cytosol Transcriptional misregulation in cancer 2.054905546448172 | |
| CEBPZ Nucleus Alzheimer disease 2.054905546448172 | |
| CEBPZ Nucleus Amyotrophic lateral sclerosis 2.054905546448172 | |
| CEBPZ Nucleus Apoptosis 2.054905546448172 | |
| CEBPZ Nucleus Lipid and atherosclerosis 2.054905546448172 | |
| CEBPZ Nucleus MAPK signaling pathway 2.054905546448172 | |
| CEBPZ Nucleus Non-alcoholic fatty liver disease 2.054905546448172 | |
| CEBPZ Nucleus Parkinson disease 2.054905546448172 | |
| CEBPZ Nucleus Pathways of neurodegeneration - multiple diseases 2.054905546448172 | |
| CEBPZ Nucleus Prion disease 2.054905546448172 | |
| CEBPZ Nucleus Protein processing in endoplasmic reticulum 2.054905546448172 | |
| CEBPZ Nucleus Transcriptional misregulation in cancer 2.054905546448172 | |
| CEBPZOS Mitochondrion Summary 1.3858550883210978 | |
| CEBPZOS Nucleus Summary 1.3858550883210978 | |
| CECR1 Extracellular space Summary 1.2524107568292404 | |
| CECR5 Mitochondrion Summary 2.484081630500381 | |
| CEL Cytosol Fat digestion and absorption 1.5320624517761865 | |
| CEL Cytosol Glycerolipid metabolism 1.5320624517761865 | |
| CEL Cytosol Metabolic pathways 1.5320624517761865 | |
| CEL Cytosol Pancreatic secretion 1.5320624517761865 | |
| CEL Cytosol Steroid biosynthesis 1.5320624517761865 | |
| CEL Extracellular space Fat digestion and absorption 1.5320624517761865 | |
| CEL Extracellular space Glycerolipid metabolism 1.5320624517761865 | |
| CEL Extracellular space Metabolic pathways 1.5320624517761865 | |
| CEL Extracellular space Pancreatic secretion 1.5320624517761865 | |
| CEL Extracellular space Steroid biosynthesis 1.5320624517761865 | |
| CELF1 Nucleus Summary 1.7240272141515989 | |
| CELF2 Cytoskeleton Summary 1.7613555510776069 | |
| CELF2 Cytosol Summary 1.7613555510776069 | |
| CELF2 Nucleus Summary 1.7613555510776069 | |
| CELSR1 Nucleus Summary 0.24835921022154436 | |
| CELSR1 Plasma membrane Summary 0.24835921022154436 | |
| CELSR2 Cytosol Summary 0.4001583866812613 | |
| CELSR2 Plasma membrane Summary 0.4001583866812613 | |
| CEMIP Nucleus Summary 1.691917430000745 | |
| CENPB Endoplasmic Reticulum Summary 0.971001297016601 | |
| CENPB Nucleus Summary 0.971001297016601 | |
| CENPC Cytoskeleton Summary 1.6284087480662968 | |
| CENPC Endoplasmic Reticulum Summary 1.6284087480662968 | |
| CENPC Nucleus Summary 1.6284087480662968 | |
| CENPE Cytoskeleton Summary 0.991130667080064 | |
| CENPE Cytosol Summary 0.991130667080064 | |
| CENPE Endoplasmic Reticulum Summary 0.991130667080064 | |
| CENPE Nucleus Summary 0.991130667080064 | |
| CENPF Cytoskeleton Summary 2.906219524556203 | |
| CENPF Nucleus Summary 2.906219524556203 | |
| CENPH Mitochondrion Summary 2.661950467627936 | |
| CENPH Nucleus Summary 2.661950467627936 | |
| CENPJ Cytoskeleton Summary 1.0247693548030006 | |
| CENPJ Cytosol Summary 1.0247693548030006 | |
| CENPJ Nucleus Summary 1.0247693548030006 | |
| CENPJ Plasma membrane Summary 1.0247693548030006 | |
| CENPM Cytosol Summary 1.3563582458151615 | |
| CENPM Nucleus Summary 1.3563582458151615 | |
| CENPQ Endoplasmic Reticulum Summary 2.9381099425168435 | |
| CENPQ Nucleus Summary 2.9381099425168435 | |
| CENPU Nucleus Summary 3.142969108703208 | |
| CENPV Cytoskeleton Summary 1.23876384299149 | |
| CENPV Cytosol Summary 1.23876384299149 | |
| CENPV Endoplasmic Reticulum Summary 1.23876384299149 | |
| CENPV Nucleus Summary 1.23876384299149 | |
| CEP104 Cytoskeleton Summary 3.0301794830506164 | |
| CEP112 Cytoskeleton Summary 2.53679561363408 | |
| CEP112 Cytosol Summary 2.53679561363408 | |
| CEP112 Golgi apparatus Summary 2.53679561363408 | |
| CEP112 Nucleus Summary 2.53679561363408 | |
| CEP120 Cytoskeleton Summary 0.9112464333003344 | |
| CEP120 Cytosol Summary 0.9112464333003344 | |
| CEP128 Cytoskeleton Summary 1.4322729662624616 | |
| CEP128 Cytosol Summary 1.4322729662624616 | |
| CEP131 Cytoskeleton Summary 1.0773378094270183 | |
| CEP131 Cytosol Summary 1.0773378094270183 | |
| CEP135 Cytoskeleton Summary 1.2389764387524551 | |
| CEP135 Cytosol Summary 1.2389764387524551 | |
| CEP152 Cytoskeleton Summary 1.967329598644904 | |
| CEP152 Cytosol Summary 1.967329598644904 | |
| CEP162 Cytoskeleton Summary 1.3402479962228515 | |
| CEP162 Cytosol Summary 1.3402479962228515 | |
| CEP162 Nucleus Summary 1.3402479962228515 | |
| CEP162 Plasma membrane Summary 1.3402479962228515 | |
| CEP164 Cytoskeleton Summary 1.0974194231598595 | |
| CEP164 Cytosol Summary 1.0974194231598595 | |
| CEP164 Nucleus Summary 1.0974194231598595 | |
| CEP170 Cytoskeleton Summary 2.415264403637916 | |
| CEP170 Cytosol Summary 2.415264403637916 | |
| CEP170 Mitochondrion Summary 2.415264403637916 | |
| CEP170B Cytoskeleton Summary 0.9287769803645112 | |
| CEP170B Cytosol Summary 0.9287769803645112 | |
| CEP192 Cytoskeleton Summary 1.6381246828496887 | |
| CEP192 Cytosol Summary 1.6381246828496887 | |
| CEP250 Cytoskeleton Summary 1.193592658757236 | |
| CEP250 Nucleus Summary 1.193592658757236 | |
| CEP290 Cytoskeleton Summary 1.088153480313135 | |
| CEP290 Cytosol Summary 1.088153480313135 | |
| CEP290 Nucleus Summary 1.088153480313135 | |
| CEP295 Cytoskeleton Summary 0.8499241236437266 | |
| CEP295 Cytosol Summary 0.8499241236437266 | |
| CEP295 Plasma membrane Summary 0.8499241236437266 | |
| CEP350 Cytoskeleton Summary 1.289727387540185 | |
| CEP350 Cytosol Summary 1.289727387540185 | |
| CEP350 Nucleus Summary 1.289727387540185 | |
| CEP41 Cytoskeleton Summary 1.654610337655245 | |
| CEP41 Cytosol Summary 1.654610337655245 | |
| CEP44 Cytoskeleton Summary 1.4993908963626932 | |
| CEP44 Cytosol Summary 1.4993908963626932 | |
| CEP55 Cytoskeleton Summary 2.4929490010830544 | |
| CEP55 Cytosol Summary 2.4929490010830544 | |
| CEP55 Plasma membrane Summary 2.4929490010830544 | |
| CEP57 Cytoskeleton Summary 1.5900481995045823 | |
| CEP57 Cytosol Summary 1.5900481995045823 | |
| CEP57 Golgi apparatus Summary 1.5900481995045823 | |
| CEP57 Nucleus Summary 1.5900481995045823 | |
| CEP63 Cytoskeleton Summary 1.81788474014345 | |
| CEP63 Cytosol Summary 1.81788474014345 | |
| CEP63 Nucleus Summary 1.81788474014345 | |
| CEP68 Cytoskeleton Summary 0.5810909720100054 | |
| CEP68 Cytosol Summary 0.5810909720100054 | |
| CEP68 Nucleus Summary 0.5810909720100054 | |
| CEP76 Cytoskeleton Summary 1.290601740245343 | |
| CEP76 Cytosol Summary 1.290601740245343 | |
| CEP78 Cytoskeleton Summary 1.5011806889120665 | |
| CEP78 Cytosol Summary 1.5011806889120665 | |
| CEP83 Cytosol Summary 0.992437905876938 | |
| CEP83 Golgi apparatus Summary 0.992437905876938 | |
| CEP83 Nucleus Summary 0.992437905876938 | |
| CEP85 Cytoskeleton Summary 1.5072411668679702 | |
| CEP85 Cytosol Summary 1.5072411668679702 | |
| CEP85 Golgi apparatus Summary 1.5072411668679702 | |
| CEP85 Nucleus Summary 1.5072411668679702 | |
| CEP89 Cytoskeleton Summary 2.2153493426341986 | |
| CEP89 Cytosol Summary 2.2153493426341986 | |
| CEP89 Plasma membrane Summary 2.2153493426341986 | |
| CEP95 Cytoskeleton Summary 1.949960467563324 | |
| CEP95 Cytosol Summary 1.949960467563324 | |
| CEP95 Mitochondrion Summary 1.949960467563324 | |
| CEP95 Nucleus Summary 1.949960467563324 | |
| CEP97 Cytoskeleton Summary 1.2809688514501305 | |
| CEP97 Cytosol Summary 1.2809688514501305 | |
| CERCAM Endoplasmic Reticulum Summary 1.4382320038814096 | |
| CERCAM Nucleus Summary 1.4382320038814096 | |
| CERCAM Plasma membrane Summary 1.4382320038814096 | |
| CERS2 Endoplasmic Reticulum Metabolic pathways 0.2767707160805299 | |
| CERS2 Endoplasmic Reticulum Sphingolipid metabolism 0.2767707160805299 | |
| CERS2 Endoplasmic Reticulum Sphingolipid signaling pathway 0.2767707160805299 | |
| CERS2 Nucleus Metabolic pathways 0.2767707160805299 | |
| CERS2 Nucleus Sphingolipid metabolism 0.2767707160805299 | |
| CERS2 Nucleus Sphingolipid signaling pathway 0.2767707160805299 | |
| CERS4 Cytosol Metabolic pathways 0.1530453603847661 | |
| CERS4 Cytosol Sphingolipid metabolism 0.1530453603847661 | |
| CERS4 Cytosol Sphingolipid signaling pathway 0.1530453603847661 | |
| CERS4 Endoplasmic Reticulum Metabolic pathways 0.1530453603847661 | |
| CERS4 Endoplasmic Reticulum Sphingolipid metabolism 0.1530453603847661 | |
| CERS4 Endoplasmic Reticulum Sphingolipid signaling pathway 0.1530453603847661 | |
| CERS4 Nucleus Metabolic pathways 0.1530453603847661 | |
| CERS4 Nucleus Sphingolipid metabolism 0.1530453603847661 | |
| CERS4 Nucleus Sphingolipid signaling pathway 0.1530453603847661 | |
| CERS5 Endoplasmic Reticulum Metabolic pathways 0.12042884726322367 | |
| CERS5 Endoplasmic Reticulum Sphingolipid metabolism 0.12042884726322367 | |
| CERS5 Endoplasmic Reticulum Sphingolipid signaling pathway 0.12042884726322367 | |
| CERS5 Nucleus Metabolic pathways 0.12042884726322367 | |
| CERS5 Nucleus Sphingolipid metabolism 0.12042884726322367 | |
| CERS5 Nucleus Sphingolipid signaling pathway 0.12042884726322367 | |
| CERS6 Cytosol Metabolic pathways 0.2518781401806112 | |
| CERS6 Cytosol Sphingolipid metabolism 0.2518781401806112 | |
| CERS6 Cytosol Sphingolipid signaling pathway 0.2518781401806112 | |
| CERS6 Endoplasmic Reticulum Metabolic pathways 0.2518781401806112 | |
| CERS6 Endoplasmic Reticulum Sphingolipid metabolism 0.2518781401806112 | |
| CERS6 Endoplasmic Reticulum Sphingolipid signaling pathway 0.2518781401806112 | |
| CERS6 Nucleus Metabolic pathways 0.2518781401806112 | |
| CERS6 Nucleus Sphingolipid metabolism 0.2518781401806112 | |
| CERS6 Nucleus Sphingolipid signaling pathway 0.2518781401806112 | |
| CES1 Endoplasmic Reticulum Drug metabolism - other enzymes 0.8027418779421525 | |
| CES2 Cytosol Summary 0.8295879660807726 | |
| CES2 Endoplasmic Reticulum Summary 0.8295879660807726 | |
| CES2 Golgi apparatus Summary 0.8295879660807726 | |
| CETN2 Cytoskeleton Nucleotide excision repair 0.7154428850370049 | |
| CETN2 Cytosol Nucleotide excision repair 0.7154428850370049 | |
| CETN2 Nucleus Nucleotide excision repair 0.7154428850370049 | |
| CETN3 Cytoskeleton Summary 0.5801473129219121 | |
| CETN3 Cytosol Summary 0.5801473129219121 | |
| CETP Extracellular space Cholesterol metabolism 4.291525520130008 | |
| CFAP20 Nucleus Summary 1.6157068214527353 | |
| CFAP36 Cytosol Summary 0.8111919764958904 | |
| CFAP36 Nucleus Summary 0.8111919764958904 | |
| CFAP43 Nucleus Summary 1.1080417819508317 | |
| CFAP54 Cytoskeleton Summary 2.558370616175909 | |
| CFAP54 Cytosol Summary 2.558370616175909 | |
| CFAP58 Cytosol Summary 1.2697518355429354 | |
| CFAP58 Nucleus Summary 1.2697518355429354 | |
| CFAP58 Plasma membrane Summary 1.2697518355429354 | |
| CFAP97 Nucleus Summary 1.17868904482933 | |
| CFB Cytosol Complement and coagulation cascades 2.2838280546098284 | |
| CFB Cytosol Coronavirus disease - COVID-19 2.2838280546098284 | |
| CFB Cytosol Staphylococcus aureus infection 2.2838280546098284 | |
| CFB Endoplasmic Reticulum Complement and coagulation cascades 2.2838280546098284 | |
| CFB Endoplasmic Reticulum Coronavirus disease - COVID-19 2.2838280546098284 | |
| CFB Endoplasmic Reticulum Staphylococcus aureus infection 2.2838280546098284 | |
| CFB Extracellular space Complement and coagulation cascades 2.2838280546098284 | |
| CFB Extracellular space Coronavirus disease - COVID-19 2.2838280546098284 | |
| CFB Extracellular space Staphylococcus aureus infection 2.2838280546098284 | |
| CFB Plasma membrane Complement and coagulation cascades 2.2838280546098284 | |
| CFB Plasma membrane Coronavirus disease - COVID-19 2.2838280546098284 | |
| CFB Plasma membrane Staphylococcus aureus infection 2.2838280546098284 | |
| CFD Extracellular space Complement and coagulation cascades 1.3022545530341902 | |
| CFD Extracellular space Coronavirus disease - COVID-19 1.3022545530341902 | |
| CFD Extracellular space Inositol phosphate metabolism 1.3022545530341902 | |
| CFD Extracellular space Metabolic pathways 1.3022545530341902 | |
| CFD Extracellular space Phagosome 1.3022545530341902 | |
| CFD Extracellular space Phosphatidylinositol signaling system 1.3022545530341902 | |
| CFD Extracellular space Regulation of actin cytoskeleton 1.3022545530341902 | |
| CFD Extracellular space Staphylococcus aureus infection 1.3022545530341902 | |
| CFD Plasma membrane Complement and coagulation cascades 1.3022545530341902 | |
| CFD Plasma membrane Coronavirus disease - COVID-19 1.3022545530341902 | |
| CFD Plasma membrane Inositol phosphate metabolism 1.3022545530341902 | |
| CFD Plasma membrane Metabolic pathways 1.3022545530341902 | |
| CFD Plasma membrane Phagosome 1.3022545530341902 | |
| CFD Plasma membrane Phosphatidylinositol signaling system 1.3022545530341902 | |
| CFD Plasma membrane Regulation of actin cytoskeleton 1.3022545530341902 | |
| CFD Plasma membrane Staphylococcus aureus infection 1.3022545530341902 | |
| CFDP1 Cytosol Summary 1.4108465069012222 | |
| CFDP1 Endoplasmic Reticulum Summary 1.4108465069012222 | |
| CFDP1 Nucleus Summary 1.4108465069012222 | |
| CFH Cytosol Complement and coagulation cascades 3.1700780990443858 | |
| CFH Cytosol Staphylococcus aureus infection 3.1700780990443858 | |
| CFH Extracellular space Complement and coagulation cascades 3.1700780990443858 | |
| CFH Extracellular space Staphylococcus aureus infection 3.1700780990443858 | |
| CFHR1 Cytosol Complement and coagulation cascades 1.3178465428597688 | |
| CFHR1 Extracellular space Complement and coagulation cascades 1.3178465428597688 | |
| CFHR2 Extracellular space Complement and coagulation cascades 2.241717054947572 | |
| CFHR3 Extracellular space Complement and coagulation cascades 2.346371384593333 | |
| CFHR4 Extracellular space Complement and coagulation cascades 2.2254860846122395 | |
| CFHR5 Extracellular space Complement and coagulation cascades 2.2182694595066854 | |
| CFI Extracellular space Complement and coagulation cascades 2.2965247634922337 | |
| CFI Extracellular space Staphylococcus aureus infection 2.2965247634922337 | |
| CFL1 Cytoskeleton Axon guidance 1.4831425845795687 | |
| CFL1 Cytoskeleton Fc gamma R-mediated phagocytosis 1.4831425845795687 | |
| CFL1 Cytoskeleton Human immunodeficiency virus 1 infection 1.4831425845795687 | |
| CFL1 Cytoskeleton Pertussis 1.4831425845795687 | |
| CFL1 Cytoskeleton Regulation of actin cytoskeleton 1.4831425845795687 | |
| CFL1 Cytosol Axon guidance 1.4831425845795687 | |
| CFL1 Cytosol Fc gamma R-mediated phagocytosis 1.4831425845795687 | |
| CFL1 Cytosol Human immunodeficiency virus 1 infection 1.4831425845795687 | |
| CFL1 Cytosol Pertussis 1.4831425845795687 | |
| CFL1 Cytosol Regulation of actin cytoskeleton 1.4831425845795687 | |
| CFL1 Nucleus Axon guidance 1.4831425845795687 | |
| CFL1 Nucleus Fc gamma R-mediated phagocytosis 1.4831425845795687 | |
| CFL1 Nucleus Human immunodeficiency virus 1 infection 1.4831425845795687 | |
| CFL1 Nucleus Pertussis 1.4831425845795687 | |
| CFL1 Nucleus Regulation of actin cytoskeleton 1.4831425845795687 | |
| CFL1 Plasma membrane Axon guidance 1.4831425845795687 | |
| CFL1 Plasma membrane Fc gamma R-mediated phagocytosis 1.4831425845795687 | |
| CFL1 Plasma membrane Human immunodeficiency virus 1 infection 1.4831425845795687 | |
| CFL1 Plasma membrane Pertussis 1.4831425845795687 | |
| CFL1 Plasma membrane Regulation of actin cytoskeleton 1.4831425845795687 | |
| CFL2 Cytosol Summary 2.5424880547865887 | |
| CFL2 Nucleus Summary 2.5424880547865887 | |
| CFL2 Plasma membrane Summary 2.5424880547865887 | |
| CFLAR Cytosol Apoptosis 1.7838065822114673 | |
| CFLAR Cytosol Autophagy - animal 1.7838065822114673 | |
| CFLAR Cytosol Chagas disease 1.7838065822114673 | |
| CFLAR Cytosol Hepatitis C 1.7838065822114673 | |
| CFLAR Cytosol NF-kappa B signaling pathway 1.7838065822114673 | |
| CFLAR Cytosol Necroptosis 1.7838065822114673 | |
| CFLAR Cytosol TNF signaling pathway 1.7838065822114673 | |
| CFLAR Nucleus Apoptosis 1.7838065822114673 | |
| CFLAR Nucleus Autophagy - animal 1.7838065822114673 | |
| CFLAR Nucleus Chagas disease 1.7838065822114673 | |
| CFLAR Nucleus Hepatitis C 1.7838065822114673 | |
| CFLAR Nucleus NF-kappa B signaling pathway 1.7838065822114673 | |
| CFLAR Nucleus Necroptosis 1.7838065822114673 | |
| CFLAR Nucleus TNF signaling pathway 1.7838065822114673 | |
| CFLAR Plasma membrane Apoptosis 1.7838065822114673 | |
| CFLAR Plasma membrane Autophagy - animal 1.7838065822114673 | |
| CFLAR Plasma membrane Chagas disease 1.7838065822114673 | |
| CFLAR Plasma membrane Hepatitis C 1.7838065822114673 | |
| CFLAR Plasma membrane NF-kappa B signaling pathway 1.7838065822114673 | |
| CFLAR Plasma membrane Necroptosis 1.7838065822114673 | |
| CFLAR Plasma membrane TNF signaling pathway 1.7838065822114673 | |
| CFP Cytosol Herpes simplex virus 1 infection 2.3982544799614174 | |
| CFP Extracellular space Herpes simplex virus 1 infection 2.3982544799614174 | |
| CGA Extracellular space Autoimmune thyroid disease 0.07339920690631759 | |
| CGA Extracellular space GnRH secretion 0.07339920690631759 | |
| CGA Extracellular space GnRH signaling pathway 0.07339920690631759 | |
| CGA Extracellular space Neuroactive ligand-receptor interaction 0.07339920690631759 | |
| CGA Extracellular space Ovarian steroidogenesis 0.07339920690631759 | |
| CGA Extracellular space Prolactin signaling pathway 0.07339920690631759 | |
| CGA Extracellular space Regulation of lipolysis in adipocytes 0.07339920690631759 | |
| CGA Extracellular space Thyroid hormone synthesis 0.07339920690631759 | |
| CGA Extracellular space cAMP signaling pathway 0.07339920690631759 | |
| CGGBP1 Nucleus Summary 1.1558080354692342 | |
| CGN Plasma membrane Tight junction 1.2023010856969427 | |
| CGNL1 Nucleus Summary 0.6712898291692401 | |
| CGNL1 Plasma membrane Summary 0.6712898291692401 | |
| CGREF1 Golgi apparatus Summary 1.8540696507307224 | |
| CHAC2 Cytosol Summary 2.0493308898808458 | |
| CHAD Extracellular space ECM-receptor interaction 0.06888953230824761 | |
| CHAD Extracellular space Focal adhesion 0.06888953230824761 | |
| CHAD Extracellular space Human papillomavirus infection 0.06888953230824761 | |
| CHAD Extracellular space PI3K-Akt signaling pathway 0.06888953230824761 | |
| CHAF1A Cytosol Summary 1.9331931880427693 | |
| CHAF1A Nucleus Summary 1.9331931880427693 | |
| CHAF1B Nucleus Summary 2.7627150553313338 | |
| CHAMP1 Cytoskeleton Summary 1.4196286144096817 | |
| CHAMP1 Nucleus Summary 1.4196286144096817 | |
| CHCHD1 Mitochondrion Summary 1.9473356505789272 | |
| CHCHD1 Nucleus Summary 1.9473356505789272 | |
| CHCHD10 Mitochondrion Summary 2.4377035682025783 | |
| CHCHD2 Mitochondrion Summary 1.9122289349730948 | |
| CHCHD2 Nucleus Summary 1.9122289349730948 | |
| CHCHD3 Mitochondrion Summary 1.3310122174051855 | |
| CHCHD4 Mitochondrion Summary 1.3690991358964844 | |
| CHCHD5 Mitochondrion Summary 0.662863537809812 | |
| CHCHD6 Mitochondrion Summary 0.7063608473911579 | |
| CHCHD7 Mitochondrion Summary 1.5249803222855578 | |
| CHCHD7 Plasma membrane Summary 1.5249803222855578 | |
| CHD1 Nucleus Summary 0.7901360731917214 | |
| CHD1L Cytosol Summary 1.809507782138715 | |
| CHD1L Nucleus Summary 1.809507782138715 | |
| CHD2 Nucleus Summary 1.3034939798160787 | |
| CHD3 Cytoskeleton Summary 0.7442963235859813 | |
| CHD3 Nucleus Summary 0.7442963235859813 | |
| CHD4 Cytoskeleton Human papillomavirus infection 1.7312388184635819 | |
| CHD4 Cytoskeleton Viral carcinogenesis 1.7312388184635819 | |
| CHD4 Nucleus Human papillomavirus infection 1.7312388184635819 | |
| CHD4 Nucleus Viral carcinogenesis 1.7312388184635819 | |
| CHD5 Cytosol Summary 1.330254452176889 | |
| CHD5 Nucleus Summary 1.330254452176889 | |
| CHD6 Nucleus Summary 0.9020061417898748 | |
| CHD7 Nucleus Summary 1.8292224284951184 | |
| CHD8 Nucleus Wnt signaling pathway 1.6945761874429457 | |
| CHD9 Cytosol Summary 0.9819378295366712 | |
| CHD9 Nucleus Summary 0.9819378295366712 | |
| CHDH Mitochondrion Summary 0.8559855340463293 | |
| CHEK1 Cytoskeleton Cell cycle 2.201732816196856 | |
| CHEK1 Cytoskeleton Cellular senescence 2.201732816196856 | |
| CHEK1 Cytoskeleton Human T-cell leukemia virus 1 infection 2.201732816196856 | |
| CHEK1 Cytoskeleton Human immunodeficiency virus 1 infection 2.201732816196856 | |
| CHEK1 Cytoskeleton Viral carcinogenesis 2.201732816196856 | |
| CHEK1 Cytoskeleton p53 signaling pathway 2.201732816196856 | |
| CHEK1 Cytosol Cell cycle 2.201732816196856 | |
| CHEK1 Cytosol Cellular senescence 2.201732816196856 | |
| CHEK1 Cytosol Human T-cell leukemia virus 1 infection 2.201732816196856 | |
| CHEK1 Cytosol Human immunodeficiency virus 1 infection 2.201732816196856 | |
| CHEK1 Cytosol Viral carcinogenesis 2.201732816196856 | |
| CHEK1 Cytosol p53 signaling pathway 2.201732816196856 | |
| CHEK1 Nucleus Cell cycle 2.201732816196856 | |
| CHEK1 Nucleus Cellular senescence 2.201732816196856 | |
| CHEK1 Nucleus Human T-cell leukemia virus 1 infection 2.201732816196856 | |
| CHEK1 Nucleus Human immunodeficiency virus 1 infection 2.201732816196856 | |
| CHEK1 Nucleus Viral carcinogenesis 2.201732816196856 | |
| CHEK1 Nucleus p53 signaling pathway 2.201732816196856 | |
| CHEK2 Golgi apparatus Cell cycle 1.4313982349955463 | |
| CHEK2 Golgi apparatus Cellular senescence 1.4313982349955463 | |
| CHEK2 Golgi apparatus Human T-cell leukemia virus 1 infection 1.4313982349955463 | |
| CHEK2 Golgi apparatus p53 signaling pathway 1.4313982349955463 | |
| CHEK2 Nucleus Cell cycle 1.4313982349955463 | |
| CHEK2 Nucleus Cellular senescence 1.4313982349955463 | |
| CHEK2 Nucleus Human T-cell leukemia virus 1 infection 1.4313982349955463 | |
| CHEK2 Nucleus p53 signaling pathway 1.4313982349955463 | |
| CHERP Cytosol Spliceosome 2.003047738340837 | |
| CHERP Endoplasmic Reticulum Spliceosome 2.003047738340837 | |
| CHFR Cytoskeleton Summary 1.5694050728682398 | |
| CHFR Nucleus Summary 1.5694050728682398 | |
| CHGA Cytosol Summary 0.09564417821977833 | |
| CHGA Endoplasmic Reticulum Summary 0.09564417821977833 | |
| CHGA Extracellular space Summary 0.09564417821977833 | |
| CHGB Cytosol Summary 0.03893403985709115 | |
| CHGB Extracellular space Summary 0.03893403985709115 | |
| CHI3L1 Cytosol Summary 2.57015389844138 | |
| CHI3L1 Extracellular space Summary 2.57015389844138 | |
| CHI3L1 Golgi apparatus Summary 2.57015389844138 | |
| CHID1 Cytoskeleton Summary 0.8275417166486233 | |
| CHID1 Nucleus Summary 0.8275417166486233 | |
| CHIT1 Extracellular space Amino sugar and nucleotide sugar metabolism 1.6294486110106088 | |
| CHIT1 Extracellular space Metabolic pathways 1.6294486110106088 | |
| CHIT1 Lysosome Amino sugar and nucleotide sugar metabolism 1.6294486110106088 | |
| CHIT1 Lysosome Metabolic pathways 1.6294486110106088 | |
| CHKA Cytosol Summary 1.3624073902865252 | |
| CHKA Endoplasmic Reticulum Summary 1.3624073902865252 | |
| CHKB Cytosol Summary 0.8028415573872401 | |
| CHL1 Plasma membrane Summary 1.3727899492404438 | |
| CHM Cytosol Summary 0.9621658049840048 | |
| CHM Nucleus Summary 0.9621658049840048 | |
| CHML Cytosol Summary 1.9247179001835704 | |
| CHML Nucleus Summary 1.9247179001835704 | |
| CHMP1A Nucleus Summary 0.992235931866112 | |
| CHMP1B Cytoskeleton Summary 1.3534252525013095 | |
| CHMP1B Endosome Summary 1.3534252525013095 | |
| CHMP1B Nucleus Summary 1.3534252525013095 | |
| CHMP2A Cytosol Endocytosis 0.7354352150545694 | |
| CHMP2A Cytosol Necroptosis 0.7354352150545694 | |
| CHMP2A Endosome Endocytosis 0.7354352150545694 | |
| CHMP2A Endosome Necroptosis 0.7354352150545694 | |
| CHMP2A Nucleus Endocytosis 0.7354352150545694 | |
| CHMP2A Nucleus Necroptosis 0.7354352150545694 | |
| CHMP2A Plasma membrane Endocytosis 0.7354352150545694 | |
| CHMP2A Plasma membrane Necroptosis 0.7354352150545694 | |
| CHMP2B Cytosol Amyotrophic lateral sclerosis 0.8132281508081222 | |
| CHMP2B Cytosol Endocytosis 0.8132281508081222 | |
| CHMP2B Cytosol Necroptosis 0.8132281508081222 | |
| CHMP2B Cytosol Pathways of neurodegeneration - multiple diseases 0.8132281508081222 | |
| CHMP2B Endosome Amyotrophic lateral sclerosis 0.8132281508081222 | |
| CHMP2B Endosome Endocytosis 0.8132281508081222 | |
| CHMP2B Endosome Necroptosis 0.8132281508081222 | |
| CHMP2B Endosome Pathways of neurodegeneration - multiple diseases 0.8132281508081222 | |
| CHMP3 Cytosol Endocytosis 1.1350911687081782 | |
| CHMP3 Cytosol Necroptosis 1.1350911687081782 | |
| CHMP3 Endosome Endocytosis 1.1350911687081782 | |
| CHMP3 Endosome Necroptosis 1.1350911687081782 | |
| CHMP4A Endosome Endocytosis 0.9816066911183337 | |
| CHMP4A Endosome Necroptosis 0.9816066911183337 | |
| CHMP4B Cytosol Endocytosis 0.9775707944608004 | |
| CHMP4B Cytosol Necroptosis 0.9775707944608004 | |
| CHMP4B Endosome Endocytosis 0.9775707944608004 | |
| CHMP4B Endosome Necroptosis 0.9775707944608004 | |
| CHMP4C Cytosol Endocytosis 1.4420828332567792 | |
| CHMP4C Cytosol Necroptosis 1.4420828332567792 | |
| CHMP4C Endosome Endocytosis 1.4420828332567792 | |
| CHMP4C Endosome Necroptosis 1.4420828332567792 | |
| CHMP5 Cytoskeleton Endocytosis 1.311395665059102 | |
| CHMP5 Cytoskeleton Necroptosis 1.311395665059102 | |
| CHMP5 Cytosol Endocytosis 1.311395665059102 | |
| CHMP5 Cytosol Necroptosis 1.311395665059102 | |
| CHMP5 Endosome Endocytosis 1.311395665059102 | |
| CHMP5 Endosome Necroptosis 1.311395665059102 | |
| CHMP6 Endosome Endocytosis 0.702527753528751 | |
| CHMP6 Endosome Necroptosis 0.702527753528751 | |
| CHMP7 Cytosol Endocytosis 1.3539215481260514 | |
| CHMP7 Cytosol Necroptosis 1.3539215481260514 | |
| CHMP7 Endosome Endocytosis 1.3539215481260514 | |
| CHMP7 Endosome Necroptosis 1.3539215481260514 | |
| CHMP7 Nucleus Endocytosis 1.3539215481260514 | |
| CHMP7 Nucleus Necroptosis 1.3539215481260514 | |
| CHN1 Cytosol Summary 1.548142676036797 | |
| CHN2 Nucleus Summary 0.7937508185940473 | |
| CHORDC1 Cytosol Summary 1.7114008614952287 | |
| CHP1 Cytosol Summary 1.4614844540303238 | |
| CHP1 Nucleus Summary 1.4614844540303238 | |
| CHPF Cytoskeleton Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 1.58689889369515 | |
| CHPF Cytoskeleton Metabolic pathways 1.58689889369515 | |
| CHPF Cytosol Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 1.58689889369515 | |
| CHPF Cytosol Metabolic pathways 1.58689889369515 | |
| CHPF Golgi apparatus Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 1.58689889369515 | |
| CHPF Golgi apparatus Metabolic pathways 1.58689889369515 | |
| CHPF2 Cytosol Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 1.2464995484807726 | |
| CHPF2 Cytosol Metabolic pathways 1.2464995484807726 | |
| CHPF2 Golgi apparatus Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 1.2464995484807726 | |
| CHPF2 Golgi apparatus Metabolic pathways 1.2464995484807726 | |
| CHPF2 Nucleus Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 1.2464995484807726 | |
| CHPF2 Nucleus Metabolic pathways 1.2464995484807726 | |
| CHPT1 Cytosol Choline metabolism in cancer 0.3828078518055278 | |
| CHPT1 Cytosol Ether lipid metabolism 0.3828078518055278 | |
| CHPT1 Cytosol Glycerophospholipid metabolism 0.3828078518055278 | |
| CHPT1 Cytosol Metabolic pathways 0.3828078518055278 | |
| CHPT1 Cytosol Phosphonate and phosphinate metabolism 0.3828078518055278 | |
| CHPT1 Golgi apparatus Choline metabolism in cancer 0.3828078518055278 | |
| CHPT1 Golgi apparatus Ether lipid metabolism 0.3828078518055278 | |
| CHPT1 Golgi apparatus Glycerophospholipid metabolism 0.3828078518055278 | |
| CHPT1 Golgi apparatus Metabolic pathways 0.3828078518055278 | |
| CHPT1 Golgi apparatus Phosphonate and phosphinate metabolism 0.3828078518055278 | |
| CHRAC1 Nucleus Summary 2.9037434688588415 | |
| CHST14 Cytosol Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 1.1926660104633282 | |
| CHST14 Golgi apparatus Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 1.1926660104633282 | |
| CHST15 Cytoskeleton Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 0.8364107320249738 | |
| CHST15 Cytosol Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 0.8364107320249738 | |
| CHST15 Golgi apparatus Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 0.8364107320249738 | |
| CHST3 Cytosol Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 2.8107765141398118 | |
| CHST3 Golgi apparatus Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 2.8107765141398118 | |
| CHSY1 Extracellular space Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 1.7407056478896141 | |
| CHSY1 Extracellular space Metabolic pathways 1.7407056478896141 | |
| CHSY1 Golgi apparatus Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate 1.7407056478896141 | |
| CHSY1 Golgi apparatus Metabolic pathways 1.7407056478896141 | |
| CHTF18 Cytosol Summary 1.711207654241325 | |
| CHTF18 Nucleus Summary 1.711207654241325 | |
| CHTF8 Nucleus Summary 1.236579960528729 | |
| CHTOP Nucleus Summary 1.8239687752811418 | |
| CHUK Cytosol Acute myeloid leukemia 0.9970192023814304 | |
| CHUK Cytosol Adipocytokine signaling pathway 0.9970192023814304 | |
| CHUK Cytosol Alzheimer disease 0.9970192023814304 | |
| CHUK Cytosol Antifolate resistance 0.9970192023814304 | |
| CHUK Cytosol Apoptosis 0.9970192023814304 | |
| CHUK Cytosol B cell receptor signaling pathway 0.9970192023814304 | |
| CHUK Cytosol C-type lectin receptor signaling pathway 0.9970192023814304 | |
| CHUK Cytosol Chagas disease 0.9970192023814304 | |
| CHUK Cytosol Chemokine signaling pathway 0.9970192023814304 | |
| CHUK Cytosol Chronic myeloid leukemia 0.9970192023814304 | |
| CHUK Cytosol Coronavirus disease - COVID-19 0.9970192023814304 | |
| CHUK Cytosol Cytosolic DNA-sensing pathway 0.9970192023814304 | |
| CHUK Cytosol Epithelial cell signaling in Helicobacter pylori infection 0.9970192023814304 | |
| CHUK Cytosol Epstein-Barr virus infection 0.9970192023814304 | |
| CHUK Cytosol Fluid shear stress and atherosclerosis 0.9970192023814304 | |
| CHUK Cytosol FoxO signaling pathway 0.9970192023814304 | |
| CHUK Cytosol Hepatitis B 0.9970192023814304 | |
| CHUK Cytosol Hepatitis C 0.9970192023814304 | |
| CHUK Cytosol Herpes simplex virus 1 infection 0.9970192023814304 | |
| CHUK Cytosol Human T-cell leukemia virus 1 infection 0.9970192023814304 | |
| CHUK Cytosol Human cytomegalovirus infection 0.9970192023814304 | |
| CHUK Cytosol Human immunodeficiency virus 1 infection 0.9970192023814304 | |
| CHUK Cytosol Human papillomavirus infection 0.9970192023814304 | |
| CHUK Cytosol IL-17 signaling pathway 0.9970192023814304 | |
| CHUK Cytosol Influenza A 0.9970192023814304 | |
| CHUK Cytosol Kaposi sarcoma-associated herpesvirus infection 0.9970192023814304 | |
| CHUK Cytosol Lipid and atherosclerosis 0.9970192023814304 | |
| CHUK Cytosol MAPK signaling pathway 0.9970192023814304 | |
| CHUK Cytosol Measles 0.9970192023814304 | |
| CHUK Cytosol NF-kappa B signaling pathway 0.9970192023814304 | |
| CHUK Cytosol NOD-like receptor signaling pathway 0.9970192023814304 | |
| CHUK Cytosol Osteoclast differentiation 0.9970192023814304 | |
| CHUK Cytosol PD-L1 expression and PD-1 checkpoint pathway in cancer 0.9970192023814304 | |
| CHUK Cytosol PI3K-Akt signaling pathway 0.9970192023814304 | |
| CHUK Cytosol Pancreatic cancer 0.9970192023814304 | |
| CHUK Cytosol Pathogenic Escherichia coli infection 0.9970192023814304 | |
| CHUK Cytosol Pathways in cancer 0.9970192023814304 | |
| CHUK Cytosol Prostate cancer 0.9970192023814304 | |
| CHUK Cytosol RIG-I-like receptor signaling pathway 0.9970192023814304 | |
| CHUK Cytosol Ras signaling pathway 0.9970192023814304 | |
| CHUK Cytosol Salmonella infection 0.9970192023814304 | |
| CHUK Cytosol Shigellosis 0.9970192023814304 | |
| CHUK Cytosol Small cell lung cancer 0.9970192023814304 | |
| CHUK Cytosol T cell receptor signaling pathway 0.9970192023814304 | |
| CHUK Cytosol TNF signaling pathway 0.9970192023814304 | |
| CHUK Cytosol Th1 and Th2 cell differentiation 0.9970192023814304 | |
| CHUK Cytosol Th17 cell differentiation 0.9970192023814304 | |
| CHUK Cytosol Toll-like receptor signaling pathway 0.9970192023814304 | |
| CHUK Cytosol Toxoplasmosis 0.9970192023814304 | |
| CHUK Cytosol Yersinia infection 0.9970192023814304 | |
| CHUK Cytosol mTOR signaling pathway 0.9970192023814304 | |
| CHUK Nucleus Acute myeloid leukemia 0.9970192023814304 | |
| CHUK Nucleus Adipocytokine signaling pathway 0.9970192023814304 | |
| CHUK Nucleus Alzheimer disease 0.9970192023814304 | |
| CHUK Nucleus Antifolate resistance 0.9970192023814304 | |
| CHUK Nucleus Apoptosis 0.9970192023814304 | |
| CHUK Nucleus B cell receptor signaling pathway 0.9970192023814304 | |
| CHUK Nucleus C-type lectin receptor signaling pathway 0.9970192023814304 | |
| CHUK Nucleus Chagas disease 0.9970192023814304 | |
| CHUK Nucleus Chemokine signaling pathway 0.9970192023814304 | |
| CHUK Nucleus Chronic myeloid leukemia 0.9970192023814304 | |
| CHUK Nucleus Coronavirus disease - COVID-19 0.9970192023814304 | |
| CHUK Nucleus Cytosolic DNA-sensing pathway 0.9970192023814304 | |
| CHUK Nucleus Epithelial cell signaling in Helicobacter pylori infection 0.9970192023814304 | |
| CHUK Nucleus Epstein-Barr virus infection 0.9970192023814304 | |
| CHUK Nucleus Fluid shear stress and atherosclerosis 0.9970192023814304 | |
| CHUK Nucleus FoxO signaling pathway 0.9970192023814304 | |
| CHUK Nucleus Hepatitis B 0.9970192023814304 | |
| CHUK Nucleus Hepatitis C 0.9970192023814304 | |
| CHUK Nucleus Herpes simplex virus 1 infection 0.9970192023814304 | |
| CHUK Nucleus Human T-cell leukemia virus 1 infection 0.9970192023814304 | |
| CHUK Nucleus Human cytomegalovirus infection 0.9970192023814304 | |
| CHUK Nucleus Human immunodeficiency virus 1 infection 0.9970192023814304 | |
| CHUK Nucleus Human papillomavirus infection 0.9970192023814304 | |
| CHUK Nucleus IL-17 signaling pathway 0.9970192023814304 | |
| CHUK Nucleus Influenza A 0.9970192023814304 | |
| CHUK Nucleus Kaposi sarcoma-associated herpesvirus infection 0.9970192023814304 | |
| CHUK Nucleus Lipid and atherosclerosis 0.9970192023814304 | |
| CHUK Nucleus MAPK signaling pathway 0.9970192023814304 | |
| CHUK Nucleus Measles 0.9970192023814304 | |
| CHUK Nucleus NF-kappa B signaling pathway 0.9970192023814304 | |
| CHUK Nucleus NOD-like receptor signaling pathway 0.9970192023814304 | |
| CHUK Nucleus Osteoclast differentiation 0.9970192023814304 | |
| CHUK Nucleus PD-L1 expression and PD-1 checkpoint pathway in cancer 0.9970192023814304 | |
| CHUK Nucleus PI3K-Akt signaling pathway 0.9970192023814304 | |
| CHUK Nucleus Pancreatic cancer 0.9970192023814304 | |
| CHUK Nucleus Pathogenic Escherichia coli infection 0.9970192023814304 | |
| CHUK Nucleus Pathways in cancer 0.9970192023814304 | |
| CHUK Nucleus Prostate cancer 0.9970192023814304 | |
| CHUK Nucleus RIG-I-like receptor signaling pathway 0.9970192023814304 | |
| CHUK Nucleus Ras signaling pathway 0.9970192023814304 | |
| CHUK Nucleus Salmonella infection 0.9970192023814304 | |
| CHUK Nucleus Shigellosis 0.9970192023814304 | |
| CHUK Nucleus Small cell lung cancer 0.9970192023814304 | |
| CHUK Nucleus T cell receptor signaling pathway 0.9970192023814304 | |
| CHUK Nucleus TNF signaling pathway 0.9970192023814304 | |
| CHUK Nucleus Th1 and Th2 cell differentiation 0.9970192023814304 | |
| CHUK Nucleus Th17 cell differentiation 0.9970192023814304 | |
| CHUK Nucleus Toll-like receptor signaling pathway 0.9970192023814304 | |
| CHUK Nucleus Toxoplasmosis 0.9970192023814304 | |
| CHUK Nucleus Yersinia infection 0.9970192023814304 | |
| CHUK Nucleus mTOR signaling pathway 0.9970192023814304 | |
| CIAPIN1 Cytosol Summary 1.1138616997582065 | |
| CIAPIN1 Mitochondrion Summary 1.1138616997582065 | |
| CIAPIN1 Nucleus Summary 1.1138616997582065 | |
| CIB1 Nucleus Summary 0.35134461998990824 | |
| CIB1 Plasma membrane Summary 0.35134461998990824 | |
| CIC Cytosol Summary 0.9594625818391476 | |
| CIC Nucleus Summary 0.9594625818391476 | |
| CILP Extracellular space Summary 1.3752305469122783 | |
| CILP2 Extracellular space Summary 0.7986111083806203 | |
| CINP Nucleus Summary 1.4797730260561508 | |
| CIR1 Cytoskeleton Epstein-Barr virus infection 1.150992112659944 | |
| CIR1 Cytoskeleton Notch signaling pathway 1.150992112659944 | |
| CIR1 Cytoskeleton Shigellosis 1.150992112659944 | |
| CIR1 Nucleus Epstein-Barr virus infection 1.150992112659944 | |
| CIR1 Nucleus Notch signaling pathway 1.150992112659944 | |
| CIR1 Nucleus Shigellosis 1.150992112659944 | |
| CIRBP Cytosol Summary 0.5216164466170055 | |
| CIRBP Nucleus Summary 0.5216164466170055 | |
| CISD1 Mitochondrion Summary 1.9856443739998328 | |
| CISD1 Plasma membrane Summary 1.9856443739998328 | |
| CISD2 Endoplasmic Reticulum Summary 1.2213638261273791 | |
| CISD2 Mitochondrion Summary 1.2213638261273791 | |
| CISD3 Mitochondrion Summary 0.22348953347614012 | |
| CIT Cytosol Summary 2.067306150702526 | |
| CITED2 Nucleus Mitophagy - animal 0.8608862997173434 | |
| CIZ1 Nucleus Summary 0.9137828374074708 | |
| CKAP2 Cytoskeleton Summary 2.484379836315465 | |
| CKAP2 Cytosol Summary 2.484379836315465 | |
| CKAP2 Mitochondrion Summary 2.484379836315465 | |
| CKAP4 Cytoskeleton Protein processing in endoplasmic reticulum 1.4282762305758874 | |
| CKAP4 Cytosol Protein processing in endoplasmic reticulum 1.4282762305758874 | |
| CKAP4 Endoplasmic Reticulum Protein processing in endoplasmic reticulum 1.4282762305758874 | |
| CKAP4 Nucleus Protein processing in endoplasmic reticulum 1.4282762305758874 | |
| CKAP4 Plasma membrane Protein processing in endoplasmic reticulum 1.4282762305758874 | |
| CKAP5 Cytoskeleton Summary 1.5087247776168653 | |
| CKAP5 Cytosol Summary 1.5087247776168653 | |
| CKAP5 Nucleus Summary 1.5087247776168653 | |
| CKAP5 Plasma membrane Summary 1.5087247776168653 | |
| CKB Cytosol Summary 0.8574604960708286 | |
| CKM Cytosol Summary 1.4897561734236386 | |
| CKMT1B Mitochondrion Arginine and proline metabolism 1.4879931602511502 | |
| CKMT1B Mitochondrion Metabolic pathways 1.4879931602511502 | |
| CKMT2 Mitochondrion Arginine and proline metabolism 1.5194778549518744 | |
| CKMT2 Mitochondrion Metabolic pathways 1.5194778549518744 | |
| CKS1B Cytosol Summary 2.4484663812093688 | |
| CKS1B Mitochondrion Summary 2.4484663812093688 | |
| CKS1B Nucleus Summary 2.4484663812093688 | |
| CKS2 Cytosol Summary 1.1414159596608733 | |
| CKS2 Mitochondrion Summary 1.1414159596608733 | |
| CKS2 Nucleus Summary 1.1414159596608733 | |
| CLASP1 Cytoskeleton Summary 1.8293584042176847 | |
| CLASP1 Cytosol Summary 1.8293584042176847 | |
| CLASP1 Golgi apparatus Summary 1.8293584042176847 | |
| CLASP2 Cytoskeleton Summary 1.175151890346219 | |
| CLASP2 Cytosol Summary 1.175151890346219 | |
| CLASP2 Golgi apparatus Summary 1.175151890346219 | |
| CLASP2 Plasma membrane Summary 1.175151890346219 | |
| CLASRP Nucleus Summary 1.1533361314423445 | |
| CLC Cytosol Summary 1.1783919959669849 | |
| CLCA2 Extracellular space Pancreatic secretion 0.5303767959660439 | |
| CLCA2 Extracellular space Renin secretion 0.5303767959660439 | |
| CLCA2 Nucleus Pancreatic secretion 0.5303767959660439 | |
| CLCA2 Nucleus Renin secretion 0.5303767959660439 | |
| CLCA2 Plasma membrane Pancreatic secretion 0.5303767959660439 | |
| CLCA2 Plasma membrane Renin secretion 0.5303767959660439 | |
| CLCC1 Endoplasmic Reticulum Summary 0.6745828864638639 | |
| CLCC1 Golgi apparatus Summary 0.6745828864638639 | |
| CLCN3 Cytosol Neutrophil extracellular trap formation 0.5792908147375526 | |
| CLCN3 Endosome Neutrophil extracellular trap formation 0.5792908147375526 | |
| CLCN3 Golgi apparatus Neutrophil extracellular trap formation 0.5792908147375526 | |
| CLCN5 Cytosol Neutrophil extracellular trap formation 1.0314794575321526 | |
| CLCN5 Endosome Neutrophil extracellular trap formation 1.0314794575321526 | |
| CLCN5 Golgi apparatus Neutrophil extracellular trap formation 1.0314794575321526 | |
| CLCN5 Plasma membrane Neutrophil extracellular trap formation 1.0314794575321526 | |
| CLCN7 Lysosome Summary 0.9009858045392056 | |
| CLCN7 Nucleus Summary 0.9009858045392056 | |
| CLDN3 Plasma membrane Cell adhesion molecules 1.1957270655317225 | |
| CLDN3 Plasma membrane Hepatitis C 1.1957270655317225 | |
| CLDN3 Plasma membrane Leukocyte transendothelial migration 1.1957270655317225 | |
| CLDN3 Plasma membrane Pathogenic Escherichia coli infection 1.1957270655317225 | |
| CLDN3 Plasma membrane Tight junction 1.1957270655317225 | |
| CLDN7 Cytosol Cell adhesion molecules 0.7145862051131121 | |
| CLDN7 Cytosol Hepatitis C 0.7145862051131121 | |
| CLDN7 Cytosol Leukocyte transendothelial migration 0.7145862051131121 | |
| CLDN7 Cytosol Pathogenic Escherichia coli infection 0.7145862051131121 | |
| CLDN7 Cytosol Tight junction 0.7145862051131121 | |
| CLDN7 Plasma membrane Cell adhesion molecules 0.7145862051131121 | |
| CLDN7 Plasma membrane Hepatitis C 0.7145862051131121 | |
| CLDN7 Plasma membrane Leukocyte transendothelial migration 0.7145862051131121 | |
| CLDN7 Plasma membrane Pathogenic Escherichia coli infection 0.7145862051131121 | |
| CLDN7 Plasma membrane Tight junction 0.7145862051131121 | |
| CLDND1 Cytosol Summary 1.63201006413717 | |
| CLDND1 Nucleus Summary 1.63201006413717 | |
| CLEC11A Cytoskeleton Summary 0.4123464214531095 | |
| CLEC11A Cytosol Summary 0.4123464214531095 | |
| CLEC11A Extracellular space Summary 0.4123464214531095 | |
| CLEC14A Endoplasmic Reticulum Summary 1.539443150920775 | |
| CLEC14A Golgi apparatus Summary 1.539443150920775 | |
| CLEC16A Cytosol Summary 1.247709784163786 | |
| CLEC16A Endosome Summary 1.247709784163786 | |
| CLEC16A Nucleus Summary 1.247709784163786 | |
| CLEC3A Extracellular space Summary 0.07441505060618094 | |
| CLEC3B Extracellular space Summary 1.6626916090182728 | |
| CLEC3B Nucleus Summary 1.6626916090182728 | |
| CLGN Endoplasmic Reticulum Bladder cancer 0.16664419727164656 | |
| CLGN Endoplasmic Reticulum Coronavirus disease - COVID-19 0.16664419727164656 | |
| CLGN Endoplasmic Reticulum IL-17 signaling pathway 0.16664419727164656 | |
| CLGN Endoplasmic Reticulum Lipid and atherosclerosis 0.16664419727164656 | |
| CLGN Endoplasmic Reticulum PPAR signaling pathway 0.16664419727164656 | |
| CLGN Endoplasmic Reticulum Pathways in cancer 0.16664419727164656 | |
| CLGN Endoplasmic Reticulum Relaxin signaling pathway 0.16664419727164656 | |
| CLGN Endoplasmic Reticulum Rheumatoid arthritis 0.16664419727164656 | |
| CLIC1 Cytosol Summary 1.69687958971065 | |
| CLIC1 Nucleus Summary 1.69687958971065 | |
| CLIC2 Cytosol Summary 2.0403328370942586 | |
| CLIC2 Nucleus Summary 2.0403328370942586 | |
| CLIC2 Plasma membrane Summary 2.0403328370942586 | |
| CLIC3 Nucleus Summary 1.235326458139104 | |
| CLIC4 Cytoskeleton Summary 2.3897645515564485 | |
| CLIC4 Cytosol Summary 2.3897645515564485 | |
| CLIC4 Mitochondrion Summary 2.3897645515564485 | |
| CLIC4 Nucleus Summary 2.3897645515564485 | |
| CLIC4 Plasma membrane Summary 2.3897645515564485 | |
| CLIC5 Cytoskeleton Summary 1.6296990664904074 | |
| CLIC5 Cytosol Summary 1.6296990664904074 | |
| CLIC5 Golgi apparatus Summary 1.6296990664904074 | |
| CLIC5 Nucleus Summary 1.6296990664904074 | |
| CLIC5 Plasma membrane Summary 1.6296990664904074 | |
| CLIC6 Cytosol Summary 0.12523936566687235 | |
| CLIC6 Plasma membrane Summary 0.12523936566687235 | |
| CLINT1 Cytosol Summary 0.7943187833729266 | |
| CLINT1 Golgi apparatus Summary 0.7943187833729266 | |
| CLINT1 Nucleus Summary 0.7943187833729266 | |
| CLIP1 Cytoskeleton mTOR signaling pathway 1.4212266695186817 | |
| CLIP1 Cytosol mTOR signaling pathway 1.4212266695186817 | |
| CLIP2 Cytosol Summary 1.7837231024223352 | |
| CLIP4 Cytosol Summary 1.2857520320772953 | |
| CLK1 Cytosol Biosynthesis of cofactors 1.2662625239648049 | |
| CLK1 Cytosol Legionellosis 1.2662625239648049 | |
| CLK1 Cytosol Metabolic pathways 1.2662625239648049 | |
| CLK1 Cytosol Phagosome 1.2662625239648049 | |
| CLK1 Cytosol Ubiquinone and other terpenoid-quinone biosynthesis 1.2662625239648049 | |
| CLK1 Nucleus Biosynthesis of cofactors 1.2662625239648049 | |
| CLK1 Nucleus Legionellosis 1.2662625239648049 | |
| CLK1 Nucleus Metabolic pathways 1.2662625239648049 | |
| CLK1 Nucleus Phagosome 1.2662625239648049 | |
| CLK1 Nucleus Ubiquinone and other terpenoid-quinone biosynthesis 1.2662625239648049 | |
| CLK2 Nucleus Fanconi anemia pathway 1.5600110445499993 | |
| CLK2 Nucleus mTOR signaling pathway 1.5600110445499993 | |
| CLK3 Cytoskeleton Summary 2.207563572654367 | |
| CLK3 Nucleus Summary 2.207563572654367 | |
| CLMN Cytosol Summary 0.7571944494721193 | |
| CLMN Nucleus Summary 0.7571944494721193 | |
| CLN5 Endoplasmic Reticulum Lysosome 0.6348356776567788 | |
| CLN5 Golgi apparatus Lysosome 0.6348356776567788 | |
| CLN5 Lysosome Lysosome 0.6348356776567788 | |
| CLNS1A Cytoskeleton RNA transport 1.4502065253219287 | |
| CLNS1A Cytosol RNA transport 1.4502065253219287 | |
| CLNS1A Nucleus RNA transport 1.4502065253219287 | |
| CLOCK Cytosol Circadian rhythm 0.9272276455414692 | |
| CLOCK Cytosol Dopaminergic synapse 0.9272276455414692 | |
| CLOCK Nucleus Circadian rhythm 0.9272276455414692 | |
| CLOCK Nucleus Dopaminergic synapse 0.9272276455414692 | |
| CLP1 Nucleus Phagosome 1.5245688637103112 | |
| CLP1 Nucleus mRNA surveillance pathway 1.5245688637103112 | |
| CLPB Mitochondrion Summary 1.8121470188103728 | |
| CLPP Mitochondrion Summary 1.4020270426318504 | |
| CLPTM1 Nucleus Summary 0.6356072575034261 | |
| CLPTM1L Endoplasmic Reticulum Summary 1.1698736009487685 | |
| CLPX Cytosol Summary 1.7506795992745745 | |
| CLPX Mitochondrion Summary 1.7506795992745745 | |
| CLPX Nucleus Summary 1.7506795992745745 | |
| CLSPN Golgi apparatus Summary 2.744487857633319 | |
| CLSPN Nucleus Summary 2.744487857633319 | |
| CLSTN1 Endoplasmic Reticulum Summary 1.2064596546504165 | |
| CLSTN1 Golgi apparatus Summary 1.2064596546504165 | |
| CLSTN1 Nucleus Summary 1.2064596546504165 | |
| CLSTN2 Cytosol Summary 0.07801972168535456 | |
| CLSTN2 Endoplasmic Reticulum Summary 0.07801972168535456 | |
| CLSTN2 Golgi apparatus Summary 0.07801972168535456 | |
| CLSTN2 Plasma membrane Summary 0.07801972168535456 | |
| CLSTN3 Endoplasmic Reticulum Summary 1.3328962865497809 | |
| CLSTN3 Golgi apparatus Summary 1.3328962865497809 | |
| CLSTN3 Plasma membrane Summary 1.3328962865497809 | |
| CLTA Cytosol Summary 1.5469959242303517 | |
| CLTA Endosome Summary 1.5469959242303517 | |
| CLTA Lysosome Summary 1.5469959242303517 | |
| CLTB Cytosol Summary 0.7342693659365209 | |
| CLTB Plasma membrane Summary 0.7342693659365209 | |
| CLU Cytosol Complement and coagulation cascades 1.3459446464669735 | |
| CLU Endoplasmic Reticulum Complement and coagulation cascades 1.3459446464669735 | |
| CLU Extracellular space Complement and coagulation cascades 1.3459446464669735 | |
| CLU Mitochondrion Complement and coagulation cascades 1.3459446464669735 | |
| CLU Nucleus Complement and coagulation cascades 1.3459446464669735 | |
| CLUAP1 Cytosol Summary 0.8150333474104043 | |
| CLUAP1 Nucleus Summary 0.8150333474104043 | |
| CLUH Cytosol Summary 2.4240047524561525 | |
| CLUH Nucleus Summary 2.4240047524561525 | |
| CLYBL Cytosol Summary 1.594450358724561 | |
| CLYBL Mitochondrion Summary 1.594450358724561 | |
| CMA1 Cytosol Diabetic cardiomyopathy 0.5183717046376896 | |
| CMA1 Cytosol Renin-angiotensin system 0.5183717046376896 | |
| CMA1 Extracellular space Diabetic cardiomyopathy 0.5183717046376896 | |
| CMA1 Extracellular space Renin-angiotensin system 0.5183717046376896 | |
| CMAS Cytosol Amino sugar and nucleotide sugar metabolism 1.6704620890028674 | |
| CMAS Cytosol Metabolic pathways 1.6704620890028674 | |
| CMAS Nucleus Amino sugar and nucleotide sugar metabolism 1.6704620890028674 | |
| CMAS Nucleus Metabolic pathways 1.6704620890028674 | |
| CMBL Cytosol Metabolic pathways 0.08108685667697707 | |
| CMC1 Mitochondrion Adrenergic signaling in cardiomyocytes 1.1549324131628895 | |
| CMC1 Mitochondrion African trypanosomiasis 1.1549324131628895 | |
| CMC1 Mitochondrion Aldosterone synthesis and secretion 1.1549324131628895 | |
| CMC1 Mitochondrion Alzheimer disease 1.1549324131628895 | |
| CMC1 Mitochondrion Amoebiasis 1.1549324131628895 | |
| CMC1 Mitochondrion Apelin signaling pathway 1.1549324131628895 | |
| CMC1 Mitochondrion Calcium signaling pathway 1.1549324131628895 | |
| CMC1 Mitochondrion Chagas disease 1.1549324131628895 | |
| CMC1 Mitochondrion Chemokine signaling pathway 1.1549324131628895 | |
| CMC1 Mitochondrion Cholinergic synapse 1.1549324131628895 | |
| CMC1 Mitochondrion Circadian entrainment 1.1549324131628895 | |
| CMC1 Mitochondrion Cortisol synthesis and secretion 1.1549324131628895 | |
| CMC1 Mitochondrion Cushing syndrome 1.1549324131628895 | |
| CMC1 Mitochondrion Dopaminergic synapse 1.1549324131628895 | |
| CMC1 Mitochondrion Endocrine and other factor-regulated calcium reabsorption 1.1549324131628895 | |
| CMC1 Mitochondrion Estrogen signaling pathway 1.1549324131628895 | |
| CMC1 Mitochondrion Gap junction 1.1549324131628895 | |
| CMC1 Mitochondrion Gastric acid secretion 1.1549324131628895 | |
| CMC1 Mitochondrion Glucagon signaling pathway 1.1549324131628895 | |
| CMC1 Mitochondrion Glutamatergic synapse 1.1549324131628895 | |
| CMC1 Mitochondrion GnRH secretion 1.1549324131628895 | |
| CMC1 Mitochondrion GnRH signaling pathway 1.1549324131628895 | |
| CMC1 Mitochondrion Growth hormone synthesis secretion and action 1.1549324131628895 | |
| CMC1 Mitochondrion Human cytomegalovirus infection 1.1549324131628895 | |
| CMC1 Mitochondrion Human immunodeficiency virus 1 infection 1.1549324131628895 | |
| CMC1 Mitochondrion Huntington disease 1.1549324131628895 | |
| CMC1 Mitochondrion Inflammatory mediator regulation of TRP channels 1.1549324131628895 | |
| CMC1 Mitochondrion Insulin secretion 1.1549324131628895 | |
| CMC1 Mitochondrion Long-term depression 1.1549324131628895 | |
| CMC1 Mitochondrion Long-term potentiation 1.1549324131628895 | |
| CMC1 Mitochondrion Melanogenesis 1.1549324131628895 | |
| CMC1 Mitochondrion Oxytocin signaling pathway 1.1549324131628895 | |
| CMC1 Mitochondrion Pancreatic secretion 1.1549324131628895 | |
| CMC1 Mitochondrion Parathyroid hormone synthesis secretion and action 1.1549324131628895 | |
| CMC1 Mitochondrion Pathways in cancer 1.1549324131628895 | |
| CMC1 Mitochondrion Pathways of neurodegeneration - multiple diseases 1.1549324131628895 | |
| CMC1 Mitochondrion Platelet activation 1.1549324131628895 | |
| CMC1 Mitochondrion Rap1 signaling pathway 1.1549324131628895 | |
| CMC1 Mitochondrion Renin secretion 1.1549324131628895 | |
| CMC1 Mitochondrion Retrograde endocannabinoid signaling 1.1549324131628895 | |
| CMC1 Mitochondrion Salivary secretion 1.1549324131628895 | |
| CMC1 Mitochondrion Serotonergic synapse 1.1549324131628895 | |
| CMC1 Mitochondrion Sphingolipid signaling pathway 1.1549324131628895 | |
| CMC1 Mitochondrion Spinocerebellar ataxia 1.1549324131628895 | |
| CMC1 Mitochondrion Thyroid hormone synthesis 1.1549324131628895 | |
| CMC1 Mitochondrion Vascular smooth muscle contraction 1.1549324131628895 | |
| CMC1 Mitochondrion Yersinia infection 1.1549324131628895 | |
| CMC1 Mitochondrion cGMP-PKG signaling pathway 1.1549324131628895 | |
| CMC1 Plasma membrane Adrenergic signaling in cardiomyocytes 1.1549324131628895 | |
| CMC1 Plasma membrane African trypanosomiasis 1.1549324131628895 | |
| CMC1 Plasma membrane Aldosterone synthesis and secretion 1.1549324131628895 | |
| CMC1 Plasma membrane Alzheimer disease 1.1549324131628895 | |
| CMC1 Plasma membrane Amoebiasis 1.1549324131628895 | |
| CMC1 Plasma membrane Apelin signaling pathway 1.1549324131628895 | |
| CMC1 Plasma membrane Calcium signaling pathway 1.1549324131628895 | |
| CMC1 Plasma membrane Chagas disease 1.1549324131628895 | |
| CMC1 Plasma membrane Chemokine signaling pathway 1.1549324131628895 | |
| CMC1 Plasma membrane Cholinergic synapse 1.1549324131628895 | |
| CMC1 Plasma membrane Circadian entrainment 1.1549324131628895 | |
| CMC1 Plasma membrane Cortisol synthesis and secretion 1.1549324131628895 | |
| CMC1 Plasma membrane Cushing syndrome 1.1549324131628895 | |
| CMC1 Plasma membrane Dopaminergic synapse 1.1549324131628895 | |
| CMC1 Plasma membrane Endocrine and other factor-regulated calcium reabsorption 1.1549324131628895 | |
| CMC1 Plasma membrane Estrogen signaling pathway 1.1549324131628895 | |
| CMC1 Plasma membrane Gap junction 1.1549324131628895 | |
| CMC1 Plasma membrane Gastric acid secretion 1.1549324131628895 | |
| CMC1 Plasma membrane Glucagon signaling pathway 1.1549324131628895 | |
| CMC1 Plasma membrane Glutamatergic synapse 1.1549324131628895 | |
| CMC1 Plasma membrane GnRH secretion 1.1549324131628895 | |
| CMC1 Plasma membrane GnRH signaling pathway 1.1549324131628895 | |
| CMC1 Plasma membrane Growth hormone synthesis secretion and action 1.1549324131628895 | |
| CMC1 Plasma membrane Human cytomegalovirus infection 1.1549324131628895 | |
| CMC1 Plasma membrane Human immunodeficiency virus 1 infection 1.1549324131628895 | |
| CMC1 Plasma membrane Huntington disease 1.1549324131628895 | |
| CMC1 Plasma membrane Inflammatory mediator regulation of TRP channels 1.1549324131628895 | |
| CMC1 Plasma membrane Insulin secretion 1.1549324131628895 | |
| CMC1 Plasma membrane Long-term depression 1.1549324131628895 | |
| CMC1 Plasma membrane Long-term potentiation 1.1549324131628895 | |
| CMC1 Plasma membrane Melanogenesis 1.1549324131628895 | |
| CMC1 Plasma membrane Oxytocin signaling pathway 1.1549324131628895 | |
| CMC1 Plasma membrane Pancreatic secretion 1.1549324131628895 | |
| CMC1 Plasma membrane Parathyroid hormone synthesis secretion and action 1.1549324131628895 | |
| CMC1 Plasma membrane Pathways in cancer 1.1549324131628895 | |
| CMC1 Plasma membrane Pathways of neurodegeneration - multiple diseases 1.1549324131628895 | |
| CMC1 Plasma membrane Platelet activation 1.1549324131628895 | |
| CMC1 Plasma membrane Rap1 signaling pathway 1.1549324131628895 | |
| CMC1 Plasma membrane Renin secretion 1.1549324131628895 | |
| CMC1 Plasma membrane Retrograde endocannabinoid signaling 1.1549324131628895 | |
| CMC1 Plasma membrane Salivary secretion 1.1549324131628895 | |
| CMC1 Plasma membrane Serotonergic synapse 1.1549324131628895 | |
| CMC1 Plasma membrane Sphingolipid signaling pathway 1.1549324131628895 | |
| CMC1 Plasma membrane Spinocerebellar ataxia 1.1549324131628895 | |
| CMC1 Plasma membrane Thyroid hormone synthesis 1.1549324131628895 | |
| CMC1 Plasma membrane Vascular smooth muscle contraction 1.1549324131628895 | |
| CMC1 Plasma membrane Yersinia infection 1.1549324131628895 | |
| CMC1 Plasma membrane cGMP-PKG signaling pathway 1.1549324131628895 | |
| CMC2 Mitochondrion Summary 2.321227935290723 | |
| CMC2 Plasma membrane Summary 2.321227935290723 | |
| CMC4 Mitochondrion Summary 1.2661657475403454 | |
| CMIP Cytosol Summary 1.1684362541509479 | |
| CMIP Nucleus Summary 1.1684362541509479 | |
| CMPK1 Nucleus Biosynthesis of cofactors 0.9206639656612426 | |
| CMPK1 Nucleus Drug metabolism - other enzymes 0.9206639656612426 | |
| CMPK1 Nucleus Metabolic pathways 0.9206639656612426 | |
| CMPK1 Nucleus Pyrimidine metabolism 0.9206639656612426 | |
| CMPK2 Mitochondrion Biosynthesis of cofactors 1.2957467684747357 | |
| CMPK2 Mitochondrion Metabolic pathways 1.2957467684747357 | |
| CMPK2 Mitochondrion Pyrimidine metabolism 1.2957467684747357 | |
| CMPK2 Nucleus Biosynthesis of cofactors 1.2957467684747357 | |
| CMPK2 Nucleus Metabolic pathways 1.2957467684747357 | |
| CMPK2 Nucleus Pyrimidine metabolism 1.2957467684747357 | |
| CMSS1 Mitochondrion Summary 3.0737498749684615 | |
| CMSS1 Nucleus Summary 3.0737498749684615 | |
| CMTM4 Cytosol Summary 0.2310466567378184 | |
| CMTM4 Golgi apparatus Summary 0.2310466567378184 | |
| CMTM4 Plasma membrane Summary 0.2310466567378184 | |
| CMTR1 Cytosol Summary 1.2980298824280316 | |
| CMTR1 Nucleus Summary 1.2980298824280316 | |
| CMTR2 Nucleus Summary 1.0343992292355 | |
| CMTR2 Plasma membrane Summary 1.0343992292355 | |
| CNBP Cytosol Summary 1.9030511750841812 | |
| CNBP Nucleus Summary 1.9030511750841812 | |
| CNDP1 Extracellular space Arginine and proline metabolism 1.5697307068210105 | |
| CNDP1 Extracellular space Histidine metabolism 1.5697307068210105 | |
| CNDP1 Extracellular space Metabolic pathways 1.5697307068210105 | |
| CNDP1 Extracellular space beta-Alanine metabolism 1.5697307068210105 | |
| CNDP2 Cytosol Summary 1.147245693486617 | |
| CNDP2 Nucleus Summary 1.147245693486617 | |
| CNKSR1 Cytosol Summary 0.6724836293679476 | |
| CNKSR3 Cytosol Summary 1.3830215403728618 | |
| CNKSR3 Mitochondrion Summary 1.3830215403728618 | |
| CNN1 Cytoskeleton Summary 1.9846381202569456 | |
| CNN2 Cytoskeleton Summary 1.7663928602747692 | |
| CNN2 Cytosol Summary 1.7663928602747692 | |
| CNN2 Nucleus Summary 1.7663928602747692 | |
| CNN3 Cytoskeleton Summary 2.150754533011304 | |
| CNN3 Cytosol Summary 2.150754533011304 | |
| CNNM3 Cytosol Summary 0.6852755537183763 | |
| CNNM3 Plasma membrane Summary 0.6852755537183763 | |
| CNNM4 Cytoskeleton Summary 0.6060734969481654 | |
| CNNM4 Plasma membrane Summary 0.6060734969481654 | |
| CNOT11 Cytosol Summary 1.0098223958088233 | |
| CNOT11 Nucleus Summary 1.0098223958088233 | |
| CNOT4 Cytosol Summary 1.547208723417366 | |
| CNOT6 Cytosol Summary 1.307823512462145 | |
| CNOT6L Cytosol Summary 1.4924307232844924 | |
| CNOT7 Nucleus RNA degradation 1.186017588855074 | |
| CNOT8 Cytosol RNA degradation 0.7936758973765831 | |
| CNOT8 Nucleus RNA degradation 0.7936758973765831 | |
| CNOT9 Cytosol Summary 1.2240893654044267 | |
| CNOT9 Nucleus Summary 1.2240893654044267 | |
| CNP Endoplasmic Reticulum Summary 1.3659695919650514 | |
| CNP Nucleus Summary 1.3659695919650514 | |
| CNP Plasma membrane Summary 1.3659695919650514 | |
| CNPY2 Cytosol Summary 1.3228899056196983 | |
| CNPY2 Endoplasmic Reticulum Summary 1.3228899056196983 | |
| CNPY3 Endoplasmic Reticulum Summary 1.5705178901567034 | |
| CNPY4 Cytosol Summary 1.5311014588162055 | |
| CNRIP1 Cytosol Summary 1.2314543285940711 | |
| CNST Cytosol Summary 0.935447717619346 | |
| CNST Plasma membrane Summary 0.935447717619346 | |
| CNTFR Golgi apparatus Cytokine-cytokine receptor interaction 1.4284728496999477 | |
| CNTFR Golgi apparatus JAK-STAT signaling pathway 1.4284728496999477 | |
| CNTFR Plasma membrane Cytokine-cytokine receptor interaction 1.4284728496999477 | |
| CNTFR Plasma membrane JAK-STAT signaling pathway 1.4284728496999477 | |
| CNTLN Cytoskeleton Summary 0.5004753218536869 | |
| CNTLN Cytosol Summary 0.5004753218536869 | |
| CNTLN Nucleus Summary 0.5004753218536869 | |
| CNTN1 Extracellular space Cell adhesion molecules 1.2071552049864471 | |
| CNTN1 Plasma membrane Cell adhesion molecules 1.2071552049864471 | |
| CNTN4 Plasma membrane Summary 0.78413267192358 | |
| CNTNAP4 Plasma membrane Summary 1.3588484217217545 | |
| CNTRL Cytoskeleton Summary 1.4177195959853075 | |
| CNTRL Cytosol Summary 1.4177195959853075 | |
| CNTROB Cytoskeleton Summary 1.310411101213471 | |
| CNTROB Cytosol Summary 1.310411101213471 | |
| COA1 Mitochondrion Summary 1.9089076006073995 | |
| COA3 Mitochondrion Summary 0.8002113326947822 | |
| COA4 Mitochondrion Summary 1.3509501832722572 | |
| COA4 Nucleus Summary 1.3509501832722572 | |
| COA5 Mitochondrion Summary 1.458951693408652 | |
| COA6 Mitochondrion Summary 1.4168452921134058 | |
| COA6 Nucleus Summary 1.4168452921134058 | |
| COA7 Mitochondrion Summary 1.7230082701758205 | |
| COA7 Nucleus Summary 1.7230082701758205 | |
| COASY Cytosol Summary 0.46753385733341 | |
| COASY Nucleus Summary 0.46753385733341 | |
| COBL Plasma membrane Summary 1.1516528753327182 | |
| COBLL1 Nucleus Summary 0.7870811994899205 | |
| COBLL1 Plasma membrane Summary 0.7870811994899205 | |
| COCH Cytosol Summary 1.0391086618988588 | |
| COCH Extracellular space Summary 1.0391086618988588 | |
| COG1 Golgi apparatus Summary 0.4803234063092868 | |
| COG2 Golgi apparatus Summary 0.546701550601263 | |
| COG3 Cytosol Summary 0.6010210762156503 | |
| COG3 Golgi apparatus Summary 0.6010210762156503 | |
| COG3 Nucleus Summary 0.6010210762156503 | |
| COG3 Plasma membrane Summary 0.6010210762156503 | |
| COG4 Cytosol Summary 0.6007081699323462 | |
| COG4 Golgi apparatus Summary 0.6007081699323462 | |
| COG5 Cytosol Summary 0.5419433503136362 | |
| COG5 Golgi apparatus Summary 0.5419433503136362 | |
| COG5 Nucleus Summary 0.5419433503136362 | |
| COG6 Golgi apparatus Summary 0.6273730834580047 | |
| COG6 Nucleus Summary 0.6273730834580047 | |
| COG7 Golgi apparatus Summary 0.5931283469775572 | |
| COG8 Golgi apparatus Summary 0.4669075364629564 | |
| COIL Nucleus Summary 1.5734085012748598 | |
| COL10A1 Endoplasmic Reticulum Summary 1.550143903370251 | |
| COL10A1 Extracellular space Summary 1.550143903370251 | |
| COL11A1 Endoplasmic Reticulum Protein digestion and absorption 0.7893083430376729 | |
| COL11A1 Extracellular space Protein digestion and absorption 0.7893083430376729 | |
| COL11A2 Extracellular space Protein digestion and absorption 1.591814906682133 | |
| COL12A1 Cytosol Protein digestion and absorption 1.6114483921697778 | |
| COL12A1 Extracellular space Protein digestion and absorption 1.6114483921697778 | |
| COL12A1 Nucleus Protein digestion and absorption 1.6114483921697778 | |
| COL14A1 Cytosol Protein digestion and absorption 1.0199501239653868 | |
| COL14A1 Extracellular space Protein digestion and absorption 1.0199501239653868 | |
| COL15A1 Endoplasmic Reticulum Protein digestion and absorption 2.147721518298145 | |
| COL15A1 Extracellular space Protein digestion and absorption 2.147721518298145 | |
| COL16A1 Cytosol Protein digestion and absorption 1.3063995419786965 | |
| COL16A1 Extracellular space Protein digestion and absorption 1.3063995419786965 | |
| COL16A1 Golgi apparatus Protein digestion and absorption 1.3063995419786965 | |
| COL16A1 Plasma membrane Protein digestion and absorption 1.3063995419786965 | |
| COL17A1 Golgi apparatus Summary 1.1414735343978624 | |
| COL17A1 Plasma membrane Summary 1.1414735343978624 | |
| COL18A1 Extracellular space Summary 1.22932470764829 | |
| COL18A1 Golgi apparatus Summary 1.22932470764829 | |
| COL1A1 Cytosol Summary 0.5230990120445134 | |
| COL1A1 Endoplasmic Reticulum Summary 0.5230990120445134 | |
| COL1A1 Extracellular space Summary 0.5230990120445134 | |
| COL1A2 Endoplasmic Reticulum AGE-RAGE signaling pathway in diabetic complications 0.5860346775604777 | |
| COL1A2 Endoplasmic Reticulum Amoebiasis 0.5860346775604777 | |
| COL1A2 Endoplasmic Reticulum Diabetic cardiomyopathy 0.5860346775604777 | |
| COL1A2 Endoplasmic Reticulum ECM-receptor interaction 0.5860346775604777 | |
| COL1A2 Endoplasmic Reticulum Focal adhesion 0.5860346775604777 | |
| COL1A2 Endoplasmic Reticulum Human papillomavirus infection 0.5860346775604777 | |
| COL1A2 Endoplasmic Reticulum PI3K-Akt signaling pathway 0.5860346775604777 | |
| COL1A2 Endoplasmic Reticulum Platelet activation 0.5860346775604777 | |
| COL1A2 Endoplasmic Reticulum Protein digestion and absorption 0.5860346775604777 | |
| COL1A2 Endoplasmic Reticulum Proteoglycans in cancer 0.5860346775604777 | |
| COL1A2 Endoplasmic Reticulum Relaxin signaling pathway 0.5860346775604777 | |
| COL1A2 Extracellular space AGE-RAGE signaling pathway in diabetic complications 0.5860346775604777 | |
| COL1A2 Extracellular space Amoebiasis 0.5860346775604777 | |
| COL1A2 Extracellular space Diabetic cardiomyopathy 0.5860346775604777 | |
| COL1A2 Extracellular space ECM-receptor interaction 0.5860346775604777 | |
| COL1A2 Extracellular space Focal adhesion 0.5860346775604777 | |
| COL1A2 Extracellular space Human papillomavirus infection 0.5860346775604777 | |
| COL1A2 Extracellular space PI3K-Akt signaling pathway 0.5860346775604777 | |
| COL1A2 Extracellular space Platelet activation 0.5860346775604777 | |
| COL1A2 Extracellular space Protein digestion and absorption 0.5860346775604777 | |
| COL1A2 Extracellular space Proteoglycans in cancer 0.5860346775604777 | |
| COL1A2 Extracellular space Relaxin signaling pathway 0.5860346775604777 | |
| COL21A1 Cytosol Protein digestion and absorption 2.4135884367201466 | |
| COL21A1 Extracellular space Protein digestion and absorption 2.4135884367201466 | |
| COL22A1 Cytosol Protein digestion and absorption 1.3211005345267075 | |
| COL22A1 Endoplasmic Reticulum Protein digestion and absorption 1.3211005345267075 | |
| COL22A1 Extracellular space Protein digestion and absorption 1.3211005345267075 | |
| COL24A1 Extracellular space Summary 0.871605739057761 | |
| COL27A1 Extracellular space Protein digestion and absorption 1.1087927336024153 | |
| COL28A1 Cytosol Summary 0.4064252589218769 | |
| COL28A1 Extracellular space Summary 0.4064252589218769 | |
| COL28A1 Nucleus Summary 0.4064252589218769 | |
| COL2A1 Extracellular space Summary 0.9735928501101392 | |
| COL2A1 Nucleus Summary 0.9735928501101392 | |
| COL3A1 Endoplasmic Reticulum AGE-RAGE signaling pathway in diabetic complications 0.5622674346090151 | |
| COL3A1 Endoplasmic Reticulum Amoebiasis 0.5622674346090151 | |
| COL3A1 Endoplasmic Reticulum Diabetic cardiomyopathy 0.5622674346090151 | |
| COL3A1 Endoplasmic Reticulum Platelet activation 0.5622674346090151 | |
| COL3A1 Endoplasmic Reticulum Protein digestion and absorption 0.5622674346090151 | |
| COL3A1 Endoplasmic Reticulum Relaxin signaling pathway 0.5622674346090151 | |
| COL3A1 Extracellular space AGE-RAGE signaling pathway in diabetic complications 0.5622674346090151 | |
| COL3A1 Extracellular space Amoebiasis 0.5622674346090151 | |
| COL3A1 Extracellular space Diabetic cardiomyopathy 0.5622674346090151 | |
| COL3A1 Extracellular space Platelet activation 0.5622674346090151 | |
| COL3A1 Extracellular space Protein digestion and absorption 0.5622674346090151 | |
| COL3A1 Extracellular space Relaxin signaling pathway 0.5622674346090151 | |
| COL4A1 Extracellular space AGE-RAGE signaling pathway in diabetic complications 1.2848265074042513 | |
| COL4A1 Extracellular space Amoebiasis 1.2848265074042513 | |
| COL4A1 Extracellular space ECM-receptor interaction 1.2848265074042513 | |
| COL4A1 Extracellular space Focal adhesion 1.2848265074042513 | |
| COL4A1 Extracellular space Human papillomavirus infection 1.2848265074042513 | |
| COL4A1 Extracellular space PI3K-Akt signaling pathway 1.2848265074042513 | |
| COL4A1 Extracellular space Pathways in cancer 1.2848265074042513 | |
| COL4A1 Extracellular space Protein digestion and absorption 1.2848265074042513 | |
| COL4A1 Extracellular space Relaxin signaling pathway 1.2848265074042513 | |
| COL4A1 Extracellular space Small cell lung cancer 1.2848265074042513 | |
| COL4A1 Nucleus AGE-RAGE signaling pathway in diabetic complications 1.2848265074042513 | |
| COL4A1 Nucleus Amoebiasis 1.2848265074042513 | |
| COL4A1 Nucleus ECM-receptor interaction 1.2848265074042513 | |
| COL4A1 Nucleus Focal adhesion 1.2848265074042513 | |
| COL4A1 Nucleus Human papillomavirus infection 1.2848265074042513 | |
| COL4A1 Nucleus PI3K-Akt signaling pathway 1.2848265074042513 | |
| COL4A1 Nucleus Pathways in cancer 1.2848265074042513 | |
| COL4A1 Nucleus Protein digestion and absorption 1.2848265074042513 | |
| COL4A1 Nucleus Relaxin signaling pathway 1.2848265074042513 | |
| COL4A1 Nucleus Small cell lung cancer 1.2848265074042513 | |
| COL4A2 Cytosol AGE-RAGE signaling pathway in diabetic complications 2.7710185819682303 | |
| COL4A2 Cytosol Amoebiasis 2.7710185819682303 | |
| COL4A2 Cytosol ECM-receptor interaction 2.7710185819682303 | |
| COL4A2 Cytosol Focal adhesion 2.7710185819682303 | |
| COL4A2 Cytosol Human papillomavirus infection 2.7710185819682303 | |
| COL4A2 Cytosol PI3K-Akt signaling pathway 2.7710185819682303 | |
| COL4A2 Cytosol Pathways in cancer 2.7710185819682303 | |
| COL4A2 Cytosol Protein digestion and absorption 2.7710185819682303 | |
| COL4A2 Cytosol Relaxin signaling pathway 2.7710185819682303 | |
| COL4A2 Cytosol Small cell lung cancer 2.7710185819682303 | |
| COL4A2 Extracellular space AGE-RAGE signaling pathway in diabetic complications 2.7710185819682303 | |
| COL4A2 Extracellular space Amoebiasis 2.7710185819682303 | |
| COL4A2 Extracellular space ECM-receptor interaction 2.7710185819682303 | |
| COL4A2 Extracellular space Focal adhesion 2.7710185819682303 | |
| COL4A2 Extracellular space Human papillomavirus infection 2.7710185819682303 | |
| COL4A2 Extracellular space PI3K-Akt signaling pathway 2.7710185819682303 | |
| COL4A2 Extracellular space Pathways in cancer 2.7710185819682303 | |
| COL4A2 Extracellular space Protein digestion and absorption 2.7710185819682303 | |
| COL4A2 Extracellular space Relaxin signaling pathway 2.7710185819682303 | |
| COL4A2 Extracellular space Small cell lung cancer 2.7710185819682303 | |
| COL4A3 Cytosol AGE-RAGE signaling pathway in diabetic complications 1.18349853596385 | |
| COL4A3 Cytosol Amoebiasis 1.18349853596385 | |
| COL4A3 Cytosol ECM-receptor interaction 1.18349853596385 | |
| COL4A3 Cytosol Focal adhesion 1.18349853596385 | |
| COL4A3 Cytosol Human papillomavirus infection 1.18349853596385 | |
| COL4A3 Cytosol PI3K-Akt signaling pathway 1.18349853596385 | |
| COL4A3 Cytosol Pathways in cancer 1.18349853596385 | |
| COL4A3 Cytosol Protein digestion and absorption 1.18349853596385 | |
| COL4A3 Cytosol Relaxin signaling pathway 1.18349853596385 | |
| COL4A3 Cytosol Small cell lung cancer 1.18349853596385 | |
| COL4A3 Endoplasmic Reticulum AGE-RAGE signaling pathway in diabetic complications 1.18349853596385 | |
| COL4A3 Endoplasmic Reticulum Amoebiasis 1.18349853596385 | |
| COL4A3 Endoplasmic Reticulum ECM-receptor interaction 1.18349853596385 | |
| COL4A3 Endoplasmic Reticulum Focal adhesion 1.18349853596385 | |
| COL4A3 Endoplasmic Reticulum Human papillomavirus infection 1.18349853596385 | |
| COL4A3 Endoplasmic Reticulum PI3K-Akt signaling pathway 1.18349853596385 | |
| COL4A3 Endoplasmic Reticulum Pathways in cancer 1.18349853596385 | |
| COL4A3 Endoplasmic Reticulum Protein digestion and absorption 1.18349853596385 | |
| COL4A3 Endoplasmic Reticulum Relaxin signaling pathway 1.18349853596385 | |
| COL4A3 Endoplasmic Reticulum Small cell lung cancer 1.18349853596385 | |
| COL4A3 Extracellular space AGE-RAGE signaling pathway in diabetic complications 1.18349853596385 | |
| COL4A3 Extracellular space Amoebiasis 1.18349853596385 | |
| COL4A3 Extracellular space ECM-receptor interaction 1.18349853596385 | |
| COL4A3 Extracellular space Focal adhesion 1.18349853596385 | |
| COL4A3 Extracellular space Human papillomavirus infection 1.18349853596385 | |
| COL4A3 Extracellular space PI3K-Akt signaling pathway 1.18349853596385 | |
| COL4A3 Extracellular space Pathways in cancer 1.18349853596385 | |
| COL4A3 Extracellular space Protein digestion and absorption 1.18349853596385 | |
| COL4A3 Extracellular space Relaxin signaling pathway 1.18349853596385 | |
| COL4A3 Extracellular space Small cell lung cancer 1.18349853596385 | |
| COL4A3BP Golgi apparatus Summary 0.6843157107861793 | |
| COL4A3BP Nucleus Summary 0.6843157107861793 | |
| COL4A4 Extracellular space AGE-RAGE signaling pathway in diabetic complications 1.5495784763187723 | |
| COL4A4 Extracellular space Amoebiasis 1.5495784763187723 | |
| COL4A4 Extracellular space ECM-receptor interaction 1.5495784763187723 | |
| COL4A4 Extracellular space Focal adhesion 1.5495784763187723 | |
| COL4A4 Extracellular space Human papillomavirus infection 1.5495784763187723 | |
| COL4A4 Extracellular space PI3K-Akt signaling pathway 1.5495784763187723 | |
| COL4A4 Extracellular space Pathways in cancer 1.5495784763187723 | |
| COL4A4 Extracellular space Protein digestion and absorption 1.5495784763187723 | |
| COL4A4 Extracellular space Relaxin signaling pathway 1.5495784763187723 | |
| COL4A4 Extracellular space Small cell lung cancer 1.5495784763187723 | |
| COL4A5 Cytosol AGE-RAGE signaling pathway in diabetic complications 1.0848221854291085 | |
| COL4A5 Cytosol Amoebiasis 1.0848221854291085 | |
| COL4A5 Cytosol ECM-receptor interaction 1.0848221854291085 | |
| COL4A5 Cytosol Focal adhesion 1.0848221854291085 | |
| COL4A5 Cytosol Human papillomavirus infection 1.0848221854291085 | |
| COL4A5 Cytosol PI3K-Akt signaling pathway 1.0848221854291085 | |
| COL4A5 Cytosol Pathways in cancer 1.0848221854291085 | |
| COL4A5 Cytosol Protein digestion and absorption 1.0848221854291085 | |
| COL4A5 Cytosol Relaxin signaling pathway 1.0848221854291085 | |
| COL4A5 Cytosol Small cell lung cancer 1.0848221854291085 | |
| COL4A5 Extracellular space AGE-RAGE signaling pathway in diabetic complications 1.0848221854291085 | |
| COL4A5 Extracellular space Amoebiasis 1.0848221854291085 | |
| COL4A5 Extracellular space ECM-receptor interaction 1.0848221854291085 | |
| COL4A5 Extracellular space Focal adhesion 1.0848221854291085 | |
| COL4A5 Extracellular space Human papillomavirus infection 1.0848221854291085 | |
| COL4A5 Extracellular space PI3K-Akt signaling pathway 1.0848221854291085 | |
| COL4A5 Extracellular space Pathways in cancer 1.0848221854291085 | |
| COL4A5 Extracellular space Protein digestion and absorption 1.0848221854291085 | |
| COL4A5 Extracellular space Relaxin signaling pathway 1.0848221854291085 | |
| COL4A5 Extracellular space Small cell lung cancer 1.0848221854291085 | |
| COL4A5 Plasma membrane AGE-RAGE signaling pathway in diabetic complications 1.0848221854291085 | |
| COL4A5 Plasma membrane Amoebiasis 1.0848221854291085 | |
| COL4A5 Plasma membrane ECM-receptor interaction 1.0848221854291085 | |
| COL4A5 Plasma membrane Focal adhesion 1.0848221854291085 | |
| COL4A5 Plasma membrane Human papillomavirus infection 1.0848221854291085 | |
| COL4A5 Plasma membrane PI3K-Akt signaling pathway 1.0848221854291085 | |
| COL4A5 Plasma membrane Pathways in cancer 1.0848221854291085 | |
| COL4A5 Plasma membrane Protein digestion and absorption 1.0848221854291085 | |
| COL4A5 Plasma membrane Relaxin signaling pathway 1.0848221854291085 | |
| COL4A5 Plasma membrane Small cell lung cancer 1.0848221854291085 | |
| COL4A6 Endoplasmic Reticulum AGE-RAGE signaling pathway in diabetic complications 1.167269638671461 | |
| COL4A6 Endoplasmic Reticulum Amoebiasis 1.167269638671461 | |
| COL4A6 Endoplasmic Reticulum ECM-receptor interaction 1.167269638671461 | |
| COL4A6 Endoplasmic Reticulum Focal adhesion 1.167269638671461 | |
| COL4A6 Endoplasmic Reticulum Human papillomavirus infection 1.167269638671461 | |
| COL4A6 Endoplasmic Reticulum PI3K-Akt signaling pathway 1.167269638671461 | |
| COL4A6 Endoplasmic Reticulum Pathways in cancer 1.167269638671461 | |
| COL4A6 Endoplasmic Reticulum Protein digestion and absorption 1.167269638671461 | |
| COL4A6 Endoplasmic Reticulum Relaxin signaling pathway 1.167269638671461 | |
| COL4A6 Endoplasmic Reticulum Small cell lung cancer 1.167269638671461 | |
| COL4A6 Extracellular space AGE-RAGE signaling pathway in diabetic complications 1.167269638671461 | |
| COL4A6 Extracellular space Amoebiasis 1.167269638671461 | |
| COL4A6 Extracellular space ECM-receptor interaction 1.167269638671461 | |
| COL4A6 Extracellular space Focal adhesion 1.167269638671461 | |
| COL4A6 Extracellular space Human papillomavirus infection 1.167269638671461 | |
| COL4A6 Extracellular space PI3K-Akt signaling pathway 1.167269638671461 | |
| COL4A6 Extracellular space Pathways in cancer 1.167269638671461 | |
| COL4A6 Extracellular space Protein digestion and absorption 1.167269638671461 | |
| COL4A6 Extracellular space Relaxin signaling pathway 1.167269638671461 | |
| COL4A6 Extracellular space Small cell lung cancer 1.167269638671461 | |
| COL5A1 Cytosol Summary 1.41020535427479 | |
| COL5A1 Extracellular space Summary 1.41020535427479 | |
| COL5A2 Extracellular space Summary 0.6082888106830487 | |
| COL5A3 Extracellular space Protein digestion and absorption 0.8747780857879037 | |
| COL6A1 Cytosol ECM-receptor interaction 1.1418457492647247 | |
| COL6A1 Cytosol Focal adhesion 1.1418457492647247 | |
| COL6A1 Cytosol Human papillomavirus infection 1.1418457492647247 | |
| COL6A1 Cytosol PI3K-Akt signaling pathway 1.1418457492647247 | |
| COL6A1 Cytosol Protein digestion and absorption 1.1418457492647247 | |
| COL6A1 Extracellular space ECM-receptor interaction 1.1418457492647247 | |
| COL6A1 Extracellular space Focal adhesion 1.1418457492647247 | |
| COL6A1 Extracellular space Human papillomavirus infection 1.1418457492647247 | |
| COL6A1 Extracellular space PI3K-Akt signaling pathway 1.1418457492647247 | |
| COL6A1 Extracellular space Protein digestion and absorption 1.1418457492647247 | |
| COL6A2 Cytosol ECM-receptor interaction 1.2471123812318727 | |
| COL6A2 Cytosol Focal adhesion 1.2471123812318727 | |
| COL6A2 Cytosol Human papillomavirus infection 1.2471123812318727 | |
| COL6A2 Cytosol PI3K-Akt signaling pathway 1.2471123812318727 | |
| COL6A2 Cytosol Protein digestion and absorption 1.2471123812318727 | |
| COL6A2 Extracellular space ECM-receptor interaction 1.2471123812318727 | |
| COL6A2 Extracellular space Focal adhesion 1.2471123812318727 | |
| COL6A2 Extracellular space Human papillomavirus infection 1.2471123812318727 | |
| COL6A2 Extracellular space PI3K-Akt signaling pathway 1.2471123812318727 | |
| COL6A2 Extracellular space Protein digestion and absorption 1.2471123812318727 | |
| COL6A2 Plasma membrane ECM-receptor interaction 1.2471123812318727 | |
| COL6A2 Plasma membrane Focal adhesion 1.2471123812318727 | |
| COL6A2 Plasma membrane Human papillomavirus infection 1.2471123812318727 | |
| COL6A2 Plasma membrane PI3K-Akt signaling pathway 1.2471123812318727 | |
| COL6A2 Plasma membrane Protein digestion and absorption 1.2471123812318727 | |
| COL6A3 Cytosol Summary 1.3883488500768824 | |
| COL6A3 Endoplasmic Reticulum Summary 1.3883488500768824 | |
| COL6A3 Extracellular space Summary 1.3883488500768824 | |
| COL6A5 Extracellular space ECM-receptor interaction 1.2405356188063217 | |
| COL6A5 Extracellular space Focal adhesion 1.2405356188063217 | |
| COL6A5 Extracellular space Human papillomavirus infection 1.2405356188063217 | |
| COL6A5 Extracellular space PI3K-Akt signaling pathway 1.2405356188063217 | |
| COL6A5 Extracellular space Protein digestion and absorption 1.2405356188063217 | |
| COL6A6 Extracellular space Summary 1.3698201364712712 | |
| COL7A1 Cytosol Protein digestion and absorption 1.5494718076537222 | |
| COL7A1 Endoplasmic Reticulum Protein digestion and absorption 1.5494718076537222 | |
| COL7A1 Extracellular space Protein digestion and absorption 1.5494718076537222 | |
| COL8A1 Cytosol Protein digestion and absorption 2.122351990044077 | |
| COL8A1 Extracellular space Protein digestion and absorption 2.122351990044077 | |
| COL8A2 Extracellular space Protein digestion and absorption 0.5309057341017782 | |
| COL8A2 Golgi apparatus Protein digestion and absorption 0.5309057341017782 | |
| COL9A1 Extracellular space ECM-receptor interaction 0.9313875603963474 | |
| COL9A1 Extracellular space Focal adhesion 0.9313875603963474 | |
| COL9A1 Extracellular space Human papillomavirus infection 0.9313875603963474 | |
| COL9A1 Extracellular space PI3K-Akt signaling pathway 0.9313875603963474 | |
| COL9A1 Extracellular space Protein digestion and absorption 0.9313875603963474 | |
| COL9A2 Cytosol Summary 1.4178292687325649 | |
| COL9A2 Extracellular space Summary 1.4178292687325649 | |
| COL9A2 Nucleus Summary 1.4178292687325649 | |
| COL9A3 Cytoskeleton Summary 0.7796993876661164 | |
| COL9A3 Nucleus Summary 0.7796993876661164 | |
| COLEC10 Extracellular space Summary 0.6098090580275229 | |
| COLEC12 Cytosol Summary 0.4014465486018717 | |
| COLEC12 Golgi apparatus Summary 0.4014465486018717 | |
| COLEC12 Plasma membrane Summary 0.4014465486018717 | |
| COLGALT1 Cytosol Lysine degradation 3.5118591510021937 | |
| COLGALT1 Cytosol Metabolic pathways 3.5118591510021937 | |
| COLGALT1 Cytosol Other types of O-glycan biosynthesis 3.5118591510021937 | |
| COLGALT1 Endoplasmic Reticulum Lysine degradation 3.5118591510021937 | |
| COLGALT1 Endoplasmic Reticulum Metabolic pathways 3.5118591510021937 | |
| COLGALT1 Endoplasmic Reticulum Other types of O-glycan biosynthesis 3.5118591510021937 | |
| COLGALT2 Cytosol Summary 2.7580051087673403 | |
| COLGALT2 Endoplasmic Reticulum Summary 2.7580051087673403 | |
| COLGALT2 Nucleus Summary 2.7580051087673403 | |
| COMMD1 Cytosol Summary 1.374435893914343 | |
| COMMD1 Nucleus Summary 1.374435893914343 | |
| COMMD10 Cytosol Summary 1.4706020349735898 | |
| COMMD10 Nucleus Summary 1.4706020349735898 | |
| COMMD2 Cytosol Summary 1.652805155745229 | |
| COMMD2 Nucleus Summary 1.652805155745229 | |
| COMMD3 Cytosol Summary 2.0963123033121596 | |
| COMMD3-BMI1 Cytosol Summary 0.8763730346576042 | |
| COMMD3-BMI1 Nucleus Summary 0.8763730346576042 | |
| COMMD4 Cytosol Summary 1.1943794179075229 | |
| COMMD4 Nucleus Summary 1.1943794179075229 | |
| COMMD4 Plasma membrane Summary 1.1943794179075229 | |
| COMMD5 Cytosol Summary 1.2320647736136296 | |
| COMMD5 Nucleus Summary 1.2320647736136296 | |
| COMMD6 Nucleus Summary 1.7854411164267137 | |
| COMMD7 Cytosol Summary 1.1339566582728515 | |
| COMMD8 Cytosol Summary 1.5663888245142972 | |
| COMMD8 Nucleus Summary 1.5663888245142972 | |
| COMMD9 Cytosol Summary 1.434350643226313 | |
| COMMD9 Golgi apparatus Summary 1.434350643226313 | |
| COMMD9 Nucleus Summary 1.434350643226313 | |
| COMP Extracellular space ECM-receptor interaction 0.7936848829920975 | |
| COMP Extracellular space Focal adhesion 0.7936848829920975 | |
| COMP Extracellular space Human papillomavirus infection 0.7936848829920975 | |
| COMP Extracellular space Malaria 0.7936848829920975 | |
| COMP Extracellular space PI3K-Akt signaling pathway 0.7936848829920975 | |
| COMP Extracellular space Phagosome 0.7936848829920975 | |
| COMP Golgi apparatus ECM-receptor interaction 0.7936848829920975 | |
| COMP Golgi apparatus Focal adhesion 0.7936848829920975 | |
| COMP Golgi apparatus Human papillomavirus infection 0.7936848829920975 | |
| COMP Golgi apparatus Malaria 0.7936848829920975 | |
| COMP Golgi apparatus PI3K-Akt signaling pathway 0.7936848829920975 | |
| COMP Golgi apparatus Phagosome 0.7936848829920975 | |
| COMT Cytosol Dopaminergic synapse 0.6151666038701552 | |
| COMT Cytosol Metabolic pathways 0.6151666038701552 | |
| COMT Cytosol Steroid hormone biosynthesis 0.6151666038701552 | |
| COMT Cytosol Tyrosine metabolism 0.6151666038701552 | |
| COMT Endoplasmic Reticulum Dopaminergic synapse 0.6151666038701552 | |
| COMT Endoplasmic Reticulum Metabolic pathways 0.6151666038701552 | |
| COMT Endoplasmic Reticulum Steroid hormone biosynthesis 0.6151666038701552 | |
| COMT Endoplasmic Reticulum Tyrosine metabolism 0.6151666038701552 | |
| COMT Plasma membrane Dopaminergic synapse 0.6151666038701552 | |
| COMT Plasma membrane Metabolic pathways 0.6151666038701552 | |
| COMT Plasma membrane Steroid hormone biosynthesis 0.6151666038701552 | |
| COMT Plasma membrane Tyrosine metabolism 0.6151666038701552 | |
| COMTD1 Cytosol Summary 1.3607533584389522 | |
| COMTD1 Golgi apparatus Summary 1.3607533584389522 | |
| COMTD1 Plasma membrane Summary 1.3607533584389522 | |
| COPA Cytosol Summary 0.9970250850790934 | |
| COPA Extracellular space Summary 0.9970250850790934 | |
| COPA Golgi apparatus Summary 0.9970250850790934 | |
| COPA Nucleus Summary 0.9970250850790934 | |
| COPB1 Cytosol Summary 1.0875739392505512 | |
| COPB1 Golgi apparatus Summary 1.0875739392505512 | |
| COPB1 Plasma membrane Summary 1.0875739392505512 | |
| COPB2 Cytosol Summary 0.8613469353114209 | |
| COPB2 Golgi apparatus Summary 0.8613469353114209 | |
| COPE Cytosol Summary 1.2431651766526803 | |
| COPE Golgi apparatus Summary 1.2431651766526803 | |
| COPG1 Cytosol Summary 0.9516923337297728 | |
| COPG1 Golgi apparatus Summary 0.9516923337297728 | |
| COPG1 Nucleus Summary 0.9516923337297728 | |
| COPG2 Cytosol Summary 0.8720127260261791 | |
| COPRS Cytosol Summary 0.97640676882289 | |
| COPRS Nucleus Summary 0.97640676882289 | |
| COPRS Plasma membrane Summary 0.97640676882289 | |
| COPS2 Cytosol Summary 1.1662838476469728 | |
| COPS2 Nucleus Summary 1.1662838476469728 | |
| COPS4 Cytosol Summary 1.1146801554180759 | |
| COPS4 Nucleus Summary 1.1146801554180759 | |
| COPS5 Cytosol Summary 1.0083155024760069 | |
| COPS5 Nucleus Summary 1.0083155024760069 | |
| COPS6 Nucleus Summary 1.0351782463327754 | |
| COPS7A Cytosol Summary 0.6831771366190641 | |
| COPS7A Nucleus Summary 0.6831771366190641 | |
| COPS7B Nucleus Summary 1.4373458170009743 | |
| COPS8 Cytosol Summary 1.4927376405716537 | |
| COPS8 Nucleus Summary 1.4927376405716537 | |
| COPS9 Cytosol Summary 1.6755495694648508 | |
| COPS9 Nucleus Summary 1.6755495694648508 | |
| COPZ1 Cytosol Summary 0.9582611235163052 | |
| COPZ1 Golgi apparatus Summary 0.9582611235163052 | |
| COPZ2 Cytosol Summary 1.8051509952089504 | |
| COQ10B Cytosol Summary 0.5739363056952635 | |
| COQ10B Mitochondrion Summary 0.5739363056952635 | |
| COQ3 Mitochondrion Summary 1.74396511479081 | |
| COQ3 Nucleus Summary 1.74396511479081 | |
| COQ5 Mitochondrion Summary 1.1998749678968457 | |
| COQ5 Nucleus Summary 1.1998749678968457 | |
| COQ6 Mitochondrion Summary 1.2877200586146464 | |
| COQ7 Mitochondrion Biosynthesis of cofactors 1.1813968534969719 | |
| COQ7 Mitochondrion Metabolic pathways 1.1813968534969719 | |
| COQ7 Mitochondrion Ubiquinone and other terpenoid-quinone biosynthesis 1.1813968534969719 | |
| COQ7 Nucleus Biosynthesis of cofactors 1.1813968534969719 | |
| COQ7 Nucleus Metabolic pathways 1.1813968534969719 | |
| COQ7 Nucleus Ubiquinone and other terpenoid-quinone biosynthesis 1.1813968534969719 | |
| COQ7 Plasma membrane Biosynthesis of cofactors 1.1813968534969719 | |
| COQ7 Plasma membrane Metabolic pathways 1.1813968534969719 | |
| COQ7 Plasma membrane Ubiquinone and other terpenoid-quinone biosynthesis 1.1813968534969719 | |
| COQ8A Mitochondrion Summary 2.617864308168609 | |
| COQ8B Mitochondrion Summary 1.438594662564339 | |
| COQ9 Cytosol Summary 1.6208116298217372 | |
| COQ9 Mitochondrion Summary 1.6208116298217372 | |
| CORO1A Cytoskeleton Phagosome 1.3050395656076093 | |
| CORO1A Cytoskeleton Tuberculosis 1.3050395656076093 | |
| CORO1A Cytosol Phagosome 1.3050395656076093 | |
| CORO1A Cytosol Tuberculosis 1.3050395656076093 | |
| CORO1A Plasma membrane Phagosome 1.3050395656076093 | |
| CORO1A Plasma membrane Tuberculosis 1.3050395656076093 | |
| CORO1B Cytoskeleton Summary 0.6532996686937117 | |
| CORO1B Cytosol Summary 0.6532996686937117 | |
| CORO1B Plasma membrane Summary 0.6532996686937117 | |
| CORO1C Plasma membrane Summary 2.1592844035445715 | |
| CORO2A Cytosol Summary 0.34137590271486584 | |
| CORO2A Nucleus Summary 0.34137590271486584 | |
| CORO2A Plasma membrane Summary 0.34137590271486584 | |
| CORO2B Cytoskeleton Summary 1.138377769949727 | |
| CORO2B Cytosol Summary 1.138377769949727 | |
| CORO2B Plasma membrane Summary 1.138377769949727 | |
| CORO6 Golgi apparatus Summary 1.2757719696588528 | |
| CORO7 Golgi apparatus Summary 1.3065035387069732 | |
| CORO7-PAM16 Cytoskeleton Summary 1.290486125806448 | |
| CORO7-PAM16 Cytosol Summary 1.290486125806448 | |
| CORO7-PAM16 Mitochondrion Summary 1.290486125806448 | |
| CORO7-PAM16 Nucleus Summary 1.290486125806448 | |
| COTL1 Cytosol Summary 2.0749104745251907 | |
| COX11 Mitochondrion Metabolic pathways 2.291003466627775 | |
| COX11 Mitochondrion Oxidative phosphorylation 2.291003466627775 | |
| COX11 Mitochondrion Thermogenesis 2.291003466627775 | |
| COX11 Plasma membrane Metabolic pathways 2.291003466627775 | |
| COX11 Plasma membrane Oxidative phosphorylation 2.291003466627775 | |
| COX11 Plasma membrane Thermogenesis 2.291003466627775 | |
| COX15 Mitochondrion Biosynthesis of cofactors 1.992802588287776 | |
| COX15 Mitochondrion Metabolic pathways 1.992802588287776 | |
| COX15 Mitochondrion Oxidative phosphorylation 1.992802588287776 | |
| COX15 Mitochondrion Porphyrin and chlorophyll metabolism 1.992802588287776 | |
| COX15 Mitochondrion Thermogenesis 1.992802588287776 | |
| COX15 Plasma membrane Biosynthesis of cofactors 1.992802588287776 | |
| COX15 Plasma membrane Metabolic pathways 1.992802588287776 | |
| COX15 Plasma membrane Oxidative phosphorylation 1.992802588287776 | |
| COX15 Plasma membrane Porphyrin and chlorophyll metabolism 1.992802588287776 | |
| COX15 Plasma membrane Thermogenesis 1.992802588287776 | |
| COX17 Mitochondrion Summary 0.5294095736065287 | |
| COX19 Cytosol Thermogenesis 1.848284296236814 | |
| COX20 Mitochondrion Thermogenesis 2.2041058457178577 | |
| COX4I1 Mitochondrion Alzheimer disease 1.142983341869528 | |
| COX4I1 Mitochondrion Amyotrophic lateral sclerosis 1.142983341869528 | |
| COX4I1 Mitochondrion Cardiac muscle contraction 1.142983341869528 | |
| COX4I1 Mitochondrion Diabetic cardiomyopathy 1.142983341869528 | |
| COX4I1 Mitochondrion Huntington disease 1.142983341869528 | |
| COX4I1 Mitochondrion Metabolic pathways 1.142983341869528 | |
| COX4I1 Mitochondrion Non-alcoholic fatty liver disease 1.142983341869528 | |
| COX4I1 Mitochondrion Oxidative phosphorylation 1.142983341869528 | |
| COX4I1 Mitochondrion Parkinson disease 1.142983341869528 | |
| COX4I1 Mitochondrion Pathways of neurodegeneration - multiple diseases 1.142983341869528 | |
| COX4I1 Mitochondrion Prion disease 1.142983341869528 | |
| COX4I1 Mitochondrion Thermogenesis 1.142983341869528 | |
| COX5A Mitochondrion Alzheimer disease 2.5342944401180474 | |
| COX5A Mitochondrion Amyotrophic lateral sclerosis 2.5342944401180474 | |
| COX5A Mitochondrion Cardiac muscle contraction 2.5342944401180474 | |
| COX5A Mitochondrion Diabetic cardiomyopathy 2.5342944401180474 | |
| COX5A Mitochondrion Huntington disease 2.5342944401180474 | |
| COX5A Mitochondrion Metabolic pathways 2.5342944401180474 | |
| COX5A Mitochondrion Non-alcoholic fatty liver disease 2.5342944401180474 | |
| COX5A Mitochondrion Oxidative phosphorylation 2.5342944401180474 | |
| COX5A Mitochondrion Parkinson disease 2.5342944401180474 | |
| COX5A Mitochondrion Pathways of neurodegeneration - multiple diseases 2.5342944401180474 | |
| COX5A Mitochondrion Prion disease 2.5342944401180474 | |
| COX5A Mitochondrion Thermogenesis 2.5342944401180474 | |
| COX5B Mitochondrion Alzheimer disease 1.7021279990324547 | |
| COX5B Mitochondrion Amyotrophic lateral sclerosis 1.7021279990324547 | |
| COX5B Mitochondrion Cardiac muscle contraction 1.7021279990324547 | |
| COX5B Mitochondrion Diabetic cardiomyopathy 1.7021279990324547 | |
| COX5B Mitochondrion Huntington disease 1.7021279990324547 | |
| COX5B Mitochondrion Metabolic pathways 1.7021279990324547 | |
| COX5B Mitochondrion Non-alcoholic fatty liver disease 1.7021279990324547 | |
| COX5B Mitochondrion Oxidative phosphorylation 1.7021279990324547 | |
| COX5B Mitochondrion Parkinson disease 1.7021279990324547 | |
| COX5B Mitochondrion Pathways of neurodegeneration - multiple diseases 1.7021279990324547 | |
| COX5B Mitochondrion Prion disease 1.7021279990324547 | |
| COX5B Mitochondrion Thermogenesis 1.7021279990324547 | |
| COX6A1 Mitochondrion Alzheimer disease 1.2571658584334715 | |
| COX6A1 Mitochondrion Amyotrophic lateral sclerosis 1.2571658584334715 | |
| COX6A1 Mitochondrion Cardiac muscle contraction 1.2571658584334715 | |
| COX6A1 Mitochondrion Diabetic cardiomyopathy 1.2571658584334715 | |
| COX6A1 Mitochondrion Huntington disease 1.2571658584334715 | |
| COX6A1 Mitochondrion Metabolic pathways 1.2571658584334715 | |
| COX6A1 Mitochondrion Non-alcoholic fatty liver disease 1.2571658584334715 | |
| COX6A1 Mitochondrion Oxidative phosphorylation 1.2571658584334715 | |
| COX6A1 Mitochondrion Parkinson disease 1.2571658584334715 | |
| COX6A1 Mitochondrion Pathways of neurodegeneration - multiple diseases 1.2571658584334715 | |
| COX6A1 Mitochondrion Prion disease 1.2571658584334715 | |
| COX6A1 Mitochondrion Thermogenesis 1.2571658584334715 | |
| COX6B1 Mitochondrion Summary 1.363225719333589 | |
| COX6C Mitochondrion Alzheimer disease 2.161359720093597 | |
| COX6C Mitochondrion Amyotrophic lateral sclerosis 2.161359720093597 | |
| COX6C Mitochondrion Cardiac muscle contraction 2.161359720093597 | |
| COX6C Mitochondrion Diabetic cardiomyopathy 2.161359720093597 | |
| COX6C Mitochondrion Huntington disease 2.161359720093597 | |
| COX6C Mitochondrion Metabolic pathways 2.161359720093597 | |
| COX6C Mitochondrion Non-alcoholic fatty liver disease 2.161359720093597 | |
| COX6C Mitochondrion Oxidative phosphorylation 2.161359720093597 | |
| COX6C Mitochondrion Parkinson disease 2.161359720093597 | |
| COX6C Mitochondrion Pathways of neurodegeneration - multiple diseases 2.161359720093597 | |
| COX6C Mitochondrion Prion disease 2.161359720093597 | |
| COX6C Mitochondrion Thermogenesis 2.161359720093597 | |
| COX7A1 Mitochondrion Alzheimer disease 1.8932663185931893 | |
| COX7A1 Mitochondrion Amyotrophic lateral sclerosis 1.8932663185931893 | |
| COX7A1 Mitochondrion Cardiac muscle contraction 1.8932663185931893 | |
| COX7A1 Mitochondrion Diabetic cardiomyopathy 1.8932663185931893 | |
| COX7A1 Mitochondrion Huntington disease 1.8932663185931893 | |
| COX7A1 Mitochondrion Metabolic pathways 1.8932663185931893 | |
| COX7A1 Mitochondrion Non-alcoholic fatty liver disease 1.8932663185931893 | |
| COX7A1 Mitochondrion Oxidative phosphorylation 1.8932663185931893 | |
| COX7A1 Mitochondrion Parkinson disease 1.8932663185931893 | |
| COX7A1 Mitochondrion Pathways of neurodegeneration - multiple diseases 1.8932663185931893 | |
| COX7A1 Mitochondrion Prion disease 1.8932663185931893 | |
| COX7A1 Mitochondrion Thermogenesis 1.8932663185931893 | |
| COX7A2L Mitochondrion Summary 1.5510759491716348 | |
| COX7A2L Nucleus Summary 1.5510759491716348 | |
| COX7C Mitochondrion Summary 1.4499939301498648 | |
| COX8A Mitochondrion Alzheimer disease 1.1805071598805714 | |
| COX8A Mitochondrion Amyotrophic lateral sclerosis 1.1805071598805714 | |
| COX8A Mitochondrion Cardiac muscle contraction 1.1805071598805714 | |
| COX8A Mitochondrion Diabetic cardiomyopathy 1.1805071598805714 | |
| COX8A Mitochondrion Huntington disease 1.1805071598805714 | |
| COX8A Mitochondrion Metabolic pathways 1.1805071598805714 | |
| COX8A Mitochondrion Non-alcoholic fatty liver disease 1.1805071598805714 | |
| COX8A Mitochondrion Oxidative phosphorylation 1.1805071598805714 | |
| COX8A Mitochondrion Parkinson disease 1.1805071598805714 | |
| COX8A Mitochondrion Pathways of neurodegeneration - multiple diseases 1.1805071598805714 | |
| COX8A Mitochondrion Prion disease 1.1805071598805714 | |
| COX8A Mitochondrion Thermogenesis 1.1805071598805714 | |
| CP Extracellular space Ferroptosis 2.2504207708251704 | |
| CP Extracellular space Porphyrin and chlorophyll metabolism 2.2504207708251704 | |
| CPA3 Cytosol Summary 0.5753721412314688 | |
| CPA3 Golgi apparatus Summary 0.5753721412314688 | |
| CPA3 Nucleus Summary 0.5753721412314688 | |
| CPA4 Cytoskeleton Summary 1.4558888547087248 | |
| CPA4 Cytosol Summary 1.4558888547087248 | |
| CPA4 Nucleus Summary 1.4558888547087248 | |
| CPB1 Extracellular space Pancreatic secretion 0.010798266065915742 | |
| CPB1 Extracellular space Protein digestion and absorption 0.010798266065915742 | |
| CPB2 Extracellular space Complement and coagulation cascades 1.8415000898275755 | |
| CPB2 Extracellular space Pancreatic secretion 1.8415000898275755 | |
| CPB2 Extracellular space Protein digestion and absorption 1.8415000898275755 | |
| CPD Nucleus Summary 0.4850554416375755 | |
| CPD Plasma membrane Summary 0.4850554416375755 | |
| CPE Cytoskeleton Type I diabetes mellitus 0.3146581985572688 | |
| CPE Cytosol Type I diabetes mellitus 0.3146581985572688 | |
| CPE Nucleus Type I diabetes mellitus 0.3146581985572688 | |
| CPEB2 Cytosol Summary 0.6407900512283699 | |
| CPEB2 Nucleus Summary 0.6407900512283699 | |
| CPEB4 Cytosol Summary 0.6948928792589695 | |
| CPEB4 Golgi apparatus Summary 0.6948928792589695 | |
| CPEB4 Nucleus Summary 0.6948928792589695 | |
| CPLX2 Cytosol Synaptic vesicle cycle 0.0887401597709294 | |
| CPLX2 Nucleus Synaptic vesicle cycle 0.0887401597709294 | |
| CPM Cytosol Summary 1.4398052963369563 | |
| CPM Plasma membrane Summary 1.4398052963369563 | |
| CPN1 Extracellular space Cortisol synthesis and secretion 2.0891736488178307 | |
| CPN1 Extracellular space Cushing syndrome 2.0891736488178307 | |
| CPN1 Extracellular space Metabolic pathways 2.0891736488178307 | |
| CPN1 Extracellular space Steroid hormone biosynthesis 2.0891736488178307 | |
| CPN1 Nucleus Cortisol synthesis and secretion 2.0891736488178307 | |
| CPN1 Nucleus Cushing syndrome 2.0891736488178307 | |
| CPN1 Nucleus Metabolic pathways 2.0891736488178307 | |
| CPN1 Nucleus Steroid hormone biosynthesis 2.0891736488178307 | |
| CPN2 Extracellular space Aldosterone synthesis and secretion 2.383134456455149 | |
| CPN2 Extracellular space Metabolic pathways 2.383134456455149 | |
| CPN2 Extracellular space Steroid hormone biosynthesis 2.383134456455149 | |
| CPNE1 Nucleus Summary 1.7487376603717262 | |
| CPNE2 Cytosol Summary 2.6381401855402 | |
| CPNE2 Mitochondrion Summary 2.6381401855402 | |
| CPNE2 Nucleus Summary 2.6381401855402 | |
| CPNE3 Cytosol Summary 1.4267611720578792 | |
| CPNE3 Mitochondrion Summary 1.4267611720578792 | |
| CPNE3 Nucleus Summary 1.4267611720578792 | |
| CPOX Mitochondrion Summary 1.482982134176065 | |
| CPPED1 Cytosol Summary 1.4336264389630198 | |
| CPPED1 Plasma membrane Summary 1.4336264389630198 | |
| CPQ Cytosol Summary 1.4384531236256768 | |
| CPQ Endoplasmic Reticulum Summary 1.4384531236256768 | |
| CPQ Extracellular space Summary 1.4384531236256768 | |
| CPQ Golgi apparatus Summary 1.4384531236256768 | |
| CPS1 Mitochondrion Alanine aspartate and glutamate metabolism 1.1623163604805953 | |
| CPS1 Mitochondrion Aldosterone synthesis and secretion 1.1623163604805953 | |
| CPS1 Mitochondrion Arginine biosynthesis 1.1623163604805953 | |
| CPS1 Mitochondrion Biosynthesis of amino acids 1.1623163604805953 | |
| CPS1 Mitochondrion Carbon metabolism 1.1623163604805953 | |
| CPS1 Mitochondrion Cortisol synthesis and secretion 1.1623163604805953 | |
| CPS1 Mitochondrion Cushing syndrome 1.1623163604805953 | |
| CPS1 Mitochondrion Metabolic pathways 1.1623163604805953 | |
| CPS1 Mitochondrion Nitrogen metabolism 1.1623163604805953 | |
| CPS1 Mitochondrion Steroid hormone biosynthesis 1.1623163604805953 | |
| CPS1 Nucleus Alanine aspartate and glutamate metabolism 1.1623163604805953 | |
| CPS1 Nucleus Aldosterone synthesis and secretion 1.1623163604805953 | |
| CPS1 Nucleus Arginine biosynthesis 1.1623163604805953 | |
| CPS1 Nucleus Biosynthesis of amino acids 1.1623163604805953 | |
| CPS1 Nucleus Carbon metabolism 1.1623163604805953 | |
| CPS1 Nucleus Cortisol synthesis and secretion 1.1623163604805953 | |
| CPS1 Nucleus Cushing syndrome 1.1623163604805953 | |
| CPS1 Nucleus Metabolic pathways 1.1623163604805953 | |
| CPS1 Nucleus Nitrogen metabolism 1.1623163604805953 | |
| CPS1 Nucleus Steroid hormone biosynthesis 1.1623163604805953 | |
| CPSF1 Nucleus Summary 1.4531812637861097 | |
| CPSF3 Nucleus mRNA surveillance pathway 1.6431306408113218 | |
| CPSF4 Cytosol Influenza A 1.815221079124988 | |
| CPSF4 Cytosol mRNA surveillance pathway 1.815221079124988 | |
| CPSF4 Mitochondrion Influenza A 1.815221079124988 | |
| CPSF4 Mitochondrion mRNA surveillance pathway 1.815221079124988 | |
| CPSF4 Nucleus Influenza A 1.815221079124988 | |
| CPSF4 Nucleus mRNA surveillance pathway 1.815221079124988 | |
| CPSF6 Nucleus mRNA surveillance pathway 1.2386912921931406 | |
| CPSF7 Cytosol mRNA surveillance pathway 1.4437096863611925 | |
| CPSF7 Nucleus mRNA surveillance pathway 1.4437096863611925 | |
| CPT1A Mitochondrion AMPK signaling pathway 0.34785544238836114 | |
| CPT1A Mitochondrion Adipocytokine signaling pathway 0.34785544238836114 | |
| CPT1A Mitochondrion Fatty acid degradation 0.34785544238836114 | |
| CPT1A Mitochondrion Fatty acid metabolism 0.34785544238836114 | |
| CPT1A Mitochondrion Glucagon signaling pathway 0.34785544238836114 | |
| CPT1A Mitochondrion Insulin resistance 0.34785544238836114 | |
| CPT1A Mitochondrion PPAR signaling pathway 0.34785544238836114 | |
| CPT1A Mitochondrion Thermogenesis 0.34785544238836114 | |
| CPT2 Mitochondrion Diabetic cardiomyopathy 1.0758365553887297 | |
| CPT2 Mitochondrion Fatty acid degradation 1.0758365553887297 | |
| CPT2 Mitochondrion Fatty acid metabolism 1.0758365553887297 | |
| CPT2 Mitochondrion PPAR signaling pathway 1.0758365553887297 | |
| CPT2 Mitochondrion Thermogenesis 1.0758365553887297 | |
| CPT2 Nucleus Diabetic cardiomyopathy 1.0758365553887297 | |
| CPT2 Nucleus Fatty acid degradation 1.0758365553887297 | |
| CPT2 Nucleus Fatty acid metabolism 1.0758365553887297 | |
| CPT2 Nucleus PPAR signaling pathway 1.0758365553887297 | |
| CPT2 Nucleus Thermogenesis 1.0758365553887297 | |
| CPTP Cytosol Summary 1.7513502593205237 | |
| CPVL Endoplasmic Reticulum Summary 2.16618196877179 | |
| CPZ Extracellular space Summary 1.4788334810196344 | |
| CPZ Plasma membrane Summary 1.4788334810196344 | |
| CRABP1 Cytosol Summary 1.4690139211624316 | |
| CRABP2 Cytosol Summary 1.3838741281359992 | |
| CRABP2 Endoplasmic Reticulum Summary 1.3838741281359992 | |
| CRABP2 Nucleus Summary 1.3838741281359992 | |
| CRACR2A Cytosol Summary 0.2528273531293379 | |
| CRADD Cytosol Summary 1.309644258461124 | |
| CRADD Nucleus Summary 1.309644258461124 | |
| CRAMP1 Cytosol Summary 1.275074819219869 | |
| CRAMP1 Nucleus Summary 1.275074819219869 | |
| CRAT Endoplasmic Reticulum Peroxisome 0.07468347305521238 | |
| CRAT Mitochondrion Peroxisome 0.07468347305521238 | |
| CRAT Nucleus Peroxisome 0.07468347305521238 | |
| CRBN Cytosol Summary 0.9945078955605238 | |
| CRBN Nucleus Summary 0.9945078955605238 | |
| CRCP Nucleus Summary 1.2403950595328936 | |
| CRCP Plasma membrane Summary 1.2403950595328936 | |
| CREB1 Nucleus AMPK signaling pathway 1.516215500477209 | |
| CREB1 Nucleus Adrenergic signaling in cardiomyocytes 1.516215500477209 | |
| CREB1 Nucleus Alcoholism 1.516215500477209 | |
| CREB1 Nucleus Aldosterone synthesis and secretion 1.516215500477209 | |
| CREB1 Nucleus Amphetamine addiction 1.516215500477209 | |
| CREB1 Nucleus Antigen processing and presentation 1.516215500477209 | |
| CREB1 Nucleus Chemical carcinogenesis - receptor activation 1.516215500477209 | |
| CREB1 Nucleus Cholinergic synapse 1.516215500477209 | |
| CREB1 Nucleus Circadian entrainment 1.516215500477209 | |
| CREB1 Nucleus Circadian rhythm 1.516215500477209 | |
| CREB1 Nucleus Cocaine addiction 1.516215500477209 | |
| CREB1 Nucleus Cortisol synthesis and secretion 1.516215500477209 | |
| CREB1 Nucleus Cushing syndrome 1.516215500477209 | |
| CREB1 Nucleus Dopaminergic synapse 1.516215500477209 | |
| CREB1 Nucleus Estrogen signaling pathway 1.516215500477209 | |
| CREB1 Nucleus Glucagon signaling pathway 1.516215500477209 | |
| CREB1 Nucleus Growth hormone synthesis secretion and action 1.516215500477209 | |
| CREB1 Nucleus Hepatitis B 1.516215500477209 | |
| CREB1 Nucleus Human T-cell leukemia virus 1 infection 1.516215500477209 | |
| CREB1 Nucleus Human cytomegalovirus infection 1.516215500477209 | |
| CREB1 Nucleus Human papillomavirus infection 1.516215500477209 | |
| CREB1 Nucleus Huntington disease 1.516215500477209 | |
| CREB1 Nucleus Insulin resistance 1.516215500477209 | |
| CREB1 Nucleus Insulin secretion 1.516215500477209 | |
| CREB1 Nucleus Kaposi sarcoma-associated herpesvirus infection 1.516215500477209 | |
| CREB1 Nucleus Longevity regulating pathway 1.516215500477209 | |
| CREB1 Nucleus Melanogenesis 1.516215500477209 | |
| CREB1 Nucleus Osteoclast differentiation 1.516215500477209 | |
| CREB1 Nucleus PI3K-Akt signaling pathway 1.516215500477209 | |
| CREB1 Nucleus Parathyroid hormone synthesis secretion and action 1.516215500477209 | |
| CREB1 Nucleus Prion disease 1.516215500477209 | |
| CREB1 Nucleus Prostate cancer 1.516215500477209 | |
| CREB1 Nucleus Relaxin signaling pathway 1.516215500477209 | |
| CREB1 Nucleus Renin secretion 1.516215500477209 | |
| CREB1 Nucleus TNF signaling pathway 1.516215500477209 | |
| CREB1 Nucleus Thermogenesis 1.516215500477209 | |
| CREB1 Nucleus Thyroid hormone synthesis 1.516215500477209 | |
| CREB1 Nucleus Tuberculosis 1.516215500477209 | |
| CREB1 Nucleus Vasopressin-regulated water reabsorption 1.516215500477209 | |
| CREB1 Nucleus Viral carcinogenesis 1.516215500477209 | |
| CREB1 Nucleus cAMP signaling pathway 1.516215500477209 | |
| CREB1 Nucleus cGMP-PKG signaling pathway 1.516215500477209 | |
| CREB3L4 Endoplasmic Reticulum AMPK signaling pathway 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Adrenergic signaling in cardiomyocytes 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Alcoholism 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Aldosterone synthesis and secretion 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Amphetamine addiction 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Chemical carcinogenesis - receptor activation 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Cholinergic synapse 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Cocaine addiction 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Cortisol synthesis and secretion 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Cushing syndrome 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Dopaminergic synapse 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Estrogen signaling pathway 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Glucagon signaling pathway 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Growth hormone synthesis secretion and action 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Hepatitis B 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Human T-cell leukemia virus 1 infection 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Human cytomegalovirus infection 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Human papillomavirus infection 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Huntington disease 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Insulin resistance 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Insulin secretion 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Longevity regulating pathway 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Melanogenesis 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum PI3K-Akt signaling pathway 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Parathyroid hormone synthesis secretion and action 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Prion disease 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Prostate cancer 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Relaxin signaling pathway 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum TNF signaling pathway 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Thermogenesis 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Thyroid hormone synthesis 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Vasopressin-regulated water reabsorption 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum Viral carcinogenesis 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum cAMP signaling pathway 0.21271145775023054 | |
| CREB3L4 Endoplasmic Reticulum cGMP-PKG signaling pathway 0.21271145775023054 | |
| CREB3L4 Golgi apparatus AMPK signaling pathway 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Adrenergic signaling in cardiomyocytes 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Alcoholism 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Aldosterone synthesis and secretion 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Amphetamine addiction 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Chemical carcinogenesis - receptor activation 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Cholinergic synapse 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Cocaine addiction 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Cortisol synthesis and secretion 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Cushing syndrome 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Dopaminergic synapse 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Estrogen signaling pathway 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Glucagon signaling pathway 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Growth hormone synthesis secretion and action 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Hepatitis B 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Human T-cell leukemia virus 1 infection 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Human cytomegalovirus infection 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Human papillomavirus infection 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Huntington disease 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Insulin resistance 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Insulin secretion 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Longevity regulating pathway 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Melanogenesis 0.21271145775023054 | |
| CREB3L4 Golgi apparatus PI3K-Akt signaling pathway 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Parathyroid hormone synthesis secretion and action 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Prion disease 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Prostate cancer 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Relaxin signaling pathway 0.21271145775023054 | |
| CREB3L4 Golgi apparatus TNF signaling pathway 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Thermogenesis 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Thyroid hormone synthesis 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Vasopressin-regulated water reabsorption 0.21271145775023054 | |
| CREB3L4 Golgi apparatus Viral carcinogenesis 0.21271145775023054 | |
| CREB3L4 Golgi apparatus cAMP signaling pathway 0.21271145775023054 | |
| CREB3L4 Golgi apparatus cGMP-PKG signaling pathway 0.21271145775023054 | |
| CREB3L4 Mitochondrion AMPK signaling pathway 0.21271145775023054 | |
| CREB3L4 Mitochondrion Adrenergic signaling in cardiomyocytes 0.21271145775023054 | |
| CREB3L4 Mitochondrion Alcoholism 0.21271145775023054 | |
| CREB3L4 Mitochondrion Aldosterone synthesis and secretion 0.21271145775023054 | |
| CREB3L4 Mitochondrion Amphetamine addiction 0.21271145775023054 | |
| CREB3L4 Mitochondrion Chemical carcinogenesis - receptor activation 0.21271145775023054 | |
| CREB3L4 Mitochondrion Cholinergic synapse 0.21271145775023054 | |
| CREB3L4 Mitochondrion Cocaine addiction 0.21271145775023054 | |
| CREB3L4 Mitochondrion Cortisol synthesis and secretion 0.21271145775023054 | |
| CREB3L4 Mitochondrion Cushing syndrome 0.21271145775023054 | |
| CREB3L4 Mitochondrion Dopaminergic synapse 0.21271145775023054 | |
| CREB3L4 Mitochondrion Estrogen signaling pathway 0.21271145775023054 | |
| CREB3L4 Mitochondrion Glucagon signaling pathway 0.21271145775023054 | |
| CREB3L4 Mitochondrion Growth hormone synthesis secretion and action 0.21271145775023054 | |
| CREB3L4 Mitochondrion Hepatitis B 0.21271145775023054 | |
| CREB3L4 Mitochondrion Human T-cell leukemia virus 1 infection 0.21271145775023054 | |
| CREB3L4 Mitochondrion Human cytomegalovirus infection 0.21271145775023054 | |
| CREB3L4 Mitochondrion Human papillomavirus infection 0.21271145775023054 | |
| CREB3L4 Mitochondrion Huntington disease 0.21271145775023054 | |
| CREB3L4 Mitochondrion Insulin resistance 0.21271145775023054 | |
| CREB3L4 Mitochondrion Insulin secretion 0.21271145775023054 | |
| CREB3L4 Mitochondrion Longevity regulating pathway 0.21271145775023054 | |
| CREB3L4 Mitochondrion Melanogenesis 0.21271145775023054 | |
| CREB3L4 Mitochondrion PI3K-Akt signaling pathway 0.21271145775023054 | |
| CREB3L4 Mitochondrion Parathyroid hormone synthesis secretion and action 0.21271145775023054 | |
| CREB3L4 Mitochondrion Prion disease 0.21271145775023054 | |
| CREB3L4 Mitochondrion Prostate cancer 0.21271145775023054 | |
| CREB3L4 Mitochondrion Relaxin signaling pathway 0.21271145775023054 | |
| CREB3L4 Mitochondrion TNF signaling pathway 0.21271145775023054 | |
| CREB3L4 Mitochondrion Thermogenesis 0.21271145775023054 | |
| CREB3L4 Mitochondrion Thyroid hormone synthesis 0.21271145775023054 | |
| CREB3L4 Mitochondrion Vasopressin-regulated water reabsorption 0.21271145775023054 | |
| CREB3L4 Mitochondrion Viral carcinogenesis 0.21271145775023054 | |
| CREB3L4 Mitochondrion cAMP signaling pathway 0.21271145775023054 | |
| CREB3L4 Mitochondrion cGMP-PKG signaling pathway 0.21271145775023054 | |
| CREB3L4 Nucleus AMPK signaling pathway 0.21271145775023054 | |
| CREB3L4 Nucleus Adrenergic signaling in cardiomyocytes 0.21271145775023054 | |
| CREB3L4 Nucleus Alcoholism 0.21271145775023054 | |
| CREB3L4 Nucleus Aldosterone synthesis and secretion 0.21271145775023054 | |
| CREB3L4 Nucleus Amphetamine addiction 0.21271145775023054 | |
| CREB3L4 Nucleus Chemical carcinogenesis - receptor activation 0.21271145775023054 | |
| CREB3L4 Nucleus Cholinergic synapse 0.21271145775023054 | |
| CREB3L4 Nucleus Cocaine addiction 0.21271145775023054 | |
| CREB3L4 Nucleus Cortisol synthesis and secretion 0.21271145775023054 | |
| CREB3L4 Nucleus Cushing syndrome 0.21271145775023054 | |
| CREB3L4 Nucleus Dopaminergic synapse 0.21271145775023054 | |
| CREB3L4 Nucleus Estrogen signaling pathway 0.21271145775023054 | |
| CREB3L4 Nucleus Glucagon signaling pathway 0.21271145775023054 | |
| CREB3L4 Nucleus Growth hormone synthesis secretion and action 0.21271145775023054 | |
| CREB3L4 Nucleus Hepatitis B 0.21271145775023054 | |
| CREB3L4 Nucleus Human T-cell leukemia virus 1 infection 0.21271145775023054 | |
| CREB3L4 Nucleus Human cytomegalovirus infection 0.21271145775023054 | |
| CREB3L4 Nucleus Human papillomavirus infection 0.21271145775023054 | |
| CREB3L4 Nucleus Huntington disease 0.21271145775023054 | |
| CREB3L4 Nucleus Insulin resistance 0.21271145775023054 | |
| CREB3L4 Nucleus Insulin secretion 0.21271145775023054 | |
| CREB3L4 Nucleus Longevity regulating pathway 0.21271145775023054 | |
| CREB3L4 Nucleus Melanogenesis 0.21271145775023054 | |
| CREB3L4 Nucleus PI3K-Akt signaling pathway 0.21271145775023054 | |
| CREB3L4 Nucleus Parathyroid hormone synthesis secretion and action 0.21271145775023054 | |
| CREB3L4 Nucleus Prion disease 0.21271145775023054 | |
| CREB3L4 Nucleus Prostate cancer 0.21271145775023054 | |
| CREB3L4 Nucleus Relaxin signaling pathway 0.21271145775023054 | |
| CREB3L4 Nucleus TNF signaling pathway 0.21271145775023054 | |
| CREB3L4 Nucleus Thermogenesis 0.21271145775023054 | |
| CREB3L4 Nucleus Thyroid hormone synthesis 0.21271145775023054 | |
| CREB3L4 Nucleus Vasopressin-regulated water reabsorption 0.21271145775023054 | |
| CREB3L4 Nucleus Viral carcinogenesis 0.21271145775023054 | |
| CREB3L4 Nucleus cAMP signaling pathway 0.21271145775023054 | |
| CREB3L4 Nucleus cGMP-PKG signaling pathway 0.21271145775023054 | |
| CREB5 Cytosol Summary 1.032329073406653 | |
| CREB5 Nucleus Summary 1.032329073406653 | |
| CREB5 Plasma membrane Summary 1.032329073406653 | |
| CREBBP Nucleus Adherens junction 0.9838122202926428 | |
| CREBBP Nucleus Cell cycle 0.9838122202926428 | |
| CREBBP Nucleus FoxO signaling pathway 0.9838122202926428 | |
| CREBBP Nucleus Glucagon signaling pathway 0.9838122202926428 | |
| CREBBP Nucleus Growth hormone synthesis secretion and action 0.9838122202926428 | |
| CREBBP Nucleus HIF-1 signaling pathway 0.9838122202926428 | |
| CREBBP Nucleus Hepatitis B 0.9838122202926428 | |
| CREBBP Nucleus Human T-cell leukemia virus 1 infection 0.9838122202926428 | |
| CREBBP Nucleus Human papillomavirus infection 0.9838122202926428 | |
| CREBBP Nucleus Huntington disease 0.9838122202926428 | |
| CREBBP Nucleus Influenza A 0.9838122202926428 | |
| CREBBP Nucleus JAK-STAT signaling pathway 0.9838122202926428 | |
| CREBBP Nucleus Kaposi sarcoma-associated herpesvirus infection 0.9838122202926428 | |
| CREBBP Nucleus Long-term potentiation 0.9838122202926428 | |
| CREBBP Nucleus Melanogenesis 0.9838122202926428 | |
| CREBBP Nucleus MicroRNAs in cancer 0.9838122202926428 | |
| CREBBP Nucleus Notch signaling pathway 0.9838122202926428 | |
| CREBBP Nucleus Pathways in cancer 0.9838122202926428 | |
| CREBBP Nucleus Prostate cancer 0.9838122202926428 | |
| CREBBP Nucleus Renal cell carcinoma 0.9838122202926428 | |
| CREBBP Nucleus TGF-beta signaling pathway 0.9838122202926428 | |
| CREBBP Nucleus Thyroid hormone signaling pathway 0.9838122202926428 | |
| CREBBP Nucleus Tuberculosis 0.9838122202926428 | |
| CREBBP Nucleus Viral carcinogenesis 0.9838122202926428 | |
| CREBBP Nucleus Wnt signaling pathway 0.9838122202926428 | |
| CREBBP Nucleus cAMP signaling pathway 0.9838122202926428 | |
| CREG1 Cytoskeleton Summary 2.453594450997144 | |
| CREG1 Cytosol Summary 2.453594450997144 | |
| CREG1 Extracellular space Summary 2.453594450997144 | |
| CRELD1 Cytosol Summary 0.7664084073464977 | |
| CRELD1 Nucleus Summary 0.7664084073464977 | |
| CRELD2 Endoplasmic Reticulum Summary 1.6252038710343666 | |
| CRIM1 Extracellular space Summary 1.0739657570890122 | |
| CRIM1 Plasma membrane Summary 1.0739657570890122 | |
| CRIP1 Cytoskeleton Summary 0.19365290779277802 | |
| CRIP1 Cytosol Summary 0.19365290779277802 | |
| CRIP1 Nucleus Summary 0.19365290779277802 | |
| CRIP1 Plasma membrane Summary 0.19365290779277802 | |
| CRIP2 Nucleus Summary 0.7787147993877632 | |
| CRIP2 Plasma membrane Summary 0.7787147993877632 | |
| CRIPT Cytosol Summary 1.7580178071027492 | |
| CRIPT Nucleus Summary 1.7580178071027492 | |
| CRISP3 Extracellular space Summary 1.0963281433094556 | |
| CRISPLD2 Nucleus Summary 1.862772673204566 | |
| CRK Cytosol Summary 1.1354571227052557 | |
| CRK Plasma membrane Summary 1.1354571227052557 | |
| CRKL Cytosol Summary 1.1809040409949092 | |
| CRKL Nucleus Summary 1.1809040409949092 | |
| CRLF1 Extracellular space Summary 2.7416091478531883 | |
| CRLF3 Cytosol Summary 1.8842114577541482 | |
| CRLF3 Plasma membrane Summary 1.8842114577541482 | |
| CRMP1 Cytoskeleton Summary 0.3910824658823618 | |
| CRMP1 Cytosol Summary 0.3910824658823618 | |
| CRNKL1 Nucleus Spliceosome 1.1492227709817189 | |
| CROCC Cytoskeleton Summary 0.5535218852466272 | |
| CROCC Cytosol Summary 0.5535218852466272 | |
| CROCC Plasma membrane Summary 0.5535218852466272 | |
| CROT Cytosol Summary 0.2750427301063488 | |
| CROT Peroxisome Summary 0.2750427301063488 | |
| CRP Cytoskeleton Summary 1.7705958083673332 | |
| CRP Cytosol Summary 1.7705958083673332 | |
| CRP Extracellular space Summary 1.7705958083673332 | |
| CRP Nucleus Summary 1.7705958083673332 | |
| CRTAC1 Extracellular space Summary 1.4768492431885083 | |
| CRTAP Cytoskeleton Summary 1.9265889079577925 | |
| CRTAP Cytosol Summary 1.9265889079577925 | |
| CRTAP Extracellular space Summary 1.9265889079577925 | |
| CRTC1 Cytosol Human T-cell leukemia virus 1 infection 0.8095314938730193 | |
| CRTC1 Nucleus Human T-cell leukemia virus 1 infection 0.8095314938730193 | |
| CRTC1 Plasma membrane Human T-cell leukemia virus 1 infection 0.8095314938730193 | |
| CRTC2 Cytosol AMPK signaling pathway 1.283649280839543 | |
| CRTC2 Cytosol Glucagon signaling pathway 1.283649280839543 | |
| CRTC2 Cytosol Human T-cell leukemia virus 1 infection 1.283649280839543 | |
| CRTC2 Cytosol Insulin resistance 1.283649280839543 | |
| CRTC2 Cytosol PI3K-Akt signaling pathway 1.283649280839543 | |
| CRTC2 Nucleus AMPK signaling pathway 1.283649280839543 | |
| CRTC2 Nucleus Glucagon signaling pathway 1.283649280839543 | |
| CRTC2 Nucleus Human T-cell leukemia virus 1 infection 1.283649280839543 | |
| CRTC2 Nucleus Insulin resistance 1.283649280839543 | |
| CRTC2 Nucleus PI3K-Akt signaling pathway 1.283649280839543 | |
| CRTC3 Cytosol Human T-cell leukemia virus 1 infection 1.1123370865654545 | |
| CRTC3 Nucleus Human T-cell leukemia virus 1 infection 1.1123370865654545 | |
| CRY2 Cytosol Circadian rhythm 1.4470181528701656 | |
| CRY2 Nucleus Circadian rhythm 1.4470181528701656 | |
| CRYAB Cytosol Longevity regulating pathway - multiple species 2.2947928244376548 | |
| CRYAB Cytosol Protein processing in endoplasmic reticulum 2.2947928244376548 | |
| CRYAB Nucleus Longevity regulating pathway - multiple species 2.2947928244376548 | |
| CRYAB Nucleus Protein processing in endoplasmic reticulum 2.2947928244376548 | |
| CRYAB Plasma membrane Longevity regulating pathway - multiple species 2.2947928244376548 | |
| CRYAB Plasma membrane Protein processing in endoplasmic reticulum 2.2947928244376548 | |
| CRYBG3 Nucleus Summary 1.9710578438675133 | |
| CRYBG3 Plasma membrane Summary 1.9710578438675133 | |
| CRYL1 Cytosol Summary 0.6307500730652646 | |
| CRYL1 Golgi apparatus Summary 0.6307500730652646 | |
| CRYL1 Nucleus Summary 0.6307500730652646 | |
| CRYL1 Plasma membrane Summary 0.6307500730652646 | |
| CRYM Cytosol Summary 0.14469153063485135 | |
| CRYZ Cytosol Summary 0.6965000104204669 | |
| CRYZL1 Cytosol Summary 1.0620345624000966 | |
| CRYZL1 Nucleus Summary 1.0620345624000966 | |
| CS Extracellular space 2-Oxocarboxylic acid metabolism 1.2115996119755854 | |
| CS Extracellular space Biosynthesis of amino acids 1.2115996119755854 | |
| CS Extracellular space Carbon metabolism 1.2115996119755854 | |
| CS Extracellular space Citrate cycle (TCA cycle) 1.2115996119755854 | |
| CS Extracellular space Glyoxylate and dicarboxylate metabolism 1.2115996119755854 | |
| CS Extracellular space Metabolic pathways 1.2115996119755854 | |
| CS Mitochondrion 2-Oxocarboxylic acid metabolism 1.2115996119755854 | |
| CS Mitochondrion Biosynthesis of amino acids 1.2115996119755854 | |
| CS Mitochondrion Carbon metabolism 1.2115996119755854 | |
| CS Mitochondrion Citrate cycle (TCA cycle) 1.2115996119755854 | |
| CS Mitochondrion Glyoxylate and dicarboxylate metabolism 1.2115996119755854 | |
| CS Mitochondrion Metabolic pathways 1.2115996119755854 | |
| CSDE1 Cytosol Summary 1.5197579263381418 | |
| CSDE1 Plasma membrane Summary 1.5197579263381418 | |
| CSE1L Cytosol Salmonella infection 1.7071703557441988 | |
| CSE1L Nucleus Salmonella infection 1.7071703557441988 | |
| CSF1 Extracellular space Alzheimer disease 0.7911318473391803 | |
| CSF1 Extracellular space Cytokine-cytokine receptor interaction 0.7911318473391803 | |
| CSF1 Extracellular space Hematopoietic cell lineage 0.7911318473391803 | |
| CSF1 Extracellular space MAPK signaling pathway 0.7911318473391803 | |
| CSF1 Extracellular space Osteoclast differentiation 0.7911318473391803 | |
| CSF1 Extracellular space PI3K-Akt signaling pathway 0.7911318473391803 | |
| CSF1 Extracellular space Pathways of neurodegeneration - multiple diseases 0.7911318473391803 | |
| CSF1 Extracellular space Rap1 signaling pathway 0.7911318473391803 | |
| CSF1 Extracellular space Ras signaling pathway 0.7911318473391803 | |
| CSF1 Extracellular space Rheumatoid arthritis 0.7911318473391803 | |
| CSF1 Extracellular space TNF signaling pathway 0.7911318473391803 | |
| CSF1 Extracellular space Viral protein interaction with cytokine and cytokine receptor 0.7911318473391803 | |
| CSF1 Nucleus Alzheimer disease 0.7911318473391803 | |
| CSF1 Nucleus Cytokine-cytokine receptor interaction 0.7911318473391803 | |
| CSF1 Nucleus Hematopoietic cell lineage 0.7911318473391803 | |
| CSF1 Nucleus MAPK signaling pathway 0.7911318473391803 | |
| CSF1 Nucleus Osteoclast differentiation 0.7911318473391803 | |
| CSF1 Nucleus PI3K-Akt signaling pathway 0.7911318473391803 | |
| CSF1 Nucleus Pathways of neurodegeneration - multiple diseases 0.7911318473391803 | |
| CSF1 Nucleus Rap1 signaling pathway 0.7911318473391803 | |
| CSF1 Nucleus Ras signaling pathway 0.7911318473391803 | |
| CSF1 Nucleus Rheumatoid arthritis 0.7911318473391803 | |
| CSF1 Nucleus TNF signaling pathway 0.7911318473391803 | |
| CSF1 Nucleus Viral protein interaction with cytokine and cytokine receptor 0.7911318473391803 | |
| CSF1 Plasma membrane Alzheimer disease 0.7911318473391803 | |
| CSF1 Plasma membrane Cytokine-cytokine receptor interaction 0.7911318473391803 | |
| CSF1 Plasma membrane Hematopoietic cell lineage 0.7911318473391803 | |
| CSF1 Plasma membrane MAPK signaling pathway 0.7911318473391803 | |
| CSF1 Plasma membrane Osteoclast differentiation 0.7911318473391803 | |
| CSF1 Plasma membrane PI3K-Akt signaling pathway 0.7911318473391803 | |
| CSF1 Plasma membrane Pathways of neurodegeneration - multiple diseases 0.7911318473391803 | |
| CSF1 Plasma membrane Rap1 signaling pathway 0.7911318473391803 | |
| CSF1 Plasma membrane Ras signaling pathway 0.7911318473391803 | |
| CSF1 Plasma membrane Rheumatoid arthritis 0.7911318473391803 | |
| CSF1 Plasma membrane TNF signaling pathway 0.7911318473391803 | |
| CSF1 Plasma membrane Viral protein interaction with cytokine and cytokine receptor 0.7911318473391803 | |
| CSF1R Cytosol Acute myeloid leukemia 1.304043214984063 | |
| CSF1R Cytosol Cytokine-cytokine receptor interaction 1.304043214984063 | |
| CSF1R Cytosol Hematopoietic cell lineage 1.304043214984063 | |
| CSF1R Cytosol MAPK signaling pathway 1.304043214984063 | |
| CSF1R Cytosol Osteoclast differentiation 1.304043214984063 | |
| CSF1R Cytosol PI3K-Akt signaling pathway 1.304043214984063 | |
| CSF1R Cytosol Pathways in cancer 1.304043214984063 | |
| CSF1R Cytosol Rap1 signaling pathway 1.304043214984063 | |
| CSF1R Cytosol Ras signaling pathway 1.304043214984063 | |
| CSF1R Cytosol Transcriptional misregulation in cancer 1.304043214984063 | |
| CSF1R Cytosol Viral protein interaction with cytokine and cytokine receptor 1.304043214984063 | |
| CSF1R Plasma membrane Acute myeloid leukemia 1.304043214984063 | |
| CSF1R Plasma membrane Cytokine-cytokine receptor interaction 1.304043214984063 | |
| CSF1R Plasma membrane Hematopoietic cell lineage 1.304043214984063 | |
| CSF1R Plasma membrane MAPK signaling pathway 1.304043214984063 | |
| CSF1R Plasma membrane Osteoclast differentiation 1.304043214984063 | |
| CSF1R Plasma membrane PI3K-Akt signaling pathway 1.304043214984063 | |
| CSF1R Plasma membrane Pathways in cancer 1.304043214984063 | |
| CSF1R Plasma membrane Rap1 signaling pathway 1.304043214984063 | |
| CSF1R Plasma membrane Ras signaling pathway 1.304043214984063 | |
| CSF1R Plasma membrane Transcriptional misregulation in cancer 1.304043214984063 | |
| CSF1R Plasma membrane Viral protein interaction with cytokine and cytokine receptor 1.304043214984063 | |
| CSK Cytosol Summary 1.7964108193573154 | |
| CSMD3 Plasma membrane Summary 1.557156714849386 | |
| CSN3 Extracellular space Summary 0.15251407066866007 | |
| CSNK1A1 Cytoskeleton Alzheimer disease 1.0118342092495014 | |
| CSNK1A1 Cytoskeleton Breast cancer 1.0118342092495014 | |
| CSNK1A1 Cytoskeleton Gastric cancer 1.0118342092495014 | |
| CSNK1A1 Cytoskeleton Hedgehog signaling pathway 1.0118342092495014 | |
| CSNK1A1 Cytoskeleton Hepatocellular carcinoma 1.0118342092495014 | |
| CSNK1A1 Cytoskeleton Human papillomavirus infection 1.0118342092495014 | |
| CSNK1A1 Cytoskeleton Pathways of neurodegeneration - multiple diseases 1.0118342092495014 | |
| CSNK1A1 Cytoskeleton Wnt signaling pathway 1.0118342092495014 | |
| CSNK1A1 Cytosol Alzheimer disease 1.0118342092495014 | |
| CSNK1A1 Cytosol Breast cancer 1.0118342092495014 | |
| CSNK1A1 Cytosol Gastric cancer 1.0118342092495014 | |
| CSNK1A1 Cytosol Hedgehog signaling pathway 1.0118342092495014 | |
| CSNK1A1 Cytosol Hepatocellular carcinoma 1.0118342092495014 | |
| CSNK1A1 Cytosol Human papillomavirus infection 1.0118342092495014 | |
| CSNK1A1 Cytosol Pathways of neurodegeneration - multiple diseases 1.0118342092495014 | |
| CSNK1A1 Cytosol Wnt signaling pathway 1.0118342092495014 | |
| CSNK1A1 Nucleus Alzheimer disease 1.0118342092495014 | |
| CSNK1A1 Nucleus Breast cancer 1.0118342092495014 | |
| CSNK1A1 Nucleus Gastric cancer 1.0118342092495014 | |
| CSNK1A1 Nucleus Hedgehog signaling pathway 1.0118342092495014 | |
| CSNK1A1 Nucleus Hepatocellular carcinoma 1.0118342092495014 | |
| CSNK1A1 Nucleus Human papillomavirus infection 1.0118342092495014 | |
| CSNK1A1 Nucleus Pathways of neurodegeneration - multiple diseases 1.0118342092495014 | |
| CSNK1A1 Nucleus Wnt signaling pathway 1.0118342092495014 | |
| CSNK1E Cytosol Summary 0.649890441329832 | |
| CSNK1E Nucleus Summary 0.649890441329832 | |
| CSNK1G1 Cytosol Summary 0.9388805192910882 | |
| CSNK1G3 Cytosol Summary 0.7010979282224616 | |
| CSNK2A2 Nucleus Adherens junction 1.173280536455072 | |
| CSNK2A2 Nucleus Alzheimer disease 1.173280536455072 | |
| CSNK2A2 Nucleus Measles 1.173280536455072 | |
| CSNK2A2 Nucleus Mitophagy - animal 1.173280536455072 | |
| CSNK2A2 Nucleus NF-kappa B signaling pathway 1.173280536455072 | |
| CSNK2A2 Nucleus PD-L1 expression and PD-1 checkpoint pathway in cancer 1.173280536455072 | |
| CSNK2A2 Nucleus Pathways of neurodegeneration - multiple diseases 1.173280536455072 | |
| CSNK2A2 Nucleus Prion disease 1.173280536455072 | |
| CSNK2A2 Nucleus Ribosome biogenesis in eukaryotes 1.173280536455072 | |
| CSNK2A2 Nucleus Wnt signaling pathway 1.173280536455072 | |
| CSPG4 Nucleus Summary 1.911445541593526 | |
| CSPG4 Plasma membrane Summary 1.911445541593526 | |
| CSPP1 Cytoskeleton Summary 1.5598725731893155 | |
| CSPP1 Cytosol Summary 1.5598725731893155 | |
| CSRP1 Nucleus Summary 1.3656279704869496 | |
| CSRP2 Nucleus Summary 1.7418914333131934 | |
| CSRP3 Nucleus Summary 1.067228790366321 | |
| CST3 Cytosol Salivary secretion 0.5035503034488438 | |
| CST3 Extracellular space Salivary secretion 0.5035503034488438 | |
| CST3 Golgi apparatus Salivary secretion 0.5035503034488438 | |
| CST4 Extracellular space Salivary secretion 0.3831539039282602 | |
| CST5 Extracellular space Salivary secretion 0.07696286243609894 | |
| CST6 Cytosol Summary 0.7620624052434067 | |
| CST6 Extracellular space Summary 0.7620624052434067 | |
| CST6 Plasma membrane Summary 0.7620624052434067 | |
| CSTA Cytoskeleton Summary 0.3951393500729176 | |
| CSTA Cytosol Summary 0.3951393500729176 | |
| CSTA Nucleus Summary 0.3951393500729176 | |
| CSTB Cytosol Summary 1.0721569880307795 | |
| CSTB Nucleus Summary 1.0721569880307795 | |
| CSTF1 Nucleus mRNA surveillance pathway 1.1651492518438429 | |
| CSTF2 Nucleus mRNA surveillance pathway 1.0729524741310557 | |
| CSTF2T Cytosol Summary 1.3838176155216122 | |
| CSTF2T Nucleus Summary 1.3838176155216122 | |
| CSTF3 Nucleus mRNA surveillance pathway 1.162480484187972 | |
| CTAGE5 Endoplasmic Reticulum Summary 0.4425210903128196 | |
| CTBP1 Cytosol Chronic myeloid leukemia 1.9471949257804433 | |
| CTBP1 Cytosol Notch signaling pathway 1.9471949257804433 | |
| CTBP1 Cytosol Pathways in cancer 1.9471949257804433 | |
| CTBP1 Cytosol Wnt signaling pathway 1.9471949257804433 | |
| CTBP1 Nucleus Chronic myeloid leukemia 1.9471949257804433 | |
| CTBP1 Nucleus Notch signaling pathway 1.9471949257804433 | |
| CTBP1 Nucleus Pathways in cancer 1.9471949257804433 | |
| CTBP1 Nucleus Wnt signaling pathway 1.9471949257804433 | |
| CTBP2 Cytosol Summary 1.2163104933592617 | |
| CTBP2 Nucleus Summary 1.2163104933592617 | |
| CTBS Cytosol Summary 0.5430367169202923 | |
| CTBS Lysosome Summary 0.5430367169202923 | |
| CTC1 Cytosol Summary 2.111591486367832 | |
| CTC1 Nucleus Summary 2.111591486367832 | |
| CTCF Endoplasmic Reticulum Summary 1.6280298432427658 | |
| CTCF Nucleus Summary 1.6280298432427658 | |
| CTCFL Cytosol Summary 1.0864661184549984 | |
| CTCFL Nucleus Summary 1.0864661184549984 | |
| CTDP1 Cytosol Summary 1.6436127968777838 | |
| CTDP1 Nucleus Summary 1.6436127968777838 | |
| CTDSP1 Nucleus Summary 0.7466610938720228 | |
| CTDSPL2 Nucleus Summary 2.0227789102129865 | |
| CTF1 Extracellular space Cytokine-cytokine receptor interaction 1.2929094561892591 | |
| CTF1 Extracellular space JAK-STAT signaling pathway 1.2929094561892591 | |
| CTGF Cytosol Summary 1.8518115990660104 | |
| CTGF Golgi apparatus Summary 1.8518115990660104 | |
| CTH Cytosol Summary 1.018276164731845 | |
| CTHRC1 Extracellular space Summary 2.0038225592182277 | |
| CTHRC1 Nucleus Summary 2.0038225592182277 | |
| CTIF Cytosol Summary 1.5741394140895844 | |
| CTIF Nucleus Summary 1.5741394140895844 | |
| CTNNA1 Cytoskeleton Adherens junction 0.9481935448687684 | |
| CTNNA1 Cytoskeleton Arrhythmogenic right ventricular cardiomyopathy 0.9481935448687684 | |
| CTNNA1 Cytoskeleton Bacterial invasion of epithelial cells 0.9481935448687684 | |
| CTNNA1 Cytoskeleton Endometrial cancer 0.9481935448687684 | |
| CTNNA1 Cytoskeleton Gastric cancer 0.9481935448687684 | |
| CTNNA1 Cytoskeleton Hippo signaling pathway 0.9481935448687684 | |
| CTNNA1 Cytoskeleton Leukocyte transendothelial migration 0.9481935448687684 | |
| CTNNA1 Cytoskeleton Pathways in cancer 0.9481935448687684 | |
| CTNNA1 Cytosol Adherens junction 0.9481935448687684 | |
| CTNNA1 Cytosol Arrhythmogenic right ventricular cardiomyopathy 0.9481935448687684 | |
| CTNNA1 Cytosol Bacterial invasion of epithelial cells 0.9481935448687684 | |
| CTNNA1 Cytosol Endometrial cancer 0.9481935448687684 | |
| CTNNA1 Cytosol Gastric cancer 0.9481935448687684 | |
| CTNNA1 Cytosol Hippo signaling pathway 0.9481935448687684 | |
| CTNNA1 Cytosol Leukocyte transendothelial migration 0.9481935448687684 | |
| CTNNA1 Cytosol Pathways in cancer 0.9481935448687684 | |
| CTNNA1 Plasma membrane Adherens junction 0.9481935448687684 | |
| CTNNA1 Plasma membrane Arrhythmogenic right ventricular cardiomyopathy 0.9481935448687684 | |
| CTNNA1 Plasma membrane Bacterial invasion of epithelial cells 0.9481935448687684 | |
| CTNNA1 Plasma membrane Endometrial cancer 0.9481935448687684 | |
| CTNNA1 Plasma membrane Gastric cancer 0.9481935448687684 | |
| CTNNA1 Plasma membrane Hippo signaling pathway 0.9481935448687684 | |
| CTNNA1 Plasma membrane Leukocyte transendothelial migration 0.9481935448687684 | |
| CTNNA1 Plasma membrane Pathways in cancer 0.9481935448687684 | |
| CTNNB1 Cytoskeleton Adherens junction 1.350564322809097 | |
| CTNNB1 Cytoskeleton Alzheimer disease 1.350564322809097 | |
| CTNNB1 Cytoskeleton Arrhythmogenic right ventricular cardiomyopathy 1.350564322809097 | |
| CTNNB1 Cytoskeleton Bacterial invasion of epithelial cells 1.350564322809097 | |
| CTNNB1 Cytoskeleton Basal cell carcinoma 1.350564322809097 | |
| CTNNB1 Cytoskeleton Breast cancer 1.350564322809097 | |
| CTNNB1 Cytoskeleton Colorectal cancer 1.350564322809097 | |
| CTNNB1 Cytoskeleton Cushing syndrome 1.350564322809097 | |
| CTNNB1 Cytoskeleton Endometrial cancer 1.350564322809097 | |
| CTNNB1 Cytoskeleton Fluid shear stress and atherosclerosis 1.350564322809097 | |
| CTNNB1 Cytoskeleton Focal adhesion 1.350564322809097 | |
| CTNNB1 Cytoskeleton Gastric cancer 1.350564322809097 | |
| CTNNB1 Cytoskeleton Hepatitis C 1.350564322809097 | |
| CTNNB1 Cytoskeleton Hepatocellular carcinoma 1.350564322809097 | |
| CTNNB1 Cytoskeleton Hippo signaling pathway 1.350564322809097 | |
| CTNNB1 Cytoskeleton Human cytomegalovirus infection 1.350564322809097 | |
| CTNNB1 Cytoskeleton Human papillomavirus infection 1.350564322809097 | |
| CTNNB1 Cytoskeleton Kaposi sarcoma-associated herpesvirus infection 1.350564322809097 | |
| CTNNB1 Cytoskeleton Leukocyte transendothelial migration 1.350564322809097 | |
| CTNNB1 Cytoskeleton Melanogenesis 1.350564322809097 | |
| CTNNB1 Cytoskeleton Pathways in cancer 1.350564322809097 | |
| CTNNB1 Cytoskeleton Pathways of neurodegeneration - multiple diseases 1.350564322809097 | |
| CTNNB1 Cytoskeleton Prostate cancer 1.350564322809097 | |
| CTNNB1 Cytoskeleton Proteoglycans in cancer 1.350564322809097 | |
| CTNNB1 Cytoskeleton Rap1 signaling pathway 1.350564322809097 | |
| CTNNB1 Cytoskeleton Salmonella infection 1.350564322809097 | |
| CTNNB1 Cytoskeleton Signaling pathways regulating pluripotency of stem cells 1.350564322809097 | |
| CTNNB1 Cytoskeleton Thyroid cancer 1.350564322809097 | |
| CTNNB1 Cytoskeleton Thyroid hormone signaling pathway 1.350564322809097 | |
| CTNNB1 Cytoskeleton Wnt signaling pathway 1.350564322809097 | |
| CTNNB1 Cytosol Adherens junction 1.350564322809097 | |
| CTNNB1 Cytosol Alzheimer disease 1.350564322809097 | |
| CTNNB1 Cytosol Arrhythmogenic right ventricular cardiomyopathy 1.350564322809097 | |
| CTNNB1 Cytosol Bacterial invasion of epithelial cells 1.350564322809097 | |
| CTNNB1 Cytosol Basal cell carcinoma 1.350564322809097 | |
| CTNNB1 Cytosol Breast cancer 1.350564322809097 | |
| CTNNB1 Cytosol Colorectal cancer 1.350564322809097 | |
| CTNNB1 Cytosol Cushing syndrome 1.350564322809097 | |
| CTNNB1 Cytosol Endometrial cancer 1.350564322809097 | |
| CTNNB1 Cytosol Fluid shear stress and atherosclerosis 1.350564322809097 | |
| CTNNB1 Cytosol Focal adhesion 1.350564322809097 | |
| CTNNB1 Cytosol Gastric cancer 1.350564322809097 | |
| CTNNB1 Cytosol Hepatitis C 1.350564322809097 | |
| CTNNB1 Cytosol Hepatocellular carcinoma 1.350564322809097 | |
| CTNNB1 Cytosol Hippo signaling pathway 1.350564322809097 | |
| CTNNB1 Cytosol Human cytomegalovirus infection 1.350564322809097 | |
| CTNNB1 Cytosol Human papillomavirus infection 1.350564322809097 | |
| CTNNB1 Cytosol Kaposi sarcoma-associated herpesvirus infection 1.350564322809097 | |
| CTNNB1 Cytosol Leukocyte transendothelial migration 1.350564322809097 | |
| CTNNB1 Cytosol Melanogenesis 1.350564322809097 | |
| CTNNB1 Cytosol Pathways in cancer 1.350564322809097 | |
| CTNNB1 Cytosol Pathways of neurodegeneration - multiple diseases 1.350564322809097 | |
| CTNNB1 Cytosol Prostate cancer 1.350564322809097 | |
| CTNNB1 Cytosol Proteoglycans in cancer 1.350564322809097 | |
| CTNNB1 Cytosol Rap1 signaling pathway 1.350564322809097 | |
| CTNNB1 Cytosol Salmonella infection 1.350564322809097 | |
| CTNNB1 Cytosol Signaling pathways regulating pluripotency of stem cells 1.350564322809097 | |
| CTNNB1 Cytosol Thyroid cancer 1.350564322809097 | |
| CTNNB1 Cytosol Thyroid hormone signaling pathway 1.350564322809097 | |
| CTNNB1 Cytosol Wnt signaling pathway 1.350564322809097 | |
| CTNNB1 Nucleus Adherens junction 1.350564322809097 | |
| CTNNB1 Nucleus Alzheimer disease 1.350564322809097 | |
| CTNNB1 Nucleus Arrhythmogenic right ventricular cardiomyopathy 1.350564322809097 | |
| CTNNB1 Nucleus Bacterial invasion of epithelial cells 1.350564322809097 | |
| CTNNB1 Nucleus Basal cell carcinoma 1.350564322809097 | |
| CTNNB1 Nucleus Breast cancer 1.350564322809097 | |
| CTNNB1 Nucleus Colorectal cancer 1.350564322809097 | |
| CTNNB1 Nucleus Cushing syndrome 1.350564322809097 | |
| CTNNB1 Nucleus Endometrial cancer 1.350564322809097 | |
| CTNNB1 Nucleus Fluid shear stress and atherosclerosis 1.350564322809097 | |
| CTNNB1 Nucleus Focal adhesion 1.350564322809097 | |
| CTNNB1 Nucleus Gastric cancer 1.350564322809097 | |
| CTNNB1 Nucleus Hepatitis C 1.350564322809097 | |
| CTNNB1 Nucleus Hepatocellular carcinoma 1.350564322809097 | |
| CTNNB1 Nucleus Hippo signaling pathway 1.350564322809097 | |
| CTNNB1 Nucleus Human cytomegalovirus infection 1.350564322809097 | |
| CTNNB1 Nucleus Human papillomavirus infection 1.350564322809097 | |
| CTNNB1 Nucleus Kaposi sarcoma-associated herpesvirus infection 1.350564322809097 | |
| CTNNB1 Nucleus Leukocyte transendothelial migration 1.350564322809097 | |
| CTNNB1 Nucleus Melanogenesis 1.350564322809097 | |
| CTNNB1 Nucleus Pathways in cancer 1.350564322809097 | |
| CTNNB1 Nucleus Pathways of neurodegeneration - multiple diseases 1.350564322809097 | |
| CTNNB1 Nucleus Prostate cancer 1.350564322809097 | |
| CTNNB1 Nucleus Proteoglycans in cancer 1.350564322809097 | |
| CTNNB1 Nucleus Rap1 signaling pathway 1.350564322809097 | |
| CTNNB1 Nucleus Salmonella infection 1.350564322809097 | |
| CTNNB1 Nucleus Signaling pathways regulating pluripotency of stem cells 1.350564322809097 | |
| CTNNB1 Nucleus Thyroid cancer 1.350564322809097 | |
| CTNNB1 Nucleus Thyroid hormone signaling pathway 1.350564322809097 | |
| CTNNB1 Nucleus Wnt signaling pathway 1.350564322809097 | |
| CTNNB1 Plasma membrane Adherens junction 1.350564322809097 | |
| CTNNB1 Plasma membrane Alzheimer disease 1.350564322809097 | |
| CTNNB1 Plasma membrane Arrhythmogenic right ventricular cardiomyopathy 1.350564322809097 | |
| CTNNB1 Plasma membrane Bacterial invasion of epithelial cells 1.350564322809097 | |
| CTNNB1 Plasma membrane Basal cell carcinoma 1.350564322809097 | |
| CTNNB1 Plasma membrane Breast cancer 1.350564322809097 | |
| CTNNB1 Plasma membrane Colorectal cancer 1.350564322809097 | |
| CTNNB1 Plasma membrane Cushing syndrome 1.350564322809097 | |
| CTNNB1 Plasma membrane Endometrial cancer 1.350564322809097 | |
| CTNNB1 Plasma membrane Fluid shear stress and atherosclerosis 1.350564322809097 | |
| CTNNB1 Plasma membrane Focal adhesion 1.350564322809097 | |
| CTNNB1 Plasma membrane Gastric cancer 1.350564322809097 | |
| CTNNB1 Plasma membrane Hepatitis C 1.350564322809097 | |
| CTNNB1 Plasma membrane Hepatocellular carcinoma 1.350564322809097 | |
| CTNNB1 Plasma membrane Hippo signaling pathway 1.350564322809097 | |
| CTNNB1 Plasma membrane Human cytomegalovirus infection 1.350564322809097 | |
| CTNNB1 Plasma membrane Human papillomavirus infection 1.350564322809097 | |
| CTNNB1 Plasma membrane Kaposi sarcoma-associated herpesvirus infection 1.350564322809097 | |
| CTNNB1 Plasma membrane Leukocyte transendothelial migration 1.350564322809097 | |
| CTNNB1 Plasma membrane Melanogenesis 1.350564322809097 | |
| CTNNB1 Plasma membrane Pathways in cancer 1.350564322809097 | |
| CTNNB1 Plasma membrane Pathways of neurodegeneration - multiple diseases 1.350564322809097 | |
| CTNNB1 Plasma membrane Prostate cancer 1.350564322809097 | |
| CTNNB1 Plasma membrane Proteoglycans in cancer 1.350564322809097 | |
| CTNNB1 Plasma membrane Rap1 signaling pathway 1.350564322809097 | |
| CTNNB1 Plasma membrane Salmonella infection 1.350564322809097 | |
| CTNNB1 Plasma membrane Signaling pathways regulating pluripotency of stem cells 1.350564322809097 | |
| CTNNB1 Plasma membrane Thyroid cancer 1.350564322809097 | |
| CTNNB1 Plasma membrane Thyroid hormone signaling pathway 1.350564322809097 | |
| CTNNB1 Plasma membrane Wnt signaling pathway 1.350564322809097 | |
| CTNNBIP1 Cytosol Summary 1.9448478363258592 | |
| CTNNBIP1 Mitochondrion Summary 1.9448478363258592 | |
| CTNNBIP1 Plasma membrane Summary 1.9448478363258592 | |
| CTNNBL1 Cytoskeleton Spliceosome 1.7795292279789885 | |
| CTNNBL1 Cytosol Spliceosome 1.7795292279789885 | |
| CTNNBL1 Nucleus Spliceosome 1.7795292279789885 | |
| CTNND1 Nucleus Adherens junction 0.9724933880518122 | |
| CTNND1 Nucleus Leukocyte transendothelial migration 0.9724933880518122 | |
| CTNND1 Nucleus Rap1 signaling pathway 0.9724933880518122 | |
| CTNND1 Plasma membrane Adherens junction 0.9724933880518122 | |
| CTNND1 Plasma membrane Leukocyte transendothelial migration 0.9724933880518122 | |
| CTNND1 Plasma membrane Rap1 signaling pathway 0.9724933880518122 | |
| CTNND2 Cytosol Summary 0.8424911069813784 | |
| CTNND2 Nucleus Summary 0.8424911069813784 | |
| CTNND2 Plasma membrane Summary 0.8424911069813784 | |
| CTPS1 Cytoskeleton Summary 2.23019394849082 | |
| CTPS1 Cytosol Summary 2.23019394849082 | |
| CTPS2 Cytosol Summary 1.093167992132568 | |
| CTPS2 Mitochondrion Summary 1.093167992132568 | |
| CTPS2 Nucleus Summary 1.093167992132568 | |
| CTSA Cytosol Lysosome 1.233840963092667 | |
| CTSA Cytosol Renin-angiotensin system 1.233840963092667 | |
| CTSA Lysosome Lysosome 1.233840963092667 | |
| CTSA Lysosome Renin-angiotensin system 1.233840963092667 | |
| CTSB Cytosol Antigen processing and presentation 2.3215643693256105 | |
| CTSB Cytosol Apoptosis 2.3215643693256105 | |
| CTSB Cytosol Autophagy - animal 2.3215643693256105 | |
| CTSB Cytosol Lysosome 2.3215643693256105 | |
| CTSB Cytosol NOD-like receptor signaling pathway 2.3215643693256105 | |
| CTSB Cytosol Renin secretion 2.3215643693256105 | |
| CTSB Lysosome Antigen processing and presentation 2.3215643693256105 | |
| CTSB Lysosome Apoptosis 2.3215643693256105 | |
| CTSB Lysosome Autophagy - animal 2.3215643693256105 | |
| CTSB Lysosome Lysosome 2.3215643693256105 | |
| CTSB Lysosome NOD-like receptor signaling pathway 2.3215643693256105 | |
| CTSB Lysosome Renin secretion 2.3215643693256105 | |
| CTSB Nucleus Antigen processing and presentation 2.3215643693256105 | |
| CTSB Nucleus Apoptosis 2.3215643693256105 | |
| CTSB Nucleus Autophagy - animal 2.3215643693256105 | |
| CTSB Nucleus Lysosome 2.3215643693256105 | |
| CTSB Nucleus NOD-like receptor signaling pathway 2.3215643693256105 | |
| CTSB Nucleus Renin secretion 2.3215643693256105 | |
| CTSC Cytosol Apoptosis 2.1895248910318337 | |
| CTSC Cytosol Lysosome 2.1895248910318337 | |
| CTSC Lysosome Apoptosis 2.1895248910318337 | |
| CTSC Lysosome Lysosome 2.1895248910318337 | |
| CTSD Extracellular space Apoptosis 1.1735466087037734 | |
| CTSD Extracellular space Autophagy - animal 1.1735466087037734 | |
| CTSD Extracellular space Diabetic cardiomyopathy 1.1735466087037734 | |
| CTSD Extracellular space Estrogen signaling pathway 1.1735466087037734 | |
| CTSD Extracellular space Lysosome 1.1735466087037734 | |
| CTSD Extracellular space Sphingolipid signaling pathway 1.1735466087037734 | |
| CTSD Extracellular space Tuberculosis 1.1735466087037734 | |
| CTSD Lysosome Apoptosis 1.1735466087037734 | |
| CTSD Lysosome Autophagy - animal 1.1735466087037734 | |
| CTSD Lysosome Diabetic cardiomyopathy 1.1735466087037734 | |
| CTSD Lysosome Estrogen signaling pathway 1.1735466087037734 | |
| CTSD Lysosome Lysosome 1.1735466087037734 | |
| CTSD Lysosome Sphingolipid signaling pathway 1.1735466087037734 | |
| CTSD Lysosome Tuberculosis 1.1735466087037734 | |
| CTSF Cytosol Apoptosis 0.5283417281942503 | |
| CTSF Cytosol Lysosome 0.5283417281942503 | |
| CTSF Lysosome Apoptosis 0.5283417281942503 | |
| CTSF Lysosome Lysosome 0.5283417281942503 | |
| CTSF Plasma membrane Apoptosis 0.5283417281942503 | |
| CTSF Plasma membrane Lysosome 0.5283417281942503 | |
| CTSG Plasma membrane Amoebiasis 1.1211373782058194 | |
| CTSG Plasma membrane Lysosome 1.1211373782058194 | |
| CTSG Plasma membrane Neuroactive ligand-receptor interaction 1.1211373782058194 | |
| CTSG Plasma membrane Neutrophil extracellular trap formation 1.1211373782058194 | |
| CTSG Plasma membrane Renin-angiotensin system 1.1211373782058194 | |
| CTSG Plasma membrane Systemic lupus erythematosus 1.1211373782058194 | |
| CTSH Cytosol Apoptosis 0.9360030749570132 | |
| CTSH Cytosol Lysosome 0.9360030749570132 | |
| CTSH Extracellular space Apoptosis 0.9360030749570132 | |
| CTSH Extracellular space Lysosome 0.9360030749570132 | |
| CTSH Lysosome Apoptosis 0.9360030749570132 | |
| CTSH Lysosome Lysosome 0.9360030749570132 | |
| CTSK Cytosol Apoptosis 1.5352228109464563 | |
| CTSK Cytosol Lysosome 1.5352228109464563 | |
| CTSK Cytosol Osteoclast differentiation 1.5352228109464563 | |
| CTSK Cytosol Rheumatoid arthritis 1.5352228109464563 | |
| CTSK Cytosol Toll-like receptor signaling pathway 1.5352228109464563 | |
| CTSK Lysosome Apoptosis 1.5352228109464563 | |
| CTSK Lysosome Lysosome 1.5352228109464563 | |
| CTSK Lysosome Osteoclast differentiation 1.5352228109464563 | |
| CTSK Lysosome Rheumatoid arthritis 1.5352228109464563 | |
| CTSK Lysosome Toll-like receptor signaling pathway 1.5352228109464563 | |
| CTSL Cytosol Antigen processing and presentation 1.8820426173491729 | |
| CTSL Cytosol Apoptosis 1.8820426173491729 | |
| CTSL Cytosol Autophagy - animal 1.8820426173491729 | |
| CTSL Cytosol Fluid shear stress and atherosclerosis 1.8820426173491729 | |
| CTSL Cytosol Lysosome 1.8820426173491729 | |
| CTSL Cytosol Phagosome 1.8820426173491729 | |
| CTSL Cytosol Proteoglycans in cancer 1.8820426173491729 | |
| CTSL Cytosol Rheumatoid arthritis 1.8820426173491729 | |
| CTSL Extracellular space Antigen processing and presentation 1.8820426173491729 | |
| CTSL Extracellular space Apoptosis 1.8820426173491729 | |
| CTSL Extracellular space Autophagy - animal 1.8820426173491729 | |
| CTSL Extracellular space Fluid shear stress and atherosclerosis 1.8820426173491729 | |
| CTSL Extracellular space Lysosome 1.8820426173491729 | |
| CTSL Extracellular space Phagosome 1.8820426173491729 | |
| CTSL Extracellular space Proteoglycans in cancer 1.8820426173491729 | |
| CTSL Extracellular space Rheumatoid arthritis 1.8820426173491729 | |
| CTSL Golgi apparatus Antigen processing and presentation 1.8820426173491729 | |
| CTSL Golgi apparatus Apoptosis 1.8820426173491729 | |
| CTSL Golgi apparatus Autophagy - animal 1.8820426173491729 | |
| CTSL Golgi apparatus Fluid shear stress and atherosclerosis 1.8820426173491729 | |
| CTSL Golgi apparatus Lysosome 1.8820426173491729 | |
| CTSL Golgi apparatus Phagosome 1.8820426173491729 | |
| CTSL Golgi apparatus Proteoglycans in cancer 1.8820426173491729 | |
| CTSL Golgi apparatus Rheumatoid arthritis 1.8820426173491729 | |
| CTSL Lysosome Antigen processing and presentation 1.8820426173491729 | |
| CTSL Lysosome Apoptosis 1.8820426173491729 | |
| CTSL Lysosome Autophagy - animal 1.8820426173491729 | |
| CTSL Lysosome Fluid shear stress and atherosclerosis 1.8820426173491729 | |
| CTSL Lysosome Lysosome 1.8820426173491729 | |
| CTSL Lysosome Phagosome 1.8820426173491729 | |
| CTSL Lysosome Proteoglycans in cancer 1.8820426173491729 | |
| CTSL Lysosome Rheumatoid arthritis 1.8820426173491729 | |
| CTSO Lysosome Summary 0.7666730425485062 | |
| CTSS Cytosol Antigen processing and presentation 2.243646236119543 | |
| CTSS Cytosol Apoptosis 2.243646236119543 | |
| CTSS Cytosol Lysosome 2.243646236119543 | |
| CTSS Cytosol Phagosome 2.243646236119543 | |
| CTSS Cytosol Tuberculosis 2.243646236119543 | |
| CTSS Extracellular space Antigen processing and presentation 2.243646236119543 | |
| CTSS Extracellular space Apoptosis 2.243646236119543 | |
| CTSS Extracellular space Lysosome 2.243646236119543 | |
| CTSS Extracellular space Phagosome 2.243646236119543 | |
| CTSS Extracellular space Tuberculosis 2.243646236119543 | |
| CTSS Lysosome Antigen processing and presentation 2.243646236119543 | |
| CTSS Lysosome Apoptosis 2.243646236119543 | |
| CTSS Lysosome Lysosome 2.243646236119543 | |
| CTSS Lysosome Phagosome 2.243646236119543 | |
| CTSS Lysosome Tuberculosis 2.243646236119543 | |
| CTSV Cytosol Summary 1.9779828742684158 | |
| CTSV Lysosome Summary 1.9779828742684158 | |
| CTSV Nucleus Summary 1.9779828742684158 | |
| CTSV Plasma membrane Summary 1.9779828742684158 | |
| CTSW Endoplasmic Reticulum Summary 1.7980229546134567 | |
| CTSZ Cytosol Apoptosis 1.6546048588521811 | |
| CTSZ Cytosol Lysosome 1.6546048588521811 | |
| CTSZ Lysosome Apoptosis 1.6546048588521811 | |
| CTSZ Lysosome Lysosome 1.6546048588521811 | |
| CTTN Cytoskeleton Bacterial invasion of epithelial cells 0.9070085500470626 | |
| CTTN Cytoskeleton Pathogenic Escherichia coli infection 0.9070085500470626 | |
| CTTN Cytoskeleton Proteoglycans in cancer 0.9070085500470626 | |
| CTTN Cytoskeleton Shigellosis 0.9070085500470626 | |
| CTTN Cytoskeleton Tight junction 0.9070085500470626 | |
| CTTN Cytosol Bacterial invasion of epithelial cells 0.9070085500470626 | |
| CTTN Cytosol Pathogenic Escherichia coli infection 0.9070085500470626 | |
| CTTN Cytosol Proteoglycans in cancer 0.9070085500470626 | |
| CTTN Cytosol Shigellosis 0.9070085500470626 | |
| CTTN Cytosol Tight junction 0.9070085500470626 | |
| CTTN Golgi apparatus Bacterial invasion of epithelial cells 0.9070085500470626 | |
| CTTN Golgi apparatus Pathogenic Escherichia coli infection 0.9070085500470626 | |
| CTTN Golgi apparatus Proteoglycans in cancer 0.9070085500470626 | |
| CTTN Golgi apparatus Shigellosis 0.9070085500470626 | |
| CTTN Golgi apparatus Tight junction 0.9070085500470626 | |
| CTTN Plasma membrane Bacterial invasion of epithelial cells 0.9070085500470626 | |
| CTTN Plasma membrane Pathogenic Escherichia coli infection 0.9070085500470626 | |
| CTTN Plasma membrane Proteoglycans in cancer 0.9070085500470626 | |
| CTTN Plasma membrane Shigellosis 0.9070085500470626 | |
| CTTN Plasma membrane Tight junction 0.9070085500470626 | |
| CTTNBP2 Cytoskeleton Summary 0.4204340023292233 | |
| CTTNBP2 Cytosol Summary 0.4204340023292233 | |
| CTTNBP2NL Cytosol Summary 1.8060074210964847 | |
| CTTNBP2NL Nucleus Summary 1.8060074210964847 | |
| CTU1 Cytosol Summary 1.289873142090057 | |
| CTU2 Cytosol Summary 1.6947133981986064 | |
| CTU2 Mitochondrion Summary 1.6947133981986064 | |
| CUEDC1 Cytoskeleton Summary 0.5124289874367371 | |
| CUEDC1 Cytosol Summary 0.5124289874367371 | |
| CUEDC1 Mitochondrion Summary 0.5124289874367371 | |
| CUEDC1 Plasma membrane Summary 0.5124289874367371 | |
| CUEDC2 Cytosol Summary 1.6481465053459932 | |
| CUEDC2 Nucleus Summary 1.6481465053459932 | |
| CUL1 Nucleus Summary 1.7615453646554142 | |
| CUL2 Nucleus Summary 1.7315667508178232 | |
| CUL4A Nucleus Summary 1.3062034723574525 | |
| CUL5 Cytosol Summary 0.9098539311829588 | |
| CUL5 Golgi apparatus Summary 0.9098539311829588 | |
| CUL7 Nucleus Ubiquitin mediated proteolysis 1.3464503910223018 | |
| CUL9 Cytosol Summary 0.8845279911050825 | |
| CUTA Plasma membrane Summary 1.8667530300440487 | |
| CUTC Cytosol Summary 1.4836131019645316 | |
| CUTC Nucleus Summary 1.4836131019645316 | |
| CUX1 Cytosol Summary 1.1171487390883172 | |
| CUX1 Golgi apparatus Summary 1.1171487390883172 | |
| CUX1 Nucleus Summary 1.1171487390883172 | |
| CWC15 Mitochondrion Summary 1.668415252536461 | |
| CWC15 Nucleus Summary 1.668415252536461 | |
| CWC22 Cytosol Summary 1.7604928693273698 | |
| CWC22 Nucleus Summary 1.7604928693273698 | |
| CWC25 Nucleus Summary 0.9326622744913814 | |
| CWC27 Nucleus Summary 1.7400553286612297 | |
| CWF19L1 Golgi apparatus Summary 1.40537254956964 | |
| CWF19L1 Nucleus Summary 1.40537254956964 | |
| CWF19L2 Cytosol Summary 2.2336077033921806 | |
| CWF19L2 Nucleus Summary 2.2336077033921806 | |
| CXADR Extracellular space Viral myocarditis 2.4269229135806336 | |
| CXADR Plasma membrane Viral myocarditis 2.4269229135806336 | |
| CXCL10 Extracellular space Chemokine signaling pathway 1.7285015037655214 | |
| CXCL10 Extracellular space Coronavirus disease - COVID-19 1.7285015037655214 | |
| CXCL10 Extracellular space Cytokine-cytokine receptor interaction 1.7285015037655214 | |
| CXCL10 Extracellular space Cytosolic DNA-sensing pathway 1.7285015037655214 | |
| CXCL10 Extracellular space Epstein-Barr virus infection 1.7285015037655214 | |
| CXCL10 Extracellular space Hepatitis C 1.7285015037655214 | |
| CXCL10 Extracellular space IL-17 signaling pathway 1.7285015037655214 | |
| CXCL10 Extracellular space Influenza A 1.7285015037655214 | |
| CXCL10 Extracellular space RIG-I-like receptor signaling pathway 1.7285015037655214 | |
| CXCL10 Extracellular space TNF signaling pathway 1.7285015037655214 | |
| CXCL10 Extracellular space Toll-like receptor signaling pathway 1.7285015037655214 | |
| CXCL10 Extracellular space Viral protein interaction with cytokine and cytokine receptor 1.7285015037655214 | |
| CXCL12 Extracellular space Axon guidance 2.2004065863237416 | |
| CXCL12 Extracellular space Chemokine signaling pathway 2.2004065863237416 | |
| CXCL12 Extracellular space Cytokine-cytokine receptor interaction 2.2004065863237416 | |
| CXCL12 Extracellular space Human cytomegalovirus infection 2.2004065863237416 | |
| CXCL12 Extracellular space Intestinal immune network for IgA production 2.2004065863237416 | |
| CXCL12 Extracellular space Leukocyte transendothelial migration 2.2004065863237416 | |
| CXCL12 Extracellular space NF-kappa B signaling pathway 2.2004065863237416 | |
| CXCL12 Extracellular space Pathways in cancer 2.2004065863237416 | |
| CXCL12 Extracellular space Regulation of actin cytoskeleton 2.2004065863237416 | |
| CXCL12 Extracellular space Rheumatoid arthritis 2.2004065863237416 | |
| CXCL12 Extracellular space Viral protein interaction with cytokine and cytokine receptor 2.2004065863237416 | |
| CXCL13 Extracellular space Chemokine signaling pathway 0.8327853284160285 | |
| CXCL13 Extracellular space Cytokine-cytokine receptor interaction 0.8327853284160285 | |
| CXCL13 Extracellular space Viral protein interaction with cytokine and cytokine receptor 0.8327853284160285 | |
| CXCL14 Extracellular space Chemokine signaling pathway 0.15016430433298653 | |
| CXCL14 Extracellular space Cytokine-cytokine receptor interaction 0.15016430433298653 | |
| CXCL14 Extracellular space Viral protein interaction with cytokine and cytokine receptor 0.15016430433298653 | |
| CXCL9 Extracellular space Chemokine signaling pathway 1.7781819072291505 | |
| CXCL9 Extracellular space Cytokine-cytokine receptor interaction 1.7781819072291505 | |
| CXCL9 Extracellular space Toll-like receptor signaling pathway 1.7781819072291505 | |
| CXCL9 Extracellular space Viral protein interaction with cytokine and cytokine receptor 1.7781819072291505 | |
| CXCL9 Plasma membrane Chemokine signaling pathway 1.7781819072291505 | |
| CXCL9 Plasma membrane Cytokine-cytokine receptor interaction 1.7781819072291505 | |
| CXCL9 Plasma membrane Toll-like receptor signaling pathway 1.7781819072291505 | |
| CXCL9 Plasma membrane Viral protein interaction with cytokine and cytokine receptor 1.7781819072291505 | |
| CXXC1 Nucleus Summary 1.132327208571894 | |
| CXXC5 Cytosol Summary 0.21863286782153868 | |
| CXXC5 Nucleus Summary 0.21863286782153868 | |
| CXorf23 Nucleus Summary 1.4761854627818818 | |
| CXorf38 Cytosol Summary 1.3057517347592775 | |
| CXorf56 Cytoskeleton Summary 1.9159771226485207 | |
| CXorf56 Nucleus Summary 1.9159771226485207 | |
| CXorf57 Cytoskeleton Summary 0.8613854473031509 | |
| CXorf57 Nucleus Summary 0.8613854473031509 | |
| CYB5A Cytosol Summary 0.16564689082018738 | |
| CYB5A Endoplasmic Reticulum Summary 0.16564689082018738 | |
| CYB5B Cytosol Summary 0.5198166670592148 | |
| CYB5B Endoplasmic Reticulum Summary 0.5198166670592148 | |
| CYB5B Mitochondrion Summary 0.5198166670592148 | |
| CYB5R1 Cytosol Summary 0.7328956647168428 | |
| CYB5R1 Mitochondrion Summary 0.7328956647168428 | |
| CYB5R1 Nucleus Summary 0.7328956647168428 | |
| CYB5R2 Golgi apparatus Summary 1.7603785439272237 | |
| CYB5R2 Nucleus Summary 1.7603785439272237 | |
| CYB5R3 Endoplasmic Reticulum Amino sugar and nucleotide sugar metabolism 1.1834523005126103 | |
| CYB5R3 Mitochondrion Amino sugar and nucleotide sugar metabolism 1.1834523005126103 | |
| CYB5R4 Endoplasmic Reticulum Amino sugar and nucleotide sugar metabolism 1.5712882120403089 | |
| CYBA Plasma membrane Summary 1.3533250127587586 | |
| CYBB Endoplasmic Reticulum Summary 1.6348152545885113 | |
| CYBRD1 Golgi apparatus Summary 0.06504027594482698 | |
| CYBRD1 Plasma membrane Summary 0.06504027594482698 | |
| CYC1 Cytosol Alzheimer disease 2.4562273677283395 | |
| CYC1 Cytosol Amyotrophic lateral sclerosis 2.4562273677283395 | |
| CYC1 Cytosol Cardiac muscle contraction 2.4562273677283395 | |
| CYC1 Cytosol Diabetic cardiomyopathy 2.4562273677283395 | |
| CYC1 Cytosol Huntington disease 2.4562273677283395 | |
| CYC1 Cytosol Metabolic pathways 2.4562273677283395 | |
| CYC1 Cytosol Non-alcoholic fatty liver disease 2.4562273677283395 | |
| CYC1 Cytosol Oxidative phosphorylation 2.4562273677283395 | |
| CYC1 Cytosol Parkinson disease 2.4562273677283395 | |
| CYC1 Cytosol Pathways of neurodegeneration - multiple diseases 2.4562273677283395 | |
| CYC1 Cytosol Prion disease 2.4562273677283395 | |
| CYC1 Cytosol Thermogenesis 2.4562273677283395 | |
| CYC1 Mitochondrion Alzheimer disease 2.4562273677283395 | |
| CYC1 Mitochondrion Amyotrophic lateral sclerosis 2.4562273677283395 | |
| CYC1 Mitochondrion Cardiac muscle contraction 2.4562273677283395 | |
| CYC1 Mitochondrion Diabetic cardiomyopathy 2.4562273677283395 | |
| CYC1 Mitochondrion Huntington disease 2.4562273677283395 | |
| CYC1 Mitochondrion Metabolic pathways 2.4562273677283395 | |
| CYC1 Mitochondrion Non-alcoholic fatty liver disease 2.4562273677283395 | |
| CYC1 Mitochondrion Oxidative phosphorylation 2.4562273677283395 | |
| CYC1 Mitochondrion Parkinson disease 2.4562273677283395 | |
| CYC1 Mitochondrion Pathways of neurodegeneration - multiple diseases 2.4562273677283395 | |
| CYC1 Mitochondrion Prion disease 2.4562273677283395 | |
| CYC1 Mitochondrion Thermogenesis 2.4562273677283395 | |
| CYC1 Nucleus Alzheimer disease 2.4562273677283395 | |
| CYC1 Nucleus Amyotrophic lateral sclerosis 2.4562273677283395 | |
| CYC1 Nucleus Cardiac muscle contraction 2.4562273677283395 | |
| CYC1 Nucleus Diabetic cardiomyopathy 2.4562273677283395 | |
| CYC1 Nucleus Huntington disease 2.4562273677283395 | |
| CYC1 Nucleus Metabolic pathways 2.4562273677283395 | |
| CYC1 Nucleus Non-alcoholic fatty liver disease 2.4562273677283395 | |
| CYC1 Nucleus Oxidative phosphorylation 2.4562273677283395 | |
| CYC1 Nucleus Parkinson disease 2.4562273677283395 | |
| CYC1 Nucleus Pathways of neurodegeneration - multiple diseases 2.4562273677283395 | |
| CYC1 Nucleus Prion disease 2.4562273677283395 | |
| CYC1 Nucleus Thermogenesis 2.4562273677283395 | |
| CYCS Mitochondrion Alzheimer disease 2.0873919263609837 | |
| CYCS Mitochondrion Amyotrophic lateral sclerosis 2.0873919263609837 | |
| CYCS Mitochondrion Apoptosis 2.0873919263609837 | |
| CYCS Mitochondrion Apoptosis - multiple species 2.0873919263609837 | |
| CYCS Mitochondrion Colorectal cancer 2.0873919263609837 | |
| CYCS Mitochondrion Epstein-Barr virus infection 2.0873919263609837 | |
| CYCS Mitochondrion Hepatitis B 2.0873919263609837 | |
| CYCS Mitochondrion Hepatitis C 2.0873919263609837 | |
| CYCS Mitochondrion Herpes simplex virus 1 infection 2.0873919263609837 | |
| CYCS Mitochondrion Human cytomegalovirus infection 2.0873919263609837 | |
| CYCS Mitochondrion Human immunodeficiency virus 1 infection 2.0873919263609837 | |
| CYCS Mitochondrion Huntington disease 2.0873919263609837 | |
| CYCS Mitochondrion Influenza A 2.0873919263609837 | |
| CYCS Mitochondrion Kaposi sarcoma-associated herpesvirus infection 2.0873919263609837 | |
| CYCS Mitochondrion Legionellosis 2.0873919263609837 | |
| CYCS Mitochondrion Lipid and atherosclerosis 2.0873919263609837 | |
| CYCS Mitochondrion Measles 2.0873919263609837 | |
| CYCS Mitochondrion Non-alcoholic fatty liver disease 2.0873919263609837 | |
| CYCS Mitochondrion Oxidative phosphorylation 2.0873919263609837 | |
| CYCS Mitochondrion Parkinson disease 2.0873919263609837 | |
| CYCS Mitochondrion Pathogenic Escherichia coli infection 2.0873919263609837 | |
| CYCS Mitochondrion Pathways in cancer 2.0873919263609837 | |
| CYCS Mitochondrion Pathways of neurodegeneration - multiple diseases 2.0873919263609837 | |
| CYCS Mitochondrion Platinum drug resistance 2.0873919263609837 | |
| CYCS Mitochondrion Prion disease 2.0873919263609837 | |
| CYCS Mitochondrion Salmonella infection 2.0873919263609837 | |
| CYCS Mitochondrion Shigellosis 2.0873919263609837 | |
| CYCS Mitochondrion Small cell lung cancer 2.0873919263609837 | |
| CYCS Mitochondrion Spinocerebellar ataxia 2.0873919263609837 | |
| CYCS Mitochondrion Toxoplasmosis 2.0873919263609837 | |
| CYCS Mitochondrion Tuberculosis 2.0873919263609837 | |
| CYCS Mitochondrion Viral myocarditis 2.0873919263609837 | |
| CYCS Mitochondrion p53 signaling pathway 2.0873919263609837 | |
| CYFIP1 Cytosol Summary 1.5820749937737657 | |
| CYFIP2 Cytosol Summary 0.7650969468466948 | |
| CYFIP2 Endoplasmic Reticulum Summary 0.7650969468466948 | |
| CYFIP2 Plasma membrane Summary 0.7650969468466948 | |
| CYGB Cytosol Summary 1.5140954934356394 | |
| CYGB Nucleus Summary 1.5140954934356394 | |
| CYHR1 Cytosol Summary 2.3916406944146726 | |
| CYHR1 Nucleus Summary 2.3916406944146726 | |
| CYLD Cytoskeleton C-type lectin receptor signaling pathway 1.097675981143984 | |
| CYLD Cytoskeleton NF-kappa B signaling pathway 1.097675981143984 | |
| CYLD Cytoskeleton Necroptosis 1.097675981143984 | |
| CYLD Cytoskeleton Osteoclast differentiation 1.097675981143984 | |
| CYLD Cytoskeleton RIG-I-like receptor signaling pathway 1.097675981143984 | |
| CYLD Cytosol C-type lectin receptor signaling pathway 1.097675981143984 | |
| CYLD Cytosol NF-kappa B signaling pathway 1.097675981143984 | |
| CYLD Cytosol Necroptosis 1.097675981143984 | |
| CYLD Cytosol Osteoclast differentiation 1.097675981143984 | |
| CYLD Cytosol RIG-I-like receptor signaling pathway 1.097675981143984 | |
| CYLD Nucleus C-type lectin receptor signaling pathway 1.097675981143984 | |
| CYLD Nucleus NF-kappa B signaling pathway 1.097675981143984 | |
| CYLD Nucleus Necroptosis 1.097675981143984 | |
| CYLD Nucleus Osteoclast differentiation 1.097675981143984 | |
| CYLD Nucleus RIG-I-like receptor signaling pathway 1.097675981143984 | |
| CYLD Plasma membrane C-type lectin receptor signaling pathway 1.097675981143984 | |
| CYLD Plasma membrane NF-kappa B signaling pathway 1.097675981143984 | |
| CYLD Plasma membrane Necroptosis 1.097675981143984 | |
| CYLD Plasma membrane Osteoclast differentiation 1.097675981143984 | |
| CYLD Plasma membrane RIG-I-like receptor signaling pathway 1.097675981143984 | |
| CYP1B1 Endoplasmic Reticulum Summary 1.3743367706346006 | |
| CYP1B1 Mitochondrion Summary 1.3743367706346006 | |
| CYP20A1 Cytoskeleton Summary 0.6270049683013532 | |
| CYP20A1 Nucleus Summary 0.6270049683013532 | |
| CYP20A1 Plasma membrane Summary 0.6270049683013532 | |
| CYP27A1 Cytosol Cholesterol metabolism 2.482839969452208 | |
| CYP27A1 Cytosol Metabolic pathways 2.482839969452208 | |
| CYP27A1 Cytosol PPAR signaling pathway 2.482839969452208 | |
| CYP27A1 Cytosol Primary bile acid biosynthesis 2.482839969452208 | |
| CYP27A1 Mitochondrion Cholesterol metabolism 2.482839969452208 | |
| CYP27A1 Mitochondrion Metabolic pathways 2.482839969452208 | |
| CYP27A1 Mitochondrion PPAR signaling pathway 2.482839969452208 | |
| CYP27A1 Mitochondrion Primary bile acid biosynthesis 2.482839969452208 | |
| CYP2A6 Endoplasmic Reticulum Caffeine metabolism 0.038319619021000416 | |
| CYP2A6 Endoplasmic Reticulum Chemical carcinogenesis - DNA adducts 0.038319619021000416 | |
| CYP2A6 Endoplasmic Reticulum Drug metabolism - cytochrome P450 0.038319619021000416 | |
| CYP2A6 Endoplasmic Reticulum Drug metabolism - other enzymes 0.038319619021000416 | |
| CYP2A6 Endoplasmic Reticulum Lipid and atherosclerosis 0.038319619021000416 | |
| CYP2A6 Endoplasmic Reticulum Metabolic pathways 0.038319619021000416 | |
| CYP2A6 Endoplasmic Reticulum Metabolism of xenobiotics by cytochrome P450 0.038319619021000416 | |
| CYP2A6 Endoplasmic Reticulum Retinol metabolism 0.038319619021000416 | |
| CYP2J2 Endoplasmic Reticulum Arachidonic acid metabolism 0.4951821527862447 | |
| CYP2J2 Endoplasmic Reticulum Inflammatory mediator regulation of TRP channels 0.4951821527862447 | |
| CYP2J2 Endoplasmic Reticulum Linoleic acid metabolism 0.4951821527862447 | |
| CYP2J2 Endoplasmic Reticulum Lipid and atherosclerosis 0.4951821527862447 | |
| CYP2J2 Endoplasmic Reticulum Metabolic pathways 0.4951821527862447 | |
| CYP2J2 Endoplasmic Reticulum Ovarian steroidogenesis 0.4951821527862447 | |
| CYP2J2 Endoplasmic Reticulum Serotonergic synapse 0.4951821527862447 | |
| CYP2S1 Endoplasmic Reticulum Metabolic pathways 1.2846015124206092 | |
| CYP2S1 Endoplasmic Reticulum Metabolism of xenobiotics by cytochrome P450 1.2846015124206092 | |
| CYP2S1 Endoplasmic Reticulum Retinol metabolism 1.2846015124206092 | |
| CYP4X1 Endoplasmic Reticulum Serotonergic synapse 0.23979394700837 | |
| CYP4Z1 Endoplasmic Reticulum Summary 0.3689946900994424 | |
| CYP51A1 Endoplasmic Reticulum Summary 1.2402216984620251 | |
| CYP7B1 Endoplasmic Reticulum Primary bile acid biosynthesis 1.867178921837085 | |
| CYP7B1 Endoplasmic Reticulum Steroid hormone biosynthesis 1.867178921837085 | |
| CYR61 Extracellular space Summary 1.4270110606048083 | |
| CYTH1 Nucleus Endocytosis 1.1429494711237649 | |
| CYTH1 Nucleus Pathogenic Escherichia coli infection 1.1429494711237649 | |
| CYTH1 Nucleus Phospholipase D signaling pathway 1.1429494711237649 | |
| CYTH1 Nucleus Salmonella infection 1.1429494711237649 | |
| CYTH1 Nucleus Shigellosis 1.1429494711237649 | |
| CYTH1 Plasma membrane Endocytosis 1.1429494711237649 | |
| CYTH1 Plasma membrane Pathogenic Escherichia coli infection 1.1429494711237649 | |
| CYTH1 Plasma membrane Phospholipase D signaling pathway 1.1429494711237649 | |
| CYTH1 Plasma membrane Salmonella infection 1.1429494711237649 | |
| CYTH1 Plasma membrane Shigellosis 1.1429494711237649 | |
| CYTH2 Cytosol Endocytosis 1.0381918293832135 | |
| CYTH2 Cytosol Pathogenic Escherichia coli infection 1.0381918293832135 | |
| CYTH2 Cytosol Phospholipase D signaling pathway 1.0381918293832135 | |
| CYTH2 Cytosol Salmonella infection 1.0381918293832135 | |
| CYTH2 Cytosol Shigellosis 1.0381918293832135 | |
| CYTH2 Golgi apparatus Endocytosis 1.0381918293832135 | |
| CYTH2 Golgi apparatus Pathogenic Escherichia coli infection 1.0381918293832135 | |
| CYTH2 Golgi apparatus Phospholipase D signaling pathway 1.0381918293832135 | |
| CYTH2 Golgi apparatus Salmonella infection 1.0381918293832135 | |
| CYTH2 Golgi apparatus Shigellosis 1.0381918293832135 | |
| CYTH2 Plasma membrane Endocytosis 1.0381918293832135 | |
| CYTH2 Plasma membrane Pathogenic Escherichia coli infection 1.0381918293832135 | |
| CYTH2 Plasma membrane Phospholipase D signaling pathway 1.0381918293832135 | |
| CYTH2 Plasma membrane Salmonella infection 1.0381918293832135 | |
| CYTH2 Plasma membrane Shigellosis 1.0381918293832135 | |
| CYTH3 Cytosol Endocytosis 1.118027992477047 | |
| CYTH3 Cytosol Pathogenic Escherichia coli infection 1.118027992477047 | |
| CYTH3 Cytosol Phospholipase D signaling pathway 1.118027992477047 | |
| CYTH3 Cytosol Salmonella infection 1.118027992477047 | |
| CYTH3 Cytosol Shigellosis 1.118027992477047 | |
| CYTH3 Nucleus Endocytosis 1.118027992477047 | |
| CYTH3 Nucleus Pathogenic Escherichia coli infection 1.118027992477047 | |
| CYTH3 Nucleus Phospholipase D signaling pathway 1.118027992477047 | |
| CYTH3 Nucleus Salmonella infection 1.118027992477047 | |
| CYTH3 Nucleus Shigellosis 1.118027992477047 | |
| CYTH3 Plasma membrane Endocytosis 1.118027992477047 | |
| CYTH3 Plasma membrane Pathogenic Escherichia coli infection 1.118027992477047 | |
| CYTH3 Plasma membrane Phospholipase D signaling pathway 1.118027992477047 | |
| CYTH3 Plasma membrane Salmonella infection 1.118027992477047 | |
| CYTH3 Plasma membrane Shigellosis 1.118027992477047 | |
| CYTH4 Cytosol Endocytosis 1.6811383761824878 | |
| CYTH4 Cytosol Pathogenic Escherichia coli infection 1.6811383761824878 | |
| CYTH4 Cytosol Phospholipase D signaling pathway 1.6811383761824878 | |
| CYTH4 Cytosol Salmonella infection 1.6811383761824878 | |
| CYTH4 Cytosol Shigellosis 1.6811383761824878 | |
| CYTH4 Plasma membrane Endocytosis 1.6811383761824878 | |
| CYTH4 Plasma membrane Pathogenic Escherichia coli infection 1.6811383761824878 | |
| CYTH4 Plasma membrane Phospholipase D signaling pathway 1.6811383761824878 | |
| CYTH4 Plasma membrane Salmonella infection 1.6811383761824878 | |
| CYTH4 Plasma membrane Shigellosis 1.6811383761824878 | |
| CYTIP Cytosol Summary 1.8356514610000252 | |
| CYTIP Endosome Summary 1.8356514610000252 | |
| CYTIP Nucleus Summary 1.8356514610000252 | |
| D2HGDH Mitochondrion Summary 1.4705282646953806 | |
| DAAM1 Cytosol Summary 0.7025738225095913 | |
| DAAM1 Plasma membrane Summary 0.7025738225095913 | |
| DAAM2 Cytosol Summary 2.242557004009836 | |
| DAAM2 Nucleus Summary 2.242557004009836 | |
| DAB2 Cytosol Summary 2.020771103566153 | |
| DAB2 Mitochondrion Summary 2.020771103566153 | |
| DAB2 Nucleus Summary 2.020771103566153 | |
| DAB2 Plasma membrane Summary 2.020771103566153 | |
| DACH1 Cytosol Summary 0.11782796701585126 | |
| DACH1 Golgi apparatus Summary 0.11782796701585126 | |
| DACH1 Nucleus Summary 0.11782796701585126 | |
| DAD1 Cytosol Summary 1.3839293894504754 | |
| DAD1 Endoplasmic Reticulum Summary 1.3839293894504754 | |
| DAG1 Cytoskeleton Arrhythmogenic right ventricular cardiomyopathy 1.4137667944110854 | |
| DAG1 Cytoskeleton Dilated cardiomyopathy 1.4137667944110854 | |
| DAG1 Cytoskeleton ECM-receptor interaction 1.4137667944110854 | |
| DAG1 Cytoskeleton Hypertrophic cardiomyopathy 1.4137667944110854 | |
| DAG1 Cytoskeleton Viral myocarditis 1.4137667944110854 | |
| DAG1 Cytosol Arrhythmogenic right ventricular cardiomyopathy 1.4137667944110854 | |
| DAG1 Cytosol Dilated cardiomyopathy 1.4137667944110854 | |
| DAG1 Cytosol ECM-receptor interaction 1.4137667944110854 | |
| DAG1 Cytosol Hypertrophic cardiomyopathy 1.4137667944110854 | |
| DAG1 Cytosol Viral myocarditis 1.4137667944110854 | |
| DAG1 Extracellular space Arrhythmogenic right ventricular cardiomyopathy 1.4137667944110854 | |
| DAG1 Extracellular space Dilated cardiomyopathy 1.4137667944110854 | |
| DAG1 Extracellular space ECM-receptor interaction 1.4137667944110854 | |
| DAG1 Extracellular space Hypertrophic cardiomyopathy 1.4137667944110854 | |
| DAG1 Extracellular space Viral myocarditis 1.4137667944110854 | |
| DAG1 Nucleus Arrhythmogenic right ventricular cardiomyopathy 1.4137667944110854 | |
| DAG1 Nucleus Dilated cardiomyopathy 1.4137667944110854 | |
| DAG1 Nucleus ECM-receptor interaction 1.4137667944110854 | |
| DAG1 Nucleus Hypertrophic cardiomyopathy 1.4137667944110854 | |
| DAG1 Nucleus Viral myocarditis 1.4137667944110854 | |
| DAG1 Plasma membrane Arrhythmogenic right ventricular cardiomyopathy 1.4137667944110854 | |
| DAG1 Plasma membrane Dilated cardiomyopathy 1.4137667944110854 | |
| DAG1 Plasma membrane ECM-receptor interaction 1.4137667944110854 | |
| DAG1 Plasma membrane Hypertrophic cardiomyopathy 1.4137667944110854 | |
| DAG1 Plasma membrane Viral myocarditis 1.4137667944110854 | |
| DAGLB Nucleus Aldosterone synthesis and secretion 1.1170285914947249 | |
| DAGLB Nucleus Retrograde endocannabinoid signaling 1.1170285914947249 | |
| DAGLB Plasma membrane Aldosterone synthesis and secretion 1.1170285914947249 | |
| DAGLB Plasma membrane Retrograde endocannabinoid signaling 1.1170285914947249 | |
| DALRD3 Cytosol Summary 0.6469644300972753 | |
| DALRD3 Nucleus Summary 0.6469644300972753 | |
| DAP Cytosol Summary 1.0716047158941682 | |
| DAP Mitochondrion Summary 1.0716047158941682 | |
| DAP Nucleus Summary 1.0716047158941682 | |
| DAP3 Mitochondrion Summary 1.7962319056816078 | |
| DAP3 Nucleus Summary 1.7962319056816078 | |
| DAPK1 Cytoskeleton Autophagy - animal 1.7122020855457343 | |
| DAPK1 Cytoskeleton Bladder cancer 1.7122020855457343 | |
| DAPK1 Cytoskeleton Pathways in cancer 1.7122020855457343 | |
| DAPK1 Cytosol Autophagy - animal 1.7122020855457343 | |
| DAPK1 Cytosol Bladder cancer 1.7122020855457343 | |
| DAPK1 Cytosol Pathways in cancer 1.7122020855457343 | |
| DAPK2 Cytosol Summary 2.2387454043685646 | |
| DAPK2 Golgi apparatus Summary 2.2387454043685646 | |
| DAPK3 Cytoskeleton Autophagy - animal 2.3422937073080936 | |
| DAPK3 Cytoskeleton Bladder cancer 2.3422937073080936 | |
| DAPK3 Cytoskeleton Pathways in cancer 2.3422937073080936 | |
| DAPK3 Nucleus Autophagy - animal 2.3422937073080936 | |
| DAPK3 Nucleus Bladder cancer 2.3422937073080936 | |
| DAPK3 Nucleus Pathways in cancer 2.3422937073080936 | |
| DAPP1 Cytosol B cell receptor signaling pathway 1.8793680887121773 | |
| DAPP1 Plasma membrane B cell receptor signaling pathway 1.8793680887121773 | |
| DARS Cytosol Summary 1.3845158501906183 | |
| DARS2 Mitochondrion Summary 1.8616086296127927 | |
| DARS2 Nucleus Summary 1.8616086296127927 | |
| DAXX Cytosol Amyotrophic lateral sclerosis 1.87878332817004 | |
| DAXX Cytosol Apoptosis 1.87878332817004 | |
| DAXX Cytosol Herpes simplex virus 1 infection 1.87878332817004 | |
| DAXX Cytosol MAPK signaling pathway 1.87878332817004 | |
| DAXX Cytosol Parkinson disease 1.87878332817004 | |
| DAXX Cytosol Pathways of neurodegeneration - multiple diseases 1.87878332817004 | |
| DAXX Nucleus Amyotrophic lateral sclerosis 1.87878332817004 | |
| DAXX Nucleus Apoptosis 1.87878332817004 | |
| DAXX Nucleus Herpes simplex virus 1 infection 1.87878332817004 | |
| DAXX Nucleus MAPK signaling pathway 1.87878332817004 | |
| DAXX Nucleus Parkinson disease 1.87878332817004 | |
| DAXX Nucleus Pathways of neurodegeneration - multiple diseases 1.87878332817004 | |
| DAZAP1 Cytosol mRNA surveillance pathway 1.8566159802139972 | |
| DAZAP1 Nucleus mRNA surveillance pathway 1.8566159802139972 | |
| DAZAP2 Cytosol Summary 1.2789665995538362 | |
| DAZAP2 Nucleus Summary 1.2789665995538362 | |
| DBI Endoplasmic Reticulum Summary 1.0074984972778136 | |
| DBN1 Cytoskeleton Summary 2.1973569797377155 | |
| DBN1 Cytosol Summary 2.1973569797377155 | |
| DBN1 Plasma membrane Summary 2.1973569797377155 | |
| DBNDD1 Cytosol Summary 1.1175982710094343 | |
| DBNDD1 Nucleus Summary 1.1175982710094343 | |
| DBNL Cytosol Summary 1.3123211526928216 | |
| DBNL Nucleus Summary 1.3123211526928216 | |
| DBT Mitochondrion Metabolic pathways 1.7053619232424757 | |
| DBT Mitochondrion Propanoate metabolism 1.7053619232424757 | |
| DBT Mitochondrion Valine leucine and isoleucine degradation 1.7053619232424757 | |
| DCAF1 Nucleus Summary 0.721586513287513 | |
| DCAF10 Nucleus Summary 0.5263419635149803 | |
| DCAF11 Nucleus Summary 0.95676070585976 | |
| DCAF13 Cytoskeleton Summary 1.9322050722481847 | |
| DCAF13 Cytosol Summary 1.9322050722481847 | |
| DCAF13 Nucleus Summary 1.9322050722481847 | |
| DCAF13 Plasma membrane Summary 1.9322050722481847 | |
| DCAF15 Cytosol Summary 1.8242964471016128 | |
| DCAF15 Mitochondrion Summary 1.8242964471016128 | |
| DCAF16 Cytosol Summary 0.901031530373074 | |
| DCAF16 Nucleus Summary 0.901031530373074 | |
| DCAF16 Plasma membrane Summary 0.901031530373074 | |
| DCAF5 Mitochondrion Summary 0.5376711214512138 | |
| DCAF6 Nucleus Summary 1.203021691266081 | |
| DCAF7 Cytosol Summary 1.0929079036652 | |
| DCAF7 Nucleus Summary 1.0929079036652 | |
| DCAF8 Cytosol Summary 0.6677604693667639 | |
| DCAF8 Nucleus Summary 0.6677604693667639 | |
| DCAKD Nucleus Summary 0.7588856051221251 | |
| DCD Extracellular space Summary 0.11011199395469264 | |
| DCHS1 Plasma membrane Hippo signaling pathway - multiple species 1.4265464663489116 | |
| DCK Cytosol Metabolic pathways 1.5331642412597069 | |
| DCK Cytosol Purine metabolism 1.5331642412597069 | |
| DCK Cytosol Pyrimidine metabolism 1.5331642412597069 | |
| DCK Nucleus Metabolic pathways 1.5331642412597069 | |
| DCK Nucleus Purine metabolism 1.5331642412597069 | |
| DCK Nucleus Pyrimidine metabolism 1.5331642412597069 | |
| DCLK1 Cytosol Summary 0.9141519931779184 | |
| DCLK1 Nucleus Summary 0.9141519931779184 | |
| DCLK2 Cytoskeleton Summary 1.7456559148673925 | |
| DCLK2 Cytosol Summary 1.7456559148673925 | |
| DCLK3 Cytosol Summary 1.6559309947026897 | |
| DCLRE1C Golgi apparatus Non-homologous end-joining 1.9214094432521092 | |
| DCLRE1C Golgi apparatus Primary immunodeficiency 1.9214094432521092 | |
| DCLRE1C Nucleus Non-homologous end-joining 1.9214094432521092 | |
| DCLRE1C Nucleus Primary immunodeficiency 1.9214094432521092 | |
| DCN Extracellular space Proteoglycans in cancer 0.4382138231550327 | |
| DCN Extracellular space TGF-beta signaling pathway 0.4382138231550327 | |
| DCP1A Cytosol Summary 1.4099783666596992 | |
| DCP1B Cytosol Summary 1.7981230088715046 | |
| DCP2 Cytosol RNA degradation 1.6832073171658268 | |
| DCP2 Nucleus RNA degradation 1.6832073171658268 | |
| DCP2 Plasma membrane RNA degradation 1.6832073171658268 | |
| DCPS Cytosol RNA degradation 1.5991071567158637 | |
| DCPS Nucleus RNA degradation 1.5991071567158637 | |
| DCTD Cytosol Summary 1.4866937881589957 | |
| DCTD Nucleus Summary 1.4866937881589957 | |
| DCTN2 Cytoskeleton Amyotrophic lateral sclerosis 1.3042605716723892 | |
| DCTN2 Cytoskeleton Huntington disease 1.3042605716723892 | |
| DCTN2 Cytoskeleton Pathways of neurodegeneration - multiple diseases 1.3042605716723892 | |
| DCTN2 Cytoskeleton Salmonella infection 1.3042605716723892 | |
| DCTN2 Cytoskeleton Vasopressin-regulated water reabsorption 1.3042605716723892 | |
| DCTN2 Cytosol Amyotrophic lateral sclerosis 1.3042605716723892 | |
| DCTN2 Cytosol Huntington disease 1.3042605716723892 | |
| DCTN2 Cytosol Pathways of neurodegeneration - multiple diseases 1.3042605716723892 | |
| DCTN2 Cytosol Salmonella infection 1.3042605716723892 | |
| DCTN2 Cytosol Vasopressin-regulated water reabsorption 1.3042605716723892 | |
| DCTN3 Cytoskeleton Amyotrophic lateral sclerosis 1.038256250563662 | |
| DCTN3 Cytoskeleton Huntington disease 1.038256250563662 | |
| DCTN3 Cytoskeleton Pathways of neurodegeneration - multiple diseases 1.038256250563662 | |
| DCTN3 Cytoskeleton Salmonella infection 1.038256250563662 | |
| DCTN3 Cytosol Amyotrophic lateral sclerosis 1.038256250563662 | |
| DCTN3 Cytosol Huntington disease 1.038256250563662 | |
| DCTN3 Cytosol Pathways of neurodegeneration - multiple diseases 1.038256250563662 | |
| DCTN3 Cytosol Salmonella infection 1.038256250563662 | |
| DCTN3 Nucleus Amyotrophic lateral sclerosis 1.038256250563662 | |
| DCTN3 Nucleus Huntington disease 1.038256250563662 | |
| DCTN3 Nucleus Pathways of neurodegeneration - multiple diseases 1.038256250563662 | |
| DCTN3 Nucleus Salmonella infection 1.038256250563662 | |
| DCTN4 Cytoskeleton Amyotrophic lateral sclerosis 0.9603112410261908 | |
| DCTN4 Cytoskeleton Huntington disease 0.9603112410261908 | |
| DCTN4 Cytoskeleton Pathways of neurodegeneration - multiple diseases 0.9603112410261908 | |
| DCTN4 Cytoskeleton Salmonella infection 0.9603112410261908 | |
| DCTN4 Cytoskeleton Vasopressin-regulated water reabsorption 0.9603112410261908 | |
| DCTN4 Cytosol Amyotrophic lateral sclerosis 0.9603112410261908 | |
| DCTN4 Cytosol Huntington disease 0.9603112410261908 | |
| DCTN4 Cytosol Pathways of neurodegeneration - multiple diseases 0.9603112410261908 | |
| DCTN4 Cytosol Salmonella infection 0.9603112410261908 | |
| DCTN4 Cytosol Vasopressin-regulated water reabsorption 0.9603112410261908 | |
| DCTN4 Nucleus Amyotrophic lateral sclerosis 0.9603112410261908 | |
| DCTN4 Nucleus Huntington disease 0.9603112410261908 | |
| DCTN4 Nucleus Pathways of neurodegeneration - multiple diseases 0.9603112410261908 | |
| DCTN4 Nucleus Salmonella infection 0.9603112410261908 | |
| DCTN4 Nucleus Vasopressin-regulated water reabsorption 0.9603112410261908 | |
| DCTN5 Cytoskeleton Amyotrophic lateral sclerosis 1.0803597833267558 | |
| DCTN5 Cytoskeleton Huntington disease 1.0803597833267558 | |
| DCTN5 Cytoskeleton Pathways of neurodegeneration - multiple diseases 1.0803597833267558 | |
| DCTN5 Cytoskeleton Salmonella infection 1.0803597833267558 | |
| DCTN5 Cytoskeleton Vasopressin-regulated water reabsorption 1.0803597833267558 | |
| DCTN5 Cytosol Amyotrophic lateral sclerosis 1.0803597833267558 | |
| DCTN5 Cytosol Huntington disease 1.0803597833267558 | |
| DCTN5 Cytosol Pathways of neurodegeneration - multiple diseases 1.0803597833267558 | |
| DCTN5 Cytosol Salmonella infection 1.0803597833267558 | |
| DCTN5 Cytosol Vasopressin-regulated water reabsorption 1.0803597833267558 | |
| DCTN5 Nucleus Amyotrophic lateral sclerosis 1.0803597833267558 | |
| DCTN5 Nucleus Huntington disease 1.0803597833267558 | |
| DCTN5 Nucleus Pathways of neurodegeneration - multiple diseases 1.0803597833267558 | |
| DCTN5 Nucleus Salmonella infection 1.0803597833267558 | |
| DCTN5 Nucleus Vasopressin-regulated water reabsorption 1.0803597833267558 | |
| DCTN6 Cytoskeleton Amyotrophic lateral sclerosis 0.943341508623098 | |
| DCTN6 Cytoskeleton Huntington disease 0.943341508623098 | |
| DCTN6 Cytoskeleton Pathways of neurodegeneration - multiple diseases 0.943341508623098 | |
| DCTN6 Cytoskeleton Salmonella infection 0.943341508623098 | |
| DCTN6 Cytoskeleton Vasopressin-regulated water reabsorption 0.943341508623098 | |
| DCTN6 Cytosol Amyotrophic lateral sclerosis 0.943341508623098 | |
| DCTN6 Cytosol Huntington disease 0.943341508623098 | |
| DCTN6 Cytosol Pathways of neurodegeneration - multiple diseases 0.943341508623098 | |
| DCTN6 Cytosol Salmonella infection 0.943341508623098 | |
| DCTN6 Cytosol Vasopressin-regulated water reabsorption 0.943341508623098 | |
| DCTN6 Nucleus Amyotrophic lateral sclerosis 0.943341508623098 | |
| DCTN6 Nucleus Huntington disease 0.943341508623098 | |
| DCTN6 Nucleus Pathways of neurodegeneration - multiple diseases 0.943341508623098 | |
| DCTN6 Nucleus Salmonella infection 0.943341508623098 | |
| DCTN6 Nucleus Vasopressin-regulated water reabsorption 0.943341508623098 | |
| DCTN6 Plasma membrane Amyotrophic lateral sclerosis 0.943341508623098 | |
| DCTN6 Plasma membrane Huntington disease 0.943341508623098 | |
| DCTN6 Plasma membrane Pathways of neurodegeneration - multiple diseases 0.943341508623098 | |
| DCTN6 Plasma membrane Salmonella infection 0.943341508623098 | |
| DCTN6 Plasma membrane Vasopressin-regulated water reabsorption 0.943341508623098 | |
| DCTPP1 Cytosol Summary 0.5598587411381853 | |
| DCTPP1 Mitochondrion Summary 0.5598587411381853 | |
| DCTPP1 Nucleus Summary 0.5598587411381853 | |
| DCUN1D1 Cytosol Summary 1.4229691321876294 | |
| DCUN1D1 Nucleus Summary 1.4229691321876294 | |
| DCUN1D3 Cytosol Summary 0.9065498916394256 | |
| DCUN1D3 Nucleus Summary 0.9065498916394256 | |
| DCUN1D3 Plasma membrane Summary 0.9065498916394256 | |
| DCUN1D4 Cytosol Summary 1.3551140923051563 | |
| DCUN1D4 Nucleus Summary 1.3551140923051563 | |
| DCUN1D5 Nucleus Summary 2.2566475238048063 | |
| DCX Cytosol Summary 0.3494614350804345 | |
| DCXR Cytoskeleton Summary 0.35299041408645937 | |
| DCXR Nucleus Summary 0.35299041408645937 | |
| DDA1 Nucleus Summary 1.0231621599256406 | |
| DDAH1 Cytosol Summary 0.4644097233496242 | |
| DDAH1 Nucleus Summary 0.4644097233496242 | |
| DDAH1 Plasma membrane Summary 0.4644097233496242 | |
| DDAH2 Cytosol Summary 1.1312895979368487 | |
| DDAH2 Mitochondrion Summary 1.1312895979368487 | |
| DDB2 Nucleus Basal cell carcinoma 0.8344574767716725 | |
| DDB2 Nucleus Breast cancer 0.8344574767716725 | |
| DDB2 Nucleus Chronic myeloid leukemia 0.8344574767716725 | |
| DDB2 Nucleus Colorectal cancer 0.8344574767716725 | |
| DDB2 Nucleus Endometrial cancer 0.8344574767716725 | |
| DDB2 Nucleus Epstein-Barr virus infection 0.8344574767716725 | |
| DDB2 Nucleus Gastric cancer 0.8344574767716725 | |
| DDB2 Nucleus Glioma 0.8344574767716725 | |
| DDB2 Nucleus Hepatitis B 0.8344574767716725 | |
| DDB2 Nucleus Hepatocellular carcinoma 0.8344574767716725 | |
| DDB2 Nucleus Melanoma 0.8344574767716725 | |
| DDB2 Nucleus Non-small cell lung cancer 0.8344574767716725 | |
| DDB2 Nucleus Nucleotide excision repair 0.8344574767716725 | |
| DDB2 Nucleus Pancreatic cancer 0.8344574767716725 | |
| DDB2 Nucleus Pathways in cancer 0.8344574767716725 | |
| DDB2 Nucleus Small cell lung cancer 0.8344574767716725 | |
| DDB2 Nucleus Thyroid cancer 0.8344574767716725 | |
| DDB2 Nucleus Transcriptional misregulation in cancer 0.8344574767716725 | |
| DDB2 Nucleus Ubiquitin mediated proteolysis 0.8344574767716725 | |
| DDB2 Nucleus p53 signaling pathway 0.8344574767716725 | |
| DDB2 Plasma membrane Basal cell carcinoma 0.8344574767716725 | |
| DDB2 Plasma membrane Breast cancer 0.8344574767716725 | |
| DDB2 Plasma membrane Chronic myeloid leukemia 0.8344574767716725 | |
| DDB2 Plasma membrane Colorectal cancer 0.8344574767716725 | |
| DDB2 Plasma membrane Endometrial cancer 0.8344574767716725 | |
| DDB2 Plasma membrane Epstein-Barr virus infection 0.8344574767716725 | |
| DDB2 Plasma membrane Gastric cancer 0.8344574767716725 | |
| DDB2 Plasma membrane Glioma 0.8344574767716725 | |
| DDB2 Plasma membrane Hepatitis B 0.8344574767716725 | |
| DDB2 Plasma membrane Hepatocellular carcinoma 0.8344574767716725 | |
| DDB2 Plasma membrane Melanoma 0.8344574767716725 | |
| DDB2 Plasma membrane Non-small cell lung cancer 0.8344574767716725 | |
| DDB2 Plasma membrane Nucleotide excision repair 0.8344574767716725 | |
| DDB2 Plasma membrane Pancreatic cancer 0.8344574767716725 | |
| DDB2 Plasma membrane Pathways in cancer 0.8344574767716725 | |
| DDB2 Plasma membrane Small cell lung cancer 0.8344574767716725 | |
| DDB2 Plasma membrane Thyroid cancer 0.8344574767716725 | |
| DDB2 Plasma membrane Transcriptional misregulation in cancer 0.8344574767716725 | |
| DDB2 Plasma membrane Ubiquitin mediated proteolysis 0.8344574767716725 | |
| DDB2 Plasma membrane p53 signaling pathway 0.8344574767716725 | |
| DDHD1 Cytosol Summary 1.4350552568243091 | |
| DDHD2 Cytosol Summary 0.9582884542193496 | |
| DDHD2 Endoplasmic Reticulum Summary 0.9582884542193496 | |
| DDI2 Cytosol Summary 1.1316213647015123 | |
| DDI2 Nucleus Summary 1.1316213647015123 | |
| DDOST Endoplasmic Reticulum Summary 1.3665627022547189 | |
| DDR1 Nucleus Summary 0.9595498056907424 | |
| DDR1 Plasma membrane Summary 0.9595498056907424 | |
| DDR2 Cytoskeleton Summary 1.9304190801919061 | |
| DDR2 Plasma membrane Summary 1.9304190801919061 | |
| DDRGK1 Endoplasmic Reticulum Summary 0.6855191978054143 | |
| DDRGK1 Nucleus Summary 0.6855191978054143 | |
| DDT Cytosol Summary 1.0883855704260497 | |
| DDT Mitochondrion Summary 1.0883855704260497 | |
| DDTL Cytosol Summary 1.2824140082673503 | |
| DDX10 Nucleus Summary 2.2364083699253254 | |
| DDX11 Cytoskeleton Summary 1.399231140624806 | |
| DDX11 Nucleus Summary 1.399231140624806 | |
| DDX18 Mitochondrion Summary 3.2700371632471903 | |
| DDX18 Nucleus Summary 3.2700371632471903 | |
| DDX19A Cytosol RNA transport 1.541621640960804 | |
| DDX19A Cytosol mRNA surveillance pathway 1.541621640960804 | |
| DDX19A Nucleus RNA transport 1.541621640960804 | |
| DDX19A Nucleus mRNA surveillance pathway 1.541621640960804 | |
| DDX19B Cytosol RNA transport 1.7281412574442114 | |
| DDX19B Cytosol mRNA surveillance pathway 1.7281412574442114 | |
| DDX19B Nucleus RNA transport 1.7281412574442114 | |
| DDX19B Nucleus mRNA surveillance pathway 1.7281412574442114 | |
| DDX20 Cytosol RNA transport 1.4345829561066987 | |
| DDX20 Nucleus RNA transport 1.4345829561066987 | |
| DDX21 Mitochondrion Summary 2.8311529206023294 | |
| DDX21 Nucleus Summary 2.8311529206023294 | |
| DDX23 Nucleus Spliceosome 1.5088603402637568 | |
| DDX24 Cytosol Summary 1.7745628041377026 | |
| DDX24 Nucleus Summary 1.7745628041377026 | |
| DDX27 Nucleus Summary 2.763752412419344 | |
| DDX28 Cytosol Summary 1.6001549357912102 | |
| DDX28 Mitochondrion Summary 1.6001549357912102 | |
| DDX28 Nucleus Summary 1.6001549357912102 | |
| DDX31 Cytosol Biosynthesis of cofactors 1.6510720771164684 | |
| DDX31 Cytosol Metabolic pathways 1.6510720771164684 | |
| DDX31 Cytosol Purine metabolism 1.6510720771164684 | |
| DDX31 Cytosol Thiamine metabolism 1.6510720771164684 | |
| DDX31 Golgi apparatus Biosynthesis of cofactors 1.6510720771164684 | |
| DDX31 Golgi apparatus Metabolic pathways 1.6510720771164684 | |
| DDX31 Golgi apparatus Purine metabolism 1.6510720771164684 | |
| DDX31 Golgi apparatus Thiamine metabolism 1.6510720771164684 | |
| DDX31 Nucleus Biosynthesis of cofactors 1.6510720771164684 | |
| DDX31 Nucleus Metabolic pathways 1.6510720771164684 | |
| DDX31 Nucleus Purine metabolism 1.6510720771164684 | |
| DDX31 Nucleus Thiamine metabolism 1.6510720771164684 | |
| DDX39A Nucleus Summary 2.6280884946556995 | |
| DDX3X Cytosol Hepatitis B 1.7117170064067802 | |
| DDX3X Cytosol RIG-I-like receptor signaling pathway 1.7117170064067802 | |
| DDX3X Cytosol Viral carcinogenesis 1.7117170064067802 | |
| DDX3X Nucleus Hepatitis B 1.7117170064067802 | |
| DDX3X Nucleus RIG-I-like receptor signaling pathway 1.7117170064067802 | |
| DDX3X Nucleus Viral carcinogenesis 1.7117170064067802 | |
| DDX41 Nucleus Summary 1.6742588030333585 | |
| DDX42 Nucleus Spliceosome 1.4276295274108606 | |
| DDX46 Nucleus Spliceosome 2.037686313180896 | |
| DDX47 Nucleus Summary 2.5246881386697155 | |
| DDX49 Mitochondrion Summary 2.0680945640089847 | |
| DDX49 Nucleus Summary 2.0680945640089847 | |
| DDX5 Nucleus Proteoglycans in cancer 2.129748739988637 | |
| DDX5 Nucleus Spliceosome 2.129748739988637 | |
| DDX5 Nucleus Transcriptional misregulation in cancer 2.129748739988637 | |
| DDX50 Nucleus Summary 2.0913470709393267 | |
| DDX51 Cytosol Summary 2.057821744944875 | |
| DDX51 Nucleus Summary 2.057821744944875 | |
| DDX52 Nucleus Summary 2.464523121280084 | |
| DDX54 Golgi apparatus Summary 2.2670633943095977 | |
| DDX54 Nucleus Summary 2.2670633943095977 | |
| DDX55 Nucleus Summary 1.8702845233554408 | |
| DDX56 Mitochondrion Summary 2.202958163664642 | |
| DDX56 Nucleus Summary 2.202958163664642 | |
| DDX58 Cytoskeleton Coronavirus disease - COVID-19 0.869866179983654 | |
| DDX58 Cytoskeleton Cytosolic DNA-sensing pathway 0.869866179983654 | |
| DDX58 Cytoskeleton Epstein-Barr virus infection 0.869866179983654 | |
| DDX58 Cytoskeleton Hepatitis B 0.869866179983654 | |
| DDX58 Cytoskeleton Hepatitis C 0.869866179983654 | |
| DDX58 Cytoskeleton Herpes simplex virus 1 infection 0.869866179983654 | |
| DDX58 Cytoskeleton Influenza A 0.869866179983654 | |
| DDX58 Cytoskeleton Measles 0.869866179983654 | |
| DDX58 Cytoskeleton NF-kappa B signaling pathway 0.869866179983654 | |
| DDX58 Cytoskeleton RIG-I-like receptor signaling pathway 0.869866179983654 | |
| DDX58 Cytosol Coronavirus disease - COVID-19 0.869866179983654 | |
| DDX58 Cytosol Cytosolic DNA-sensing pathway 0.869866179983654 | |
| DDX58 Cytosol Epstein-Barr virus infection 0.869866179983654 | |
| DDX58 Cytosol Hepatitis B 0.869866179983654 | |
| DDX58 Cytosol Hepatitis C 0.869866179983654 | |
| DDX58 Cytosol Herpes simplex virus 1 infection 0.869866179983654 | |
| DDX58 Cytosol Influenza A 0.869866179983654 | |
| DDX58 Cytosol Measles 0.869866179983654 | |
| DDX58 Cytosol NF-kappa B signaling pathway 0.869866179983654 | |
| DDX58 Cytosol RIG-I-like receptor signaling pathway 0.869866179983654 | |
| DDX58 Nucleus Coronavirus disease - COVID-19 0.869866179983654 | |
| DDX58 Nucleus Cytosolic DNA-sensing pathway 0.869866179983654 | |
| DDX58 Nucleus Epstein-Barr virus infection 0.869866179983654 | |
| DDX58 Nucleus Hepatitis B 0.869866179983654 | |
| DDX58 Nucleus Hepatitis C 0.869866179983654 | |
| DDX58 Nucleus Herpes simplex virus 1 infection 0.869866179983654 | |
| DDX58 Nucleus Influenza A 0.869866179983654 | |
| DDX58 Nucleus Measles 0.869866179983654 | |
| DDX58 Nucleus NF-kappa B signaling pathway 0.869866179983654 | |
| DDX58 Nucleus RIG-I-like receptor signaling pathway 0.869866179983654 | |
| DDX58 Plasma membrane Coronavirus disease - COVID-19 0.869866179983654 | |
| DDX58 Plasma membrane Cytosolic DNA-sensing pathway 0.869866179983654 | |
| DDX58 Plasma membrane Epstein-Barr virus infection 0.869866179983654 | |
| DDX58 Plasma membrane Hepatitis B 0.869866179983654 | |
| DDX58 Plasma membrane Hepatitis C 0.869866179983654 | |
| DDX58 Plasma membrane Herpes simplex virus 1 infection 0.869866179983654 | |
| DDX58 Plasma membrane Influenza A 0.869866179983654 | |
| DDX58 Plasma membrane Measles 0.869866179983654 | |
| DDX58 Plasma membrane NF-kappa B signaling pathway 0.869866179983654 | |
| DDX58 Plasma membrane RIG-I-like receptor signaling pathway 0.869866179983654 | |
| DDX59 Cytoskeleton Summary 1.2048392312735714 | |
| DDX59 Cytosol Summary 1.2048392312735714 | |
| DDX59 Nucleus Summary 1.2048392312735714 | |
| DDX60 Cytoskeleton Summary 0.7782246243090282 | |
| DDX60 Cytosol Summary 0.7782246243090282 | |
| DDX60L Cytosol Summary 1.2815025759817722 | |
| DDX60L Plasma membrane Summary 1.2815025759817722 | |
| DECR1 Cytosol Summary 2.1181621254213274 | |
| DECR1 Mitochondrion Summary 2.1181621254213274 | |
| DECR2 Cytoskeleton Summary 0.8996718596130225 | |
| DECR2 Peroxisome Summary 0.8996718596130225 | |
| DEDD Nucleus Summary 1.0634058445392187 | |
| DEF6 Cytosol NOD-like receptor signaling pathway 1.308258563987012 | |
| DEF6 Cytosol Staphylococcus aureus infection 1.308258563987012 | |
| DEF6 Cytosol Transcriptional misregulation in cancer 1.308258563987012 | |
| DEF6 Extracellular space NOD-like receptor signaling pathway 1.308258563987012 | |
| DEF6 Extracellular space Staphylococcus aureus infection 1.308258563987012 | |
| DEF6 Extracellular space Transcriptional misregulation in cancer 1.308258563987012 | |
| DEF6 Nucleus NOD-like receptor signaling pathway 1.308258563987012 | |
| DEF6 Nucleus Staphylococcus aureus infection 1.308258563987012 | |
| DEF6 Nucleus Transcriptional misregulation in cancer 1.308258563987012 | |
| DEF6 Plasma membrane NOD-like receptor signaling pathway 1.308258563987012 | |
| DEF6 Plasma membrane Staphylococcus aureus infection 1.308258563987012 | |
| DEF6 Plasma membrane Transcriptional misregulation in cancer 1.308258563987012 | |
| DEF8 Cytosol Summary 1.547642656477204 | |
| DEF8 Nucleus Summary 1.547642656477204 | |
| DEFA3 Extracellular space NOD-like receptor signaling pathway 1.0641583303330906 | |
| DEFA3 Extracellular space Staphylococcus aureus infection 1.0641583303330906 | |
| DEFA3 Extracellular space Transcriptional misregulation in cancer 1.0641583303330906 | |
| DEFA4 Extracellular space NOD-like receptor signaling pathway 2.5750839512651402 | |
| DEFA4 Extracellular space Staphylococcus aureus infection 2.5750839512651402 | |
| DEFA4 Extracellular space Transcriptional misregulation in cancer 2.5750839512651402 | |
| DEGS1 Endoplasmic Reticulum Metabolic pathways 1.7240706425414631 | |
| DEGS1 Endoplasmic Reticulum Sphingolipid metabolism 1.7240706425414631 | |
| DEGS1 Endoplasmic Reticulum Sphingolipid signaling pathway 1.7240706425414631 | |
| DEGS1 Mitochondrion Metabolic pathways 1.7240706425414631 | |
| DEGS1 Mitochondrion Sphingolipid metabolism 1.7240706425414631 | |
| DEGS1 Mitochondrion Sphingolipid signaling pathway 1.7240706425414631 | |
| DEGS2 Endoplasmic Reticulum Metabolic pathways 1.1879098036950049 | |
| DEGS2 Endoplasmic Reticulum Sphingolipid metabolism 1.1879098036950049 | |
| DEGS2 Endoplasmic Reticulum Sphingolipid signaling pathway 1.1879098036950049 | |
| DEGS2 Nucleus Metabolic pathways 1.1879098036950049 | |
| DEGS2 Nucleus Sphingolipid metabolism 1.1879098036950049 | |
| DEGS2 Nucleus Sphingolipid signaling pathway 1.1879098036950049 | |
| DEK Nucleus Summary 2.9176090112915025 | |
| DENND1A Cytosol Summary 0.7348565414630354 | |
| DENND1A Nucleus Summary 0.7348565414630354 | |
| DENND1B Cytosol Summary 0.4557947164210683 | |
| DENND1B Nucleus Summary 0.4557947164210683 | |
| DENND1C Cytoskeleton Summary 1.3692352902761888 | |
| DENND1C Cytosol Summary 1.3692352902761888 | |
| DENND1C Nucleus Summary 1.3692352902761888 | |
| DENND2C Nucleus Summary 1.1607117574756085 | |
| DENND2D Cytosol Summary 0.281196586503195 | |
| DENND2D Nucleus Summary 0.281196586503195 | |
| DENND3 Cytosol Summary 1.8446167936160691 | |
| DENND4A Mitochondrion Summary 1.0291385517218723 | |
| DENND4A Nucleus Summary 1.0291385517218723 | |
| DENND4B Golgi apparatus Summary 1.433085303912652 | |
| DENND4B Nucleus Summary 1.433085303912652 | |
| DENND4C Cytosol Summary 0.9347092689073964 | |
| DENND4C Golgi apparatus Summary 0.9347092689073964 | |
| DENND5A Cytosol Summary 1.2802233107675658 | |
| DENND5A Golgi apparatus Summary 1.2802233107675658 | |
| DENND6A Cytosol Summary 1.1806538065465924 | |
| DENND6A Endosome Summary 1.1806538065465924 | |
| DENR Cytosol Summary 0.9755781859021972 | |
| DEPDC5 Golgi apparatus Summary 0.8130353341492644 | |
| DEPTOR Mitochondrion Summary 0.5916044489684367 | |
| DEPTOR Nucleus Summary 0.5916044489684367 | |
| DERA Cytosol Summary 1.1247333777303417 | |
| DERA Nucleus Summary 1.1247333777303417 | |
| DERL1 Endoplasmic Reticulum Amyotrophic lateral sclerosis 1.0318345298775626 | |
| DERL1 Endoplasmic Reticulum Pathways of neurodegeneration - multiple diseases 1.0318345298775626 | |
| DERL1 Endoplasmic Reticulum Protein processing in endoplasmic reticulum 1.0318345298775626 | |
| DERL1 Endosome Amyotrophic lateral sclerosis 1.0318345298775626 | |
| DERL1 Endosome Pathways of neurodegeneration - multiple diseases 1.0318345298775626 | |
| DERL1 Endosome Protein processing in endoplasmic reticulum 1.0318345298775626 | |
| DERL2 Endoplasmic Reticulum Protein processing in endoplasmic reticulum 1.1184426411133521 | |
| DERL2 Endosome Protein processing in endoplasmic reticulum 1.1184426411133521 | |
| DES Cytoskeleton Summary 0.5557666607770364 | |
| DES Cytosol Summary 0.5557666607770364 | |
| DESI1 Cytosol Summary 2.0901828293788958 | |
| DESI2 Cytosol Summary 1.8268723477356847 | |
| DET1 Cytoskeleton Summary 1.4606362177934595 | |
| DET1 Cytosol Summary 1.4606362177934595 | |
| DET1 Nucleus Summary 1.4606362177934595 | |
| DFFA Cytosol Apoptosis 2.0033847785486376 | |
| DFFA Nucleus Apoptosis 2.0033847785486376 | |
| DFFA Plasma membrane Apoptosis 2.0033847785486376 | |
| DFFB Nucleus Apoptosis 1.4471136586620543 | |
| DFNA5 Cytosol Summary 1.4166691637687332 | |
| DGCR14 Nucleus Summary 1.5280039169718362 | |
| DGCR8 Cytosol Summary 1.7640422881282023 | |
| DGCR8 Nucleus Summary 1.7640422881282023 | |
| DGKA Cytosol Summary 1.1457370454869171 | |
| DGKA Mitochondrion Summary 1.1457370454869171 | |
| DGKA Nucleus Summary 1.1457370454869171 | |
| DGKB Plasma membrane Summary 1.274071830376502 | |
| DGKD Cytosol Choline metabolism in cancer 1.2382323868107918 | |
| DGKD Cytosol Glycerolipid metabolism 1.2382323868107918 | |
| DGKD Cytosol Glycerophospholipid metabolism 1.2382323868107918 | |
| DGKD Cytosol Metabolic pathways 1.2382323868107918 | |
| DGKD Cytosol Phosphatidylinositol signaling system 1.2382323868107918 | |
| DGKD Cytosol Phospholipase D signaling pathway 1.2382323868107918 | |
| DGKD Plasma membrane Choline metabolism in cancer 1.2382323868107918 | |
| DGKD Plasma membrane Glycerolipid metabolism 1.2382323868107918 | |
| DGKD Plasma membrane Glycerophospholipid metabolism 1.2382323868107918 | |
| DGKD Plasma membrane Metabolic pathways 1.2382323868107918 | |
| DGKD Plasma membrane Phosphatidylinositol signaling system 1.2382323868107918 | |
| DGKD Plasma membrane Phospholipase D signaling pathway 1.2382323868107918 | |
| DGKH Cytosol Choline metabolism in cancer 1.7293774074494332 | |
| DGKH Cytosol Glycerolipid metabolism 1.7293774074494332 | |
| DGKH Cytosol Glycerophospholipid metabolism 1.7293774074494332 | |
| DGKH Cytosol Metabolic pathways 1.7293774074494332 | |
| DGKH Cytosol Phosphatidylinositol signaling system 1.7293774074494332 | |
| DGKH Cytosol Phospholipase D signaling pathway 1.7293774074494332 | |
| DGKH Endosome Choline metabolism in cancer 1.7293774074494332 | |
| DGKH Endosome Glycerolipid metabolism 1.7293774074494332 | |
| DGKH Endosome Glycerophospholipid metabolism 1.7293774074494332 | |
| DGKH Endosome Metabolic pathways 1.7293774074494332 | |
| DGKH Endosome Phosphatidylinositol signaling system 1.7293774074494332 | |
| DGKH Endosome Phospholipase D signaling pathway 1.7293774074494332 | |
| DGKH Plasma membrane Choline metabolism in cancer 1.7293774074494332 | |
| DGKH Plasma membrane Glycerolipid metabolism 1.7293774074494332 | |
| DGKH Plasma membrane Glycerophospholipid metabolism 1.7293774074494332 | |
| DGKH Plasma membrane Metabolic pathways 1.7293774074494332 | |
| DGKH Plasma membrane Phosphatidylinositol signaling system 1.7293774074494332 | |
| DGKH Plasma membrane Phospholipase D signaling pathway 1.7293774074494332 | |
| DGKQ Cytoskeleton Choline metabolism in cancer 0.667482022589382 | |
| DGKQ Cytoskeleton Glycerolipid metabolism 0.667482022589382 | |
| DGKQ Cytoskeleton Glycerophospholipid metabolism 0.667482022589382 | |
| DGKQ Cytoskeleton Metabolic pathways 0.667482022589382 | |
| DGKQ Cytoskeleton Phosphatidylinositol signaling system 0.667482022589382 | |
| DGKQ Cytoskeleton Phospholipase D signaling pathway 0.667482022589382 | |
| DGKQ Cytosol Choline metabolism in cancer 0.667482022589382 | |
| DGKQ Cytosol Glycerolipid metabolism 0.667482022589382 | |
| DGKQ Cytosol Glycerophospholipid metabolism 0.667482022589382 | |
| DGKQ Cytosol Metabolic pathways 0.667482022589382 | |
| DGKQ Cytosol Phosphatidylinositol signaling system 0.667482022589382 | |
| DGKQ Cytosol Phospholipase D signaling pathway 0.667482022589382 | |
| DGKQ Nucleus Choline metabolism in cancer 0.667482022589382 | |
| DGKQ Nucleus Glycerolipid metabolism 0.667482022589382 | |
| DGKQ Nucleus Glycerophospholipid metabolism 0.667482022589382 | |
| DGKQ Nucleus Metabolic pathways 0.667482022589382 | |
| DGKQ Nucleus Phosphatidylinositol signaling system 0.667482022589382 | |
| DGKQ Nucleus Phospholipase D signaling pathway 0.667482022589382 | |
| DGKQ Plasma membrane Choline metabolism in cancer 0.667482022589382 | |
| DGKQ Plasma membrane Glycerolipid metabolism 0.667482022589382 | |
| DGKQ Plasma membrane Glycerophospholipid metabolism 0.667482022589382 | |
| DGKQ Plasma membrane Metabolic pathways 0.667482022589382 | |
| DGKQ Plasma membrane Phosphatidylinositol signaling system 0.667482022589382 | |
| DGKQ Plasma membrane Phospholipase D signaling pathway 0.667482022589382 | |
| DGKZ Nucleus Choline metabolism in cancer 1.6735365748136957 | |
| DGKZ Nucleus Glycerolipid metabolism 1.6735365748136957 | |
| DGKZ Nucleus Glycerophospholipid metabolism 1.6735365748136957 | |
| DGKZ Nucleus Metabolic pathways 1.6735365748136957 | |
| DGKZ Nucleus Phosphatidylinositol signaling system 1.6735365748136957 | |
| DGKZ Nucleus Phospholipase D signaling pathway 1.6735365748136957 | |
| DGKZ Plasma membrane Choline metabolism in cancer 1.6735365748136957 | |
| DGKZ Plasma membrane Glycerolipid metabolism 1.6735365748136957 | |
| DGKZ Plasma membrane Glycerophospholipid metabolism 1.6735365748136957 | |
| DGKZ Plasma membrane Metabolic pathways 1.6735365748136957 | |
| DGKZ Plasma membrane Phosphatidylinositol signaling system 1.6735365748136957 | |
| DGKZ Plasma membrane Phospholipase D signaling pathway 1.6735365748136957 | |
| DGUOK Cytosol Metabolic pathways 1.0578703734469073 | |
| DGUOK Cytosol Purine metabolism 1.0578703734469073 | |
| DGUOK Mitochondrion Metabolic pathways 1.0578703734469073 | |
| DGUOK Mitochondrion Purine metabolism 1.0578703734469073 | |
| DHCR24 Endoplasmic Reticulum Metabolic pathways 0.16721037678971126 | |
| DHCR24 Endoplasmic Reticulum Steroid biosynthesis 0.16721037678971126 | |
| DHCR24 Golgi apparatus Metabolic pathways 0.16721037678971126 | |
| DHCR24 Golgi apparatus Steroid biosynthesis 0.16721037678971126 | |
| DHCR24 Nucleus Metabolic pathways 0.16721037678971126 | |
| DHCR24 Nucleus Steroid biosynthesis 0.16721037678971126 | |
| DHCR7 Endoplasmic Reticulum Metabolic pathways 0.7373181768989358 | |
| DHCR7 Endoplasmic Reticulum Steroid biosynthesis 0.7373181768989358 | |
| DHCR7 Nucleus Metabolic pathways 0.7373181768989358 | |
| DHCR7 Nucleus Steroid biosynthesis 0.7373181768989358 | |
| DHDDS Endoplasmic Reticulum Summary 1.5913433366811458 | |
| DHDDS Plasma membrane Summary 1.5913433366811458 | |
| DHFR Mitochondrion Summary 1.255004064869731 | |
| DHODH Cytosol Biosynthesis of cofactors 2.066998185197653 | |
| DHODH Cytosol Metabolic pathways 2.066998185197653 | |
| DHODH Cytosol Pyrimidine metabolism 2.066998185197653 | |
| DHODH Mitochondrion Biosynthesis of cofactors 2.066998185197653 | |
| DHODH Mitochondrion Metabolic pathways 2.066998185197653 | |
| DHODH Mitochondrion Pyrimidine metabolism 2.066998185197653 | |
| DHODH Nucleus Biosynthesis of cofactors 2.066998185197653 | |
| DHODH Nucleus Metabolic pathways 2.066998185197653 | |
| DHODH Nucleus Pyrimidine metabolism 2.066998185197653 | |
| DHPS Cytosol Summary 2.0879836961892635 | |
| DHPS Nucleus Summary 2.0879836961892635 | |
| DHPS Plasma membrane Summary 2.0879836961892635 | |
| DHRS1 Cytoskeleton Summary 1.0958747172777783 | |
| DHRS1 Cytosol Summary 1.0958747172777783 | |
| DHRS1 Nucleus Summary 1.0958747172777783 | |
| DHRS11 Cytosol Summary 1.3059556189279151 | |
| DHRS11 Golgi apparatus Summary 1.3059556189279151 | |
| DHRS13 Cytosol Summary 0.6547914360796078 | |
| DHRS2 Mitochondrion Summary 0.06802598006884462 | |
| DHRS2 Nucleus Summary 0.06802598006884462 | |
| DHRS3 Mitochondrion Summary 2.332506488228335 | |
| DHRS3 Nucleus Summary 2.332506488228335 | |
| DHRS4 Cytosol Metabolic pathways 0.9612325766691288 | |
| DHRS4 Cytosol Peroxisome 0.9612325766691288 | |
| DHRS4 Cytosol Retinol metabolism 0.9612325766691288 | |
| DHRS4 Nucleus Metabolic pathways 0.9612325766691288 | |
| DHRS4 Nucleus Peroxisome 0.9612325766691288 | |
| DHRS4 Nucleus Retinol metabolism 0.9612325766691288 | |
| DHRS4 Peroxisome Metabolic pathways 0.9612325766691288 | |
| DHRS4 Peroxisome Peroxisome 0.9612325766691288 | |
| DHRS4 Peroxisome Retinol metabolism 0.9612325766691288 | |
| DHRS7 Mitochondrion Summary 0.4250859279831729 | |
| DHRS7 Nucleus Summary 0.4250859279831729 | |
| DHRS7B Cytosol Summary 0.9960199568456491 | |
| DHRS7B Endoplasmic Reticulum Summary 0.9960199568456491 | |
| DHRS7B Peroxisome Summary 0.9960199568456491 | |
| DHRS7B Plasma membrane Summary 0.9960199568456491 | |
| DHRSX Cytosol Summary 0.9198106285038632 | |
| DHRSX Mitochondrion Summary 0.9198106285038632 | |
| DHTKD1 Mitochondrion Summary 1.9409996793584388 | |
| DHX16 Nucleus Summary 1.6649521230444768 | |
| DHX29 Cytosol Summary 0.8975496328613797 | |
| DHX30 Cytosol Summary 1.0617589895858264 | |
| DHX30 Mitochondrion Summary 1.0617589895858264 | |
| DHX32 Mitochondrion Summary 0.6157220472315088 | |
| DHX32 Nucleus Summary 0.6157220472315088 | |
| DHX33 Nucleus NOD-like receptor signaling pathway 1.9374617655878201 | |
| DHX34 Cytoskeleton Summary 1.6778304012286418 | |
| DHX34 Nucleus Summary 1.6778304012286418 | |
| DHX35 Cytoskeleton Summary 1.932240273099329 | |
| DHX35 Nucleus Summary 1.932240273099329 | |
| DHX36 Cytosol RNA degradation 1.6207659497756086 | |
| DHX36 Nucleus RNA degradation 1.6207659497756086 | |
| DHX37 Nucleus Summary 1.804365367600516 | |
| DHX38 Nucleus Spliceosome 1.466509227706345 | |
| DHX40 Nucleus Summary 1.0779810661939706 | |
| DHX57 Cytoskeleton Summary 1.1652054831402414 | |
| DHX57 Cytosol Summary 1.1652054831402414 | |
| DHX57 Nucleus Summary 1.1652054831402414 | |
| DHX58 Cytosol Summary 0.9749376104372732 | |
| DHX58 Golgi apparatus Summary 0.9749376104372732 | |
| DHX58 Nucleus Summary 0.9749376104372732 | |
| DHX8 Nucleus Spliceosome 1.7566017014448962 | |
| DIABLO Mitochondrion Apoptosis 1.0701837075489495 | |
| DIABLO Mitochondrion Apoptosis - multiple species 1.0701837075489495 | |
| DIAPH1 Cytoskeleton AGE-RAGE signaling pathway in diabetic complications 1.2643233420988649 | |
| DIAPH1 Cytoskeleton Focal adhesion 1.2643233420988649 | |
| DIAPH1 Cytoskeleton Regulation of actin cytoskeleton 1.2643233420988649 | |
| DIAPH1 Cytoskeleton Shigellosis 1.2643233420988649 | |
| DIAPH1 Plasma membrane AGE-RAGE signaling pathway in diabetic complications 1.2643233420988649 | |
| DIAPH1 Plasma membrane Focal adhesion 1.2643233420988649 | |
| DIAPH1 Plasma membrane Regulation of actin cytoskeleton 1.2643233420988649 | |
| DIAPH1 Plasma membrane Shigellosis 1.2643233420988649 | |
| DIAPH2 Cytosol Regulation of actin cytoskeleton 1.9974749682527435 | |
| DIAPH2 Endoplasmic Reticulum Regulation of actin cytoskeleton 1.9974749682527435 | |
| DIAPH2 Endosome Regulation of actin cytoskeleton 1.9974749682527435 | |
| DIAPH2 Nucleus Regulation of actin cytoskeleton 1.9974749682527435 | |
| DIAPH3 Cytoskeleton Regulation of actin cytoskeleton 2.3992623235774437 | |
| DIAPH3 Cytosol Regulation of actin cytoskeleton 2.3992623235774437 | |
| DIAPH3 Plasma membrane Regulation of actin cytoskeleton 2.3992623235774437 | |
| DICER1 Cytosol Summary 1.6536528923039142 | |
| DIDO1 Cytosol Summary 1.0166985646623303 | |
| DIDO1 Nucleus Summary 1.0166985646623303 | |
| DIEXF Nucleus Summary 2.2481527118067497 | |
| DIMT1 Cytosol Summary 1.9048746404553565 | |
| DIMT1 Nucleus Summary 1.9048746404553565 | |
| DIP2A Nucleus Summary 0.8238924371908605 | |
| DIP2A Plasma membrane Summary 0.8238924371908605 | |
| DIP2B Endoplasmic Reticulum Summary 1.1978342562589444 | |
| DIP2C Cytosol Summary 1.198426899655792 | |
| DIP2C Nucleus Summary 1.198426899655792 | |
| DIS3 Cytosol RNA degradation 1.4312315989879565 | |
| DIS3 Nucleus RNA degradation 1.4312315989879565 | |
| DIS3L Cytoskeleton Summary 1.4942713484692818 | |
| DIS3L Cytosol Summary 1.4942713484692818 | |
| DIS3L Plasma membrane Summary 1.4942713484692818 | |
| DIS3L2 Cytosol Summary 1.28571912146906 | |
| DKC1 Nucleus Ribosome biogenesis in eukaryotes 1.3910531745295485 | |
| DLAT Mitochondrion Carbon metabolism 2.65397149206885 | |
| DLAT Mitochondrion Citrate cycle (TCA cycle) 2.65397149206885 | |
| DLAT Mitochondrion Glycolysis / Gluconeogenesis 2.65397149206885 | |
| DLAT Mitochondrion Metabolic pathways 2.65397149206885 | |
| DLAT Mitochondrion Pyruvate metabolism 2.65397149206885 | |
| DLC1 Cytosol Salmonella infection 1.6630915619347424 | |
| DLC1 Cytosol Vasopressin-regulated water reabsorption 1.6630915619347424 | |
| DLC1 Golgi apparatus Salmonella infection 1.6630915619347424 | |
| DLC1 Golgi apparatus Vasopressin-regulated water reabsorption 1.6630915619347424 | |
| DLC1 Nucleus Salmonella infection 1.6630915619347424 | |
| DLC1 Nucleus Vasopressin-regulated water reabsorption 1.6630915619347424 | |
| DLC1 Plasma membrane Salmonella infection 1.6630915619347424 | |
| DLC1 Plasma membrane Vasopressin-regulated water reabsorption 1.6630915619347424 | |
| DLD Mitochondrion Biosynthesis of cofactors 1.9043429915885532 | |
| DLD Mitochondrion Carbon metabolism 1.9043429915885532 | |
| DLD Mitochondrion Citrate cycle (TCA cycle) 1.9043429915885532 | |
| DLD Mitochondrion Glycine serine and threonine metabolism 1.9043429915885532 | |
| DLD Mitochondrion Glycolysis / Gluconeogenesis 1.9043429915885532 | |
| DLD Mitochondrion Glyoxylate and dicarboxylate metabolism 1.9043429915885532 | |
| DLD Mitochondrion Lysine degradation 1.9043429915885532 | |
| DLD Mitochondrion Metabolic pathways 1.9043429915885532 | |
| DLD Mitochondrion Propanoate metabolism 1.9043429915885532 | |
| DLD Mitochondrion Pyruvate metabolism 1.9043429915885532 | |
| DLD Mitochondrion Tryptophan metabolism 1.9043429915885532 | |
| DLD Mitochondrion Valine leucine and isoleucine degradation 1.9043429915885532 | |
| DLD Nucleus Biosynthesis of cofactors 1.9043429915885532 | |
| DLD Nucleus Carbon metabolism 1.9043429915885532 | |
| DLD Nucleus Citrate cycle (TCA cycle) 1.9043429915885532 | |
| DLD Nucleus Glycine serine and threonine metabolism 1.9043429915885532 | |
| DLD Nucleus Glycolysis / Gluconeogenesis 1.9043429915885532 | |
| DLD Nucleus Glyoxylate and dicarboxylate metabolism 1.9043429915885532 | |
| DLD Nucleus Lysine degradation 1.9043429915885532 | |
| DLD Nucleus Metabolic pathways 1.9043429915885532 | |
| DLD Nucleus Propanoate metabolism 1.9043429915885532 | |
| DLD Nucleus Pyruvate metabolism 1.9043429915885532 | |
| DLD Nucleus Tryptophan metabolism 1.9043429915885532 | |
| DLD Nucleus Valine leucine and isoleucine degradation 1.9043429915885532 | |
| DLEC1 Cytosol Summary 1.087098555159098 | |
| DLG1 Cytosol Hippo signaling pathway 0.7445033516414352 | |
| DLG1 Cytosol Human T-cell leukemia virus 1 infection 0.7445033516414352 | |
| DLG1 Cytosol Human papillomavirus infection 0.7445033516414352 | |
| DLG1 Cytosol T cell receptor signaling pathway 0.7445033516414352 | |
| DLG1 Cytosol Tight junction 0.7445033516414352 | |
| DLG1 Cytosol Viral carcinogenesis 0.7445033516414352 | |
| DLG1 Plasma membrane Hippo signaling pathway 0.7445033516414352 | |
| DLG1 Plasma membrane Human T-cell leukemia virus 1 infection 0.7445033516414352 | |
| DLG1 Plasma membrane Human papillomavirus infection 0.7445033516414352 | |
| DLG1 Plasma membrane T cell receptor signaling pathway 0.7445033516414352 | |
| DLG1 Plasma membrane Tight junction 0.7445033516414352 | |
| DLG1 Plasma membrane Viral carcinogenesis 0.7445033516414352 | |
| DLG3 Nucleus Summary 0.3319977586077496 | |
| DLG5 Plasma membrane Hippo signaling pathway 0.5095914857558677 | |
| DLGAP4 Cytosol Summary 1.0030023785202211 | |
| DLGAP4 Nucleus Summary 1.0030023785202211 | |
| DLGAP5 Cytoskeleton Summary 2.8219180822219614 | |
| DLGAP5 Cytosol Summary 2.8219180822219614 | |
| DLGAP5 Nucleus Summary 2.8219180822219614 | |
| DLST Mitochondrion Carbon metabolism 1.8485416293945882 | |
| DLST Mitochondrion Citrate cycle (TCA cycle) 1.8485416293945882 | |
| DLST Mitochondrion Lysine degradation 1.8485416293945882 | |
| DLST Mitochondrion Metabolic pathways 1.8485416293945882 | |
| DLST Mitochondrion Tryptophan metabolism 1.8485416293945882 | |
| DLST Nucleus Carbon metabolism 1.8485416293945882 | |
| DLST Nucleus Citrate cycle (TCA cycle) 1.8485416293945882 | |
| DLST Nucleus Lysine degradation 1.8485416293945882 | |
| DLST Nucleus Metabolic pathways 1.8485416293945882 | |
| DLST Nucleus Tryptophan metabolism 1.8485416293945882 | |
| DMD Cytoskeleton Arrhythmogenic right ventricular cardiomyopathy 1.206496007297371 | |
| DMD Cytoskeleton Dilated cardiomyopathy 1.206496007297371 | |
| DMD Cytoskeleton Hypertrophic cardiomyopathy 1.206496007297371 | |
| DMD Cytoskeleton Viral myocarditis 1.206496007297371 | |
| DMD Plasma membrane Arrhythmogenic right ventricular cardiomyopathy 1.206496007297371 | |
| DMD Plasma membrane Dilated cardiomyopathy 1.206496007297371 | |
| DMD Plasma membrane Hypertrophic cardiomyopathy 1.206496007297371 | |
| DMD Plasma membrane Viral myocarditis 1.206496007297371 | |
| DMPK Cytosol Summary 1.074793806315534 | |
| DMPK Endoplasmic Reticulum Summary 1.074793806315534 | |
| DMPK Mitochondrion Summary 1.074793806315534 | |
| DMPK Nucleus Summary 1.074793806315534 | |
| DMTN Cytoskeleton Summary 1.1803471964752084 | |
| DMTN Nucleus Summary 1.1803471964752084 | |
| DMWD Cytoskeleton Summary 1.1012633958081899 | |
| DMWD Endoplasmic Reticulum Summary 1.1012633958081899 | |
| DMWD Plasma membrane Summary 1.1012633958081899 | |
| DMXL1 Cytosol Summary 0.6919757999168348 | |
| DMXL1 Nucleus Summary 0.6919757999168348 | |
| DMXL2 Cytosol Summary 1.560673550518317 | |
| DNA2 Mitochondrion DNA replication 1.6984919240526144 | |
| DNA2 Nucleus DNA replication 1.6984919240526144 | |
| DNAAF2 Cytosol Summary 1.3692934057715738 | |
| DNAAF5 Cytosol Summary 1.146428900089138 | |
| DNAAF5 Nucleus Summary 1.146428900089138 | |
| DNAH1 Cytoskeleton Amyotrophic lateral sclerosis 1.8569913091145795 | |
| DNAH1 Cytoskeleton Huntington disease 1.8569913091145795 | |
| DNAH1 Cytoskeleton Pathways of neurodegeneration - multiple diseases 1.8569913091145795 | |
| DNAH1 Cytosol Amyotrophic lateral sclerosis 1.8569913091145795 | |
| DNAH1 Cytosol Huntington disease 1.8569913091145795 | |
| DNAH1 Cytosol Pathways of neurodegeneration - multiple diseases 1.8569913091145795 | |
| DNAH11 Cytosol Summary 0.7662643429082239 | |
| DNAH12 Cytosol Summary 1.1735299161987416 | |
| DNAH14 Cytoskeleton Summary 1.1432331961187612 | |
| DNAH14 Cytosol Summary 1.1432331961187612 | |
| DNAH17 Cytoskeleton Amyotrophic lateral sclerosis 1.231849290029679 | |
| DNAH17 Cytoskeleton Huntington disease 1.231849290029679 | |
| DNAH17 Cytoskeleton Pathways of neurodegeneration - multiple diseases 1.231849290029679 | |
| DNAH17 Cytosol Amyotrophic lateral sclerosis 1.231849290029679 | |
| DNAH17 Cytosol Huntington disease 1.231849290029679 | |
| DNAH17 Cytosol Pathways of neurodegeneration - multiple diseases 1.231849290029679 | |
| DNAH17 Nucleus Amyotrophic lateral sclerosis 1.231849290029679 | |
| DNAH17 Nucleus Huntington disease 1.231849290029679 | |
| DNAH17 Nucleus Pathways of neurodegeneration - multiple diseases 1.231849290029679 | |
| DNAH17 Plasma membrane Amyotrophic lateral sclerosis 1.231849290029679 | |
| DNAH17 Plasma membrane Huntington disease 1.231849290029679 | |
| DNAH17 Plasma membrane Pathways of neurodegeneration - multiple diseases 1.231849290029679 | |
| DNAH2 Cytoskeleton Amyotrophic lateral sclerosis 1.5166428066989244 | |
| DNAH2 Cytoskeleton Huntington disease 1.5166428066989244 | |
| DNAH2 Cytoskeleton Pathways of neurodegeneration - multiple diseases 1.5166428066989244 | |
| DNAH2 Cytosol Amyotrophic lateral sclerosis 1.5166428066989244 | |
| DNAH2 Cytosol Huntington disease 1.5166428066989244 | |
| DNAH2 Cytosol Pathways of neurodegeneration - multiple diseases 1.5166428066989244 | |
| DNAH3 Cytoskeleton Amyotrophic lateral sclerosis 0.8622078093314502 | |
| DNAH3 Cytoskeleton Huntington disease 0.8622078093314502 | |
| DNAH3 Cytoskeleton Pathways of neurodegeneration - multiple diseases 0.8622078093314502 | |
| DNAH3 Cytosol Amyotrophic lateral sclerosis 0.8622078093314502 | |
| DNAH3 Cytosol Huntington disease 0.8622078093314502 | |
| DNAH3 Cytosol Pathways of neurodegeneration - multiple diseases 0.8622078093314502 | |
| DNAH3 Nucleus Amyotrophic lateral sclerosis 0.8622078093314502 | |
| DNAH3 Nucleus Huntington disease 0.8622078093314502 | |
| DNAH3 Nucleus Pathways of neurodegeneration - multiple diseases 0.8622078093314502 | |
| DNAH5 Cytosol Summary 1.167504610563329 | |
| DNAH6 Cytosol Summary 1.4582902169310872 | |
| DNAH8 Cytoskeleton Amyotrophic lateral sclerosis 1.1643419640081332 | |
| DNAH8 Cytoskeleton Huntington disease 1.1643419640081332 | |
| DNAH8 Cytoskeleton Pathways of neurodegeneration - multiple diseases 1.1643419640081332 | |
| DNAH8 Cytosol Amyotrophic lateral sclerosis 1.1643419640081332 | |
| DNAH8 Cytosol Huntington disease 1.1643419640081332 | |
| DNAH8 Cytosol Pathways of neurodegeneration - multiple diseases 1.1643419640081332 | |
| DNAH9 Cytoskeleton Amyotrophic lateral sclerosis 1.7276338672733182 | |
| DNAH9 Cytoskeleton Huntington disease 1.7276338672733182 | |
| DNAH9 Cytoskeleton Pathways of neurodegeneration - multiple diseases 1.7276338672733182 | |
| DNAH9 Cytosol Amyotrophic lateral sclerosis 1.7276338672733182 | |
| DNAH9 Cytosol Huntington disease 1.7276338672733182 | |
| DNAH9 Cytosol Pathways of neurodegeneration - multiple diseases 1.7276338672733182 | |
| DNAI2 Cytosol Summary 0.3889689117831191 | |
| DNAJA1 Cytoskeleton Summary 1.7636112392410042 | |
| DNAJA1 Cytosol Summary 1.7636112392410042 | |
| DNAJA2 Cytoskeleton Summary 1.3456578836273938 | |
| DNAJA2 Cytosol Summary 1.3456578836273938 | |
| DNAJA2 Nucleus Summary 1.3456578836273938 | |
| DNAJA3 Cytosol Viral carcinogenesis 1.8520235607994284 | |
| DNAJA3 Mitochondrion Viral carcinogenesis 1.8520235607994284 | |
| DNAJA3 Nucleus Viral carcinogenesis 1.8520235607994284 | |
| DNAJA4 Cytosol Summary 0.6034069886529361 | |
| DNAJA4 Plasma membrane Summary 0.6034069886529361 | |
| DNAJB1 Cytosol Influenza A 1.4435468321935354 | |
| DNAJB1 Cytosol Protein processing in endoplasmic reticulum 1.4435468321935354 | |
| DNAJB1 Nucleus Influenza A 1.4435468321935354 | |
| DNAJB1 Nucleus Protein processing in endoplasmic reticulum 1.4435468321935354 | |
| DNAJB11 Endoplasmic Reticulum Protein processing in endoplasmic reticulum 1.684993642121157 | |
| DNAJB12 Endoplasmic Reticulum Summary 0.9562325383694832 | |
| DNAJB12 Nucleus Summary 0.9562325383694832 | |
| DNAJB14 Endoplasmic Reticulum Summary 0.6861344136082461 | |
| DNAJB2 Cytosol Summary 1.962744360074532 | |
| DNAJB2 Nucleus Summary 1.962744360074532 | |
| DNAJB4 Cytosol Summary 2.1395578485645363 | |
| DNAJB4 Nucleus Summary 2.1395578485645363 | |
| DNAJB4 Plasma membrane Summary 2.1395578485645363 | |
| DNAJB6 Cytosol Summary 1.4316114572261205 | |
| DNAJB6 Nucleus Summary 1.4316114572261205 | |
| DNAJB9 Cytosol Summary 1.426706373442486 | |
| DNAJB9 Endoplasmic Reticulum Summary 1.426706373442486 | |
| DNAJC1 Endoplasmic Reticulum Protein processing in endoplasmic reticulum 0.17558506327742526 | |
| DNAJC1 Nucleus Protein processing in endoplasmic reticulum 0.17558506327742526 | |
| DNAJC10 Endoplasmic Reticulum Protein processing in endoplasmic reticulum 1.2055891308193858 | |
| DNAJC11 Cytosol Summary 1.285639311703705 | |
| DNAJC11 Mitochondrion Summary 1.285639311703705 | |
| DNAJC12 Cytosol Summary 0.06490224162216833 | |
| DNAJC12 Nucleus Summary 0.06490224162216833 | |
| DNAJC13 Cytosol Summary 0.9126764200870936 | |
| DNAJC13 Endosome Summary 0.9126764200870936 | |
| DNAJC14 Endoplasmic Reticulum Summary 0.4248014090437944 | |
| DNAJC16 Cytosol Summary 0.7782947754000931 | |
| DNAJC17 Cytosol Summary 1.1571232646404557 | |
| DNAJC17 Nucleus Summary 1.1571232646404557 | |
| DNAJC19 Mitochondrion Summary 1.3336661476999638 | |
| DNAJC2 Cytosol Summary 2.291144620116627 | |
| DNAJC2 Nucleus Summary 2.291144620116627 | |
| DNAJC21 Cytosol Summary 1.3717484430805191 | |
| DNAJC21 Nucleus Summary 1.3717484430805191 | |
| DNAJC25 Cytosol Summary 0.6544099146864428 | |
| DNAJC25 Nucleus Summary 0.6544099146864428 | |
| DNAJC25-GNG10 Plasma membrane Summary 1.094648638030833 | |
| DNAJC3 Endoplasmic Reticulum Summary 1.5555700472057636 | |
| DNAJC30 Mitochondrion Summary 1.2084544780616668 | |
| DNAJC5 Cytosol Protein processing in endoplasmic reticulum 0.6063088103971878 | |
| DNAJC5 Golgi apparatus Protein processing in endoplasmic reticulum 0.6063088103971878 | |
| DNAJC5 Plasma membrane Protein processing in endoplasmic reticulum 0.6063088103971878 | |
| DNAJC6 Cytosol Summary 3.275991842413592 | |
| DNAJC6 Nucleus Summary 3.275991842413592 | |
| DNAJC6 Plasma membrane Summary 3.275991842413592 | |
| DNAJC7 Cytoskeleton Summary 1.6008473301777422 | |
| DNAJC7 Cytosol Summary 1.6008473301777422 | |
| DNAJC7 Nucleus Summary 1.6008473301777422 | |
| DNAJC8 Nucleus Summary 1.3153357636036849 | |
| DNAJC9 Nucleus Summary 2.6458788321236817 | |
| DNAJC9 Plasma membrane Summary 2.6458788321236817 | |
| DNAL1 Cytosol Summary 0.4963637490735236 | |
| DNAL1 Nucleus Summary 0.4963637490735236 | |
| DNAL4 Cytoskeleton Amyotrophic lateral sclerosis 0.5731935254564425 | |
| DNAL4 Cytoskeleton Huntington disease 0.5731935254564425 | |
| DNAL4 Cytoskeleton Pathways of neurodegeneration - multiple diseases 0.5731935254564425 | |
| DNAL4 Cytosol Amyotrophic lateral sclerosis 0.5731935254564425 | |
| DNAL4 Cytosol Huntington disease 0.5731935254564425 | |
| DNAL4 Cytosol Pathways of neurodegeneration - multiple diseases 0.5731935254564425 | |
| DNAL4 Nucleus Amyotrophic lateral sclerosis 0.5731935254564425 | |
| DNAL4 Nucleus Huntington disease 0.5731935254564425 | |
| DNAL4 Nucleus Pathways of neurodegeneration - multiple diseases 0.5731935254564425 | |
| DNASE2 Lysosome Lysosome 2.040383350175777 | |
| DNHD1 Nucleus Summary 1.0068092378352038 | |
| DNLZ Mitochondrion Summary 1.5510156605872705 | |
| DNLZ Nucleus Summary 1.5510156605872705 | |
| DNM1 Cytoskeleton Bacterial invasion of epithelial cells 0.9471508227499692 | |
| DNM1 Cytoskeleton Endocrine and other factor-regulated calcium reabsorption 0.9471508227499692 | |
| DNM1 Cytoskeleton Endocytosis 0.9471508227499692 | |
| DNM1 Cytoskeleton Phospholipase D signaling pathway 0.9471508227499692 | |
| DNM1 Cytoskeleton Synaptic vesicle cycle 0.9471508227499692 | |
| DNM1 Cytosol Bacterial invasion of epithelial cells 0.9471508227499692 | |
| DNM1 Cytosol Endocrine and other factor-regulated calcium reabsorption 0.9471508227499692 | |
| DNM1 Cytosol Endocytosis 0.9471508227499692 | |
| DNM1 Cytosol Phospholipase D signaling pathway 0.9471508227499692 | |
| DNM1 Cytosol Synaptic vesicle cycle 0.9471508227499692 | |
| DNM1 Nucleus Bacterial invasion of epithelial cells 0.9471508227499692 | |
| DNM1 Nucleus Endocrine and other factor-regulated calcium reabsorption 0.9471508227499692 | |
| DNM1 Nucleus Endocytosis 0.9471508227499692 | |
| DNM1 Nucleus Phospholipase D signaling pathway 0.9471508227499692 | |
| DNM1 Nucleus Synaptic vesicle cycle 0.9471508227499692 | |
| DNM1L Cytosol NOD-like receptor signaling pathway 1.732845642664144 | |
| DNM1L Cytosol Necroptosis 1.732845642664144 | |
| DNM1L Cytosol TNF signaling pathway 1.732845642664144 | |
| DNM1L Golgi apparatus NOD-like receptor signaling pathway 1.732845642664144 | |
| DNM1L Golgi apparatus Necroptosis 1.732845642664144 | |
| DNM1L Golgi apparatus TNF signaling pathway 1.732845642664144 | |
| DNM1L Mitochondrion NOD-like receptor signaling pathway 1.732845642664144 | |
| DNM1L Mitochondrion Necroptosis 1.732845642664144 | |
| DNM1L Mitochondrion TNF signaling pathway 1.732845642664144 | |
| DNM2 Cytoskeleton Bacterial invasion of epithelial cells 1.3991123363089388 | |
| DNM2 Cytoskeleton Endocrine and other factor-regulated calcium reabsorption 1.3991123363089388 | |
| DNM2 Cytoskeleton Endocytosis 1.3991123363089388 | |
| DNM2 Cytoskeleton Fc gamma R-mediated phagocytosis 1.3991123363089388 | |
| DNM2 Cytoskeleton Phospholipase D signaling pathway 1.3991123363089388 | |
| DNM2 Cytoskeleton Salmonella infection 1.3991123363089388 | |
| DNM2 Cytoskeleton Synaptic vesicle cycle 1.3991123363089388 | |
| DNM2 Cytosol Bacterial invasion of epithelial cells 1.3991123363089388 | |
| DNM2 Cytosol Endocrine and other factor-regulated calcium reabsorption 1.3991123363089388 | |
| DNM2 Cytosol Endocytosis 1.3991123363089388 | |
| DNM2 Cytosol Fc gamma R-mediated phagocytosis 1.3991123363089388 | |
| DNM2 Cytosol Phospholipase D signaling pathway 1.3991123363089388 | |
| DNM2 Cytosol Salmonella infection 1.3991123363089388 | |
| DNM2 Cytosol Synaptic vesicle cycle 1.3991123363089388 | |
| DNM2 Golgi apparatus Bacterial invasion of epithelial cells 1.3991123363089388 | |
| DNM2 Golgi apparatus Endocrine and other factor-regulated calcium reabsorption 1.3991123363089388 | |
| DNM2 Golgi apparatus Endocytosis 1.3991123363089388 | |
| DNM2 Golgi apparatus Fc gamma R-mediated phagocytosis 1.3991123363089388 | |
| DNM2 Golgi apparatus Phospholipase D signaling pathway 1.3991123363089388 | |
| DNM2 Golgi apparatus Salmonella infection 1.3991123363089388 | |
| DNM2 Golgi apparatus Synaptic vesicle cycle 1.3991123363089388 | |
| DNM3 Cytosol Summary 0.4069841259214956 | |
| DNM3 Golgi apparatus Summary 0.4069841259214956 | |
| DNMBP Cytosol Summary 0.7440795350913054 | |
| DNMBP Golgi apparatus Summary 0.7440795350913054 | |
| DNMBP Nucleus Summary 0.7440795350913054 | |
| DNMT1 Endoplasmic Reticulum Cysteine and methionine metabolism 1.6276981911926371 | |
| DNMT1 Endoplasmic Reticulum Metabolic pathways 1.6276981911926371 | |
| DNMT1 Endoplasmic Reticulum MicroRNAs in cancer 1.6276981911926371 | |
| DNMT1 Nucleus Cysteine and methionine metabolism 1.6276981911926371 | |
| DNMT1 Nucleus Metabolic pathways 1.6276981911926371 | |
| DNMT1 Nucleus MicroRNAs in cancer 1.6276981911926371 | |
| DNMT3A Nucleus Cysteine and methionine metabolism 2.330590846993139 | |
| DNMT3A Nucleus Metabolic pathways 2.330590846993139 | |
| DNMT3A Nucleus MicroRNAs in cancer 2.330590846993139 | |
| DNPEP Cytosol Summary 0.5091506684219871 | |
| DNPH1 Cytosol Summary 1.3049992106548485 | |
| DNPH1 Nucleus Summary 1.3049992106548485 | |
| DNTTIP1 Mitochondrion Summary 0.9803197888799938 | |
| DNTTIP1 Nucleus Summary 0.9803197888799938 | |
| DNTTIP2 Mitochondrion Summary 1.9688941228928871 | |
| DNTTIP2 Nucleus Summary 1.9688941228928871 | |
| DOCK1 Cytosol Summary 0.8536431725168832 | |
| DOCK1 Nucleus Summary 0.8536431725168832 | |
| DOCK11 Nucleus Summary 1.5588967746682911 | |
| DOCK3 Cytosol Summary 0.9290722010249778 | |
| DOCK4 Cytosol Rap1 signaling pathway 1.1904205547255906 | |
| DOCK4 Golgi apparatus Rap1 signaling pathway 1.1904205547255906 | |
| DOCK4 Nucleus Rap1 signaling pathway 1.1904205547255906 | |
| DOCK4 Plasma membrane Rap1 signaling pathway 1.1904205547255906 | |
| DOCK5 Cytosol Summary 1.1746460890855797 | |
| DOCK6 Cytosol Summary 1.1296369179174643 | |
| DOCK8 Cytoskeleton Summary 1.424774804054462 | |
| DOCK8 Cytosol Summary 1.424774804054462 | |
| DOCK8 Mitochondrion Summary 1.424774804054462 | |
| DOCK8 Nucleus Summary 1.424774804054462 | |
| DOHH Cytosol Summary 1.4391837644815948 | |
| DOHH Nucleus Summary 1.4391837644815948 | |
| DOK1 Cytosol Summary 1.1822149813759002 | |
| DOK1 Nucleus Summary 1.1822149813759002 | |
| DOK2 Cytosol Summary 2.024238132808442 | |
| DOK2 Golgi apparatus Summary 2.024238132808442 | |
| DOK2 Nucleus Summary 2.024238132808442 | |
| DOK3 Cytosol Summary 1.7534031147004503 | |
| DOK3 Nucleus Summary 1.7534031147004503 | |
| DOK3 Plasma membrane Summary 1.7534031147004503 | |
| DOPEY1 Cytosol Summary 1.846195327231683 | |
| DOPEY1 Nucleus Summary 1.846195327231683 | |
| DOPEY2 Mitochondrion Summary 0.4177058873145213 | |
| DOPEY2 Nucleus Summary 0.4177058873145213 | |
| DOT1L Nucleus Summary 2.0206301732170666 | |
| DPAGT1 Endoplasmic Reticulum Metabolic pathways 1.171111102408282 | |
| DPAGT1 Endoplasmic Reticulum N-Glycan biosynthesis 1.171111102408282 | |
| DPCD Nucleus Summary 0.9262981940698112 | |
| DPF1 Cytosol Summary 1.5854427810599174 | |
| DPF1 Mitochondrion Summary 1.5854427810599174 | |
| DPF1 Nucleus Summary 1.5854427810599174 | |
| DPF2 Nucleus Summary 1.5845477373513732 | |
| DPF3 Nucleus Summary 1.6118939098710172 | |
| DPH1 Nucleus Summary 1.8035738184107288 | |
| DPH1 Plasma membrane Summary 1.8035738184107288 | |
| DPH2 Nucleus Summary 1.6629349837113327 | |
| DPH3 Cytosol Summary 1.5047864743697728 | |
| DPH3 Nucleus Summary 1.5047864743697728 | |
| DPH5 Golgi apparatus Summary 1.6711617137492605 | |
| DPH5 Nucleus Summary 1.6711617137492605 | |
| DPH6 Nucleus Summary 0.9036004959226732 | |
| DPH7 Nucleus Summary 1.432262001774807 | |
| DPM1 Endoplasmic Reticulum Metabolic pathways 1.2522085512234875 | |
| DPM1 Endoplasmic Reticulum N-Glycan biosynthesis 1.2522085512234875 | |
| DPM3 Endoplasmic Reticulum Metabolic pathways 0.5476204832419943 | |
| DPM3 Endoplasmic Reticulum N-Glycan biosynthesis 0.5476204832419943 | |
| DPP3 Cytosol Summary 0.7784852464642036 | |
| DPP3 Nucleus Summary 0.7784852464642036 | |
| DPP4 Extracellular space Protein digestion and absorption 0.8481389291467719 | |
| DPP4 Plasma membrane Protein digestion and absorption 0.8481389291467719 | |
| DPP7 Cytosol Summary 0.3798852140403773 | |
| DPP7 Extracellular space Summary 0.3798852140403773 | |
| DPP7 Golgi apparatus Summary 0.3798852140403773 | |
| DPP7 Lysosome Summary 0.3798852140403773 | |
| DPP8 Cytosol Summary 0.5939260015561401 | |
| DPP9 Cytosol Summary 0.7262235821489018 | |
| DPT Cytosol Summary 1.161774410189238 | |
| DPT Extracellular space Summary 1.161774410189238 | |
| DPY19L1 Cytosol Summary 0.7397634945583833 | |
| DPY30 Golgi apparatus Summary 2.287571104283489 | |
| DPY30 Nucleus Summary 2.287571104283489 | |
| DPYD Cytosol Drug metabolism - other enzymes 1.7766440401693264 | |
| DPYD Cytosol Metabolic pathways 1.7766440401693264 | |
| DPYD Cytosol Pantothenate and CoA biosynthesis 1.7766440401693264 | |
| DPYD Cytosol Pyrimidine metabolism 1.7766440401693264 | |
| DPYD Cytosol beta-Alanine metabolism 1.7766440401693264 | |
| DPYSL2 Cytosol Summary 0.38338645652122455 | |
| DPYSL2 Plasma membrane Summary 0.38338645652122455 | |
| DPYSL3 Cytosol Summary 1.0988768790832235 | |
| DPYSL4 Cytosol Summary 0.7919043285777806 | |
| DPYSL4 Mitochondrion Summary 0.7919043285777806 | |
| DPYSL5 Cytosol Summary 1.9681731115299703 | |
| DPYSL5 Nucleus Summary 1.9681731115299703 | |
| DR1 Nucleus Summary 1.2361163842386065 | |
| DRAP1 Cytosol Summary 1.2188324723550341 | |
| DRAP1 Nucleus Summary 1.2188324723550341 | |
| DRG1 Cytosol Summary 1.641446423190305 | |
| DRG1 Nucleus Summary 1.641446423190305 | |
| DRG2 Cytosol Summary 1.001901119619805 | |
| DRG2 Nucleus Summary 1.001901119619805 | |
| DROSHA Cytosol Proteoglycans in cancer 1.8189464453522304 | |
| DROSHA Cytosol Ribosome biogenesis in eukaryotes 1.8189464453522304 | |
| DROSHA Nucleus Proteoglycans in cancer 1.8189464453522304 | |
| DROSHA Nucleus Ribosome biogenesis in eukaryotes 1.8189464453522304 | |
| DSC2 Plasma membrane Arrhythmogenic right ventricular cardiomyopathy 2.4122910952885332 | |
| DSC3 Plasma membrane Arrhythmogenic right ventricular cardiomyopathy 2.0547774660766067 | |
| DSCC1 Nucleus Summary 2.3545743757188453 | |
| DSCR3 Mitochondrion Summary 1.1528892597179603 | |
| DSG1 Plasma membrane Staphylococcus aureus infection 0.6439219404673879 | |
| DSG2 Plasma membrane Arrhythmogenic right ventricular cardiomyopathy 2.2507129683471496 | |
| DSG3 Plasma membrane Summary 0.8205054966315778 | |
| DSN1 Cytosol Summary 1.0843563467136896 | |
| DSN1 Nucleus Summary 1.0843563467136896 | |
| DSP Cytoskeleton Arrhythmogenic right ventricular cardiomyopathy 1.847939383036564 | |
| DSP Cytoskeleton ECM-receptor interaction 1.847939383036564 | |
| DSP Plasma membrane Arrhythmogenic right ventricular cardiomyopathy 1.847939383036564 | |
| DSP Plasma membrane ECM-receptor interaction 1.847939383036564 | |
| DST Cytoskeleton Summary 1.0230693886284503 | |
| DST Cytosol Summary 1.0230693886284503 | |
| DST Nucleus Summary 1.0230693886284503 | |
| DSTYK Cytoskeleton Summary 1.4505725613616776 | |
| DSTYK Cytosol Summary 1.4505725613616776 | |
| DSTYK Nucleus Summary 1.4505725613616776 | |
| DTD1 Cytosol Summary 1.5457234533036517 | |
| DTD1 Nucleus Summary 1.5457234533036517 | |
| DTD2 Cytosol Summary 1.3283860676719674 | |
| DTL Cytoskeleton Cytokine-cytokine receptor interaction 1.3738831240878357 | |
| DTL Cytoskeleton Intestinal immune network for IgA production 1.3738831240878357 | |
| DTL Cytoskeleton NF-kappa B signaling pathway 1.3738831240878357 | |
| DTL Cytoskeleton Rheumatoid arthritis 1.3738831240878357 | |
| DTL Cytosol Cytokine-cytokine receptor interaction 1.3738831240878357 | |
| DTL Cytosol Intestinal immune network for IgA production 1.3738831240878357 | |
| DTL Cytosol NF-kappa B signaling pathway 1.3738831240878357 | |
| DTL Cytosol Rheumatoid arthritis 1.3738831240878357 | |
| DTL Nucleus Cytokine-cytokine receptor interaction 1.3738831240878357 | |
| DTL Nucleus Intestinal immune network for IgA production 1.3738831240878357 | |
| DTL Nucleus NF-kappa B signaling pathway 1.3738831240878357 | |
| DTL Nucleus Rheumatoid arthritis 1.3738831240878357 | |
| DTNA Cytoskeleton Summary 0.8528386592188649 | |
| DTNA Cytosol Summary 0.8528386592188649 | |
| DTNA Nucleus Summary 0.8528386592188649 | |
| DTNA Plasma membrane Summary 0.8528386592188649 | |
| DTNB Cytosol Summary 1.298963599902124 | |
| DTNB Mitochondrion Summary 1.298963599902124 | |
| DTNBP1 Cytoskeleton Summary 1.3256245306307408 | |
| DTNBP1 Cytosol Summary 1.3256245306307408 | |
| DTNBP1 Endosome Summary 1.3256245306307408 | |
| DTNBP1 Nucleus Summary 1.3256245306307408 | |
| DTWD1 Cytosol Summary 1.1170537620477758 | |
| DTWD1 Mitochondrion Summary 1.1170537620477758 | |
| DTWD1 Nucleus Summary 1.1170537620477758 | |
| DTWD2 Cytosol Summary 0.3700770092007833 | |
| DTWD2 Nucleus Summary 0.3700770092007833 | |
| DTX2 Cytosol Notch signaling pathway 1.7485946620665291 | |
| DTX2 Nucleus Notch signaling pathway 1.7485946620665291 | |
| DTX3 Cytosol Summary 0.6838443626255309 | |
| DTX3 Golgi apparatus Summary 0.6838443626255309 | |
| DTX3 Nucleus Summary 0.6838443626255309 | |
| DTX3L Cytosol Notch signaling pathway 1.3382893902445885 | |
| DTX3L Nucleus Notch signaling pathway 1.3382893902445885 | |
| DTYMK Mitochondrion Summary 1.2726266926087582 | |
| DUOX1 Plasma membrane Thyroid hormone synthesis 0.8913379879643286 | |
| DUS1L Plasma membrane Summary 1.3763106897395192 | |
| DUS2 Cytosol Summary 1.07948959297273 | |
| DUS2 Endoplasmic Reticulum Summary 1.07948959297273 | |
| DUS2 Nucleus Summary 1.07948959297273 | |
| DUS3L Cytosol Summary 1.6849592097474873 | |
| DUS3L Nucleus Summary 1.6849592097474873 | |
| DUSP11 Nucleus Summary 1.915794502548223 | |
| DUSP12 Nucleus Summary 2.3426067461459708 | |
| DUSP14 Cytosol Summary 2.0990628531616844 | |
| DUSP14 Nucleus Summary 2.0990628531616844 | |
| DUSP16 Nucleus MAPK signaling pathway 1.3999106332357194 | |
| DUSP22 Cytosol Summary 1.4119813493602549 | |
| DUSP22 Nucleus Summary 1.4119813493602549 | |
| DUSP23 Cytosol Summary 2.4062222699587204 | |
| DUSP23 Nucleus Summary 2.4062222699587204 | |
| DUSP3 Cytosol MAPK signaling pathway 1.2679065055536354 | |
| DUSP3 Nucleus MAPK signaling pathway 1.2679065055536354 | |
| DUSP3 Plasma membrane MAPK signaling pathway 1.2679065055536354 | |
| DUSP4 Nucleus MAPK signaling pathway 0.5431742803792269 | |
| DUT Mitochondrion Drug metabolism - other enzymes 1.7844149783829841 | |
| DUT Mitochondrion Metabolic pathways 1.7844149783829841 | |
| DUT Mitochondrion Pyrimidine metabolism 1.7844149783829841 | |
| DUT Nucleus Drug metabolism - other enzymes 1.7844149783829841 | |
| DUT Nucleus Metabolic pathways 1.7844149783829841 | |
| DUT Nucleus Pyrimidine metabolism 1.7844149783829841 | |
| DVL1 Plasma membrane Alzheimer disease 1.2241204506972951 | |
| DVL1 Plasma membrane Basal cell carcinoma 1.2241204506972951 | |
| DVL1 Plasma membrane Breast cancer 1.2241204506972951 | |
| DVL1 Plasma membrane Cushing syndrome 1.2241204506972951 | |
| DVL1 Plasma membrane Gastric cancer 1.2241204506972951 | |
| DVL1 Plasma membrane Hepatocellular carcinoma 1.2241204506972951 | |
| DVL1 Plasma membrane Hippo signaling pathway 1.2241204506972951 | |
| DVL1 Plasma membrane Human papillomavirus infection 1.2241204506972951 | |
| DVL1 Plasma membrane Melanogenesis 1.2241204506972951 | |
| DVL1 Plasma membrane Notch signaling pathway 1.2241204506972951 | |
| DVL1 Plasma membrane Pathways in cancer 1.2241204506972951 | |
| DVL1 Plasma membrane Pathways of neurodegeneration - multiple diseases 1.2241204506972951 | |
| DVL1 Plasma membrane Signaling pathways regulating pluripotency of stem cells 1.2241204506972951 | |
| DVL1 Plasma membrane Wnt signaling pathway 1.2241204506972951 | |
| DVL1 Plasma membrane mTOR signaling pathway 1.2241204506972951 | |
| DVL2 Nucleus Alzheimer disease 1.6532491941870415 | |
| DVL2 Nucleus Basal cell carcinoma 1.6532491941870415 | |
| DVL2 Nucleus Breast cancer 1.6532491941870415 | |
| DVL2 Nucleus Cushing syndrome 1.6532491941870415 | |
| DVL2 Nucleus Gastric cancer 1.6532491941870415 | |
| DVL2 Nucleus Hepatocellular carcinoma 1.6532491941870415 | |
| DVL2 Nucleus Hippo signaling pathway 1.6532491941870415 | |
| DVL2 Nucleus Human papillomavirus infection 1.6532491941870415 | |
| DVL2 Nucleus Melanogenesis 1.6532491941870415 | |
| DVL2 Nucleus Notch signaling pathway 1.6532491941870415 | |
| DVL2 Nucleus Pathways in cancer 1.6532491941870415 | |
| DVL2 Nucleus Pathways of neurodegeneration - multiple diseases 1.6532491941870415 | |
| DVL2 Nucleus Signaling pathways regulating pluripotency of stem cells 1.6532491941870415 | |
| DVL2 Nucleus Wnt signaling pathway 1.6532491941870415 | |
| DVL2 Nucleus mTOR signaling pathway 1.6532491941870415 | |
| DVL2 Plasma membrane Alzheimer disease 1.6532491941870415 | |
| DVL2 Plasma membrane Basal cell carcinoma 1.6532491941870415 | |
| DVL2 Plasma membrane Breast cancer 1.6532491941870415 | |
| DVL2 Plasma membrane Cushing syndrome 1.6532491941870415 | |
| DVL2 Plasma membrane Gastric cancer 1.6532491941870415 | |
| DVL2 Plasma membrane Hepatocellular carcinoma 1.6532491941870415 | |
| DVL2 Plasma membrane Hippo signaling pathway 1.6532491941870415 | |
| DVL2 Plasma membrane Human papillomavirus infection 1.6532491941870415 | |
| DVL2 Plasma membrane Melanogenesis 1.6532491941870415 | |
| DVL2 Plasma membrane Notch signaling pathway 1.6532491941870415 | |
| DVL2 Plasma membrane Pathways in cancer 1.6532491941870415 | |
| DVL2 Plasma membrane Pathways of neurodegeneration - multiple diseases 1.6532491941870415 | |
| DVL2 Plasma membrane Signaling pathways regulating pluripotency of stem cells 1.6532491941870415 | |
| DVL2 Plasma membrane Wnt signaling pathway 1.6532491941870415 | |
| DVL2 Plasma membrane mTOR signaling pathway 1.6532491941870415 | |
| DVL3 Cytoskeleton Summary 1.789969391034998 | |
| DVL3 Cytosol Summary 1.789969391034998 | |
| DXO Cytosol Summary 1.4474818209537996 | |
| DXO Nucleus Summary 1.4474818209537996 | |
| DXO Plasma membrane Summary 1.4474818209537996 | |
| DYM Golgi apparatus Summary 1.1550065396644469 | |
| DYNC1H1 Cytoskeleton Phagosome 0.9466076234727404 | |
| DYNC1H1 Cytoskeleton Salmonella infection 0.9466076234727404 | |
| DYNC1H1 Cytoskeleton Vasopressin-regulated water reabsorption 0.9466076234727404 | |
| DYNC1H1 Cytosol Phagosome 0.9466076234727404 | |
| DYNC1H1 Cytosol Salmonella infection 0.9466076234727404 | |
| DYNC1H1 Cytosol Vasopressin-regulated water reabsorption 0.9466076234727404 | |
| DYNC1I1 Cytoskeleton Phagosome 0.8721960249689109 | |
| DYNC1I1 Cytoskeleton Salmonella infection 0.8721960249689109 | |
| DYNC1I1 Cytoskeleton Vasopressin-regulated water reabsorption 0.8721960249689109 | |
| DYNC1I1 Cytosol Phagosome 0.8721960249689109 | |
| DYNC1I1 Cytosol Salmonella infection 0.8721960249689109 | |
| DYNC1I1 Cytosol Vasopressin-regulated water reabsorption 0.8721960249689109 | |
| DYNC1I2 Cytoskeleton Phagosome 1.1573196591780133 | |
| DYNC1I2 Cytoskeleton Salmonella infection 1.1573196591780133 | |
| DYNC1I2 Cytoskeleton Vasopressin-regulated water reabsorption 1.1573196591780133 | |
| DYNC1I2 Cytosol Phagosome 1.1573196591780133 | |
| DYNC1I2 Cytosol Salmonella infection 1.1573196591780133 | |
| DYNC1I2 Cytosol Vasopressin-regulated water reabsorption 1.1573196591780133 | |
| DYNC1I2 Endoplasmic Reticulum Phagosome 1.1573196591780133 | |
| DYNC1I2 Endoplasmic Reticulum Salmonella infection 1.1573196591780133 | |
| DYNC1I2 Endoplasmic Reticulum Vasopressin-regulated water reabsorption 1.1573196591780133 | |
| DYNC1I2 Nucleus Phagosome 1.1573196591780133 | |
| DYNC1I2 Nucleus Salmonella infection 1.1573196591780133 | |
| DYNC1I2 Nucleus Vasopressin-regulated water reabsorption 1.1573196591780133 | |
| DYNC1LI1 Cytoskeleton Phagosome 1.3276400191417268 | |
| DYNC1LI1 Cytoskeleton Salmonella infection 1.3276400191417268 | |
| DYNC1LI1 Cytoskeleton Vasopressin-regulated water reabsorption 1.3276400191417268 | |
| DYNC1LI1 Cytosol Phagosome 1.3276400191417268 | |
| DYNC1LI1 Cytosol Salmonella infection 1.3276400191417268 | |
| DYNC1LI1 Cytosol Vasopressin-regulated water reabsorption 1.3276400191417268 | |
| DYNC1LI2 Cytoskeleton Phagosome 1.23322297237835 | |
| DYNC1LI2 Cytoskeleton Salmonella infection 1.23322297237835 | |
| DYNC1LI2 Cytoskeleton Vasopressin-regulated water reabsorption 1.23322297237835 | |
| DYNC1LI2 Cytosol Phagosome 1.23322297237835 | |
| DYNC1LI2 Cytosol Salmonella infection 1.23322297237835 | |
| DYNC1LI2 Cytosol Vasopressin-regulated water reabsorption 1.23322297237835 | |
| DYNC2H1 Cytosol Summary 0.5810493878734836 | |
| DYNC2H1 Mitochondrion Summary 0.5810493878734836 | |
| DYNC2H1 Nucleus Summary 0.5810493878734836 | |
| DYNC2LI1 Cytosol Summary 0.5362281914961394 | |
| DYNC2LI1 Golgi apparatus Summary 0.5362281914961394 | |
| DYNLL1 Cytoskeleton Salmonella infection 1.8075691114353702 | |
| DYNLL1 Cytoskeleton Vasopressin-regulated water reabsorption 1.8075691114353702 | |
| DYNLL1 Cytosol Salmonella infection 1.8075691114353702 | |
| DYNLL1 Cytosol Vasopressin-regulated water reabsorption 1.8075691114353702 | |
| DYNLL1 Mitochondrion Salmonella infection 1.8075691114353702 | |
| DYNLL1 Mitochondrion Vasopressin-regulated water reabsorption 1.8075691114353702 | |
| DYNLL1 Nucleus Salmonella infection 1.8075691114353702 | |
| DYNLL1 Nucleus Vasopressin-regulated water reabsorption 1.8075691114353702 | |
| DYNLL2 Cytosol Summary 0.5427299351238951 | |
| DYNLL2 Nucleus Summary 0.5427299351238951 | |
| DYNLRB1 Cytoskeleton Salmonella infection 1.4293459429149158 | |
| DYNLRB1 Cytosol Salmonella infection 1.4293459429149158 | |
| DYNLT1 Golgi apparatus Summary 1.7934729323494805 | |
| DYNLT1 Nucleus Summary 1.7934729323494805 | |
| DYNLT3 Cytoskeleton Salmonella infection 1.158788300746987 | |
| DYNLT3 Nucleus Salmonella infection 1.158788300746987 | |
| DYRK1A Cytosol Summary 1.2683504176523932 | |
| DYRK1A Nucleus Summary 1.2683504176523932 | |
| DYRK1B Mitochondrion Summary 1.0663508125138608 | |
| DYRK1B Nucleus Summary 1.0663508125138608 | |
| DYSF Cytoskeleton Summary 2.31648059809884 | |
| DYSF Cytosol Summary 2.31648059809884 | |
| DYSF Plasma membrane Summary 2.31648059809884 | |
| DZIP3 Cytosol Summary 1.2650611746830007 | |
| E2F3 Cytosol Bladder cancer 2.9844013118897914 | |
| E2F3 Cytosol Breast cancer 2.9844013118897914 | |
| E2F3 Cytosol Cell cycle 2.9844013118897914 | |
| E2F3 Cytosol Cellular senescence 2.9844013118897914 | |
| E2F3 Cytosol Chronic myeloid leukemia 2.9844013118897914 | |
| E2F3 Cytosol Cushing syndrome 2.9844013118897914 | |
| E2F3 Cytosol Endocrine resistance 2.9844013118897914 | |
| E2F3 Cytosol Epstein-Barr virus infection 2.9844013118897914 | |
| E2F3 Cytosol Gastric cancer 2.9844013118897914 | |
| E2F3 Cytosol Glioma 2.9844013118897914 | |
| E2F3 Cytosol Hepatitis B 2.9844013118897914 | |
| E2F3 Cytosol Hepatitis C 2.9844013118897914 | |
| E2F3 Cytosol Hepatocellular carcinoma 2.9844013118897914 | |
| E2F3 Cytosol Human T-cell leukemia virus 1 infection 2.9844013118897914 | |
| E2F3 Cytosol Human cytomegalovirus infection 2.9844013118897914 | |
| E2F3 Cytosol Kaposi sarcoma-associated herpesvirus infection 2.9844013118897914 | |
| E2F3 Cytosol Melanoma 2.9844013118897914 | |
| E2F3 Cytosol MicroRNAs in cancer 2.9844013118897914 | |
| E2F3 Cytosol Non-small cell lung cancer 2.9844013118897914 | |
| E2F3 Cytosol Pancreatic cancer 2.9844013118897914 | |
| E2F3 Cytosol Pathways in cancer 2.9844013118897914 | |
| E2F3 Cytosol Prostate cancer 2.9844013118897914 | |
| E2F3 Cytosol Small cell lung cancer 2.9844013118897914 | |
| E2F3 Nucleus Bladder cancer 2.9844013118897914 | |
| E2F3 Nucleus Breast cancer 2.9844013118897914 | |
| E2F3 Nucleus Cell cycle 2.9844013118897914 | |
| E2F3 Nucleus Cellular senescence 2.9844013118897914 | |
| E2F3 Nucleus Chronic myeloid leukemia 2.9844013118897914 | |
| E2F3 Nucleus Cushing syndrome 2.9844013118897914 | |
| E2F3 Nucleus Endocrine resistance 2.9844013118897914 | |
| E2F3 Nucleus Epstein-Barr virus infection 2.9844013118897914 | |
| E2F3 Nucleus Gastric cancer 2.9844013118897914 | |
| E2F3 Nucleus Glioma 2.9844013118897914 | |
| E2F3 Nucleus Hepatitis B 2.9844013118897914 | |
| E2F3 Nucleus Hepatitis C 2.9844013118897914 | |
| E2F3 Nucleus Hepatocellular carcinoma 2.9844013118897914 | |
| E2F3 Nucleus Human T-cell leukemia virus 1 infection 2.9844013118897914 | |
| E2F3 Nucleus Human cytomegalovirus infection 2.9844013118897914 | |
| E2F3 Nucleus Kaposi sarcoma-associated herpesvirus infection 2.9844013118897914 | |
| E2F3 Nucleus Melanoma 2.9844013118897914 | |
| E2F3 Nucleus MicroRNAs in cancer 2.9844013118897914 | |
| E2F3 Nucleus Non-small cell lung cancer 2.9844013118897914 | |
| E2F3 Nucleus Pancreatic cancer 2.9844013118897914 | |
| E2F3 Nucleus Pathways in cancer 2.9844013118897914 | |
| E2F3 Nucleus Prostate cancer 2.9844013118897914 | |
| E2F3 Nucleus Small cell lung cancer 2.9844013118897914 | |
| E2F4 Nucleus Cell cycle 1.6054832997385813 | |
| E2F4 Nucleus Cellular senescence 1.6054832997385813 | |
| E2F4 Nucleus TGF-beta signaling pathway 1.6054832997385813 | |
| E2F5 Cytosol Cell cycle 2.2491061203100347 | |
| E2F5 Cytosol Cellular senescence 2.2491061203100347 | |
| E2F5 Cytosol TGF-beta signaling pathway 2.2491061203100347 | |
| E2F5 Nucleus Cell cycle 2.2491061203100347 | |
| E2F5 Nucleus Cellular senescence 2.2491061203100347 | |
| E2F5 Nucleus TGF-beta signaling pathway 2.2491061203100347 | |
| E2F6 Nucleus Summary 1.2066949469254855 | |
| E4F1 Nucleus Summary 1.2334860140374877 | |
| EAF1 Cytosol Summary 1.1028868896388506 | |
| EAF1 Nucleus Summary 1.1028868896388506 | |
| EAPP Cytosol Summary 1.128131330590499 | |
| EAPP Golgi apparatus Summary 1.128131330590499 | |
| EAPP Nucleus Summary 1.128131330590499 | |
| EARS2 Mitochondrion Summary 1.0498939771087206 | |
| EARS2 Nucleus Summary 1.0498939771087206 | |
| EBAG9 Golgi apparatus Estrogen signaling pathway 0.754539975330985 | |
| EBF1 Cytosol Summary 1.635180481481186 | |
| EBF1 Nucleus Summary 1.635180481481186 | |
| EBNA1BP2 Mitochondrion Summary 2.6804196430698712 | |
| EBNA1BP2 Nucleus Summary 2.6804196430698712 | |
| ECD Cytosol Alzheimer disease 1.4461274092017022 | |
| ECD Cytosol Amyotrophic lateral sclerosis 1.4461274092017022 | |
| ECD Cytosol Epstein-Barr virus infection 1.4461274092017022 | |
| ECD Cytosol Homologous recombination 1.4461274092017022 | |
| ECD Cytosol Huntington disease 1.4461274092017022 | |
| ECD Cytosol Parkinson disease 1.4461274092017022 | |
| ECD Cytosol Pathways of neurodegeneration - multiple diseases 1.4461274092017022 | |
| ECD Cytosol Prion disease 1.4461274092017022 | |
| ECD Cytosol Proteasome 1.4461274092017022 | |
| ECD Cytosol Spinocerebellar ataxia 1.4461274092017022 | |
| ECD Nucleus Alzheimer disease 1.4461274092017022 | |
| ECD Nucleus Amyotrophic lateral sclerosis 1.4461274092017022 | |
| ECD Nucleus Epstein-Barr virus infection 1.4461274092017022 | |
| ECD Nucleus Homologous recombination 1.4461274092017022 | |
| ECD Nucleus Huntington disease 1.4461274092017022 | |
| ECD Nucleus Parkinson disease 1.4461274092017022 | |
| ECD Nucleus Pathways of neurodegeneration - multiple diseases 1.4461274092017022 | |
| ECD Nucleus Prion disease 1.4461274092017022 | |
| ECD Nucleus Proteasome 1.4461274092017022 | |
| ECD Nucleus Spinocerebellar ataxia 1.4461274092017022 | |
| ECE1 Endosome Summary 0.5482104416761138 | |
| ECE1 Plasma membrane Summary 0.5482104416761138 | |
| ECE2 Nucleus Summary 2.0058128841318403 | |
| ECH1 Mitochondrion Peroxisome 2.1985282313884933 | |
| ECH1 Peroxisome Peroxisome 2.1985282313884933 | |
| ECHDC1 Cytosol Summary 2.055861352094994 | |
| ECHDC2 Mitochondrion Summary 0.3868670857942344 | |
| ECHDC3 Mitochondrion Summary 2.408159395589856 | |
| ECHDC3 Nucleus Summary 2.408159395589856 | |
| ECHS1 Mitochondrion Butanoate metabolism 1.3640641471961654 | |
| ECHS1 Mitochondrion Carbon metabolism 1.3640641471961654 | |
| ECHS1 Mitochondrion Fatty acid degradation 1.3640641471961654 | |
| ECHS1 Mitochondrion Fatty acid elongation 1.3640641471961654 | |
| ECHS1 Mitochondrion Fatty acid metabolism 1.3640641471961654 | |
| ECHS1 Mitochondrion Lysine degradation 1.3640641471961654 | |
| ECHS1 Mitochondrion Metabolic pathways 1.3640641471961654 | |
| ECHS1 Mitochondrion Propanoate metabolism 1.3640641471961654 | |
| ECHS1 Mitochondrion Tryptophan metabolism 1.3640641471961654 | |
| ECHS1 Mitochondrion Valine leucine and isoleucine degradation 1.3640641471961654 | |
| ECHS1 Mitochondrion beta-Alanine metabolism 1.3640641471961654 | |
| ECI1 Mitochondrion Fatty acid degradation 1.168968717711512 | |
| ECI2 Mitochondrion Fatty acid degradation 0.5786458552136394 | |
| ECI2 Mitochondrion Peroxisome 0.5786458552136394 | |
| ECI2 Peroxisome Fatty acid degradation 0.5786458552136394 | |
| ECI2 Peroxisome Peroxisome 0.5786458552136394 | |
| ECM1 Cytosol Summary 0.5065983878066661 | |
| ECM1 Extracellular space Summary 0.5065983878066661 | |
| ECM1 Nucleus Summary 0.5065983878066661 | |
| ECM2 Endoplasmic Reticulum Summary 1.1205026664444346 | |
| ECM2 Extracellular space Summary 1.1205026664444346 | |
| ECSIT Cytosol MAPK signaling pathway 1.5870422899532777 | |
| ECSIT Mitochondrion MAPK signaling pathway 1.5870422899532777 | |
| ECSIT Nucleus MAPK signaling pathway 1.5870422899532777 | |
| ECT2 Cytoskeleton Summary 2.5462822009922568 | |
| ECT2 Cytosol Summary 2.5462822009922568 | |
| ECT2 Nucleus Summary 2.5462822009922568 | |
| ECT2 Plasma membrane Summary 2.5462822009922568 | |
| EDARADD Cytosol Summary 0.3662326072032702 | |
| EDARADD Nucleus Summary 0.3662326072032702 | |
| EDC3 Cytosol Summary 1.5851538934599234 | |
| EDC4 Cytosol RNA degradation 1.6943372176961358 | |
| EDC4 Nucleus RNA degradation 1.6943372176961358 | |
| EDEM3 Endoplasmic Reticulum Summary 1.1471058458135779 | |
| EDF1 Cytosol Summary 1.1775317799963712 | |
| EDF1 Nucleus Summary 1.1775317799963712 | |
| EDIL3 Extracellular space Summary 0.8899900744718828 | |
| EDRF1 Cytoskeleton Summary 1.887975836757915 | |
| EDRF1 Cytosol Summary 1.887975836757915 | |
| EDRF1 Nucleus Summary 1.887975836757915 | |
| EEA1 Cytosol Endocytosis 0.9317184232407786 | |
| EEA1 Cytosol Phagosome 0.9317184232407786 | |
| EEA1 Cytosol Tuberculosis 0.9317184232407786 | |
| EEA1 Endosome Endocytosis 0.9317184232407786 | |
| EEA1 Endosome Phagosome 0.9317184232407786 | |
| EEA1 Endosome Tuberculosis 0.9317184232407786 | |
| EEA1 Plasma membrane Endocytosis 0.9317184232407786 | |
| EEA1 Plasma membrane Phagosome 0.9317184232407786 | |
| EEA1 Plasma membrane Tuberculosis 0.9317184232407786 | |
| EED Nucleus Summary 1.7840743537147283 | |
| EEF1A1 Cytosol Legionellosis 1.9332824185363573 | |
| EEF1A1 Cytosol Leishmaniasis 1.9332824185363573 | |
| EEF1A1 Cytosol RNA transport 1.9332824185363573 | |
| EEF1A1 Nucleus Legionellosis 1.9332824185363573 | |
| EEF1A1 Nucleus Leishmaniasis 1.9332824185363573 | |
| EEF1A1 Nucleus RNA transport 1.9332824185363573 | |
| EEF1A2 Cytosol Summary 0.8147946846712806 | |
| EEF1A2 Nucleus Summary 0.8147946846712806 | |
| EEF1AKMT1 Cytosol Summary 0.7397022141495235 | |
| EEF1AKMT1 Plasma membrane Summary 0.7397022141495235 | |
| EEF1B2 Cytosol Summary 2.1053286509529 | |
| EEF1B2 Nucleus Summary 2.1053286509529 | |
| EEF1D Nucleus Summary 2.2772553884749995 | |
| EEF1E1 Cytosol Summary 0.9712578689937028 | |
| EEF1E1 Nucleus Summary 0.9712578689937028 | |
| EEF1G Mitochondrion Summary 1.8796337978243118 | |
| EEF2 Cytosol Summary 1.4207494499968456 | |
| EEF2 Plasma membrane Summary 1.4207494499968456 | |
| EEF2K Nucleus Summary 0.7288017492616935 | |
| EEFSEC Cytosol Summary 1.1934138455452563 | |
| EEFSEC Nucleus Summary 1.1934138455452563 | |
| EEPD1 Cytosol Summary 2.184364289471174 | |
| EEPD1 Nucleus Summary 2.184364289471174 | |
| EFCAB14 Cytosol Summary 1.0560429538376994 | |
| EFCAB14 Golgi apparatus Summary 1.0560429538376994 | |
| EFCAB14 Nucleus Summary 1.0560429538376994 | |
| EFCAB7 Cytosol Summary 1.2522736468002718 | |
| EFCAB7 Nucleus Summary 1.2522736468002718 | |
| EFCAB7 Plasma membrane Summary 1.2522736468002718 | |
| EFEMP1 Extracellular space Summary 1.7964725678861655 | |
| EFEMP1 Mitochondrion Summary 1.7964725678861655 | |
| EFEMP2 Extracellular space Summary 1.140627328419458 | |
| EFHD1 Golgi apparatus Summary 0.5007299260233761 | |
| EFHD1 Mitochondrion Summary 0.5007299260233761 | |
| EFHD1 Nucleus Summary 0.5007299260233761 | |
| EFHD2 Cytosol Summary 2.0903381634638243 | |
| EFL1 Cytosol Summary 1.4390770339975347 | |
| EFNA1 Extracellular space Axon guidance 1.1776825304682832 | |
| EFNA1 Extracellular space MAPK signaling pathway 1.1776825304682832 | |
| EFNA1 Extracellular space MicroRNAs in cancer 1.1776825304682832 | |
| EFNA1 Extracellular space PI3K-Akt signaling pathway 1.1776825304682832 | |
| EFNA1 Extracellular space Rap1 signaling pathway 1.1776825304682832 | |
| EFNA1 Extracellular space Ras signaling pathway 1.1776825304682832 | |
| EFNA1 Plasma membrane Axon guidance 1.1776825304682832 | |
| EFNA1 Plasma membrane MAPK signaling pathway 1.1776825304682832 | |
| EFNA1 Plasma membrane MicroRNAs in cancer 1.1776825304682832 | |
| EFNA1 Plasma membrane PI3K-Akt signaling pathway 1.1776825304682832 | |
| EFNA1 Plasma membrane Rap1 signaling pathway 1.1776825304682832 | |
| EFNA1 Plasma membrane Ras signaling pathway 1.1776825304682832 | |
| EFNB1 Plasma membrane Summary 1.5398457166367876 | |
| EFNB2 Cytosol Summary 0.9708878715992192 | |
| EFNB2 Nucleus Summary 0.9708878715992192 | |
| EFR3A Cytosol Summary 1.113637517140914 | |
| EFR3A Plasma membrane Summary 1.113637517140914 | |
| EFS Cytosol Summary 1.1987296795546976 | |
| EFS Nucleus Summary 1.1987296795546976 | |
| EGFLAM Extracellular space Summary 1.2782484543019628 | |
| EGFR Endoplasmic Reticulum Adherens junction 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Bladder cancer 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Breast cancer 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Calcium signaling pathway 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Central carbon metabolism in cancer 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Chemical carcinogenesis - receptor activation 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Choline metabolism in cancer 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Colorectal cancer 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Coronavirus disease - COVID-19 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Cushing syndrome 2.683009644150858 | |
| EGFR Endoplasmic Reticulum EGFR tyrosine kinase inhibitor resistance 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Endocrine resistance 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Endocytosis 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Endometrial cancer 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Epithelial cell signaling in Helicobacter pylori infection 2.683009644150858 | |
| EGFR Endoplasmic Reticulum ErbB signaling pathway 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Estrogen signaling pathway 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Focal adhesion 2.683009644150858 | |
| EGFR Endoplasmic Reticulum FoxO signaling pathway 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Gap junction 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Gastric cancer 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Glioma 2.683009644150858 | |
| EGFR Endoplasmic Reticulum GnRH signaling pathway 2.683009644150858 | |
| EGFR Endoplasmic Reticulum HIF-1 signaling pathway 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Hepatitis C 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Hepatocellular carcinoma 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Human cytomegalovirus infection 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Human papillomavirus infection 2.683009644150858 | |
| EGFR Endoplasmic Reticulum JAK-STAT signaling pathway 2.683009644150858 | |
| EGFR Endoplasmic Reticulum MAPK signaling pathway 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Melanoma 2.683009644150858 | |
| EGFR Endoplasmic Reticulum MicroRNAs in cancer 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Non-small cell lung cancer 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Oxytocin signaling pathway 2.683009644150858 | |
| EGFR Endoplasmic Reticulum PD-L1 expression and PD-1 checkpoint pathway in cancer 2.683009644150858 | |
| EGFR Endoplasmic Reticulum PI3K-Akt signaling pathway 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Pancreatic cancer 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Parathyroid hormone synthesis secretion and action 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Pathways in cancer 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Phospholipase D signaling pathway 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Prostate cancer 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Proteoglycans in cancer 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Rap1 signaling pathway 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Ras signaling pathway 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Regulation of actin cytoskeleton 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Relaxin signaling pathway 2.683009644150858 | |
| EGFR Endoplasmic Reticulum Shigellosis 2.683009644150858 | |
| EGFR Endosome Adherens junction 2.683009644150858 | |
| EGFR Endosome Bladder cancer 2.683009644150858 | |
| EGFR Endosome Breast cancer 2.683009644150858 | |
| EGFR Endosome Calcium signaling pathway 2.683009644150858 | |
| EGFR Endosome Central carbon metabolism in cancer 2.683009644150858 | |
| EGFR Endosome Chemical carcinogenesis - receptor activation 2.683009644150858 | |
| EGFR Endosome Choline metabolism in cancer 2.683009644150858 | |
| EGFR Endosome Colorectal cancer 2.683009644150858 | |
| EGFR Endosome Coronavirus disease - COVID-19 2.683009644150858 | |
| EGFR Endosome Cushing syndrome 2.683009644150858 | |
| EGFR Endosome EGFR tyrosine kinase inhibitor resistance 2.683009644150858 | |
| EGFR Endosome Endocrine resistance 2.683009644150858 | |
| EGFR Endosome Endocytosis 2.683009644150858 | |
| EGFR Endosome Endometrial cancer 2.683009644150858 | |
| EGFR Endosome Epithelial cell signaling in Helicobacter pylori infection 2.683009644150858 | |
| EGFR Endosome ErbB signaling pathway 2.683009644150858 | |
| EGFR Endosome Estrogen signaling pathway 2.683009644150858 | |
| EGFR Endosome Focal adhesion 2.683009644150858 | |
| EGFR Endosome FoxO signaling pathway 2.683009644150858 | |
| EGFR Endosome Gap junction 2.683009644150858 | |
| EGFR Endosome Gastric cancer 2.683009644150858 | |
| EGFR Endosome Glioma 2.683009644150858 | |
| EGFR Endosome GnRH signaling pathway 2.683009644150858 | |
| EGFR Endosome HIF-1 signaling pathway 2.683009644150858 | |
| EGFR Endosome Hepatitis C 2.683009644150858 | |
| EGFR Endosome Hepatocellular carcinoma 2.683009644150858 | |
| EGFR Endosome Human cytomegalovirus infection 2.683009644150858 | |
| EGFR Endosome Human papillomavirus infection 2.683009644150858 | |
| EGFR Endosome JAK-STAT signaling pathway 2.683009644150858 | |
| EGFR Endosome MAPK signaling pathway 2.683009644150858 | |
| EGFR Endosome Melanoma 2.683009644150858 | |
| EGFR Endosome MicroRNAs in cancer 2.683009644150858 | |
| EGFR Endosome Non-small cell lung cancer 2.683009644150858 | |
| EGFR Endosome Oxytocin signaling pathway 2.683009644150858 | |
| EGFR Endosome PD-L1 expression and PD-1 checkpoint pathway in cancer 2.683009644150858 | |
| EGFR Endosome PI3K-Akt signaling pathway 2.683009644150858 | |
| EGFR Endosome Pancreatic cancer 2.683009644150858 | |
| EGFR Endosome Parathyroid hormone synthesis secretion and action 2.683009644150858 | |
| EGFR Endosome Pathways in cancer 2.683009644150858 | |
| EGFR Endosome Phospholipase D signaling pathway 2.683009644150858 | |
| EGFR Endosome Prostate cancer 2.683009644150858 | |
| EGFR Endosome Proteoglycans in cancer 2.683009644150858 | |
| EGFR Endosome Rap1 signaling pathway 2.683009644150858 | |
| EGFR Endosome Ras signaling pathway 2.683009644150858 | |
| EGFR Endosome Regulation of actin cytoskeleton 2.683009644150858 | |
| EGFR Endosome Relaxin signaling pathway 2.683009644150858 | |
| EGFR Endosome Shigellosis 2.683009644150858 | |
| EGFR Extracellular space Adherens junction 2.683009644150858 | |
| EGFR Extracellular space Bladder cancer 2.683009644150858 | |
| EGFR Extracellular space Breast cancer 2.683009644150858 | |
| EGFR Extracellular space Calcium signaling pathway 2.683009644150858 | |
| EGFR Extracellular space Central carbon metabolism in cancer 2.683009644150858 | |
| EGFR Extracellular space Chemical carcinogenesis - receptor activation 2.683009644150858 | |
| EGFR Extracellular space Choline metabolism in cancer 2.683009644150858 | |
| EGFR Extracellular space Colorectal cancer 2.683009644150858 | |
| EGFR Extracellular space Coronavirus disease - COVID-19 2.683009644150858 | |
| EGFR Extracellular space Cushing syndrome 2.683009644150858 | |
| EGFR Extracellular space EGFR tyrosine kinase inhibitor resistance 2.683009644150858 | |
| EGFR Extracellular space Endocrine resistance 2.683009644150858 | |
| EGFR Extracellular space Endocytosis 2.683009644150858 | |
| EGFR Extracellular space Endometrial cancer 2.683009644150858 | |
| EGFR Extracellular space Epithelial cell signaling in Helicobacter pylori infection 2.683009644150858 | |
| EGFR Extracellular space ErbB signaling pathway 2.683009644150858 | |
| EGFR Extracellular space Estrogen signaling pathway 2.683009644150858 | |
| EGFR Extracellular space Focal adhesion 2.683009644150858 | |
| EGFR Extracellular space FoxO signaling pathway 2.683009644150858 | |
| EGFR Extracellular space Gap junction 2.683009644150858 | |
| EGFR Extracellular space Gastric cancer 2.683009644150858 | |
| EGFR Extracellular space Glioma 2.683009644150858 | |
| EGFR Extracellular space GnRH signaling pathway 2.683009644150858 | |
| EGFR Extracellular space HIF-1 signaling pathway 2.683009644150858 | |
| EGFR Extracellular space Hepatitis C 2.683009644150858 | |
| EGFR Extracellular space Hepatocellular carcinoma 2.683009644150858 | |
| EGFR Extracellular space Human cytomegalovirus infection 2.683009644150858 | |
| EGFR Extracellular space Human papillomavirus infection 2.683009644150858 | |
| EGFR Extracellular space JAK-STAT signaling pathway 2.683009644150858 | |
| EGFR Extracellular space MAPK signaling pathway 2.683009644150858 | |
| EGFR Extracellular space Melanoma 2.683009644150858 | |
| EGFR Extracellular space MicroRNAs in cancer 2.683009644150858 | |
| EGFR Extracellular space Non-small cell lung cancer 2.683009644150858 | |
| EGFR Extracellular space Oxytocin signaling pathway 2.683009644150858 | |
| EGFR Extracellular space PD-L1 expression and PD-1 checkpoint pathway in cancer 2.683009644150858 | |
| EGFR Extracellular space PI3K-Akt signaling pathway 2.683009644150858 | |
| EGFR Extracellular space Pancreatic cancer 2.683009644150858 | |
| EGFR Extracellular space Parathyroid hormone synthesis secretion and action 2.683009644150858 | |
| EGFR Extracellular space Pathways in cancer 2.683009644150858 | |
| EGFR Extracellular space Phospholipase D signaling pathway 2.683009644150858 | |
| EGFR Extracellular space Prostate cancer 2.683009644150858 | |
| EGFR Extracellular space Proteoglycans in cancer 2.683009644150858 | |
| EGFR Extracellular space Rap1 signaling pathway 2.683009644150858 | |
| EGFR Extracellular space Ras signaling pathway 2.683009644150858 | |
| EGFR Extracellular space Regulation of actin cytoskeleton 2.683009644150858 | |
| EGFR Extracellular space Relaxin signaling pathway 2.683009644150858 | |
| EGFR Extracellular space Shigellosis 2.683009644150858 | |
| EGFR Golgi apparatus Adherens junction 2.683009644150858 | |
| EGFR Golgi apparatus Bladder cancer 2.683009644150858 | |
| EGFR Golgi apparatus Breast cancer 2.683009644150858 | |
| EGFR Golgi apparatus Calcium signaling pathway 2.683009644150858 | |
| EGFR Golgi apparatus Central carbon metabolism in cancer 2.683009644150858 | |
| EGFR Golgi apparatus Chemical carcinogenesis - receptor activation 2.683009644150858 | |
| EGFR Golgi apparatus Choline metabolism in cancer 2.683009644150858 | |
| EGFR Golgi apparatus Colorectal cancer 2.683009644150858 | |
| EGFR Golgi apparatus Coronavirus disease - COVID-19 2.683009644150858 | |
| EGFR Golgi apparatus Cushing syndrome 2.683009644150858 | |
| EGFR Golgi apparatus EGFR tyrosine kinase inhibitor resistance 2.683009644150858 | |
| EGFR Golgi apparatus Endocrine resistance 2.683009644150858 | |
| EGFR Golgi apparatus Endocytosis 2.683009644150858 | |
| EGFR Golgi apparatus Endometrial cancer 2.683009644150858 | |
| EGFR Golgi apparatus Epithelial cell signaling in Helicobacter pylori infection 2.683009644150858 | |
| EGFR Golgi apparatus ErbB signaling pathway 2.683009644150858 | |
| EGFR Golgi apparatus Estrogen signaling pathway 2.683009644150858 | |
| EGFR Golgi apparatus Focal adhesion 2.683009644150858 | |
| EGFR Golgi apparatus FoxO signaling pathway 2.683009644150858 | |
| EGFR Golgi apparatus Gap junction 2.683009644150858 | |
| EGFR Golgi apparatus Gastric cancer 2.683009644150858 | |
| EGFR Golgi apparatus Glioma 2.683009644150858 | |
| EGFR Golgi apparatus GnRH signaling pathway 2.683009644150858 | |
| EGFR Golgi apparatus HIF-1 signaling pathway 2.683009644150858 | |
| EGFR Golgi apparatus Hepatitis C 2.683009644150858 | |
| EGFR Golgi apparatus Hepatocellular carcinoma 2.683009644150858 | |
| EGFR Golgi apparatus Human cytomegalovirus infection 2.683009644150858 | |
| EGFR Golgi apparatus Human papillomavirus infection 2.683009644150858 | |
| EGFR Golgi apparatus JAK-STAT signaling pathway 2.683009644150858 | |
| EGFR Golgi apparatus MAPK signaling pathway 2.683009644150858 | |
| EGFR Golgi apparatus Melanoma 2.683009644150858 | |
| EGFR Golgi apparatus MicroRNAs in cancer 2.683009644150858 | |
| EGFR Golgi apparatus Non-small cell lung cancer 2.683009644150858 | |
| EGFR Golgi apparatus Oxytocin signaling pathway 2.683009644150858 | |
| EGFR Golgi apparatus PD-L1 expression and PD-1 checkpoint pathway in cancer 2.683009644150858 | |
| EGFR Golgi apparatus PI3K-Akt signaling pathway 2.683009644150858 | |
| EGFR Golgi apparatus Pancreatic cancer 2.683009644150858 | |
| EGFR Golgi apparatus Parathyroid hormone synthesis secretion and action 2.683009644150858 | |
| EGFR Golgi apparatus Pathways in cancer 2.683009644150858 | |
| EGFR Golgi apparatus Phospholipase D signaling pathway 2.683009644150858 | |
| EGFR Golgi apparatus Prostate cancer 2.683009644150858 | |
| EGFR Golgi apparatus Proteoglycans in cancer 2.683009644150858 | |
| EGFR Golgi apparatus Rap1 signaling pathway 2.683009644150858 | |
| EGFR Golgi apparatus Ras signaling pathway 2.683009644150858 | |
| EGFR Golgi apparatus Regulation of actin cytoskeleton 2.683009644150858 | |
| EGFR Golgi apparatus Relaxin signaling pathway 2.683009644150858 | |
| EGFR Golgi apparatus Shigellosis 2.683009644150858 | |
| EGFR Nucleus Adherens junction 2.683009644150858 | |
| EGFR Nucleus Bladder cancer 2.683009644150858 | |
| EGFR Nucleus Breast cancer 2.683009644150858 | |
| EGFR Nucleus Calcium signaling pathway 2.683009644150858 | |
| EGFR Nucleus Central carbon metabolism in cancer 2.683009644150858 | |
| EGFR Nucleus Chemical carcinogenesis - receptor activation 2.683009644150858 | |
| EGFR Nucleus Choline metabolism in cancer 2.683009644150858 | |
| EGFR Nucleus Colorectal cancer 2.683009644150858 | |
| EGFR Nucleus Coronavirus disease - COVID-19 2.683009644150858 | |
| EGFR Nucleus Cushing syndrome 2.683009644150858 | |
| EGFR Nucleus EGFR tyrosine kinase inhibitor resistance 2.683009644150858 | |
| EGFR Nucleus Endocrine resistance 2.683009644150858 | |
| EGFR Nucleus Endocytosis 2.683009644150858 | |
| EGFR Nucleus Endometrial cancer 2.683009644150858 | |
| EGFR Nucleus Epithelial cell signaling in Helicobacter pylori infection 2.683009644150858 | |
| EGFR Nucleus ErbB signaling pathway 2.683009644150858 | |
| EGFR Nucleus Estrogen signaling pathway 2.683009644150858 | |
| EGFR Nucleus Focal adhesion 2.683009644150858 | |
| EGFR Nucleus FoxO signaling pathway 2.683009644150858 | |
| EGFR Nucleus Gap junction 2.683009644150858 | |
| EGFR Nucleus Gastric cancer 2.683009644150858 | |
| EGFR Nucleus Glioma 2.683009644150858 | |
| EGFR Nucleus GnRH signaling pathway 2.683009644150858 | |
| EGFR Nucleus HIF-1 signaling pathway 2.683009644150858 | |
| EGFR Nucleus Hepatitis C 2.683009644150858 | |
| EGFR Nucleus Hepatocellular carcinoma 2.683009644150858 | |
| EGFR Nucleus Human cytomegalovirus infection 2.683009644150858 | |
| EGFR Nucleus Human papillomavirus infection 2.683009644150858 | |
| EGFR Nucleus JAK-STAT signaling pathway 2.683009644150858 | |
| EGFR Nucleus MAPK signaling pathway 2.683009644150858 | |
| EGFR Nucleus Melanoma 2.683009644150858 | |
| EGFR Nucleus MicroRNAs in cancer 2.683009644150858 | |
| EGFR Nucleus Non-small cell lung cancer 2.683009644150858 | |
| EGFR Nucleus Oxytocin signaling pathway 2.683009644150858 | |
| EGFR Nucleus PD-L1 expression and PD-1 checkpoint pathway in cancer 2.683009644150858 | |
| EGFR Nucleus PI3K-Akt signaling pathway 2.683009644150858 | |
| EGFR Nucleus Pancreatic cancer 2.683009644150858 | |
| EGFR Nucleus Parathyroid hormone synthesis secretion and action 2.683009644150858 | |
| EGFR Nucleus Pathways in cancer 2.683009644150858 | |
| EGFR Nucleus Phospholipase D signaling pathway 2.683009644150858 | |
| EGFR Nucleus Prostate cancer 2.683009644150858 | |
| EGFR Nucleus Proteoglycans in cancer 2.683009644150858 | |
| EGFR Nucleus Rap1 signaling pathway 2.683009644150858 | |
| EGFR Nucleus Ras signaling pathway 2.683009644150858 | |
| EGFR Nucleus Regulation of actin cytoskeleton 2.683009644150858 | |
| EGFR Nucleus Relaxin signaling pathway 2.683009644150858 | |
| EGFR Nucleus Shigellosis 2.683009644150858 | |
| EGFR Plasma membrane Adherens junction 2.683009644150858 | |
| EGFR Plasma membrane Bladder cancer 2.683009644150858 | |
| EGFR Plasma membrane Breast cancer 2.683009644150858 | |
| EGFR Plasma membrane Calcium signaling pathway 2.683009644150858 | |
| EGFR Plasma membrane Central carbon metabolism in cancer 2.683009644150858 | |
| EGFR Plasma membrane Chemical carcinogenesis - receptor activation 2.683009644150858 | |
| EGFR Plasma membrane Choline metabolism in cancer 2.683009644150858 | |
| EGFR Plasma membrane Colorectal cancer 2.683009644150858 | |
| EGFR Plasma membrane Coronavirus disease - COVID-19 2.683009644150858 | |
| EGFR Plasma membrane Cushing syndrome 2.683009644150858 | |
| EGFR Plasma membrane EGFR tyrosine kinase inhibitor resistance 2.683009644150858 | |
| EGFR Plasma membrane Endocrine resistance 2.683009644150858 | |
| EGFR Plasma membrane Endocytosis 2.683009644150858 | |
| EGFR Plasma membrane Endometrial cancer 2.683009644150858 | |
| EGFR Plasma membrane Epithelial cell signaling in Helicobacter pylori infection 2.683009644150858 | |
| EGFR Plasma membrane ErbB signaling pathway 2.683009644150858 | |
| EGFR Plasma membrane Estrogen signaling pathway 2.683009644150858 | |
| EGFR Plasma membrane Focal adhesion 2.683009644150858 | |
| EGFR Plasma membrane FoxO signaling pathway 2.683009644150858 | |
| EGFR Plasma membrane Gap junction 2.683009644150858 | |
| EGFR Plasma membrane Gastric cancer 2.683009644150858 | |
| EGFR Plasma membrane Glioma 2.683009644150858 | |
| EGFR Plasma membrane GnRH signaling pathway 2.683009644150858 | |
| EGFR Plasma membrane HIF-1 signaling pathway 2.683009644150858 | |
| EGFR Plasma membrane Hepatitis C 2.683009644150858 | |
| EGFR Plasma membrane Hepatocellular carcinoma 2.683009644150858 | |
| EGFR Plasma membrane Human cytomegalovirus infection 2.683009644150858 | |
| EGFR Plasma membrane Human papillomavirus infection 2.683009644150858 | |
| EGFR Plasma membrane JAK-STAT signaling pathway 2.683009644150858 | |
| EGFR Plasma membrane MAPK signaling pathway 2.683009644150858 | |
| EGFR Plasma membrane Melanoma 2.683009644150858 | |
| EGFR Plasma membrane MicroRNAs in cancer 2.683009644150858 | |
| EGFR Plasma membrane Non-small cell lung cancer 2.683009644150858 | |
| EGFR Plasma membrane Oxytocin signaling pathway 2.683009644150858 | |
| EGFR Plasma membrane PD-L1 expression and PD-1 checkpoint pathway in cancer 2.683009644150858 | |
| EGFR Plasma membrane PI3K-Akt signaling pathway 2.683009644150858 | |
| EGFR Plasma membrane Pancreatic cancer 2.683009644150858 | |
| EGFR Plasma membrane Parathyroid hormone synthesis secretion and action 2.683009644150858 | |
| EGFR Plasma membrane Pathways in cancer 2.683009644150858 | |
| EGFR Plasma membrane Phospholipase D signaling pathway 2.683009644150858 | |
| EGFR Plasma membrane Prostate cancer 2.683009644150858 | |
| EGFR Plasma membrane Proteoglycans in cancer 2.683009644150858 | |
| EGFR Plasma membrane Rap1 signaling pathway 2.683009644150858 | |
| EGFR Plasma membrane Ras signaling pathway 2.683009644150858 | |
| EGFR Plasma membrane Regulation of actin cytoskeleton 2.683009644150858 | |
| EGFR Plasma membrane Relaxin signaling pathway 2.683009644150858 | |
| EGFR Plasma membrane Shigellosis 2.683009644150858 | |
| EGLN1 Cytosol HIF-1 signaling pathway 1.8112719110407225 | |
| EGLN1 Cytosol Pathways in cancer 1.8112719110407225 | |
| EGLN1 Cytosol Renal cell carcinoma 1.8112719110407225 | |
| EGLN1 Nucleus HIF-1 signaling pathway 1.8112719110407225 | |
| EGLN1 Nucleus Pathways in cancer 1.8112719110407225 | |
| EGLN1 Nucleus Renal cell carcinoma 1.8112719110407225 | |
| EHBP1 Cytosol Summary 2.662938732910251 | |
| EHBP1 Plasma membrane Summary 2.662938732910251 | |
| EHBP1L1 Endosome Summary 1.89995746278486 | |
| EHBP1L1 Nucleus Summary 1.89995746278486 | |
| EHD1 Endosome Endocytosis 1.6726920162021393 | |
| EHD1 Plasma membrane Endocytosis 1.6726920162021393 | |
| EHD2 Endosome Endocytosis 1.3744164613525491 | |
| EHD2 Plasma membrane Endocytosis 1.3744164613525491 | |
| EHD3 Endosome Endocytosis 1.8655960597513517 | |
| EHD3 Plasma membrane Endocytosis 1.8655960597513517 | |
| EHD4 Endosome Endocytosis 1.3257946381976018 | |
| EHD4 Plasma membrane Endocytosis 1.3257946381976018 | |
| EHF Golgi apparatus Summary 1.57542710175374 | |
| EHF Nucleus Summary 1.57542710175374 | |
| EHHADH Cytoskeleton Butanoate metabolism 1.4724479169514857 | |
| EHHADH Cytoskeleton Fatty acid degradation 1.4724479169514857 | |
| EHHADH Cytoskeleton Fatty acid metabolism 1.4724479169514857 | |
| EHHADH Cytoskeleton Lysine degradation 1.4724479169514857 | |
| EHHADH Cytoskeleton Metabolic pathways 1.4724479169514857 | |
| EHHADH Cytoskeleton PPAR signaling pathway 1.4724479169514857 | |
| EHHADH Cytoskeleton Peroxisome 1.4724479169514857 | |
| EHHADH Cytoskeleton Propanoate metabolism 1.4724479169514857 | |
| EHHADH Cytoskeleton Tryptophan metabolism 1.4724479169514857 | |
| EHHADH Cytoskeleton Valine leucine and isoleucine degradation 1.4724479169514857 | |
| EHHADH Cytoskeleton beta-Alanine metabolism 1.4724479169514857 | |
| EHHADH Peroxisome Butanoate metabolism 1.4724479169514857 | |
| EHHADH Peroxisome Fatty acid degradation 1.4724479169514857 | |
| EHHADH Peroxisome Fatty acid metabolism 1.4724479169514857 | |
| EHHADH Peroxisome Lysine degradation 1.4724479169514857 | |
| EHHADH Peroxisome Metabolic pathways 1.4724479169514857 | |
| EHHADH Peroxisome PPAR signaling pathway 1.4724479169514857 | |
| EHHADH Peroxisome Peroxisome 1.4724479169514857 | |
| EHHADH Peroxisome Propanoate metabolism 1.4724479169514857 | |
| EHHADH Peroxisome Tryptophan metabolism 1.4724479169514857 | |
| EHHADH Peroxisome Valine leucine and isoleucine degradation 1.4724479169514857 | |
| EHHADH Peroxisome beta-Alanine metabolism 1.4724479169514857 | |
| EHMT1 Nucleus Longevity regulating pathway 1.040327629721216 | |
| EHMT1 Nucleus Lysine degradation 1.040327629721216 | |
| EHMT1 Nucleus Metabolic pathways 1.040327629721216 | |
| EHMT2 Nucleus Longevity regulating pathway 1.5904420422336036 | |
| EHMT2 Nucleus Lysine degradation 1.5904420422336036 | |
| EHMT2 Nucleus Metabolic pathways 1.5904420422336036 | |
| EI24 Cytosol p53 signaling pathway 1.2903001909330585 | |
| EI24 Endoplasmic Reticulum p53 signaling pathway 1.2903001909330585 | |
| EI24 Golgi apparatus p53 signaling pathway 1.2903001909330585 | |
| EI24 Nucleus p53 signaling pathway 1.2903001909330585 | |
| EIF1 Nucleus Summary 1.837094176184064 | |
| EIF1AD Cytoskeleton Summary 2.397505464502982 | |
| EIF1AD Cytosol Summary 2.397505464502982 | |
| EIF1AD Nucleus Summary 2.397505464502982 | |
| EIF1AX Cytosol Summary 1.83427107507487 | |
| EIF2A Cytosol Summary 2.2547237105099764 | |
| EIF2A Mitochondrion Summary 2.2547237105099764 | |
| EIF2AK1 Cytosol Summary 1.2487790372518406 | |
| EIF2AK1 Nucleus Summary 1.2487790372518406 | |
| EIF2AK2 Cytosol Summary 1.6517750129473348 | |
| EIF2AK3 Endoplasmic Reticulum Alzheimer disease 0.9670108990539706 | |
| EIF2AK3 Endoplasmic Reticulum Amyotrophic lateral sclerosis 0.9670108990539706 | |
| EIF2AK3 Endoplasmic Reticulum Apoptosis 0.9670108990539706 | |
| EIF2AK3 Endoplasmic Reticulum Autophagy - animal 0.9670108990539706 | |
| EIF2AK3 Endoplasmic Reticulum Hepatitis C 0.9670108990539706 | |
| EIF2AK3 Endoplasmic Reticulum Herpes simplex virus 1 infection 0.9670108990539706 | |
| EIF2AK3 Endoplasmic Reticulum Lipid and atherosclerosis 0.9670108990539706 | |
| EIF2AK3 Endoplasmic Reticulum Measles 0.9670108990539706 | |
| EIF2AK3 Endoplasmic Reticulum Mitophagy - animal 0.9670108990539706 | |
| EIF2AK3 Endoplasmic Reticulum Non-alcoholic fatty liver disease 0.9670108990539706 | |
| EIF2AK3 Endoplasmic Reticulum Parkinson disease 0.9670108990539706 | |
| EIF2AK3 Endoplasmic Reticulum Pathways of neurodegeneration - multiple diseases 0.9670108990539706 | |
| EIF2AK3 Endoplasmic Reticulum Prion disease 0.9670108990539706 | |
| EIF2AK3 Endoplasmic Reticulum Protein processing in endoplasmic reticulum 0.9670108990539706 | |
| EIF2AK4 Cytosol Summary 0.8067807801183927 | |
| EIF2B1 Cytosol Summary 1.48423237687274 | |
| EIF2B2 Nucleus Summary 1.000622741495353 | |
| EIF2B2 Plasma membrane Summary 1.000622741495353 | |
| EIF2B5 Cytosol Summary 1.036327188818448 | |
| EIF2D Cytosol Summary 1.2379658091648138 | |
| EIF2D Nucleus Summary 1.2379658091648138 | |
| EIF2S2 Endoplasmic Reticulum Summary 1.3392305712994372 | |
| EIF2S2 Nucleus Summary 1.3392305712994372 | |
| EIF3CL Cytosol Summary 1.749418673284775 | |
| EIF3J Cytosol Summary 1.2780414622534042 | |
| EIF3K Cytosol Summary 1.1071671582084108 | |
| EIF3K Nucleus Summary 1.1071671582084108 | |
| EIF3M Cytosol Summary 1.4560770598994843 | |
| EIF4A2 Cytosol Summary 1.1012727374424651 | |
| EIF4A3 Nucleus Summary 1.6341246647680918 | |
| EIF4B Cytosol Summary 0.8493745483147526 | |
| EIF4E Cytosol Summary 1.2338165239531178 | |
| EIF4E Nucleus Summary 1.2338165239531178 | |
| EIF4E2 Cytosol Summary 1.239643434125846 | |
| EIF4E2 Mitochondrion Summary 1.239643434125846 | |
| EIF4E3 Nucleus Summary 0.8393314438004997 | |
| EIF4EBP1 Cytosol Summary 1.2956145705681323 | |
| EIF4EBP1 Nucleus Summary 1.2956145705681323 | |
| EIF4EBP2 Mitochondrion Summary 0.7797139762966225 | |
| EIF4EBP2 Nucleus Summary 0.7797139762966225 | |
| EIF4ENIF1 Cytosol Summary 0.8613310463200593 | |
| EIF4ENIF1 Nucleus Summary 0.8613310463200593 | |
| EIF4G1 Cytosol Summary 1.6742638744608 | |
| EIF4G2 Cytosol Summary 1.6276941505651918 | |
| EIF4G3 Cytosol Summary 0.6369172098633319 | |
| EIF4H Cytosol Summary 1.7419517679226826 | |
| EIF4H Nucleus Summary 1.7419517679226826 | |
| EIF5 Cytosol RNA transport 1.6009165314347522 | |
| EIF5 Plasma membrane RNA transport 1.6009165314347522 | |
| EIF5A Cytosol Summary 1.8283228718233973 | |
| EIF5A Endoplasmic Reticulum Summary 1.8283228718233973 | |
| EIF5A Nucleus Summary 1.8283228718233973 | |
| EIF5A2 Cytosol Summary 1.4638586005039445 | |
| EIF5A2 Endoplasmic Reticulum Summary 1.4638586005039445 | |
| EIF5B Cytosol Summary 1.392644157529284 | |
| EIF5B Plasma membrane Summary 1.392644157529284 | |
| EIF6 Nucleus Ribosome biogenesis in eukaryotes 1.6953314602313159 | |
| ELAC1 Cytosol Summary 1.4953855856288132 | |
| ELAC1 Nucleus Summary 1.4953855856288132 | |
| ELAC2 Mitochondrion Summary 2.4386349632486994 | |
| ELAC2 Nucleus Summary 2.4386349632486994 | |
| ELANE Cytosol Neutrophil extracellular trap formation 1.1172560297455545 | |
| ELANE Cytosol Systemic lupus erythematosus 1.1172560297455545 | |
| ELANE Cytosol Transcriptional misregulation in cancer 1.1172560297455545 | |
| ELANE Extracellular space Neutrophil extracellular trap formation 1.1172560297455545 | |
| ELANE Extracellular space Systemic lupus erythematosus 1.1172560297455545 | |
| ELANE Extracellular space Transcriptional misregulation in cancer 1.1172560297455545 | |
| ELAVL1 Cytosol AMPK signaling pathway 1.9834980100924997 | |
| ELAVL1 Cytosol IL-17 signaling pathway 1.9834980100924997 | |
| ELAVL1 Nucleus AMPK signaling pathway 1.9834980100924997 | |
| ELAVL1 Nucleus IL-17 signaling pathway 1.9834980100924997 | |
| ELF1 Cytosol Summary 1.1370568848940414 | |
| ELF1 Nucleus Summary 1.1370568848940414 | |
| ELF3 Cytosol Summary 1.9128630289928228 | |
| ELF3 Nucleus Summary 1.9128630289928228 | |
| ELK1 Nucleus Endometrial cancer 1.3938261456434409 | |
| ELK1 Nucleus ErbB signaling pathway 1.3938261456434409 | |
| ELK1 Nucleus Focal adhesion 1.3938261456434409 | |
| ELK1 Nucleus GnRH signaling pathway 1.3938261456434409 | |
| ELK1 Nucleus Hepatitis B 1.3938261456434409 | |
| ELK1 Nucleus Hepatocellular carcinoma 1.3938261456434409 | |
| ELK1 Nucleus Human T-cell leukemia virus 1 infection 1.3938261456434409 | |
| ELK1 Nucleus Human cytomegalovirus infection 1.3938261456434409 | |
| ELK1 Nucleus Insulin signaling pathway 1.3938261456434409 | |
| ELK1 Nucleus Leishmaniasis 1.3938261456434409 | |
| ELK1 Nucleus MAPK signaling pathway 1.3938261456434409 | |
| ELK1 Nucleus Oxytocin signaling pathway 1.3938261456434409 | |
| ELK1 Nucleus Pathways in cancer 1.3938261456434409 | |
| ELK1 Nucleus Proteoglycans in cancer 1.3938261456434409 | |
| ELK1 Nucleus Ras signaling pathway 1.3938261456434409 | |
| ELK3 Mitochondrion Summary 1.2258393708643862 | |
| ELK3 Nucleus Summary 1.2258393708643862 | |
| ELL Cytosol Summary 1.6551007557267121 | |
| ELL Nucleus Summary 1.6551007557267121 | |
| ELMO1 Cytosol Bacterial invasion of epithelial cells 1.6266217187790233 | |
| ELMO1 Cytosol Chemokine signaling pathway 1.6266217187790233 | |
| ELMO1 Cytosol Salmonella infection 1.6266217187790233 | |
| ELMO1 Cytosol Shigellosis 1.6266217187790233 | |
| ELMO1 Cytosol Yersinia infection 1.6266217187790233 | |
| ELMO1 Plasma membrane Bacterial invasion of epithelial cells 1.6266217187790233 | |
| ELMO1 Plasma membrane Chemokine signaling pathway 1.6266217187790233 | |
| ELMO1 Plasma membrane Salmonella infection 1.6266217187790233 | |
| ELMO1 Plasma membrane Shigellosis 1.6266217187790233 | |
| ELMO1 Plasma membrane Yersinia infection 1.6266217187790233 | |
| ELMO2 Cytosol Bacterial invasion of epithelial cells 1.28519210034148 | |
| ELMO2 Cytosol Salmonella infection 1.28519210034148 | |
| ELMO2 Cytosol Shigellosis 1.28519210034148 | |
| ELMO2 Cytosol Yersinia infection 1.28519210034148 | |
| ELMO3 Cytosol Summary 0.8679153244514196 | |
| ELMO3 Plasma membrane Summary 0.8679153244514196 | |
| ELMOD2 Cytosol Summary 0.3095720849771357 | |
| ELMOD2 Nucleus Summary 0.3095720849771357 | |
| ELMSAN1 Nucleus Summary 0.8436926495547606 | |
| ELN Extracellular space Protein digestion and absorption 1.2538045806598193 | |
| ELN Plasma membrane Protein digestion and absorption 1.2538045806598193 | |
| ELOF1 Cytosol Summary 1.5238277689252409 | |
| ELOF1 Nucleus Summary 1.5238277689252409 | |
| ELOVL1 Endoplasmic Reticulum Biosynthesis of unsaturated fatty acids 1.6093680538521005 | |
| ELOVL1 Endoplasmic Reticulum Fatty acid elongation 1.6093680538521005 | |
| ELOVL1 Endoplasmic Reticulum Fatty acid metabolism 1.6093680538521005 | |
| ELOVL1 Endoplasmic Reticulum Metabolic pathways 1.6093680538521005 | |
| ELOVL5 Endoplasmic Reticulum Biosynthesis of unsaturated fatty acids 0.2619503594668811 | |
| ELOVL5 Endoplasmic Reticulum Fatty acid elongation 0.2619503594668811 | |
| ELOVL5 Endoplasmic Reticulum Fatty acid metabolism 0.2619503594668811 | |
| ELOVL5 Endoplasmic Reticulum Metabolic pathways 0.2619503594668811 | |
| ELP2 Cytosol Summary 0.8233696871602096 | |
| ELP2 Nucleus Summary 0.8233696871602096 | |
| ELP3 Cytosol Summary 0.9423559298451112 | |
| ELP3 Nucleus Summary 0.9423559298451112 | |
| ELP4 Cytosol Summary 0.6699234733512229 | |
| ELP4 Nucleus Summary 0.6699234733512229 | |
| ELP5 Cytosol Summary 1.159783841632891 | |
| ELP5 Nucleus Summary 1.159783841632891 | |
| ELP6 Cytoskeleton Summary 0.5977118818268885 | |
| ELP6 Cytosol Summary 0.5977118818268885 | |
| ELP6 Nucleus Summary 0.5977118818268885 | |
| EMB Plasma membrane Summary 1.7562600942650697 | |
| EMC1 Cytoskeleton Summary 1.8936651417218635 | |
| EMC1 Endoplasmic Reticulum Summary 1.8936651417218635 | |
| EMC10 Endoplasmic Reticulum Summary 1.6015636527843318 | |
| EMC10 Extracellular space Summary 1.6015636527843318 | |
| EMC2 Endoplasmic Reticulum Summary 1.9550289631608613 | |
| EMC3 Cytoskeleton Summary 1.2485432434023995 | |
| EMC3 Cytosol Summary 1.2485432434023995 | |
| EMC3 Endoplasmic Reticulum Summary 1.2485432434023995 | |
| EMC4 Endoplasmic Reticulum Summary 1.2329967275883993 | |
| EMC4 Plasma membrane Summary 1.2329967275883993 | |
| EMC7 Endoplasmic Reticulum Summary 1.9492641200284 | |
| EMC7 Nucleus Summary 1.9492641200284 | |
| EMC8 Cytosol Summary 1.6446935799007674 | |
| EMC8 Endoplasmic Reticulum Summary 1.6446935799007674 | |
| EMC9 Cytosol Summary 2.941687681374529 | |
| EMC9 Endoplasmic Reticulum Summary 2.941687681374529 | |
| EMC9 Golgi apparatus Summary 2.941687681374529 | |
| EMD Endoplasmic Reticulum Arrhythmogenic right ventricular cardiomyopathy 1.0382987793127831 | |
| EMD Endoplasmic Reticulum Dilated cardiomyopathy 1.0382987793127831 | |
| EMD Endoplasmic Reticulum Hypertrophic cardiomyopathy 1.0382987793127831 | |
| EMD Nucleus Arrhythmogenic right ventricular cardiomyopathy 1.0382987793127831 | |
| EMD Nucleus Dilated cardiomyopathy 1.0382987793127831 | |
| EMD Nucleus Hypertrophic cardiomyopathy 1.0382987793127831 | |
| EME1 Cytosol Fanconi anemia pathway 2.7145135720790248 | |
| EME1 Cytosol Homologous recombination 2.7145135720790248 | |
| EME1 Nucleus Fanconi anemia pathway 2.7145135720790248 | |
| EME1 Nucleus Homologous recombination 2.7145135720790248 | |
| EMG1 Mitochondrion Summary 2.300422560685448 | |
| EMG1 Nucleus Summary 2.300422560685448 | |
| EMILIN1 Extracellular space Summary 2.2399946284988337 | |
| EMILIN2 Extracellular space Summary 2.4821093072838774 | |
| EML1 Cytosol Summary 0.9014897509752628 | |
| EML2 Cytosol Summary 0.20157743137709372 | |
| EML3 Cytosol Summary 0.9487474929186952 | |
| EML4 Cytoskeleton Summary 1.90989266300336 | |
| EML4 Cytosol Summary 1.90989266300336 | |
| EML5 Cytosol Summary 0.4946554862700826 | |
| EML6 Cytosol Summary 0.9678594157725228 | |
| EML6 Mitochondrion Summary 0.9678594157725228 | |
| EMSY Nucleus Summary 1.5342745499241883 | |
| EN1 Nucleus Summary 3.136106967259484 | |
| ENAH Cytosol Axon guidance 1.5791758109478944 | |
| ENAH Cytosol Rap1 signaling pathway 1.5791758109478944 | |
| ENAH Cytosol Regulation of actin cytoskeleton 1.5791758109478944 | |
| ENAH Plasma membrane Axon guidance 1.5791758109478944 | |
| ENAH Plasma membrane Rap1 signaling pathway 1.5791758109478944 | |
| ENAH Plasma membrane Regulation of actin cytoskeleton 1.5791758109478944 | |
| ENDOD1 Nucleus Summary 1.2573825273752441 | |
| ENDOG Mitochondrion Apoptosis 1.4281230167397307 | |
| ENDOV Cytosol Summary 0.6848522232100113 | |
| ENG Nucleus Summary 1.3219528091240498 | |
| ENG Plasma membrane Summary 1.3219528091240498 | |
| ENGASE Cytoskeleton Summary 1.5436284132482767 | |
| ENGASE Cytosol Summary 1.5436284132482767 | |
| ENO1 Cytosol Biosynthesis of amino acids 2.517398469710684 | |
| ENO1 Cytosol Carbon metabolism 2.517398469710684 | |
| ENO1 Cytosol Glycolysis / Gluconeogenesis 2.517398469710684 | |
| ENO1 Cytosol HIF-1 signaling pathway 2.517398469710684 | |
| ENO1 Cytosol Metabolic pathways 2.517398469710684 | |
| ENO1 Cytosol RNA degradation 2.517398469710684 | |
| ENO1 Nucleus Biosynthesis of amino acids 2.517398469710684 | |
| ENO1 Nucleus Carbon metabolism 2.517398469710684 | |
| ENO1 Nucleus Glycolysis / Gluconeogenesis 2.517398469710684 | |
| ENO1 Nucleus HIF-1 signaling pathway 2.517398469710684 | |
| ENO1 Nucleus Metabolic pathways 2.517398469710684 | |
| ENO1 Nucleus RNA degradation 2.517398469710684 | |
| ENO1 Plasma membrane Biosynthesis of amino acids 2.517398469710684 | |
| ENO1 Plasma membrane Carbon metabolism 2.517398469710684 | |
| ENO1 Plasma membrane Glycolysis / Gluconeogenesis 2.517398469710684 | |
| ENO1 Plasma membrane HIF-1 signaling pathway 2.517398469710684 | |
| ENO1 Plasma membrane Metabolic pathways 2.517398469710684 | |
| ENO1 Plasma membrane RNA degradation 2.517398469710684 | |
| ENO2 Cytosol Summary 1.3539091141463122 | |
| ENO2 Nucleus Summary 1.3539091141463122 | |
| ENO2 Plasma membrane Summary 1.3539091141463122 | |
| ENO3 Cytosol Summary 2.0453973383017647 | |
| ENO3 Plasma membrane Summary 2.0453973383017647 | |
| ENOPH1 Cytosol Summary 0.3812512834207507 | |
| ENOPH1 Nucleus Summary 0.3812512834207507 | |
| ENOX1 Extracellular space Summary 1.6041569572197976 | |
| ENOX1 Plasma membrane Summary 1.6041569572197976 | |
| ENPEP Plasma membrane Renin-angiotensin system 1.9706144700065689 | |
| ENPP2 Cytoskeleton Ether lipid metabolism 1.4718471705265168 | |
| ENPP2 Extracellular space Ether lipid metabolism 1.4718471705265168 | |
| ENPP2 Golgi apparatus Ether lipid metabolism 1.4718471705265168 | |
| ENPP2 Nucleus Ether lipid metabolism 1.4718471705265168 | |
| ENPP3 Extracellular space Metabolic pathways 0.8089328299873534 | |
| ENPP3 Extracellular space Nicotinate and nicotinamide metabolism 0.8089328299873534 | |
| ENPP3 Extracellular space Pantothenate and CoA biosynthesis 0.8089328299873534 | |
| ENPP3 Extracellular space Purine metabolism 0.8089328299873534 | |
| ENPP3 Extracellular space Pyrimidine metabolism 0.8089328299873534 | |
| ENPP3 Extracellular space Riboflavin metabolism 0.8089328299873534 | |
| ENPP3 Extracellular space Starch and sucrose metabolism 0.8089328299873534 | |
| ENPP3 Plasma membrane Metabolic pathways 0.8089328299873534 | |
| ENPP3 Plasma membrane Nicotinate and nicotinamide metabolism 0.8089328299873534 | |
| ENPP3 Plasma membrane Pantothenate and CoA biosynthesis 0.8089328299873534 | |
| ENPP3 Plasma membrane Purine metabolism 0.8089328299873534 | |
| ENPP3 Plasma membrane Pyrimidine metabolism 0.8089328299873534 | |
| ENPP3 Plasma membrane Riboflavin metabolism 0.8089328299873534 | |
| ENPP3 Plasma membrane Starch and sucrose metabolism 0.8089328299873534 | |
| ENPP4 Plasma membrane Summary 0.6176519218027158 | |
| ENPP5 Cytosol Summary 0.3566804998333469 | |
| ENPP5 Nucleus Summary 0.3566804998333469 | |
| ENSA Cytoskeleton Summary 1.1087168181890976 | |
| ENSA Cytosol Summary 1.1087168181890976 | |
| ENSA Nucleus Summary 1.1087168181890976 | |
| ENTPD1 Cytoskeleton Summary 1.2362585812661828 | |
| ENTPD2 Endoplasmic Reticulum Summary 0.7878235996384563 | |
| ENTPD5 Cytosol Summary 0.09570835783490632 | |
| ENTPD5 Endoplasmic Reticulum Summary 0.09570835783490632 | |
| ENY2 Mitochondrion Summary 1.3821202327198845 | |
| ENY2 Nucleus Summary 1.3821202327198845 | |
| EOGT Cytosol Summary 1.6315334134134412 | |
| EOGT Endoplasmic Reticulum Summary 1.6315334134134412 | |
| EOGT Nucleus Summary 1.6315334134134412 | |
| EP300 Cytosol Adherens junction 1.20561364633033 | |
| EP300 Cytosol Cell cycle 1.20561364633033 | |
| EP300 Cytosol FoxO signaling pathway 1.20561364633033 | |
| EP300 Cytosol Glucagon signaling pathway 1.20561364633033 | |
| EP300 Cytosol Growth hormone synthesis secretion and action 1.20561364633033 | |
| EP300 Cytosol HIF-1 signaling pathway 1.20561364633033 | |
| EP300 Cytosol Hepatitis B 1.20561364633033 | |
| EP300 Cytosol Human T-cell leukemia virus 1 infection 1.20561364633033 | |
| EP300 Cytosol Human papillomavirus infection 1.20561364633033 | |
| EP300 Cytosol Huntington disease 1.20561364633033 | |
| EP300 Cytosol Influenza A 1.20561364633033 | |
| EP300 Cytosol JAK-STAT signaling pathway 1.20561364633033 | |
| EP300 Cytosol Kaposi sarcoma-associated herpesvirus infection 1.20561364633033 | |
| EP300 Cytosol Long-term potentiation 1.20561364633033 | |
| EP300 Cytosol Melanogenesis 1.20561364633033 | |
| EP300 Cytosol MicroRNAs in cancer 1.20561364633033 | |
| EP300 Cytosol Notch signaling pathway 1.20561364633033 | |
| EP300 Cytosol Pathways in cancer 1.20561364633033 | |
| EP300 Cytosol Prostate cancer 1.20561364633033 | |
| EP300 Cytosol Renal cell carcinoma 1.20561364633033 | |
| EP300 Cytosol TGF-beta signaling pathway 1.20561364633033 | |
| EP300 Cytosol Thyroid hormone signaling pathway 1.20561364633033 | |
| EP300 Cytosol Tuberculosis 1.20561364633033 | |
| EP300 Cytosol Viral carcinogenesis 1.20561364633033 | |
| EP300 Cytosol Wnt signaling pathway 1.20561364633033 | |
| EP300 Cytosol cAMP signaling pathway 1.20561364633033 | |
| EP300 Nucleus Adherens junction 1.20561364633033 | |
| EP300 Nucleus Cell cycle 1.20561364633033 | |
| EP300 Nucleus FoxO signaling pathway 1.20561364633033 | |
| EP300 Nucleus Glucagon signaling pathway 1.20561364633033 | |
| EP300 Nucleus Growth hormone synthesis secretion and action 1.20561364633033 | |
| EP300 Nucleus HIF-1 signaling pathway 1.20561364633033 | |
| EP300 Nucleus Hepatitis B 1.20561364633033 | |
| EP300 Nucleus Human T-cell leukemia virus 1 infection 1.20561364633033 | |
| EP300 Nucleus Human papillomavirus infection 1.20561364633033 | |
| EP300 Nucleus Huntington disease 1.20561364633033 | |
| EP300 Nucleus Influenza A 1.20561364633033 | |
| EP300 Nucleus JAK-STAT signaling pathway 1.20561364633033 | |
| EP300 Nucleus Kaposi sarcoma-associated herpesvirus infection 1.20561364633033 | |
| EP300 Nucleus Long-term potentiation 1.20561364633033 | |
| EP300 Nucleus Melanogenesis 1.20561364633033 | |
| EP300 Nucleus MicroRNAs in cancer 1.20561364633033 | |
| EP300 Nucleus Notch signaling pathway 1.20561364633033 | |
| EP300 Nucleus Pathways in cancer 1.20561364633033 | |
| EP300 Nucleus Prostate cancer 1.20561364633033 | |
| EP300 Nucleus Renal cell carcinoma 1.20561364633033 | |
| EP300 Nucleus TGF-beta signaling pathway 1.20561364633033 | |
| EP300 Nucleus Thyroid hormone signaling pathway 1.20561364633033 | |
| EP300 Nucleus Tuberculosis 1.20561364633033 | |
| EP300 Nucleus Viral carcinogenesis 1.20561364633033 | |
| EP300 Nucleus Wnt signaling pathway 1.20561364633033 | |
| EP300 Nucleus cAMP signaling pathway 1.20561364633033 | |
| EP400 Nucleus Summary 1.5251880414676378 | |
| EPB41 Cytoskeleton Summary 1.9468172621337372 | |
| EPB41 Cytosol Summary 1.9468172621337372 | |
| EPB41 Mitochondrion Summary 1.9468172621337372 | |
| EPB41 Nucleus Summary 1.9468172621337372 | |
| EPB41 Plasma membrane Summary 1.9468172621337372 | |
| EPB41L1 Cytoskeleton Summary 1.335264261686084 | |
| EPB41L1 Cytosol Summary 1.335264261686084 | |
| EPB41L1 Plasma membrane Summary 1.335264261686084 | |
| EPB41L2 Cytosol Summary 1.679891795406142 | |
| EPB41L2 Nucleus Summary 1.679891795406142 | |
| EPB41L2 Plasma membrane Summary 1.679891795406142 | |
| EPB41L3 Cytosol Summary 1.5979809318655387 | |
| EPB41L3 Plasma membrane Summary 1.5979809318655387 | |
| EPB41L4A Cytosol Summary 0.9779874552256836 | |
| EPB41L4A Nucleus Summary 0.9779874552256836 | |
| EPB41L4A Plasma membrane Summary 0.9779874552256836 | |
| EPB41L5 Cytosol Summary 0.37035020130839424 | |
| EPB41L5 Plasma membrane Summary 0.37035020130839424 | |
| EPB42 Cytosol Summary 1.6049008058632963 | |
| EPB42 Nucleus Summary 1.6049008058632963 | |
| EPC1 Cytosol Summary 1.9261067610549991 | |
| EPC1 Nucleus Summary 1.9261067610549991 | |
| EPC2 Nucleus Summary 2.0363771696438744 | |
| EPCAM Plasma membrane Summary 1.9892578924688282 | |
| EPDR1 Extracellular space Summary 0.3559741266427888 | |
| EPDR1 Lysosome Summary 0.3559741266427888 | |
| EPG5 Nucleus Summary 1.198964879200721 | |
| EPHA1 Plasma membrane Axon guidance 0.9966683721236954 | |
| EPHA4 Plasma membrane Axon guidance 0.5535881723533739 | |
| EPHB2 Nucleus Axon guidance 2.506190363341932 | |
| EPHB2 Plasma membrane Axon guidance 2.506190363341932 | |
| EPHB3 Plasma membrane Axon guidance 2.125031132182417 | |
| EPHB4 Plasma membrane Axon guidance 0.8647741839248646 | |
| EPHX1 Endoplasmic Reticulum Bile secretion 0.7374109647827141 | |
| EPHX1 Endoplasmic Reticulum Chemical carcinogenesis - DNA adducts 0.7374109647827141 | |
| EPHX1 Endoplasmic Reticulum Chemical carcinogenesis - receptor activation 0.7374109647827141 | |
| EPHX1 Endoplasmic Reticulum Metabolism of xenobiotics by cytochrome P450 0.7374109647827141 | |
| EPHX2 Cytosol Arachidonic acid metabolism 0.5451101693814685 | |
| EPHX2 Cytosol Chemical carcinogenesis - receptor activation 0.5451101693814685 | |
| EPHX2 Cytosol Metabolic pathways 0.5451101693814685 | |
| EPHX2 Cytosol Peroxisome 0.5451101693814685 | |
| EPHX2 Peroxisome Arachidonic acid metabolism 0.5451101693814685 | |
| EPHX2 Peroxisome Chemical carcinogenesis - receptor activation 0.5451101693814685 | |
| EPHX2 Peroxisome Metabolic pathways 0.5451101693814685 | |
| EPHX2 Peroxisome Peroxisome 0.5451101693814685 | |
| EPM2A Cytosol Ubiquitin mediated proteolysis 0.9441461956131956 | |
| EPM2A Endoplasmic Reticulum Ubiquitin mediated proteolysis 0.9441461956131956 | |
| EPM2A Nucleus Ubiquitin mediated proteolysis 0.9441461956131956 | |
| EPM2A Plasma membrane Ubiquitin mediated proteolysis 0.9441461956131956 | |
| EPM2AIP1 Endoplasmic Reticulum Summary 0.5703563530217722 | |
| EPN1 Cytosol Endocytosis 1.1080260979374308 | |
| EPN1 Nucleus Endocytosis 1.1080260979374308 | |
| EPN1 Plasma membrane Endocytosis 1.1080260979374308 | |
| EPN2 Cytosol Summary 1.453298588733395 | |
| EPN3 Cytosol Summary 0.3427912683362346 | |
| EPN3 Nucleus Summary 0.3427912683362346 | |
| EPPK1 Cytoskeleton Summary 1.0941295353271947 | |
| EPPK1 Cytosol Summary 1.0941295353271947 | |
| EPRS Cytosol Summary 1.6435587520411468 | |
| EPS15 Cytosol Endocytosis 1.5031065785436424 | |
| EPS15 Endosome Endocytosis 1.5031065785436424 | |
| EPS15 Nucleus Endocytosis 1.5031065785436424 | |
| EPS15 Plasma membrane Endocytosis 1.5031065785436424 | |
| EPS15L1 Cytosol Endocytosis 1.1376040592269072 | |
| EPS15L1 Plasma membrane Endocytosis 1.1376040592269072 | |
| EPS8 Cytosol Summary 1.0642141688808655 | |
| EPS8 Golgi apparatus Summary 1.0642141688808655 | |
| EPS8L1 Cytosol Summary 0.5852110915756327 | |
| EPS8L2 Cytosol Summary 1.3498124557645734 | |
| EPS8L2 Plasma membrane Summary 1.3498124557645734 | |
| EPSTI1 Cytosol Summary 1.3192562251798563 | |
| EPX Cytosol Summary 2.0948345476070322 | |
| ERAL1 Cytosol Summary 1.1316791768918524 | |
| ERAL1 Mitochondrion Summary 1.1316791768918524 | |
| ERAP1 Cytosol Summary 1.807191842730211 | |
| ERAP1 Endoplasmic Reticulum Summary 1.807191842730211 | |
| ERAP1 Extracellular space Summary 1.807191842730211 | |
| ERAP1 Nucleus Summary 1.807191842730211 | |
| ERAP1 Plasma membrane Summary 1.807191842730211 | |
| ERAP2 Endoplasmic Reticulum Summary 1.5881533860937211 | |
| ERAP2 Golgi apparatus Summary 1.5881533860937211 | |
| ERAP2 Mitochondrion Summary 1.5881533860937211 | |
| ERBB2 Cytosol Adherens junction 0.04272171776959504 | |
| ERBB2 Cytosol Bladder cancer 0.04272171776959504 | |
| ERBB2 Cytosol Breast cancer 0.04272171776959504 | |
| ERBB2 Cytosol Calcium signaling pathway 0.04272171776959504 | |
| ERBB2 Cytosol Central carbon metabolism in cancer 0.04272171776959504 | |
| ERBB2 Cytosol EGFR tyrosine kinase inhibitor resistance 0.04272171776959504 | |
| ERBB2 Cytosol Endocrine resistance 0.04272171776959504 | |
| ERBB2 Cytosol Endometrial cancer 0.04272171776959504 | |
| ERBB2 Cytosol ErbB signaling pathway 0.04272171776959504 | |
| ERBB2 Cytosol Focal adhesion 0.04272171776959504 | |
| ERBB2 Cytosol Gastric cancer 0.04272171776959504 | |
| ERBB2 Cytosol HIF-1 signaling pathway 0.04272171776959504 | |
| ERBB2 Cytosol MAPK signaling pathway 0.04272171776959504 | |
| ERBB2 Cytosol MicroRNAs in cancer 0.04272171776959504 | |
| ERBB2 Cytosol Non-small cell lung cancer 0.04272171776959504 | |
| ERBB2 Cytosol PI3K-Akt signaling pathway 0.04272171776959504 | |
| ERBB2 Cytosol Pancreatic cancer 0.04272171776959504 | |
| ERBB2 Cytosol Pathways in cancer 0.04272171776959504 | |
| ERBB2 Cytosol Platinum drug resistance 0.04272171776959504 | |
| ERBB2 Cytosol Prostate cancer 0.04272171776959504 | |
| ERBB2 Cytosol Proteoglycans in cancer 0.04272171776959504 | |
| ERBB2 Cytosol Tight junction 0.04272171776959504 | |
| ERBB2 Endosome Adherens junction 0.04272171776959504 | |
| ERBB2 Endosome Bladder cancer 0.04272171776959504 | |
| ERBB2 Endosome Breast cancer 0.04272171776959504 | |
| ERBB2 Endosome Calcium signaling pathway 0.04272171776959504 | |
| ERBB2 Endosome Central carbon metabolism in cancer 0.04272171776959504 | |
| ERBB2 Endosome EGFR tyrosine kinase inhibitor resistance 0.04272171776959504 | |
| ERBB2 Endosome Endocrine resistance 0.04272171776959504 | |
| ERBB2 Endosome Endometrial cancer 0.04272171776959504 | |
| ERBB2 Endosome ErbB signaling pathway 0.04272171776959504 | |
| ERBB2 Endosome Focal adhesion 0.04272171776959504 | |
| ERBB2 Endosome Gastric cancer 0.04272171776959504 | |
| ERBB2 Endosome HIF-1 signaling pathway 0.04272171776959504 | |
| ERBB2 Endosome MAPK signaling pathway 0.04272171776959504 | |
| ERBB2 Endosome MicroRNAs in cancer 0.04272171776959504 | |
| ERBB2 Endosome Non-small cell lung cancer 0.04272171776959504 | |
| ERBB2 Endosome PI3K-Akt signaling pathway 0.04272171776959504 | |
| ERBB2 Endosome Pancreatic cancer 0.04272171776959504 | |
| ERBB2 Endosome Pathways in cancer 0.04272171776959504 | |
| ERBB2 Endosome Platinum drug resistance 0.04272171776959504 | |
| ERBB2 Endosome Prostate cancer 0.04272171776959504 | |
| ERBB2 Endosome Proteoglycans in cancer 0.04272171776959504 | |
| ERBB2 Endosome Tight junction 0.04272171776959504 | |
| ERBB2 Nucleus Adherens junction 0.04272171776959504 | |
| ERBB2 Nucleus Bladder cancer 0.04272171776959504 | |
| ERBB2 Nucleus Breast cancer 0.04272171776959504 | |
| ERBB2 Nucleus Calcium signaling pathway 0.04272171776959504 | |
| ERBB2 Nucleus Central carbon metabolism in cancer 0.04272171776959504 | |
| ERBB2 Nucleus EGFR tyrosine kinase inhibitor resistance 0.04272171776959504 | |
| ERBB2 Nucleus Endocrine resistance 0.04272171776959504 | |
| ERBB2 Nucleus Endometrial cancer 0.04272171776959504 | |
| ERBB2 Nucleus ErbB signaling pathway 0.04272171776959504 | |
| ERBB2 Nucleus Focal adhesion 0.04272171776959504 | |
| ERBB2 Nucleus Gastric cancer 0.04272171776959504 | |
| ERBB2 Nucleus HIF-1 signaling pathway 0.04272171776959504 | |
| ERBB2 Nucleus MAPK signaling pathway 0.04272171776959504 | |
| ERBB2 Nucleus MicroRNAs in cancer 0.04272171776959504 | |
| ERBB2 Nucleus Non-small cell lung cancer 0.04272171776959504 | |
| ERBB2 Nucleus PI3K-Akt signaling pathway 0.04272171776959504 | |
| ERBB2 Nucleus Pancreatic cancer 0.04272171776959504 | |
| ERBB2 Nucleus Pathways in cancer 0.04272171776959504 | |
| ERBB2 Nucleus Platinum drug resistance 0.04272171776959504 | |
| ERBB2 Nucleus Prostate cancer 0.04272171776959504 | |
| ERBB2 Nucleus Proteoglycans in cancer 0.04272171776959504 | |
| ERBB2 Nucleus Tight junction 0.04272171776959504 | |
| ERBB2 Plasma membrane Adherens junction 0.04272171776959504 | |
| ERBB2 Plasma membrane Bladder cancer 0.04272171776959504 | |
| ERBB2 Plasma membrane Breast cancer 0.04272171776959504 | |
| ERBB2 Plasma membrane Calcium signaling pathway 0.04272171776959504 | |
| ERBB2 Plasma membrane Central carbon metabolism in cancer 0.04272171776959504 | |
| ERBB2 Plasma membrane EGFR tyrosine kinase inhibitor resistance 0.04272171776959504 | |
| ERBB2 Plasma membrane Endocrine resistance 0.04272171776959504 | |
| ERBB2 Plasma membrane Endometrial cancer 0.04272171776959504 | |
| ERBB2 Plasma membrane ErbB signaling pathway 0.04272171776959504 | |
| ERBB2 Plasma membrane Focal adhesion 0.04272171776959504 | |
| ERBB2 Plasma membrane Gastric cancer 0.04272171776959504 | |
| ERBB2 Plasma membrane HIF-1 signaling pathway 0.04272171776959504 | |
| ERBB2 Plasma membrane MAPK signaling pathway 0.04272171776959504 | |
| ERBB2 Plasma membrane MicroRNAs in cancer 0.04272171776959504 | |
| ERBB2 Plasma membrane Non-small cell lung cancer 0.04272171776959504 | |
| ERBB2 Plasma membrane PI3K-Akt signaling pathway 0.04272171776959504 | |
| ERBB2 Plasma membrane Pancreatic cancer 0.04272171776959504 | |
| ERBB2 Plasma membrane Pathways in cancer 0.04272171776959504 | |
| ERBB2 Plasma membrane Platinum drug resistance 0.04272171776959504 | |
| ERBB2 Plasma membrane Prostate cancer 0.04272171776959504 | |
| ERBB2 Plasma membrane Proteoglycans in cancer 0.04272171776959504 | |
| ERBB2 Plasma membrane Tight junction 0.04272171776959504 | |
| ERBB3 Cytoskeleton Calcium signaling pathway 0.40396556610199613 | |
| ERBB3 Cytoskeleton EGFR tyrosine kinase inhibitor resistance 0.40396556610199613 | |
| ERBB3 Cytoskeleton ErbB signaling pathway 0.40396556610199613 | |
| ERBB3 Cytoskeleton MAPK signaling pathway 0.40396556610199613 | |
| ERBB3 Cytoskeleton MicroRNAs in cancer 0.40396556610199613 | |
| ERBB3 Cytoskeleton PI3K-Akt signaling pathway 0.40396556610199613 | |
| ERBB3 Cytoskeleton Proteoglycans in cancer 0.40396556610199613 | |
| ERBB3 Extracellular space Calcium signaling pathway 0.40396556610199613 | |
| ERBB3 Extracellular space EGFR tyrosine kinase inhibitor resistance 0.40396556610199613 | |
| ERBB3 Extracellular space ErbB signaling pathway 0.40396556610199613 | |
| ERBB3 Extracellular space MAPK signaling pathway 0.40396556610199613 | |
| ERBB3 Extracellular space MicroRNAs in cancer 0.40396556610199613 | |
| ERBB3 Extracellular space PI3K-Akt signaling pathway 0.40396556610199613 | |
| ERBB3 Extracellular space Proteoglycans in cancer 0.40396556610199613 | |
| ERBB3 Plasma membrane Calcium signaling pathway 0.40396556610199613 | |
| ERBB3 Plasma membrane EGFR tyrosine kinase inhibitor resistance 0.40396556610199613 | |
| ERBB3 Plasma membrane ErbB signaling pathway 0.40396556610199613 | |
| ERBB3 Plasma membrane MAPK signaling pathway 0.40396556610199613 | |
| ERBB3 Plasma membrane MicroRNAs in cancer 0.40396556610199613 | |
| ERBB3 Plasma membrane PI3K-Akt signaling pathway 0.40396556610199613 | |
| ERBB3 Plasma membrane Proteoglycans in cancer 0.40396556610199613 | |
| ERBB4 Mitochondrion Amyotrophic lateral sclerosis 0.16802339521613893 | |
| ERBB4 Mitochondrion Calcium signaling pathway 0.16802339521613893 | |
| ERBB4 Mitochondrion ErbB signaling pathway 0.16802339521613893 | |
| ERBB4 Mitochondrion MAPK signaling pathway 0.16802339521613893 | |
| ERBB4 Mitochondrion PI3K-Akt signaling pathway 0.16802339521613893 | |
| ERBB4 Mitochondrion Proteoglycans in cancer 0.16802339521613893 | |
| ERBB4 Nucleus Amyotrophic lateral sclerosis 0.16802339521613893 | |
| ERBB4 Nucleus Calcium signaling pathway 0.16802339521613893 | |
| ERBB4 Nucleus ErbB signaling pathway 0.16802339521613893 | |
| ERBB4 Nucleus MAPK signaling pathway 0.16802339521613893 | |
| ERBB4 Nucleus PI3K-Akt signaling pathway 0.16802339521613893 | |
| ERBB4 Nucleus Proteoglycans in cancer 0.16802339521613893 | |
| ERBB4 Plasma membrane Amyotrophic lateral sclerosis 0.16802339521613893 | |
| ERBB4 Plasma membrane Calcium signaling pathway 0.16802339521613893 | |
| ERBB4 Plasma membrane ErbB signaling pathway 0.16802339521613893 | |
| ERBB4 Plasma membrane MAPK signaling pathway 0.16802339521613893 | |
| ERBB4 Plasma membrane PI3K-Akt signaling pathway 0.16802339521613893 | |
| ERBB4 Plasma membrane Proteoglycans in cancer 0.16802339521613893 | |
| ERBIN Nucleus NOD-like receptor signaling pathway 0.7489718688570994 | |
| ERBIN Plasma membrane NOD-like receptor signaling pathway 0.7489718688570994 | |
| ERC1 Cytosol NF-kappa B signaling pathway 1.7335105743019428 | |
| ERC1 Golgi apparatus NF-kappa B signaling pathway 1.7335105743019428 | |
| ERC1 Plasma membrane NF-kappa B signaling pathway 1.7335105743019428 | |
| ERCC1 Cytosol Fanconi anemia pathway 0.8248126665271215 | |
| ERCC1 Cytosol Nucleotide excision repair 0.8248126665271215 | |
| ERCC1 Cytosol Platinum drug resistance 0.8248126665271215 | |
| ERCC1 Nucleus Fanconi anemia pathway 0.8248126665271215 | |
| ERCC1 Nucleus Nucleotide excision repair 0.8248126665271215 | |
| ERCC1 Nucleus Platinum drug resistance 0.8248126665271215 | |
| ERCC2 Cytoskeleton Basal transcription factors 1.1458363332523809 | |
| ERCC2 Cytoskeleton Nucleotide excision repair 1.1458363332523809 | |
| ERCC2 Cytosol Basal transcription factors 1.1458363332523809 | |
| ERCC2 Cytosol Nucleotide excision repair 1.1458363332523809 | |
| ERCC2 Nucleus Basal transcription factors 1.1458363332523809 | |
| ERCC2 Nucleus Nucleotide excision repair 1.1458363332523809 | |
| ERCC3 Nucleus Basal transcription factors 1.2071898088471205 | |
| ERCC3 Nucleus Nucleotide excision repair 1.2071898088471205 | |
| ERCC4 Nucleus Fanconi anemia pathway 0.6948887941469418 | |
| ERCC4 Nucleus Nucleotide excision repair 0.6948887941469418 | |
| ERCC4 Plasma membrane Fanconi anemia pathway 0.6948887941469418 | |
| ERCC4 Plasma membrane Nucleotide excision repair 0.6948887941469418 | |
| ERCC5 Nucleus Summary 1.4891526770739756 | |
| ERCC6 Nucleus Nucleotide excision repair 1.6192793547340096 | |
| ERCC6L Cytoskeleton Summary 2.3991854060355946 | |
| ERCC6L Cytosol Summary 2.3991854060355946 | |
| ERCC6L Endoplasmic Reticulum Summary 2.3991854060355946 | |
| ERCC6L Nucleus Summary 2.3991854060355946 | |
| ERCC8 Nucleus Nucleotide excision repair 0.9421281582846444 | |
| ERCC8 Nucleus Ubiquitin mediated proteolysis 0.9421281582846444 | |
| ERF Nucleus mRNA surveillance pathway 1.5603123504542684 | |
| ERGIC1 Cytosol Summary 0.14889936609200966 | |
| ERGIC1 Endoplasmic Reticulum Summary 0.14889936609200966 | |
| ERGIC1 Golgi apparatus Summary 0.14889936609200966 | |
| ERGIC1 Nucleus Summary 0.14889936609200966 | |
| ERGIC2 Cytosol Summary 1.461464770960877 | |
| ERGIC2 Endoplasmic Reticulum Summary 1.461464770960877 | |
| ERGIC2 Golgi apparatus Summary 1.461464770960877 | |
| ERGIC2 Nucleus Summary 1.461464770960877 | |
| ERGIC3 Endoplasmic Reticulum Summary 1.708441960948744 | |
| ERGIC3 Nucleus Summary 1.708441960948744 | |
| ERH Cytosol Summary 1.9320171081748738 | |
| ERH Nucleus Summary 1.9320171081748738 | |
| ERI1 Cytoskeleton Summary 1.796041028867934 | |
| ERI1 Cytosol Summary 1.796041028867934 | |
| ERI1 Nucleus Summary 1.796041028867934 | |
| ERI3 Cytosol Summary 1.4424868771576078 | |
| ERI3 Nucleus Summary 1.4424868771576078 | |
| ERICH1 Cytosol Summary 1.5142002823773344 | |
| ERICH1 Nucleus Summary 1.5142002823773344 | |
| ERLEC1 Endoplasmic Reticulum Protein processing in endoplasmic reticulum 1.017592526019801 | |
| ERLIN1 Endoplasmic Reticulum Summary 1.8045459030308628 | |
| ERLIN2 Endoplasmic Reticulum Summary 0.5758204913285919 | |
| ERMP1 Endoplasmic Reticulum Summary 0.5166229636456874 | |
| ERMP1 Nucleus Summary 0.5166229636456874 | |
| ERN1 Endoplasmic Reticulum Alzheimer disease 1.381568132189592 | |
| ERN1 Endoplasmic Reticulum Amyotrophic lateral sclerosis 1.381568132189592 | |
| ERN1 Endoplasmic Reticulum Apoptosis 1.381568132189592 | |
| ERN1 Endoplasmic Reticulum Autophagy - animal 1.381568132189592 | |
| ERN1 Endoplasmic Reticulum Huntington disease 1.381568132189592 | |
| ERN1 Endoplasmic Reticulum Lipid and atherosclerosis 1.381568132189592 | |
| ERN1 Endoplasmic Reticulum Non-alcoholic fatty liver disease 1.381568132189592 | |
| ERN1 Endoplasmic Reticulum Parkinson disease 1.381568132189592 | |
| ERN1 Endoplasmic Reticulum Pathways of neurodegeneration - multiple diseases 1.381568132189592 | |
| ERN1 Endoplasmic Reticulum Protein processing in endoplasmic reticulum 1.381568132189592 | |
| ERN1 Endoplasmic Reticulum Spinocerebellar ataxia 1.381568132189592 | |
| ERO1A Endoplasmic Reticulum Lipid and atherosclerosis 1.4155971215962366 | |
| ERO1A Endoplasmic Reticulum Protein processing in endoplasmic reticulum 1.4155971215962366 | |
| ERO1A Endoplasmic Reticulum Vibrio cholerae infection 1.4155971215962366 | |
| ERO1B Endoplasmic Reticulum Protein processing in endoplasmic reticulum 0.9336121010041888 | |
| ERP29 Cytoskeleton Protein processing in endoplasmic reticulum 1.457683545402604 | |
| ERP29 Endoplasmic Reticulum Protein processing in endoplasmic reticulum 1.457683545402604 | |
| ERP29 Nucleus Protein processing in endoplasmic reticulum 1.457683545402604 | |
| ERP44 Endoplasmic Reticulum Summary 2.238514841986344 | |
| ERRFI1 Cytosol Summary 2.1649618236249792 | |
| ERRFI1 Plasma membrane Summary 2.1649618236249792 | |
| ESAM Cytoskeleton Cell adhesion molecules 1.5311860347372672 | |
| ESAM Cytoskeleton Leukocyte transendothelial migration 1.5311860347372672 | |
| ESAM Plasma membrane Cell adhesion molecules 1.5311860347372672 | |
| ESAM Plasma membrane Leukocyte transendothelial migration 1.5311860347372672 | |
| ESCO1 Nucleus Summary 1.4459576704876185 | |
| ESD Cytosol Summary 1.029019636583988 | |
| ESD Golgi apparatus Summary 1.029019636583988 | |
| ESD Nucleus Summary 1.029019636583988 | |
| ESF1 Nucleus Summary 1.9007331280302409 | |
| ESPL1 Cytoskeleton Cell cycle 1.3229026115100515 | |
| ESPL1 Cytoskeleton Human T-cell leukemia virus 1 infection 1.3229026115100515 | |
| ESPL1 Cytoskeleton Oocyte meiosis 1.3229026115100515 | |
| ESPL1 Cytosol Cell cycle 1.3229026115100515 | |
| ESPL1 Cytosol Human T-cell leukemia virus 1 infection 1.3229026115100515 | |
| ESPL1 Cytosol Oocyte meiosis 1.3229026115100515 | |
| ESPL1 Nucleus Cell cycle 1.3229026115100515 | |
| ESPL1 Nucleus Human T-cell leukemia virus 1 infection 1.3229026115100515 | |
| ESPL1 Nucleus Oocyte meiosis 1.3229026115100515 | |
| ESPN Cytosol Summary 0.9198527781223691 | |
| ESR1 Cytosol Breast cancer 0.0527178831227943 | |
| ESR1 Cytosol Chemical carcinogenesis - receptor activation 0.0527178831227943 | |
| ESR1 Cytosol Endocrine and other factor-regulated calcium reabsorption 0.0527178831227943 | |
| ESR1 Cytosol Endocrine resistance 0.0527178831227943 | |
| ESR1 Cytosol Estrogen signaling pathway 0.0527178831227943 | |
| ESR1 Cytosol Pathways in cancer 0.0527178831227943 | |
| ESR1 Cytosol Prolactin signaling pathway 0.0527178831227943 | |
| ESR1 Cytosol Proteoglycans in cancer 0.0527178831227943 | |
| ESR1 Cytosol Thyroid hormone signaling pathway 0.0527178831227943 | |
| ESR1 Golgi apparatus Breast cancer 0.0527178831227943 | |
| ESR1 Golgi apparatus Chemical carcinogenesis - receptor activation 0.0527178831227943 | |
| ESR1 Golgi apparatus Endocrine and other factor-regulated calcium reabsorption 0.0527178831227943 | |
| ESR1 Golgi apparatus Endocrine resistance 0.0527178831227943 | |
| ESR1 Golgi apparatus Estrogen signaling pathway 0.0527178831227943 | |
| ESR1 Golgi apparatus Pathways in cancer 0.0527178831227943 | |
| ESR1 Golgi apparatus Prolactin signaling pathway 0.0527178831227943 | |
| ESR1 Golgi apparatus Proteoglycans in cancer 0.0527178831227943 | |
| ESR1 Golgi apparatus Thyroid hormone signaling pathway 0.0527178831227943 | |
| ESR1 Nucleus Breast cancer 0.0527178831227943 | |
| ESR1 Nucleus Chemical carcinogenesis - receptor activation 0.0527178831227943 | |
| ESR1 Nucleus Endocrine and other factor-regulated calcium reabsorption 0.0527178831227943 | |
| ESR1 Nucleus Endocrine resistance 0.0527178831227943 | |
| ESR1 Nucleus Estrogen signaling pathway 0.0527178831227943 | |
| ESR1 Nucleus Pathways in cancer 0.0527178831227943 | |
| ESR1 Nucleus Prolactin signaling pathway 0.0527178831227943 | |
| ESR1 Nucleus Proteoglycans in cancer 0.0527178831227943 | |
| ESR1 Nucleus Thyroid hormone signaling pathway 0.0527178831227943 | |
| ESR1 Plasma membrane Breast cancer 0.0527178831227943 | |
| ESR1 Plasma membrane Chemical carcinogenesis - receptor activation 0.0527178831227943 | |
| ESR1 Plasma membrane Endocrine and other factor-regulated calcium reabsorption 0.0527178831227943 | |
| ESR1 Plasma membrane Endocrine resistance 0.0527178831227943 | |
| ESR1 Plasma membrane Estrogen signaling pathway 0.0527178831227943 | |
| ESR1 Plasma membrane Pathways in cancer 0.0527178831227943 | |
| ESR1 Plasma membrane Prolactin signaling pathway 0.0527178831227943 | |
| ESR1 Plasma membrane Proteoglycans in cancer 0.0527178831227943 | |
| ESR1 Plasma membrane Thyroid hormone signaling pathway 0.0527178831227943 | |
| ESRP1 Nucleus Summary 1.9698573364649847 | |
| ESRP2 Cytoskeleton Summary 0.7295471419254829 | |
| ESRP2 Nucleus Summary 0.7295471419254829 | |
| ESRRA Cytoskeleton Summary 1.1056436836237626 | |
| ESRRA Nucleus Summary 1.1056436836237626 | |
| ESYT1 Endoplasmic Reticulum Summary 1.0241238459202844 | |
| ESYT2 Cytosol Summary 1.0096466678820937 | |
| ESYT2 Plasma membrane Summary 1.0096466678820937 | |
| ETAA1 Cytosol Summary 1.2181196557685017 | |
| ETAA1 Nucleus Summary 1.2181196557685017 | |
| ETF1 Cytosol Summary 1.0682213143437624 | |
| ETFA Mitochondrion Summary 1.405718548381905 | |
| ETFB Mitochondrion Summary 1.2498192585511878 | |
| ETFDH Mitochondrion Summary 0.8194400713773792 | |
| ETFRF1 Mitochondrion Summary 0.6107640967248844 | |
| ETHE1 Cytosol Metabolic pathways 1.5149291294544052 | |
| ETHE1 Cytosol Sulfur metabolism 1.5149291294544052 | |
| ETHE1 Mitochondrion Metabolic pathways 1.5149291294544052 | |
| ETHE1 Mitochondrion Sulfur metabolism 1.5149291294544052 | |
| ETHE1 Nucleus Metabolic pathways 1.5149291294544052 | |
| ETHE1 Nucleus Sulfur metabolism 1.5149291294544052 | |
| ETNK1 Cytosol Summary 1.3090216255069205 | |
| ETNK1 Nucleus Summary 1.3090216255069205 | |
| ETNK1 Plasma membrane Summary 1.3090216255069205 | |
| ETS1 Cytosol Cellular senescence 2.2885955744065294 | |
| ETS1 Cytosol Human T-cell leukemia virus 1 infection 2.2885955744065294 | |
| ETS1 Cytosol Pathways in cancer 2.2885955744065294 | |
| ETS1 Cytosol Ras signaling pathway 2.2885955744065294 | |
| ETS1 Cytosol Renal cell carcinoma 2.2885955744065294 | |
| ETS1 Nucleus Cellular senescence 2.2885955744065294 | |
| ETS1 Nucleus Human T-cell leukemia virus 1 infection 2.2885955744065294 | |
| ETS1 Nucleus Pathways in cancer 2.2885955744065294 | |
| ETS1 Nucleus Ras signaling pathway 2.2885955744065294 | |
| ETS1 Nucleus Renal cell carcinoma 2.2885955744065294 | |
| ETS2 Cytosol Human T-cell leukemia virus 1 infection 1.2820829610870728 | |
| ETS2 Cytosol Ras signaling pathway 1.2820829610870728 | |
| ETS2 Nucleus Human T-cell leukemia virus 1 infection 1.2820829610870728 | |
| ETS2 Nucleus Ras signaling pathway 1.2820829610870728 | |
| ETS2 Plasma membrane Human T-cell leukemia virus 1 infection 1.2820829610870728 | |
| ETS2 Plasma membrane Ras signaling pathway 1.2820829610870728 | |
| ETV3 Cytosol Summary 2.4530820359912804 | |
| ETV3 Nucleus Summary 2.4530820359912804 | |
| ETV6 Cytosol Transcriptional misregulation in cancer 2.5917558739356577 | |
| ETV6 Nucleus Transcriptional misregulation in cancer 2.5917558739356577 | |
| EVA1B Cytosol Summary 0.4170023855875581 | |
| EVC2 Mitochondrion Hedgehog signaling pathway 1.785844877122088 | |
| EVC2 Plasma membrane Hedgehog signaling pathway 1.785844877122088 | |
| EVI2B Nucleus Summary 1.5581594582702027 | |
| EVI2B Plasma membrane Summary 1.5581594582702027 | |
| EVI5 Cytoskeleton Summary 0.9604710717677708 | |
| EVI5 Cytosol Summary 0.9604710717677708 | |
| EVI5 Golgi apparatus Summary 0.9604710717677708 | |
| EVI5 Nucleus Summary 0.9604710717677708 | |
| EVI5L Nucleus Summary 0.7148158187130452 | |
| EVL Cytosol Summary 0.5830066991735402 | |
| EVPL Cytoskeleton Summary 1.2179182982684034 | |
| EVPL Cytosol Summary 1.2179182982684034 | |
| EWSR1 Nucleus Transcriptional misregulation in cancer 1.043788610105769 | |
| EWSR1 Plasma membrane Transcriptional misregulation in cancer 1.043788610105769 | |
| EXD2 Cytoskeleton Summary 1.1291079074034012 | |
| EXD2 Mitochondrion Summary 1.1291079074034012 | |
| EXO1 Nucleus Mismatch repair 1.345014683044599 | |
| EXOC1 Cytoskeleton Summary 0.7336117571803089 | |
| EXOC1 Cytosol Summary 0.7336117571803089 | |
| EXOC1 Plasma membrane Summary 0.7336117571803089 | |
| EXOC2 Cytoskeleton Summary 0.6662978086304325 | |
| EXOC2 Cytosol Summary 0.6662978086304325 | |
| EXOC3 Cytosol Summary 0.7294208840282215 | |
| EXOC3 Mitochondrion Summary 0.7294208840282215 | |
| EXOC3 Nucleus Summary 0.7294208840282215 | |
| EXOC3L2 Cytosol Summary 1.889962758447517 | |
| EXOC3L2 Golgi apparatus Summary 1.889962758447517 | |
| EXOC3L2 Nucleus Summary 1.889962758447517 | |
| EXOC4 Cytoskeleton Summary 0.7426021796377362 | |
| EXOC4 Cytosol Summary 0.7426021796377362 | |
| EXOC4 Nucleus Summary 0.7426021796377362 | |
| EXOC5 Cytosol Summary 0.769023131701158 | |
| EXOC6 Cytosol Summary 0.4638686142089338 | |
| EXOC6 Nucleus Summary 0.4638686142089338 | |
| EXOC6B Cytosol Summary 0.9603841221560818 | |
| EXOC6B Nucleus Summary 0.9603841221560818 | |
| EXOC7 Cytosol Insulin signaling pathway 0.8611850106275317 | |
| EXOC7 Cytosol Salmonella infection 0.8611850106275317 | |
| EXOC7 Plasma membrane Insulin signaling pathway 0.8611850106275317 | |
| EXOC7 Plasma membrane Salmonella infection 0.8611850106275317 | |
| EXOC8 Cytosol Summary 0.654287915613305 | |
| EXOG Mitochondrion Summary 1.0948378163578385 | |
| EXOSC1 Nucleus RNA degradation 2.06004065938369 | |
| EXOSC2 Nucleus RNA degradation 1.807364255452513 | |
| EXOSC3 Cytosol RNA degradation 1.7279205767987682 | |
| EXOSC3 Nucleus RNA degradation 1.7279205767987682 | |
| EXOSC4 Cytosol RNA degradation 1.4140624727524342 | |
| EXOSC4 Nucleus RNA degradation 1.4140624727524342 | |
| EXOSC5 Nucleus RNA degradation 1.5588765769025972 | |
| EXOSC6 Cytosol Summary 1.3028403948770868 | |
| EXOSC7 Nucleus RNA degradation 1.3683226894166454 | |
| EXOSC8 Cytosol RNA degradation 1.604070063125954 | |
| EXOSC8 Mitochondrion RNA degradation 1.604070063125954 | |
| EXOSC8 Nucleus RNA degradation 1.604070063125954 | |
| EXOSC9 Cytosol RNA degradation 1.5963175655548414 | |
| EXOSC9 Nucleus RNA degradation 1.5963175655548414 | |
| EXPH5 Endosome Summary 1.6323768710111417 | |
| EXT1 Endoplasmic Reticulum Glycosaminoglycan biosynthesis - heparan sulfate / heparin 2.0560788581670533 | |
| EXT1 Endoplasmic Reticulum Metabolic pathways 2.0560788581670533 | |
| EXT1 Golgi apparatus Glycosaminoglycan biosynthesis - heparan sulfate / heparin 2.0560788581670533 | |
| EXT1 Golgi apparatus Metabolic pathways 2.0560788581670533 | |
| EXT2 Endoplasmic Reticulum Glycosaminoglycan biosynthesis - heparan sulfate / heparin 1.9464835847349544 | |
| EXT2 Endoplasmic Reticulum Metabolic pathways 1.9464835847349544 | |
| EXT2 Golgi apparatus Glycosaminoglycan biosynthesis - heparan sulfate / heparin 1.9464835847349544 | |
| EXT2 Golgi apparatus Metabolic pathways 1.9464835847349544 | |
| EXTL2 Cytosol Glycosaminoglycan biosynthesis - heparan sulfate / heparin 3.0230385464594924 | |
| EXTL2 Cytosol Metabolic pathways 3.0230385464594924 | |
| EXTL2 Endoplasmic Reticulum Glycosaminoglycan biosynthesis - heparan sulfate / heparin 3.0230385464594924 | |
| EXTL2 Endoplasmic Reticulum Metabolic pathways 3.0230385464594924 | |
| EXTL2 Extracellular space Glycosaminoglycan biosynthesis - heparan sulfate / heparin 3.0230385464594924 | |
| EXTL2 Extracellular space Metabolic pathways 3.0230385464594924 | |
| EXTL2 Nucleus Glycosaminoglycan biosynthesis - heparan sulfate / heparin 3.0230385464594924 | |
| EXTL2 Nucleus Metabolic pathways 3.0230385464594924 | |
| EYA3 Cytosol Summary 1.2432728732104643 | |
| EYA3 Nucleus Summary 1.2432728732104643 | |
| EYS Endoplasmic Reticulum Summary 1.378152088125799 | |
| EZH1 Nucleus Lysine degradation 0.9973980656150224 | |
| EZH1 Nucleus Metabolic pathways 0.9973980656150224 | |
| EZH2 Nucleus Lysine degradation 2.041842572765324 | |
| EZH2 Nucleus Metabolic pathways 2.041842572765324 | |
| EZH2 Nucleus MicroRNAs in cancer 2.041842572765324 | |
| EZR Cytoskeleton Gastric acid secretion 0.6119712495733568 | |
| EZR Cytoskeleton Leukocyte transendothelial migration 0.6119712495733568 | |
| EZR Cytoskeleton MicroRNAs in cancer 0.6119712495733568 | |
| EZR Cytoskeleton Pathogenic Escherichia coli infection 0.6119712495733568 | |
| EZR Cytoskeleton Proteoglycans in cancer 0.6119712495733568 | |
| EZR Cytoskeleton Regulation of actin cytoskeleton 0.6119712495733568 | |
| EZR Cytoskeleton Tight junction 0.6119712495733568 | |
| EZR Cytosol Gastric acid secretion 0.6119712495733568 | |
| EZR Cytosol Leukocyte transendothelial migration 0.6119712495733568 | |
| EZR Cytosol MicroRNAs in cancer 0.6119712495733568 | |
| EZR Cytosol Pathogenic Escherichia coli infection 0.6119712495733568 | |
| EZR Cytosol Proteoglycans in cancer 0.6119712495733568 | |
| EZR Cytosol Regulation of actin cytoskeleton 0.6119712495733568 | |
| EZR Cytosol Tight junction 0.6119712495733568 | |
| EZR Plasma membrane Gastric acid secretion 0.6119712495733568 | |
| EZR Plasma membrane Leukocyte transendothelial migration 0.6119712495733568 | |
| EZR Plasma membrane MicroRNAs in cancer 0.6119712495733568 | |
| EZR Plasma membrane Pathogenic Escherichia coli infection 0.6119712495733568 | |
| EZR Plasma membrane Proteoglycans in cancer 0.6119712495733568 | |
| EZR Plasma membrane Regulation of actin cytoskeleton 0.6119712495733568 | |
| EZR Plasma membrane Tight junction 0.6119712495733568 | |
| F10 Extracellular space Complement and coagulation cascades 2.063283789651853 | |
| F11 Cytosol Complement and coagulation cascades 2.393093640385178 | |
| F11 Cytosol Herpes simplex virus 1 infection 2.393093640385178 | |
| F11 Extracellular space Complement and coagulation cascades 2.393093640385178 | |
| F11 Extracellular space Herpes simplex virus 1 infection 2.393093640385178 | |
| F11R Cytoskeleton Summary 2.134331725219844 | |
| F11R Plasma membrane Summary 2.134331725219844 | |
| F12 Extracellular space Complement and coagulation cascades 1.3757418315029617 | |
| F13A1 Cytosol Complement and coagulation cascades 1.2404775188414467 | |
| F13A1 Cytosol Coronavirus disease - COVID-19 1.2404775188414467 | |
| F13A1 Extracellular space Complement and coagulation cascades 1.2404775188414467 | |
| F13A1 Extracellular space Coronavirus disease - COVID-19 1.2404775188414467 | |
| F13B Extracellular space Complement and coagulation cascades 2.2544978509732254 | |
| F13B Extracellular space Coronavirus disease - COVID-19 2.2544978509732254 | |
| F2 Extracellular space Complement and coagulation cascades 2.750141266576158 | |
| F2 Extracellular space Coronavirus disease - COVID-19 2.750141266576158 | |
| F2 Extracellular space Neuroactive ligand-receptor interaction 2.750141266576158 | |
| F2 Extracellular space Pathogenic Escherichia coli infection 2.750141266576158 | |
| F2 Extracellular space Pathways in cancer 2.750141266576158 | |
| F2 Extracellular space Phospholipase D signaling pathway 2.750141266576158 | |
| F2 Extracellular space Platelet activation 2.750141266576158 | |
| F2 Extracellular space Regulation of actin cytoskeleton 2.750141266576158 | |
| F2 Extracellular space Thyroid hormone synthesis 2.750141266576158 | |
| F3 Cytosol AGE-RAGE signaling pathway in diabetic complications 1.0370132906299174 | |
| F3 Cytosol Cell adhesion molecules 1.0370132906299174 | |
| F3 Cytosol Complement and coagulation cascades 1.0370132906299174 | |
| F3 Extracellular space AGE-RAGE signaling pathway in diabetic complications 1.0370132906299174 | |
| F3 Extracellular space Cell adhesion molecules 1.0370132906299174 | |
| F3 Extracellular space Complement and coagulation cascades 1.0370132906299174 | |
| F5 Extracellular space Complement and coagulation cascades 2.114643071892018 | |
| F5 Golgi apparatus Complement and coagulation cascades 2.114643071892018 | |
| F8 Extracellular space Complement and coagulation cascades 1.075370653242567 | |
| F8A1 Cytosol Summary 1.0557681528196532 | |
| F9 Extracellular space Complement and coagulation cascades 2.190640895298031 | |
| FAAH Cytoskeleton Retrograde endocannabinoid signaling 0.2789140337262764 | |
| FAAH Cytosol Retrograde endocannabinoid signaling 0.2789140337262764 | |
| FAAP100 Cytosol Fanconi anemia pathway 2.036187811501453 | |
| FAAP100 Nucleus Fanconi anemia pathway 2.036187811501453 | |
| FABP3 Cytosol Summary 1.0655276110441678 | |
| FABP3 Golgi apparatus Summary 1.0655276110441678 | |
| FABP3 Plasma membrane Summary 1.0655276110441678 | |
| FABP4 Cytosol PPAR signaling pathway 2.3568029427506496 | |
| FABP4 Cytosol Regulation of lipolysis in adipocytes 2.3568029427506496 | |
| FABP4 Nucleus PPAR signaling pathway 2.3568029427506496 | |
| FABP4 Nucleus Regulation of lipolysis in adipocytes 2.3568029427506496 | |
| FABP5 Cytosol Summary 2.6930158475693085 | |
| FABP5 Plasma membrane Summary 2.6930158475693085 | |
| FABP6 Cytosol Summary 0.23850963486544696 | |
| FABP7 Cytosol Summary 0.7271870266654725 | |
| FABP7 Golgi apparatus Summary 0.7271870266654725 | |
| FABP7 Nucleus Summary 0.7271870266654725 | |
| FADD Cytosol Alzheimer disease 1.450882228169941 | |
| FADD Cytosol Apoptosis 1.450882228169941 | |
| FADD Cytosol Apoptosis - multiple species 1.450882228169941 | |
| FADD Cytosol Chagas disease 1.450882228169941 | |
| FADD Cytosol Epstein-Barr virus infection 1.450882228169941 | |
| FADD Cytosol Hepatitis B 1.450882228169941 | |
| FADD Cytosol Hepatitis C 1.450882228169941 | |
| FADD Cytosol Herpes simplex virus 1 infection 1.450882228169941 | |
| FADD Cytosol Human cytomegalovirus infection 1.450882228169941 | |
| FADD Cytosol Human immunodeficiency virus 1 infection 1.450882228169941 | |
| FADD Cytosol Human papillomavirus infection 1.450882228169941 | |
| FADD Cytosol IL-17 signaling pathway 1.450882228169941 | |
| FADD Cytosol Influenza A 1.450882228169941 | |
| FADD Cytosol Kaposi sarcoma-associated herpesvirus infection 1.450882228169941 | |
| FADD Cytosol Measles 1.450882228169941 | |
| FADD Cytosol NOD-like receptor signaling pathway 1.450882228169941 | |
| FADD Cytosol Necroptosis 1.450882228169941 | |
| FADD Cytosol Pathogenic Escherichia coli infection 1.450882228169941 | |
| FADD Cytosol Pathways in cancer 1.450882228169941 | |
| FADD Cytosol Pathways of neurodegeneration - multiple diseases 1.450882228169941 | |
| FADD Cytosol Platinum drug resistance 1.450882228169941 | |
| FADD Cytosol RIG-I-like receptor signaling pathway 1.450882228169941 | |
| FADD Cytosol Salmonella infection 1.450882228169941 | |
| FADD Cytosol TNF signaling pathway 1.450882228169941 | |
| FADD Cytosol Toll-like receptor signaling pathway 1.450882228169941 | |
| FADD Cytosol Tuberculosis 1.450882228169941 | |
| FADD Nucleus Alzheimer disease 1.450882228169941 | |
| FADD Nucleus Apoptosis 1.450882228169941 | |
| FADD Nucleus Apoptosis - multiple species 1.450882228169941 | |
| FADD Nucleus Chagas disease 1.450882228169941 | |
| FADD Nucleus Epstein-Barr virus infection 1.450882228169941 | |
| FADD Nucleus Hepatitis B 1.450882228169941 | |
| FADD Nucleus Hepatitis C 1.450882228169941 | |
| FADD Nucleus Herpes simplex virus 1 infection 1.450882228169941 | |
| FADD Nucleus Human cytomegalovirus infection 1.450882228169941 | |
| FADD Nucleus Human immunodeficiency virus 1 infection 1.450882228169941 | |
| FADD Nucleus Human papillomavirus infection 1.450882228169941 | |
| FADD Nucleus IL-17 signaling pathway 1.450882228169941 | |
| FADD Nucleus Influenza A 1.450882228169941 | |
| FADD Nucleus Kaposi sarcoma-associated herpesvirus infection 1.450882228169941 | |
| FADD Nucleus Measles 1.450882228169941 | |
| FADD Nucleus NOD-like receptor signaling pathway 1.450882228169941 | |
| FADD Nucleus Necroptosis 1.450882228169941 | |
| FADD Nucleus Pathogenic Escherichia coli infection 1.450882228169941 | |
| FADD Nucleus Pathways in cancer 1.450882228169941 | |
| FADD Nucleus Pathways of neurodegeneration - multiple diseases 1.450882228169941 | |
| FADD Nucleus Platinum drug resistance 1.450882228169941 | |
| FADD Nucleus RIG-I-like receptor signaling pathway 1.450882228169941 | |
| FADD Nucleus Salmonella infection 1.450882228169941 | |
| FADD Nucleus TNF signaling pathway 1.450882228169941 | |
| FADD Nucleus Toll-like receptor signaling pathway 1.450882228169941 | |
| FADD Nucleus Tuberculosis 1.450882228169941 | |
| FADD Plasma membrane Alzheimer disease 1.450882228169941 | |
| FADD Plasma membrane Apoptosis 1.450882228169941 | |
| FADD Plasma membrane Apoptosis - multiple species 1.450882228169941 | |
| FADD Plasma membrane Chagas disease 1.450882228169941 | |
| FADD Plasma membrane Epstein-Barr virus infection 1.450882228169941 | |
| FADD Plasma membrane Hepatitis B 1.450882228169941 | |
| FADD Plasma membrane Hepatitis C 1.450882228169941 | |
| FADD Plasma membrane Herpes simplex virus 1 infection 1.450882228169941 | |
| FADD Plasma membrane Human cytomegalovirus infection 1.450882228169941 | |
| FADD Plasma membrane Human immunodeficiency virus 1 infection 1.450882228169941 | |
| FADD Plasma membrane Human papillomavirus infection 1.450882228169941 | |
| FADD Plasma membrane IL-17 signaling pathway 1.450882228169941 | |
| FADD Plasma membrane Influenza A 1.450882228169941 | |
| FADD Plasma membrane Kaposi sarcoma-associated herpesvirus infection 1.450882228169941 | |
| FADD Plasma membrane Measles 1.450882228169941 | |
| FADD Plasma membrane NOD-like receptor signaling pathway 1.450882228169941 | |
| FADD Plasma membrane Necroptosis 1.450882228169941 | |
| FADD Plasma membrane Pathogenic Escherichia coli infection 1.450882228169941 | |
| FADD Plasma membrane Pathways in cancer 1.450882228169941 | |
| FADD Plasma membrane Pathways of neurodegeneration - multiple diseases 1.450882228169941 | |
| FADD Plasma membrane Platinum drug resistance 1.450882228169941 | |
| FADD Plasma membrane RIG-I-like receptor signaling pathway 1.450882228169941 | |
| FADD Plasma membrane Salmonella infection 1.450882228169941 | |
| FADD Plasma membrane TNF signaling pathway 1.450882228169941 | |
| FADD Plasma membrane Toll-like receptor signaling pathway 1.450882228169941 | |
| FADD Plasma membrane Tuberculosis 1.450882228169941 | |
| FADS1 Endoplasmic Reticulum Biosynthesis of unsaturated fatty acids 1.3681227372981644 | |
| FADS1 Endoplasmic Reticulum Fatty acid metabolism 1.3681227372981644 | |
| FADS1 Endoplasmic Reticulum Metabolic pathways 1.3681227372981644 | |
| FADS2 Endoplasmic Reticulum Biosynthesis of unsaturated fatty acids 1.282692187936581 | |
| FADS2 Endoplasmic Reticulum Fatty acid metabolism 1.282692187936581 | |
| FADS2 Endoplasmic Reticulum Metabolic pathways 1.282692187936581 | |
| FADS2 Endoplasmic Reticulum PPAR signaling pathway 1.282692187936581 | |
| FADS2 Endoplasmic Reticulum alpha-Linolenic acid metabolism 1.282692187936581 | |
| FAF1 Cytosol Necroptosis 1.682971205680209 | |
| FAF1 Nucleus Necroptosis 1.682971205680209 | |
| FAF1 Plasma membrane Necroptosis 1.682971205680209 | |
| FAF2 Cytosol Summary 0.7974699465189917 | |
| FAF2 Endoplasmic Reticulum Summary 0.7974699465189917 | |
| FAH Cytosol Summary 0.22657899668220244 | |
| FAH Nucleus Summary 0.22657899668220244 | |
| FAHD1 Cytosol Metabolic pathways 1.416517132788104 | |
| FAHD1 Cytosol Tyrosine metabolism 1.416517132788104 | |
| FAHD1 Mitochondrion Metabolic pathways 1.416517132788104 | |
| FAHD1 Mitochondrion Tyrosine metabolism 1.416517132788104 | |
| FAHD1 Nucleus Metabolic pathways 1.416517132788104 | |
| FAHD1 Nucleus Tyrosine metabolism 1.416517132788104 | |
| FAIM Cytosol Summary 2.0614712486505558 | |
| FAIM Plasma membrane Summary 2.0614712486505558 | |
| FAM102A Cytosol Summary 0.2597882812549595 | |
| FAM102B Cytosol Summary 0.4641137244045314 | |
| FAM102B Nucleus Summary 0.4641137244045314 | |
| FAM103A1 Nucleus Summary 2.2056504351673545 | |
| FAM104A Cytosol Summary 1.3479045163837635 | |
| FAM104A Nucleus Summary 1.3479045163837635 | |
| FAM105A Cytosol Summary 1.0486495104933224 | |
| FAM105A Nucleus Summary 1.0486495104933224 | |
| FAM107B Golgi apparatus Summary 0.9313444818427141 | |
| FAM107B Nucleus Summary 0.9313444818427141 | |
| FAM110A Cytoskeleton Summary 1.194939472382471 | |
| FAM110A Cytosol Summary 1.194939472382471 | |
| FAM110A Nucleus Summary 1.194939472382471 | |
| FAM110B Cytoskeleton Summary 0.4964461202148654 | |
| FAM110B Cytosol Summary 0.4964461202148654 | |
| FAM110B Mitochondrion Summary 0.4964461202148654 | |
| FAM111A Nucleus Summary 1.5720827660144163 | |
| FAM111B Cytosol Summary 1.837611513539761 | |
| FAM111B Nucleus Summary 1.837611513539761 | |
| FAM114A1 Cytosol Summary 0.9859087196602068 | |
| FAM114A1 Golgi apparatus Summary 0.9859087196602068 | |
| FAM114A1 Nucleus Summary 0.9859087196602068 | |
| FAM114A2 Cytosol Summary 0.6351141138258845 | |
| FAM117A Nucleus Summary 1.1698741547227691 | |
| FAM117B Cytoskeleton Summary 1.9558855543497065 | |
| FAM117B Nucleus Summary 1.9558855543497065 | |
| FAM118A Cytoskeleton Summary 1.7631242168092869 | |
| FAM118A Cytosol Summary 1.7631242168092869 | |
| FAM118B Cytosol Summary 1.9681231891361783 | |
| FAM118B Nucleus Summary 1.9681231891361783 | |
| FAM120A Cytosol Summary 0.5607035914663719 | |
| FAM120A Plasma membrane Summary 0.5607035914663719 | |
| FAM120B Cytosol Summary 0.6837243502900999 | |
| FAM120B Nucleus Summary 0.6837243502900999 | |
| FAM120C Nucleus Summary 1.1984565507768303 | |
| FAM122A Nucleus Summary 1.2142795016111336 | |
| FAM122B Nucleus Summary 1.1409957023365147 | |
| FAM126A Cytosol Summary 1.6690132567003972 | |
| FAM126A Plasma membrane Summary 1.6690132567003972 | |
| FAM126B Cytosol Summary 1.2253835163877191 | |
| FAM126B Nucleus Summary 1.2253835163877191 | |
| FAM126B Plasma membrane Summary 1.2253835163877191 | |
| FAM129A Cytosol Summary 0.4219833571257557 | |
| FAM129A Plasma membrane Summary 0.4219833571257557 | |
| FAM129B Cytosol Summary 1.3052024481431237 | |
| FAM129B Nucleus Summary 1.3052024481431237 | |
| FAM129B Plasma membrane Summary 1.3052024481431237 | |
| FAM133A Nucleus Summary 2.5512568159323448 | |
| FAM133B Nucleus Summary 1.082338270967914 | |
| FAM134A Cytosol Summary 0.8953332252157441 | |
| FAM134C Nucleus Summary 0.6817326818856448 | |
| FAM136A Mitochondrion Summary 1.9128291501810684 | |
| FAM13A Cytosol Summary 1.2048588218461185 | |
| FAM13A Nucleus Summary 1.2048588218461185 | |
| FAM13A Plasma membrane Summary 1.2048588218461185 | |
| FAM151B Cytosol Summary 0.8446676000150145 | |
| FAM160A1 Cytosol Summary 1.4341700289548864 | |
| FAM160A2 Mitochondrion Summary 1.0766210252135722 | |
| FAM160B1 Cytosol Summary 0.9598756020936192 | |
| FAM160B1 Nucleus Summary 0.9598756020936192 | |
| FAM160B2 Cytosol Summary 0.97454951936125 | |
| FAM160B2 Nucleus Summary 0.97454951936125 | |
| FAM162A Cytosol Summary 1.1409355493226625 | |
| FAM162A Mitochondrion Summary 1.1409355493226625 | |
| FAM168A Nucleus Summary 1.7437028629213909 | |
| FAM168B Nucleus Summary 1.8911817739402217 | |
| FAM168B Plasma membrane Summary 1.8911817739402217 | |
| FAM169A Cytosol Summary 0.2249046365229276 | |
| FAM169A Nucleus Summary 0.2249046365229276 | |
| FAM172A Cytosol Summary 0.7997632522944315 | |
| FAM172A Nucleus Summary 0.7997632522944315 | |
| FAM173A Cytosol Summary 0.9243119722281218 | |
| FAM174A Cytosol Summary 0.2576779877197959 | |
| FAM174A Golgi apparatus Summary 0.2576779877197959 | |
| FAM174B Cytoskeleton Summary 0.3322091176107578 | |
| FAM174B Plasma membrane Summary 0.3322091176107578 | |
| FAM175A Nucleus Summary 1.4542327093245817 | |
| FAM175B Cytosol Summary 0.8563746495641195 | |
| FAM177A1 Cytosol Summary 1.7258221015184358 | |
| FAM177A1 Nucleus Summary 1.7258221015184358 | |
| FAM184A Cytosol Summary 1.7695421128111033 | |
| FAM184A Golgi apparatus Summary 1.7695421128111033 | |
| FAM184A Nucleus Summary 1.7695421128111033 | |
| FAM185A Cytosol Summary 1.1616771666874857 | |
| FAM188A Nucleus Summary 1.7634218353927928 | |
| FAM188B Cytosol Summary 1.4864535229275182 | |
| FAM192A Cytosol Summary 1.2120338690781962 | |
| FAM192A Nucleus Summary 1.2120338690781962 | |
| FAM193A Cytosol Summary 1.4757912382954128 | |
| FAM193A Plasma membrane Summary 1.4757912382954128 | |
| FAM193B Cytosol Summary 1.4752537550494909 | |
| FAM193B Nucleus Summary 1.4752537550494909 | |
| FAM198B Golgi apparatus Summary 0.19778375563804804 | |
| FAM198B Nucleus Summary 0.19778375563804804 | |
| FAM204A Nucleus Summary 1.1174363148817854 | |
| FAM206A Cytosol Summary 1.5309755550105988 | |
| FAM206A Nucleus Summary 1.5309755550105988 | |
| FAM207A Cytosol Summary 2.2045549140759717 | |
| FAM207A Golgi apparatus Summary 2.2045549140759717 | |
| FAM208A Nucleus Summary 0.9881824821047792 | |
| FAM208B Cytosol Summary 1.736271304014792 | |
| FAM208B Nucleus Summary 1.736271304014792 | |
| FAM20B Golgi apparatus Summary 0.536231558629475 | |
| FAM20B Nucleus Summary 0.536231558629475 | |
| FAM210A Golgi apparatus Summary 1.7091233885169057 | |
| FAM210A Mitochondrion Summary 1.7091233885169057 | |
| FAM210A Nucleus Summary 1.7091233885169057 | |
| FAM210B Cytosol Summary 0.875766092507966 | |
| FAM210B Mitochondrion Summary 0.875766092507966 | |
| FAM210B Plasma membrane Summary 0.875766092507966 | |
| FAM213B Cytosol Summary 1.0008147463214356 | |
| FAM213B Nucleus Summary 1.0008147463214356 | |
| FAM219A Cytosol Summary 2.3258817016784854 | |
| FAM219A Golgi apparatus Summary 2.3258817016784854 | |
| FAM219A Nucleus Summary 2.3258817016784854 | |
| FAM21C Nucleus Summary 1.2504074233001086 | |
| FAM221A Cytosol Summary 0.8266853789203565 | |
| FAM222B Nucleus Summary 0.6622262235434677 | |
| FAM234A Mitochondrion Summary 0.9897046590331098 | |
| FAM234A Nucleus Summary 0.9897046590331098 | |
| FAM234B Endoplasmic Reticulum Summary 0.8595073694577537 | |
| FAM26E Golgi apparatus Summary 0.9245511914244686 | |
| FAM32A Nucleus Summary 1.7906201785817406 | |
| FAM3A Mitochondrion Summary 1.0756186243824328 | |
| FAM3A Nucleus Summary 1.0756186243824328 | |
| FAM3B Cytosol Summary 0.26351237613580625 | |
| FAM3B Extracellular space Summary 0.26351237613580625 | |
| FAM3B Nucleus Summary 0.26351237613580625 | |
| FAM3C Extracellular space Summary 1.6936871746619555 | |
| FAM3C Golgi apparatus Summary 1.6936871746619555 | |
| FAM45A Cytoskeleton Summary 0.9743736954022691 | |
| FAM45A Cytosol Summary 0.9743736954022691 | |
| FAM45A Plasma membrane Summary 0.9743736954022691 | |
| FAM46A Cytosol Summary 2.233475422640308 | |
| FAM46A Nucleus Summary 2.233475422640308 | |
| FAM49A Nucleus Summary 1.6025380000264635 | |
| FAM49B Cytosol Summary 1.6062055025370283 | |
| FAM49B Nucleus Summary 1.6062055025370283 | |
| FAM50A Nucleus Summary 1.3415996927026999 | |
| FAM50B Cytoskeleton Summary 2.147835715432069 | |
| FAM50B Nucleus Summary 2.147835715432069 | |
| FAM53B Cytosol Summary 1.2449567227879272 | |
| FAM53B Nucleus Summary 1.2449567227879272 | |
| FAM60A Nucleus Summary 3.2306626551014213 | |
| FAM63A Nucleus Summary 0.24658448977857775 | |
| FAM63B Nucleus Summary 1.7418019602901562 | |
| FAM64A Nucleus Summary 3.350163200603653 | |
| FAM65A Golgi apparatus Summary 1.3697971670353748 | |
| FAM76A Cytosol Summary 1.965714373449645 | |
| FAM76A Nucleus Summary 1.965714373449645 | |
| FAM76B Nucleus Summary 1.5040676386594831 | |
| FAM83B Cytosol Summary 2.027029713849254 | |
| FAM83D Cytoskeleton Summary 1.2921851711847312 | |
| FAM83D Cytosol Summary 1.2921851711847312 | |
| FAM83D Mitochondrion Summary 1.2921851711847312 | |
| FAM83F Mitochondrion Summary 0.8602714616179868 | |
| FAM83F Nucleus Summary 0.8602714616179868 | |
| FAM83G Cytosol Summary 1.768225887254896 | |
| FAM83H Cytosol Summary 1.0187714778654324 | |
| FAM84A Nucleus Summary 2.860985744867887 | |
| FAM84B Nucleus Summary 0.2519840061760014 | |
| FAM89A Cytosol Summary 2.5469207703579233 | |
| FAM89A Golgi apparatus Summary 2.5469207703579233 | |
| FAM89A Nucleus Summary 2.5469207703579233 | |
| FAM89B Cytosol Summary 1.4799628986787077 | |
| FAM8A1 Golgi apparatus Summary 0.6759978602978554 | |
| FAM91A1 Cytoskeleton Summary 1.4102731130957926 | |
| FAM91A1 Golgi apparatus Summary 1.4102731130957926 | |
| FAM91A1 Nucleus Summary 1.4102731130957926 | |
| FAM96A Cytosol Summary 1.841914391062952 | |
| FAM96A Nucleus Summary 1.841914391062952 | |
| FAM96B Cytosol Summary 1.6829232782530583 | |
| FAM96B Nucleus Summary 1.6829232782530583 | |
| FAM98A Cytosol Summary 1.5053579735088225 | |
| FAM98B Cytosol Summary 0.9360119759164628 | |
| FAM98B Nucleus Summary 0.9360119759164628 | |
| FAM98C Cytosol Summary 0.40501242157459816 | |
| FAM98C Nucleus Summary 0.40501242157459816 | |
| FANCD2 Cytosol Fanconi anemia pathway 2.0695379282617465 | |
| FANCD2 Nucleus Fanconi anemia pathway 2.0695379282617465 | |
| FANCG Cytosol Fanconi anemia pathway 0.7365874449380544 | |
| FANCG Mitochondrion Fanconi anemia pathway 0.7365874449380544 | |
| FANCG Nucleus Fanconi anemia pathway 0.7365874449380544 | |
| FANCG Plasma membrane Fanconi anemia pathway 0.7365874449380544 | |
| FANCI Nucleus Fanconi anemia pathway 2.358422620805039 | |
| FAP Plasma membrane Fat digestion and absorption 1.1714403157833169 | |
| FAP Plasma membrane Glycerolipid metabolism 1.1714403157833169 | |
| FAP Plasma membrane Metabolic pathways 1.1714403157833169 | |
| FAP Plasma membrane Pancreatic secretion 1.1714403157833169 | |
| FAP Plasma membrane Shigellosis 1.1714403157833169 | |
| FAP Plasma membrane Steroid biosynthesis 1.1714403157833169 | |
| FAR1 Peroxisome Peroxisome 0.8158872581497167 | |
| FARP1 Cytosol Summary 0.9057384881786236 | |
| FARP2 Cytosol Summary 1.0120439420996994 | |
| FARS2 Mitochondrion Summary 1.2822535776090769 | |
| FARS2 Plasma membrane Summary 1.2822535776090769 | |
| FARSA Cytosol Summary 1.2681308914208844 | |
| FARSB Cytosol Summary 1.352450831961865 | |
| FARSB Nucleus Summary 1.352450831961865 | |
| FAS Cytosol AMPK signaling pathway 1.3840339523088774 | |
| FAS Cytosol African trypanosomiasis 1.3840339523088774 | |
| FAS Cytosol Allograft rejection 1.3840339523088774 | |
| FAS Cytosol Alzheimer disease 1.3840339523088774 | |
| FAS Cytosol Apoptosis 1.3840339523088774 | |
| FAS Cytosol Autoimmune thyroid disease 1.3840339523088774 | |
| FAS Cytosol Chagas disease 1.3840339523088774 | |
| FAS Cytosol Cytokine-cytokine receptor interaction 1.3840339523088774 | |
| FAS Cytosol Epstein-Barr virus infection 1.3840339523088774 | |
| FAS Cytosol Fatty acid biosynthesis 1.3840339523088774 | |
| FAS Cytosol Fatty acid metabolism 1.3840339523088774 | |
| FAS Cytosol Graft-versus-host disease 1.3840339523088774 | |
| FAS Cytosol Hepatitis B 1.3840339523088774 | |
| FAS Cytosol Hepatitis C 1.3840339523088774 | |
| FAS Cytosol Herpes simplex virus 1 infection 1.3840339523088774 | |
| FAS Cytosol Human cytomegalovirus infection 1.3840339523088774 | |
| FAS Cytosol Human immunodeficiency virus 1 infection 1.3840339523088774 | |
| FAS Cytosol Human papillomavirus infection 1.3840339523088774 | |
| FAS Cytosol Influenza A 1.3840339523088774 | |
| FAS Cytosol Insulin signaling pathway 1.3840339523088774 | |
| FAS Cytosol Kaposi sarcoma-associated herpesvirus infection 1.3840339523088774 | |
| FAS Cytosol Lipid and atherosclerosis 1.3840339523088774 | |
| FAS Cytosol MAPK signaling pathway 1.3840339523088774 | |
| FAS Cytosol Measles 1.3840339523088774 | |
| FAS Cytosol Metabolic pathways 1.3840339523088774 | |
| FAS Cytosol Natural killer cell mediated cytotoxicity 1.3840339523088774 | |
| FAS Cytosol Necroptosis 1.3840339523088774 | |
| FAS Cytosol Non-alcoholic fatty liver disease 1.3840339523088774 | |
| FAS Cytosol Pathogenic Escherichia coli infection 1.3840339523088774 | |
| FAS Cytosol Pathways in cancer 1.3840339523088774 | |
| FAS Cytosol Pathways of neurodegeneration - multiple diseases 1.3840339523088774 | |
| FAS Cytosol Platinum drug resistance 1.3840339523088774 | |
| FAS Cytosol Proteoglycans in cancer 1.3840339523088774 | |
| FAS Cytosol TNF signaling pathway 1.3840339523088774 | |
| FAS Cytosol Type I diabetes mellitus 1.3840339523088774 | |
| FAS Cytosol p53 signaling pathway 1.3840339523088774 | |
| FAS Extracellular space AMPK signaling pathway 1.3840339523088774 | |
| FAS Extracellular space African trypanosomiasis 1.3840339523088774 | |
| FAS Extracellular space Allograft rejection 1.3840339523088774 | |
| FAS Extracellular space Alzheimer disease 1.3840339523088774 | |
| FAS Extracellular space Apoptosis 1.3840339523088774 | |
| FAS Extracellular space Autoimmune thyroid disease 1.3840339523088774 | |
| FAS Extracellular space Chagas disease 1.3840339523088774 | |
| FAS Extracellular space Cytokine-cytokine receptor interaction 1.3840339523088774 | |
| FAS Extracellular space Epstein-Barr virus infection 1.3840339523088774 | |
| FAS Extracellular space Fatty acid biosynthesis 1.3840339523088774 | |
| FAS Extracellular space Fatty acid metabolism 1.3840339523088774 | |
| FAS Extracellular space Graft-versus-host disease 1.3840339523088774 | |
| FAS Extracellular space Hepatitis B 1.3840339523088774 | |
| FAS Extracellular space Hepatitis C 1.3840339523088774 | |
| FAS Extracellular space Herpes simplex virus 1 infection 1.3840339523088774 | |
| FAS Extracellular space Human cytomegalovirus infection 1.3840339523088774 | |
| FAS Extracellular space Human immunodeficiency virus 1 infection 1.3840339523088774 | |
| FAS Extracellular space Human papillomavirus infection 1.3840339523088774 | |
| FAS Extracellular space Influenza A 1.3840339523088774 | |
| FAS Extracellular space Insulin signaling pathway 1.3840339523088774 | |
| FAS Extracellular space Kaposi sarcoma-associated herpesvirus infection 1.3840339523088774 | |
| FAS Extracellular space Lipid and atherosclerosis 1.3840339523088774 | |
| FAS Extracellular space MAPK signaling pathway 1.3840339523088774 | |
| FAS Extracellular space Measles 1.3840339523088774 | |
| FAS Extracellular space Metabolic pathways 1.3840339523088774 | |
| FAS Extracellular space Natural killer cell mediated cytotoxicity 1.3840339523088774 | |
| FAS Extracellular space Necroptosis 1.3840339523088774 | |
| FAS Extracellular space Non-alcoholic fatty liver disease 1.3840339523088774 | |
| FAS Extracellular space Pathogenic Escherichia coli infection 1.3840339523088774 | |
| FAS Extracellular space Pathways in cancer 1.3840339523088774 | |
| FAS Extracellular space Pathways of neurodegeneration - multiple diseases 1.3840339523088774 | |
| FAS Extracellular space Platinum drug resistance 1.3840339523088774 | |
| FAS Extracellular space Proteoglycans in cancer 1.3840339523088774 | |
| FAS Extracellular space TNF signaling pathway 1.3840339523088774 | |
| FAS Extracellular space Type I diabetes mellitus 1.3840339523088774 | |
| FAS Extracellular space p53 signaling pathway 1.3840339523088774 | |
| FAS Nucleus AMPK signaling pathway 1.3840339523088774 | |
| FAS Nucleus African trypanosomiasis 1.3840339523088774 | |
| FAS Nucleus Allograft rejection 1.3840339523088774 | |
| FAS Nucleus Alzheimer disease 1.3840339523088774 | |
| FAS Nucleus Apoptosis 1.3840339523088774 | |
| FAS Nucleus Autoimmune thyroid disease 1.3840339523088774 | |
| FAS Nucleus Chagas disease 1.3840339523088774 | |
| FAS Nucleus Cytokine-cytokine receptor interaction 1.3840339523088774 | |
| FAS Nucleus Epstein-Barr virus infection 1.3840339523088774 | |
| FAS Nucleus Fatty acid biosynthesis 1.3840339523088774 | |
| FAS Nucleus Fatty acid metabolism 1.3840339523088774 | |
| FAS Nucleus Graft-versus-host disease 1.3840339523088774 | |
| FAS Nucleus Hepatitis B 1.3840339523088774 | |
| FAS Nucleus Hepatitis C 1.3840339523088774 | |
| FAS Nucleus Herpes simplex virus 1 infection 1.3840339523088774 | |
| FAS Nucleus Human cytomegalovirus infection 1.3840339523088774 | |
| FAS Nucleus Human immunodeficiency virus 1 infection 1.3840339523088774 | |
| FAS Nucleus Human papillomavirus infection 1.3840339523088774 | |
| FAS Nucleus Influenza A 1.3840339523088774 | |
| FAS Nucleus Insulin signaling pathway 1.3840339523088774 | |
| FAS Nucleus Kaposi sarcoma-associated herpesvirus infection 1.3840339523088774 | |
| FAS Nucleus Lipid and atherosclerosis 1.3840339523088774 | |
| FAS Nucleus MAPK signaling pathway 1.3840339523088774 | |
| FAS Nucleus Measles 1.3840339523088774 | |
| FAS Nucleus Metabolic pathways 1.3840339523088774 | |
| FAS Nucleus Natural killer cell mediated cytotoxicity 1.3840339523088774 | |
| FAS Nucleus Necroptosis 1.3840339523088774 | |
| FAS Nucleus Non-alcoholic fatty liver disease 1.3840339523088774 | |
| FAS Nucleus Pathogenic Escherichia coli infection 1.3840339523088774 | |
| FAS Nucleus Pathways in cancer 1.3840339523088774 | |
| FAS Nucleus Pathways of neurodegeneration - multiple diseases 1.3840339523088774 | |
| FAS Nucleus Platinum drug resistance 1.3840339523088774 | |
| FAS Nucleus Proteoglycans in cancer 1.3840339523088774 | |
| FAS Nucleus TNF signaling pathway 1.3840339523088774 | |
| FAS Nucleus Type I diabetes mellitus 1.3840339523088774 | |
| FAS Nucleus p53 signaling pathway 1.3840339523088774 | |
| FAS Plasma membrane AMPK signaling pathway 1.3840339523088774 | |
| FAS Plasma membrane African trypanosomiasis 1.3840339523088774 | |
| FAS Plasma membrane Allograft rejection 1.3840339523088774 | |
| FAS Plasma membrane Alzheimer disease 1.3840339523088774 | |
| FAS Plasma membrane Apoptosis 1.3840339523088774 | |
| FAS Plasma membrane Autoimmune thyroid disease 1.3840339523088774 | |
| FAS Plasma membrane Chagas disease 1.3840339523088774 | |
| FAS Plasma membrane Cytokine-cytokine receptor interaction 1.3840339523088774 | |
| FAS Plasma membrane Epstein-Barr virus infection 1.3840339523088774 | |
| FAS Plasma membrane Fatty acid biosynthesis 1.3840339523088774 | |
| FAS Plasma membrane Fatty acid metabolism 1.3840339523088774 | |
| FAS Plasma membrane Graft-versus-host disease 1.3840339523088774 | |
| FAS Plasma membrane Hepatitis B 1.3840339523088774 | |
| FAS Plasma membrane Hepatitis C 1.3840339523088774 | |
| FAS Plasma membrane Herpes simplex virus 1 infection 1.3840339523088774 | |
| FAS Plasma membrane Human cytomegalovirus infection 1.3840339523088774 | |
| FAS Plasma membrane Human immunodeficiency virus 1 infection 1.3840339523088774 | |
| FAS Plasma membrane Human papillomavirus infection 1.3840339523088774 | |
| FAS Plasma membrane Influenza A 1.3840339523088774 | |
| FAS Plasma membrane Insulin signaling pathway 1.3840339523088774 | |
| FAS Plasma membrane Kaposi sarcoma-associated herpesvirus infection 1.3840339523088774 | |
| FAS Plasma membrane Lipid and atherosclerosis 1.3840339523088774 | |
| FAS Plasma membrane MAPK signaling pathway 1.3840339523088774 | |
| FAS Plasma membrane Measles 1.3840339523088774 | |
| FAS Plasma membrane Metabolic pathways 1.3840339523088774 | |
| FAS Plasma membrane Natural killer cell mediated cytotoxicity 1.3840339523088774 | |
| FAS Plasma membrane Necroptosis 1.3840339523088774 | |
| FAS Plasma membrane Non-alcoholic fatty liver disease 1.3840339523088774 | |
| FAS Plasma membrane Pathogenic Escherichia coli infection 1.3840339523088774 | |
| FAS Plasma membrane Pathways in cancer 1.3840339523088774 | |
| FAS Plasma membrane Pathways of neurodegeneration - multiple diseases 1.3840339523088774 | |
| FAS Plasma membrane Platinum drug resistance 1.3840339523088774 | |
| FAS Plasma membrane Proteoglycans in cancer 1.3840339523088774 | |
| FAS Plasma membrane TNF signaling pathway 1.3840339523088774 | |
| FAS Plasma membrane Type I diabetes mellitus 1.3840339523088774 | |
| FAS Plasma membrane p53 signaling pathway 1.3840339523088774 | |
| FASN Cytosol Summary 0.2623532946632835 | |
| FASN Plasma membrane Summary 0.2623532946632835 | |
| FASTKD1 Mitochondrion Summary 1.5744301084665857 | |
| FASTKD1 Nucleus Summary 1.5744301084665857 | |
| FASTKD2 Mitochondrion Summary 1.7218538400410632 | |
| FASTKD2 Nucleus Summary 1.7218538400410632 | |
| FASTKD5 Mitochondrion Summary 1.4624464092872411 | |
| FASTKD5 Nucleus Summary 1.4624464092872411 | |
| FAT1 Nucleus Summary 2.428449856450995 | |
| FAT1 Plasma membrane Summary 2.428449856450995 | |
| FAT2 Nucleus Summary 1.0742214611154626 | |
| FAT2 Plasma membrane Summary 1.0742214611154626 | |
| FAT4 Cytosol Summary 0.5522050622972458 | |
| FAU Cytosol Coronavirus disease - COVID-19 0.9360737468364811 | |
| FAU Cytosol Ribosome 0.9360737468364811 | |
| FAU Endoplasmic Reticulum Coronavirus disease - COVID-19 0.9360737468364811 | |
| FAU Endoplasmic Reticulum Ribosome 0.9360737468364811 | |
| FAU Nucleus Coronavirus disease - COVID-19 0.9360737468364811 | |
| FAU Nucleus Ribosome 0.9360737468364811 | |
| FBL Nucleus Ribosome biogenesis in eukaryotes 1.3828734024451903 | |
| FBLIM1 Cytoskeleton Summary 2.484034342777215 | |
| FBLIM1 Nucleus Summary 2.484034342777215 | |
| FBLIM1 Plasma membrane Summary 2.484034342777215 | |
| FBLN1 Endoplasmic Reticulum Summary 1.8656477881571643 | |
| FBLN1 Extracellular space Summary 1.8656477881571643 | |
| FBLN2 Extracellular space Summary 1.3348205386154903 | |
| FBLN2 Plasma membrane Summary 1.3348205386154903 | |
| FBLN5 Cytosol Summary 1.0737529647228805 | |
| FBLN5 Extracellular space Summary 1.0737529647228805 | |
| FBLN5 Plasma membrane Summary 1.0737529647228805 | |
| FBLN7 Extracellular space Summary 1.08090324223684 | |
| FBLN7 Plasma membrane Summary 1.08090324223684 | |
| FBN1 Cytosol TGF-beta signaling pathway 1.6316470483482135 | |
| FBN1 Extracellular space TGF-beta signaling pathway 1.6316470483482135 | |
| FBN2 Cytosol Summary 2.0680668222465397 | |
| FBN2 Extracellular space Summary 2.0680668222465397 | |
| FBN2 Nucleus Summary 2.0680668222465397 | |
| FBP1 Mitochondrion Summary 0.20987981533078234 | |
| FBP2 Cytosol Summary 0.2873565897508819 | |
| FBP2 Nucleus Summary 0.2873565897508819 | |
| FBP2 Plasma membrane Summary 0.2873565897508819 | |
| FBRS Nucleus Summary 1.0521361716931834 | |
| FBRSL1 Cytosol Summary 1.1729146754515585 | |
| FBRSL1 Nucleus Summary 1.1729146754515585 | |
| FBRSL1 Plasma membrane Summary 1.1729146754515585 | |
| FBXL12 Mitochondrion Summary 1.5379878702430456 | |
| FBXL17 Cytosol Summary 0.7153588379242191 | |
| FBXL17 Nucleus Summary 0.7153588379242191 | |
| FBXL18 Cytosol Summary 1.3484746479069318 | |
| FBXL18 Nucleus Summary 1.3484746479069318 | |
| FBXL19 Cytoskeleton Summary 1.5160149664215847 | |
| FBXL19 Nucleus Summary 1.5160149664215847 | |
| FBXL20 Cytoskeleton Summary 0.20358754418996486 | |
| FBXL20 Cytosol Summary 0.20358754418996486 | |
| FBXL3 Nucleus Circadian rhythm 1.890548856297344 | |
| FBXL4 Nucleus Summary 1.8258465650356948 | |
| FBXL6 Cytosol Summary 1.0035686989716428 | |
| FBXL6 Nucleus Summary 1.0035686989716428 | |
| FBXL8 Golgi apparatus Summary 1.0358306175007312 | |
| FBXO11 Nucleus Summary 1.2563634820807437 | |
| FBXO2 Cytosol Summary 0.9180157741241938 | |
| FBXO2 Nucleus Summary 0.9180157741241938 | |
| FBXO21 Mitochondrion Summary 0.9540034434056024 | |
| FBXO22 Cytosol Summary 0.991943792367444 | |
| FBXO28 Endoplasmic Reticulum Summary 1.0452921372299486 | |
| FBXO28 Nucleus Summary 1.0452921372299486 | |
| FBXO3 Cytosol Summary 0.8846262332604597 | |
| FBXO3 Nucleus Summary 0.8846262332604597 | |
| FBXO30 Cytoskeleton Summary 1.698547808118921 | |
| FBXO38 Cytosol Summary 0.4694135795280134 | |
| FBXO38 Nucleus Summary 0.4694135795280134 | |
| FBXO38 Plasma membrane Summary 0.4694135795280134 | |
| FBXO4 Cytosol Summary 0.6924688316590158 | |
| FBXO4 Nucleus Summary 0.6924688316590158 | |
| FBXO42 Nucleus Summary 1.30080767181492 | |
| FBXO44 Nucleus Summary 0.6570293041841869 | |
| FBXO45 Cytosol Summary 1.1318967471920258 | |
| FBXO45 Plasma membrane Summary 1.1318967471920258 | |
| FBXO46 Cytosol Summary 1.548070305326735 | |
| FBXO46 Nucleus Summary 1.548070305326735 | |
| FBXO6 Cytosol Summary 0.8041133417591352 | |
| FBXO7 Cytosol Summary 1.5339330805367075 | |
| FBXO7 Nucleus Summary 1.5339330805367075 | |
| FBXO9 Cytoskeleton Summary 0.947289237584254 | |
| FBXO9 Cytosol Summary 0.947289237584254 | |
| FBXW11 Cytoskeleton Cellular senescence 0.9841243376620904 | |
| FBXW11 Cytoskeleton Circadian rhythm 0.9841243376620904 | |
| FBXW11 Cytoskeleton Hedgehog signaling pathway 0.9841243376620904 | |
| FBXW11 Cytoskeleton Hippo signaling pathway 0.9841243376620904 | |
| FBXW11 Cytoskeleton Human immunodeficiency virus 1 infection 0.9841243376620904 | |
| FBXW11 Cytoskeleton Oocyte meiosis 0.9841243376620904 | |
| FBXW11 Cytoskeleton Shigellosis 0.9841243376620904 | |
| FBXW11 Cytoskeleton Ubiquitin mediated proteolysis 0.9841243376620904 | |
| FBXW11 Cytoskeleton Wnt signaling pathway 0.9841243376620904 | |
| FBXW11 Cytosol Cellular senescence 0.9841243376620904 | |
| FBXW11 Cytosol Circadian rhythm 0.9841243376620904 | |
| FBXW11 Cytosol Hedgehog signaling pathway 0.9841243376620904 | |
| FBXW11 Cytosol Hippo signaling pathway 0.9841243376620904 | |
| FBXW11 Cytosol Human immunodeficiency virus 1 infection 0.9841243376620904 | |
| FBXW11 Cytosol Oocyte meiosis 0.9841243376620904 | |
| FBXW11 Cytosol Shigellosis 0.9841243376620904 | |
| FBXW11 Cytosol Ubiquitin mediated proteolysis 0.9841243376620904 | |
| FBXW11 Cytosol Wnt signaling pathway 0.9841243376620904 | |
| FBXW11 Nucleus Cellular senescence 0.9841243376620904 | |
| FBXW11 Nucleus Circadian rhythm 0.9841243376620904 | |
| FBXW11 Nucleus Hedgehog signaling pathway 0.9841243376620904 | |
| FBXW11 Nucleus Hippo signaling pathway 0.9841243376620904 | |
| FBXW11 Nucleus Human immunodeficiency virus 1 infection 0.9841243376620904 | |
| FBXW11 Nucleus Oocyte meiosis 0.9841243376620904 | |
| FBXW11 Nucleus Shigellosis 0.9841243376620904 | |
| FBXW11 Nucleus Ubiquitin mediated proteolysis 0.9841243376620904 | |
| FBXW11 Nucleus Wnt signaling pathway 0.9841243376620904 | |
| FBXW11 Plasma membrane Cellular senescence 0.9841243376620904 | |
| FBXW11 Plasma membrane Circadian rhythm 0.9841243376620904 | |
| FBXW11 Plasma membrane Hedgehog signaling pathway 0.9841243376620904 | |
| FBXW11 Plasma membrane Hippo signaling pathway 0.9841243376620904 | |
| FBXW11 Plasma membrane Human immunodeficiency virus 1 infection 0.9841243376620904 | |
| FBXW11 Plasma membrane Oocyte meiosis 0.9841243376620904 | |
| FBXW11 Plasma membrane Shigellosis 0.9841243376620904 | |
| FBXW11 Plasma membrane Ubiquitin mediated proteolysis 0.9841243376620904 | |
| FBXW11 Plasma membrane Wnt signaling pathway 0.9841243376620904 | |
| FBXW2 Nucleus Summary 0.6313612832855046 | |
| FBXW5 Cytosol Summary 1.1415856950927814 | |
| FBXW5 Mitochondrion Summary 1.1415856950927814 | |
| FBXW8 Cytosol Summary 1.59858605578213 | |
| FBXW9 Cytosol Summary 0.5757883799174005 | |
| FCER1G Plasma membrane Asthma 1.6739866959878298 | |
| FCER1G Plasma membrane C-type lectin receptor signaling pathway 1.6739866959878298 | |
| FCER1G Plasma membrane Fc epsilon RI signaling pathway 1.6739866959878298 | |
| FCER1G Plasma membrane Natural killer cell mediated cytotoxicity 1.6739866959878298 | |
| FCER1G Plasma membrane Phospholipase D signaling pathway 1.6739866959878298 | |
| FCER1G Plasma membrane Platelet activation 1.6739866959878298 | |
| FCER1G Plasma membrane Sphingolipid signaling pathway 1.6739866959878298 | |
| FCER1G Plasma membrane Tuberculosis 1.6739866959878298 | |
| FCF1 Nucleus Summary 1.9561616074981127 | |
| FCGBP Golgi apparatus Summary 0.689134150373929 | |
| FCGBP Plasma membrane Summary 0.689134150373929 | |
| FCGR1A Cytosol Acute myeloid leukemia 1.724682268712256 | |
| FCGR1A Cytosol Fc gamma R-mediated phagocytosis 1.724682268712256 | |
| FCGR1A Cytosol Hematopoietic cell lineage 1.724682268712256 | |
| FCGR1A Cytosol Leishmaniasis 1.724682268712256 | |
| FCGR1A Cytosol Neutrophil extracellular trap formation 1.724682268712256 | |
| FCGR1A Cytosol Osteoclast differentiation 1.724682268712256 | |
| FCGR1A Cytosol Phagosome 1.724682268712256 | |
| FCGR1A Cytosol Staphylococcus aureus infection 1.724682268712256 | |
| FCGR1A Cytosol Systemic lupus erythematosus 1.724682268712256 | |
| FCGR1A Cytosol Transcriptional misregulation in cancer 1.724682268712256 | |
| FCGR1A Cytosol Tuberculosis 1.724682268712256 | |
| FCGR1A Golgi apparatus Acute myeloid leukemia 1.724682268712256 | |
| FCGR1A Golgi apparatus Fc gamma R-mediated phagocytosis 1.724682268712256 | |
| FCGR1A Golgi apparatus Hematopoietic cell lineage 1.724682268712256 | |
| FCGR1A Golgi apparatus Leishmaniasis 1.724682268712256 | |
| FCGR1A Golgi apparatus Neutrophil extracellular trap formation 1.724682268712256 | |
| FCGR1A Golgi apparatus Osteoclast differentiation 1.724682268712256 | |
| FCGR1A Golgi apparatus Phagosome 1.724682268712256 | |
| FCGR1A Golgi apparatus Staphylococcus aureus infection 1.724682268712256 | |
| FCGR1A Golgi apparatus Systemic lupus erythematosus 1.724682268712256 | |
| FCGR1A Golgi apparatus Transcriptional misregulation in cancer 1.724682268712256 | |
| FCGR1A Golgi apparatus Tuberculosis 1.724682268712256 | |
| FCGR1A Plasma membrane Acute myeloid leukemia 1.724682268712256 | |
| FCGR1A Plasma membrane Fc gamma R-mediated phagocytosis 1.724682268712256 | |
| FCGR1A Plasma membrane Hematopoietic cell lineage 1.724682268712256 | |
| FCGR1A Plasma membrane Leishmaniasis 1.724682268712256 | |
| FCGR1A Plasma membrane Neutrophil extracellular trap formation 1.724682268712256 | |
| FCGR1A Plasma membrane Osteoclast differentiation 1.724682268712256 | |
| FCGR1A Plasma membrane Phagosome 1.724682268712256 | |
| FCGR1A Plasma membrane Staphylococcus aureus infection 1.724682268712256 | |
| FCGR1A Plasma membrane Systemic lupus erythematosus 1.724682268712256 | |
| FCGR1A Plasma membrane Transcriptional misregulation in cancer 1.724682268712256 | |
| FCGR1A Plasma membrane Tuberculosis 1.724682268712256 | |
| FCGR2A Golgi apparatus Coronavirus disease - COVID-19 1.9285185154590176 | |
| FCGR2A Golgi apparatus Fc gamma R-mediated phagocytosis 1.9285185154590176 | |
| FCGR2A Golgi apparatus Leishmaniasis 1.9285185154590176 | |
| FCGR2A Golgi apparatus Neutrophil extracellular trap formation 1.9285185154590176 | |
| FCGR2A Golgi apparatus Osteoclast differentiation 1.9285185154590176 | |
| FCGR2A Golgi apparatus Pathogenic Escherichia coli infection 1.9285185154590176 | |
| FCGR2A Golgi apparatus Phagosome 1.9285185154590176 | |
| FCGR2A Golgi apparatus Platelet activation 1.9285185154590176 | |
| FCGR2A Golgi apparatus Staphylococcus aureus infection 1.9285185154590176 | |
| FCGR2A Golgi apparatus Systemic lupus erythematosus 1.9285185154590176 | |
| FCGR2A Golgi apparatus Tuberculosis 1.9285185154590176 | |
| FCGR2A Golgi apparatus Yersinia infection 1.9285185154590176 | |
| FCGR2A Plasma membrane Coronavirus disease - COVID-19 1.9285185154590176 | |
| FCGR2A Plasma membrane Fc gamma R-mediated phagocytosis 1.9285185154590176 | |
| FCGR2A Plasma membrane Leishmaniasis 1.9285185154590176 | |
| FCGR2A Plasma membrane Neutrophil extracellular trap formation 1.9285185154590176 | |
| FCGR2A Plasma membrane Osteoclast differentiation 1.9285185154590176 | |
| FCGR2A Plasma membrane Pathogenic Escherichia coli infection 1.9285185154590176 | |
| FCGR2A Plasma membrane Phagosome 1.9285185154590176 | |
| FCGR2A Plasma membrane Platelet activation 1.9285185154590176 | |
| FCGR2A Plasma membrane Staphylococcus aureus infection 1.9285185154590176 | |
| FCGR2A Plasma membrane Systemic lupus erythematosus 1.9285185154590176 | |
| FCGR2A Plasma membrane Tuberculosis 1.9285185154590176 | |
| FCGR2A Plasma membrane Yersinia infection 1.9285185154590176 | |
| FCGR2B Plasma membrane B cell receptor signaling pathway 1.693792913210325 | |
| FCGR2B Plasma membrane Fc gamma R-mediated phagocytosis 1.693792913210325 | |
| FCGR2B Plasma membrane Measles 1.693792913210325 | |
| FCGR2B Plasma membrane Osteoclast differentiation 1.693792913210325 | |
| FCGR2B Plasma membrane Phagosome 1.693792913210325 | |
| FCGR2B Plasma membrane Staphylococcus aureus infection 1.693792913210325 | |
| FCGR2B Plasma membrane Tuberculosis 1.693792913210325 | |
| FCGRT Plasma membrane Summary 1.015129247150147 | |
| FCHO1 Cytosol Summary 0.8244185525013109 | |
| FCHO1 Nucleus Summary 0.8244185525013109 | |
| FCHO1 Plasma membrane Summary 0.8244185525013109 | |
| FCHO2 Cytoskeleton Summary 1.2494246772500126 | |
| FCHO2 Cytosol Summary 1.2494246772500126 | |
| FCHSD1 Cytosol Summary 1.2760913444659554 | |
| FCHSD1 Nucleus Summary 1.2760913444659554 | |
| FCHSD2 Cytoskeleton Summary 1.5662950338409252 | |
| FCHSD2 Cytosol Summary 1.5662950338409252 | |
| FCHSD2 Nucleus Summary 1.5662950338409252 | |
| FCHSD2 Plasma membrane Summary 1.5662950338409252 | |
| FCN1 Extracellular space Summary 1.4697628744340272 | |
| FCN2 Extracellular space Summary 1.188526971557039 | |
| FCN3 Extracellular space Summary 1.2091560317880157 | |
| FCN3 Plasma membrane Summary 1.2091560317880157 | |
| FDFT1 Endoplasmic Reticulum Metabolic pathways 0.8974377407691061 | |
| FDFT1 Endoplasmic Reticulum Steroid biosynthesis 0.8974377407691061 | |
| FDPS Cytosol Summary 1.3898728416297113 | |
| FDPS Nucleus Summary 1.3898728416297113 | |
| FDX1 Mitochondrion Summary 1.9861273763892735 | |
| FDXR Mitochondrion Summary 1.2326848315009078 | |
| FECH Mitochondrion Biosynthesis of cofactors 1.733715735397079 | |
| FECH Mitochondrion Metabolic pathways 1.733715735397079 | |
| FECH Mitochondrion Porphyrin and chlorophyll metabolism 1.733715735397079 | |
| FEM1B Cytosol Summary 1.1453597764307413 | |
| FEM1B Nucleus Summary 1.1453597764307413 | |
| FEN1 Mitochondrion Base excision repair 2.439180912412309 | |
| FEN1 Mitochondrion DNA replication 2.439180912412309 | |
| FEN1 Mitochondrion Non-homologous end-joining 2.439180912412309 | |
| FEN1 Nucleus Base excision repair 2.439180912412309 | |
| FEN1 Nucleus DNA replication 2.439180912412309 | |
| FEN1 Nucleus Non-homologous end-joining 2.439180912412309 | |
| FER Cytoskeleton Adherens junction 1.1329762454495929 | |
| FER Cytosol Adherens junction 1.1329762454495929 | |
| FER Nucleus Adherens junction 1.1329762454495929 | |
| FER Plasma membrane Adherens junction 1.1329762454495929 | |
| FERMT1 Cytoskeleton Summary 2.509586876882784 | |
| FERMT1 Cytosol Summary 2.509586876882784 | |
| FERMT1 Plasma membrane Summary 2.509586876882784 | |
| FERMT2 Cytoskeleton Summary 1.7053692942010918 | |
| FERMT2 Cytosol Summary 1.7053692942010918 | |
| FERMT2 Nucleus Summary 1.7053692942010918 | |
| FERMT2 Plasma membrane Summary 1.7053692942010918 | |
| FERMT3 Cytosol Summary 2.2543992437721814 | |
| FES Cytoskeleton Axon guidance 1.6626047625610012 | |
| FES Cytosol Axon guidance 1.6626047625610012 | |
| FES Golgi apparatus Axon guidance 1.6626047625610012 | |
| FES Nucleus Axon guidance 1.6626047625610012 | |
| FES Plasma membrane Axon guidance 1.6626047625610012 | |
| FETUB Cytosol Summary 2.0289429963502568 | |
| FETUB Extracellular space Summary 2.0289429963502568 | |
| FEZ2 Cytosol Summary 1.3493736868766573 | |
| FEZ2 Golgi apparatus Summary 1.3493736868766573 | |
| FEZ2 Nucleus Summary 1.3493736868766573 | |
| FGA Endoplasmic Reticulum Summary 2.1968836201646558 | |
| FGB Endoplasmic Reticulum Complement and coagulation cascades 2.8546830064123867 | |
| FGB Endoplasmic Reticulum Coronavirus disease - COVID-19 2.8546830064123867 | |
| FGB Endoplasmic Reticulum Neutrophil extracellular trap formation 2.8546830064123867 | |
| FGB Endoplasmic Reticulum Platelet activation 2.8546830064123867 | |
| FGB Extracellular space Complement and coagulation cascades 2.8546830064123867 | |
| FGB Extracellular space Coronavirus disease - COVID-19 2.8546830064123867 | |
| FGB Extracellular space Neutrophil extracellular trap formation 2.8546830064123867 | |
| FGB Extracellular space Platelet activation 2.8546830064123867 | |
| FGD1 Cytosol Summary 2.186616063228332 | |
| FGD1 Plasma membrane Summary 2.186616063228332 | |
| FGD2 Cytosol Summary 1.5870344852205902 | |
| FGD3 Cytosol Summary 0.2305629639944349 | |
| FGD3 Nucleus Summary 0.2305629639944349 | |
| FGD4 Cytoskeleton Summary 1.1688850189265336 | |
| FGD4 Cytosol Summary 1.1688850189265336 | |
| FGD5 Cytosol Summary 1.107831706133793 | |
| FGD5 Plasma membrane Summary 1.107831706133793 | |
| FGD6 Cytosol Summary 1.0393930145936945 | |
| FGF1 Cytosol Breast cancer 1.9214847406831963 | |
| FGF1 Cytosol Calcium signaling pathway 1.9214847406831963 | |
| FGF1 Cytosol Gastric cancer 1.9214847406831963 | |
| FGF1 Cytosol Hippo signaling pathway 1.9214847406831963 | |
| FGF1 Cytosol MAPK signaling pathway 1.9214847406831963 | |
| FGF1 Cytosol Melanoma 1.9214847406831963 | |
| FGF1 Cytosol PI3K-Akt signaling pathway 1.9214847406831963 | |
| FGF1 Cytosol Pathways in cancer 1.9214847406831963 | |
| FGF1 Cytosol Rap1 signaling pathway 1.9214847406831963 | |
| FGF1 Cytosol Ras signaling pathway 1.9214847406831963 | |
| FGF1 Cytosol Regulation of actin cytoskeleton 1.9214847406831963 | |
| FGF1 Extracellular space Breast cancer 1.9214847406831963 | |
| FGF1 Extracellular space Calcium signaling pathway 1.9214847406831963 | |
| FGF1 Extracellular space Gastric cancer 1.9214847406831963 | |
| FGF1 Extracellular space Hippo signaling pathway 1.9214847406831963 | |
| FGF1 Extracellular space MAPK signaling pathway 1.9214847406831963 | |
| FGF1 Extracellular space Melanoma 1.9214847406831963 | |
| FGF1 Extracellular space PI3K-Akt signaling pathway 1.9214847406831963 | |
| FGF1 Extracellular space Pathways in cancer 1.9214847406831963 | |
| FGF1 Extracellular space Rap1 signaling pathway 1.9214847406831963 | |
| FGF1 Extracellular space Ras signaling pathway 1.9214847406831963 | |
| FGF1 Extracellular space Regulation of actin cytoskeleton 1.9214847406831963 | |
| FGF1 Nucleus Breast cancer 1.9214847406831963 | |
| FGF1 Nucleus Calcium signaling pathway 1.9214847406831963 | |
| FGF1 Nucleus Gastric cancer 1.9214847406831963 | |
| FGF1 Nucleus Hippo signaling pathway 1.9214847406831963 | |
| FGF1 Nucleus MAPK signaling pathway 1.9214847406831963 | |
| FGF1 Nucleus Melanoma 1.9214847406831963 | |
| FGF1 Nucleus PI3K-Akt signaling pathway 1.9214847406831963 | |
| FGF1 Nucleus Pathways in cancer 1.9214847406831963 | |
| FGF1 Nucleus Rap1 signaling pathway 1.9214847406831963 | |
| FGF1 Nucleus Ras signaling pathway 1.9214847406831963 | |
| FGF1 Nucleus Regulation of actin cytoskeleton 1.9214847406831963 | |
| FGF2 Extracellular space Breast cancer 0.8754164128074214 | |
| FGF2 Extracellular space Calcium signaling pathway 0.8754164128074214 | |
| FGF2 Extracellular space Chemical carcinogenesis - receptor activation 0.8754164128074214 | |
| FGF2 Extracellular space EGFR tyrosine kinase inhibitor resistance 0.8754164128074214 | |
| FGF2 Extracellular space Gastric cancer 0.8754164128074214 | |
| FGF2 Extracellular space Kaposi sarcoma-associated herpesvirus infection 0.8754164128074214 | |
| FGF2 Extracellular space MAPK signaling pathway 0.8754164128074214 | |
| FGF2 Extracellular space Melanoma 0.8754164128074214 | |
| FGF2 Extracellular space PI3K-Akt signaling pathway 0.8754164128074214 | |
| FGF2 Extracellular space Pathways in cancer 0.8754164128074214 | |
| FGF2 Extracellular space Proteoglycans in cancer 0.8754164128074214 | |
| FGF2 Extracellular space Rap1 signaling pathway 0.8754164128074214 | |
| FGF2 Extracellular space Ras signaling pathway 0.8754164128074214 | |
| FGF2 Extracellular space Regulation of actin cytoskeleton 0.8754164128074214 | |
| FGF2 Extracellular space Signaling pathways regulating pluripotency of stem cells 0.8754164128074214 | |
| FGF2 Nucleus Breast cancer 0.8754164128074214 | |
| FGF2 Nucleus Calcium signaling pathway 0.8754164128074214 | |
| FGF2 Nucleus Chemical carcinogenesis - receptor activation 0.8754164128074214 | |
| FGF2 Nucleus EGFR tyrosine kinase inhibitor resistance 0.8754164128074214 | |
| FGF2 Nucleus Gastric cancer 0.8754164128074214 | |
| FGF2 Nucleus Kaposi sarcoma-associated herpesvirus infection 0.8754164128074214 | |
| FGF2 Nucleus MAPK signaling pathway 0.8754164128074214 | |
| FGF2 Nucleus Melanoma 0.8754164128074214 | |
| FGF2 Nucleus PI3K-Akt signaling pathway 0.8754164128074214 | |
| FGF2 Nucleus Pathways in cancer 0.8754164128074214 | |
| FGF2 Nucleus Proteoglycans in cancer 0.8754164128074214 | |
| FGF2 Nucleus Rap1 signaling pathway 0.8754164128074214 | |
| FGF2 Nucleus Ras signaling pathway 0.8754164128074214 | |
| FGF2 Nucleus Regulation of actin cytoskeleton 0.8754164128074214 | |
| FGF2 Nucleus Signaling pathways regulating pluripotency of stem cells 0.8754164128074214 | |
| FGFR1 Cytosol Adherens junction 1.8855034513531257 | |
| FGFR1 Cytosol Breast cancer 1.8855034513531257 | |
| FGFR1 Cytosol Calcium signaling pathway 1.8855034513531257 | |
| FGFR1 Cytosol Central carbon metabolism in cancer 1.8855034513531257 | |
| FGFR1 Cytosol MAPK signaling pathway 1.8855034513531257 | |
| FGFR1 Cytosol Melanoma 1.8855034513531257 | |
| FGFR1 Cytosol PI3K-Akt signaling pathway 1.8855034513531257 | |
| FGFR1 Cytosol Parathyroid hormone synthesis secretion and action 1.8855034513531257 | |
| FGFR1 Cytosol Pathways in cancer 1.8855034513531257 | |
| FGFR1 Cytosol Prostate cancer 1.8855034513531257 | |
| FGFR1 Cytosol Proteoglycans in cancer 1.8855034513531257 | |
| FGFR1 Cytosol Rap1 signaling pathway 1.8855034513531257 | |
| FGFR1 Cytosol Ras signaling pathway 1.8855034513531257 | |
| FGFR1 Cytosol Regulation of actin cytoskeleton 1.8855034513531257 | |
| FGFR1 Cytosol Signaling pathways regulating pluripotency of stem cells 1.8855034513531257 | |
| FGFR1 Cytosol Thermogenesis 1.8855034513531257 | |
| FGFR1 Extracellular space Adherens junction 1.8855034513531257 | |
| FGFR1 Extracellular space Breast cancer 1.8855034513531257 | |
| FGFR1 Extracellular space Calcium signaling pathway 1.8855034513531257 | |
| FGFR1 Extracellular space Central carbon metabolism in cancer 1.8855034513531257 | |
| FGFR1 Extracellular space MAPK signaling pathway 1.8855034513531257 | |
| FGFR1 Extracellular space Melanoma 1.8855034513531257 | |
| FGFR1 Extracellular space PI3K-Akt signaling pathway 1.8855034513531257 | |
| FGFR1 Extracellular space Parathyroid hormone synthesis secretion and action 1.8855034513531257 | |
| FGFR1 Extracellular space Pathways in cancer 1.8855034513531257 | |
| FGFR1 Extracellular space Prostate cancer 1.8855034513531257 | |
| FGFR1 Extracellular space Proteoglycans in cancer 1.8855034513531257 | |
| FGFR1 Extracellular space Rap1 signaling pathway 1.8855034513531257 | |
| FGFR1 Extracellular space Ras signaling pathway 1.8855034513531257 | |
| FGFR1 Extracellular space Regulation of actin cytoskeleton 1.8855034513531257 | |
| FGFR1 Extracellular space Signaling pathways regulating pluripotency of stem cells 1.8855034513531257 | |
| FGFR1 Extracellular space Thermogenesis 1.8855034513531257 | |
| FGFR1 Nucleus Adherens junction 1.8855034513531257 | |
| FGFR1 Nucleus Breast cancer 1.8855034513531257 | |
| FGFR1 Nucleus Calcium signaling pathway 1.8855034513531257 | |
| FGFR1 Nucleus Central carbon metabolism in cancer 1.8855034513531257 | |
| FGFR1 Nucleus MAPK signaling pathway 1.8855034513531257 | |
| FGFR1 Nucleus Melanoma 1.8855034513531257 | |
| FGFR1 Nucleus PI3K-Akt signaling pathway 1.8855034513531257 | |
| FGFR1 Nucleus Parathyroid hormone synthesis secretion and action 1.8855034513531257 | |
| FGFR1 Nucleus Pathways in cancer 1.8855034513531257 | |
| FGFR1 Nucleus Prostate cancer 1.8855034513531257 | |
| FGFR1 Nucleus Proteoglycans in cancer 1.8855034513531257 | |
| FGFR1 Nucleus Rap1 signaling pathway 1.8855034513531257 | |
| FGFR1 Nucleus Ras signaling pathway 1.8855034513531257 | |
| FGFR1 Nucleus Regulation of actin cytoskeleton 1.8855034513531257 | |
| FGFR1 Nucleus Signaling pathways regulating pluripotency of stem cells 1.8855034513531257 | |
| FGFR1 Nucleus Thermogenesis 1.8855034513531257 | |
| FGFR1 Plasma membrane Adherens junction 1.8855034513531257 | |
| FGFR1 Plasma membrane Breast cancer 1.8855034513531257 | |
| FGFR1 Plasma membrane Calcium signaling pathway 1.8855034513531257 | |
| FGFR1 Plasma membrane Central carbon metabolism in cancer 1.8855034513531257 | |
| FGFR1 Plasma membrane MAPK signaling pathway 1.8855034513531257 | |
| FGFR1 Plasma membrane Melanoma 1.8855034513531257 | |
| FGFR1 Plasma membrane PI3K-Akt signaling pathway 1.8855034513531257 | |
| FGFR1 Plasma membrane Parathyroid hormone synthesis secretion and action 1.8855034513531257 | |
| FGFR1 Plasma membrane Pathways in cancer 1.8855034513531257 | |
| FGFR1 Plasma membrane Prostate cancer 1.8855034513531257 | |
| FGFR1 Plasma membrane Proteoglycans in cancer 1.8855034513531257 | |
| FGFR1 Plasma membrane Rap1 signaling pathway 1.8855034513531257 | |
| FGFR1 Plasma membrane Ras signaling pathway 1.8855034513531257 | |
| FGFR1 Plasma membrane Regulation of actin cytoskeleton 1.8855034513531257 | |
| FGFR1 Plasma membrane Signaling pathways regulating pluripotency of stem cells 1.8855034513531257 | |
| FGFR1 Plasma membrane Thermogenesis 1.8855034513531257 | |
| FGFR1OP Cytoskeleton Summary 1.3636443656681647 | |
| FGFR1OP2 Cytosol Summary 1.2001547231708058 | |
| FGFR1OP2 Mitochondrion Summary 1.2001547231708058 | |
| FGFR2 Cytosol Calcium signaling pathway 0.3566135071205056 | |
| FGFR2 Cytosol Central carbon metabolism in cancer 0.3566135071205056 | |
| FGFR2 Cytosol EGFR tyrosine kinase inhibitor resistance 0.3566135071205056 | |
| FGFR2 Cytosol Endocytosis 0.3566135071205056 | |
| FGFR2 Cytosol Gastric cancer 0.3566135071205056 | |
| FGFR2 Cytosol MAPK signaling pathway 0.3566135071205056 | |
| FGFR2 Cytosol PI3K-Akt signaling pathway 0.3566135071205056 | |
| FGFR2 Cytosol Pathways in cancer 0.3566135071205056 | |
| FGFR2 Cytosol Prostate cancer 0.3566135071205056 | |
| FGFR2 Cytosol Rap1 signaling pathway 0.3566135071205056 | |
| FGFR2 Cytosol Ras signaling pathway 0.3566135071205056 | |
| FGFR2 Cytosol Regulation of actin cytoskeleton 0.3566135071205056 | |
| FGFR2 Cytosol Signaling pathways regulating pluripotency of stem cells 0.3566135071205056 | |
| FGFR2 Extracellular space Calcium signaling pathway 0.3566135071205056 | |
| FGFR2 Extracellular space Central carbon metabolism in cancer 0.3566135071205056 | |
| FGFR2 Extracellular space EGFR tyrosine kinase inhibitor resistance 0.3566135071205056 | |
| FGFR2 Extracellular space Endocytosis 0.3566135071205056 | |
| FGFR2 Extracellular space Gastric cancer 0.3566135071205056 | |
| FGFR2 Extracellular space MAPK signaling pathway 0.3566135071205056 | |
| FGFR2 Extracellular space PI3K-Akt signaling pathway 0.3566135071205056 | |
| FGFR2 Extracellular space Pathways in cancer 0.3566135071205056 | |
| FGFR2 Extracellular space Prostate cancer 0.3566135071205056 | |
| FGFR2 Extracellular space Rap1 signaling pathway 0.3566135071205056 | |
| FGFR2 Extracellular space Ras signaling pathway 0.3566135071205056 | |
| FGFR2 Extracellular space Regulation of actin cytoskeleton 0.3566135071205056 | |
| FGFR2 Extracellular space Signaling pathways regulating pluripotency of stem cells 0.3566135071205056 | |
| FGFR2 Golgi apparatus Calcium signaling pathway 0.3566135071205056 | |
| FGFR2 Golgi apparatus Central carbon metabolism in cancer 0.3566135071205056 | |
| FGFR2 Golgi apparatus EGFR tyrosine kinase inhibitor resistance 0.3566135071205056 | |
| FGFR2 Golgi apparatus Endocytosis 0.3566135071205056 | |
| FGFR2 Golgi apparatus Gastric cancer 0.3566135071205056 | |
| FGFR2 Golgi apparatus MAPK signaling pathway 0.3566135071205056 | |
| FGFR2 Golgi apparatus PI3K-Akt signaling pathway 0.3566135071205056 | |
| FGFR2 Golgi apparatus Pathways in cancer 0.3566135071205056 | |
| FGFR2 Golgi apparatus Prostate cancer 0.3566135071205056 | |
| FGFR2 Golgi apparatus Rap1 signaling pathway 0.3566135071205056 | |
| FGFR2 Golgi apparatus Ras signaling pathway 0.3566135071205056 | |
| FGFR2 Golgi apparatus Regulation of actin cytoskeleton 0.3566135071205056 | |
| FGFR2 Golgi apparatus Signaling pathways regulating pluripotency of stem cells 0.3566135071205056 | |
| FGFR2 Nucleus Calcium signaling pathway 0.3566135071205056 | |
| FGFR2 Nucleus Central carbon metabolism in cancer 0.3566135071205056 | |
| FGFR2 Nucleus EGFR tyrosine kinase inhibitor resistance 0.3566135071205056 | |
| FGFR2 Nucleus Endocytosis 0.3566135071205056 | |
| FGFR2 Nucleus Gastric cancer 0.3566135071205056 | |
| FGFR2 Nucleus MAPK signaling pathway 0.3566135071205056 | |
| FGFR2 Nucleus PI3K-Akt signaling pathway 0.3566135071205056 | |
| FGFR2 Nucleus Pathways in cancer 0.3566135071205056 | |
| FGFR2 Nucleus Prostate cancer 0.3566135071205056 | |
| FGFR2 Nucleus Rap1 signaling pathway 0.3566135071205056 | |
| FGFR2 Nucleus Ras signaling pathway 0.3566135071205056 | |
| FGFR2 Nucleus Regulation of actin cytoskeleton 0.3566135071205056 | |
| FGFR2 Nucleus Signaling pathways regulating pluripotency of stem cells 0.3566135071205056 | |
| FGFR2 Plasma membrane Calcium signaling pathway 0.3566135071205056 | |
| FGFR2 Plasma membrane Central carbon metabolism in cancer 0.3566135071205056 | |
| FGFR2 Plasma membrane EGFR tyrosine kinase inhibitor resistance 0.3566135071205056 | |
| FGFR2 Plasma membrane Endocytosis 0.3566135071205056 | |
| FGFR2 Plasma membrane Gastric cancer 0.3566135071205056 | |
| FGFR2 Plasma membrane MAPK signaling pathway 0.3566135071205056 | |
| FGFR2 Plasma membrane PI3K-Akt signaling pathway 0.3566135071205056 | |
| FGFR2 Plasma membrane Pathways in cancer 0.3566135071205056 | |
| FGFR2 Plasma membrane Prostate cancer 0.3566135071205056 | |
| FGFR2 Plasma membrane Rap1 signaling pathway 0.3566135071205056 | |
| FGFR2 Plasma membrane Ras signaling pathway 0.3566135071205056 | |
| FGFR2 Plasma membrane Regulation of actin cytoskeleton 0.3566135071205056 | |
| FGFR2 Plasma membrane Signaling pathways regulating pluripotency of stem cells 0.3566135071205056 | |
| FGFRL1 Cytosol Summary 0.31617449682292303 | |
| FGFRL1 Nucleus Summary 0.31617449682292303 | |
| FGFRL1 Plasma membrane Summary 0.31617449682292303 | |
| FGG Endoplasmic Reticulum Complement and coagulation cascades 2.25850761326992 | |
| FGG Endoplasmic Reticulum Coronavirus disease - COVID-19 2.25850761326992 | |
| FGG Endoplasmic Reticulum Neutrophil extracellular trap formation 2.25850761326992 | |
| FGG Endoplasmic Reticulum Platelet activation 2.25850761326992 | |
| FGG Endoplasmic Reticulum Staphylococcus aureus infection 2.25850761326992 | |
| FGG Extracellular space Complement and coagulation cascades 2.25850761326992 | |
| FGG Extracellular space Coronavirus disease - COVID-19 2.25850761326992 | |
| FGG Extracellular space Neutrophil extracellular trap formation 2.25850761326992 | |
| FGG Extracellular space Platelet activation 2.25850761326992 | |
| FGG Extracellular space Staphylococcus aureus infection 2.25850761326992 | |
| FGGY Nucleus Summary 0.3842606848416811 | |
| FGL2 Extracellular space Summary 1.3202258214675258 | |
| FGR Cytoskeleton Chemokine signaling pathway 2.5998492938680893 | |
| FGR Cytosol Chemokine signaling pathway 2.5998492938680893 | |
| FGR Plasma membrane Chemokine signaling pathway 2.5998492938680893 | |
| FH Mitochondrion Aldosterone synthesis and secretion 2.6296708133397506 | |
| FH Mitochondrion Bile secretion 2.6296708133397506 | |
| FH Mitochondrion Carbon metabolism 2.6296708133397506 | |
| FH Mitochondrion Cholesterol metabolism 2.6296708133397506 | |
| FH Mitochondrion Citrate cycle (TCA cycle) 2.6296708133397506 | |
| FH Mitochondrion Complement and coagulation cascades 2.6296708133397506 | |
| FH Mitochondrion Cortisol synthesis and secretion 2.6296708133397506 | |
| FH Mitochondrion Cushing syndrome 2.6296708133397506 | |
| FH Mitochondrion Endocytosis 2.6296708133397506 | |
| FH Mitochondrion Hepatitis C 2.6296708133397506 | |
| FH Mitochondrion Lipid and atherosclerosis 2.6296708133397506 | |
| FH Mitochondrion Metabolic pathways 2.6296708133397506 | |
| FH Mitochondrion Ovarian steroidogenesis 2.6296708133397506 | |
| FH Mitochondrion Pathways in cancer 2.6296708133397506 | |
| FH Mitochondrion Pyruvate metabolism 2.6296708133397506 | |
| FH Mitochondrion Renal cell carcinoma 2.6296708133397506 | |
| FH Mitochondrion Staphylococcus aureus infection 2.6296708133397506 | |
| FH Mitochondrion Toxoplasmosis 2.6296708133397506 | |
| FHIT Cytosol Summary 0.7918183252389486 | |
| FHIT Nucleus Summary 0.7918183252389486 | |
| FHIT Plasma membrane Summary 0.7918183252389486 | |
| FHL1 Cytosol Summary 2.2779962958327005 | |
| FHL1 Nucleus Summary 2.2779962958327005 | |
| FHL1 Plasma membrane Summary 2.2779962958327005 | |
| FHL2 Cytoskeleton Osteoclast differentiation 1.5733205679003266 | |
| FHL2 Cytosol Osteoclast differentiation 1.5733205679003266 | |
| FHL2 Nucleus Osteoclast differentiation 1.5733205679003266 | |
| FHL3 Nucleus Summary 2.46497963455388 | |
| FHL5 Nucleus Summary 0.903958600160128 | |
| FHOD1 Cytoskeleton Salmonella infection 0.7270969056323731 | |
| FHOD1 Cytosol Salmonella infection 0.7270969056323731 | |
| FIBIN Endoplasmic Reticulum Summary 0.7777929166435983 | |
| FIBP Nucleus Summary 1.100995395474197 | |
| FIG4 Cytosol Amyotrophic lateral sclerosis 1.4304921672250217 | |
| FIG4 Cytosol Inositol phosphate metabolism 1.4304921672250217 | |
| FIG4 Cytosol Metabolic pathways 1.4304921672250217 | |
| FIG4 Cytosol Pathways of neurodegeneration - multiple diseases 1.4304921672250217 | |
| FIG4 Endosome Amyotrophic lateral sclerosis 1.4304921672250217 | |
| FIG4 Endosome Inositol phosphate metabolism 1.4304921672250217 | |
| FIG4 Endosome Metabolic pathways 1.4304921672250217 | |
| FIG4 Endosome Pathways of neurodegeneration - multiple diseases 1.4304921672250217 | |
| FIGNL1 Nucleus Summary 3.0763745708758563 | |
| FILIP1 Cytoskeleton Summary 1.7700249748665655 | |
| FILIP1 Cytosol Summary 1.7700249748665655 | |
| FILIP1 Plasma membrane Summary 1.7700249748665655 | |
| FILIP1L Cytoskeleton Summary 1.7082549624293442 | |
| FILIP1L Cytosol Summary 1.7082549624293442 | |
| FILIP1L Nucleus Summary 1.7082549624293442 | |
| FILIP1L Plasma membrane Summary 1.7082549624293442 | |
| FIP1L1 Nucleus mRNA surveillance pathway 1.4273904598927785 | |
| FIS1 Mitochondrion Mitophagy - animal 1.3957737296255797 | |
| FIS1 Peroxisome Mitophagy - animal 1.3957737296255797 | |
| FIZ1 Cytosol Summary 1.2917634250752106 | |
| FIZ1 Nucleus Summary 1.2917634250752106 | |
| FKBP10 Cytosol Summary 2.356890360245397 | |
| FKBP10 Endoplasmic Reticulum Summary 2.356890360245397 | |
| FKBP10 Mitochondrion Summary 2.356890360245397 | |
| FKBP11 Cytoskeleton Summary 0.9886990563807121 | |
| FKBP14 Cytosol Summary 2.4277227015529914 | |
| FKBP14 Endoplasmic Reticulum Summary 2.4277227015529914 | |
| FKBP14 Golgi apparatus Summary 2.4277227015529914 | |
| FKBP14 Nucleus Summary 2.4277227015529914 | |
| FKBP15 Cytosol Summary 1.0681967912940131 | |
| FKBP15 Endosome Summary 1.0681967912940131 | |
| FKBP15 Nucleus Summary 1.0681967912940131 | |
| FKBP1A Cytoskeleton Summary 1.4906737717574854 | |
| FKBP1A Cytosol Summary 1.4906737717574854 | |
| FKBP2 Endoplasmic Reticulum Summary 0.6382991107946447 | |
| FKBP2 Plasma membrane Summary 0.6382991107946447 | |
| FKBP3 Cytosol Summary 1.198875611693747 | |
| FKBP3 Nucleus Summary 1.198875611693747 | |
| FKBP4 Cytosol Estrogen signaling pathway 1.0842188699932669 | |
| FKBP4 Nucleus Estrogen signaling pathway 1.0842188699932669 | |
| FKBP5 Cytosol Summary 0.6288744118494359 | |
| FKBP5 Nucleus Summary 0.6288744118494359 | |
| FKBP7 Endoplasmic Reticulum Summary 2.1556310916566543 | |
| FKBP8 Cytosol Summary 1.6084885123819754 | |
| FKBP8 Endoplasmic Reticulum Summary 1.6084885123819754 | |
| FKBP8 Mitochondrion Summary 1.6084885123819754 | |
| FKBP9 Cytosol Summary 2.379836670687815 | |
| FKBP9 Endoplasmic Reticulum Summary 2.379836670687815 | |
| FKBP9 Golgi apparatus Summary 2.379836670687815 | |
| FKBP9 Mitochondrion Summary 2.379836670687815 | |
| FKBPL Mitochondrion Summary 1.1481579149695504 | |
| FKBPL Nucleus Summary 1.1481579149695504 | |
| FLAD1 Cytosol Summary 1.5406440404148856 | |
| FLAD1 Mitochondrion Summary 1.5406440404148856 | |
| FLAD1 Plasma membrane Summary 1.5406440404148856 | |
| FLCN Cytosol Renal cell carcinoma 1.5015165686237275 | |
| FLCN Cytosol mTOR signaling pathway 1.5015165686237275 | |
| FLCN Lysosome Renal cell carcinoma 1.5015165686237275 | |
| FLCN Lysosome mTOR signaling pathway 1.5015165686237275 | |
| FLCN Nucleus Renal cell carcinoma 1.5015165686237275 | |
| FLCN Nucleus mTOR signaling pathway 1.5015165686237275 | |
| FLCN Plasma membrane Renal cell carcinoma 1.5015165686237275 | |
| FLCN Plasma membrane mTOR signaling pathway 1.5015165686237275 | |
| FLG Cytoskeleton Adherens junction 1.1447949294418478 | |
| FLG Cytoskeleton Breast cancer 1.1447949294418478 | |
| FLG Cytoskeleton Calcium signaling pathway 1.1447949294418478 | |
| FLG Cytoskeleton Central carbon metabolism in cancer 1.1447949294418478 | |
| FLG Cytoskeleton MAPK signaling pathway 1.1447949294418478 | |
| FLG Cytoskeleton Melanoma 1.1447949294418478 | |
| FLG Cytoskeleton PI3K-Akt signaling pathway 1.1447949294418478 | |
| FLG Cytoskeleton Parathyroid hormone synthesis secretion and action 1.1447949294418478 | |
| FLG Cytoskeleton Pathways in cancer 1.1447949294418478 | |
| FLG Cytoskeleton Prostate cancer 1.1447949294418478 | |
| FLG Cytoskeleton Proteoglycans in cancer 1.1447949294418478 | |
| FLG Cytoskeleton Rap1 signaling pathway 1.1447949294418478 | |
| FLG Cytoskeleton Ras signaling pathway 1.1447949294418478 | |
| FLG Cytoskeleton Regulation of actin cytoskeleton 1.1447949294418478 | |
| FLG Cytoskeleton Signaling pathways regulating pluripotency of stem cells 1.1447949294418478 | |
| FLG Cytoskeleton Thermogenesis 1.1447949294418478 | |
| FLG Cytosol Adherens junction 1.1447949294418478 | |
| FLG Cytosol Breast cancer 1.1447949294418478 | |
| FLG Cytosol Calcium signaling pathway 1.1447949294418478 | |
| FLG Cytosol Central carbon metabolism in cancer 1.1447949294418478 | |
| FLG Cytosol MAPK signaling pathway 1.1447949294418478 | |
| FLG Cytosol Melanoma 1.1447949294418478 | |
| FLG Cytosol PI3K-Akt signaling pathway 1.1447949294418478 | |
| FLG Cytosol Parathyroid hormone synthesis secretion and action 1.1447949294418478 | |
| FLG Cytosol Pathways in cancer 1.1447949294418478 | |
| FLG Cytosol Prostate cancer 1.1447949294418478 | |
| FLG Cytosol Proteoglycans in cancer 1.1447949294418478 | |
| FLG Cytosol Rap1 signaling pathway 1.1447949294418478 | |
| FLG Cytosol Ras signaling pathway 1.1447949294418478 | |
| FLG Cytosol Regulation of actin cytoskeleton 1.1447949294418478 | |
| FLG Cytosol Signaling pathways regulating pluripotency of stem cells 1.1447949294418478 | |
| FLG Cytosol Thermogenesis 1.1447949294418478 | |
| FLI1 Nucleus Transcriptional misregulation in cancer 1.213241987145412 | |
| FLII Cytosol Summary 0.9656491277663456 | |
| FLII Nucleus Summary 0.9656491277663456 | |
| FLNA Cytoskeleton Focal adhesion 2.0242766252369884 | |
| FLNA Cytoskeleton MAPK signaling pathway 2.0242766252369884 | |
| FLNA Cytoskeleton Proteoglycans in cancer 2.0242766252369884 | |
| FLNA Cytoskeleton Salmonella infection 2.0242766252369884 | |
| FLNA Cytosol Focal adhesion 2.0242766252369884 | |
| FLNA Cytosol MAPK signaling pathway 2.0242766252369884 | |
| FLNA Cytosol Proteoglycans in cancer 2.0242766252369884 | |
| FLNA Cytosol Salmonella infection 2.0242766252369884 | |
| FLNA Nucleus Focal adhesion 2.0242766252369884 | |
| FLNA Nucleus MAPK signaling pathway 2.0242766252369884 | |
| FLNA Nucleus Proteoglycans in cancer 2.0242766252369884 | |
| FLNA Nucleus Salmonella infection 2.0242766252369884 | |
| FLNA Plasma membrane Focal adhesion 2.0242766252369884 | |
| FLNA Plasma membrane MAPK signaling pathway 2.0242766252369884 | |
| FLNA Plasma membrane Proteoglycans in cancer 2.0242766252369884 | |
| FLNA Plasma membrane Salmonella infection 2.0242766252369884 | |
| FLNB Cytoskeleton Focal adhesion 0.9811489019218426 | |
| FLNB Cytoskeleton MAPK signaling pathway 0.9811489019218426 | |
| FLNB Cytoskeleton Proteoglycans in cancer 0.9811489019218426 | |
| FLNB Cytoskeleton Salmonella infection 0.9811489019218426 | |
| FLNB Cytosol Focal adhesion 0.9811489019218426 | |
| FLNB Cytosol MAPK signaling pathway 0.9811489019218426 | |
| FLNB Cytosol Proteoglycans in cancer 0.9811489019218426 | |
| FLNB Cytosol Salmonella infection 0.9811489019218426 | |
| FLNB Golgi apparatus Focal adhesion 0.9811489019218426 | |
| FLNB Golgi apparatus MAPK signaling pathway 0.9811489019218426 | |
| FLNB Golgi apparatus Proteoglycans in cancer 0.9811489019218426 | |
| FLNB Golgi apparatus Salmonella infection 0.9811489019218426 | |
| FLNB Plasma membrane Focal adhesion 0.9811489019218426 | |
| FLNB Plasma membrane MAPK signaling pathway 0.9811489019218426 | |
| FLNB Plasma membrane Proteoglycans in cancer 0.9811489019218426 | |
| FLNB Plasma membrane Salmonella infection 0.9811489019218426 | |
| FLNC Cytoskeleton Focal adhesion 1.8590175834355684 | |
| FLNC Cytoskeleton MAPK signaling pathway 1.8590175834355684 | |
| FLNC Cytoskeleton Proteoglycans in cancer 1.8590175834355684 | |
| FLNC Cytoskeleton Salmonella infection 1.8590175834355684 | |
| FLNC Cytosol Focal adhesion 1.8590175834355684 | |
| FLNC Cytosol MAPK signaling pathway 1.8590175834355684 | |
| FLNC Cytosol Proteoglycans in cancer 1.8590175834355684 | |
| FLNC Cytosol Salmonella infection 1.8590175834355684 | |
| FLNC Plasma membrane Focal adhesion 1.8590175834355684 | |
| FLNC Plasma membrane MAPK signaling pathway 1.8590175834355684 | |
| FLNC Plasma membrane Proteoglycans in cancer 1.8590175834355684 | |
| FLNC Plasma membrane Salmonella infection 1.8590175834355684 | |
| FLOT1 Cytosol Summary 0.841056445102438 | |
| FLOT1 Golgi apparatus Summary 0.841056445102438 | |
| FLOT1 Plasma membrane Summary 0.841056445102438 | |
| FLOT2 Cytosol Insulin signaling pathway 0.5474099241405038 | |
| FLOT2 Endosome Insulin signaling pathway 0.5474099241405038 | |
| FLOT2 Plasma membrane Insulin signaling pathway 0.5474099241405038 | |
| FLT1 Cytoskeleton Calcium signaling pathway 1.4282533896034058 | |
| FLT1 Cytoskeleton Focal adhesion 1.4282533896034058 | |
| FLT1 Cytoskeleton HIF-1 signaling pathway 1.4282533896034058 | |
| FLT1 Cytoskeleton MAPK signaling pathway 1.4282533896034058 | |
| FLT1 Cytoskeleton PI3K-Akt signaling pathway 1.4282533896034058 | |
| FLT1 Cytoskeleton Rap1 signaling pathway 1.4282533896034058 | |
| FLT1 Cytoskeleton Ras signaling pathway 1.4282533896034058 | |
| FLT1 Cytoskeleton Rheumatoid arthritis 1.4282533896034058 | |
| FLT1 Cytoskeleton Transcriptional misregulation in cancer 1.4282533896034058 | |
| FLT1 Endosome Calcium signaling pathway 1.4282533896034058 | |
| FLT1 Endosome Focal adhesion 1.4282533896034058 | |
| FLT1 Endosome HIF-1 signaling pathway 1.4282533896034058 | |
| FLT1 Endosome MAPK signaling pathway 1.4282533896034058 | |
| FLT1 Endosome PI3K-Akt signaling pathway 1.4282533896034058 | |
| FLT1 Endosome Rap1 signaling pathway 1.4282533896034058 | |
| FLT1 Endosome Ras signaling pathway 1.4282533896034058 | |
| FLT1 Endosome Rheumatoid arthritis 1.4282533896034058 | |
| FLT1 Endosome Transcriptional misregulation in cancer 1.4282533896034058 | |
| FLT1 Extracellular space Calcium signaling pathway 1.4282533896034058 | |
| FLT1 Extracellular space Focal adhesion 1.4282533896034058 | |
| FLT1 Extracellular space HIF-1 signaling pathway 1.4282533896034058 | |
| FLT1 Extracellular space MAPK signaling pathway 1.4282533896034058 | |
| FLT1 Extracellular space PI3K-Akt signaling pathway 1.4282533896034058 | |
| FLT1 Extracellular space Rap1 signaling pathway 1.4282533896034058 | |
| FLT1 Extracellular space Ras signaling pathway 1.4282533896034058 | |
| FLT1 Extracellular space Rheumatoid arthritis 1.4282533896034058 | |
| FLT1 Extracellular space Transcriptional misregulation in cancer 1.4282533896034058 | |
| FLT1 Plasma membrane Calcium signaling pathway 1.4282533896034058 | |
| FLT1 Plasma membrane Focal adhesion 1.4282533896034058 | |
| FLT1 Plasma membrane HIF-1 signaling pathway 1.4282533896034058 | |
| FLT1 Plasma membrane MAPK signaling pathway 1.4282533896034058 | |
| FLT1 Plasma membrane PI3K-Akt signaling pathway 1.4282533896034058 | |
| FLT1 Plasma membrane Rap1 signaling pathway 1.4282533896034058 | |
| FLT1 Plasma membrane Ras signaling pathway 1.4282533896034058 | |
| FLT1 Plasma membrane Rheumatoid arthritis 1.4282533896034058 | |
| FLT1 Plasma membrane Transcriptional misregulation in cancer 1.4282533896034058 | |
| FLT4 Extracellular space Breast cancer 1.5384989011108092 | |
| FLT4 Extracellular space Calcium signaling pathway 1.5384989011108092 | |
| FLT4 Extracellular space Focal adhesion 1.5384989011108092 | |
| FLT4 Extracellular space MAPK signaling pathway 1.5384989011108092 | |
| FLT4 Extracellular space PI3K-Akt signaling pathway 1.5384989011108092 | |
| FLT4 Extracellular space Pathways in cancer 1.5384989011108092 | |
| FLT4 Extracellular space Rap1 signaling pathway 1.5384989011108092 | |
| FLT4 Extracellular space Ras signaling pathway 1.5384989011108092 | |
| FLT4 Nucleus Breast cancer 1.5384989011108092 | |
| FLT4 Nucleus Calcium signaling pathway 1.5384989011108092 | |
| FLT4 Nucleus Focal adhesion 1.5384989011108092 | |
| FLT4 Nucleus MAPK signaling pathway 1.5384989011108092 | |
| FLT4 Nucleus PI3K-Akt signaling pathway 1.5384989011108092 | |
| FLT4 Nucleus Pathways in cancer 1.5384989011108092 | |
| FLT4 Nucleus Rap1 signaling pathway 1.5384989011108092 | |
| FLT4 Nucleus Ras signaling pathway 1.5384989011108092 | |
| FLT4 Plasma membrane Breast cancer 1.5384989011108092 | |
| FLT4 Plasma membrane Calcium signaling pathway 1.5384989011108092 | |
| FLT4 Plasma membrane Focal adhesion 1.5384989011108092 | |
| FLT4 Plasma membrane MAPK signaling pathway 1.5384989011108092 | |
| FLT4 Plasma membrane PI3K-Akt signaling pathway 1.5384989011108092 | |
| FLT4 Plasma membrane Pathways in cancer 1.5384989011108092 | |
| FLT4 Plasma membrane Rap1 signaling pathway 1.5384989011108092 | |
| FLT4 Plasma membrane Ras signaling pathway 1.5384989011108092 | |
| FLYWCH1 Cytosol Summary 1.5021795831958664 | |
| FLYWCH1 Nucleus Summary 1.5021795831958664 | |
| FLYWCH2 Nucleus Summary 0.7083289334962519 | |
| FMC1 Mitochondrion Summary 1.0776727139016409 | |
| FMN1 Cytosol Summary 0.4038929948219781 | |
| FMN1 Nucleus Summary 0.4038929948219781 | |
| FMN1 Plasma membrane Summary 0.4038929948219781 | |
| FMNL1 Cytosol Summary 1.422620352428916 | |
| FMNL2 Cytosol Summary 2.9196907695530494 | |
| FMNL2 Golgi apparatus Summary 2.9196907695530494 | |
| FMNL2 Plasma membrane Summary 2.9196907695530494 | |
| FMNL3 Cytosol Summary 1.5756439115634024 | |
| FMNL3 Golgi apparatus Summary 1.5756439115634024 | |
| FMNL3 Plasma membrane Summary 1.5756439115634024 | |
| FMO1 Endoplasmic Reticulum Drug metabolism - cytochrome P450 0.7284251865345187 | |
| FMO3 Endoplasmic Reticulum Drug metabolism - cytochrome P450 1.284661618470308 | |
| FMO5 Cytosol Drug metabolism - cytochrome P450 0.12276236970341985 | |
| FMO5 Endoplasmic Reticulum Drug metabolism - cytochrome P450 0.12276236970341985 | |
| FMOD Extracellular space TGF-beta signaling pathway 1.351807032614749 | |
| FMR1 Cytosol RNA transport 2.308947743656072 | |
| FMR1 Nucleus RNA transport 2.308947743656072 | |
| FN1 Extracellular space AGE-RAGE signaling pathway in diabetic complications 1.8335008930406291 | |
| FN1 Extracellular space Amoebiasis 1.8335008930406291 | |
| FN1 Extracellular space Bacterial invasion of epithelial cells 1.8335008930406291 | |
| FN1 Extracellular space ECM-receptor interaction 1.8335008930406291 | |
| FN1 Extracellular space Focal adhesion 1.8335008930406291 | |
| FN1 Extracellular space Human papillomavirus infection 1.8335008930406291 | |
| FN1 Extracellular space PI3K-Akt signaling pathway 1.8335008930406291 | |
| FN1 Extracellular space Pathways in cancer 1.8335008930406291 | |
| FN1 Extracellular space Proteoglycans in cancer 1.8335008930406291 | |
| FN1 Extracellular space Regulation of actin cytoskeleton 1.8335008930406291 | |
| FN1 Extracellular space Small cell lung cancer 1.8335008930406291 | |
| FN1 Extracellular space Yersinia infection 1.8335008930406291 | |
| FN3K Mitochondrion Summary 1.0590053134402355 | |
| FN3KRP Nucleus Summary 0.8728557911801598 | |
| FNBP1 Cytoskeleton Shigellosis 1.8094378239695037 | |
| FNBP1 Cytosol Shigellosis 1.8094378239695037 | |
| FNBP1 Lysosome Shigellosis 1.8094378239695037 | |
| FNBP1 Plasma membrane Shigellosis 1.8094378239695037 | |
| FNBP1L Cytosol Shigellosis 1.2644210120859682 | |
| FNBP1L Plasma membrane Shigellosis 1.2644210120859682 | |
| FNBP4 Nucleus Summary 1.815764850937696 | |
| FNDC1 Nucleus Summary 1.5730920484793331 | |
| FNDC3A Cytoskeleton Summary 0.7497623828536583 | |
| FNDC3A Cytosol Summary 0.7497623828536583 | |
| FNDC3A Endoplasmic Reticulum Summary 0.7497623828536583 | |
| FNDC3A Golgi apparatus Summary 0.7497623828536583 | |
| FNDC3A Nucleus Summary 0.7497623828536583 | |
| FNDC3B Endoplasmic Reticulum Summary 1.8946639991270573 | |
| FNIP1 Cytosol Summary 0.5907941422132389 | |
| FNIP1 Lysosome Summary 0.5907941422132389 | |
| FNTA Cytosol Summary 1.2169307390510506 | |
| FNTB Cytoskeleton Summary 2.0722556517560164 | |
| FOCAD Mitochondrion Summary 1.1706157850975485 | |
| FOCAD Plasma membrane Summary 1.1706157850975485 | |
| FOLR2 Plasma membrane Antifolate resistance 1.1204733426984332 | |
| FOLR2 Plasma membrane Endocytosis 1.1204733426984332 | |
| FOPNL Cytoskeleton Summary 1.3058149748994847 | |
| FOSL2 Nucleus Osteoclast differentiation 1.726474355668873 | |
| FOXA1 Nucleus Summary 0.09106851316384457 | |
| FOXC1 Cytosol Summary 3.1140999885034395 | |
| FOXC1 Nucleus Summary 3.1140999885034395 | |
| FOXG1 Nucleus FoxO signaling pathway 1.5688550688772882 | |
| FOXJ1 Nucleus Summary 1.6704935685344973 | |
| FOXJ2 Nucleus Summary 1.2353778956742667 | |
| FOXJ3 Cytosol Summary 1.6238956916616916 | |
| FOXJ3 Nucleus Summary 1.6238956916616916 | |
| FOXK1 Nucleus Summary 2.227414041998014 | |
| FOXK2 Cytosol Summary 1.3966983451757315 | |
| FOXK2 Mitochondrion Summary 1.3966983451757315 | |
| FOXK2 Nucleus Summary 1.3966983451757315 | |
| FOXN1 Nucleus Summary 1.2706891161375151 | |
| FOXN3 Nucleus Summary 1.2585793914206858 | |
| FOXN3 Plasma membrane Summary 1.2585793914206858 | |
| FOXO1 Cytosol AGE-RAGE signaling pathway in diabetic complications 2.0574082870161066 | |
| FOXO1 Cytosol AMPK signaling pathway 2.0574082870161066 | |
| FOXO1 Cytosol Cellular senescence 2.0574082870161066 | |
| FOXO1 Cytosol FoxO signaling pathway 2.0574082870161066 | |
| FOXO1 Cytosol Glucagon signaling pathway 2.0574082870161066 | |
| FOXO1 Cytosol Human papillomavirus infection 2.0574082870161066 | |
| FOXO1 Cytosol Insulin resistance 2.0574082870161066 | |
| FOXO1 Cytosol Insulin signaling pathway 2.0574082870161066 | |
| FOXO1 Cytosol Longevity regulating pathway 2.0574082870161066 | |
| FOXO1 Cytosol Longevity regulating pathway - multiple species 2.0574082870161066 | |
| FOXO1 Cytosol Pathways in cancer 2.0574082870161066 | |
| FOXO1 Cytosol Prostate cancer 2.0574082870161066 | |
| FOXO1 Cytosol Shigellosis 2.0574082870161066 | |
| FOXO1 Cytosol Thyroid hormone signaling pathway 2.0574082870161066 | |
| FOXO1 Cytosol Transcriptional misregulation in cancer 2.0574082870161066 | |
| FOXO1 Nucleus AGE-RAGE signaling pathway in diabetic complications 2.0574082870161066 | |
| FOXO1 Nucleus AMPK signaling pathway 2.0574082870161066 | |
| FOXO1 Nucleus Cellular senescence 2.0574082870161066 | |
| FOXO1 Nucleus FoxO signaling pathway 2.0574082870161066 | |
| FOXO1 Nucleus Glucagon signaling pathway 2.0574082870161066 | |
| FOXO1 Nucleus Human papillomavirus infection 2.0574082870161066 | |
| FOXO1 Nucleus Insulin resistance 2.0574082870161066 | |
| FOXO1 Nucleus Insulin signaling pathway 2.0574082870161066 | |
| FOXO1 Nucleus Longevity regulating pathway 2.0574082870161066 | |
| FOXO1 Nucleus Longevity regulating pathway - multiple species 2.0574082870161066 | |
| FOXO1 Nucleus Pathways in cancer 2.0574082870161066 | |
| FOXO1 Nucleus Prostate cancer 2.0574082870161066 | |
| FOXO1 Nucleus Shigellosis 2.0574082870161066 | |
| FOXO1 Nucleus Thyroid hormone signaling pathway 2.0574082870161066 | |
| FOXO1 Nucleus Transcriptional misregulation in cancer 2.0574082870161066 | |
| FOXO3 Cytosol AMPK signaling pathway 1.1773200383895523 | |
| FOXO3 Cytosol Cellular senescence 1.1773200383895523 | |
| FOXO3 Cytosol Chemokine signaling pathway 1.1773200383895523 | |
| FOXO3 Cytosol EGFR tyrosine kinase inhibitor resistance 1.1773200383895523 | |
| FOXO3 Cytosol Endometrial cancer 1.1773200383895523 | |
| FOXO3 Cytosol FoxO signaling pathway 1.1773200383895523 | |
| FOXO3 Cytosol Longevity regulating pathway 1.1773200383895523 | |
| FOXO3 Cytosol Longevity regulating pathway - multiple species 1.1773200383895523 | |
| FOXO3 Cytosol Mitophagy - animal 1.1773200383895523 | |
| FOXO3 Cytosol Neurotrophin signaling pathway 1.1773200383895523 | |
| FOXO3 Cytosol Non-small cell lung cancer 1.1773200383895523 | |
| FOXO3 Cytosol PI3K-Akt signaling pathway 1.1773200383895523 | |
| FOXO3 Cytosol Prolactin signaling pathway 1.1773200383895523 | |
| FOXO3 Cytosol Shigellosis 1.1773200383895523 | |
| FOXO3 Nucleus AMPK signaling pathway 1.1773200383895523 | |
| FOXO3 Nucleus Cellular senescence 1.1773200383895523 | |
| FOXO3 Nucleus Chemokine signaling pathway 1.1773200383895523 | |
| FOXO3 Nucleus EGFR tyrosine kinase inhibitor resistance 1.1773200383895523 | |
| FOXO3 Nucleus Endometrial cancer 1.1773200383895523 | |
| FOXO3 Nucleus FoxO signaling pathway 1.1773200383895523 | |
| FOXO3 Nucleus Longevity regulating pathway 1.1773200383895523 | |
| FOXO3 Nucleus Longevity regulating pathway - multiple species 1.1773200383895523 | |
| FOXO3 Nucleus Mitophagy - animal 1.1773200383895523 | |
| FOXO3 Nucleus Neurotrophin signaling pathway 1.1773200383895523 | |
| FOXO3 Nucleus Non-small cell lung cancer 1.1773200383895523 | |
| FOXO3 Nucleus PI3K-Akt signaling pathway 1.1773200383895523 | |
| FOXO3 Nucleus Prolactin signaling pathway 1.1773200383895523 | |
| FOXO3 Nucleus Shigellosis 1.1773200383895523 | |
| FOXP1 Nucleus MicroRNAs in cancer 1.0144040591464647 | |
| FOXP4 Cytosol Summary 1.6408246850474957 | |
| FOXP4 Nucleus Summary 1.6408246850474957 | |
| FOXRED1 Mitochondrion Summary 1.4979531096813348 | |
| FPGS Mitochondrion Antifolate resistance 1.5545502447896529 | |
| FPGS Mitochondrion Biosynthesis of cofactors 1.5545502447896529 | |
| FPGS Mitochondrion Folate biosynthesis 1.5545502447896529 | |
| FPGS Mitochondrion Metabolic pathways 1.5545502447896529 | |
| FPGT Cytosol Summary 0.4523930496435288 | |
| FPGT-TNNI3K Cytosol Summary 1.1164191454756631 | |
| FRA10AC1 Nucleus Summary 1.0931494760334088 | |
| FREM2 Cytosol ECM-receptor interaction 0.9946342503898944 | |
| FREM2 Plasma membrane ECM-receptor interaction 0.9946342503898944 | |
| FRG1 Nucleus Summary 1.6865382743266488 | |
| FRK Cytosol Summary 1.0278972493154388 | |
| FRK Nucleus Summary 1.0278972493154388 | |
| FRMD4A Cytosol Summary 2.416786397299751 | |
| FRMD4A Golgi apparatus Summary 2.416786397299751 | |
| FRMD4A Nucleus Summary 2.416786397299751 | |
| FRMD4B Cytosol Summary 0.3506189632265819 | |
| FRMD6 Cytosol Hippo signaling pathway 0.8325967266256258 | |
| FRMD6 Cytosol Hippo signaling pathway - multiple species 0.8325967266256258 | |
| FRMD6 Mitochondrion Hippo signaling pathway 0.8325967266256258 | |
| FRMD6 Mitochondrion Hippo signaling pathway - multiple species 0.8325967266256258 | |
| FRMD6 Plasma membrane Hippo signaling pathway 0.8325967266256258 | |
| FRMD6 Plasma membrane Hippo signaling pathway - multiple species 0.8325967266256258 | |
| FRMD8 Cytosol Summary 1.231311802196631 | |
| FRMD8 Nucleus Summary 1.231311802196631 | |
| FRMD8 Plasma membrane Summary 1.231311802196631 | |
| FRMPD1 Cytosol Summary 1.9651924099881932 | |
| FRMPD1 Plasma membrane Summary 1.9651924099881932 | |
| FRS2 Cytosol Summary 0.50546458093681 | |
| FRS2 Plasma membrane Summary 0.50546458093681 | |
| FRY Cytosol Summary 0.6513504492181458 | |
| FRYL Cytoskeleton Summary 0.8281234796667057 | |
| FRYL Cytosol Summary 0.8281234796667057 | |
| FSCN1 Cytoskeleton MicroRNAs in cancer 2.387027824100765 | |
| FSCN1 Cytosol MicroRNAs in cancer 2.387027824100765 | |
| FSCN1 Plasma membrane MicroRNAs in cancer 2.387027824100765 | |
| FSD1L Cytoskeleton Summary 0.5220426460400314 | |
| FSIP2 Cytoskeleton Summary 1.42669710507089 | |
| FSIP2 Mitochondrion Summary 1.42669710507089 | |
| FST Cytosol TGF-beta signaling pathway 0.6652033593255605 | |
| FST Extracellular space TGF-beta signaling pathway 0.6652033593255605 | |
| FSTL1 Cytosol Summary 2.386769125332626 | |
| FSTL3 Extracellular space Summary 0.7869137992469192 | |
| FSTL3 Nucleus Summary 0.7869137992469192 | |
| FTH1 Cytoskeleton Summary 1.2134457476501506 | |
| FTL Cytosol Summary 0.9905153860350776 | |
| FTO Cytosol Summary 1.3261888040092742 | |
| FTO Nucleus Summary 1.3261888040092742 | |
| FTSJ1 Cytosol Summary 1.2581961221418525 | |
| FTSJ3 Mitochondrion Summary 2.4119408908294955 | |
| FTSJ3 Nucleus Summary 2.4119408908294955 | |
| FUBP1 Nucleus Summary 1.4688516245911178 | |
| FUCA1 Lysosome Lysosome 0.2866215218293543 | |
| FUCA1 Lysosome Other glycan degradation 0.2866215218293543 | |
| FUK Cytosol Summary 0.6883540027348869 | |
| FUS Cytosol Amyotrophic lateral sclerosis 1.9996012798303175 | |
| FUS Cytosol Pathways of neurodegeneration - multiple diseases 1.9996012798303175 | |
| FUS Cytosol RNA transport 1.9996012798303175 | |
| FUS Cytosol Spliceosome 1.9996012798303175 | |
| FUS Cytosol Transcriptional misregulation in cancer 1.9996012798303175 | |
| FUS Cytosol mRNA surveillance pathway 1.9996012798303175 | |
| FUS Nucleus Amyotrophic lateral sclerosis 1.9996012798303175 | |
| FUS Nucleus Pathways of neurodegeneration - multiple diseases 1.9996012798303175 | |
| FUS Nucleus RNA transport 1.9996012798303175 | |
| FUS Nucleus Spliceosome 1.9996012798303175 | |
| FUS Nucleus Transcriptional misregulation in cancer 1.9996012798303175 | |
| FUS Nucleus mRNA surveillance pathway 1.9996012798303175 | |
| FUT11 Golgi apparatus Summary 1.5688498611378892 | |
| FUT11 Nucleus Summary 1.5688498611378892 | |
| FUT8 Cytosol Glycosaminoglycan biosynthesis - keratan sulfate 0.5402915334708045 | |
| FUT8 Cytosol Metabolic pathways 0.5402915334708045 | |
| FUT8 Cytosol N-Glycan biosynthesis 0.5402915334708045 | |
| FUT8 Cytosol Transcriptional misregulation in cancer 0.5402915334708045 | |
| FUT8 Cytosol Various types of N-glycan biosynthesis 0.5402915334708045 | |
| FUT8 Golgi apparatus Glycosaminoglycan biosynthesis - keratan sulfate 0.5402915334708045 | |
| FUT8 Golgi apparatus Metabolic pathways 0.5402915334708045 | |
| FUT8 Golgi apparatus N-Glycan biosynthesis 0.5402915334708045 | |
| FUT8 Golgi apparatus Transcriptional misregulation in cancer 0.5402915334708045 | |
| FUT8 Golgi apparatus Various types of N-glycan biosynthesis 0.5402915334708045 | |
| FUT8 Nucleus Glycosaminoglycan biosynthesis - keratan sulfate 0.5402915334708045 | |
| FUT8 Nucleus Metabolic pathways 0.5402915334708045 | |
| FUT8 Nucleus N-Glycan biosynthesis 0.5402915334708045 | |
| FUT8 Nucleus Transcriptional misregulation in cancer 0.5402915334708045 | |
| FUT8 Nucleus Various types of N-glycan biosynthesis 0.5402915334708045 | |
| FXN Cytosol Porphyrin and chlorophyll metabolism 1.5845974987915177 | |
| FXN Mitochondrion Porphyrin and chlorophyll metabolism 1.5845974987915177 | |
| FXR1 Cytosol Summary 2.022080460355676 | |
| FXR1 Endoplasmic Reticulum Summary 2.022080460355676 | |
| FXR2 Cytosol Summary 1.3691201371195036 | |
| FYB Plasma membrane Summary 1.9324849081018929 | |
| FYCO1 Cytosol Salmonella infection 0.3012655718805845 | |
| FYCO1 Endosome Salmonella infection 0.3012655718805845 | |
| FYCO1 Lysosome Salmonella infection 0.3012655718805845 | |
| FYTTD1 Nucleus Summary 1.6105279495080886 | |
| FZD1 Plasma membrane Alzheimer disease 0.3463091971816536 | |
| FZD1 Plasma membrane Basal cell carcinoma 0.3463091971816536 | |
| FZD1 Plasma membrane Breast cancer 0.3463091971816536 | |
| FZD1 Plasma membrane Cushing syndrome 0.3463091971816536 | |
| FZD1 Plasma membrane Gastric cancer 0.3463091971816536 | |
| FZD1 Plasma membrane Hepatocellular carcinoma 0.3463091971816536 | |
| FZD1 Plasma membrane Hippo signaling pathway 0.3463091971816536 | |
| FZD1 Plasma membrane Human papillomavirus infection 0.3463091971816536 | |
| FZD1 Plasma membrane Melanogenesis 0.3463091971816536 | |
| FZD1 Plasma membrane Pathways in cancer 0.3463091971816536 | |
| FZD1 Plasma membrane Pathways of neurodegeneration - multiple diseases 0.3463091971816536 | |
| FZD1 Plasma membrane Proteoglycans in cancer 0.3463091971816536 | |
| FZD1 Plasma membrane Signaling pathways regulating pluripotency of stem cells 0.3463091971816536 | |
| FZD1 Plasma membrane Wnt signaling pathway 0.3463091971816536 | |
| FZD1 Plasma membrane mTOR signaling pathway 0.3463091971816536 | |
| FZD6 Plasma membrane Alzheimer disease 1.7648725942101808 | |
| FZD6 Plasma membrane Basal cell carcinoma 1.7648725942101808 | |
| FZD6 Plasma membrane Breast cancer 1.7648725942101808 | |
| FZD6 Plasma membrane Cushing syndrome 1.7648725942101808 | |
| FZD6 Plasma membrane Gastric cancer 1.7648725942101808 | |
| FZD6 Plasma membrane Hepatocellular carcinoma 1.7648725942101808 | |
| FZD6 Plasma membrane Hippo signaling pathway 1.7648725942101808 | |
| FZD6 Plasma membrane Human papillomavirus infection 1.7648725942101808 | |
| FZD6 Plasma membrane Melanogenesis 1.7648725942101808 | |
| FZD6 Plasma membrane Pathways in cancer 1.7648725942101808 | |
| FZD6 Plasma membrane Pathways of neurodegeneration - multiple diseases 1.7648725942101808 | |
| FZD6 Plasma membrane Proteoglycans in cancer 1.7648725942101808 | |
| FZD6 Plasma membrane Signaling pathways regulating pluripotency of stem cells 1.7648725942101808 | |
| FZD6 Plasma membrane Wnt signaling pathway 1.7648725942101808 | |
| FZD6 Plasma membrane mTOR signaling pathway 1.7648725942101808 | |
| FZD7 Cytosol Alzheimer disease 0.9742094153651804 | |
| FZD7 Cytosol Basal cell carcinoma 0.9742094153651804 | |
| FZD7 Cytosol Breast cancer 0.9742094153651804 | |
| FZD7 Cytosol Cushing syndrome 0.9742094153651804 | |
| FZD7 Cytosol Gastric cancer 0.9742094153651804 | |
| FZD7 Cytosol Hepatocellular carcinoma 0.9742094153651804 | |
| FZD7 Cytosol Hippo signaling pathway 0.9742094153651804 | |
| FZD7 Cytosol Human papillomavirus infection 0.9742094153651804 | |
| FZD7 Cytosol Melanogenesis 0.9742094153651804 | |
| FZD7 Cytosol Pathways in cancer 0.9742094153651804 | |
| FZD7 Cytosol Pathways of neurodegeneration - multiple diseases 0.9742094153651804 | |
| FZD7 Cytosol Proteoglycans in cancer 0.9742094153651804 | |
| FZD7 Cytosol Signaling pathways regulating pluripotency of stem cells 0.9742094153651804 | |
| FZD7 Cytosol Wnt signaling pathway 0.9742094153651804 | |
| FZD7 Cytosol mTOR signaling pathway 0.9742094153651804 | |
| FZD7 Nucleus Alzheimer disease 0.9742094153651804 | |
| FZD7 Nucleus Basal cell carcinoma 0.9742094153651804 | |
| FZD7 Nucleus Breast cancer 0.9742094153651804 | |
| FZD7 Nucleus Cushing syndrome 0.9742094153651804 | |
| FZD7 Nucleus Gastric cancer 0.9742094153651804 | |
| FZD7 Nucleus Hepatocellular carcinoma 0.9742094153651804 | |
| FZD7 Nucleus Hippo signaling pathway 0.9742094153651804 | |
| FZD7 Nucleus Human papillomavirus infection 0.9742094153651804 | |
| FZD7 Nucleus Melanogenesis 0.9742094153651804 | |
| FZD7 Nucleus Pathways in cancer 0.9742094153651804 | |
| FZD7 Nucleus Pathways of neurodegeneration - multiple diseases 0.9742094153651804 | |
| FZD7 Nucleus Proteoglycans in cancer 0.9742094153651804 | |
| FZD7 Nucleus Signaling pathways regulating pluripotency of stem cells 0.9742094153651804 | |
| FZD7 Nucleus Wnt signaling pathway 0.9742094153651804 | |
| FZD7 Nucleus mTOR signaling pathway 0.9742094153651804 | |
| FZD7 Plasma membrane Alzheimer disease 0.9742094153651804 | |
| FZD7 Plasma membrane Basal cell carcinoma 0.9742094153651804 | |
| FZD7 Plasma membrane Breast cancer 0.9742094153651804 | |
| FZD7 Plasma membrane Cushing syndrome 0.9742094153651804 | |
| FZD7 Plasma membrane Gastric cancer 0.9742094153651804 | |
| FZD7 Plasma membrane Hepatocellular carcinoma 0.9742094153651804 | |
| FZD7 Plasma membrane Hippo signaling pathway 0.9742094153651804 | |
| FZD7 Plasma membrane Human papillomavirus infection 0.9742094153651804 | |
| FZD7 Plasma membrane Melanogenesis 0.9742094153651804 | |
| FZD7 Plasma membrane Pathways in cancer 0.9742094153651804 | |
| FZD7 Plasma membrane Pathways of neurodegeneration - multiple diseases 0.9742094153651804 | |
| FZD7 Plasma membrane Proteoglycans in cancer 0.9742094153651804 | |
| FZD7 Plasma membrane Signaling pathways regulating pluripotency of stem cells 0.9742094153651804 | |
| FZD7 Plasma membrane Wnt signaling pathway 0.9742094153651804 | |
| FZD7 Plasma membrane mTOR signaling pathway 0.9742094153651804 | |
| FZR1 Nucleus Cell cycle 1.3223585437558851 | |
| FZR1 Nucleus Progesterone-mediated oocyte maturation 1.3223585437558851 | |
| FZR1 Nucleus Ubiquitin mediated proteolysis 1.3223585437558851 | |
| G3BP2 Cytosol Summary 1.4426658824678078 | |
| G6PD Cytosol Summary 0.3877503614894103 | |
| GAA Cytosol Galactose metabolism 0.7787097812753331 | |
| GAA Cytosol Lysosome 0.7787097812753331 | |
| GAA Cytosol Metabolic pathways 0.7787097812753331 | |
| GAA Cytosol Starch and sucrose metabolism 0.7787097812753331 | |
| GAA Lysosome Galactose metabolism 0.7787097812753331 | |
| GAA Lysosome Lysosome 0.7787097812753331 | |
| GAA Lysosome Metabolic pathways 0.7787097812753331 | |
| GAA Lysosome Starch and sucrose metabolism 0.7787097812753331 | |
| GAB1 Cytosol Summary 0.9579076008137241 | |
| GAB1 Nucleus Summary 0.9579076008137241 | |
| GAB1 Plasma membrane Summary 0.9579076008137241 | |
| GAB2 Cytosol Summary 0.8772920238810339 | |
| GAB2 Plasma membrane Summary 0.8772920238810339 | |
| GABARAP Cytosol Summary 1.7684358486945273 | |
| GABARAPL2 Cytosol Summary 1.6631290808343897 | |
| GABARAPL2 Nucleus Summary 1.6631290808343897 | |
| GABPB1 Cytosol Summary 0.9492953684716754 | |
| GABPB1 Nucleus Summary 0.9492953684716754 | |
| GABRG2 Plasma membrane GABAergic synapse 1.0565759860571928 | |
| GABRG2 Plasma membrane Morphine addiction 1.0565759860571928 | |
| GABRG2 Plasma membrane Neuroactive ligand-receptor interaction 1.0565759860571928 | |
| GABRG2 Plasma membrane Nicotine addiction 1.0565759860571928 | |
| GABRG2 Plasma membrane Retrograde endocannabinoid signaling 1.0565759860571928 | |
| GADD45GIP1 Mitochondrion Summary 1.2291765468124491 | |
| GADD45GIP1 Nucleus Summary 1.2291765468124491 | |
| GAK Cytosol Summary 0.683412117115662 | |
| GAK Golgi apparatus Summary 0.683412117115662 | |
| GAK Nucleus Summary 0.683412117115662 | |
| GAL3ST4 Cytosol Summary 1.7678271380964012 | |
| GAL3ST4 Golgi apparatus Summary 1.7678271380964012 | |
| GAL3ST4 Nucleus Summary 1.7678271380964012 | |
| GALC Lysosome Lysosome 0.5947242523250306 | |
| GALC Lysosome Metabolic pathways 0.5947242523250306 | |
| GALC Lysosome Sphingolipid metabolism 0.5947242523250306 | |
| GALE Cytosol Summary 0.38091785092338093 | |
| GALE Nucleus Summary 0.38091785092338093 | |
| GALK1 Cytosol Summary 1.1305971268913166 | |
| GALK1 Golgi apparatus Summary 1.1305971268913166 | |
| GALK2 Cytosol Summary 1.4968496096082267 | |
| GALK2 Nucleus Summary 1.4968496096082267 | |
| GALM Cytosol Summary 1.486706634518216 | |
| GALM Nucleus Summary 1.486706634518216 | |
| GALNS Cytosol Glycosaminoglycan degradation 1.6121600003404382 | |
| GALNS Cytosol Lysosome 1.6121600003404382 | |
| GALNS Cytosol Metabolic pathways 1.6121600003404382 | |
| GALNS Lysosome Glycosaminoglycan degradation 1.6121600003404382 | |
| GALNS Lysosome Lysosome 1.6121600003404382 | |
| GALNS Lysosome Metabolic pathways 1.6121600003404382 | |
| GALNT1 Extracellular space Metabolic pathways 1.0570117377950263 | |
| GALNT1 Extracellular space Mucin type O-glycan biosynthesis 1.0570117377950263 | |
| GALNT1 Extracellular space Other types of O-glycan biosynthesis 1.0570117377950263 | |
| GALNT1 Golgi apparatus Metabolic pathways 1.0570117377950263 | |
| GALNT1 Golgi apparatus Mucin type O-glycan biosynthesis 1.0570117377950263 | |
| GALNT1 Golgi apparatus Other types of O-glycan biosynthesis 1.0570117377950263 | |
| GALNT10 Golgi apparatus Metabolic pathways 0.3945841050888881 | |
| GALNT10 Golgi apparatus Mucin type O-glycan biosynthesis 0.3945841050888881 | |
| GALNT10 Golgi apparatus Other types of O-glycan biosynthesis 0.3945841050888881 | |
| GALNT10 Nucleus Metabolic pathways 0.3945841050888881 | |
| GALNT10 Nucleus Mucin type O-glycan biosynthesis 0.3945841050888881 | |
| GALNT10 Nucleus Other types of O-glycan biosynthesis 0.3945841050888881 | |
| GALNT10 Plasma membrane Metabolic pathways 0.3945841050888881 | |
| GALNT10 Plasma membrane Mucin type O-glycan biosynthesis 0.3945841050888881 | |
| GALNT10 Plasma membrane Other types of O-glycan biosynthesis 0.3945841050888881 | |
| GALNT2 Extracellular space Metabolic pathways 1.508400043566292 | |
| GALNT2 Extracellular space Mucin type O-glycan biosynthesis 1.508400043566292 | |
| GALNT2 Extracellular space Other types of O-glycan biosynthesis 1.508400043566292 | |
| GALNT2 Golgi apparatus Metabolic pathways 1.508400043566292 | |
| GALNT2 Golgi apparatus Mucin type O-glycan biosynthesis 1.508400043566292 | |
| GALNT2 Golgi apparatus Other types of O-glycan biosynthesis 1.508400043566292 | |
| GALNT3 Golgi apparatus Metabolic pathways 1.283307246456202 | |
| GALNT3 Golgi apparatus Mucin type O-glycan biosynthesis 1.283307246456202 | |
| GALNT3 Golgi apparatus Other types of O-glycan biosynthesis 1.283307246456202 | |
| GALNT5 Cytosol Metabolic pathways 0.6880239817711659 | |
| GALNT5 Cytosol Mucin type O-glycan biosynthesis 0.6880239817711659 | |
| GALNT5 Cytosol Other types of O-glycan biosynthesis 0.6880239817711659 | |
| GALNT5 Golgi apparatus Metabolic pathways 0.6880239817711659 | |
| GALNT5 Golgi apparatus Mucin type O-glycan biosynthesis 0.6880239817711659 | |
| GALNT5 Golgi apparatus Other types of O-glycan biosynthesis 0.6880239817711659 | |
| GALNT5 Nucleus Metabolic pathways 0.6880239817711659 | |
| GALNT5 Nucleus Mucin type O-glycan biosynthesis 0.6880239817711659 | |
| GALNT5 Nucleus Other types of O-glycan biosynthesis 0.6880239817711659 | |
| GALNT6 Golgi apparatus Metabolic pathways 0.09776796013926664 | |
| GALNT6 Golgi apparatus Mucin type O-glycan biosynthesis 0.09776796013926664 | |
| GALNT6 Golgi apparatus Other types of O-glycan biosynthesis 0.09776796013926664 | |
| GALNT6 Nucleus Metabolic pathways 0.09776796013926664 | |
| GALNT6 Nucleus Mucin type O-glycan biosynthesis 0.09776796013926664 | |
| GALNT6 Nucleus Other types of O-glycan biosynthesis 0.09776796013926664 | |
| GALNT7 Golgi apparatus Metabolic pathways 0.1833071726097464 | |
| GALNT7 Golgi apparatus Mucin type O-glycan biosynthesis 0.1833071726097464 | |
| GALNT7 Golgi apparatus Other types of O-glycan biosynthesis 0.1833071726097464 | |
| GALNT7 Nucleus Metabolic pathways 0.1833071726097464 | |
| GALNT7 Nucleus Mucin type O-glycan biosynthesis 0.1833071726097464 | |
| GALNT7 Nucleus Other types of O-glycan biosynthesis 0.1833071726097464 | |
| GALNT9 Cytosol Metabolic pathways 0.472876056684542 | |
| GALNT9 Cytosol Mucin type O-glycan biosynthesis 0.472876056684542 | |
| GALNT9 Cytosol Other types of O-glycan biosynthesis 0.472876056684542 | |
| GALNT9 Golgi apparatus Metabolic pathways 0.472876056684542 | |
| GALNT9 Golgi apparatus Mucin type O-glycan biosynthesis 0.472876056684542 | |
| GALNT9 Golgi apparatus Other types of O-glycan biosynthesis 0.472876056684542 | |
| GALT Cytosol Summary 1.099848357210335 | |
| GAN Cytoskeleton Summary 1.6781815301181755 | |
| GANAB Endoplasmic Reticulum Summary 1.347760632166907 | |
| GANAB Nucleus Summary 1.347760632166907 | |
| GANC Cytosol Summary 1.3836737030775184 | |
| GANC Nucleus Summary 1.3836737030775184 | |
| GAP43 Plasma membrane Summary 0.2825184136916945 | |
| GAPDH Cytosol Alzheimer disease 2.0444233937385663 | |
| GAPDH Cytosol Biosynthesis of amino acids 2.0444233937385663 | |
| GAPDH Cytosol Carbon metabolism 2.0444233937385663 | |
| GAPDH Cytosol Diabetic cardiomyopathy 2.0444233937385663 | |
| GAPDH Cytosol Glycolysis / Gluconeogenesis 2.0444233937385663 | |
| GAPDH Cytosol HIF-1 signaling pathway 2.0444233937385663 | |
| GAPDH Cytosol Metabolic pathways 2.0444233937385663 | |
| GAPDH Cytosol Pathogenic Escherichia coli infection 2.0444233937385663 | |
| GAPDH Cytosol Salmonella infection 2.0444233937385663 | |
| GAPDH Nucleus Alzheimer disease 2.0444233937385663 | |
| GAPDH Nucleus Biosynthesis of amino acids 2.0444233937385663 | |
| GAPDH Nucleus Carbon metabolism 2.0444233937385663 | |
| GAPDH Nucleus Diabetic cardiomyopathy 2.0444233937385663 | |
| GAPDH Nucleus Glycolysis / Gluconeogenesis 2.0444233937385663 | |
| GAPDH Nucleus HIF-1 signaling pathway 2.0444233937385663 | |
| GAPDH Nucleus Metabolic pathways 2.0444233937385663 | |
| GAPDH Nucleus Pathogenic Escherichia coli infection 2.0444233937385663 | |
| GAPDH Nucleus Salmonella infection 2.0444233937385663 | |
| GAPDH Plasma membrane Alzheimer disease 2.0444233937385663 | |
| GAPDH Plasma membrane Biosynthesis of amino acids 2.0444233937385663 | |
| GAPDH Plasma membrane Carbon metabolism 2.0444233937385663 | |
| GAPDH Plasma membrane Diabetic cardiomyopathy 2.0444233937385663 | |
| GAPDH Plasma membrane Glycolysis / Gluconeogenesis 2.0444233937385663 | |
| GAPDH Plasma membrane HIF-1 signaling pathway 2.0444233937385663 | |
| GAPDH Plasma membrane Metabolic pathways 2.0444233937385663 | |
| GAPDH Plasma membrane Pathogenic Escherichia coli infection 2.0444233937385663 | |
| GAPDH Plasma membrane Salmonella infection 2.0444233937385663 | |
| GAPDHS Cytoskeleton Summary 2.2810396592967104 | |
| GAPDHS Cytosol Summary 2.2810396592967104 | |
| GAPDHS Nucleus Summary 2.2810396592967104 | |
| GAPVD1 Cytosol Summary 1.063383842952559 | |
| GAPVD1 Endosome Summary 1.063383842952559 | |
| GAPVD1 Plasma membrane Summary 1.063383842952559 | |
| GAR1 Nucleus Olfactory transduction 1.714512587847028 | |
| GAR1 Nucleus Phototransduction 1.714512587847028 | |
| GAR1 Nucleus Ribosome biogenesis in eukaryotes 1.714512587847028 | |
| GAR1 Nucleus cAMP signaling pathway 1.714512587847028 | |
| GAR1 Nucleus cGMP-PKG signaling pathway 1.714512587847028 | |
| GARS Cytosol Summary 3.00215102749608 | |
| GART Cytosol Summary 2.0166333362329927 | |
| GART Mitochondrion Summary 2.0166333362329927 | |
| GART Nucleus Summary 2.0166333362329927 | |
| GAS1 Nucleus Hedgehog signaling pathway 1.0173196280209271 | |
| GAS1 Plasma membrane Hedgehog signaling pathway 1.0173196280209271 | |
| GAS2L1 Plasma membrane Summary 0.9414280441261405 | |
| GAS6 Cytosol EGFR tyrosine kinase inhibitor resistance 1.7130204492685508 | |
| GAS6 Endoplasmic Reticulum EGFR tyrosine kinase inhibitor resistance 1.7130204492685508 | |
| GAS6 Extracellular space EGFR tyrosine kinase inhibitor resistance 1.7130204492685508 | |
| GAS7 Cytoskeleton Summary 1.4737811672715715 | |
| GAS7 Cytosol Summary 1.4737811672715715 | |
| GAS7 Plasma membrane Summary 1.4737811672715715 | |
| GATA3 Nucleus Inflammatory bowel disease 0.09735042972499236 | |
| GATA3 Nucleus Parathyroid hormone synthesis secretion and action 0.09735042972499236 | |
| GATA3 Nucleus Th1 and Th2 cell differentiation 0.09735042972499236 | |
| GATA3 Nucleus Th17 cell differentiation 0.09735042972499236 | |
| GATAD1 Nucleus Summary 1.389144972990098 | |
| GATAD2A Nucleus Summary 1.5335382851123314 | |
| GATAD2B Nucleus Summary 2.0926100013533406 | |
| GATB Endoplasmic Reticulum Aminoacyl-tRNA biosynthesis 1.4209087010732082 | |
| GATB Endoplasmic Reticulum Metabolic pathways 1.4209087010732082 | |
| GATB Mitochondrion Aminoacyl-tRNA biosynthesis 1.4209087010732082 | |
| GATB Mitochondrion Metabolic pathways 1.4209087010732082 | |
| GATC Endoplasmic Reticulum Aminoacyl-tRNA biosynthesis 1.5357623134494434 | |
| GATC Endoplasmic Reticulum Metabolic pathways 1.5357623134494434 | |
| GATC Mitochondrion Aminoacyl-tRNA biosynthesis 1.5357623134494434 | |
| GATC Mitochondrion Metabolic pathways 1.5357623134494434 | |
| GATM Mitochondrion Arginine and proline metabolism 0.9307642687260708 | |
| GATM Mitochondrion Glycine serine and threonine metabolism 0.9307642687260708 | |
| GATM Mitochondrion Metabolic pathways 0.9307642687260708 | |
| GBA Lysosome Lysosome 1.601486081951388 | |
| GBA Lysosome Metabolic pathways 1.601486081951388 | |
| GBA Lysosome Other glycan degradation 1.601486081951388 | |
| GBA Lysosome Sphingolipid metabolism 1.601486081951388 | |
| GBA2 Cytosol Metabolic pathways 0.8824983942154923 | |
| GBA2 Cytosol Other glycan degradation 0.8824983942154923 | |
| GBA2 Cytosol Sphingolipid metabolism 0.8824983942154923 | |
| GBA2 Endoplasmic Reticulum Metabolic pathways 0.8824983942154923 | |
| GBA2 Endoplasmic Reticulum Other glycan degradation 0.8824983942154923 | |
| GBA2 Endoplasmic Reticulum Sphingolipid metabolism 0.8824983942154923 | |
| GBA2 Golgi apparatus Metabolic pathways 0.8824983942154923 | |
| GBA2 Golgi apparatus Other glycan degradation 0.8824983942154923 | |
| GBA2 Golgi apparatus Sphingolipid metabolism 0.8824983942154923 | |
| GBA2 Nucleus Metabolic pathways 0.8824983942154923 | |
| GBA2 Nucleus Other glycan degradation 0.8824983942154923 | |
| GBA2 Nucleus Sphingolipid metabolism 0.8824983942154923 | |
| GBA2 Plasma membrane Metabolic pathways 0.8824983942154923 | |
| GBA2 Plasma membrane Other glycan degradation 0.8824983942154923 | |
| GBA2 Plasma membrane Sphingolipid metabolism 0.8824983942154923 | |
| GBAS Mitochondrion Summary 1.2572566532132041 | |
| GBE1 Cytosol Summary 1.1054087552372 | |
| GBE1 Nucleus Summary 1.1054087552372 | |
| GBF1 Golgi apparatus Summary 0.7461185684045143 | |
| GBP1 Cytosol NOD-like receptor signaling pathway 1.942328401019361 | |
| GBP1 Plasma membrane NOD-like receptor signaling pathway 1.942328401019361 | |
| GBP2 Cytosol NOD-like receptor signaling pathway 1.2402752887506097 | |
| GBP2 Nucleus NOD-like receptor signaling pathway 1.2402752887506097 | |
| GBP2 Plasma membrane NOD-like receptor signaling pathway 1.2402752887506097 | |
| GBP3 Cytosol Summary 1.305307531852348 | |
| GBP4 Cytosol Summary 2.3334248510539317 | |
| GBP4 Golgi apparatus Summary 2.3334248510539317 | |
| GBP4 Plasma membrane Summary 2.3334248510539317 | |
| GBP5 Cytosol Summary 1.50024658061319 | |
| GBP5 Endoplasmic Reticulum Summary 1.50024658061319 | |
| GC Extracellular space Summary 1.868006004015724 | |
| GCA Cytosol Summary 2.893134992962316 | |
| GCA Plasma membrane Summary 2.893134992962316 | |
| GCAT Mitochondrion Glycine serine and threonine metabolism 1.6448745582821098 | |
| GCAT Mitochondrion Metabolic pathways 1.6448745582821098 | |
| GCAT Nucleus Glycine serine and threonine metabolism 1.6448745582821098 | |
| GCAT Nucleus Metabolic pathways 1.6448745582821098 | |
| GCC1 Cytosol Summary 0.8023892515472563 | |
| GCC1 Golgi apparatus Summary 0.8023892515472563 | |
| GCC1 Plasma membrane Summary 0.8023892515472563 | |
| GCC2 Golgi apparatus Salmonella infection 0.6051029476465921 | |
| GCC2 Nucleus Salmonella infection 0.6051029476465921 | |
| GCDH Mitochondrion Fatty acid degradation 2.0740792814054774 | |
| GCDH Mitochondrion Lysine degradation 2.0740792814054774 | |
| GCDH Mitochondrion Metabolic pathways 2.0740792814054774 | |
| GCDH Mitochondrion Tryptophan metabolism 2.0740792814054774 | |
| GCFC2 Nucleus Summary 1.4427410323441288 | |
| GCH1 Cytosol Biosynthesis of cofactors 2.1118032811688705 | |
| GCH1 Cytosol Folate biosynthesis 2.1118032811688705 | |
| GCH1 Cytosol Metabolic pathways 2.1118032811688705 | |
| GCH1 Nucleus Biosynthesis of cofactors 2.1118032811688705 | |
| GCH1 Nucleus Folate biosynthesis 2.1118032811688705 | |
| GCH1 Nucleus Metabolic pathways 2.1118032811688705 | |
| GCHFR Cytosol Summary 0.8175214596610999 | |
| GCHFR Nucleus Summary 0.8175214596610999 | |
| GCLC Cytosol Summary 1.4937073710401294 | |
| GCLC Nucleus Summary 1.4937073710401294 | |
| GCLM Cytosol Biosynthesis of cofactors 2.2656464390347915 | |
| GCLM Cytosol Cysteine and methionine metabolism 2.2656464390347915 | |
| GCLM Cytosol Ferroptosis 2.2656464390347915 | |
| GCLM Cytosol Glutathione metabolism 2.2656464390347915 | |
| GCLM Cytosol Metabolic pathways 2.2656464390347915 | |
| GCLM Nucleus Biosynthesis of cofactors 2.2656464390347915 | |
| GCLM Nucleus Cysteine and methionine metabolism 2.2656464390347915 | |
| GCLM Nucleus Ferroptosis 2.2656464390347915 | |
| GCLM Nucleus Glutathione metabolism 2.2656464390347915 | |
| GCLM Nucleus Metabolic pathways 2.2656464390347915 | |
| GCLM Plasma membrane Biosynthesis of cofactors 2.2656464390347915 | |
| GCLM Plasma membrane Cysteine and methionine metabolism 2.2656464390347915 | |
| GCLM Plasma membrane Ferroptosis 2.2656464390347915 | |
| GCLM Plasma membrane Glutathione metabolism 2.2656464390347915 | |
| GCLM Plasma membrane Metabolic pathways 2.2656464390347915 | |
| GCN1 Cytosol Summary 1.1693523867218258 | |
| GCOM1 Nucleus Summary 0.9655724280149254 | |
| GCOM1 Plasma membrane Summary 0.9655724280149254 | |
| GCSH Cytosol Carbon metabolism 1.3131780054933266 | |
| GCSH Cytosol Glycine serine and threonine metabolism 1.3131780054933266 | |
| GCSH Cytosol Glyoxylate and dicarboxylate metabolism 1.3131780054933266 | |
| GCSH Cytosol Metabolic pathways 1.3131780054933266 | |
| GCSH Mitochondrion Carbon metabolism 1.3131780054933266 | |
| GCSH Mitochondrion Glycine serine and threonine metabolism 1.3131780054933266 | |
| GCSH Mitochondrion Glyoxylate and dicarboxylate metabolism 1.3131780054933266 | |
| GCSH Mitochondrion Metabolic pathways 1.3131780054933266 | |
| GDAP1 Cytosol Summary 0.3554374211840197 | |
| GDAP1 Mitochondrion Summary 0.3554374211840197 | |
| GDAP2 Endoplasmic Reticulum Summary 1.1488544555454352 | |
| GDE1 Cytosol Summary 1.3590069186945664 | |
| GDE1 Nucleus Summary 1.3590069186945664 | |
| GDE1 Plasma membrane Summary 1.3590069186945664 | |
| GDF15 Golgi apparatus Summary 0.3020299666623106 | |
| GDI1 Cytosol Summary 0.8337837766006501 | |
| GDI2 Cytosol Summary 1.8167522868557644 | |
| GDPD1 Cytosol Summary 0.2674045277461612 | |
| GDPD3 Cytosol Summary 0.06815784434813338 | |
| GDPD3 Nucleus Summary 0.06815784434813338 | |
| GDPGP1 Cytosol Summary 0.9446884868563138 | |
| GEM Cytosol Summary 1.8936913488084413 | |
| GEM Plasma membrane Summary 1.8936913488084413 | |
| GEMIN2 Nucleus RNA transport 2.074099106362798 | |
| GEMIN4 Cytosol RNA transport 1.1895616632272898 | |
| GEMIN4 Nucleus RNA transport 1.1895616632272898 | |
| GEMIN5 Cytosol RNA transport 1.478431659836987 | |
| GEMIN5 Nucleus RNA transport 1.478431659836987 | |
| GEMIN6 Nucleus RNA transport 1.6891528980379331 | |
| GEMIN7 Cytosol RNA transport 1.2991165467358323 | |
| GEMIN7 Nucleus RNA transport 1.2991165467358323 | |
| GEMIN8 Cytosol RNA transport 1.1615505309170209 | |
| GEMIN8 Nucleus RNA transport 1.1615505309170209 | |
| GEN1 Nucleus Summary 1.8241439246573996 | |
| GET4 Cytosol Summary 0.8579495637528299 | |
| GET4 Mitochondrion Summary 0.8579495637528299 | |
| GET4 Nucleus Summary 0.8579495637528299 | |
| GFAP Cytoskeleton Summary 1.2382156617193958 | |
| GFAP Cytosol Summary 1.2382156617193958 | |
| GFER Cytosol Summary 0.9773047760635706 | |
| GFER Extracellular space Summary 0.9773047760635706 | |
| GFER Mitochondrion Summary 0.9773047760635706 | |
| GFM1 Mitochondrion Summary 1.3778743294633409 | |
| GFM1 Nucleus Summary 1.3778743294633409 | |
| GFM2 Mitochondrion Summary 0.8702698737372202 | |
| GFM2 Nucleus Summary 0.8702698737372202 | |
| GFOD1 Cytosol Summary 2.0227831940122543 | |
| GFOD1 Nucleus Summary 2.0227831940122543 | |
| GFOD1 Plasma membrane Summary 2.0227831940122543 | |
| GFOD2 Cytosol Summary 0.9924831251809114 | |
| GFOD2 Extracellular space Summary 0.9924831251809114 | |
| GFOD2 Nucleus Summary 0.9924831251809114 | |
| GFPT1 Nucleus Summary 1.473740097880654 | |
| GFPT2 Cytosol Summary 2.287709854473132 | |
| GFRA1 Golgi apparatus Summary 0.053380472610720126 | |
| GFRA1 Nucleus Summary 0.053380472610720126 | |
| GFRA1 Plasma membrane Summary 0.053380472610720126 | |
| GGA1 Cytosol Lysosome 0.8959510593803345 | |
| GGA1 Endosome Lysosome 0.8959510593803345 | |
| GGA1 Golgi apparatus Lysosome 0.8959510593803345 | |
| GGA1 Nucleus Lysosome 0.8959510593803345 | |
| GGA2 Endosome Lysosome 0.7153528813948625 | |
| GGA2 Golgi apparatus Lysosome 0.7153528813948625 | |
| GGA3 Golgi apparatus Summary 1.1249027524630453 | |
| GGCT Cytosol Glutathione metabolism 0.4350464753214779 | |
| GGCT Cytosol Metabolic pathways 0.4350464753214779 | |
| GGCX Endoplasmic Reticulum Biosynthesis of cofactors 1.2176634999826164 | |
| GGCX Endoplasmic Reticulum Metabolic pathways 1.2176634999826164 | |
| GGCX Endoplasmic Reticulum Ubiquinone and other terpenoid-quinone biosynthesis 1.2176634999826164 | |
| GGH Extracellular space Antifolate resistance 2.2377789515884823 | |
| GGH Extracellular space Biosynthesis of cofactors 2.2377789515884823 | |
| GGH Extracellular space Folate biosynthesis 2.2377789515884823 | |
| GGH Lysosome Antifolate resistance 2.2377789515884823 | |
| GGH Lysosome Biosynthesis of cofactors 2.2377789515884823 | |
| GGH Lysosome Folate biosynthesis 2.2377789515884823 | |
| GGNBP2 Cytosol Summary 1.259864847047924 | |
| GGNBP2 Endoplasmic Reticulum Summary 1.259864847047924 | |
| GGPS1 Cytosol Summary 0.8743823544440027 | |
| GGT1 Cytosol Summary 0.25720749394146936 | |
| GGT1 Plasma membrane Summary 0.25720749394146936 | |
| GGT5 Nucleus Arachidonic acid metabolism 0.7662534557554069 | |
| GGT5 Nucleus Glutathione metabolism 0.7662534557554069 | |
| GGT5 Nucleus Metabolic pathways 0.7662534557554069 | |
| GGT5 Nucleus Taurine and hypotaurine metabolism 0.7662534557554069 | |
| GGT5 Plasma membrane Arachidonic acid metabolism 0.7662534557554069 | |
| GGT5 Plasma membrane Glutathione metabolism 0.7662534557554069 | |
| GGT5 Plasma membrane Metabolic pathways 0.7662534557554069 | |
| GGT5 Plasma membrane Taurine and hypotaurine metabolism 0.7662534557554069 | |
| GGT7 Cytosol Glutathione metabolism 1.6659863866756397 | |
| GGT7 Cytosol Metabolic pathways 1.6659863866756397 | |
| GGT7 Cytosol Taurine and hypotaurine metabolism 1.6659863866756397 | |
| GGT7 Nucleus Glutathione metabolism 1.6659863866756397 | |
| GGT7 Nucleus Metabolic pathways 1.6659863866756397 | |
| GGT7 Nucleus Taurine and hypotaurine metabolism 1.6659863866756397 | |
| GGT7 Plasma membrane Glutathione metabolism 1.6659863866756397 | |
| GGT7 Plasma membrane Metabolic pathways 1.6659863866756397 | |
| GGT7 Plasma membrane Taurine and hypotaurine metabolism 1.6659863866756397 | |
| GHDC Endoplasmic Reticulum Summary 0.3250015736168293 | |
| GHITM Mitochondrion Summary 1.1219066483349982 | |
| GID4 Cytosol Summary 2.0692646701462003 | |
| GID8 Cytosol Summary 1.7021107638666242 | |
| GID8 Nucleus Summary 1.7021107638666242 | |
| GID8 Plasma membrane Summary 1.7021107638666242 | |
| GIGYF1 Cytoskeleton Summary 1.2893268368541642 | |
| GIGYF1 Cytosol Summary 1.2893268368541642 | |
| GIGYF2 Cytosol Summary 1.0391684577878924 | |
| GIMAP1 Endoplasmic Reticulum Summary 0.7523865756526612 | |
| GIMAP1-GIMAP5 Endoplasmic Reticulum Summary 0.9918651771089778 | |
| GIMAP4 Cytosol Summary 1.3550562605823973 | |
| GIMAP6 Nucleus Summary 1.0216718310545054 | |
| GIMAP7 Cytosol Summary 1.2874959982001508 | |
| GIMAP7 Golgi apparatus Summary 1.2874959982001508 | |
| GIMAP8 Endoplasmic Reticulum Summary 2.088338791760683 | |
| GINS1 Nucleus Summary 2.134615689757537 | |
| GINS2 Nucleus Summary 2.687229644578402 | |
| GINS3 Nucleus Summary 2.9740255059275187 | |
| GINS4 Cytoskeleton Summary 2.9515294723976875 | |
| GINS4 Nucleus Summary 2.9515294723976875 | |
| GIPC1 Cytosol Summary 1.8351736306409825 | |
| GIPC1 Nucleus Summary 1.8351736306409825 | |
| GIPC1 Plasma membrane Summary 1.8351736306409825 | |
| GIPC2 Cytosol Summary 1.0850109278103297 | |
| GIPC2 Nucleus Summary 1.0850109278103297 | |
| GIPC3 Golgi apparatus Summary 1.6759064189294348 | |
| GIPC3 Nucleus Summary 1.6759064189294348 | |
| GIT1 Cytosol Summary 1.2128451903198176 | |
| GIT1 Mitochondrion Summary 1.2128451903198176 | |
| GIT2 Cytoskeleton Endocytosis 1.6539801238636709 | |
| GIT2 Cytoskeleton Yersinia infection 1.6539801238636709 | |
| GIT2 Nucleus Endocytosis 1.6539801238636709 | |
| GIT2 Nucleus Yersinia infection 1.6539801238636709 | |
| GJA1 Cytosol Arrhythmogenic right ventricular cardiomyopathy 0.5492449096519331 | |
| GJA1 Cytosol Gap junction 0.5492449096519331 | |
| GJA1 Nucleus Arrhythmogenic right ventricular cardiomyopathy 0.5492449096519331 | |
| GJA1 Nucleus Gap junction 0.5492449096519331 | |
| GJA1 Plasma membrane Arrhythmogenic right ventricular cardiomyopathy 0.5492449096519331 | |
| GJA1 Plasma membrane Gap junction 0.5492449096519331 | |
| GK Mitochondrion Amino sugar and nucleotide sugar metabolism 1.2172108627443992 | |
| GK Mitochondrion Carbon metabolism 1.2172108627443992 | |
| GK Mitochondrion Central carbon metabolism in cancer 1.2172108627443992 | |
| GK Mitochondrion Galactose metabolism 1.2172108627443992 | |
| GK Mitochondrion Glucagon signaling pathway 1.2172108627443992 | |
| GK Mitochondrion Glycerolipid metabolism 1.2172108627443992 | |
| GK Mitochondrion Glycolysis / Gluconeogenesis 1.2172108627443992 | |
| GK Mitochondrion Insulin secretion 1.2172108627443992 | |
| GK Mitochondrion Insulin signaling pathway 1.2172108627443992 | |
| GK Mitochondrion Maturity onset diabetes of the young 1.2172108627443992 | |
| GK Mitochondrion Metabolic pathways 1.2172108627443992 | |
| GK Mitochondrion Neomycin kanamycin and gentamicin biosynthesis 1.2172108627443992 | |
| GK Mitochondrion PPAR signaling pathway 1.2172108627443992 | |
| GK Mitochondrion Prolactin signaling pathway 1.2172108627443992 | |
| GK Mitochondrion Starch and sucrose metabolism 1.2172108627443992 | |
| GK Mitochondrion Type II diabetes mellitus 1.2172108627443992 | |
| GK5 Cytosol Summary 1.0807868542438042 | |
| GK5 Nucleus Summary 1.0807868542438042 | |
| GKAP1 Cytosol Summary 0.8139249366553637 | |
| GKAP1 Golgi apparatus Summary 0.8139249366553637 | |
| GLA Extracellular space Galactose metabolism 0.8257886908061662 | |
| GLA Extracellular space Glutathione metabolism 0.8257886908061662 | |
| GLA Extracellular space Glycerolipid metabolism 0.8257886908061662 | |
| GLA Extracellular space Glycosphingolipid biosynthesis - globo and isoglobo series 0.8257886908061662 | |
| GLA Extracellular space Lysosome 0.8257886908061662 | |
| GLA Extracellular space Metabolic pathways 0.8257886908061662 | |
| GLA Extracellular space Sphingolipid metabolism 0.8257886908061662 | |
| GLA Lysosome Galactose metabolism 0.8257886908061662 | |
| GLA Lysosome Glutathione metabolism 0.8257886908061662 | |
| GLA Lysosome Glycerolipid metabolism 0.8257886908061662 | |
| GLA Lysosome Glycosphingolipid biosynthesis - globo and isoglobo series 0.8257886908061662 | |
| GLA Lysosome Lysosome 0.8257886908061662 | |
| GLA Lysosome Metabolic pathways 0.8257886908061662 | |
| GLA Lysosome Sphingolipid metabolism 0.8257886908061662 | |
| GLB1 Cytosol Galactose metabolism 1.2458524210618351 | |
| GLB1 Cytosol Glycosaminoglycan degradation 1.2458524210618351 | |
| GLB1 Cytosol Glycosphingolipid biosynthesis - ganglio series 1.2458524210618351 | |
| GLB1 Cytosol Lysosome 1.2458524210618351 | |
| GLB1 Cytosol Metabolic pathways 1.2458524210618351 | |
| GLB1 Cytosol Other glycan degradation 1.2458524210618351 | |
| GLB1 Cytosol Sphingolipid metabolism 1.2458524210618351 | |
| GLB1 Golgi apparatus Galactose metabolism 1.2458524210618351 | |
| GLB1 Golgi apparatus Glycosaminoglycan degradation 1.2458524210618351 | |
| GLB1 Golgi apparatus Glycosphingolipid biosynthesis - ganglio series 1.2458524210618351 | |
| GLB1 Golgi apparatus Lysosome 1.2458524210618351 | |
| GLB1 Golgi apparatus Metabolic pathways 1.2458524210618351 | |
| GLB1 Golgi apparatus Other glycan degradation 1.2458524210618351 | |
| GLB1 Golgi apparatus Sphingolipid metabolism 1.2458524210618351 | |
| GLB1 Lysosome Galactose metabolism 1.2458524210618351 | |
| GLB1 Lysosome Glycosaminoglycan degradation 1.2458524210618351 | |
| GLB1 Lysosome Glycosphingolipid biosynthesis - ganglio series 1.2458524210618351 | |
| GLB1 Lysosome Lysosome 1.2458524210618351 | |
| GLB1 Lysosome Metabolic pathways 1.2458524210618351 | |
| GLB1 Lysosome Other glycan degradation 1.2458524210618351 | |
| GLB1 Lysosome Sphingolipid metabolism 1.2458524210618351 | |
| GLCCI1 Nucleus Summary 1.120668262749242 | |
| GLCE Golgi apparatus Glycosaminoglycan biosynthesis - heparan sulfate / heparin 0.8727997982711312 | |
| GLCE Golgi apparatus Metabolic pathways 0.8727997982711312 | |
| GLCE Mitochondrion Glycosaminoglycan biosynthesis - heparan sulfate / heparin 0.8727997982711312 | |
| GLCE Mitochondrion Metabolic pathways 0.8727997982711312 | |
| GLDC Mitochondrion Carbon metabolism 0.7686513487944744 | |
| GLDC Mitochondrion Glycine serine and threonine metabolism 0.7686513487944744 | |
| GLDC Mitochondrion Glyoxylate and dicarboxylate metabolism 0.7686513487944744 | |
| GLDC Mitochondrion Metabolic pathways 0.7686513487944744 | |
| GLDC Nucleus Carbon metabolism 0.7686513487944744 | |
| GLDC Nucleus Glycine serine and threonine metabolism 0.7686513487944744 | |
| GLDC Nucleus Glyoxylate and dicarboxylate metabolism 0.7686513487944744 | |
| GLDC Nucleus Metabolic pathways 0.7686513487944744 | |
| GLE1 Nucleus Amyotrophic lateral sclerosis 1.6103694868821556 | |
| GLE1 Nucleus RNA transport 1.6103694868821556 | |
| GLE1 Nucleus mRNA surveillance pathway 1.6103694868821556 | |
| GLG1 Golgi apparatus Cell adhesion molecules 1.4664089494616126 | |
| GLI3 Cytosol Summary 0.5899421805696289 | |
| GLI3 Nucleus Summary 0.5899421805696289 | |
| GLIPR2 Cytoskeleton Summary 3.1644286809306106 | |
| GLIPR2 Cytosol Summary 3.1644286809306106 | |
| GLIPR2 Golgi apparatus Summary 3.1644286809306106 | |
| GLMN Cytosol Summary 1.4897833555396742 | |
| GLMN Nucleus Summary 1.4897833555396742 | |
| GLMP Lysosome Summary 1.8470918971104424 | |
| GLO1 Cytosol Summary 0.947466344919886 | |
| GLO1 Nucleus Summary 0.947466344919886 | |
| GLO1 Plasma membrane Summary 0.947466344919886 | |
| GLOD4 Cytosol Summary 1.0388887169142131 | |
| GLOD4 Mitochondrion Summary 1.0388887169142131 | |
| GLOD4 Nucleus Summary 1.0388887169142131 | |
| GLRX Cytosol Summary 1.4146649488515184 | |
| GLRX Plasma membrane Summary 1.4146649488515184 | |
| GLRX2 Cytosol Summary 1.4043841127190644 | |
| GLRX2 Mitochondrion Summary 1.4043841127190644 | |
| GLRX2 Nucleus Summary 1.4043841127190644 | |
| GLRX3 Cytosol Summary 2.2912717712201647 | |
| GLRX5 Mitochondrion Summary 1.7216257779114261 | |
| GLS Cytosol Alanine aspartate and glutamate metabolism 2.3323702460749973 | |
| GLS Cytosol Arginine biosynthesis 2.3323702460749973 | |
| GLS Cytosol Central carbon metabolism in cancer 2.3323702460749973 | |
| GLS Cytosol D-Glutamine and D-glutamate metabolism 2.3323702460749973 | |
| GLS Cytosol GABAergic synapse 2.3323702460749973 | |
| GLS Cytosol Glutamatergic synapse 2.3323702460749973 | |
| GLS Cytosol Metabolic pathways 2.3323702460749973 | |
| GLS Cytosol MicroRNAs in cancer 2.3323702460749973 | |
| GLS Cytosol Proximal tubule bicarbonate reclamation 2.3323702460749973 | |
| GLS Mitochondrion Alanine aspartate and glutamate metabolism 2.3323702460749973 | |
| GLS Mitochondrion Arginine biosynthesis 2.3323702460749973 | |
| GLS Mitochondrion Central carbon metabolism in cancer 2.3323702460749973 | |
| GLS Mitochondrion D-Glutamine and D-glutamate metabolism 2.3323702460749973 | |
| GLS Mitochondrion GABAergic synapse 2.3323702460749973 | |
| GLS Mitochondrion Glutamatergic synapse 2.3323702460749973 | |
| GLS Mitochondrion Metabolic pathways 2.3323702460749973 | |
| GLS Mitochondrion MicroRNAs in cancer 2.3323702460749973 | |
| GLS Mitochondrion Proximal tubule bicarbonate reclamation 2.3323702460749973 | |
| GLT8D1 Mitochondrion Summary 0.8748443804042719 | |
| GLT8D2 Cytosol Summary 0.9122048510116154 | |
| GLT8D2 Golgi apparatus Summary 0.9122048510116154 | |
| GLTP Cytosol Summary 0.5745491813933585 | |
| GLTSCR1 Nucleus Summary 1.3520487319087264 | |
| GLTSCR1L Nucleus Summary 1.6326169368201984 | |
| GLTSCR2 Nucleus Summary 1.964685218442392 | |
| GLUD1 Mitochondrion Alanine aspartate and glutamate metabolism 0.595532395571922 | |
| GLUD1 Mitochondrion Arginine biosynthesis 0.595532395571922 | |
| GLUD1 Mitochondrion Carbon metabolism 0.595532395571922 | |
| GLUD1 Mitochondrion D-Glutamine and D-glutamate metabolism 0.595532395571922 | |
| GLUD1 Mitochondrion Metabolic pathways 0.595532395571922 | |
| GLUD1 Mitochondrion Necroptosis 0.595532395571922 | |
| GLUD1 Mitochondrion Nitrogen metabolism 0.595532395571922 | |
| GLUD1 Mitochondrion Proximal tubule bicarbonate reclamation 0.595532395571922 | |
| GLUD2 Mitochondrion Alanine aspartate and glutamate metabolism 0.8877218341439704 | |
| GLUD2 Mitochondrion Arginine biosynthesis 0.8877218341439704 | |
| GLUD2 Mitochondrion Carbon metabolism 0.8877218341439704 | |
| GLUD2 Mitochondrion D-Glutamine and D-glutamate metabolism 0.8877218341439704 | |
| GLUD2 Mitochondrion Metabolic pathways 0.8877218341439704 | |
| GLUD2 Mitochondrion Necroptosis 0.8877218341439704 | |
| GLUD2 Mitochondrion Nitrogen metabolism 0.8877218341439704 | |
| GLUD2 Mitochondrion Proximal tubule bicarbonate reclamation 0.8877218341439704 | |
| GLUL Cytosol Summary 0.7216182668812511 | |
| GLUL Mitochondrion Summary 0.7216182668812511 | |
| GLUL Plasma membrane Summary 0.7216182668812511 | |
| GLYAT Mitochondrion Summary 1.5907916852435573 | |
| GLYATL1 Cytosol Summary 0.312237121792801 | |
| GLYATL1 Golgi apparatus Summary 0.312237121792801 | |
| GLYATL2 Endoplasmic Reticulum Summary 0.5120372254712938 | |
| GLYATL2 Mitochondrion Summary 0.5120372254712938 | |
| GLYR1 Cytosol Summary 1.2618163235431699 | |
| GLYR1 Nucleus Summary 1.2618163235431699 | |
| GM2A Cytosol Lysosome 1.321456362731944 | |
| GM2A Lysosome Lysosome 1.321456362731944 | |
| GMEB1 Nucleus Summary 1.3362589512568577 | |
| GMEB2 Cytosol Summary 1.4190764245877647 | |
| GMEB2 Nucleus Summary 1.4190764245877647 | |
| GMFB Cytosol Summary 0.8408347790286271 | |
| GMFB Nucleus Summary 0.8408347790286271 | |
| GMFG Cytosol Summary 2.0164573880611374 | |
| GMFG Nucleus Summary 2.0164573880611374 | |
| GMIP Cytosol Summary 1.7715433920742063 | |
| GMIP Nucleus Summary 1.7715433920742063 | |
| GMIP Plasma membrane Summary 1.7715433920742063 | |
| GMNN Cytosol Summary 3.0547264437368256 | |
| GMNN Nucleus Summary 3.0547264437368256 | |
| GMPPA Cytosol Summary 0.7922117250749953 | |
| GMPPA Nucleus Summary 0.7922117250749953 | |
| GMPPB Cytosol Summary 0.8408037208953871 | |
| GMPPB Nucleus Summary 0.8408037208953871 | |
| GMPR2 Nucleus Summary 1.1220332522878853 | |
| GMPS Cytosol Summary 2.0981809135823744 | |
| GNA11 Plasma membrane Aldosterone synthesis and secretion 0.4456756877691124 | |
| GNA11 Plasma membrane Amoebiasis 0.4456756877691124 | |
| GNA11 Plasma membrane Calcium signaling pathway 0.4456756877691124 | |
| GNA11 Plasma membrane Chagas disease 0.4456756877691124 | |
| GNA11 Plasma membrane Cholinergic synapse 0.4456756877691124 | |
| GNA11 Plasma membrane Cortisol synthesis and secretion 0.4456756877691124 | |
| GNA11 Plasma membrane Cushing syndrome 0.4456756877691124 | |
| GNA11 Plasma membrane Gap junction 0.4456756877691124 | |
| GNA11 Plasma membrane GnRH secretion 0.4456756877691124 | |
| GNA11 Plasma membrane GnRH signaling pathway 0.4456756877691124 | |
| GNA11 Plasma membrane Growth hormone synthesis secretion and action 0.4456756877691124 | |
| GNA11 Plasma membrane Human cytomegalovirus infection 0.4456756877691124 | |
| GNA11 Plasma membrane Human immunodeficiency virus 1 infection 0.4456756877691124 | |
| GNA11 Plasma membrane Insulin secretion 0.4456756877691124 | |
| GNA11 Plasma membrane Long-term depression 0.4456756877691124 | |
| GNA11 Plasma membrane Parathyroid hormone synthesis secretion and action 0.4456756877691124 | |
| GNA11 Plasma membrane Pathways in cancer 0.4456756877691124 | |
| GNA11 Plasma membrane Vascular smooth muscle contraction 0.4456756877691124 | |
| GNA11 Plasma membrane cGMP-PKG signaling pathway 0.4456756877691124 | |
| GNA12 Cytosol Summary 1.0694319500702991 | |
| GNA12 Plasma membrane Summary 1.0694319500702991 | |
| GNA13 Cytosol Summary 0.5819826579275911 | |
| GNA13 Plasma membrane Summary 0.5819826579275911 | |
| GNA15 Plasma membrane Amoebiasis 0.9743230934926386 | |
| GNA15 Plasma membrane Calcium signaling pathway 0.9743230934926386 | |
| GNA15 Plasma membrane Chagas disease 0.9743230934926386 | |
| GNA15 Plasma membrane Relaxin signaling pathway 0.9743230934926386 | |
| GNAI1 Cytoskeleton Adrenergic signaling in cardiomyocytes 1.4385796090534284 | |
| GNAI1 Cytoskeleton Alcoholism 1.4385796090534284 | |
| GNAI1 Cytoskeleton Apelin signaling pathway 1.4385796090534284 | |
| GNAI1 Cytoskeleton Axon guidance 1.4385796090534284 | |
| GNAI1 Cytoskeleton Chagas disease 1.4385796090534284 | |
| GNAI1 Cytoskeleton Chemical carcinogenesis - receptor activation 1.4385796090534284 | |
| GNAI1 Cytoskeleton Chemokine signaling pathway 1.4385796090534284 | |
| GNAI1 Cytoskeleton Cholinergic synapse 1.4385796090534284 | |
| GNAI1 Cytoskeleton Circadian entrainment 1.4385796090534284 | |
| GNAI1 Cytoskeleton Cocaine addiction 1.4385796090534284 | |
| GNAI1 Cytoskeleton Cushing syndrome 1.4385796090534284 | |
| GNAI1 Cytoskeleton Dopaminergic synapse 1.4385796090534284 | |
| GNAI1 Cytoskeleton Estrogen signaling pathway 1.4385796090534284 | |
| GNAI1 Cytoskeleton GABAergic synapse 1.4385796090534284 | |
| GNAI1 Cytoskeleton Gap junction 1.4385796090534284 | |
| GNAI1 Cytoskeleton Gastric acid secretion 1.4385796090534284 | |
| GNAI1 Cytoskeleton Glutamatergic synapse 1.4385796090534284 | |
| GNAI1 Cytoskeleton Growth hormone synthesis secretion and action 1.4385796090534284 | |
| GNAI1 Cytoskeleton Human cytomegalovirus infection 1.4385796090534284 | |
| GNAI1 Cytoskeleton Human immunodeficiency virus 1 infection 1.4385796090534284 | |
| GNAI1 Cytoskeleton Leukocyte transendothelial migration 1.4385796090534284 | |
| GNAI1 Cytoskeleton Long-term depression 1.4385796090534284 | |
| GNAI1 Cytoskeleton Melanogenesis 1.4385796090534284 | |
| GNAI1 Cytoskeleton Morphine addiction 1.4385796090534284 | |
| GNAI1 Cytoskeleton Oxytocin signaling pathway 1.4385796090534284 | |
| GNAI1 Cytoskeleton Parathyroid hormone synthesis secretion and action 1.4385796090534284 | |
| GNAI1 Cytoskeleton Parkinson disease 1.4385796090534284 | |
| GNAI1 Cytoskeleton Pathways in cancer 1.4385796090534284 | |
| GNAI1 Cytoskeleton Pertussis 1.4385796090534284 | |
| GNAI1 Cytoskeleton Platelet activation 1.4385796090534284 | |
| GNAI1 Cytoskeleton Progesterone-mediated oocyte maturation 1.4385796090534284 | |
| GNAI1 Cytoskeleton Rap1 signaling pathway 1.4385796090534284 | |
| GNAI1 Cytoskeleton Regulation of lipolysis in adipocytes 1.4385796090534284 | |
| GNAI1 Cytoskeleton Relaxin signaling pathway 1.4385796090534284 | |
| GNAI1 Cytoskeleton Renin secretion 1.4385796090534284 | |
| GNAI1 Cytoskeleton Retrograde endocannabinoid signaling 1.4385796090534284 | |
| GNAI1 Cytoskeleton Serotonergic synapse 1.4385796090534284 | |
| GNAI1 Cytoskeleton Sphingolipid signaling pathway 1.4385796090534284 | |
| GNAI1 Cytoskeleton Toxoplasmosis 1.4385796090534284 | |
| GNAI1 Cytoskeleton cAMP signaling pathway 1.4385796090534284 | |
| GNAI1 Cytoskeleton cGMP-PKG signaling pathway 1.4385796090534284 | |
| GNAI1 Nucleus Adrenergic signaling in cardiomyocytes 1.4385796090534284 | |
| GNAI1 Nucleus Alcoholism 1.4385796090534284 | |
| GNAI1 Nucleus Apelin signaling pathway 1.4385796090534284 | |
| GNAI1 Nucleus Axon guidance 1.4385796090534284 | |
| GNAI1 Nucleus Chagas disease 1.4385796090534284 | |
| GNAI1 Nucleus Chemical carcinogenesis - receptor activation 1.4385796090534284 | |
| GNAI1 Nucleus Chemokine signaling pathway 1.4385796090534284 | |
| GNAI1 Nucleus Cholinergic synapse 1.4385796090534284 | |
| GNAI1 Nucleus Circadian entrainment 1.4385796090534284 | |
| GNAI1 Nucleus Cocaine addiction 1.4385796090534284 | |
| GNAI1 Nucleus Cushing syndrome 1.4385796090534284 | |
| GNAI1 Nucleus Dopaminergic synapse 1.4385796090534284 | |
| GNAI1 Nucleus Estrogen signaling pathway 1.4385796090534284 | |
| GNAI1 Nucleus GABAergic synapse 1.4385796090534284 | |
| GNAI1 Nucleus Gap junction 1.4385796090534284 | |
| GNAI1 Nucleus Gastric acid secretion 1.4385796090534284 | |
| GNAI1 Nucleus Glutamatergic synapse 1.4385796090534284 | |
| GNAI1 Nucleus Growth hormone synthesis secretion and action 1.4385796090534284 | |
| GNAI1 Nucleus Human cytomegalovirus infection 1.4385796090534284 | |
| GNAI1 Nucleus Human immunodeficiency virus 1 infection 1.4385796090534284 | |
| GNAI1 Nucleus Leukocyte transendothelial migration 1.4385796090534284 | |
| GNAI1 Nucleus Long-term depression 1.4385796090534284 | |
| GNAI1 Nucleus Melanogenesis 1.4385796090534284 | |
| GNAI1 Nucleus Morphine addiction 1.4385796090534284 | |
| GNAI1 Nucleus Oxytocin signaling pathway 1.4385796090534284 | |
| GNAI1 Nucleus Parathyroid hormone synthesis secretion and action 1.4385796090534284 | |
| GNAI1 Nucleus Parkinson disease 1.4385796090534284 | |
| GNAI1 Nucleus Pathways in cancer 1.4385796090534284 | |
| GNAI1 Nucleus Pertussis 1.4385796090534284 | |
| GNAI1 Nucleus Platelet activation 1.4385796090534284 | |
| GNAI1 Nucleus Progesterone-mediated oocyte maturation 1.4385796090534284 | |
| GNAI1 Nucleus Rap1 signaling pathway 1.4385796090534284 | |
| GNAI1 Nucleus Regulation of lipolysis in adipocytes 1.4385796090534284 | |
| GNAI1 Nucleus Relaxin signaling pathway 1.4385796090534284 | |
| GNAI1 Nucleus Renin secretion 1.4385796090534284 | |
| GNAI1 Nucleus Retrograde endocannabinoid signaling 1.4385796090534284 | |
| GNAI1 Nucleus Serotonergic synapse 1.4385796090534284 | |
| GNAI1 Nucleus Sphingolipid signaling pathway 1.4385796090534284 | |
| GNAI1 Nucleus Toxoplasmosis 1.4385796090534284 | |
| GNAI1 Nucleus cAMP signaling pathway 1.4385796090534284 | |
| GNAI1 Nucleus cGMP-PKG signaling pathway 1.4385796090534284 | |
| GNAI1 Plasma membrane Adrenergic signaling in cardiomyocytes 1.4385796090534284 | |
| GNAI1 Plasma membrane Alcoholism 1.4385796090534284 | |
| GNAI1 Plasma membrane Apelin signaling pathway 1.4385796090534284 | |
| GNAI1 Plasma membrane Axon guidance 1.4385796090534284 | |
| GNAI1 Plasma membrane Chagas disease 1.4385796090534284 | |
| GNAI1 Plasma membrane Chemical carcinogenesis - receptor activation 1.4385796090534284 | |
| GNAI1 Plasma membrane Chemokine signaling pathway 1.4385796090534284 | |
| GNAI1 Plasma membrane Cholinergic synapse 1.4385796090534284 | |
| GNAI1 Plasma membrane Circadian entrainment 1.4385796090534284 | |
| GNAI1 Plasma membrane Cocaine addiction 1.4385796090534284 | |
| GNAI1 Plasma membrane Cushing syndrome 1.4385796090534284 | |
| GNAI1 Plasma membrane Dopaminergic synapse 1.4385796090534284 | |
| GNAI1 Plasma membrane Estrogen signaling pathway 1.4385796090534284 | |
| GNAI1 Plasma membrane GABAergic synapse 1.4385796090534284 | |
| GNAI1 Plasma membrane Gap junction 1.4385796090534284 | |
| GNAI1 Plasma membrane Gastric acid secretion 1.4385796090534284 | |
| GNAI1 Plasma membrane Glutamatergic synapse 1.4385796090534284 | |
| GNAI1 Plasma membrane Growth hormone synthesis secretion and action 1.4385796090534284 | |
| GNAI1 Plasma membrane Human cytomegalovirus infection 1.4385796090534284 | |
| GNAI1 Plasma membrane Human immunodeficiency virus 1 infection 1.4385796090534284 | |
| GNAI1 Plasma membrane Leukocyte transendothelial migration 1.4385796090534284 | |
| GNAI1 Plasma membrane Long-term depression 1.4385796090534284 | |
| GNAI1 Plasma membrane Melanogenesis 1.4385796090534284 | |
| GNAI1 Plasma membrane Morphine addiction 1.4385796090534284 | |
| GNAI1 Plasma membrane Oxytocin signaling pathway 1.4385796090534284 | |
| GNAI1 Plasma membrane Parathyroid hormone synthesis secretion and action 1.4385796090534284 | |
| GNAI1 Plasma membrane Parkinson disease 1.4385796090534284 | |
| GNAI1 Plasma membrane Pathways in cancer 1.4385796090534284 | |
| GNAI1 Plasma membrane Pertussis 1.4385796090534284 | |
| GNAI1 Plasma membrane Platelet activation 1.4385796090534284 | |
| GNAI1 Plasma membrane Progesterone-mediated oocyte maturation 1.4385796090534284 | |
| GNAI1 Plasma membrane Rap1 signaling pathway 1.4385796090534284 | |
| GNAI1 Plasma membrane Regulation of lipolysis in adipocytes 1.4385796090534284 | |
| GNAI1 Plasma membrane Relaxin signaling pathway 1.4385796090534284 | |
| GNAI1 Plasma membrane Renin secretion 1.4385796090534284 | |
| GNAI1 Plasma membrane Retrograde endocannabinoid signaling 1.4385796090534284 | |
| GNAI1 Plasma membrane Serotonergic synapse 1.4385796090534284 | |
| GNAI1 Plasma membrane Sphingolipid signaling pathway 1.4385796090534284 | |
| GNAI1 Plasma membrane Toxoplasmosis 1.4385796090534284 | |
| GNAI1 Plasma membrane cAMP signaling pathway 1.4385796090534284 | |
| GNAI1 Plasma membrane cGMP-PKG signaling pathway 1.4385796090534284 | |
| GNAI2 Cytoskeleton Adrenergic signaling in cardiomyocytes 1.180555388854245 | |
| GNAI2 Cytoskeleton Alcoholism 1.180555388854245 | |
| GNAI2 Cytoskeleton Apelin signaling pathway 1.180555388854245 | |
| GNAI2 Cytoskeleton Axon guidance 1.180555388854245 | |
| GNAI2 Cytoskeleton Chagas disease 1.180555388854245 | |
| GNAI2 Cytoskeleton Chemical carcinogenesis - receptor activation 1.180555388854245 | |
| GNAI2 Cytoskeleton Chemokine signaling pathway 1.180555388854245 | |
| GNAI2 Cytoskeleton Cholinergic synapse 1.180555388854245 | |
| GNAI2 Cytoskeleton Circadian entrainment 1.180555388854245 | |
| GNAI2 Cytoskeleton Cocaine addiction 1.180555388854245 | |
| GNAI2 Cytoskeleton Cushing syndrome 1.180555388854245 | |
| GNAI2 Cytoskeleton Dopaminergic synapse 1.180555388854245 | |
| GNAI2 Cytoskeleton Estrogen signaling pathway 1.180555388854245 | |
| GNAI2 Cytoskeleton GABAergic synapse 1.180555388854245 | |
| GNAI2 Cytoskeleton Gap junction 1.180555388854245 | |
| GNAI2 Cytoskeleton Gastric acid secretion 1.180555388854245 | |
| GNAI2 Cytoskeleton Glutamatergic synapse 1.180555388854245 | |
| GNAI2 Cytoskeleton Growth hormone synthesis secretion and action 1.180555388854245 | |
| GNAI2 Cytoskeleton Human cytomegalovirus infection 1.180555388854245 | |
| GNAI2 Cytoskeleton Human immunodeficiency virus 1 infection 1.180555388854245 | |
| GNAI2 Cytoskeleton Leukocyte transendothelial migration 1.180555388854245 | |
| GNAI2 Cytoskeleton Long-term depression 1.180555388854245 | |
| GNAI2 Cytoskeleton Melanogenesis 1.180555388854245 | |
| GNAI2 Cytoskeleton Morphine addiction 1.180555388854245 | |
| GNAI2 Cytoskeleton Oxytocin signaling pathway 1.180555388854245 | |
| GNAI2 Cytoskeleton Parathyroid hormone synthesis secretion and action 1.180555388854245 | |
| GNAI2 Cytoskeleton Parkinson disease 1.180555388854245 | |
| GNAI2 Cytoskeleton Pathways in cancer 1.180555388854245 | |
| GNAI2 Cytoskeleton Pertussis 1.180555388854245 | |
| GNAI2 Cytoskeleton Platelet activation 1.180555388854245 | |
| GNAI2 Cytoskeleton Progesterone-mediated oocyte maturation 1.180555388854245 | |
| GNAI2 Cytoskeleton Rap1 signaling pathway 1.180555388854245 | |
| GNAI2 Cytoskeleton Regulation of lipolysis in adipocytes 1.180555388854245 | |
| GNAI2 Cytoskeleton Relaxin signaling pathway 1.180555388854245 | |
| GNAI2 Cytoskeleton Renin secretion 1.180555388854245 | |
| GNAI2 Cytoskeleton Retrograde endocannabinoid signaling 1.180555388854245 | |
| GNAI2 Cytoskeleton Serotonergic synapse 1.180555388854245 | |
| GNAI2 Cytoskeleton Sphingolipid signaling pathway 1.180555388854245 | |
| GNAI2 Cytoskeleton Toxoplasmosis 1.180555388854245 | |
| GNAI2 Cytoskeleton cAMP signaling pathway 1.180555388854245 | |
| GNAI2 Cytoskeleton cGMP-PKG signaling pathway 1.180555388854245 | |
| GNAI2 Cytosol Adrenergic signaling in cardiomyocytes 1.180555388854245 | |
| GNAI2 Cytosol Alcoholism 1.180555388854245 | |
| GNAI2 Cytosol Apelin signaling pathway 1.180555388854245 | |
| GNAI2 Cytosol Axon guidance 1.180555388854245 | |
| GNAI2 Cytosol Chagas disease 1.180555388854245 | |
| GNAI2 Cytosol Chemical carcinogenesis - receptor activation 1.180555388854245 | |
| GNAI2 Cytosol Chemokine signaling pathway 1.180555388854245 | |
| GNAI2 Cytosol Cholinergic synapse 1.180555388854245 | |
| GNAI2 Cytosol Circadian entrainment 1.180555388854245 | |
| GNAI2 Cytosol Cocaine addiction 1.180555388854245 | |
| GNAI2 Cytosol Cushing syndrome 1.180555388854245 | |
| GNAI2 Cytosol Dopaminergic synapse 1.180555388854245 | |
| GNAI2 Cytosol Estrogen signaling pathway 1.180555388854245 | |
| GNAI2 Cytosol GABAergic synapse 1.180555388854245 | |
| GNAI2 Cytosol Gap junction 1.180555388854245 | |
| GNAI2 Cytosol Gastric acid secretion 1.180555388854245 | |
| GNAI2 Cytosol Glutamatergic synapse 1.180555388854245 | |
| GNAI2 Cytosol Growth hormone synthesis secretion and action 1.180555388854245 | |
| GNAI2 Cytosol Human cytomegalovirus infection 1.180555388854245 | |
| GNAI2 Cytosol Human immunodeficiency virus 1 infection 1.180555388854245 | |
| GNAI2 Cytosol Leukocyte transendothelial migration 1.180555388854245 | |
| GNAI2 Cytosol Long-term depression 1.180555388854245 | |
| GNAI2 Cytosol Melanogenesis 1.180555388854245 | |
| GNAI2 Cytosol Morphine addiction 1.180555388854245 | |
| GNAI2 Cytosol Oxytocin signaling pathway 1.180555388854245 | |
| GNAI2 Cytosol Parathyroid hormone synthesis secretion and action 1.180555388854245 | |
| GNAI2 Cytosol Parkinson disease 1.180555388854245 | |
| GNAI2 Cytosol Pathways in cancer 1.180555388854245 | |
| GNAI2 Cytosol Pertussis 1.180555388854245 | |
| GNAI2 Cytosol Platelet activation 1.180555388854245 | |
| GNAI2 Cytosol Progesterone-mediated oocyte maturation 1.180555388854245 | |
| GNAI2 Cytosol Rap1 signaling pathway 1.180555388854245 | |
| GNAI2 Cytosol Regulation of lipolysis in adipocytes 1.180555388854245 | |
| GNAI2 Cytosol Relaxin signaling pathway 1.180555388854245 | |
| GNAI2 Cytosol Renin secretion 1.180555388854245 | |
| GNAI2 Cytosol Retrograde endocannabinoid signaling 1.180555388854245 | |
| GNAI2 Cytosol Serotonergic synapse 1.180555388854245 | |
| GNAI2 Cytosol Sphingolipid signaling pathway 1.180555388854245 | |
| GNAI2 Cytosol Toxoplasmosis 1.180555388854245 | |
| GNAI2 Cytosol cAMP signaling pathway 1.180555388854245 | |
| GNAI2 Cytosol cGMP-PKG signaling pathway 1.180555388854245 | |
| GNAI2 Nucleus Adrenergic signaling in cardiomyocytes 1.180555388854245 | |
| GNAI2 Nucleus Alcoholism 1.180555388854245 | |
| GNAI2 Nucleus Apelin signaling pathway 1.180555388854245 | |
| GNAI2 Nucleus Axon guidance 1.180555388854245 | |
| GNAI2 Nucleus Chagas disease 1.180555388854245 | |
| GNAI2 Nucleus Chemical carcinogenesis - receptor activation 1.180555388854245 | |
| GNAI2 Nucleus Chemokine signaling pathway 1.180555388854245 | |
| GNAI2 Nucleus Cholinergic synapse 1.180555388854245 | |
| GNAI2 Nucleus Circadian entrainment 1.180555388854245 | |
| GNAI2 Nucleus Cocaine addiction 1.180555388854245 | |
| GNAI2 Nucleus Cushing syndrome 1.180555388854245 | |
| GNAI2 Nucleus Dopaminergic synapse 1.180555388854245 | |
| GNAI2 Nucleus Estrogen signaling pathway 1.180555388854245 | |
| GNAI2 Nucleus GABAergic synapse 1.180555388854245 | |
| GNAI2 Nucleus Gap junction 1.180555388854245 | |
| GNAI2 Nucleus Gastric acid secretion 1.180555388854245 | |
| GNAI2 Nucleus Glutamatergic synapse 1.180555388854245 | |
| GNAI2 Nucleus Growth hormone synthesis secretion and action 1.180555388854245 | |
| GNAI2 Nucleus Human cytomegalovirus infection 1.180555388854245 | |
| GNAI2 Nucleus Human immunodeficiency virus 1 infection 1.180555388854245 | |
| GNAI2 Nucleus Leukocyte transendothelial migration 1.180555388854245 | |
| GNAI2 Nucleus Long-term depression 1.180555388854245 | |
| GNAI2 Nucleus Melanogenesis 1.180555388854245 | |
| GNAI2 Nucleus Morphine addiction 1.180555388854245 | |
| GNAI2 Nucleus Oxytocin signaling pathway 1.180555388854245 | |
| GNAI2 Nucleus Parathyroid hormone synthesis secretion and action 1.180555388854245 | |
| GNAI2 Nucleus Parkinson disease 1.180555388854245 | |
| GNAI2 Nucleus Pathways in cancer 1.180555388854245 | |
| GNAI2 Nucleus Pertussis 1.180555388854245 | |
| GNAI2 Nucleus Platelet activation 1.180555388854245 | |
| GNAI2 Nucleus Progesterone-mediated oocyte maturation 1.180555388854245 | |
| GNAI2 Nucleus Rap1 signaling pathway 1.180555388854245 | |
| GNAI2 Nucleus Regulation of lipolysis in adipocytes 1.180555388854245 | |
| GNAI2 Nucleus Relaxin signaling pathway 1.180555388854245 | |
| GNAI2 Nucleus Renin secretion 1.180555388854245 | |
| GNAI2 Nucleus Retrograde endocannabinoid signaling 1.180555388854245 | |
| GNAI2 Nucleus Serotonergic synapse 1.180555388854245 | |
| GNAI2 Nucleus Sphingolipid signaling pathway 1.180555388854245 | |
| GNAI2 Nucleus Toxoplasmosis 1.180555388854245 | |
| GNAI2 Nucleus cAMP signaling pathway 1.180555388854245 | |
| GNAI2 Nucleus cGMP-PKG signaling pathway 1.180555388854245 | |
| GNAI2 Plasma membrane Adrenergic signaling in cardiomyocytes 1.180555388854245 | |
| GNAI2 Plasma membrane Alcoholism 1.180555388854245 | |
| GNAI2 Plasma membrane Apelin signaling pathway 1.180555388854245 | |
| GNAI2 Plasma membrane Axon guidance 1.180555388854245 | |
| GNAI2 Plasma membrane Chagas disease 1.180555388854245 | |
| GNAI2 Plasma membrane Chemical carcinogenesis - receptor activation 1.180555388854245 | |
| GNAI2 Plasma membrane Chemokine signaling pathway 1.180555388854245 | |
| GNAI2 Plasma membrane Cholinergic synapse 1.180555388854245 | |
| GNAI2 Plasma membrane Circadian entrainment 1.180555388854245 | |
| GNAI2 Plasma membrane Cocaine addiction 1.180555388854245 | |
| GNAI2 Plasma membrane Cushing syndrome 1.180555388854245 | |
| GNAI2 Plasma membrane Dopaminergic synapse 1.180555388854245 | |
| GNAI2 Plasma membrane Estrogen signaling pathway 1.180555388854245 | |
| GNAI2 Plasma membrane GABAergic synapse 1.180555388854245 | |
| GNAI2 Plasma membrane Gap junction 1.180555388854245 | |
| GNAI2 Plasma membrane Gastric acid secretion 1.180555388854245 | |
| GNAI2 Plasma membrane Glutamatergic synapse 1.180555388854245 | |
| GNAI2 Plasma membrane Growth hormone synthesis secretion and action 1.180555388854245 | |
| GNAI2 Plasma membrane Human cytomegalovirus infection 1.180555388854245 | |
| GNAI2 Plasma membrane Human immunodeficiency virus 1 infection 1.180555388854245 | |
| GNAI2 Plasma membrane Leukocyte transendothelial migration 1.180555388854245 | |
| GNAI2 Plasma membrane Long-term depression 1.180555388854245 | |
| GNAI2 Plasma membrane Melanogenesis 1.180555388854245 | |
| GNAI2 Plasma membrane Morphine addiction 1.180555388854245 | |
| GNAI2 Plasma membrane Oxytocin signaling pathway 1.180555388854245 | |
| GNAI2 Plasma membrane Parathyroid hormone synthesis secretion and action 1.180555388854245 | |
| GNAI2 Plasma membrane Parkinson disease 1.180555388854245 | |
| GNAI2 Plasma membrane Pathways in cancer 1.180555388854245 | |
| GNAI2 Plasma membrane Pertussis 1.180555388854245 | |
| GNAI2 Plasma membrane Platelet activation 1.180555388854245 | |
| GNAI2 Plasma membrane Progesterone-mediated oocyte maturation 1.180555388854245 | |
| GNAI2 Plasma membrane Rap1 signaling pathway 1.180555388854245 | |
| GNAI2 Plasma membrane Regulation of lipolysis in adipocytes 1.180555388854245 | |
| GNAI2 Plasma membrane Relaxin signaling pathway 1.180555388854245 | |
| GNAI2 Plasma membrane Renin secretion 1.180555388854245 | |
| GNAI2 Plasma membrane Retrograde endocannabinoid signaling 1.180555388854245 | |
| GNAI2 Plasma membrane Serotonergic synapse 1.180555388854245 | |
| GNAI2 Plasma membrane Sphingolipid signaling pathway 1.180555388854245 | |
| GNAI2 Plasma membrane Toxoplasmosis 1.180555388854245 | |
| GNAI2 Plasma membrane cAMP signaling pathway 1.180555388854245 | |
| GNAI2 Plasma membrane cGMP-PKG signaling pathway 1.180555388854245 | |
| GNAI3 Cytoskeleton Adrenergic signaling in cardiomyocytes 1.118793092183365 | |
| GNAI3 Cytoskeleton Alcoholism 1.118793092183365 | |
| GNAI3 Cytoskeleton Apelin signaling pathway 1.118793092183365 | |
| GNAI3 Cytoskeleton Axon guidance 1.118793092183365 | |
| GNAI3 Cytoskeleton Chagas disease 1.118793092183365 | |
| GNAI3 Cytoskeleton Chemical carcinogenesis - receptor activation 1.118793092183365 | |
| GNAI3 Cytoskeleton Chemokine signaling pathway 1.118793092183365 | |
| GNAI3 Cytoskeleton Cholinergic synapse 1.118793092183365 | |
| GNAI3 Cytoskeleton Circadian entrainment 1.118793092183365 | |
| GNAI3 Cytoskeleton Cocaine addiction 1.118793092183365 | |
| GNAI3 Cytoskeleton Cushing syndrome 1.118793092183365 | |
| GNAI3 Cytoskeleton Dopaminergic synapse 1.118793092183365 | |
| GNAI3 Cytoskeleton Estrogen signaling pathway 1.118793092183365 | |
| GNAI3 Cytoskeleton GABAergic synapse 1.118793092183365 | |
| GNAI3 Cytoskeleton Gap junction 1.118793092183365 | |
| GNAI3 Cytoskeleton Gastric acid secretion 1.118793092183365 | |
| GNAI3 Cytoskeleton Glutamatergic synapse 1.118793092183365 | |
| GNAI3 Cytoskeleton Growth hormone synthesis secretion and action 1.118793092183365 | |
| GNAI3 Cytoskeleton Human cytomegalovirus infection 1.118793092183365 | |
| GNAI3 Cytoskeleton Human immunodeficiency virus 1 infection 1.118793092183365 | |
| GNAI3 Cytoskeleton Leukocyte transendothelial migration 1.118793092183365 | |
| GNAI3 Cytoskeleton Long-term depression 1.118793092183365 | |
| GNAI3 Cytoskeleton Melanogenesis 1.118793092183365 | |
| GNAI3 Cytoskeleton Morphine addiction 1.118793092183365 | |
| GNAI3 Cytoskeleton Oxytocin signaling pathway 1.118793092183365 | |
| GNAI3 Cytoskeleton Parathyroid hormone synthesis secretion and action 1.118793092183365 | |
| GNAI3 Cytoskeleton Parkinson disease 1.118793092183365 | |
| GNAI3 Cytoskeleton Pathways in cancer 1.118793092183365 | |
| GNAI3 Cytoskeleton Pertussis 1.118793092183365 | |
| GNAI3 Cytoskeleton Platelet activation 1.118793092183365 | |
| GNAI3 Cytoskeleton Progesterone-mediated oocyte maturation 1.118793092183365 | |
| GNAI3 Cytoskeleton Rap1 signaling pathway 1.118793092183365 | |
| GNAI3 Cytoskeleton Regulation of lipolysis in adipocytes 1.118793092183365 | |
| GNAI3 Cytoskeleton Relaxin signaling pathway 1.118793092183365 | |
| GNAI3 Cytoskeleton Renin secretion 1.118793092183365 | |
| GNAI3 Cytoskeleton Retrograde endocannabinoid signaling 1.118793092183365 | |
| GNAI3 Cytoskeleton Serotonergic synapse 1.118793092183365 | |
| GNAI3 Cytoskeleton Sphingolipid signaling pathway 1.118793092183365 | |
| GNAI3 Cytoskeleton Toxoplasmosis 1.118793092183365 | |
| GNAI3 Cytoskeleton cAMP signaling pathway 1.118793092183365 | |
| GNAI3 Cytoskeleton cGMP-PKG signaling pathway 1.118793092183365 | |
| GNAI3 Cytosol Adrenergic signaling in cardiomyocytes 1.118793092183365 | |
| GNAI3 Cytosol Alcoholism 1.118793092183365 | |
| GNAI3 Cytosol Apelin signaling pathway 1.118793092183365 | |
| GNAI3 Cytosol Axon guidance 1.118793092183365 | |
| GNAI3 Cytosol Chagas disease 1.118793092183365 | |
| GNAI3 Cytosol Chemical carcinogenesis - receptor activation 1.118793092183365 | |
| GNAI3 Cytosol Chemokine signaling pathway 1.118793092183365 | |
| GNAI3 Cytosol Cholinergic synapse 1.118793092183365 | |
| GNAI3 Cytosol Circadian entrainment 1.118793092183365 | |
| GNAI3 Cytosol Cocaine addiction 1.118793092183365 | |
| GNAI3 Cytosol Cushing syndrome 1.118793092183365 | |
| GNAI3 Cytosol Dopaminergic synapse 1.118793092183365 | |
| GNAI3 Cytosol Estrogen signaling pathway 1.118793092183365 | |
| GNAI3 Cytosol GABAergic synapse 1.118793092183365 | |
| GNAI3 Cytosol Gap junction 1.118793092183365 | |
| GNAI3 Cytosol Gastric acid secretion 1.118793092183365 | |
| GNAI3 Cytosol Glutamatergic synapse 1.118793092183365 | |
| GNAI3 Cytosol Growth hormone synthesis secretion and action 1.118793092183365 | |
| GNAI3 Cytosol Human cytomegalovirus infection 1.118793092183365 | |
| GNAI3 Cytosol Human immunodeficiency virus 1 infection 1.118793092183365 | |
| GNAI3 Cytosol Leukocyte transendothelial migration 1.118793092183365 | |
| GNAI3 Cytosol Long-term depression 1.118793092183365 | |
| GNAI3 Cytosol Melanogenesis 1.118793092183365 | |
| GNAI3 Cytosol Morphine addiction 1.118793092183365 | |
| GNAI3 Cytosol Oxytocin signaling pathway 1.118793092183365 | |
| GNAI3 Cytosol Parathyroid hormone synthesis secretion and action 1.118793092183365 | |
| GNAI3 Cytosol Parkinson disease 1.118793092183365 | |
| GNAI3 Cytosol Pathways in cancer 1.118793092183365 | |
| GNAI3 Cytosol Pertussis 1.118793092183365 | |
| GNAI3 Cytosol Platelet activation 1.118793092183365 | |
| GNAI3 Cytosol Progesterone-mediated oocyte maturation 1.118793092183365 | |
| GNAI3 Cytosol Rap1 signaling pathway 1.118793092183365 | |
| GNAI3 Cytosol Regulation of lipolysis in adipocytes 1.118793092183365 | |
| GNAI3 Cytosol Relaxin signaling pathway 1.118793092183365 | |
| GNAI3 Cytosol Renin secretion 1.118793092183365 | |
| GNAI3 Cytosol Retrograde endocannabinoid signaling 1.118793092183365 | |
| GNAI3 Cytosol Serotonergic synapse 1.118793092183365 | |
| GNAI3 Cytosol Sphingolipid signaling pathway 1.118793092183365 | |
| GNAI3 Cytosol Toxoplasmosis 1.118793092183365 | |
| GNAI3 Cytosol cAMP signaling pathway 1.118793092183365 | |
| GNAI3 Cytosol cGMP-PKG signaling pathway 1.118793092183365 | |
| GNAI3 Nucleus Adrenergic signaling in cardiomyocytes 1.118793092183365 | |
| GNAI3 Nucleus Alcoholism 1.118793092183365 | |
| GNAI3 Nucleus Apelin signaling pathway 1.118793092183365 | |
| GNAI3 Nucleus Axon guidance 1.118793092183365 | |
| GNAI3 Nucleus Chagas disease 1.118793092183365 | |
| GNAI3 Nucleus Chemical carcinogenesis - receptor activation 1.118793092183365 | |
| GNAI3 Nucleus Chemokine signaling pathway 1.118793092183365 | |
| GNAI3 Nucleus Cholinergic synapse 1.118793092183365 | |
| GNAI3 Nucleus Circadian entrainment 1.118793092183365 | |
| GNAI3 Nucleus Cocaine addiction 1.118793092183365 | |
| GNAI3 Nucleus Cushing syndrome 1.118793092183365 | |
| GNAI3 Nucleus Dopaminergic synapse 1.118793092183365 | |
| GNAI3 Nucleus Estrogen signaling pathway 1.118793092183365 | |
| GNAI3 Nucleus GABAergic synapse 1.118793092183365 | |
| GNAI3 Nucleus Gap junction 1.118793092183365 | |
| GNAI3 Nucleus Gastric acid secretion 1.118793092183365 | |
| GNAI3 Nucleus Glutamatergic synapse 1.118793092183365 | |
| GNAI3 Nucleus Growth hormone synthesis secretion and action 1.118793092183365 | |
| GNAI3 Nucleus Human cytomegalovirus infection 1.118793092183365 | |
| GNAI3 Nucleus Human immunodeficiency virus 1 infection 1.118793092183365 | |
| GNAI3 Nucleus Leukocyte transendothelial migration 1.118793092183365 | |
| GNAI3 Nucleus Long-term depression 1.118793092183365 | |
| GNAI3 Nucleus Melanogenesis 1.118793092183365 | |
| GNAI3 Nucleus Morphine addiction 1.118793092183365 | |
| GNAI3 Nucleus Oxytocin signaling pathway 1.118793092183365 | |
| GNAI3 Nucleus Parathyroid hormone synthesis secretion and action 1.118793092183365 | |
| GNAI3 Nucleus Parkinson disease 1.118793092183365 | |
| GNAI3 Nucleus Pathways in cancer 1.118793092183365 | |
| GNAI3 Nucleus Pertussis 1.118793092183365 | |
| GNAI3 Nucleus Platelet activation 1.118793092183365 | |
| GNAI3 Nucleus Progesterone-mediated oocyte maturation 1.118793092183365 | |
| GNAI3 Nucleus Rap1 signaling pathway 1.118793092183365 | |
| GNAI3 Nucleus Regulation of lipolysis in adipocytes 1.118793092183365 | |
| GNAI3 Nucleus Relaxin signaling pathway 1.118793092183365 | |
| GNAI3 Nucleus Renin secretion 1.118793092183365 | |
| GNAI3 Nucleus Retrograde endocannabinoid signaling 1.118793092183365 | |
| GNAI3 Nucleus Serotonergic synapse 1.118793092183365 | |
| GNAI3 Nucleus Sphingolipid signaling pathway 1.118793092183365 | |
| GNAI3 Nucleus Toxoplasmosis 1.118793092183365 | |
| GNAI3 Nucleus cAMP signaling pathway 1.118793092183365 | |
| GNAI3 Nucleus cGMP-PKG signaling pathway 1.118793092183365 | |
| GNAI3 Plasma membrane Adrenergic signaling in cardiomyocytes 1.118793092183365 | |
| GNAI3 Plasma membrane Alcoholism 1.118793092183365 | |
| GNAI3 Plasma membrane Apelin signaling pathway 1.118793092183365 | |
| GNAI3 Plasma membrane Axon guidance 1.118793092183365 | |
| GNAI3 Plasma membrane Chagas disease 1.118793092183365 | |
| GNAI3 Plasma membrane Chemical carcinogenesis - receptor activation 1.118793092183365 | |
| GNAI3 Plasma membrane Chemokine signaling pathway 1.118793092183365 | |
| GNAI3 Plasma membrane Cholinergic synapse 1.118793092183365 | |
| GNAI3 Plasma membrane Circadian entrainment 1.118793092183365 | |
| GNAI3 Plasma membrane Cocaine addiction 1.118793092183365 | |
| GNAI3 Plasma membrane Cushing syndrome 1.118793092183365 | |
| GNAI3 Plasma membrane Dopaminergic synapse 1.118793092183365 | |
| GNAI3 Plasma membrane Estrogen signaling pathway 1.118793092183365 | |
| GNAI3 Plasma membrane GABAergic synapse 1.118793092183365 | |
| GNAI3 Plasma membrane Gap junction 1.118793092183365 | |
| GNAI3 Plasma membrane Gastric acid secretion 1.118793092183365 | |
| GNAI3 Plasma membrane Glutamatergic synapse 1.118793092183365 | |
| GNAI3 Plasma membrane Growth hormone synthesis secretion and action 1.118793092183365 | |
| GNAI3 Plasma membrane Human cytomegalovirus infection 1.118793092183365 | |
| GNAI3 Plasma membrane Human immunodeficiency virus 1 infection 1.118793092183365 | |
| GNAI3 Plasma membrane Leukocyte transendothelial migration 1.118793092183365 | |
| GNAI3 Plasma membrane Long-term depression 1.118793092183365 | |
| GNAI3 Plasma membrane Melanogenesis 1.118793092183365 | |
| GNAI3 Plasma membrane Morphine addiction 1.118793092183365 | |
| GNAI3 Plasma membrane Oxytocin signaling pathway 1.118793092183365 | |
| GNAI3 Plasma membrane Parathyroid hormone synthesis secretion and action 1.118793092183365 | |
| GNAI3 Plasma membrane Parkinson disease 1.118793092183365 | |
| GNAI3 Plasma membrane Pathways in cancer 1.118793092183365 | |
| GNAI3 Plasma membrane Pertussis 1.118793092183365 | |
| GNAI3 Plasma membrane Platelet activation 1.118793092183365 | |
| GNAI3 Plasma membrane Progesterone-mediated oocyte maturation 1.118793092183365 | |
| GNAI3 Plasma membrane Rap1 signaling pathway 1.118793092183365 | |
| GNAI3 Plasma membrane Regulation of lipolysis in adipocytes 1.118793092183365 | |
| GNAI3 Plasma membrane Relaxin signaling pathway 1.118793092183365 | |
| GNAI3 Plasma membrane Renin secretion 1.118793092183365 | |
| GNAI3 Plasma membrane Retrograde endocannabinoid signaling 1.118793092183365 | |
| GNAI3 Plasma membrane Serotonergic synapse 1.118793092183365 | |
| GNAI3 Plasma membrane Sphingolipid signaling pathway 1.118793092183365 | |
| GNAI3 Plasma membrane Toxoplasmosis 1.118793092183365 | |
| GNAI3 Plasma membrane cAMP signaling pathway 1.118793092183365 | |
| GNAI3 Plasma membrane cGMP-PKG signaling pathway 1.118793092183365 | |
| GNAO1 Plasma membrane Summary 0.4980883985857251 | |
| GNAQ Cytosol Summary 0.3393607815117959 | |
| GNAQ Nucleus Summary 0.3393607815117959 | |
| GNAQ Plasma membrane Summary 0.3393607815117959 | |
| GNAS Cytosol Adrenergic signaling in cardiomyocytes 1.07734796842536 | |
| GNAS Cytosol Alcoholism 1.07734796842536 | |
| GNAS Cytosol Aldosterone synthesis and secretion 1.07734796842536 | |
| GNAS Cytosol Amoebiasis 1.07734796842536 | |
| GNAS Cytosol Amphetamine addiction 1.07734796842536 | |
| GNAS Cytosol Bile secretion 1.07734796842536 | |
| GNAS Cytosol Calcium signaling pathway 1.07734796842536 | |
| GNAS Cytosol Chagas disease 1.07734796842536 | |
| GNAS Cytosol Chemical carcinogenesis - receptor activation 1.07734796842536 | |
| GNAS Cytosol Circadian entrainment 1.07734796842536 | |
| GNAS Cytosol Cocaine addiction 1.07734796842536 | |
| GNAS Cytosol Cortisol synthesis and secretion 1.07734796842536 | |
| GNAS Cytosol Cushing syndrome 1.07734796842536 | |
| GNAS Cytosol Dilated cardiomyopathy 1.07734796842536 | |
| GNAS Cytosol Dopaminergic synapse 1.07734796842536 | |
| GNAS Cytosol Endocrine and other factor-regulated calcium reabsorption 1.07734796842536 | |
| GNAS Cytosol Endocrine resistance 1.07734796842536 | |
| GNAS Cytosol Estrogen signaling pathway 1.07734796842536 | |
| GNAS Cytosol Gap junction 1.07734796842536 | |
| GNAS Cytosol Gastric acid secretion 1.07734796842536 | |
| GNAS Cytosol Glucagon signaling pathway 1.07734796842536 | |
| GNAS Cytosol Glutamatergic synapse 1.07734796842536 | |
| GNAS Cytosol GnRH signaling pathway 1.07734796842536 | |
| GNAS Cytosol Growth hormone synthesis secretion and action 1.07734796842536 | |
| GNAS Cytosol Human cytomegalovirus infection 1.07734796842536 | |
| GNAS Cytosol Human papillomavirus infection 1.07734796842536 | |
| GNAS Cytosol Inflammatory mediator regulation of TRP channels 1.07734796842536 | |
| GNAS Cytosol Insulin secretion 1.07734796842536 | |
| GNAS Cytosol Long-term depression 1.07734796842536 | |
| GNAS Cytosol Melanogenesis 1.07734796842536 | |
| GNAS Cytosol Morphine addiction 1.07734796842536 | |
| GNAS Cytosol Ovarian steroidogenesis 1.07734796842536 | |
| GNAS Cytosol Oxytocin signaling pathway 1.07734796842536 | |
| GNAS Cytosol Pancreatic secretion 1.07734796842536 | |
| GNAS Cytosol Parathyroid hormone synthesis secretion and action 1.07734796842536 | |
| GNAS Cytosol Parkinson disease 1.07734796842536 | |
| GNAS Cytosol Pathways in cancer 1.07734796842536 | |
| GNAS Cytosol Phospholipase D signaling pathway 1.07734796842536 | |
| GNAS Cytosol Platelet activation 1.07734796842536 | |
| GNAS Cytosol Rap1 signaling pathway 1.07734796842536 | |
| GNAS Cytosol Regulation of lipolysis in adipocytes 1.07734796842536 | |
| GNAS Cytosol Relaxin signaling pathway 1.07734796842536 | |
| GNAS Cytosol Renin secretion 1.07734796842536 | |
| GNAS Cytosol Salivary secretion 1.07734796842536 | |
| GNAS Cytosol Serotonergic synapse 1.07734796842536 | |
| GNAS Cytosol Thermogenesis 1.07734796842536 | |
| GNAS Cytosol Thyroid hormone synthesis 1.07734796842536 | |
| GNAS Cytosol Vascular smooth muscle contraction 1.07734796842536 | |
| GNAS Cytosol Vasopressin-regulated water reabsorption 1.07734796842536 | |
| GNAS Cytosol Vibrio cholerae infection 1.07734796842536 | |
| GNAS Cytosol cAMP signaling pathway 1.07734796842536 | |
| GNAS Extracellular space Adrenergic signaling in cardiomyocytes 1.07734796842536 | |
| GNAS Extracellular space Alcoholism 1.07734796842536 | |
| GNAS Extracellular space Aldosterone synthesis and secretion 1.07734796842536 | |
| GNAS Extracellular space Amoebiasis 1.07734796842536 | |
| GNAS Extracellular space Amphetamine addiction 1.07734796842536 | |
| GNAS Extracellular space Bile secretion 1.07734796842536 | |
| GNAS Extracellular space Calcium signaling pathway 1.07734796842536 | |
| GNAS Extracellular space Chagas disease 1.07734796842536 | |
| GNAS Extracellular space Chemical carcinogenesis - receptor activation 1.07734796842536 | |
| GNAS Extracellular space Circadian entrainment 1.07734796842536 | |
| GNAS Extracellular space Cocaine addiction 1.07734796842536 | |
| GNAS Extracellular space Cortisol synthesis and secretion 1.07734796842536 | |
| GNAS Extracellular space Cushing syndrome 1.07734796842536 | |
| GNAS Extracellular space Dilated cardiomyopathy 1.07734796842536 | |
| GNAS Extracellular space Dopaminergic synapse 1.07734796842536 | |
| GNAS Extracellular space Endocrine and other factor-regulated calcium reabsorption 1.07734796842536 | |
| GNAS Extracellular space Endocrine resistance 1.07734796842536 | |
| GNAS Extracellular space Estrogen signaling pathway 1.07734796842536 | |
| GNAS Extracellular space Gap junction 1.07734796842536 | |
| GNAS Extracellular space Gastric acid secretion 1.07734796842536 | |
| GNAS Extracellular space Glucagon signaling pathway 1.07734796842536 | |
| GNAS Extracellular space Glutamatergic synapse 1.07734796842536 | |
| GNAS Extracellular space GnRH signaling pathway 1.07734796842536 | |
| GNAS Extracellular space Growth hormone synthesis secretion and action 1.07734796842536 | |
| GNAS Extracellular space Human cytomegalovirus infection 1.07734796842536 | |
| GNAS Extracellular space Human papillomavirus infection 1.07734796842536 | |
| GNAS Extracellular space Inflammatory mediator regulation of TRP channels 1.07734796842536 | |
| GNAS Extracellular space Insulin secretion 1.07734796842536 | |
| GNAS Extracellular space Long-term depression 1.07734796842536 | |
| GNAS Extracellular space Melanogenesis 1.07734796842536 | |
| GNAS Extracellular space Morphine addiction 1.07734796842536 | |
| GNAS Extracellular space Ovarian steroidogenesis 1.07734796842536 | |
| GNAS Extracellular space Oxytocin signaling pathway 1.07734796842536 | |
| GNAS Extracellular space Pancreatic secretion 1.07734796842536 | |
| GNAS Extracellular space Parathyroid hormone synthesis secretion and action 1.07734796842536 | |
| GNAS Extracellular space Parkinson disease 1.07734796842536 | |
| GNAS Extracellular space Pathways in cancer 1.07734796842536 | |
| GNAS Extracellular space Phospholipase D signaling pathway 1.07734796842536 | |
| GNAS Extracellular space Platelet activation 1.07734796842536 | |
| GNAS Extracellular space Rap1 signaling pathway 1.07734796842536 | |
| GNAS Extracellular space Regulation of lipolysis in adipocytes 1.07734796842536 | |
| GNAS Extracellular space Relaxin signaling pathway 1.07734796842536 | |
| GNAS Extracellular space Renin secretion 1.07734796842536 | |
| GNAS Extracellular space Salivary secretion 1.07734796842536 | |
| GNAS Extracellular space Serotonergic synapse 1.07734796842536 | |
| GNAS Extracellular space Thermogenesis 1.07734796842536 | |
| GNAS Extracellular space Thyroid hormone synthesis 1.07734796842536 | |
| GNAS Extracellular space Vascular smooth muscle contraction 1.07734796842536 | |
| GNAS Extracellular space Vasopressin-regulated water reabsorption 1.07734796842536 | |
| GNAS Extracellular space Vibrio cholerae infection 1.07734796842536 | |
| GNAS Extracellular space cAMP signaling pathway 1.07734796842536 | |
| GNAS Nucleus Adrenergic signaling in cardiomyocytes 1.07734796842536 | |
| GNAS Nucleus Alcoholism 1.07734796842536 | |
| GNAS Nucleus Aldosterone synthesis and secretion 1.07734796842536 | |
| GNAS Nucleus Amoebiasis 1.07734796842536 | |
| GNAS Nucleus Amphetamine addiction 1.07734796842536 | |
| GNAS Nucleus Bile secretion 1.07734796842536 | |
| GNAS Nucleus Calcium signaling pathway 1.07734796842536 | |
| GNAS Nucleus Chagas disease 1.07734796842536 | |
| GNAS Nucleus Chemical carcinogenesis - receptor activation 1.07734796842536 | |
| GNAS Nucleus Circadian entrainment 1.07734796842536 | |
| GNAS Nucleus Cocaine addiction 1.07734796842536 | |
| GNAS Nucleus Cortisol synthesis and secretion 1.07734796842536 | |
| GNAS Nucleus Cushing syndrome 1.07734796842536 | |
| GNAS Nucleus Dilated cardiomyopathy 1.07734796842536 | |
| GNAS Nucleus Dopaminergic synapse 1.07734796842536 | |
| GNAS Nucleus Endocrine and other factor-regulated calcium reabsorption 1.07734796842536 | |
| GNAS Nucleus Endocrine resistance 1.07734796842536 | |
| GNAS Nucleus Estrogen signaling pathway 1.07734796842536 | |
| GNAS Nucleus Gap junction 1.07734796842536 | |
| GNAS Nucleus Gastric acid secretion 1.07734796842536 | |
| GNAS Nucleus Glucagon signaling pathway 1.07734796842536 | |
| GNAS Nucleus Glutamatergic synapse 1.07734796842536 | |
| GNAS Nucleus GnRH signaling pathway 1.07734796842536 | |
| GNAS Nucleus Growth hormone synthesis secretion and action 1.07734796842536 | |
| GNAS Nucleus Human cytomegalovirus infection 1.07734796842536 | |
| GNAS Nucleus Human papillomavirus infection 1.07734796842536 | |
| GNAS Nucleus Inflammatory mediator regulation of TRP channels 1.07734796842536 | |
| GNAS Nucleus Insulin secretion 1.07734796842536 | |
| GNAS Nucleus Long-term depression 1.07734796842536 | |
| GNAS Nucleus Melanogenesis 1.07734796842536 | |
| GNAS Nucleus Morphine addiction 1.07734796842536 | |
| GNAS Nucleus Ovarian steroidogenesis 1.07734796842536 | |
| GNAS Nucleus Oxytocin signaling pathway 1.07734796842536 | |
| GNAS Nucleus Pancreatic secretion 1.07734796842536 | |
| GNAS Nucleus Parathyroid hormone synthesis secretion and action 1.07734796842536 | |
| GNAS Nucleus Parkinson disease 1.07734796842536 | |
| GNAS Nucleus Pathways in cancer 1.07734796842536 | |
| GNAS Nucleus Phospholipase D signaling pathway 1.07734796842536 | |
| GNAS Nucleus Platelet activation 1.07734796842536 | |
| GNAS Nucleus Rap1 signaling pathway 1.07734796842536 | |
| GNAS Nucleus Regulation of lipolysis in adipocytes 1.07734796842536 | |
| GNAS Nucleus Relaxin signaling pathway 1.07734796842536 | |
| GNAS Nucleus Renin secretion 1.07734796842536 | |
| GNAS Nucleus Salivary secretion 1.07734796842536 | |
| GNAS Nucleus Serotonergic synapse 1.07734796842536 | |
| GNAS Nucleus Thermogenesis 1.07734796842536 | |
| GNAS Nucleus Thyroid hormone synthesis 1.07734796842536 | |
| GNAS Nucleus Vascular smooth muscle contraction 1.07734796842536 | |
| GNAS Nucleus Vasopressin-regulated water reabsorption 1.07734796842536 | |
| GNAS Nucleus Vibrio cholerae infection 1.07734796842536 | |
| GNAS Nucleus cAMP signaling pathway 1.07734796842536 | |
| GNAS Plasma membrane Adrenergic signaling in cardiomyocytes 1.07734796842536 | |
| GNAS Plasma membrane Alcoholism 1.07734796842536 | |
| GNAS Plasma membrane Aldosterone synthesis and secretion 1.07734796842536 | |
| GNAS Plasma membrane Amoebiasis 1.07734796842536 | |
| GNAS Plasma membrane Amphetamine addiction 1.07734796842536 | |
| GNAS Plasma membrane Bile secretion 1.07734796842536 | |
| GNAS Plasma membrane Calcium signaling pathway 1.07734796842536 | |
| GNAS Plasma membrane Chagas disease 1.07734796842536 | |
| GNAS Plasma membrane Chemical carcinogenesis - receptor activation 1.07734796842536 | |
| GNAS Plasma membrane Circadian entrainment 1.07734796842536 | |
| GNAS Plasma membrane Cocaine addiction 1.07734796842536 | |
| GNAS Pla |
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
View raw
(Sorry about that, but we can’t show files that are this big right now.)
Sign up for free
to join this conversation on GitHub.
Already have an account?
Sign in to comment